Psyllid ID: psy7529

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------13
Protein Sequence
MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD
Secondary Structure (PSIPRED)
ccccccccccccccccHHHHHHHccHHHHHHHHHHcccccHHHHHHcccccccccEEEEccccccccccccccEEEEccccEEEEEccccccccccccccccHHHHHHHHHHHHHHccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccHHHHHHHHHHHHHHHHHHHHHccccccccccHHHEEEcccccEEEcccccccccccccccEEcccccccccccccHHHHHHcEEcHHHHHHHHHHHHHHHHcccccccccccHHH
Coil and Loop (DISEMBL)
mkspngsgvvtplgsyalpyiegqiPAKVCRYLKMHKSSFHRDLAARNILLASRHQakisdfglsravnsernyykathggrwpikwyapesynfgrfssasdVWSFGITLWEMYsfgqqpygemkgsd
Flexible Loop (DISEMBL)
mkspngsgvvtpLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAkisdfglsravnsernyykathggrwpikwYAPESYNFGRFSSASDVWSFGITLWEMYSfgqqpygemkgsd
Low Complexity Region (SEG)
MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD
Disordered region (IsUnstruct)
********VVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFG***********
Disordered Region (DISOPRED)
************LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE*****
Disordered Region (DISEMBL)
********VVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD
Disordered Region (DISPRO)
*******GVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK***
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	129	2.2.26 [Sep-21-2011]
P53356	757	Tyrosine-protein kinase H	N/A	N/A	0.751	0.128	0.663	7e-35
Q24145	939	Tyrosine-protein kinase s	yes	N/A	0.689	0.094	0.674	7e-33
P43404	618	Tyrosine-protein kinase Z	yes	N/A	0.759	0.158	0.595	1e-31
P43405	635	Tyrosine-protein kinase S	yes	N/A	0.736	0.149	0.614	2e-31
Q64725	629	Tyrosine-protein kinase S	no	N/A	0.736	0.151	0.614	2e-31
P48025	629	Tyrosine-protein kinase S	no	N/A	0.736	0.151	0.614	2e-31
F1N9Y5	613	Tyrosine-protein kinase S	yes	N/A	0.689	0.145	0.640	2e-31
P43403	619	Tyrosine-protein kinase Z	no	N/A	0.759	0.158	0.595	2e-31
Q00655	628	Tyrosine-protein kinase S	no	N/A	0.697	0.143	0.633	4e-31
Q9I7F7	1337	Tyrosine-protein kinase P	no	N/A	0.767	0.074	0.514	2e-24

>sp|P53356|HTK16_HYDVU Tyrosine-protein kinase HTK16 OS=Hydra vulgaris GN=HTK16 PE=2 SV=1

 Score =  145 bits (366), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 65/98 (66%), Positives = 81/98 (82%), Gaps = 1/98 (1%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL++ K   HRDLAARNILLA++ Q KISDFGLSRAV +  +YY+A  GGRWP++WYAPE
Sbjct: 598 YLEL-KRFVHRDLAARNILLANKKQVKISDFGLSRAVGTGSDYYQAKQGGRWPVRWYAPE 656

Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           S N+G FS+ SDVWS+GITLWEM++FG  PYGEM G++
Sbjct: 657 SINYGTFSTKSDVWSYGITLWEMFTFGDLPYGEMTGNE 694

May be involved in signal transduction.
Hydra vulgaris (taxid: 6087)
EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2

>sp|Q24145|SHARK_DROME Tyrosine-protein kinase shark OS=Drosophila melanogaster GN=shark PE=2 SV=2

 Score =  139 bits (349), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 60/89 (67%), Positives = 71/89 (79%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARNILL +RHQAKISDFG+SR++      Y+ T GGRWPI+WYAPES+N G FS 
Sbjct: 787 HRDLAARNILLTARHQAKISDFGMSRSLRPGSTEYQFTQGGRWPIRWYAPESFNLGIFSH 846

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ASDVWSFG+T+WEM+S G  PYGE+   D
Sbjct: 847 ASDVWSFGVTIWEMFSLGAPPYGEISNVD 875

May be involved in signal transduction on the apical surface of ectodermal epithelia regulating their polarity during invagination. Crumbs (crb) may be the intracellular signal.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|P43404|ZAP70_MOUSE Tyrosine-protein kinase ZAP-70 OS=Mus musculus GN=Zap70 PE=1 SV=3

 Score =  135 bits (339), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 59/99 (59%), Positives = 80/99 (80%), Gaps = 1/99 (1%)

Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           +YL+  K+  HRDLAARN+LL +RH AKISDFGLS+A+ ++ +YY A   G+WP+KWYAP
Sbjct: 449 KYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 507

Query: 91  ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           E  NF +FSS SDVWS+G+T+WE +S+GQ+PY +MKG +
Sbjct: 508 ECINFRKFSSRSDVWSYGVTMWEAFSYGQKPYKKMKGPE 546

Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates motility, adhesion and cytokine expression of mature T-cells, as well as thymocyte development. Contributes also to the development and activation of primary B-lymphocytes. When antigen presenting cells (APC) activate T-cell receptor (TCR), a serie of phosphorylations lead to the recruitment of ZAP70 to the doubly phosphorylated TCR component CD3Z through ITAM motif at the plasma membrane. This recruitment serves to localization to the stimulated TCR and to relieve its autoinhibited conformation. Release of ZAP70 active conformation is further stabilized by phosphorylation mediated by LCK. Subsequently, ZAP70 phosphorylates at least 2 essential adapter proteins: LAT and LCP2. In turn, a large number of signaling molecules are recruited and ultimately lead to lymphokine production, T-cell proliferation and differentiation. Furthermore, ZAP70 controls cytoskeleton modifications, adhesion and mobility of T-lymphocytes, thus ensuring correct delivery of effectors to the APC. ZAP70 is also required for TCR-CD3Z internalization and degradation through interaction with the E3 ubiquitin-protein ligase CBL and adapter proteins SLA and SLA2. Thus, ZAP70 regulates both T-cell activation switch on and switch off by modulating TCR expression at the T-cell surface. During thymocyte development, ZAP70 promotes survival and cell-cycle progression of developing thymocytes before positive selection (when cells are still CD4/CD8 double negative). Additionally, ZAP70-dependent signaling pathway may also contribute to primary B-cells formation and activation through B-cell receptor (BCR).

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|P43405|KSYK_HUMAN Tyrosine-protein kinase SYK OS=Homo sapiens GN=SYK PE=1 SV=1

 Score =  134 bits (337), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 59/96 (61%), Positives = 79/96 (82%), Gaps = 1/96 (1%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           + +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYAPE  
Sbjct: 485 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 544

Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 580

Non-receptor tyrosine kinase which mediates signal transduction downstream of a variety of transmembrane receptors including classical immunoreceptors like the B-cell receptor (BCR). Regulates several biological processes including innate and adaptive immunity, cell adhesion, osteoclast maturation, platelet activation and vascular development. Assembles into signaling complexes with activated receptors at the plasma membrane via interaction between its SH2 domains and the receptor tyrosine-phosphorylated ITAM domains. The association with the receptor can also be indirect and mediated by adapter proteins containing ITAM or partial hemITAM domains. The phosphorylation of the ITAM domains is generally mediated by SRC subfamily kinases upon engagement of the receptor. More rarely signal transduction via SYK could be ITAM-independent. Direct downstream effectors phosphorylated by SYK include VAV1, PLCG1, PI-3-kinase, LCP2 and BLNK. Initially identified as essential in B-cell receptor (BCR) signaling, it is necessary for the maturation of B-cells most probably at the pro-B to pre-B transition. Activated upon BCR engagement, it phosphorylates and activates BLNK an adapter linking the activated BCR to downstream signaling adapters and effectors. It also phosphorylates and activates PLCG1 and the PKC signaling pathway. It also phosphorylates BTK and regulates its activity in B-cell antigen receptor (BCR)-coupled signaling. Beside its function downstream of BCR plays also a role in T-cell receptor signaling. Plays also a crucial role in the innate immune response to fungal, bacterial and viral pathogens. It is for instance activated by the membrane lectin CLEC7A. Upon stimulation by fungal proteins, CLEC7A together with SYK activates immune cells inducing the production of ROS. Also activates the inflammasome and NF-kappa-B-mediated transcription of chemokines and cytokines in presence of pathogens. Regulates neutrophil degranulation and phagocytosis through activation of the MAPK signaling cascade. Also mediates the activation of dendritic cells by cell necrosis stimuli. Also involved in mast cells activation. Also functions downstream of receptors mediating cell adhesion. Relays for instance, integrin-mediated neutrophils and macrophages activation and P-selectin receptor/SELPG-mediated recruitment of leukocytes to inflammatory loci. Plays also a role in non-immune processes. It is for instance involved in vascular development where it may regulate blood and lymphatic vascular separation. It is also required for osteoclast development and function. Functions in the activation of platelets by collagen, mediating PLCG2 phosphorylation and activation. May be coupled to the collagen receptor by the ITAM domain-containing FCER1G. Also activated by the membrane lectin CLEC1B that is required for activation of platelets by PDPN/podoplanin. Involved in platelet adhesion being activated by ITGB3 engaged by fibrinogen.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q64725|KSYK_RAT Tyrosine-protein kinase SYK OS=Rattus norvegicus GN=Syk PE=1 SV=1

 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 59/96 (61%), Positives = 79/96 (82%), Gaps = 1/96 (1%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           + +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYAPE  
Sbjct: 479 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 538

Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 539 NYFKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 574

Non-receptor tyrosine kinase which mediates signal transduction downstream of a variety of transmembrane receptors including classical immunoreceptors like the B-cell receptor (BCR). Regulates several biological processes including innate and adaptive immunity, cell adhesion, osteoclast maturation, platelet activation and vascular development. Assembles into signaling complexes with activated receptors at the plasma membrane via interaction between its SH2 domains and the receptor tyrosine-phosphorylated ITAM domains. The association with the receptor can also be indirect and mediated by adapter proteins containing ITAM or partial hemITAM domains. The phosphorylation of the ITAM domains is generally mediated by SRC subfamily kinases upon engagement of the receptor. More rarely signal transduction via SYK could be ITAM-independent. Direct downstream effectors phosphorylated by SYK include VAV1, PLCG1, PI-3-kinase, LCP2 and BLNK. Initially identified as essential in B-cell receptor (BCR) signaling, it is necessary for the maturation of B-cells most probably at the pro-B to pre-B transition. Activated upon BCR engagement, it phosphorylates and activates BLNK an adapter linking the activated BCR to downstream signaling adapters and effectors. It also phosphorylates and activates PLCG1 and the PKC signaling pathway. It also phosphorylates BTK and regulates its activity in B-cell antigen receptor (BCR)-coupled signaling. Beside its function downstream of BCR plays also a role in T-cell receptor signaling. Plays also a crucial role in the innate immune response to fungal, bacterial and viral pathogens. It is for instance activated by the membrane lectin CLEC7A. Upon stimulation by fungal proteins, CLEC7A together with SYK activates immune cells inducing the production of ROS. Also activates the inflammasome and NF-kappa-B-mediated transcription of chemokines and cytokines in presence of pathogens. Regulates neutrophil degranulation and phagocytosis through activation of the MAPK signaling cascade. Also mediates the activation of dendritic cells by cell necrosis stimuli. Also involved in mast cells activation. Also functions downstream of receptors mediating cell adhesion. Relays for instance, integrin-mediated neutrophils and macrophages activation and P-selectin receptor/SELPG-mediated recruitment of leukocytes to inflammatory loci. Plays also a role in non-immune processes. It is for instance involved in vascular development where it may regulate blood and lymphatic vascular separation. It is also required for osteoclast development and function. Functions in the activation of platelets by collagen, mediating PLCG2 phosphorylation and activation. May be coupled to the collagen receptor by the ITAM domain-containing FCER1G. Also activated by the membrane lectin CLEC1B that is required for activation of platelets by PDPN/podoplanin. Involved in platelet adhesion being activated by ITGB3 engaged by fibrinogen.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|P48025|KSYK_MOUSE Tyrosine-protein kinase SYK OS=Mus musculus GN=Syk PE=1 SV=2

 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 59/96 (61%), Positives = 79/96 (82%), Gaps = 1/96 (1%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           + +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYAPE  
Sbjct: 479 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 538

Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 539 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 574

Non-receptor tyrosine kinase which mediates signal transduction downstream of a variety of transmembrane receptors including classical immunoreceptors like the B-cell receptor (BCR). Regulates several biological processes including innate and adaptive immunity, cell adhesion, osteoclast maturation, platelet activation and vascular development. Assembles into signaling complexes with activated receptors at the plasma membrane via interaction between its SH2 domains and the receptor tyrosine-phosphorylated ITAM domains. The association with the receptor can also be indirect and mediated by adapter proteins containing ITAM or partial hemITAM domains. The phosphorylation of the ITAM domains is generally mediated by SRC subfamily kinases upon engagement of the receptor. More rarely signal transduction via SYK could be ITAM-independent. Direct downstream effectors phosphorylated by SYK include VAV1, PLCG1, PI-3-kinase, LCP2 and BLNK. Initially identified as essential in B-cell receptor (BCR) signaling, it is necessary for the maturation of B-cells most probably at the pro-B to pre-B transition. Activated upon BCR engagement, it phosphorylates and activates BLNK an adapter linking the activated BCR to downstream signaling adapters and effectors. It also phosphorylates and activates PLCG1 and the PKC signaling pathway. It also phosphorylates BTK and regulates its activity in B-cell antigen receptor (BCR)-coupled signaling. Beside its function downstream of BCR plays also a role in T-cell receptor signaling. Plays also a crucial role in the innate immune response to fungal, bacterial and viral pathogens. It is for instance activated by the membrane lectin CLEC7A. Upon stimulation by fungal proteins, CLEC7A together with SYK activates immune cells inducing the production of ROS. Also activates the inflammasome and NF-kappa-B-mediated transcription of chemokines and cytokines in presence of pathogens. Regulates neutrophil degranulation and phagocytosis through activation of the MAPK signaling cascade. Also mediates the activation of dendritic cells by cell necrosis stimuli. Also involved in mast cells activation. Also functions downstream of receptors mediating cell adhesion. Relays for instance, integrin-mediated neutrophils and macrophages activation and P-selectin receptor/SELPG-mediated recruitment of leukocytes to inflammatory loci. Plays also a role in non-immune processes. It is for instance involved in vascular development where it may regulate blood and lymphatic vascular separation. It is also required for osteoclast development and function. Functions in the activation of platelets by collagen, mediating PLCG2 phosphorylation and activation. May be coupled to the collagen receptor by the ITAM domain-containing FCER1G. Also activated by the membrane lectin CLEC1B that is required for activation of platelets by PDPN/podoplanin. Involved in platelet adhesion being activated by ITGB3 engaged by fibrinogen.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|F1N9Y5|KSYK_CHICK Tyrosine-protein kinase SYK OS=Gallus gallus GN=SYK PE=1 SV=2

 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 57/89 (64%), Positives = 74/89 (83%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN+LL ++H AKISDFGLS+A++++ NYYKA   G+WP+KWYAPE  NF +FSS
Sbjct: 470 HRDLAARNVLLVTQHYAKISDFGLSKALSADENYYKAQSHGKWPVKWYAPECMNFYKFSS 529

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            SDVWSFG+ +WE +S+GQ+PY  MKG +
Sbjct: 530 KSDVWSFGVLMWEAFSYGQKPYKGMKGGE 558

Non-receptor tyrosine kinase which mediates signal transduction downstream of a variety of transmembrane receptors including classical immunoreceptors like the B-cell receptor (BCR). Regulates several biological processes including innate and adaptive immunity, cell adhesion, osteoclast maturation, platelet activation and vascular development. Assembles into signaling complexes with activated receptors at the plasma membrane via interaction between its SH2 domains and the receptor tyrosine-phosphorylated ITAM domains. The association with the receptor can also be indirect and mediated by adapter proteins containing ITAM or partial hemITAM domains. The phosphorylation of the ITAM domains is generally mediated by SRC subfamily kinases upon engagement of the receptor. More rarely signal transduction via SYK could be ITAM-independent. Direct downstream effectors phosphorylated by SYK include VAV1, PLCG1, PI-3-kinase, LCP2 and BLNK. Initially identified as essential in B-cell receptor (BCR) signaling, it is necessary for the maturation of B-cells most probably at the pro-B to pre-B transition. Activated upon BCR engagement, it phosphorylates and activates BLNK an adapter linking the activated BCR to downstream signaling adapters and effectors.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|P43403|ZAP70_HUMAN Tyrosine-protein kinase ZAP-70 OS=Homo sapiens GN=ZAP70 PE=1 SV=1

 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 59/99 (59%), Positives = 79/99 (79%), Gaps = 1/99 (1%)

Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           +YL+  K+  HRDLAARN+LL +RH AKISDFGLS+A+ ++ +YY A   G+WP+KWYAP
Sbjct: 450 KYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508

Query: 91  ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           E  NF +FSS SDVWS+G+T+WE  S+GQ+PY +MKG +
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates motility, adhesion and cytokine expression of mature T-cells, as well as thymocyte development. Contributes also to the development and activation of primary B-lymphocytes. When antigen presenting cells (APC) activate T-cell receptor (TCR), a serie of phosphorylations lead to the recruitment of ZAP70 to the doubly phosphorylated TCR component CD247/CD3Z through ITAM motif at the plasma membrane. This recruitment serves to localization to the stimulated TCR and to relieve its autoinhibited conformation. Release of ZAP70 active conformation is further stabilized by phosphorylation mediated by LCK. Subsequently, ZAP70 phosphorylates at least 2 essential adapter proteins: LAT and LCP2. In turn, a large number of signaling molecules are recruited and ultimately lead to lymphokine production, T-cell proliferation and differentiation. Furthermore, ZAP70 controls cytoskeleton modifications, adhesion and mobility of T-lymphocytes, thus ensuring correct delivery of effectors to the APC. ZAP70 is also required for TCR-CD247/CD3Z internalization and degradation through interaction with the E3 ubiquitin-protein ligase CBL and adapter proteins SLA and SLA2. Thus, ZAP70 regulates both T-cell activation switch on and switch off by modulating TCR expression at the T-cell surface. During thymocyte development, ZAP70 promotes survival and cell-cycle progression of developing thymocytes before positive selection (when cells are still CD4/CD8 double negative). Additionally, ZAP70-dependent signaling pathway may also contribute to primary B-cells formation and activation through B-cell receptor (BCR).

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q00655|KSYK_PIG Tyrosine-protein kinase SYK OS=Sus scrofa GN=SYK PE=1 SV=1

 Score =  133 bits (334), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 57/90 (63%), Positives = 74/90 (82%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYAPE  N+ +FS
Sbjct: 484 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 543

Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           S SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 544 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 573

Non-receptor tyrosine kinase which mediates signal transduction downstream of a variety of transmembrane receptors including classical immunoreceptors like the B-cell receptor (BCR). Regulates several biological processes including innate and adaptive immunity, cell adhesion, osteoclast maturation, platelet activation and vascular development. Assembles into signaling complexes with activated receptors at the plasma membrane via interaction between its SH2 domains and the receptor tyrosine-phosphorylated ITAM domains. The association with the receptor can also be indirect and mediated by adapter proteins containing ITAM or partial hemITAM domains. The phosphorylation of the ITAM domains is generally mediated by SRC subfamily kinases upon engagement of the receptor. More rarely signal transduction via SYK could be ITAM-independent. Direct downstream effectors phosphorylated by SYK include VAV1, PLCG1, PI-3-kinase, LCP2 and BLNK. Initially identified as essential in B-cell receptor (BCR) signaling, it is necessary for the maturation of B-cells most probably at the pro-B to pre-B transition. Activated upon BCR engagement, it phosphorylates and activates BLNK an adapter linking the activated BCR to downstream signaling adapters and effectors. It also phosphorylates and activates PLCG1 and the PKC signaling pathway. It also phosphorylates BTK and regulates its activity in B-cell antigen receptor (BCR)-coupled signaling. Beside its function downstream of BCR plays also a role in T-cell receptor signaling. Plays also a crucial role in the innate immune response to fungal, bacterial and viral pathogens. It is for instance activated by the membrane lectin CLEC7A. Upon stimulation by fungal proteins, CLEC7A together with SYK activates immune cells inducing the production of ROS. Also activates the inflammasome and NF-kappa-B-mediated transcription of chemokines and cytokines in presence of pathogens. Regulates neutrophil degranulation and phagocytosis through activation of the MAPK signaling cascade. Also mediates the activation of dendritic cells by cell necrosis stimuli. Also involved in mast cells activation. Also functions downstream of receptors mediating cell adhesion. Relays for instance, integrin-mediated neutrophils and macrophages activation and P-selectin receptor/SELPG-mediated recruitment of leukocytes to inflammatory loci. Plays also a role in non-immune processes. It is for instance involved in vascular development where it may regulate blood and lymphatic vascular separation. It is also required for osteoclast development and function. Functions in the activation of platelets by collagen, mediating PLCG2 phosphorylation and activation. May be coupled to the collagen receptor by the ITAM domain-containing FCER1G. Also activated by the membrane lectin CLEC1B that is required for activation of platelets by PDPN/podoplanin. Involved in platelet adhesion being activated by ITGB3 engaged by fibrinogen.

Sus scrofa (taxid: 9823)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q9I7F7|PR2_DROME Tyrosine-protein kinase PR2 OS=Drosophila melanogaster GN=PR2 PE=1 SV=3

 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 54/105 (51%), Positives = 73/105 (69%), Gaps = 6/105 (5%)

Query: 28  KVC---RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG--R 82
           ++C   RYL+  K   HRDLAARNIL+ S+ + KISDFGLSRA+   ++YYK       +
Sbjct: 243 QICNGMRYLE-QKRLIHRDLAARNILVFSKDKVKISDFGLSRALGVGKDYYKTNFNVNLK 301

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG 127
            PI W APE  N+ RF++ASDVW+FG+ LWEM+S+G QP+  + G
Sbjct: 302 LPIAWCAPECINYLRFTNASDVWAFGVCLWEMFSYGFQPWAALTG 346

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	129
242021094	751	tyrosine-protein kinase shark, putative	0.689	0.118	0.842	1e-39
328725832	686	PREDICTED: tyrosine-protein kinase shark	0.906	0.170	0.652	7e-39
357606474	775	putative tyrosine-protein kinase shark [	0.682	0.113	0.772	4e-36
91093897	725	PREDICTED: similar to protein-tyrosine k	0.697	0.124	0.744	5e-36
321461573	586	hypothetical protein DAPPUDRAFT_110578 [	0.868	0.191	0.614	3e-35
157119639	939	tyrosine-protein kinase shark [Aedes aeg	0.759	0.104	0.696	4e-35
291233905	767	PREDICTED: Tyrosine-protein kinase HTK16	0.689	0.116	0.775	6e-35
156553385	739	PREDICTED: tyrosine-protein kinase shark	0.689	0.120	0.755	1e-34
170052532	1063	tyrosine-protein kinase shark [Culex qui	0.759	0.092	0.686	2e-34
260796603	291	hypothetical protein BRAFLDRAFT_83841 [B	0.720	0.319	0.709	1e-33

>gi|242021094|ref|XP_002430981.1| tyrosine-protein kinase shark, putative [Pediculus humanus corporis] gi|212516205|gb|EEB18243.1| tyrosine-protein kinase shark, putative [Pediculus humanus corporis]

 Score =  167 bits (424), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 75/89 (84%), Positives = 83/89 (93%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARNILL+SRHQAKISDFGLSR ++S+  YYKAT GGRWPIKWYAPES+NFG FS 
Sbjct: 598 HRDLAARNILLSSRHQAKISDFGLSRVISSDSQYYKATVGGRWPIKWYAPESFNFGTFSH 657

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ASDVWSFGITLWEM+SFGQQPYG+MKGS+
Sbjct: 658 ASDVWSFGITLWEMFSFGQQPYGDMKGSE 686

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328725832|ref|XP_003248633.1| PREDICTED: tyrosine-protein kinase shark-like [Acyrthosiphon pisum]

 Score =  165 bits (417), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 79/121 (65%), Positives = 97/121 (80%), Gaps = 4/121 (3%)

Query: 9   VVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAV 68
           +++P  +Y L     QI + +C YL+  K   HRDLAARNILLA RHQAKISDFGLSR +
Sbjct: 509 LISP--NYELKMWAAQIASGMC-YLE-QKRFVHRDLAARNILLADRHQAKISDFGLSRTL 564

Query: 69  NSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS 128
           N +++YY+A+HGGRWPIKWYAPES N+G FSSASDVWS+GITLWEM+S+GQQPY  MKG 
Sbjct: 565 NVDKDYYRASHGGRWPIKWYAPESCNYGTFSSASDVWSYGITLWEMFSYGQQPYENMKGV 624

Query: 129 D 129
           +
Sbjct: 625 E 625

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|357606474|gb|EHJ65085.1| putative tyrosine-protein kinase shark [Danaus plexippus]

 Score =  155 bits (393), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 68/88 (77%), Positives = 81/88 (92%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARNILLA+RHQAKISDFGLSRA++S+ +YYKA+ GG+WPIKWYAPESYN+G FS
Sbjct: 619 VHRDLAARNILLATRHQAKISDFGLSRALSSDSSYYKASRGGKWPIKWYAPESYNYGTFS 678

Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKG 127
             SDVWS+G+TLWEM+S G+QPYGEM+G
Sbjct: 679 HKSDVWSYGVTLWEMFSGGKQPYGEMRG 706

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|91093897|ref|XP_969153.1| PREDICTED: similar to protein-tyrosine kinase [Tribolium castaneum] gi|270014537|gb|EFA10985.1| hypothetical protein TcasGA2_TC004153 [Tribolium castaneum]

 Score =  155 bits (392), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 67/90 (74%), Positives = 79/90 (87%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARNILLAS+HQAKISDFGLSRA+ ++  YY+A  GG+WP+KWYAPESYN+G+FS
Sbjct: 571 IHRDLAARNILLASQHQAKISDFGLSRALAADHEYYRALQGGKWPLKWYAPESYNYGQFS 630

Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             SDVWSFG+ +WEMYSFG  PYGE+KGSD
Sbjct: 631 HKSDVWSFGVAIWEMYSFGDVPYGELKGSD 660

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|321461573|gb|EFX72604.1| hypothetical protein DAPPUDRAFT_110578 [Daphnia pulex]

 Score =  152 bits (385), Expect = 3e-35,   Method: Composition-based stats.
 Identities = 70/114 (61%), Positives = 87/114 (76%), Gaps = 2/114 (1%)

Query: 16  YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY 75
           +  P   GQI A    YL+  ++  HRDLAARNILLA+R+QAKISDFGLSR + +  ++Y
Sbjct: 391 FEFPLWAGQI-ADGMLYLE-QRNFVHRDLAARNILLATRYQAKISDFGLSRVLGAGESFY 448

Query: 76  KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            A+ GGRWP+KWYAPES N G FS ASDVWS+G+TLWE YSFG QPYG+M G++
Sbjct: 449 SASKGGRWPVKWYAPESINCGMFSHASDVWSYGVTLWETYSFGTQPYGDMSGAE 502

Source: Daphnia pulex

Species: Daphnia pulex

Genus: Daphnia

Family: Daphniidae

Order: Diplostraca

Class: Branchiopoda

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|157119639|ref|XP_001653430.1| tyrosine-protein kinase shark [Aedes aegypti] gi|108875239|gb|EAT39464.1| AAEL008732-PA [Aedes aegypti]

 Score =  152 bits (385), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 69/99 (69%), Positives = 83/99 (83%), Gaps = 1/99 (1%)

Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           +YL+ H    HRDLAARNILLASR+QAKISDFGLSRA+ +  +YY+A+ GG+WPIKWYAP
Sbjct: 773 QYLEQHHF-VHRDLAARNILLASRNQAKISDFGLSRAIGAGDDYYRASQGGKWPIKWYAP 831

Query: 91  ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ES+N+G FS ASDVWSFG+T+WEMYS G  PY +MKG D
Sbjct: 832 ESFNYGTFSHASDVWSFGVTMWEMYSLGAPPYQDMKGVD 870

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|291233905|ref|XP_002736895.1| PREDICTED: Tyrosine-protein kinase HTK16-like [Saccoglossus kowalevskii]

 Score =  152 bits (383), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 69/89 (77%), Positives = 75/89 (84%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLA RNILLA R +AKISDFGLSRAV    NYYKA+ GGRWP+KWYAPES  FG FS 
Sbjct: 606 HRDLATRNILLADRTKAKISDFGLSRAVGKNSNYYKASAGGRWPVKWYAPESIYFGTFSH 665

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ASDVWS+G+TLWEMYSFG QPYGEMKG +
Sbjct: 666 ASDVWSYGVTLWEMYSFGDQPYGEMKGVE 694

Source: Saccoglossus kowalevskii

Species: Saccoglossus kowalevskii

Genus: Saccoglossus

Family: Harrimaniidae

Class: Enteropneusta

Phylum: Hemichordata

Superkingdom: Eukaryota

>gi|156553385|ref|XP_001602126.1| PREDICTED: tyrosine-protein kinase shark-like [Nasonia vitripennis]

 Score =  150 bits (379), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 68/90 (75%), Positives = 80/90 (88%), Gaps = 1/90 (1%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARNILLAS+HQAKISDFGLSR   S  +YYKAT GG+WPIKWYAPESYN+G FS
Sbjct: 586 VHRDLAARNILLASKHQAKISDFGLSRTFGS-NDYYKATAGGKWPIKWYAPESYNYGTFS 644

Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            ASDVWS+GITLWEM+S+G+QPYG+ +G++
Sbjct: 645 HASDVWSYGITLWEMFSYGEQPYGDRRGTE 674

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|170052532|ref|XP_001862264.1| tyrosine-protein kinase shark [Culex quinquefasciatus] gi|167873419|gb|EDS36802.1| tyrosine-protein kinase shark [Culex quinquefasciatus]

 Score =  149 bits (377), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 68/99 (68%), Positives = 82/99 (82%), Gaps = 1/99 (1%)

Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           +YL+ H    HRDLAARNILLASR QAKISDFGLSRA+ +  +YY+A+ GG+WPIKWYAP
Sbjct: 897 QYLEQHHF-VHRDLAARNILLASRFQAKISDFGLSRAIGAGDDYYRASQGGKWPIKWYAP 955

Query: 91  ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ES+N+G FS ASDVWSFG+T+WEM+S G  PY +MKG D
Sbjct: 956 ESFNYGTFSHASDVWSFGVTMWEMFSLGAPPYHDMKGVD 994

Source: Culex quinquefasciatus

Species: Culex quinquefasciatus

Genus: Culex

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|260796603|ref|XP_002593294.1| hypothetical protein BRAFLDRAFT_83841 [Branchiostoma floridae] gi|229278518|gb|EEN49305.1| hypothetical protein BRAFLDRAFT_83841 [Branchiostoma floridae]

 Score =  147 bits (372), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 66/93 (70%), Positives = 78/93 (83%)

Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            K   HRDLAARNILLA + Q KISDFGLSRAV +  +YYKA+ GGRWP+KWYAPES N+
Sbjct: 137 EKRFVHRDLAARNILLACKDQLKISDFGLSRAVGAGSDYYKASAGGRWPVKWYAPESINY 196

Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS 128
           G FS ASDVWS+G+TLWEM+S+GQQPYG+M G+
Sbjct: 197 GTFSHASDVWSYGVTLWEMFSYGQQPYGDMTGA 229

Source: Branchiostoma floridae

Species: Branchiostoma floridae

Genus: Branchiostoma

Family: Branchiostomidae

Phylum: Chordata

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	129
UNIPROTKB|F1PJS1	457	ZAP70 "Uncharacterized protein	0.759	0.214	0.595	6e-32
RGD|3983	614	Zap70 "zeta-chain (TCR) associ	0.759	0.159	0.595	6.9e-31
UNIPROTKB|K7GRK6	615	LOC100739325 "Tyrosine-protein	0.759	0.159	0.595	6.9e-31
UNIPROTKB|E1BMP9	617	ZAP70 "Tyrosine-protein kinase	0.759	0.158	0.595	7e-31
UNIPROTKB|F1STD6	618	LOC100739325 "Tyrosine-protein	0.759	0.158	0.595	7.1e-31
MGI|MGI:99613	618	Zap70 "zeta-chain (TCR) associ	0.759	0.158	0.595	7.1e-31
UNIPROTKB|F1LSS5	618	Zap70 "Tyrosine-protein kinase	0.759	0.158	0.595	7.1e-31
MGI|MGI:99515	629	Syk "spleen tyrosine kinase" [	0.751	0.154	0.61	7.6e-31
RGD|3796	629	Syk "spleen tyrosine kinase" [	0.751	0.154	0.61	7.6e-31
UNIPROTKB|G3V7N4	629	Syk "Tyrosine-protein kinase"	0.751	0.154	0.61	7.6e-31

UNIPROTKB|F1PJS1 ZAP70 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 350 (128.3 bits), Expect = 6.0e-32, P = 6.0e-32
 Identities = 59/99 (59%), Positives = 81/99 (81%)

Query:    31 RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
             +YL+  K+  HRDLAARN+LL +RH AKISDFGLS+A+ ++ +YY A   G+WP+KWYAP
Sbjct:   288 KYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 346

Query:    91 ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             E +NF +FSS SDVWS+G+T+WE +S+GQ+PY +MKG +
Sbjct:   347 ECFNFRKFSSRSDVWSYGVTMWEAFSYGQKPYKKMKGPE 385

GO:0050852 "T cell receptor signaling pathway" evidence=IEA

GO:0050850 "positive regulation of calcium-mediated signaling" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0046641 "positive regulation of alpha-beta T cell proliferation" evidence=IEA

GO:0046638 "positive regulation of alpha-beta T cell differentiation" evidence=IEA

GO:0045060 "negative thymic T cell selection" evidence=IEA

GO:0045059 "positive thymic T cell selection" evidence=IEA

GO:0043366 "beta selection" evidence=IEA

GO:0042101 "T cell receptor complex" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IEA

GO:0006955 "immune response" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0001784 "phosphotyrosine binding" evidence=IEA

GO:0001772 "immunological synapse" evidence=IEA

RGD|3983 Zap70 "zeta-chain (TCR) associated protein kinase 70" [Rattus norvegicus (taxid:10116)]

 Score = 346 (126.9 bits), Expect = 6.9e-31, P = 6.9e-31
 Identities = 59/99 (59%), Positives = 80/99 (80%)

Query:    31 RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
             +YL+  K+  HRDLAARN+LL +RH AKISDFGLS+A+ ++ +YY A   G+WP+KWYAP
Sbjct:   445 KYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 503

Query:    91 ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             E  NF +FSS SDVWS+G+T+WE +S+GQ+PY +MKG +
Sbjct:   504 ECINFRKFSSRSDVWSYGVTMWEAFSYGQKPYKKMKGPE 542

GO:0001772 "immunological synapse" evidence=ISO

GO:0001784 "phosphotyrosine binding" evidence=ISO

GO:0003674 "molecular_function" evidence=ND

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004713 "protein tyrosine kinase activity" evidence=ISO

GO:0005524 "ATP binding" evidence=ISO

GO:0005575 "cellular_component" evidence=ND

GO:0005737 "cytoplasm" evidence=ISO

GO:0005829 "cytosol" evidence=ISO

GO:0005886 "plasma membrane" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0006955 "immune response" evidence=ISO

GO:0008150 "biological_process" evidence=ND

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=ISO

GO:0035556 "intracellular signal transduction" evidence=ISO

GO:0042101 "T cell receptor complex" evidence=ISO

GO:0043366 "beta selection" evidence=ISO

GO:0045059 "positive thymic T cell selection" evidence=ISO

GO:0045060 "negative thymic T cell selection" evidence=ISO

GO:0045061 "thymic T cell selection" evidence=ISO

GO:0045582 "positive regulation of T cell differentiation" evidence=ISO

GO:0046638 "positive regulation of alpha-beta T cell differentiation" evidence=ISO

GO:0046641 "positive regulation of alpha-beta T cell proliferation" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=ISO

GO:0050850 "positive regulation of calcium-mediated signaling" evidence=ISO

GO:0050852 "T cell receptor signaling pathway" evidence=ISO

UNIPROTKB|K7GRK6 LOC100739325 "Tyrosine-protein kinase" [Sus scrofa (taxid:9823)]

 Score = 346 (126.9 bits), Expect = 6.9e-31, P = 6.9e-31
 Identities = 59/99 (59%), Positives = 80/99 (80%)

Query:    31 RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
             +YL+  K+  HRDLAARN+LL +RH AKISDFGLS+A+ ++ +YY A   G+WP+KWYAP
Sbjct:   448 KYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 506

Query:    91 ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             E  NF +FSS SDVWS+G+T+WE +S+GQ+PY +MKG +
Sbjct:   507 ECINFRKFSSRSDVWSYGVTMWEAFSYGQKPYKKMKGPE 545

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

UNIPROTKB|E1BMP9 ZAP70 "Tyrosine-protein kinase" [Bos taurus (taxid:9913)]

 Score = 346 (126.9 bits), Expect = 7.0e-31, P = 7.0e-31
 Identities = 59/99 (59%), Positives = 80/99 (80%)

Query:    31 RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
             +YL+  K+  HRDLAARN+LL +RH AKISDFGLS+A+ ++ +YY A   G+WP+KWYAP
Sbjct:   448 KYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 506

Query:    91 ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             E  NF +FSS SDVWS+G+T+WE +S+GQ+PY +MKG +
Sbjct:   507 ECINFRKFSSRSDVWSYGVTMWEAFSYGQKPYKKMKGPE 545

GO:0050852 "T cell receptor signaling pathway" evidence=IEA

GO:0050850 "positive regulation of calcium-mediated signaling" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0046641 "positive regulation of alpha-beta T cell proliferation" evidence=IEA

GO:0046638 "positive regulation of alpha-beta T cell differentiation" evidence=IEA

GO:0045060 "negative thymic T cell selection" evidence=IEA

GO:0045059 "positive thymic T cell selection" evidence=IEA

GO:0043366 "beta selection" evidence=IEA

GO:0042101 "T cell receptor complex" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IEA

GO:0006955 "immune response" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0001784 "phosphotyrosine binding" evidence=IEA

GO:0001772 "immunological synapse" evidence=IEA

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=IEA

UNIPROTKB|F1STD6 LOC100739325 "Tyrosine-protein kinase" [Sus scrofa (taxid:9823)]

 Score = 346 (126.9 bits), Expect = 7.1e-31, P = 7.1e-31
 Identities = 59/99 (59%), Positives = 80/99 (80%)

Query:    31 RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
             +YL+  K+  HRDLAARN+LL +RH AKISDFGLS+A+ ++ +YY A   G+WP+KWYAP
Sbjct:   451 KYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 509

Query:    91 ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             E  NF +FSS SDVWS+G+T+WE +S+GQ+PY +MKG +
Sbjct:   510 ECINFRKFSSRSDVWSYGVTMWEAFSYGQKPYKKMKGPE 548

GO:0050852 "T cell receptor signaling pathway" evidence=IEA

GO:0050850 "positive regulation of calcium-mediated signaling" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0046641 "positive regulation of alpha-beta T cell proliferation" evidence=IEA

GO:0046638 "positive regulation of alpha-beta T cell differentiation" evidence=IEA

GO:0045060 "negative thymic T cell selection" evidence=IEA

GO:0045059 "positive thymic T cell selection" evidence=IEA

GO:0043366 "beta selection" evidence=IEA

GO:0042101 "T cell receptor complex" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IEA

GO:0006955 "immune response" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0001784 "phosphotyrosine binding" evidence=IEA

GO:0001772 "immunological synapse" evidence=IEA

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=IEA

MGI|MGI:99613 Zap70 "zeta-chain (TCR) associated protein kinase" [Mus musculus (taxid:10090)]

 Score = 346 (126.9 bits), Expect = 7.1e-31, P = 7.1e-31
 Identities = 59/99 (59%), Positives = 80/99 (80%)

Query:    31 RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
             +YL+  K+  HRDLAARN+LL +RH AKISDFGLS+A+ ++ +YY A   G+WP+KWYAP
Sbjct:   449 KYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 507

Query:    91 ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             E  NF +FSS SDVWS+G+T+WE +S+GQ+PY +MKG +
Sbjct:   508 ECINFRKFSSRSDVWSYGVTMWEAFSYGQKPYKKMKGPE 546

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001772 "immunological synapse" evidence=IDA

GO:0001784 "phosphotyrosine binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0004713 "protein tyrosine kinase activity" evidence=ISO;IMP;IDA

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;IDA

GO:0006955 "immune response" evidence=ISO

GO:0016020 "membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=ISO;IMP;IDA

GO:0035556 "intracellular signal transduction" evidence=IMP

GO:0042101 "T cell receptor complex" evidence=ISO

GO:0043366 "beta selection" evidence=IGI

GO:0045059 "positive thymic T cell selection" evidence=ISO;IMP

GO:0045060 "negative thymic T cell selection" evidence=IMP

GO:0045061 "thymic T cell selection" evidence=IMP

GO:0045582 "positive regulation of T cell differentiation" evidence=ISO;IMP

GO:0046638 "positive regulation of alpha-beta T cell differentiation" evidence=IGI;IMP

GO:0046641 "positive regulation of alpha-beta T cell proliferation" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IMP;IDA

GO:0050850 "positive regulation of calcium-mediated signaling" evidence=IMP

GO:0050852 "T cell receptor signaling pathway" evidence=IMP

UNIPROTKB|F1LSS5 Zap70 "Tyrosine-protein kinase" [Rattus norvegicus (taxid:10116)]

 Score = 346 (126.9 bits), Expect = 7.1e-31, P = 7.1e-31
 Identities = 59/99 (59%), Positives = 80/99 (80%)

Query:    31 RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
             +YL+  K+  HRDLAARN+LL +RH AKISDFGLS+A+ ++ +YY A   G+WP+KWYAP
Sbjct:   449 KYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 507

Query:    91 ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             E  NF +FSS SDVWS+G+T+WE +S+GQ+PY +MKG +
Sbjct:   508 ECINFRKFSSRSDVWSYGVTMWEAFSYGQKPYKKMKGPE 546

GO:0001772 "immunological synapse" evidence=IEA

GO:0001784 "phosphotyrosine binding" evidence=IEA

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0006955 "immune response" evidence=IEA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0042101 "T cell receptor complex" evidence=IEA

GO:0043366 "beta selection" evidence=IEA

GO:0045059 "positive thymic T cell selection" evidence=IEA

GO:0045060 "negative thymic T cell selection" evidence=IEA

GO:0046638 "positive regulation of alpha-beta T cell differentiation" evidence=IEA

GO:0046641 "positive regulation of alpha-beta T cell proliferation" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0050850 "positive regulation of calcium-mediated signaling" evidence=IEA

GO:0050852 "T cell receptor signaling pathway" evidence=IEA

MGI|MGI:99515 Syk "spleen tyrosine kinase" [Mus musculus (taxid:10090)]

 Score = 346 (126.9 bits), Expect = 7.6e-31, P = 7.6e-31
 Identities = 61/100 (61%), Positives = 82/100 (82%)

Query:    31 RYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYA 89
             +YL+  +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYA
Sbjct:   477 KYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 534

Query:    90 PESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             PE  N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct:   535 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 574

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000187 "activation of MAPK activity" evidence=IMP;IDA

GO:0001525 "angiogenesis" evidence=IEA

GO:0001820 "serotonin secretion" evidence=IMP

GO:0001945 "lymph vessel development" evidence=IMP

GO:0002281 "macrophage activation involved in immune response" evidence=IMP

GO:0002283 "neutrophil activation involved in immune response" evidence=IMP

GO:0002366 "leukocyte activation involved in immune response" evidence=IMP

GO:0002554 "serotonin secretion by platelet" evidence=IMP

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004713 "protein tyrosine kinase activity" evidence=IMP;IDA

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=ISO;IDA

GO:0004716 "receptor signaling protein tyrosine kinase activity" evidence=IDA

GO:0005178 "integrin binding" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IDA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007159 "leukocyte cell-cell adhesion" evidence=ISO

GO:0007166 "cell surface receptor signaling pathway" evidence=IDA;IMP

GO:0007167 "enzyme linked receptor protein signaling pathway" evidence=IDA

GO:0007186 "G-protein coupled receptor signaling pathway" evidence=TAS

GO:0007229 "integrin-mediated signaling pathway" evidence=IMP

GO:0007257 "activation of JUN kinase activity" evidence=IMP

GO:0010543 "regulation of platelet activation" evidence=IMP

GO:0016020 "membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IMP;IDA

GO:0019370 "leukotriene biosynthetic process" evidence=IMP

GO:0019815 "B cell receptor complex" evidence=IDA

GO:0019901 "protein kinase binding" evidence=IPI

GO:0019904 "protein domain specific binding" evidence=ISO

GO:0030593 "neutrophil chemotaxis" evidence=ISO

GO:0031410 "cytoplasmic vesicle" evidence=IEA

GO:0032009 "early phagosome" evidence=IDA

GO:0032928 "regulation of superoxide anion generation" evidence=IMP

GO:0033630 "positive regulation of cell adhesion mediated by integrin" evidence=IMP

GO:0035556 "intracellular signal transduction" evidence=IMP;IDA

GO:0042101 "T cell receptor complex" evidence=ISO

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0043234 "protein complex" evidence=IDA

GO:0043306 "positive regulation of mast cell degranulation" evidence=ISO;IMP

GO:0043313 "regulation of neutrophil degranulation" evidence=IMP

GO:0043366 "beta selection" evidence=IGI

GO:0045087 "innate immune response" evidence=IMP

GO:0045401 "positive regulation of interleukin-3 biosynthetic process" evidence=IMP

GO:0045425 "positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process" evidence=IMP

GO:0045579 "positive regulation of B cell differentiation" evidence=IMP

GO:0045588 "positive regulation of gamma-delta T cell differentiation" evidence=IMP

GO:0045780 "positive regulation of bone resorption" evidence=IMP

GO:0046638 "positive regulation of alpha-beta T cell differentiation" evidence=IGI

GO:0046641 "positive regulation of alpha-beta T cell proliferation" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=ISO;IDA

GO:0048514 "blood vessel morphogenesis" evidence=IMP

GO:0050715 "positive regulation of cytokine secretion" evidence=IGI

GO:0050731 "positive regulation of peptidyl-tyrosine phosphorylation" evidence=IMP

GO:0050764 "regulation of phagocytosis" evidence=IMP

GO:0050776 "regulation of immune response" evidence=ISO

GO:0050850 "positive regulation of calcium-mediated signaling" evidence=IMP

GO:0050853 "B cell receptor signaling pathway" evidence=IDA

GO:0070372 "regulation of ERK1 and ERK2 cascade" evidence=IMP

GO:0071226 "cellular response to molecule of fungal origin" evidence=IMP

GO:0090237 "regulation of arachidonic acid secretion" evidence=IMP

GO:0090330 "regulation of platelet aggregation" evidence=IMP

RGD|3796 Syk "spleen tyrosine kinase" [Rattus norvegicus (taxid:10116)]

 Score = 346 (126.9 bits), Expect = 7.6e-31, P = 7.6e-31
 Identities = 61/100 (61%), Positives = 82/100 (82%)

Query:    31 RYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYA 89
             +YL+  +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYA
Sbjct:   477 KYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 534

Query:    90 PESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             PE  N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct:   535 PECINYFKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 574

GO:0000187 "activation of MAPK activity" evidence=ISO

GO:0001525 "angiogenesis" evidence=IEA

GO:0001820 "serotonin secretion" evidence=ISO

GO:0001945 "lymph vessel development" evidence=ISO;ISS

GO:0002250 "adaptive immune response" evidence=ISS

GO:0002281 "macrophage activation involved in immune response" evidence=ISO;ISS

GO:0002283 "neutrophil activation involved in immune response" evidence=ISO;ISS

GO:0002366 "leukocyte activation involved in immune response" evidence=ISO;ISS

GO:0002554 "serotonin secretion by platelet" evidence=ISO;ISS

GO:0004672 "protein kinase activity" evidence=IDA

GO:0004713 "protein tyrosine kinase activity" evidence=ISO

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=ISO;ISS

GO:0004716 "receptor signaling protein tyrosine kinase activity" evidence=ISO

GO:0005178 "integrin binding" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA;ISO

GO:0005829 "cytosol" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007159 "leukocyte cell-cell adhesion" evidence=ISO;ISS

GO:0007166 "cell surface receptor signaling pathway" evidence=ISO

GO:0007167 "enzyme linked receptor protein signaling pathway" evidence=ISO

GO:0007229 "integrin-mediated signaling pathway" evidence=ISO;ISS

GO:0007257 "activation of JUN kinase activity" evidence=ISO

GO:0010543 "regulation of platelet activation" evidence=ISO;ISS

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=ISO

GO:0019370 "leukotriene biosynthetic process" evidence=ISO

GO:0019815 "B cell receptor complex" evidence=ISO

GO:0019901 "protein kinase binding" evidence=ISO

GO:0019904 "protein domain specific binding" evidence=IMP

GO:0030593 "neutrophil chemotaxis" evidence=ISO;ISS

GO:0032009 "early phagosome" evidence=ISO;ISS

GO:0032928 "regulation of superoxide anion generation" evidence=ISO;ISS

GO:0033630 "positive regulation of cell adhesion mediated by integrin" evidence=ISO;ISS

GO:0035556 "intracellular signal transduction" evidence=IEA;ISO

GO:0042101 "T cell receptor complex" evidence=ISO

GO:0042742 "defense response to bacterium" evidence=ISO;ISS

GO:0043306 "positive regulation of mast cell degranulation" evidence=ISO;IMP

GO:0043313 "regulation of neutrophil degranulation" evidence=ISO;ISS

GO:0043366 "beta selection" evidence=ISO

GO:0045087 "innate immune response" evidence=ISO;ISS

GO:0045401 "positive regulation of interleukin-3 biosynthetic process" evidence=ISO

GO:0045425 "positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process" evidence=ISO

GO:0045579 "positive regulation of B cell differentiation" evidence=ISO

GO:0045588 "positive regulation of gamma-delta T cell differentiation" evidence=ISO

GO:0045780 "positive regulation of bone resorption" evidence=ISO;ISS

GO:0046638 "positive regulation of alpha-beta T cell differentiation" evidence=ISO

GO:0046641 "positive regulation of alpha-beta T cell proliferation" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=ISO;IDA

GO:0048514 "blood vessel morphogenesis" evidence=ISO;ISS

GO:0050715 "positive regulation of cytokine secretion" evidence=ISO

GO:0050731 "positive regulation of peptidyl-tyrosine phosphorylation" evidence=ISO

GO:0050764 "regulation of phagocytosis" evidence=ISO;ISS

GO:0050776 "regulation of immune response" evidence=IDA

GO:0050850 "positive regulation of calcium-mediated signaling" evidence=ISO

GO:0050853 "B cell receptor signaling pathway" evidence=ISO;ISS

GO:0070372 "regulation of ERK1 and ERK2 cascade" evidence=ISO;ISS

GO:0071226 "cellular response to molecule of fungal origin" evidence=ISO;ISS

GO:0090237 "regulation of arachidonic acid secretion" evidence=ISO;ISS

GO:0090330 "regulation of platelet aggregation" evidence=ISO;ISS

UNIPROTKB|G3V7N4 Syk "Tyrosine-protein kinase" [Rattus norvegicus (taxid:10116)]

 Score = 346 (126.9 bits), Expect = 7.6e-31, P = 7.6e-31
 Identities = 61/100 (61%), Positives = 82/100 (82%)

Query:    31 RYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYA 89
             +YL+  +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYA
Sbjct:   477 KYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 534

Query:    90 PESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             PE  N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct:   535 PECINYFKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 574

GO:0001945 "lymph vessel development" evidence=IEA

GO:0002281 "macrophage activation involved in immune response" evidence=IEA

GO:0002283 "neutrophil activation involved in immune response" evidence=IEA

GO:0002554 "serotonin secretion by platelet" evidence=IEA

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=IEA

GO:0004716 "receptor signaling protein tyrosine kinase activity" evidence=IEA

GO:0005178 "integrin binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0007159 "leukocyte cell-cell adhesion" evidence=IEA

GO:0007167 "enzyme linked receptor protein signaling pathway" evidence=IEA

GO:0007229 "integrin-mediated signaling pathway" evidence=IEA

GO:0007257 "activation of JUN kinase activity" evidence=IEA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IEA

GO:0019370 "leukotriene biosynthetic process" evidence=IEA

GO:0019815 "B cell receptor complex" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0030593 "neutrophil chemotaxis" evidence=IEA

GO:0032009 "early phagosome" evidence=IEA

GO:0032928 "regulation of superoxide anion generation" evidence=IEA

GO:0033630 "positive regulation of cell adhesion mediated by integrin" evidence=IEA

GO:0042101 "T cell receptor complex" evidence=IEA

GO:0042742 "defense response to bacterium" evidence=IEA

GO:0043306 "positive regulation of mast cell degranulation" evidence=IEA

GO:0043313 "regulation of neutrophil degranulation" evidence=IEA

GO:0043366 "beta selection" evidence=IEA

GO:0045087 "innate immune response" evidence=IEA

GO:0045401 "positive regulation of interleukin-3 biosynthetic process" evidence=IEA

GO:0045425 "positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process" evidence=IEA

GO:0045579 "positive regulation of B cell differentiation" evidence=IEA

GO:0045588 "positive regulation of gamma-delta T cell differentiation" evidence=IEA

GO:0045780 "positive regulation of bone resorption" evidence=IEA

GO:0046638 "positive regulation of alpha-beta T cell differentiation" evidence=IEA

GO:0046641 "positive regulation of alpha-beta T cell proliferation" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0048514 "blood vessel morphogenesis" evidence=IEA

GO:0050715 "positive regulation of cytokine secretion" evidence=IEA

GO:0050731 "positive regulation of peptidyl-tyrosine phosphorylation" evidence=IEA

GO:0050764 "regulation of phagocytosis" evidence=IEA

GO:0050850 "positive regulation of calcium-mediated signaling" evidence=IEA

GO:0050853 "B cell receptor signaling pathway" evidence=IEA

GO:0070372 "regulation of ERK1 and ERK2 cascade" evidence=IEA

GO:0071226 "cellular response to molecule of fungal origin" evidence=IEA

GO:0090237 "regulation of arachidonic acid secretion" evidence=IEA

GO:0090330 "regulation of platelet aggregation" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
F1N9Y5	KSYK_CHICK	2, ., 7, ., 1, 0, ., 2	0.6404	0.6899	0.1451	yes	N/A
Q24145	SHARK_DROME	2, ., 7, ., 1, 0, ., 2	0.6741	0.6899	0.0947	yes	N/A
P43405	KSYK_HUMAN	2, ., 7, ., 1, 0, ., 2	0.6145	0.7364	0.1496	yes	N/A
P43404	ZAP70_MOUSE	2, ., 7, ., 1, 0, ., 2	0.5959	0.7596	0.1585	yes	N/A

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	129
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-59
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-52
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-51
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-51
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-49
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-45
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-45
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-43
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-37
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-37
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-37
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-35
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-34
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-34
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-33
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-32
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-32
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-32
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-32
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-31
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-31
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-31
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-30
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-30
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-29
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-29
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-28
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-28
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-28
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-28
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-28
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-28
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-27
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-27
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-27
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-27
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-27
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-27
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-27
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-26
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-26
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-26
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-26
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-26
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-26
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-26
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-26
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-25
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-25
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-25
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-25
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-25
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-25
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-25
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-24
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-24
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-24
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-24
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-24
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-24
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-24
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-24
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-24
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-24
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-24
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-23
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-23
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-23
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-23
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-23
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-22
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-22
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-22
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-22
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-21
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-21
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-21
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-21
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-19
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-19
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-18
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-17
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-16
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-12
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-12
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-12
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-12
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-12
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-11
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-10
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-10
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-10
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-10
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-10
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-10
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-10
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-10
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-09
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-09
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-09
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-09
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-09
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-08
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-08
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-08
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-08
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-08
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-07
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-07
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-07
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-07
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-07
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-07
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-07
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-07
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-06
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-06
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-06
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-06
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-06
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-06
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-06
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-06
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-06
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-06
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-06
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	9e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-05
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-05
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-05
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-05
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-05
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-04
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-04
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-04
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-04
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-04
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-04
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.001
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	0.001
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.001
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.001
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	0.001
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	0.002
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.002
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.002
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.002
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.002
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.003
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	0.003
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.003
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.003
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	0.003
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	0.004
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	0.004

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  183 bits (467), Expect = 2e-59
 Identities = 61/89 (68%), Positives = 78/89 (87%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN+LL +RHQAKISDFG+SRA+ +  +YY+AT  GRWP+KWYAPE  N+G+FSS
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            SDVWS+G+TLWE +S+G +PYGEMKG++
Sbjct: 178 KSDVWSYGVTLWEAFSYGAKPYGEMKGAE 206

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  164 bits (417), Expect = 5e-52
 Identities = 55/107 (51%), Positives = 70/107 (65%), Gaps = 5/107 (4%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           QI AK   YL     +F HRDLAARN L+      KISDFGLSR +  + +YY+   GG+
Sbjct: 110 QI-AKGMEYL--ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED-DYYRKRGGGK 165

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            PIKW APES   G+F+S SDVWSFG+ LWE+++ G+QPY  M   +
Sbjct: 166 LPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  163 bits (415), Expect = 1e-51
 Identities = 52/107 (48%), Positives = 68/107 (63%), Gaps = 6/107 (5%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           QI A+   YL     +F HRDLAARN L+      KISDFGLSR +  +  YY+   G +
Sbjct: 110 QI-ARGMEYL--ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-YYRKRGG-K 164

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            PI+W APES   G+F+S SDVWSFG+ LWE+++ G+QPY  M   +
Sbjct: 165 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 211

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  163 bits (414), Expect = 2e-51
 Identities = 52/107 (48%), Positives = 69/107 (64%), Gaps = 6/107 (5%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           QI A+   YL     +F HRDLAARN L+      KISDFGLSR +  +  YYK   G +
Sbjct: 111 QI-ARGMEYL--ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-YYKVKGG-K 165

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            PI+W APES   G+F+S SDVWSFG+ LWE+++ G++PY  M  ++
Sbjct: 166 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE 212

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  158 bits (401), Expect = 2e-49
 Identities = 53/107 (49%), Positives = 66/107 (61%), Gaps = 5/107 (4%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           QI AK   YL      F HRDLAARN L+      KISDFGLSR V  + +YY+   GG+
Sbjct: 113 QI-AKGMEYL--ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD-DYYRKKTGGK 168

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            PI+W APES   G F+S SDVWSFG+ LWE+++ G  PY  +   +
Sbjct: 169 LPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE 215

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score =  147 bits (371), Expect = 4e-45
 Identities = 60/99 (60%), Positives = 81/99 (81%), Gaps = 1/99 (1%)

Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           +YL+  K+  HRDLAARN+LL ++H AKISDFGLS+A+ ++ +YYKA   G+WP+KWYAP
Sbjct: 109 KYLE-GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167

Query: 91  ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           E  NF +FSS SDVWS+GIT+WE +S+GQ+PY +MKG +
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  145 bits (368), Expect = 8e-45
 Identities = 58/99 (58%), Positives = 79/99 (79%), Gaps = 1/99 (1%)

Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           +YL+   +  HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYAP
Sbjct: 109 KYLEET-NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167

Query: 91  ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           E  N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKG++
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  140 bits (356), Expect = 8e-43
 Identities = 53/106 (50%), Positives = 67/106 (63%), Gaps = 2/106 (1%)

Query: 24  QIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW 83
           QI A   RYL+  K   HRDLAARNILLAS  + KI DFGL RA+    ++Y      + 
Sbjct: 105 QI-ANGMRYLES-KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162

Query: 84  PIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           P  W APES     FS ASDVW FG+TLWEM+++G++P+  + GS 
Sbjct: 163 PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ 208

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  127 bits (321), Expect = 2e-37
 Identities = 51/103 (49%), Positives = 68/103 (66%), Gaps = 2/103 (1%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A   +YL    +  HRDLAARNIL+ S    K+SDFGLSR +      Y  T GG+ PI+
Sbjct: 116 ASGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT-TKGGKIPIR 173

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W APE+  + +F+SASDVWSFGI +WE+ S+G++PY +M   D
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD 216

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  127 bits (321), Expect = 2e-37
 Identities = 48/117 (41%), Positives = 71/117 (60%), Gaps = 3/117 (2%)

Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           +GS  L     QI AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ ++ + 
Sbjct: 106 IGSQYLLNWCVQI-AKGMSYLEEKRL-VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163

Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             Y A  GG+ PIKW A ES     ++  SDVWS+G+T+WE+ +FG +PY  +   +
Sbjct: 164 KEYHAE-GGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  125 bits (317), Expect = 9e-37
 Identities = 53/115 (46%), Positives = 72/115 (62%), Gaps = 15/115 (13%)

Query: 15  SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY 74
           S AL Y+E              K   HRD+AARN+L++S    K+ DFGLSR +  + +Y
Sbjct: 117 STALAYLES-------------KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESY 162

Query: 75  YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           YKA+ G + PIKW APES NF RF+SASDVW FG+ +WE+   G +P+  +K +D
Sbjct: 163 YKASKG-KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  122 bits (308), Expect = 2e-35
 Identities = 43/78 (55%), Positives = 57/78 (73%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARNIL+ S    KISDFGL++ +  +++YY     G  PI WYAPE     +FSS
Sbjct: 132 HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSS 191

Query: 101 ASDVWSFGITLWEMYSFG 118
           ASDVWSFG+TL+E++++G
Sbjct: 192 ASDVWSFGVTLYELFTYG 209

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 5e-34
 Identities = 47/100 (47%), Positives = 66/100 (66%), Gaps = 10/100 (10%)

Query: 29  VC---RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           VC    YL+  K+  HRDLAARN+L++    AK+SDFGL++  +  ++       G+ P+
Sbjct: 111 VCEGMEYLE-EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD------SGKLPV 163

Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           KW APE+    +FS+ SDVWSFGI LWE+YSFG+ PY  +
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  118 bits (298), Expect = 6e-34
 Identities = 41/82 (50%), Positives = 55/82 (67%), Gaps = 1/82 (1%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN ++A     KI DFG++R +  E +YY+    G  P++W APES   G F++
Sbjct: 142 HRDLAARNCMVAEDLTVKIGDFGMTRDIY-ETDYYRKGGKGLLPVRWMAPESLKDGVFTT 200

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWEM +  +QPY
Sbjct: 201 KSDVWSFGVVLWEMATLAEQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  115 bits (291), Expect = 5e-33
 Identities = 46/85 (54%), Positives = 60/85 (70%), Gaps = 2/85 (2%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARNIL+      KI+DFGL+R +  E + Y A  G ++PIKW APE+ N+GRF+ 
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAPEAANYGRFTI 183

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ ++G+ PY  M
Sbjct: 184 KSDVWSFGILLTEIVTYGRVPYPGM 208

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 1e-32
 Identities = 49/96 (51%), Positives = 62/96 (64%), Gaps = 4/96 (4%)

Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHG-GRWPIKWYA 89
            YL+  K+  HRDLAARN L+   +  KISDFG+SR    E   Y  + G  + PIKW A
Sbjct: 107 EYLE-SKNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTA 163

Query: 90  PESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           PE+ N+GR++S SDVWS+GI LWE +S G  PY  M
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM 199

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  115 bits (289), Expect = 1e-32
 Identities = 52/130 (40%), Positives = 72/130 (55%), Gaps = 11/130 (8%)

Query: 1   MKSPN--------GSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLA 52
             SP+           V + L      +I  QI A +  YL  H    HRDLAARN L+ 
Sbjct: 101 RNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGM-EYLSSH-HFVHRDLAARNCLVG 158

Query: 53  SRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLW 112
                KISDFGLSR + S  +YY+       P++W  PE+  +G+F++ SD+WSFG+ LW
Sbjct: 159 EGLTVKISDFGLSRDIYSA-DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLW 217

Query: 113 EMYSFGQQPY 122
           E++S+G QPY
Sbjct: 218 EIFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  113 bits (285), Expect = 4e-32
 Identities = 47/89 (52%), Positives = 63/89 (70%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ PI+W APE+  + +F+S
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTS 188

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ASDVWS+GI +WE+ S+G++PY EM   D
Sbjct: 189 ASDVWSYGIVMWEVMSYGERPYWEMSNQD 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  112 bits (282), Expect = 8e-32
 Identities = 46/104 (44%), Positives = 68/104 (65%), Gaps = 6/104 (5%)

Query: 29  VCR---YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           VC    YL+ +    HRDLAARN L+   +  K+SDFGL+R V  ++  Y ++ G ++P+
Sbjct: 109 VCEAMEYLESN-GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--YTSSQGTKFPV 165

Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           KW  PE +++ RFSS SDVWSFG+ +WE++S G+ PY     S+
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  111 bits (279), Expect = 3e-31
 Identities = 48/101 (47%), Positives = 70/101 (69%), Gaps = 3/101 (2%)

Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAV--NSERNYYKATHGGRWPIKWY 88
           +YL    +  HRDLAARNIL+ S    K+SDFGLSR +  ++    Y ++ GG+ PI+W 
Sbjct: 120 KYLS-EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 89  APESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           APE+  + +F+SASDVWS+GI +WE+ S+G++PY +M   D
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 219

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 4e-31
 Identities = 44/96 (45%), Positives = 63/96 (65%), Gaps = 3/96 (3%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL+   +  HRDLAARN+L+   +  K++DFGL+R +    + Y+A  G ++PIKW APE
Sbjct: 118 YLEAQ-NYIHRDLAARNVLVGENNICKVADFGLARVIKE--DIYEAREGAKFPIKWTAPE 174

Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG 127
           +  + RFS  SDVWSFGI L E+ ++G+ PY  M  
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  111 bits (280), Expect = 4e-31
 Identities = 50/129 (38%), Positives = 74/129 (57%), Gaps = 10/129 (7%)

Query: 1   MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKI 59
            ++   +     L    L Y+  QI + + RYL+     F HRDLA RN L+   +  KI
Sbjct: 115 AETSGLACNSKSLSFSTLLYMATQIASGM-RYLESLN--FVHRDLATRNCLVGKNYTIKI 171

Query: 60  SDFGLSRAVNSERNYYKATHGGR--WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
           +DFG+SR + S  +YY+    GR   PI+W A ES   G+F++ SDVW+FG+TLWE+ + 
Sbjct: 172 ADFGMSRNLYS-SDYYRV--QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228

Query: 118 GQ-QPYGEM 125
            + QPY  +
Sbjct: 229 CREQPYEHL 237

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  110 bits (275), Expect = 1e-30
 Identities = 47/85 (55%), Positives = 63/85 (74%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARNIL+ S  + K+SDFGLSR +  +      T GG+ PI+W APE+  + +F+S
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
           ASDVWSFGI +WE+ SFG++PY +M
Sbjct: 190 ASDVWSFGIVMWEVMSFGERPYWDM 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  109 bits (275), Expect = 2e-30
 Identities = 44/87 (50%), Positives = 60/87 (68%), Gaps = 3/87 (3%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN+L+   H  KI+DFGL+R ++   +YY+ T  GR P+KW APE+  F 
Sbjct: 151 KKCIHRDLAARNVLVTEDHVMKIADFGLARDIH-HIDYYRKTTNGRLPVKWMAPEAL-FD 208

Query: 97  R-FSSASDVWSFGITLWEMYSFGQQPY 122
           R ++  SDVWSFG+ LWE+++ G  PY
Sbjct: 209 RVYTHQSDVWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  106 bits (265), Expect = 2e-29
 Identities = 48/90 (53%), Positives = 60/90 (66%), Gaps = 3/90 (3%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW-PIKWYAPESYNF 95
           K   HRDLAARN L+  ++  KISDFG+SR    E   Y +T G +  P+KW APE+ N+
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNY 170

Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           GR+SS SDVWSFGI LWE +S G  PY  +
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYANL 200

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  105 bits (264), Expect = 4e-29
 Identities = 49/112 (43%), Positives = 69/112 (61%), Gaps = 4/112 (3%)

Query: 11  TPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS 70
             + +  L Y+  QI +    YL+  K+  HRDLAARN L+   H  K++DFGLSR +  
Sbjct: 99  QEVNAVVLLYMATQI-SSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156

Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           +   Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 157 DT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  104 bits (261), Expect = 1e-28
 Identities = 44/89 (49%), Positives = 59/89 (66%), Gaps = 6/89 (6%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARNIL++    AK+SDFGL+R V S           + P+KW APE+    
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLAR-VGS-----MGVDNSKLPVKWTAPEALKHK 172

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +FSS SDVWS+G+ LWE++S+G+ PY +M
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  104 bits (262), Expect = 1e-28
 Identities = 48/115 (41%), Positives = 67/115 (58%), Gaps = 9/115 (7%)

Query: 11  TPLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVN 69
             L    L  I  QI + +  YL      F HRDLA RN L+      KI DFG+SR V 
Sbjct: 117 GELTLSQLLQIAVQIASGM-VYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVY 173

Query: 70  SERNYYKATHGGR--WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           +  +YY+   GG    PI+W  PES  + +F++ SDVWSFG+ LWE++++G+QP+
Sbjct: 174 TT-DYYRV--GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  103 bits (259), Expect = 2e-28
 Identities = 43/96 (44%), Positives = 69/96 (71%), Gaps = 4/96 (4%)

Query: 29  VCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           VC  ++ + ++SF HRDLAARN L++S    K+SDFG++R V  +   Y ++ G ++P+K
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--YTSSSGAKFPVK 166

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W  PE +NF ++SS SDVWSFG+ +WE+++ G+ P+
Sbjct: 167 WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  103 bits (259), Expect = 4e-28
 Identities = 42/85 (49%), Positives = 58/85 (68%), Gaps = 1/85 (1%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLA RN L+      KI+DFGLSR + S  +YYKA+     PI+W  PES  + R+++
Sbjct: 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSA-DYYKASENDAIPIRWMPPESIFYNRYTT 211

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVW++G+ LWE++S+G QPY  M
Sbjct: 212 ESDVWAYGVVLWEIFSYGMQPYYGM 236

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  102 bits (256), Expect = 5e-28
 Identities = 39/82 (47%), Positives = 60/82 (73%), Gaps = 2/82 (2%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN L+      K+SDFG++R V  ++  Y ++ G ++P+KW +PE ++F ++SS
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ +WE++S G+ PY
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  103 bits (258), Expect = 6e-28
 Identities = 40/77 (51%), Positives = 55/77 (71%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLA RNIL+ S ++ KI DFGL++ +  ++ YYK    G  PI WYAPES    +FS 
Sbjct: 131 HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSV 190

Query: 101 ASDVWSFGITLWEMYSF 117
           ASDVWSFG+ L+E++++
Sbjct: 191 ASDVWSFGVVLYELFTY 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  101 bits (254), Expect = 1e-27
 Identities = 45/89 (50%), Positives = 60/89 (67%), Gaps = 2/89 (2%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRDL A NIL++     KI+DFGL+R +  E N Y A  G ++PIKW APE+ N+G
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYG 178

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            F+  SDVWSFGI L E+ ++G+ PY  M
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGRIPYPGM 207

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  101 bits (253), Expect = 2e-27
 Identities = 57/129 (44%), Positives = 78/129 (60%), Gaps = 8/129 (6%)

Query: 1   MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKIS 60
           +KS  G  V+ P     L     QI A+   Y++  K+  HRDL A N+L++     KI+
Sbjct: 92  LKSDEGGKVLLP----KLIDFSAQI-AEGMAYIE-RKNYIHRDLRAANVLVSESLMCKIA 145

Query: 61  DFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
           DFGL+R +  E N Y A  G ++PIKW APE+ NFG F+  SDVWSFGI L+E+ ++G+ 
Sbjct: 146 DFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKI 203

Query: 121 PYGEMKGSD 129
           PY  M  SD
Sbjct: 204 PYPGMSNSD 212

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  101 bits (253), Expect = 2e-27
 Identities = 50/113 (44%), Positives = 71/113 (62%), Gaps = 5/113 (4%)

Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           L   +L  +  Q+ A+   YL+  ++S HRDLAARNIL+      K++DFGL+R +  E 
Sbjct: 101 LPVASLIDMACQV-AEGMAYLE-EQNSIHRDLAARNILVGEDLVCKVADFGLARLIK-ED 157

Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            Y   +   + P KW APE+ + G FS+ SDVWSFGI L+EM+++GQ PY  M
Sbjct: 158 VY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  101 bits (253), Expect = 2e-27
 Identities = 48/102 (47%), Positives = 64/102 (62%), Gaps = 9/102 (8%)

Query: 27  AKVCRYL-KMHKSSFHRDLAARNILLAS-----RHQAKISDFGLSRAVNSERNYYKATHG 80
           AK C YL +MH    HRDLAARN L++          KI DFGL+R +    +YY+    
Sbjct: 116 AKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS-DYYRKEGE 172

Query: 81  GRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           G  P++W APES   G+F++ SDVWSFG+ +WE+ + GQQPY
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  100 bits (250), Expect = 4e-27
 Identities = 43/82 (52%), Positives = 60/82 (73%), Gaps = 6/82 (7%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN+L++  + AK+SDFGL++  +S ++       G+ P+KW APE+    +FS+
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------TGKLPVKWTAPEALREKKFST 178

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFGI LWE+YSFG+ PY
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  100 bits (250), Expect = 4e-27
 Identities = 48/94 (51%), Positives = 62/94 (65%), Gaps = 3/94 (3%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL+  K+  HRDLAARN L+   +  KISDFG+SR    +   Y ++   + PIKW APE
Sbjct: 108 YLES-KNCIHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPE 164

Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           + N+GR+SS SDVWS+GI LWE +S G  PY  M
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =   99 bits (249), Expect = 7e-27
 Identities = 41/86 (47%), Positives = 58/86 (67%), Gaps = 2/86 (2%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN L+  +   K+SDFGLSR V  +   Y ++ G ++P++W  PE   + 
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYS 176

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
           +FSS SDVW+FG+ +WE+YS G+ PY
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPY 202

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  100 bits (251), Expect = 9e-27
 Identities = 43/89 (48%), Positives = 55/89 (61%), Gaps = 1/89 (1%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRDLAARN+LL      KI DFGL+R + ++ NY       R P+KW APES    
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV-VKGNARLPVKWMAPESIFNC 218

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            ++  SDVWS+GI LWE++S G  PY  M
Sbjct: 219 VYTFESDVWSYGILLWEIFSLGSNPYPGM 247

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 99.4 bits (248), Expect = 1e-26
 Identities = 48/101 (47%), Positives = 63/101 (62%), Gaps = 9/101 (8%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGR- 82
           AK C+YL+      HRD+AARN LL  +     AKI+DFG++R +     Y K   GGR 
Sbjct: 126 AKGCKYLE-ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK---GGRA 181

Query: 83  -WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             PIKW  PE++  G F+S +DVWSFG+ LWE++S G  PY
Sbjct: 182 MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 99.7 bits (248), Expect = 1e-26
 Identities = 44/82 (53%), Positives = 58/82 (70%), Gaps = 1/82 (1%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           H+DLAARNIL+  +   KISD GLSR + S  +YY+       PI+W  PE+  +G+FSS
Sbjct: 147 HKDLAARNILIGEQLHVKISDLGLSREIYSA-DYYRVQPKSLLPIRWMPPEAIMYGKFSS 205

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SD+WSFG+ LWE++SFG QPY
Sbjct: 206 DSDIWSFGVVLWEIFSFGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 99.7 bits (248), Expect = 2e-26
 Identities = 47/97 (48%), Positives = 66/97 (68%), Gaps = 4/97 (4%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A+   YL+  +   HRDLAARN+L+   +  KI+DFGL+R V+ + +YYK T  GR P+K
Sbjct: 144 ARGMEYLE-SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH-DIDYYKKTSNGRLPVK 201

Query: 87  WYAPESYNFGR-FSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+  F R ++  SDVWSFGI +WE+++ G  PY
Sbjct: 202 WMAPEAL-FDRVYTHQSDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score =  100 bits (251), Expect = 2e-26
 Identities = 42/89 (47%), Positives = 57/89 (64%), Gaps = 1/89 (1%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRD+AARN+LL     AKI DFGL+R + ++ NY       R P+KW APES    
Sbjct: 231 KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV-VKGNARLPVKWMAPESIFDC 289

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            ++  SDVWS+GI LWE++S G+ PY  +
Sbjct: 290 VYTVQSDVWSYGILLWEIFSLGKSPYPGI 318

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 98.2 bits (244), Expect = 5e-26
 Identities = 43/89 (48%), Positives = 61/89 (68%), Gaps = 1/89 (1%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN+L+ S +  KI+DFGL+R ++ +   Y A  GG+ PIKW A ES    RF+ 
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD-GGKVPIKWMALESILHRRFTH 190

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            SDVWS+G+T+WE+ +FG +PY  +   +
Sbjct: 191 QSDVWSYGVTVWELMTFGAKPYDGIPARE 219

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 98.1 bits (244), Expect = 5e-26
 Identities = 47/104 (45%), Positives = 69/104 (66%), Gaps = 4/104 (3%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAV-NSERNYYKATHGGRWPI 85
           AK   YL+ H+   HR+LAARNILL S    +I+DFG++  +   ++ Y+ + H  + PI
Sbjct: 119 AKGMYYLEEHRMV-HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH--KTPI 175

Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           KW A ES  FGR++  SDVWS+G+T+WEM S+G +PY  M+  +
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 98.2 bits (244), Expect = 7e-26
 Identities = 46/96 (47%), Positives = 63/96 (65%), Gaps = 2/96 (2%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A+   YL   K   HRDLAARN+L+   +  KI+DFGL+R VN+  +YYK T  GR P+K
Sbjct: 147 ARGMEYLASQKC-IHRDLAARNVLVTENNVMKIADFGLARDVNN-IDYYKKTTNGRLPVK 204

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+     ++  SDVWSFG+ +WE+++ G  PY
Sbjct: 205 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 98.2 bits (244), Expect = 8e-26
 Identities = 45/96 (46%), Positives = 65/96 (67%), Gaps = 2/96 (2%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ S +  KI+DFGL+R +  +   Y A  GG+ PIK
Sbjct: 119 AKGMMYLE-ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD-GGKMPIK 176

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W A E  ++ +F+  SDVWS+G+T+WE+ +FG +PY
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 97.0 bits (241), Expect = 2e-25
 Identities = 44/82 (53%), Positives = 56/82 (68%), Gaps = 1/82 (1%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN+L+A   + KISDFGLSR V  E +Y K + G R P+KW A ES     +++
Sbjct: 150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKG-RIPVKWMAIESLFDHIYTT 208

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWE+ + G  PY
Sbjct: 209 QSDVWSFGVLLWEIVTLGGNPY 230

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 97.4 bits (242), Expect = 2e-25
 Identities = 44/103 (42%), Positives = 66/103 (64%), Gaps = 2/103 (1%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + ++   Y A  GG+ PIK
Sbjct: 119 AKGMNYLE-ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA-EGGKVPIK 176

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 95.7 bits (238), Expect = 4e-25
 Identities = 37/82 (45%), Positives = 53/82 (64%), Gaps = 1/82 (1%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN +L       ++DFGLS+ + S  +YY+     + P+KW A ES     ++S
Sbjct: 136 HRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPVKWIAIESLADRVYTS 194

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVW+FG+T+WE+ + GQ PY
Sbjct: 195 KSDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 96.9 bits (241), Expect = 5e-25
 Identities = 44/89 (49%), Positives = 55/89 (61%), Gaps = 1/89 (1%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRDLAARNILL      KI DFGL+R + ++ NY       R P+KW APES    
Sbjct: 233 KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV-VKGNARLPVKWMAPESIFNC 291

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            ++  SDVWS+GI LWE++S G  PY  M
Sbjct: 292 VYTFESDVWSYGILLWEIFSLGSSPYPGM 320

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 95.1 bits (236), Expect = 6e-25
 Identities = 45/93 (48%), Positives = 62/93 (66%), Gaps = 2/93 (2%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           ++  HRDL A NIL+++    KI+DFGL+R +  E N Y A  G ++PIKW APE+ NFG
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFG 178

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            F+  SDVWSFGI L E+ ++G+ PY  M   +
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 95.8 bits (238), Expect = 6e-25
 Identities = 44/87 (50%), Positives = 60/87 (68%), Gaps = 3/87 (3%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN+L+   +  KI+DFGL+R ++   +YYK T  GR P+KW APE+  F 
Sbjct: 159 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPEAL-FD 216

Query: 97  R-FSSASDVWSFGITLWEMYSFGQQPY 122
           R ++  SDVWSFG+ LWE+++ G  PY
Sbjct: 217 RIYTHQSDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 95.9 bits (238), Expect = 8e-25
 Identities = 46/96 (47%), Positives = 63/96 (65%), Gaps = 2/96 (2%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A+   YL   K   HRDLAARN+L+   +  KI+DFGL+R V++  +YYK T  GR P+K
Sbjct: 144 ARGMEYLASQKC-IHRDLAARNVLVTEDNVMKIADFGLARDVHN-IDYYKKTTNGRLPVK 201

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+     ++  SDVWSFG+ LWE+++ G  PY
Sbjct: 202 WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 94.6 bits (235), Expect = 1e-24
 Identities = 41/89 (46%), Positives = 55/89 (61%), Gaps = 2/89 (2%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           H+ LAA  +L+ S    KIS F   +   SE  Y   T  G+ P+ W APE+  +  FSS
Sbjct: 130 HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY--TTMSGKSPVLWAAPEAIQYHHFSS 187

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ASDVWSFGI +WE+ S+G++PY +M G D
Sbjct: 188 ASDVWSFGIVMWEVMSYGERPYWDMSGQD 216

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 94.3 bits (234), Expect = 2e-24
 Identities = 47/127 (37%), Positives = 72/127 (56%), Gaps = 10/127 (7%)

Query: 8   GVVTPLGSYALPY---IEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGL 64
           G     G   L     I  QI + +     +H    HRDLA RN L+      KI DFG+
Sbjct: 111 GEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGM 168

Query: 65  SRAVNSERNYYKATHGGR--WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           SR + S  +YY+   GGR   PI+W  PES  + +F++ SD+WSFG+ LWE++++G+QP+
Sbjct: 169 SRDIYST-DYYRV--GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225

Query: 123 GEMKGSD 129
            ++  ++
Sbjct: 226 YQLSNTE 232

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 94.3 bits (234), Expect = 2e-24
 Identities = 45/103 (43%), Positives = 65/103 (63%), Gaps = 3/103 (2%)

Query: 20  YIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH 79
           +I  QI A +  +L  H    H+DLA RN+L+  +   KISD GL R V +  +YYK   
Sbjct: 128 HIVTQIAAGM-EFLSSHHV-VHKDLATRNVLVFDKLNVKISDLGLFREVYAA-DYYKLMG 184

Query: 80  GGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               PI+W +PE+  +G+FS  SD+WS+G+ LWE++S+G QPY
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 93.7 bits (233), Expect = 2e-24
 Identities = 43/98 (43%), Positives = 58/98 (59%), Gaps = 4/98 (4%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA--THGGRWP 84
           AK   YL   K   HRDLAARN +L      K++DFGL+R +  ++ YY      G + P
Sbjct: 108 AKGMEYLA-SKKFVHRDLAARNCMLDESFTVKVADFGLARDI-YDKEYYSVHNHTGAKLP 165

Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           +KW A ES    +F++ SDVWSFG+ LWE+ + G  PY
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 94.9 bits (236), Expect = 2e-24
 Identities = 41/86 (47%), Positives = 56/86 (65%), Gaps = 1/86 (1%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+  +  KI DFGL+R +  + +Y +     R P+KW APES    
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA-RLPLKWMAPESIFDK 250

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +++ SDVWSFG+ LWE++S G  PY
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPY 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 93.9 bits (233), Expect = 3e-24
 Identities = 41/86 (47%), Positives = 57/86 (66%), Gaps = 1/86 (1%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN ++A     KI DFG++R +  E +YY+    G  P++W APES   G
Sbjct: 138 KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPESLKDG 196

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            F+++SD+WSFG+ LWE+ S  +QPY
Sbjct: 197 VFTTSSDMWSFGVVLWEITSLAEQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 93.1 bits (231), Expect = 5e-24
 Identities = 50/113 (44%), Positives = 72/113 (63%), Gaps = 5/113 (4%)

Query: 12  PLGSYA-LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS 70
           P  S A L Y+  QI + + +YL    +  HRDLA RN L+ + +  KI+DFG+SR + S
Sbjct: 124 PSVSIANLLYMAVQIASGM-KYLA-SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181

Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF-GQQPY 122
             +YY+       PI+W A ES   G+F++ASDVW+FG+TLWEM++   +QPY
Sbjct: 182 G-DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 93.1 bits (231), Expect = 5e-24
 Identities = 45/116 (38%), Positives = 69/116 (59%), Gaps = 3/116 (2%)

Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           LG   + +I  QI + +      H    HRDLA RN L+ +    KI DFG+SR V S  
Sbjct: 120 LGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYST- 176

Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS 128
           +YY+       PI+W  PES  + +F++ SDVWSFG+ LWE++++G+QP+ ++  +
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 92.7 bits (230), Expect = 7e-24
 Identities = 40/85 (47%), Positives = 55/85 (64%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN+L+ S HQ KI DFGL++A+ +++ YY        P+ WYAPE     +F  
Sbjct: 132 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYI 191

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
           ASDVWSFG+TL+E+ ++       M
Sbjct: 192 ASDVWSFGVTLYELLTYCDSESSPM 216

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 92.1 bits (229), Expect = 8e-24
 Identities = 36/86 (41%), Positives = 55/86 (63%), Gaps = 4/86 (4%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW-PIKWYAPESYNFGRFS 99
           HRDLAARN L++S+ + K+S   LS+ V +   YYK        P++W APE+     FS
Sbjct: 140 HRDLAARNCLVSSQREVKVSLLSLSKDVYN-SEYYK--LRNALIPLRWLAPEAVQEDDFS 196

Query: 100 SASDVWSFGITLWEMYSFGQQPYGEM 125
           + SDVWSFG+ +WE+++ G+ P+  +
Sbjct: 197 TKSDVWSFGVLMWEVFTQGELPFYGL 222

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 92.4 bits (229), Expect = 9e-24
 Identities = 43/94 (45%), Positives = 60/94 (63%), Gaps = 2/94 (2%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL  +K   HRDLAARN ++A     KI DFG++R +  E +YY+    G  P++W +PE
Sbjct: 134 YLNANKF-VHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPE 191

Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           S   G F++ SDVWSFG+ LWE+ +  +QPY  M
Sbjct: 192 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 92.4 bits (229), Expect = 1e-23
 Identities = 45/89 (50%), Positives = 57/89 (64%), Gaps = 4/89 (4%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN+L+     +KI+DFGLSR    E  Y K T G R P++W A ES N+ 
Sbjct: 138 KQFIHRDLAARNVLVGENLASKIADFGLSRG---EEVYVKKTMG-RLPVRWMAIESLNYS 193

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            +++ SDVWSFG+ LWE+ S G  PY  M
Sbjct: 194 VYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 92.8 bits (230), Expect = 1e-23
 Identities = 41/82 (50%), Positives = 55/82 (67%), Gaps = 1/82 (1%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARNILL+  +  KI DFGL+R +  + +Y +     R P+KW APES     +++
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA-RLPLKWMAPESIFDKVYTT 255

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWE++S G  PY
Sbjct: 256 QSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 91.6 bits (227), Expect = 3e-23
 Identities = 45/90 (50%), Positives = 58/90 (64%), Gaps = 4/90 (4%)

Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            K   HRDLAARNIL+   + AKI+DFGLSR    +  Y K T G R P++W A ES N+
Sbjct: 142 QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMG-RLPVRWMAIESLNY 197

Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
             +++ SDVWS+G+ LWE+ S G  PY  M
Sbjct: 198 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 90.1 bits (223), Expect = 4e-23
 Identities = 44/85 (51%), Positives = 56/85 (65%), Gaps = 2/85 (2%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      KI+DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGM 207

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 90.7 bits (225), Expect = 4e-23
 Identities = 39/86 (45%), Positives = 58/86 (67%), Gaps = 2/86 (2%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLA RN L+   +  KI+DFG+SR + S  +YY+       PI+W + ES   G+F++
Sbjct: 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSG-DYYRIQGRAVLPIRWMSWESILLGKFTT 211

Query: 101 ASDVWSFGITLWEMYSFGQ-QPYGEM 125
           ASDVW+FG+TLWE+ +  + QPY ++
Sbjct: 212 ASDVWAFGVTLWEILTLCKEQPYSQL 237

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 90.5 bits (224), Expect = 4e-23
 Identities = 45/89 (50%), Positives = 58/89 (65%), Gaps = 4/89 (4%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARNIL+   + AKI+DFGLSR    +  Y K T G R P++W A ES N+ 
Sbjct: 131 KQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMG-RLPVRWMAIESLNYS 186

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            +++ SDVWS+G+ LWE+ S G  PY  M
Sbjct: 187 VYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 90.5 bits (224), Expect = 4e-23
 Identities = 44/119 (36%), Positives = 67/119 (56%), Gaps = 3/119 (2%)

Query: 11  TPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS 70
             L    + +I  QI A +      H    HRDLA RN L+      KI DFG+SR V S
Sbjct: 115 AELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYS 172

Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             +YY+       PI+W  PES  + +F++ SDVWS G+ LWE++++G+QP+ ++  ++
Sbjct: 173 T-DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.1 bits (223), Expect = 5e-23
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL + NIL+      KI+DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGM 207

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 90.5 bits (224), Expect = 1e-22
 Identities = 41/90 (45%), Positives = 57/90 (63%), Gaps = 1/90 (1%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+  +  KI DFGL+R +  + +Y +     R P+KW APE+    
Sbjct: 198 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA-RLPLKWMAPETIFDR 256

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 257 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 89.2 bits (221), Expect = 1e-22
 Identities = 39/74 (52%), Positives = 49/74 (66%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN+LL +    KI DFGL++AV     YY+    G  P+ WYA E     +FS 
Sbjct: 130 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSY 189

Query: 101 ASDVWSFGITLWEM 114
           ASDVWSFG+TL+E+
Sbjct: 190 ASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 89.6 bits (222), Expect = 1e-22
 Identities = 40/90 (44%), Positives = 56/90 (62%), Gaps = 2/90 (2%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLA RN L+      KI+DFG+SR + +  +YY+       PI+W A E    G+F++
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAG-DYYRIQGRAVLPIRWMAWECILMGKFTT 219

Query: 101 ASDVWSFGITLWEMYSFGQ-QPYGEMKGSD 129
           ASDVW+FG+TLWE+    + QPYGE+    
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 89.0 bits (220), Expect = 1e-22
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGM 207

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 89.0 bits (221), Expect = 1e-22
 Identities = 38/85 (44%), Positives = 52/85 (61%), Gaps = 1/85 (1%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           H+D+AARN ++    Q KI+D  LSR +    +Y+        P+KW A ES     +SS
Sbjct: 140 HKDIAARNCVIDEELQVKITDNALSRDLFPM-DYHCLGDNENRPVKWMALESLVNKEYSS 198

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
           ASDVWSFG+ LWE+ + GQ PY E+
Sbjct: 199 ASDVWSFGVLLWELMTLGQTPYVEI 223

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 86.8 bits (216), Expect = 7e-22
 Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 6/89 (6%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           +H     HRDL   NILL      K++DFGL+R ++          G      + APE  
Sbjct: 113 LHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV-GTPE---YMAPEVL 168

Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               +  A D+WS G+ L+E+ + G+ P+
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLT-GKPPF 196

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 86.5 bits (214), Expect = 1e-21
 Identities = 38/93 (40%), Positives = 59/93 (63%), Gaps = 1/93 (1%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRDLAARN +L       ++DFGLS+ + S  +YY+     + P+KW A ES    
Sbjct: 132 KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG-DYYRQGCASKLPVKWLALESLADN 190

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            +++ SDVW+FG+T+WE+ + GQ PY  ++ S+
Sbjct: 191 VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 87.4 bits (216), Expect = 2e-21
 Identities = 44/90 (48%), Positives = 58/90 (64%), Gaps = 3/90 (3%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW-PIKWYAPESYNF 95
           K+  HRDLAARN+LLA     KI DFGL+R +  + NY   + G  + P+KW APES   
Sbjct: 256 KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAPESIFD 313

Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
             +++ SDVWS+GI LWE++S G  PY  M
Sbjct: 314 NLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 86.6 bits (214), Expect = 4e-21
 Identities = 42/90 (46%), Positives = 58/90 (64%), Gaps = 3/90 (3%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW-PIKWYAPESYNF 95
           K+  HRDLAARN+L+      KI DFGL+R +  + NY   + G  + P+KW APES   
Sbjct: 258 KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIFN 315

Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
             +++ SDVWSFGI LWE+++ G  PY E+
Sbjct: 316 NLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 84.3 bits (208), Expect = 7e-21
 Identities = 39/93 (41%), Positives = 59/93 (63%), Gaps = 1/93 (1%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           KS  HRDLAARN +L       ++DFGLS+ + +  +YY+     + P+KW A ES    
Sbjct: 131 KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG-DYYRQGRIAKMPVKWIAIESLADR 189

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            +++ SDVWSFG+T+WE+ + GQ PY  ++ S+
Sbjct: 190 VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 80.4 bits (199), Expect = 1e-19
 Identities = 31/86 (36%), Positives = 47/86 (54%), Gaps = 6/86 (6%)

Query: 35  MHKSSF-HRDLAARNILLASR-HQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPES 92
           +H +   HRDL   NILL S   + K++DFGLS+ + S+++  K   G      + APE 
Sbjct: 108 LHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG---TPAYMAPEV 164

Query: 93  YNF-GRFSSASDVWSFGITLWEMYSF 117
               G +S  SD+WS G+ L+E+   
Sbjct: 165 LLGKGYYSEKSDIWSLGVILYELPEL 190

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 78.8 bits (195), Expect = 9e-19
 Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 11/107 (10%)

Query: 29  VCRYLKM--------HKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH 79
           + +Y +         H +   HRD+   NIL+ S    K++DFG ++ +       + T 
Sbjct: 103 IRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI-ETGEGTG 161

Query: 80  GGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
             R    W APE      +  A+D+WS G T+ EM + G+ P+ E+ 
Sbjct: 162 SVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT-GKPPWSELG 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 76.5 bits (188), Expect = 6e-18
 Identities = 40/102 (39%), Positives = 55/102 (53%), Gaps = 11/102 (10%)

Query: 30  CRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW-PIKW 87
              L +HK++F H DLA RN LL +    KI D+GLS   N  +  Y  T    W P++W
Sbjct: 111 LGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSH--NKYKEDYYVTPDQLWVPLRW 168

Query: 88  YAPESYN--FGRF-----SSASDVWSFGITLWEMYSFGQQPY 122
            APE  +   G       +  S+VWS G+T+WE++  G QPY
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 74.6 bits (184), Expect = 3e-17
 Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 10/92 (10%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH--GGRWPIKWYAPE 91
           +H +   HRDL   NILL      KI+DFGL++     ++    T   G  W   + APE
Sbjct: 114 LHSNGIIHRDLKPENILLDENGVVKIADFGLAKK--LLKSSSSLTTFVGTPW---YMAPE 168

Query: 92  SYNFGR-FSSASDVWSFGITLWEMYSFGQQPY 122
               G  +    DVWS G+ L+E+ + G+ P+
Sbjct: 169 VLLGGNGYGPKVDVWSLGVILYELLT-GKPPF 199

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 72.6 bits (179), Expect = 1e-16
 Identities = 43/114 (37%), Positives = 57/114 (50%), Gaps = 20/114 (17%)

Query: 22  EGQIPAKVCR-------YLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSE-- 71
           E QI A VC+       YL  H +   HRD+ A NILL S  + K+ DFGLS  ++    
Sbjct: 97  ESQI-AYVCKELLKGLEYL--HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153

Query: 72  RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           RN    T        W APE  N   +   +D+WS GIT  E+ + G+ PY E+
Sbjct: 154 RNTMVGTPY------WMAPEVINGKPYDYKADIWSLGITAIEL-AEGKPPYSEL 200

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 71.5 bits (175), Expect = 6e-16
 Identities = 34/109 (31%), Positives = 53/109 (48%), Gaps = 9/109 (8%)

Query: 29  VCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKW 87
               L +H++ F H DLA RN  L +    KI D+GL+     E +YY        P++W
Sbjct: 110 ASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE-DYYITKDCHAVPLRW 168

Query: 88  YAPESYN-FG------RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            APE     G        +  S++WS G+T+WE+++   QPY ++    
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ 217

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 62.6 bits (152), Expect = 8e-13
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 9/96 (9%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE-- 91
           MHK +F H DLA RN  L S    K+ D+G+  +   + +Y +       P++W APE  
Sbjct: 115 MHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS-RYKEDYIETEDDKCVPLRWLAPELV 173

Query: 92  -SYNFGRFSSA----SDVWSFGITLWEMYSFGQQPY 122
             ++ G  ++     S+VW+ G+TLWE++    QPY
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 1e-12
 Identities = 36/107 (33%), Positives = 45/107 (42%), Gaps = 15/107 (14%)

Query: 19  PYIEGQIPAKVCRYLK-----MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
              E QI   VCR +      +H     HRDL A NILL      K++DFG+S    S  
Sbjct: 99  GLTEPQI-RYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157

Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSA-----SDVWSFGITLWEM 114
                  G  +   W APE      F        +D+WS GITL E+
Sbjct: 158 QKRDTFIGTPY---WMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 61.6 bits (150), Expect = 2e-12
 Identities = 39/118 (33%), Positives = 57/118 (48%), Gaps = 19/118 (16%)

Query: 18  LPYIEGQIP----AKVCR-------YLKMHKSSFHRDLAARNILLASRHQAKISDFGLS- 65
           L  ++G+IP     K+         YL       HRD+   NIL+ SR Q K+ DFG+S 
Sbjct: 90  LKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149

Query: 66  RAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYG 123
           + VNS    +  T        + APE      +S  SD+WS G++L E+ + G+ PY 
Sbjct: 150 QLVNSLAKTFVGTS------SYMAPERIQGNDYSVKSDIWSLGLSLIELAT-GRFPYP 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 3e-12
 Identities = 37/96 (38%), Positives = 50/96 (52%), Gaps = 17/96 (17%)

Query: 31  RYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATHGGR 82
           R LK +H ++  HRDL   N+LL +    KI DFGL+R  + E ++      Y AT    
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT---- 172

Query: 83  WPIKWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
              +WY APE   N   ++ A D+WS G  L EM S
Sbjct: 173 ---RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 60.7 bits (148), Expect = 3e-12
 Identities = 32/107 (29%), Positives = 50/107 (46%), Gaps = 13/107 (12%)

Query: 29  VCRYLK--------MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH 79
           V  Y+         +H+    HRD+ A NIL       K++DFG++  +N       +  
Sbjct: 101 VAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV 160

Query: 80  GGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
           G  +   W APE       S+ASD+WS G T+ E+ + G  PY ++ 
Sbjct: 161 GTPY---WMAPEVIEMSGASTASDIWSLGCTVIELLT-GNPPYYDLN 203

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 61.0 bits (149), Expect = 4e-12
 Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 22/93 (23%)

Query: 35  MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY--YKATHGGRWPIKWY-AP 90
           +HK   FHRDL   N+L++     KI+DFGL+R + S   Y  Y +T       +WY AP
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST-------RWYRAP 167

Query: 91  E------SYNFGRFSSASDVWSFGITLWEMYSF 117
           E      SY+     S  D+W+ G  + E+Y+ 
Sbjct: 168 EILLRSTSYS-----SPVDIWALGCIMAELYTL 195

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 4e-12
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)

Query: 35  MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           +HK    HRD+ A NIL+ +    K+ DFG++  +N   +      G  +   W APE  
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY---WMAPEVI 173

Query: 94  NFGR-FSSASDVWSFGITLWEMYSFGQQPY 122
             G+ + + +D+WS GIT++EM + G  PY
Sbjct: 174 TEGKYYDTKADIWSLGITIYEM-ATGNPPY 202

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 60.3 bits (147), Expect = 6e-12
 Identities = 37/123 (30%), Positives = 53/123 (43%), Gaps = 25/123 (20%)

Query: 16  YALPYIEGQIPAKVCR-------YL-KMHKSSFHRDLAARNILLASRHQAKISDFGLSRA 67
             +   E QI A VCR       YL   +    HRD+ + NILL+     K++DFG +  
Sbjct: 109 NFVRMNEPQI-AYVCREVLQGLEYLHSQNV--IHRDIKSDNILLSKDGSVKLADFGFAAQ 165

Query: 68  VNSERNYYKATHGGRWPIKWYAPE-----SYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           +  E++   +  G  +   W APE      Y         D+WS GI   EM + G+ PY
Sbjct: 166 LTKEKSKRNSVVGTPY---WMAPEVIKRKDYGP-----KVDIWSLGIMCIEM-AEGEPPY 216

Query: 123 GEM 125
              
Sbjct: 217 LRE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 7e-12
 Identities = 30/105 (28%), Positives = 44/105 (41%), Gaps = 21/105 (20%)

Query: 26  PAKVCRYLKM--------HKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK 76
            + +  YL          H     HRDL   N+L+ +    K++DFGL+R+  S    Y 
Sbjct: 97  ESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156

Query: 77  ---ATHGGRWPIKWY-APES-YNFGRFSSASDVWSFGITLWEMYS 116
               T       +WY APE       +S+  D+WS G    E+ S
Sbjct: 157 HYVVT-------RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS 194

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 59.6 bits (145), Expect = 1e-11
 Identities = 40/114 (35%), Positives = 59/114 (51%), Gaps = 17/114 (14%)

Query: 22  EGQIPAKVCRY-LK----MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAV---NSER 72
           E +I A +    LK    +H +   HRD+ A NILL    QAK++DFG+S  +    ++R
Sbjct: 98  EEEI-AAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156

Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
           N    T     P  W APE      +++ +D+WS GIT  EM   G+ PY ++ 
Sbjct: 157 NTVIGT-----PF-WMAPEVIQEIGYNNKADIWSLGITAIEMAE-GKPPYSDIH 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 59.4 bits (144), Expect = 1e-11
 Identities = 35/89 (39%), Positives = 48/89 (53%), Gaps = 8/89 (8%)

Query: 36  HKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN 94
           HK +F HRD+   NILL ++ Q K++DFGL+R  NSE       +  +    WY P    
Sbjct: 133 HKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE---SRPYTNKVITLWYRPPELL 189

Query: 95  FG--RFSSASDVWSFGITLWEMYSFGQQP 121
            G  R+  A DVWS G  L E+  F ++P
Sbjct: 190 LGEERYGPAIDVWSCGCILGEL--FTKKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 58.8 bits (143), Expect = 2e-11
 Identities = 27/85 (31%), Positives = 48/85 (56%), Gaps = 10/85 (11%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNS---ERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+L+ S+ + KI+DFG+S+ + +   + N +  T      + + +PE      
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGT------VTYMSPERIQGES 176

Query: 98  FSSASDVWSFGITLWEMYSFGQQPY 122
           +S A+D+WS G+TL E    G+ P+
Sbjct: 177 YSYAADIWSLGLTLLECA-LGKFPF 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 58.3 bits (141), Expect = 3e-11
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 8/90 (8%)

Query: 41  HRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
           HRD+   NIL+ SR Q K+ DFG+S   +NS  + +  T        + +PE    G+++
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTS------TYMSPERIQGGKYT 180

Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             SDVWS GI++ E+ + G+ P+      D
Sbjct: 181 VKSDVWSLGISIIEL-ALGKFPFAFSNIDD 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 4e-11
 Identities = 39/119 (32%), Positives = 54/119 (45%), Gaps = 20/119 (16%)

Query: 19  PYIEGQIPAKVCRY-LK----MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVN--- 69
           P  E QI A VCR  LK    +H     HRD+   NILL      K++DFG+S  +    
Sbjct: 97  PLSELQI-AYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155

Query: 70  SERNYYKATHGGRWPIKWYAPESYN---FGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           ++R  +  T     P  W APE       G +    D+W+ GIT  E+    Q P  ++
Sbjct: 156 AKRKSFIGT-----PY-WMAPEVAAVERKGGYDGKCDIWALGITAIELAE-LQPPMFDL 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 58.4 bits (141), Expect = 4e-11
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 8/89 (8%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRA-VNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
           HRD+   N+L+ +R Q K+ DFG+S   VNS    Y  T+       + APE  +  ++ 
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNA------YMAPERISGEQYG 171

Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGS 128
             SDVWS GI+  E+ + G+ PY +++ +
Sbjct: 172 IHSDVWSLGISFMEL-ALGRFPYPQIQKN 199

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 58.3 bits (142), Expect = 4e-11
 Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 17/97 (17%)

Query: 29  VCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATHG 80
           + R LK +H ++  HRDL   NIL+ S    KI DFGL+R V+ + +       Y  T  
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT-- 169

Query: 81  GRWPIKWY-APE-SYNFGRFSSASDVWSFGITLWEMY 115
                +WY APE   +  R++ A D+WS G    E+ 
Sbjct: 170 -----RWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 57.9 bits (140), Expect = 5e-11
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 16/98 (16%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAV-----NSERNYYKATHGGRWPIKWYAPE 91
           K   HRDL A N+L+ +    KISDFG+S+       N +    + +      + W APE
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS------VFWMAPE 180

Query: 92  ---SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
              SY+ G +S+  D+WS G  + EM++ G++P+ + +
Sbjct: 181 VIHSYSQG-YSAKVDIWSLGCVVLEMFA-GRRPWSDEE 216

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 57.5 bits (139), Expect = 7e-11
 Identities = 40/116 (34%), Positives = 56/116 (48%), Gaps = 15/116 (12%)

Query: 22  EGQIPAKVCRY-LK----MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY 75
           E QI A VC   LK    +H +   HRD+ + +ILL S  + K+SDFG    V+ E    
Sbjct: 114 EEQI-ATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172

Query: 76  KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYS-----FGQQPYGEMK 126
           K+  G  +   W APE  +   + +  D+WS GI + EM       F + P   MK
Sbjct: 173 KSLVGTPY---WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK 225

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 57.4 bits (139), Expect = 8e-11
 Identities = 35/96 (36%), Positives = 47/96 (48%), Gaps = 11/96 (11%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAP 90
           YLK      HRD+   NILL +    K+ DFG+S R V+S     KA         + AP
Sbjct: 129 YLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS-----KAKTRSAGCAAYMAP 183

Query: 91  E----SYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           E         ++   +DVWS GI+L E+ + GQ PY
Sbjct: 184 ERIDPPDPNPKYDIRADVWSLGISLVELAT-GQFPY 218

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 56.7 bits (137), Expect = 1e-10
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 10/98 (10%)

Query: 21  IEGQIPAKVCR---YLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYK 76
           I G+I   V R   YL+      HRD+   NIL+ SR + K+ DFG+S + ++S  N + 
Sbjct: 100 ILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 159

Query: 77  ATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEM 114
            T        + +PE      ++  SD+WS G++L EM
Sbjct: 160 GTR------SYMSPERLQGTHYTVQSDIWSLGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 56.6 bits (137), Expect = 1e-10
 Identities = 37/98 (37%), Positives = 49/98 (50%), Gaps = 20/98 (20%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRA--VNSERNY-----YKATHGGRWPIKWY-APE- 91
           HRDL   N+L+ +  + KI DFGL+R    N   N      Y AT       +WY APE 
Sbjct: 128 HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT-------RWYRAPEI 180

Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             +F  ++ A DVWS G  L E+   G++P    KG D
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELL--GRKPV--FKGKD 214

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 56.5 bits (136), Expect = 1e-10
 Identities = 36/107 (33%), Positives = 49/107 (45%), Gaps = 11/107 (10%)

Query: 22  EGQIPAKVCRYLK-----MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY 75
           EGQI A VCR        +H +   HRD+ + NILL      K++DFG    +  E++  
Sbjct: 114 EGQI-AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172

Query: 76  KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               G  +   W APE      +    D+WS GI   EM   G+ PY
Sbjct: 173 STMVGTPY---WMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 56.4 bits (137), Expect = 2e-10
 Identities = 24/83 (28%), Positives = 38/83 (45%), Gaps = 21/83 (25%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERN---------YYKATHGGRWPIKWYAPE 91
           HRD+  +NI L S    K+ DFG+S+ ++S  +         YY             +PE
Sbjct: 126 HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYY------------LSPE 173

Query: 92  SYNFGRFSSASDVWSFGITLWEM 114
                 ++  SD+WS G  L+E+
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYEL 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 2e-10
 Identities = 38/108 (35%), Positives = 52/108 (48%), Gaps = 26/108 (24%)

Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSE---RNYYKATHGGRWPIKW 87
            YL  +K   HRD+  +NILL    + K+ DFG+S  ++S    RN +  T     P  W
Sbjct: 127 AYLHENKV-IHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGT-----PY-W 179

Query: 88  YAPE----------SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            APE          SY+     + SDVWS GIT  E+   G+ P  +M
Sbjct: 180 MAPEVIACDEQPDASYD-----ARSDVWSLGITAIELAD-GKPPLCDM 221

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 56.0 bits (135), Expect = 2e-10
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 9/99 (9%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWP-----IK 86
           YL   +   HRD+   NIL+ ++   KISDFG+S+ +  E N       G  P     + 
Sbjct: 121 YLHN-RGIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARPSLQGSVF 177

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           W APE      ++  +D+WS G  + EM + G+ P+ + 
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLT-GKHPFPDC 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 56.1 bits (136), Expect = 2e-10
 Identities = 25/88 (28%), Positives = 43/88 (48%), Gaps = 4/88 (4%)

Query: 28  KVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
             C       ++  HRDL   NI L + +  K+ DFGL++ +  + + +  T+ G  P  
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKTYVGT-PYY 176

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEM 114
             +PE  N   +   SD+WS G  ++E+
Sbjct: 177 M-SPEQLNHMSYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 55.8 bits (135), Expect = 3e-10
 Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 12/86 (13%)

Query: 35  MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSE--RNYYKATH--GGRWPIKWYA 89
           MH +   HRDL   N+L+++    KI+DFGL+R  + E  R Y   +H    RW   + A
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY---SHQVATRW---YRA 168

Query: 90  PES-YNFGRFSSASDVWSFGITLWEM 114
           PE  Y   ++    D+W+ G    E+
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAEL 194

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 55.8 bits (134), Expect = 3e-10
 Identities = 38/117 (32%), Positives = 60/117 (51%), Gaps = 15/117 (12%)

Query: 17  ALPYIEGQIPAKVCRYLK----MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNS- 70
           A P+ E QI   +   LK    +H +   HRD+ A N+LL+ +   K++DFG++  +   
Sbjct: 95  AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154

Query: 71  --ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
             +RN +  T     P  W APE      + S +D+WS GIT  E+ + G+ P  +M
Sbjct: 155 QIKRNTFVGT-----PF-WMAPEVIQQSAYDSKADIWSLGITAIEL-AKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 55.6 bits (134), Expect = 3e-10
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 20/96 (20%)

Query: 31  RYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSER------NYYKATHGGR 82
           R LK +H ++ FHRDL  +NIL  +  + KI DFGL+R   ++         Y AT    
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT---- 169

Query: 83  WPIKWY-APE---SYNFGRFSSASDVWSFGITLWEM 114
              +WY APE   S+ F +++ A D+WS G    E+
Sbjct: 170 ---RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEV 201

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 55.5 bits (133), Expect = 4e-10
 Identities = 37/115 (32%), Positives = 59/115 (51%), Gaps = 15/115 (13%)

Query: 19  PYIEGQIPAKVCRYLK----MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNS--- 70
           P  E QI   +   LK    +H +   HRD+ A N+LL+   + K++DFG++  +     
Sbjct: 97  PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156

Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +RN +  T     P  W APE      + S +D+WS GIT  E+ + G+ P+ E+
Sbjct: 157 KRNTFVGT-----PF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 55.3 bits (134), Expect = 5e-10
 Identities = 32/90 (35%), Positives = 41/90 (45%), Gaps = 27/90 (30%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNY--------YKATHGGRWPIKWY-APE 91
           HRDL   NILL S  + K++DFGL+R+++             Y AT       +WY APE
Sbjct: 130 HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT-------RWYRAPE 182

Query: 92  ------SYNFGRFSSASDVWSFGITLWEMY 115
                  Y  G      D+WS G  L EM 
Sbjct: 183 ILLGSTRYTKG-----VDMWSVGCILGEML 207

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 54.9 bits (132), Expect = 5e-10
 Identities = 37/119 (31%), Positives = 56/119 (47%), Gaps = 20/119 (16%)

Query: 23  GQIPAKV-CRYLK--------MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAV---- 68
           G +P  V C+Y K        +H +   HRD+   N++L      K+ DFG +R +    
Sbjct: 97  GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156

Query: 69  --NSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
              +  N  K+ HG  +   W APE  N   +   SD+WS G T++EM + G+ P   M
Sbjct: 157 LHGTHSNMLKSMHGTPY---WMAPEVINESGYGRKSDIWSIGCTVFEMAT-GKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 54.5 bits (132), Expect = 7e-10
 Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 10/88 (11%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVN---SERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+ A NILL+     K++DFG+S  +    S+RN +  T     P  W APE      
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGT-----PF-WMAPEVIKQSG 174

Query: 98  FSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +   +D+WS GIT  E+   G+ P  ++
Sbjct: 175 YDEKADIWSLGITAIELAK-GEPPLSDL 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 54.4 bits (131), Expect = 7e-10
 Identities = 28/84 (33%), Positives = 41/84 (48%), Gaps = 4/84 (4%)

Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           RYL   K   HRDL   NI+L    +  I+DFGL++    E +   +  G    I +  P
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTSVVG---TILYSCP 182

Query: 91  ESYNFGRFSSASDVWSFGITLWEM 114
           E      +   +DVW+FG  L++M
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 54.5 bits (132), Expect = 8e-10
 Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 19/96 (19%)

Query: 26  PAKVCRYLKM--------HKSSF-HRDLAARNILLASRHQAKISDFGLSRA-VNSERNYY 75
           PA +  Y+ M        H +   HRDL   N+L+AS    K++DFGL+R+  +  R   
Sbjct: 101 PADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM- 159

Query: 76  KATHGGRWPIKWY-APESYNFG--RFSSASDVWSFG 108
             TH  +   +WY APE   FG   +    D+WS G
Sbjct: 160 --TH--QVVTRWYRAPELL-FGARHYGVGVDMWSVG 190

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 54.4 bits (131), Expect = 8e-10
 Identities = 30/88 (34%), Positives = 52/88 (59%), Gaps = 6/88 (6%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN-FGRFS 99
           HRD+   NIL+ +    K++DFG+++ V  E ++ K+  G  +   W APE     G + 
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSFKGSPY---WMAPEVIAQQGGYG 180

Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKG 127
            A+D+WS G T+ EM + G+ P+ +++G
Sbjct: 181 LAADIWSLGCTVLEMAT-GKPPWSQLEG 207

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 54.2 bits (131), Expect = 1e-09
 Identities = 28/76 (36%), Positives = 39/76 (51%), Gaps = 9/76 (11%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE-SYNFGRF 98
           HRDL   NI +    + KI DFGL+R  + E   Y AT       +WY APE   N+  +
Sbjct: 141 HRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVAT-------RWYRAPEIMLNWMHY 193

Query: 99  SSASDVWSFGITLWEM 114
           +   D+WS G  + E+
Sbjct: 194 NQTVDIWSVGCIMAEL 209

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 54.4 bits (131), Expect = 1e-09
 Identities = 35/97 (36%), Positives = 47/97 (48%), Gaps = 11/97 (11%)

Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYA 89
            YL    S  HRD+   N+L+    Q K+ DFG+S   V+S     K    G  P  + A
Sbjct: 117 EYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKTIDAGCKP--YMA 171

Query: 90  PESYNFGR----FSSASDVWSFGITLWEMYSFGQQPY 122
           PE  N       +   SDVWS GIT+ E+ + G+ PY
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIEL-ATGRFPY 207

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 54.3 bits (130), Expect = 1e-09
 Identities = 36/107 (33%), Positives = 49/107 (45%), Gaps = 11/107 (10%)

Query: 22  EGQIPAKVCRYLK-----MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY 75
           EGQI A VCR        +H +   HRD+ + NILL      K++DFG    +  E++  
Sbjct: 114 EGQI-AAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172

Query: 76  KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               G  +   W APE      +    D+WS GI   EM   G+ PY
Sbjct: 173 STMVGTPY---WMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 54.0 bits (130), Expect = 1e-09
 Identities = 31/76 (40%), Positives = 40/76 (52%), Gaps = 9/76 (11%)

Query: 41  HRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWY-APESYNFGRF 98
           HRD+   NILL  + Q K+ DFG+S   VNS    +  T        +Y APE      +
Sbjct: 128 HRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGT-------SFYMAPERIQGKPY 180

Query: 99  SSASDVWSFGITLWEM 114
           S  SDVWS G+TL E+
Sbjct: 181 SITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 54.0 bits (131), Expect = 1e-09
 Identities = 31/84 (36%), Positives = 39/84 (46%), Gaps = 20/84 (23%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK--WY-APE----- 91
            HRDL  +NIL+      K++DFGL+RA       Y  TH     +   WY APE     
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THE----VVTLWYRAPEILLGS 173

Query: 92  -SYNFGRFSSASDVWSFGITLWEM 114
             Y     S+A D+WS G    EM
Sbjct: 174 KHY-----STAVDIWSVGCIFAEM 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 53.9 bits (129), Expect = 1e-09
 Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 11/105 (10%)

Query: 21  IEGQIPAKVCR---YLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYK 76
           I G++   V R   YL+      HRD+   NIL+ SR + K+ DFG+S + ++S  N + 
Sbjct: 104 ILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 163

Query: 77  ATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQP 121
            T        + +PE      +S  SD+WS G++L E+ + G+ P
Sbjct: 164 GTR------SYMSPERLQGTHYSVQSDIWSMGLSLVEL-AIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 53.6 bits (128), Expect = 2e-09
 Identities = 36/107 (33%), Positives = 49/107 (45%), Gaps = 11/107 (10%)

Query: 22  EGQIPAKVCRYLK-----MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY 75
           EGQI A VCR        +H +   HRD+ + NILL      K++DFG    +  E++  
Sbjct: 115 EGQI-AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173

Query: 76  KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               G  +   W APE      +    D+WS GI   EM   G+ PY
Sbjct: 174 STMVGTPY---WMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 53.5 bits (129), Expect = 2e-09
 Identities = 26/82 (31%), Positives = 38/82 (46%), Gaps = 5/82 (6%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRD+   NILL  +    I+DF ++  V  +      T        + APE      +S 
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----TTSTSGTPGYMAPEVLCRQGYSV 178

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
           A D WS G+T +E    G++PY
Sbjct: 179 AVDWWSLGVTAYECL-RGKRPY 199

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 52.7 bits (126), Expect = 3e-09
 Identities = 29/82 (35%), Positives = 42/82 (51%), Gaps = 4/82 (4%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRD+ + +ILL    + K+SDFG    V+ E    K+  G  +   W APE  +   +  
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY---WMAPELISRLPYGP 195

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
             D+WS GI + EM   G+ PY
Sbjct: 196 EVDIWSLGIMVIEMVD-GEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 53.1 bits (127), Expect = 3e-09
 Identities = 35/110 (31%), Positives = 56/110 (50%), Gaps = 14/110 (12%)

Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSE 71
           LG  ++  I+G        YL+      HRD+   NIL+ SR + K+ DFG+S + ++S 
Sbjct: 105 LGKVSIAVIKG------LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158

Query: 72  RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQP 121
            N +  T        + +PE      +S  SD+WS G++L EM + G+ P
Sbjct: 159 ANSFVGTR------SYMSPERLQGTHYSVQSDIWSMGLSLVEM-AIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 52.7 bits (127), Expect = 3e-09
 Identities = 33/92 (35%), Positives = 44/92 (47%), Gaps = 19/92 (20%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK----WYAPE----- 91
           HRD+ A NILL      KI+DFG+S ++    +    T   R        W APE     
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGD---RTRKVRKTFVGTPCWMAPEVMEQV 181

Query: 92  -SYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y+F      +D+WSFGIT  E+ + G  PY
Sbjct: 182 HGYDFK-----ADIWSFGITAIEL-ATGAAPY 207

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 52.8 bits (125), Expect = 4e-09
 Identities = 36/115 (31%), Positives = 52/115 (45%), Gaps = 10/115 (8%)

Query: 24  QIPAKVCRYLK-MHKSSF-HRDLAARNILL-ASRHQAKISDFGLSRAVNSE--RNYYKAT 78
            I A++   L+ +H     HRD+   NILL       K+ DFGL++ +      +   A 
Sbjct: 105 FILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPAL 164

Query: 79  HGGRWPIKWY-APESY---NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                    Y APE     +    SS+SD+WS GITL+E+   G  P+   K S 
Sbjct: 165 PSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL-LTGLPPFEGEKNSS 218

Length = 384

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 52.5 bits (126), Expect = 4e-09
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 9/94 (9%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE----SYNFG 96
           HRD+   N+L+ S    KI+DFG+SR +    +   ++ G    I + +PE      N G
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVG---TIAYMSPERINTDLNHG 247

Query: 97  RFSS-ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            +   A D+WS G+++ E Y  G+ P+G  +  D
Sbjct: 248 AYDGYAGDIWSLGVSILEFY-LGRFPFGVGRQGD 280

Length = 353

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 52.4 bits (125), Expect = 5e-09
 Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 13/108 (12%)

Query: 22  EGQIPAKVCR-------YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY 74
           E QI A VCR       +L  ++   HRD+ + N+LL      K++DFG    +  E++ 
Sbjct: 114 EAQI-AAVCRECLQALEFLHANQV-IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171

Query: 75  YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                G  +   W APE      +    D+WS GI   EM   G+ PY
Sbjct: 172 RSTMVGTPY---WMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 52.1 bits (125), Expect = 5e-09
 Identities = 33/87 (37%), Positives = 45/87 (51%), Gaps = 11/87 (12%)

Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
            YL  H+   HRD+ A NILL      K++DFG S ++ S  N +  T     P  W AP
Sbjct: 129 AYLHSHER-IHRDIKAGNILLTEPGTVKLADFG-SASLVSPANSFVGT-----PY-WMAP 180

Query: 91  E---SYNFGRFSSASDVWSFGITLWEM 114
           E   + + G++    DVWS GIT  E+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 52.0 bits (124), Expect = 6e-09
 Identities = 30/82 (36%), Positives = 44/82 (53%), Gaps = 4/82 (4%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRD+ + +ILL S  + K+SDFG    V+ E    K+  G  +   W APE  +   + +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY---WMAPEVISRLPYGT 197

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
             D+WS GI + EM   G+ PY
Sbjct: 198 EVDIWSLGIMVIEMID-GEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 6e-09
 Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 6/97 (6%)

Query: 21  IEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHG 80
           IE QI  +  RYL   +   HRD+   NI +    Q  I D G ++       +     G
Sbjct: 162 IEKQI-LEGLRYLHAQRI-IHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----G 215

Query: 81  GRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
               ++  APE     +++S +D+WS GI L+EM ++
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAY 252

Length = 357

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 51.7 bits (124), Expect = 7e-09
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 14/86 (16%)

Query: 35  MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE-- 91
           +HK+   HRD+   NI L      K+ DFG+S+ + SE +  +   G  +   + +PE  
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY---YMSPELC 173

Query: 92  ---SYNFGRFSSASDVWSFGITLWEM 114
               YNF      SD+W+ G  L+E+
Sbjct: 174 QGVKYNF-----KSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 51.4 bits (124), Expect = 8e-09
 Identities = 25/89 (28%), Positives = 39/89 (43%), Gaps = 14/89 (15%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNY---YKA-THGGRWPIKWYA 89
           +H +   HRD+   NIL+ +    K++DFGL+R      +     +  T        WY 
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITL-------WYR 168

Query: 90  PESYNFG--RFSSASDVWSFGITLWEMYS 116
           P     G  R+    D+WS G  L E++ 
Sbjct: 169 PPELLLGATRYGPEVDMWSVGCILAELFL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 9e-09
 Identities = 30/84 (35%), Positives = 40/84 (47%), Gaps = 22/84 (26%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI---KWY-APE----- 91
           HRDL  +NIL+ S  Q KI+DFGL+R  + E      T      +    WY APE     
Sbjct: 130 HRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALT-----SVVVTLWYRAPEVLLQS 181

Query: 92  SYNFGRFSSASDVWSFGITLWEMY 115
           SY      +  D+WS G    E++
Sbjct: 182 SYA-----TPVDMWSVGCIFAELF 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 51.3 bits (123), Expect = 1e-08
 Identities = 28/83 (33%), Positives = 47/83 (56%), Gaps = 6/83 (7%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSR-AVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
           +RDL   NILL      K++DFGLS+ +++ E+  Y         +++ APE  N    +
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG----TVEYMAPEVVNRRGHT 176

Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
            ++D WSFG+ ++EM + G  P+
Sbjct: 177 QSADWWSFGVLMFEMLT-GSLPF 198

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 51.4 bits (124), Expect = 1e-08
 Identities = 24/102 (23%), Positives = 40/102 (39%), Gaps = 24/102 (23%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL   NILL      KI+DFG ++ ++                   +    N  RF+S
Sbjct: 125 HRDLKPENILLDKDMHIKITDFGTAKVLDPN---SSPESNKGDATNIDSQIEKNRRRFAS 181

Query: 101 --------------------ASDVWSFGITLWEMYSFGQQPY 122
                               +SD+W+ G  +++M + G+ P+
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT-GKPPF 222

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 51.1 bits (122), Expect = 1e-08
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 13/91 (14%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APES-YNFGRF 98
           HRDL   N+ +    + KI DFGL+R  +SE   Y  T       +WY APE   N+  +
Sbjct: 141 HRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVT-------RWYRAPEVILNWMHY 193

Query: 99  SSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +   D+WS G  + EM + G+  +   KG D
Sbjct: 194 TQTVDIWSVGCIMAEMLT-GKPLF---KGHD 220

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 51.3 bits (123), Expect = 1e-08
 Identities = 28/95 (29%), Positives = 39/95 (41%), Gaps = 13/95 (13%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRA-VNS--ERNYYKATHGGRWP------ 84
           +HK  F HRDL+  NI + S+   KI+DFGL+R            K     R        
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKV 194

Query: 85  -IKWYAPESYNFG--RFSSASDVWSFGITLWEMYS 116
              WY       G  ++  A D+WS G    E+ +
Sbjct: 195 VTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Length = 335

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 51.2 bits (123), Expect = 1e-08
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 18/95 (18%)

Query: 31  RYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSE----RNY---YKATHGG 81
           R LK +H ++  HRDL   N+L+    + +I DFG++R ++S     + +   Y AT   
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT--- 174

Query: 82  RWPIKWY-APE-SYNFGRFSSASDVWSFGITLWEM 114
               +WY APE   +   +++A D+WS G    EM
Sbjct: 175 ----RWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 51.0 bits (122), Expect = 1e-08
 Identities = 35/121 (28%), Positives = 50/121 (41%), Gaps = 39/121 (32%)

Query: 15  SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQA--------KISDFGLSR 66
           ++AL ++E              K   H ++ A+N+LL              K+SD G+S 
Sbjct: 110 AWALHFLE-------------DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156

Query: 67  AVNS-----ERNYYKATHGGRWPIKWYAPESYNFGR-FSSASDVWSFGITLWEMYSFGQQ 120
            V       ER            I W  PE     +  S A+D WSFG TLWE++S G +
Sbjct: 157 TVLPKEILLER------------IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDK 204

Query: 121 P 121
           P
Sbjct: 205 P 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 50.9 bits (122), Expect = 1e-08
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 6/78 (7%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR--F 98
           HRDL  +N+L+  R + K++DFGL+RA     N    T        WY       G   +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVN----TFSNEVVTLWYRAPDVLLGSRTY 178

Query: 99  SSASDVWSFGITLWEMYS 116
           S++ D+WS G  + EM +
Sbjct: 179 STSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 51.2 bits (123), Expect = 1e-08
 Identities = 31/85 (36%), Positives = 45/85 (52%), Gaps = 12/85 (14%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNY---YKATHGGRWPIKWYAPES-YNFG 96
           HRDL   N+LL +    KI DFGL+R  + + ++   Y  T   RW   + APE   N  
Sbjct: 131 HRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVT---RW---YRAPELLLNCS 184

Query: 97  RFSSASDVWSFGITLWEMYSFGQQP 121
            +++A DVWS G    E+   G++P
Sbjct: 185 EYTTAIDVWSVGCIFAEL--LGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 50.4 bits (120), Expect = 2e-08
 Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 10/88 (11%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNS---ERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+ A N+LL+ +   K++DFG++  +     +RN +  T     P  W APE      
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT-----PF-WMAPEVIKQSA 177

Query: 98  FSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +   +D+WS GIT  E+ + G+ P  ++
Sbjct: 178 YDFKADIWSLGITAIEL-AKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 50.4 bits (120), Expect = 2e-08
 Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 11/86 (12%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL  H +  HRD+ A NILL    Q K++DFG S + +S  N +  T        W APE
Sbjct: 136 YLHSH-NMIHRDIKAGNILLTEPGQVKLADFG-SASKSSPANSFVGTP------YWMAPE 187

Query: 92  ---SYNFGRFSSASDVWSFGITLWEM 114
              + + G++    DVWS GIT  E+
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 50.1 bits (120), Expect = 3e-08
 Identities = 37/95 (38%), Positives = 49/95 (51%), Gaps = 10/95 (10%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAP 90
           YLK      HRD+   NILL      K+ DFG+S + V+S     K    G  P  + AP
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS---IAKTRDAGCRP--YMAP 176

Query: 91  ESYN-FGR--FSSASDVWSFGITLWEMYSFGQQPY 122
           E  +   R  +   SDVWS GITL+E+ + G+ PY
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEV-ATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 49.6 bits (119), Expect = 5e-08
 Identities = 28/91 (30%), Positives = 43/91 (47%), Gaps = 10/91 (10%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAV--NSERNYYKATHGGR-----WPIK 86
           +H++   HRD+ A NIL+ ++   KI+DFGL+R               G R        +
Sbjct: 131 LHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190

Query: 87  WYAPESYNFG--RFSSASDVWSFGITLWEMY 115
           WY P     G  R+++A D+W  G    EM+
Sbjct: 191 WYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 49.6 bits (118), Expect = 5e-08
 Identities = 25/81 (30%), Positives = 41/81 (50%), Gaps = 6/81 (7%)

Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            +   HRDL  +N+L+  + + K++DFGL+RA    ++    T+       WY P     
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARA----KSVPTKTYSNEVVTLWYRPPDVLL 176

Query: 96  G--RFSSASDVWSFGITLWEM 114
           G   +S+  D+W  G  L+EM
Sbjct: 177 GSTEYSTPIDMWGVGCILYEM 197

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 49.5 bits (119), Expect = 5e-08
 Identities = 31/87 (35%), Positives = 40/87 (45%), Gaps = 27/87 (31%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK------- 86
           +H +   HRDL   N+LL +R   KI DFGL+R   S             P+K       
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS-------------PLKPYTQLVV 168

Query: 87  --WY-APESYNFG--RFSSASDVWSFG 108
             WY APE    G   +S+A D+WS G
Sbjct: 169 TLWYRAPELL-LGAKEYSTAIDMWSVG 194

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 49.4 bits (118), Expect = 5e-08
 Identities = 35/105 (33%), Positives = 49/105 (46%), Gaps = 19/105 (18%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQ--------AKISDFGLSRAVNSERNYYKAT 78
           A    YL+  K   H ++  +NIL+A R+          K+SD G+   V S R      
Sbjct: 111 ASALHYLE-DKKLVHGNVCGKNILVA-RYGLNEGYVPFIKLSDPGIPITVLS-REERVE- 166

Query: 79  HGGRWPIKWYAPESYNFGR--FSSASDVWSFGITLWEMYSFGQQP 121
                 I W APE    G+   + A+D WSFG TL E+ S G++P
Sbjct: 167 -----RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 49.3 bits (117), Expect = 5e-08
 Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 11/86 (12%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL  H +  HRD+ A NILL    Q K++DFG S ++ S  N +  T        W APE
Sbjct: 140 YLHSH-NMIHRDIKAGNILLTEPGQVKLADFG-SASIASPANSFVGTP------YWMAPE 191

Query: 92  ---SYNFGRFSSASDVWSFGITLWEM 114
              + + G++    DVWS GIT  E+
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 49.2 bits (118), Expect = 6e-08
 Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 13/88 (14%)

Query: 35  MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY--YKATHGGRWPIKWY-AP 90
           MH++  FHRD+   NIL+      K++DFG  R + S+  Y  Y +T       +WY AP
Sbjct: 116 MHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYIST-------RWYRAP 167

Query: 91  ES-YNFGRFSSASDVWSFGITLWEMYSF 117
           E     G +    D+W+ G   +E+ S 
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILSL 195

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 49.3 bits (117), Expect = 6e-08
 Identities = 27/82 (32%), Positives = 43/82 (52%), Gaps = 4/82 (4%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRD+ + +ILL    + K+SDFG    ++ +    K+  G  +   W APE  +   + +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY---WMAPEVISRTPYGT 196

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
             D+WS GI + EM   G+ PY
Sbjct: 197 EVDIWSLGIMVIEMVD-GEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 48.7 bits (117), Expect = 8e-08
 Identities = 29/86 (33%), Positives = 43/86 (50%), Gaps = 12/86 (13%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA---THGGRWPIKWY-APESYNFG 96
           +RDL   NILL +    K++DFGL++ ++SE +       T         Y APE     
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE-------YLAPEVLLGK 168

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +  A D WS G+ L+EM   G+ P+
Sbjct: 169 GYGKAVDWWSLGVLLYEML-TGKPPF 193

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 48.6 bits (116), Expect = 8e-08
 Identities = 30/77 (38%), Positives = 41/77 (53%), Gaps = 5/77 (6%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL + NILL +    KI D G+S+ +    N  K   G   P  + APE +    +S 
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKK--NMAKTQIGT--PH-YMAPEVWKGRPYSY 180

Query: 101 ASDVWSFGITLWEMYSF 117
            SD+WS G  L+EM +F
Sbjct: 181 KSDIWSLGCLLYEMATF 197

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 48.4 bits (115), Expect = 1e-07
 Identities = 27/79 (34%), Positives = 38/79 (48%), Gaps = 12/79 (15%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK---WY-APESYNFG 96
           HRDL   NIL+ S  Q K++DFGL+R          +      P+    WY APE     
Sbjct: 131 HRDLKPENILVTSGGQVKLADFGLARIY--------SCQMALTPVVVTLWYRAPEVLLQS 182

Query: 97  RFSSASDVWSFGITLWEMY 115
            +++  D+WS G    EM+
Sbjct: 183 TYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 48.5 bits (116), Expect = 1e-07
 Identities = 27/83 (32%), Positives = 39/83 (46%), Gaps = 19/83 (22%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAV--NSERNY--YKATHGGRWPIKWY-APE---- 91
           HRD+   NIL++     K+ DFG +RA+          Y AT       +WY APE    
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVAT-------RWYRAPELLVG 175

Query: 92  SYNFGRFSSASDVWSFGITLWEM 114
             N+G+     DVW+ G  + E+
Sbjct: 176 DTNYGK---PVDVWAIGCIMAEL 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 48.3 bits (115), Expect = 1e-07
 Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 12/98 (12%)

Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           ++LK   +  HRD+   N+L+    Q K+ DFG+S   N   +  K   G +    + AP
Sbjct: 116 KFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQ---SYMAP 170

Query: 91  ESYNFG------RFSSASDVWSFGITLWEMYSFGQQPY 122
           E    G       ++  SDVWS G+++ EM + G+ PY
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEM-ALGRYPY 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 48.3 bits (115), Expect = 1e-07
 Identities = 38/117 (32%), Positives = 55/117 (47%), Gaps = 14/117 (11%)

Query: 1   MKSPNGSGVVTPL-GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKI 59
           M +   SG+  PL  SY    ++G        +   H+   HRDL  +N+L+ +    K+
Sbjct: 89  MDASPLSGIPLPLIKSYLFQLLQG------LAFCHSHRV-LHRDLKPQNLLINTEGAIKL 141

Query: 60  SDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFGRF-SSASDVWSFGITLWEM 114
           +DFGL+RA       Y  TH       WY APE     ++ S+A D+WS G    EM
Sbjct: 142 ADFGLARAFGVPVRTY--TH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 47.9 bits (114), Expect = 2e-07
 Identities = 29/85 (34%), Positives = 46/85 (54%), Gaps = 8/85 (9%)

Query: 35  MH-KSSFHRDLAARNILLASRHQ--AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           +H K   HRDL  +NILL  +H+   KI DFG+S+ ++S+   Y        P  + +PE
Sbjct: 117 VHTKLILHRDLKTQNILL-DKHKMVVKIGDFGISKILSSKSKAYTVVGT---PC-YISPE 171

Query: 92  SYNFGRFSSASDVWSFGITLWEMYS 116
                 ++  SD+W+ G  L+E+ S
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 47.7 bits (114), Expect = 2e-07
 Identities = 30/77 (38%), Positives = 39/77 (50%), Gaps = 8/77 (10%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSE-RNYYKATHGGRWPIKWY-APESYNFGR- 97
           HRDL  +N+L+      K++DFGL+RA     R Y   TH       WY APE     R 
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY---TH--EVVTLWYRAPEILLGSRQ 176

Query: 98  FSSASDVWSFGITLWEM 114
           +S+  D+WS G    EM
Sbjct: 177 YSTPVDIWSIGCIFAEM 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 47.5 bits (113), Expect = 2e-07
 Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 4/84 (4%)

Query: 35  MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           +H K   HRD+ + N+ L +    KI D G+++ ++   N+     G  +   + +PE  
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY---YLSPELC 173

Query: 94  NFGRFSSASDVWSFGITLWEMYSF 117
               ++  SDVW+ G+ L+E  + 
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTG 197

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 47.6 bits (113), Expect = 2e-07
 Identities = 39/111 (35%), Positives = 49/111 (44%), Gaps = 26/111 (23%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQA-------KISDFG-----LSRAVNSERNY 74
           A    YL+  K+  H ++ A+NILLA    A       K+SD G     LSR    ER  
Sbjct: 127 ASALSYLE-DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVER-- 183

Query: 75  YKATHGGRWPIKWYAPESY-NFGRFSSASDVWSFGITLWEMYSFGQQPYGE 124
                     I W APE        S+A+D WSFG TL E+   G+ P  E
Sbjct: 184 ----------IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 47.6 bits (113), Expect = 2e-07
 Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 5/81 (6%)

Query: 35  MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           MH +   HRDL A+NI L   +  KI DFG+SR +    +      G  +   + +PE+ 
Sbjct: 122 MHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPY---YMSPEAL 177

Query: 94  NFGRFSSASDVWSFGITLWEM 114
               + S SD+WS G  L+EM
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 2e-07
 Identities = 26/77 (33%), Positives = 37/77 (48%), Gaps = 6/77 (7%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSR---AVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   NIL  S    K+ DFG S+    + S     K+  G  +   W +PE  +   
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY---WMSPEVISGEG 183

Query: 98  FSSASDVWSFGITLWEM 114
           +   +DVWS G T+ EM
Sbjct: 184 YGRKADVWSVGCTVVEM 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 47.7 bits (113), Expect = 2e-07
 Identities = 31/86 (36%), Positives = 44/86 (51%), Gaps = 11/86 (12%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL  H +  HRD+ A NILL+     K+ DFG S ++ +  N +  T        W APE
Sbjct: 130 YLHSH-NMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXFVGTP------YWMAPE 181

Query: 92  ---SYNFGRFSSASDVWSFGITLWEM 114
              + + G++    DVWS GIT  E+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.4 bits (112), Expect = 2e-07
 Identities = 36/118 (30%), Positives = 51/118 (43%), Gaps = 13/118 (11%)

Query: 6   GSGVVTPLGSYALPYIEGQIPAKVCR------YLKMHKSSFHRDLAARNILLASRHQAKI 59
           G G +  +     P  E QI A V R      Y    K   HRD+   NILL      K+
Sbjct: 89  GGGSLQDIYHVTGPLSESQI-AYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKL 147

Query: 60  SDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR---FSSASDVWSFGITLWEM 114
           +DFG+S  + +     K+  G  +   W APE     R   ++   D+W+ GIT  E+
Sbjct: 148 ADFGVSAQITATIAKRKSFIGTPY---WMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 47.5 bits (113), Expect = 2e-07
 Identities = 27/101 (26%), Positives = 46/101 (45%), Gaps = 10/101 (9%)

Query: 29  VCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNY--YKATHGGRWPI 85
           +C    +H+    +RDL   N+LL      +ISD GL+  +   +       T G     
Sbjct: 105 ICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG----- 159

Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            + APE      +  + D ++ G TL+EM + G+ P+ + K
Sbjct: 160 -YMAPEVLQGEVYDFSVDWFALGCTLYEMIA-GRSPFRQRK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 47.3 bits (112), Expect = 3e-07
 Identities = 26/79 (32%), Positives = 40/79 (50%), Gaps = 6/79 (7%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG--R 97
            HRDL  +N+L+  R + K++DFGL+RA    ++    T+       WY P     G   
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA----KSVPTKTYSNEVVTLWYRPPDVLLGSSE 181

Query: 98  FSSASDVWSFGITLWEMYS 116
           +S+  D+W  G   +EM S
Sbjct: 182 YSTQIDMWGVGCIFFEMAS 200

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 47.3 bits (113), Expect = 3e-07
 Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 12/101 (11%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFG----LSRAVNSERNYYKATHGGRWPIKW 87
           YL  H    HRD+   NI L      K+ DFG    L     +     ++  G   P  +
Sbjct: 114 YLHSHGIV-HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT--PA-Y 169

Query: 88  YAPESYNFGRFSS---ASDVWSFGITLWEMYSFGQQPYGEM 125
            APE    G+      A+D+WS G  + EM + G++P+ E+
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMAT-GKRPWSEL 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 47.3 bits (112), Expect = 3e-07
 Identities = 25/77 (32%), Positives = 39/77 (50%), Gaps = 6/77 (7%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-- 97
            HRDL  +N+L+  R + K++DFGL+RA    ++    T+       WY P     G   
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA----KSIPTKTYSNEVVTLWYRPPDILLGSTD 181

Query: 98  FSSASDVWSFGITLWEM 114
           +S+  D+W  G   +EM
Sbjct: 182 YSTQIDMWGVGCIFYEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 46.9 bits (111), Expect = 3e-07
 Identities = 31/91 (34%), Positives = 44/91 (48%), Gaps = 11/91 (12%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE------SYN 94
           HRD+   NILL +    K+ DFG+S  + S R     + G  +   W APE       Y+
Sbjct: 151 HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF---WMAPEVIACEQQYD 207

Query: 95  FGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +  + +  DVWS GIT  E+   G  P  +M
Sbjct: 208 YS-YDARCDVWSLGITAIELGD-GDPPLFDM 236

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 47.2 bits (112), Expect = 4e-07
 Identities = 28/83 (33%), Positives = 42/83 (50%), Gaps = 10/83 (12%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APES 92
           +H +   HRDL   N+ +    + KI DFGL+R  ++E   Y  T       +WY APE 
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT-------RWYRAPEV 185

Query: 93  -YNFGRFSSASDVWSFGITLWEM 114
             N+  ++   D+WS G  + EM
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEM 208

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 46.5 bits (110), Expect = 5e-07
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 7/85 (8%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-AP 90
           +L  H+   HRDL  +NIL+ S  Q K++DFGL+R  +     ++          WY AP
Sbjct: 125 FLHSHRV-VHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMALTSVVVTLWYRAP 178

Query: 91  ESYNFGRFSSASDVWSFGITLWEMY 115
           E      +++  D+WS G    EM+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 46.3 bits (110), Expect = 5e-07
 Identities = 25/89 (28%), Positives = 39/89 (43%), Gaps = 9/89 (10%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           +H+    HRD+   N+L+      K++DFGLSR     + +            + APE+ 
Sbjct: 113 LHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTP-------DYLAPETI 165

Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                   SD WS G  ++E   FG  P+
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFL-FGYPPF 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 46.6 bits (111), Expect = 6e-07
 Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 17/93 (18%)

Query: 34  KMHKSS-FHRDLAARNILLASRHQAKISDFGLSRAV----NSERNYYKATHGGRWPIKWY 88
            +H++   HRD+ A NIL+      K++DFGL+RA     NS+ N Y      R    WY
Sbjct: 134 YIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT----NRVVTLWY 189

Query: 89  -APE----SYNFGRFSSASDVWSFGITLWEMYS 116
             PE      ++G      D+W  G  + EM++
Sbjct: 190 RPPELLLGERDYG---PPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 46.2 bits (109), Expect = 6e-07
 Identities = 38/119 (31%), Positives = 53/119 (44%), Gaps = 33/119 (27%)

Query: 27  AKVCR-------YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVN---SERNYYK 76
           A +CR       +L  HK   HRD+  +N+LL    + K+ DFG+S  ++     RN + 
Sbjct: 114 AYICREILRGLSHLHQHKV-IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 172

Query: 77  ATHGGRWPIKWYAPE----------SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            T        W APE          +Y+F      SD+WS GIT  EM   G  P  +M
Sbjct: 173 GTP------YWMAPEVIACDENPDATYDF-----KSDLWSLGITAIEMAE-GAPPLCDM 219

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 46.2 bits (109), Expect = 8e-07
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 7/102 (6%)

Query: 27  AKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWP 84
           A++C  L+ +H+    +RDL   NILL      +ISD GL+  V  E    K   G    
Sbjct: 109 AEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVG---T 164

Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
           + + APE     R++ + D W+ G  L+EM + GQ P+ + K
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 46.2 bits (109), Expect = 8e-07
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 11/93 (11%)

Query: 28  KVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK   S+   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 180

Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 45.7 bits (108), Expect = 9e-07
 Identities = 22/76 (28%), Positives = 40/76 (52%), Gaps = 4/76 (5%)

Query: 40  FHRDLAARNILLASRHQ-AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRF 98
            HRD+ ++NI L+     AK+ DFG++R +N          G  +   + +PE      +
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPY---YLSPEICQNRPY 179

Query: 99  SSASDVWSFGITLWEM 114
           ++ +D+WS G  L+E+
Sbjct: 180 NNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 45.7 bits (108), Expect = 9e-07
 Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 6/82 (7%)

Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            +   HRDL  +N+L++   + K++DFGL+RA    ++    T+       WY P     
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARA----KSIPSQTYSSEVVTLWYRPPDVLL 176

Query: 96  G--RFSSASDVWSFGITLWEMY 115
           G   +SSA D+W  G    EM 
Sbjct: 177 GATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 45.8 bits (108), Expect = 1e-06
 Identities = 40/128 (31%), Positives = 55/128 (42%), Gaps = 36/128 (28%)

Query: 19  PYIEGQIPAKVCR-------YLKMHKSSFHRDLAARNILLASRHQAKISDFGLS----RA 67
           P  E QI   VC+       YL  +K   HRDL A NIL       K++DFG+S    R 
Sbjct: 99  PLTEPQIRV-VCKQTLEALNYLHENKI-IHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 156

Query: 68  VNSERNYYKATHGGRWPIKWYAPE----------SYNFGRFSSASDVWSFGITLWEMYSF 117
           +    ++    +       W APE           Y++      +DVWS GITL EM   
Sbjct: 157 IQRRDSFIGTPY-------WMAPEVVMCETSKDRPYDY-----KADVWSLGITLIEMAQI 204

Query: 118 GQQPYGEM 125
            + P+ E+
Sbjct: 205 -EPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 45.2 bits (107), Expect = 1e-06
 Identities = 27/89 (30%), Positives = 48/89 (53%), Gaps = 5/89 (5%)

Query: 28  KVCRYLK-MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++C  LK +H +   HRD+ ++NI L      K+ DFG++R +NS     +   G  +  
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPY-- 166

Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEM 114
            + +PE      +++ SD+W+ G  L+EM
Sbjct: 167 -YLSPEICENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 45.6 bits (108), Expect = 1e-06
 Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 13/91 (14%)

Query: 41  HRDLAARNILLASRHQA-KISDFGLSR---AVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           HRD+   N+L+ +     KISDFG S+    +N     +  T      +++ APE  + G
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGT------LQYMAPEVIDKG 184

Query: 97  R--FSSASDVWSFGITLWEMYSFGQQPYGEM 125
              + + +D+WS G T+ EM + G+ P+ E+
Sbjct: 185 PRGYGAPADIWSLGCTIVEMAT-GKPPFIEL 214

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 45.4 bits (107), Expect = 1e-06
 Identities = 37/119 (31%), Positives = 53/119 (44%), Gaps = 33/119 (27%)

Query: 27  AKVCR-------YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVN---SERNYYK 76
           A +CR       +L  HK   HRD+  +N+LL    + K+ DFG+S  ++     RN + 
Sbjct: 124 AYICREILRGLAHLHAHKV-IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 182

Query: 77  ATHGGRWPIKWYAPE----------SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            T        W APE          +Y++      SD+WS GIT  EM   G  P  +M
Sbjct: 183 GTP------YWMAPEVIACDENPDATYDY-----RSDIWSLGITAIEMAE-GAPPLCDM 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 45.5 bits (108), Expect = 1e-06
 Identities = 27/81 (33%), Positives = 41/81 (50%), Gaps = 6/81 (7%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR--F 98
           HRDL  +N+L+    + K++DFGL+RA       Y A         WY P    FG   +
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA----EVVTLWYRPPDVLFGAKLY 177

Query: 99  SSASDVWSFGITLWEMYSFGQ 119
           S++ D+WS G    E+ + G+
Sbjct: 178 STSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 45.4 bits (107), Expect = 1e-06
 Identities = 26/91 (28%), Positives = 43/91 (47%), Gaps = 4/91 (4%)

Query: 35  MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           MH +   HRD+   N+ + +    K+ D GL R  +S+     A H       + +PE  
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERI 178

Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGE 124
           +   ++  SD+WS G  L+EM +     YG+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 45.2 bits (107), Expect = 1e-06
 Identities = 30/88 (34%), Positives = 43/88 (48%), Gaps = 13/88 (14%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSR---AVNSERNY-YKATHGGRWPIKWYAPESYNFG 96
           +RD+   NILL S     ++DFGLS+   A   ER Y +  T      I++ APE    G
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT------IEYMAPEVIRGG 181

Query: 97  R--FSSASDVWSFGITLWEMYSFGQQPY 122
                 A D WS G+  +E+ + G  P+
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLT-GASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 45.0 bits (106), Expect = 2e-06
 Identities = 35/106 (33%), Positives = 49/106 (46%), Gaps = 15/106 (14%)

Query: 19  PYIEGQIPAKVCR-------YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSE 71
           P  E QI A VCR       YL   K   HRD+   NILL      K++DFG++  + + 
Sbjct: 102 PLSELQI-AYVCRETLQGLAYLH-SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159

Query: 72  RNYYKATHGGRWPIKWYAPESYNF---GRFSSASDVWSFGITLWEM 114
               K+  G  +   W APE       G ++   D+W+ GIT  E+
Sbjct: 160 IAKRKSFIGTPY---WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 44.8 bits (106), Expect = 2e-06
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 4/86 (4%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   +RDL   N+LL      KI+DFG+ +  N       +T  G  P  + APE     
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGT-P-DYIAPEILKGQ 171

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
           +++ + D WSFG+ L+EM   GQ P+
Sbjct: 172 KYNESVDWWSFGVLLYEML-IGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 44.6 bits (105), Expect = 2e-06
 Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 5/99 (5%)

Query: 28  KVCRYLK-MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++C  L+ MH +   HRD+   N+ + +    K+ D GL R  +S+     A H      
Sbjct: 114 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGTP 170

Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE 124
            + +PE  +   ++  SD+WS G  L+EM +     YG+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 44.7 bits (105), Expect = 2e-06
 Identities = 26/76 (34%), Positives = 39/76 (51%), Gaps = 9/76 (11%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE-SYNFGRF 98
           HRDL   N+ +    + +I DFGL+R  + E   Y AT       +WY APE   N+  +
Sbjct: 141 HRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVAT-------RWYRAPEIMLNWMHY 193

Query: 99  SSASDVWSFGITLWEM 114
           +   D+WS G  + E+
Sbjct: 194 NQTVDIWSVGCIMAEL 209

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 44.6 bits (106), Expect = 3e-06
 Identities = 26/98 (26%), Positives = 46/98 (46%), Gaps = 8/98 (8%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHG-GRWPIK---WYA 89
           +H   F HR + A +ILL+   +  +S    S ++       +  H   +  +K   W +
Sbjct: 117 IHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176

Query: 90  PE--SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           PE    N   ++  SD++S GIT  E+ + G  P+ +M
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVGITACELAN-GHVPFKDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 44.6 bits (105), Expect = 3e-06
 Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 1/77 (1%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL + NI L      K+ DFG S+  +   +   A+     P  + APE +   R+S 
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY-YLAPELWERKRYSK 250

Query: 101 ASDVWSFGITLWEMYSF 117
            +D+WS G+ L+E+ + 
Sbjct: 251 KADMWSLGVILYELLTL 267

Length = 478

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 44.3 bits (105), Expect = 3e-06
 Identities = 30/77 (38%), Positives = 41/77 (53%), Gaps = 8/77 (10%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFG--R 97
           HRDL  +N+L+ ++   K++DFGL+RA       Y  TH       WY APE    G  R
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY--TH--EVVTLWYRAPEVL-LGSPR 178

Query: 98  FSSASDVWSFGITLWEM 114
           +S+  D+WS G    EM
Sbjct: 179 YSTPVDIWSIGTIFAEM 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 44.6 bits (105), Expect = 3e-06
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 11/98 (11%)

Query: 29  VCRYLKMH-KSSFHRDLAARNILLASRHQAKISDFGLSRAV---NSERNYYKATHGGRWP 84
           +C    +H K   +RDL   NILL +    KI+DFG+ +     +++   +  T      
Sbjct: 106 ICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP----- 160

Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             + APE     +++++ D WSFG+ L+EM   GQ P+
Sbjct: 161 -DYIAPEILLGQKYNTSVDWWSFGVLLYEML-IGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 44.2 bits (104), Expect = 3e-06
 Identities = 37/111 (33%), Positives = 52/111 (46%), Gaps = 22/111 (19%)

Query: 23  GQIPAKVCRYLKM--------HKSSF-HRDLAARNILLASRHQAKISDFGLSRAVN--SE 71
           G  P KV  Y+          HK+   HRD+   N+L++     K+ DFG +R ++  S 
Sbjct: 96  GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155

Query: 72  RNY--YKATHGGRWPIKWY-APESYNFGRFSSASDVWSFGITLWEMYSFGQ 119
            NY  Y AT       +WY +PE      +  A D+WS G  L E+ S GQ
Sbjct: 156 ANYTEYVAT-------RWYRSPELLLGAPYGKAVDMWSVGCILGEL-SDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 44.4 bits (105), Expect = 3e-06
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 5/86 (5%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   NILL      +ISD GL  AV       +   G    + + APE     R++ 
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGL--AVEIPEG--ETIRGRVGTVGYMAPEVVKNERYTF 180

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMK 126
           + D W  G  ++EM   G+ P+ + K
Sbjct: 181 SPDWWGLGCLIYEMIE-GKSPFRQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 44.3 bits (104), Expect = 3e-06
 Identities = 33/94 (35%), Positives = 46/94 (48%), Gaps = 17/94 (18%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVN----SERNYYKATHGGRWPIKWYAP-----E 91
           HRDL A N+LL      K++DFG+S A N      R+ +  T     P  W AP     E
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS-AKNVKTLQRRDSFIGT-----PY-WMAPEVVMCE 185

Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +     +   +D+WS GITL EM    + P+ E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQI-EPPHHEL 218

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 44.5 bits (105), Expect = 3e-06
 Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 11/98 (11%)

Query: 29  VCRYLKMH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY---KATHGGRWP 84
           VC    +H K   +RDL   N++L      KI+DFG+ +      N +   +A+     P
Sbjct: 106 VCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK-----ENVFGDNRASTFCGTP 160

Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             + APE     +++ + D WSFG+ L+EM   GQ P+
Sbjct: 161 -DYIAPEILQGLKYTFSVDWWSFGVLLYEML-IGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 44.2 bits (104), Expect = 4e-06
 Identities = 27/86 (31%), Positives = 42/86 (48%), Gaps = 5/86 (5%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   NILL  R   +ISD GL+  +       +   G    + + APE  N  +++ 
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLAVQIPEG----ETVRGRVGTVGYMAPEVINNEKYTF 180

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMK 126
           + D W  G  ++EM   GQ P+ + K
Sbjct: 181 SPDWWGLGCLIYEMIQ-GQSPFRKRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 44.0 bits (104), Expect = 4e-06
 Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 17/105 (16%)

Query: 28  KVCRYLK-MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++C  L+ MH K   HRD+   N+ + +    K+ D GL R  +S+     A H      
Sbjct: 114 QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGTP 170

Query: 86  KWYAPE-----SYNFGRFSSASDVWSFGITLWEMYSFGQQP-YGE 124
            + +PE      YNF      SD+WS G  L+EM +  Q P YG+
Sbjct: 171 YYMSPERIHENGYNF-----KSDIWSLGCLLYEMAAL-QSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 43.8 bits (103), Expect = 4e-06
 Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 9/92 (9%)

Query: 39  SFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR- 97
           + HRD+   NILL +    K+ DFG+S  + S R     + G  +   W APE     + 
Sbjct: 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF---WMAPEVIACEQQ 201

Query: 98  ----FSSASDVWSFGITLWEMYSFGQQPYGEM 125
               + +  DVWS GIT  E+   G  P  ++
Sbjct: 202 LDSTYDARCDVWSLGITAIELGD-GDPPLADL 232

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 44.0 bits (104), Expect = 4e-06
 Identities = 28/77 (36%), Positives = 37/77 (48%), Gaps = 7/77 (9%)

Query: 41  HRDLAARNILL-ASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFGR- 97
           HRDL  +N+L+   +   KI+D GL RA +     Y  TH       WY APE       
Sbjct: 133 HRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--TH--EIVTLWYRAPEVLLGSTH 188

Query: 98  FSSASDVWSFGITLWEM 114
           +S+  D+WS G    EM
Sbjct: 189 YSTPVDIWSVGCIFAEM 205

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 43.7 bits (103), Expect = 5e-06
 Identities = 30/91 (32%), Positives = 44/91 (48%), Gaps = 11/91 (12%)

Query: 28  KVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK   S+   HRDL   NIL+      KI DFGL+R  + +   Y +T       
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVST------- 168

Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEM 114
           ++Y APE    + ++    D+WS G    EM
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEM 199

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 43.8 bits (103), Expect = 5e-06
 Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 4/86 (4%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   +RDL   N++L S    KI+DFG+ +  N        T  G  P  + APE   + 
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFCGT-P-DYIAPEIIAYQ 176

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +  + D W+FG+ L+EM + GQ P+
Sbjct: 177 PYGKSVDWWAFGVLLYEMLA-GQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 43.5 bits (103), Expect = 6e-06
 Identities = 28/90 (31%), Positives = 39/90 (43%), Gaps = 23/90 (25%)

Query: 36  HKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK---ATHGGRWPIKWY-AP 90
           HK +  HRD+   NIL+  + Q K+ DFG +R +    + Y    AT       +WY AP
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT-------RWYRAP 169

Query: 91  E------SYNFGRFSSASDVWSFGITLWEM 114
           E       Y         DVW+ G    E+
Sbjct: 170 ELLVGDTQYG-----PPVDVWAIGCVFAEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 43.4 bits (102), Expect = 7e-06
 Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 3/78 (3%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+ ++NI L    + K+ DFG +R + S   Y     G  +   +  PE +   
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPY---YVPPEIWENM 175

Query: 97  RFSSASDVWSFGITLWEM 114
            +++ SD+WS G  L+E+
Sbjct: 176 PYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 43.5 bits (103), Expect = 7e-06
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 4/82 (4%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   N+LL S    KI+DFG+ +             G   P  + APE  ++  +  
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT--P-DYIAPEILSYQPYGP 175

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
           A D W+ G+ L+EM + GQ P+
Sbjct: 176 AVDWWALGVLLYEMLA-GQSPF 196

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 43.2 bits (102), Expect = 8e-06
 Identities = 25/78 (32%), Positives = 37/78 (47%), Gaps = 10/78 (12%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE----SYNFG 96
           HRD+   NIL++     K+ DFG +R + +    Y      RW   + APE       +G
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW---YRAPELLVGDTKYG 179

Query: 97  RFSSASDVWSFGITLWEM 114
           R   A D+W+ G  + EM
Sbjct: 180 R---AVDIWAVGCLVTEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 43.1 bits (101), Expect = 8e-06
 Identities = 24/77 (31%), Positives = 38/77 (49%), Gaps = 6/77 (7%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG--R 97
            HRDL  +N+L++   + K++DFGL+RA    ++    T+       WY P     G   
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARA----KSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 98  FSSASDVWSFGITLWEM 114
           +S+  D+W  G    EM
Sbjct: 181 YSTCLDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 43.0 bits (102), Expect = 9e-06
 Identities = 26/78 (33%), Positives = 35/78 (44%), Gaps = 5/78 (6%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRA--VNSERNYYKATHGGRWPI---KWYAPESYNF 95
           HRDL   NIL+ S    K++DFGLS+   V  + N        +  +    + APE    
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Query: 96  GRFSSASDVWSFGITLWE 113
              S   D WS G  L+E
Sbjct: 176 QGHSKTVDWWSLGCILYE 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 43.0 bits (101), Expect = 9e-06
 Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 6/95 (6%)

Query: 29  VCRYLKMHK-SSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKW 87
           +C    +H+ ++ +RDL   NILL      +ISD GL+  +  E    +   G    + +
Sbjct: 112 LCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVG---TVGY 167

Query: 88  YAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
            APE  N  R++ + D W  G  ++EM   GQ P+
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 42.7 bits (100), Expect = 1e-05
 Identities = 24/88 (27%), Positives = 45/88 (51%), Gaps = 4/88 (4%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A   +YL   K   HRDL  +N+ L   +  K+ D G++R + ++ +      G  +   
Sbjct: 112 AMALQYLH-EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY--- 167

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEM 114
           + +PE ++   ++  SDVW+ G  ++EM
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 42.5 bits (100), Expect = 1e-05
 Identities = 32/84 (38%), Positives = 44/84 (52%), Gaps = 9/84 (10%)

Query: 41  HRDLAARNILLASRHQA-KISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFGR- 97
           HRDL  +N+L+  R  A K++DFGL+RA       +  TH       WY APE     R 
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF--TH--EVVTLWYRAPEILLGSRH 180

Query: 98  FSSASDVWSFGITLWEMYSFGQQP 121
           +S+  D+WS G    EM +  Q+P
Sbjct: 181 YSTPVDIWSVGCIFAEMVN--QKP 202

Length = 294

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 42.4 bits (100), Expect = 1e-05
 Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 11/103 (10%)

Query: 19  PYIEGQIPAKVCRYLK----MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERN 73
           P+ E Q+   + + L+    +H++   HRDL   N+LL  +   KI+DFGL+R       
Sbjct: 104 PFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163

Query: 74  YYKATHGGRWPIKWYAPESYNFG--RFSSASDVWSFGITLWEM 114
                    W   + APE    G   +++A D+W+ G  L E+
Sbjct: 164 PMTPKVVTLW---YRAPELL-LGCTTYTTAIDMWAVGCILAEL 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.2 bits (99), Expect = 1e-05
 Identities = 37/108 (34%), Positives = 46/108 (42%), Gaps = 26/108 (24%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQ-------AKISDFG-----LSRAVNSERNY 74
           A    YL+  K   H ++  +NILLA            K+SD G     LSR    ER  
Sbjct: 115 ASALSYLE-DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER-- 171

Query: 75  YKATHGGRWPIKWYAPESYNFGR-FSSASDVWSFGITLWEMYSFGQQP 121
                     I W APE     +  S A+D WSFG TLWE+   G+ P
Sbjct: 172 ----------IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 42.0 bits (99), Expect = 2e-05
 Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 12/101 (11%)

Query: 29  VCRYLKMH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKW 87
           VC    +H K   +RDL   NILL      K++DFG ++ +  +R +   T  G  P ++
Sbjct: 111 VCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTW---TLCGT-P-EY 164

Query: 88  YAPESYNFGRFSSASDVWSFGITLWEMYS-----FGQQPYG 123
            APE       + A D W+ GI ++EM       F   P+G
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 42.1 bits (99), Expect = 2e-05
 Identities = 27/85 (31%), Positives = 44/85 (51%), Gaps = 5/85 (5%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   N++L +    KI+DFG+ +         +   G   P  + APE   +  +  
Sbjct: 124 YRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGT--P-DYIAPEIIAYQPYGK 180

Query: 101 ASDVWSFGITLWEMYSFGQQPY-GE 124
           + D W+FG+ L+EM + GQ P+ GE
Sbjct: 181 SVDWWAFGVLLYEMLA-GQPPFDGE 204

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 41.9 bits (98), Expect = 2e-05
 Identities = 24/86 (27%), Positives = 43/86 (50%), Gaps = 4/86 (4%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   +RDL   N++L S    KI+DFG+ +    +    +   G      + APE   + 
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTP---DYIAPEIIAYQ 176

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +  + D W++G+ L+EM + GQ P+
Sbjct: 177 PYGKSVDWWAYGVLLYEMLA-GQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 41.6 bits (98), Expect = 3e-05
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 10/80 (12%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRA--VNSERNYYKATHGGRWPIKWYAPESYNFGR- 97
           HRDL  +N+L++ R + K++DFGL+RA  V S+      T+       WY P     G  
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLARAKSVPSK------TYSNEVVTLWYRPPDVLLGST 179

Query: 98  -FSSASDVWSFGITLWEMYS 116
            +S++ D+W  G   +EM +
Sbjct: 180 EYSTSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 41.3 bits (97), Expect = 3e-05
 Identities = 27/82 (32%), Positives = 40/82 (48%), Gaps = 4/82 (4%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   NILL ++   K++DFGL +    E      TH     I++ APE         
Sbjct: 123 YRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTFCGTIEYMAPEILMRSGHGK 179

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
           A D WS G  +++M + G  P+
Sbjct: 180 AVDWWSLGALMYDMLT-GAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 41.5 bits (97), Expect = 3e-05
 Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 4/91 (4%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL   K+  +RDL   N++L      KI+DFGL +    +    K   G     ++ APE
Sbjct: 110 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP---EYLAPE 166

Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                 +  A D W  G+ ++EM   G+ P+
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 41.0 bits (96), Expect = 4e-05
 Identities = 24/74 (32%), Positives = 39/74 (52%), Gaps = 6/74 (8%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   N+LL ++   K++DFG ++ V  +R +   T  G  P ++ APE         
Sbjct: 141 YRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTF---TLCGT-P-EYLAPEVIQSKGHGK 194

Query: 101 ASDVWSFGITLWEM 114
           A D W+ G+ L+E 
Sbjct: 195 AVDWWTMGVLLYEF 208

Length = 329

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 41.0 bits (96), Expect = 5e-05
 Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 13/84 (15%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHG---GR--WPIKWY-AP 90
           K   HRD+ + NILL S    K+ DFG S+        Y AT     GR      +Y AP
Sbjct: 162 KHMIHRDIKSANILLCSNGLVKLGDFGFSK-------MYAATVSDDVGRTFCGTPYYVAP 214

Query: 91  ESYNFGRFSSASDVWSFGITLWEM 114
           E +    +S  +D++S G+ L+E+
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYEL 238

Length = 496

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 40.7 bits (95), Expect = 6e-05
 Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 6/91 (6%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           +HK    +RD+   NILL S     ++DFGLS+  + +      +  G   I++ AP+  
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG--TIEYMAPDIV 178

Query: 94  NFGR--FSSASDVWSFGITLWEMYSFGQQPY 122
             G      A D WS G+ ++E+ + G  P+
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLT-GASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 40.8 bits (95), Expect = 6e-05
 Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 4/82 (4%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   NILL S+    ++DFGL +  N E N   +T  G    ++ APE  +   +  
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCG--TPEYLAPEVLHKQPYDR 175

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
             D W  G  L+EM  +G  P+
Sbjct: 176 TVDWWCLGAVLYEML-YGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 40.5 bits (95), Expect = 7e-05
 Identities = 31/98 (31%), Positives = 44/98 (44%), Gaps = 24/98 (24%)

Query: 31  RYLK-MHKSS-FHRDLAARNILLASRHQA-KISDFGLSRAVNSERNYYKATHGGRWP--- 84
           R LK +H ++  HRDL   N+ + +     KI DFGL+R V+    Y   +H G      
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH--Y---SHKGYLSEGL 179

Query: 85  -IKWY-------APESYNFGRFSSASDVWSFGITLWEM 114
             KWY       +P +Y       A D+W+ G    EM
Sbjct: 180 VTKWYRSPRLLLSPNNYT-----KAIDMWAAGCIFAEM 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 40.2 bits (94), Expect = 7e-05
 Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 19/99 (19%)

Query: 41  HRDLAARNILL-ASRHQAKISDFGLSRAVNSERNYYKATHGGRW------PIKWYAPE-- 91
           HRD+   N+L+ ++  + +I+DFG +  + +     K T  G +       I + APE  
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAAARLAA-----KGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 92  -SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
               +GR   + DVWS G  + EM +  + P+   K S+
Sbjct: 181 RGEQYGR---SCDVWSVGCVIIEMAT-AKPPWNAEKHSN 215

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 40.4 bits (94), Expect = 7e-05
 Identities = 33/108 (30%), Positives = 48/108 (44%), Gaps = 7/108 (6%)

Query: 25  IPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGG 81
           I   V R ++ +H++   HRD+ A NI +       + DFG +   V+   N Y   +G 
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY---YGW 243

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
              I   APE      +  A D+WS GI L+EM +       E  G D
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT-CHDSLFEKDGLD 290

Length = 391

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 40.0 bits (93), Expect = 9e-05
 Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 7/87 (8%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNS---ERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   NIL  S    K+ DFG S+ + +        K+  G  +   W +PE  +   
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY---WMSPEVISGEG 185

Query: 98  FSSASDVWSFGITLWEMYSFGQQPYGE 124
           +   +DVWS   T+ EM +  + P+ E
Sbjct: 186 YGRKADVWSVACTVVEMLT-EKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 40.0 bits (93), Expect = 1e-04
 Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 7/90 (7%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNS---ERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   NIL  S    K+ DFG S+ + +        K+  G  +   W +PE  +   
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY---WMSPEVISGEG 185

Query: 98  FSSASDVWSFGITLWEMYSFGQQPYGEMKG 127
           +   +D+WS G T+ EM +  + P+ E + 
Sbjct: 186 YGRKADIWSVGCTVVEMLT-EKPPWAEFEA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 39.9 bits (93), Expect = 1e-04
 Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 4/83 (4%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY-NFGRFS 99
           +RD+   NILL S     ++DFGLS+   SE      +  G   I++ APE     G   
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCG--TIEYMAPEIIRGKGGHG 185

Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
            A D WS GI ++E+ + G  P+
Sbjct: 186 KAVDWWSLGILIFELLT-GASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 39.6 bits (92), Expect = 1e-04
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 9/91 (9%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK-ATHGGRWPIKWYAPESYNFGR-F 98
           +RDL   NILL      +ISD GL+   + ++ +    THG      + APE    G  +
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG------YMAPEVLQKGTAY 173

Query: 99  SSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            S++D +S G  L+++   G  P+ + K  D
Sbjct: 174 DSSADWFSLGCMLFKLLR-GHSPFRQHKTKD 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 39.7 bits (93), Expect = 1e-04
 Identities = 25/82 (30%), Positives = 33/82 (40%), Gaps = 20/82 (24%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSE--------RNYYKATHGGRWPIKWYAPES 92
           HRDL   NI++ S    KI DFGL+R   +           YY+            APE 
Sbjct: 141 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR------------APEV 188

Query: 93  YNFGRFSSASDVWSFGITLWEM 114
                +    D+WS G  + EM
Sbjct: 189 ILGMGYKENVDIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 39.7 bits (92), Expect = 1e-04
 Identities = 26/87 (29%), Positives = 42/87 (48%), Gaps = 7/87 (8%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNS---ERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   NIL  S    K+ DFG S+ + +        ++  G  +   W +PE  +   
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY---WMSPEVISGEG 185

Query: 98  FSSASDVWSFGITLWEMYSFGQQPYGE 124
           +   +DVWS G T+ EM +  + P+ E
Sbjct: 186 YGRKADVWSLGCTVVEMLT-EKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 39.7 bits (93), Expect = 2e-04
 Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 12/101 (11%)

Query: 27  AKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK---ATHGG 81
           A V   L+ +H++   +RDL   N+LL +    KI+DFGL +    E   +    +T  G
Sbjct: 108 ACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCG 163

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             P ++ APE      ++ A D W  G+ ++EM   G+ P+
Sbjct: 164 T-P-EFLAPEVLTETSYTRAVDWWGLGVLIYEML-VGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 39.3 bits (92), Expect = 2e-04
 Identities = 26/87 (29%), Positives = 37/87 (42%), Gaps = 23/87 (26%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERN----------YYKATHGGRWPIKWYAP 90
           HRD+   N+L+ S    KI DFGL+R    + +          YY+            AP
Sbjct: 126 HRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR------------AP 173

Query: 91  ESYNFGR-FSSASDVWSFGITLWEMYS 116
           E     R ++SA D+WS G    E+  
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLG 200

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 39.1 bits (91), Expect = 2e-04
 Identities = 25/82 (30%), Positives = 40/82 (48%), Gaps = 4/82 (4%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   NILL +    K++DFG+ +           T  G  P  + APE      +  
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGT-P-DYIAPEILQELEYGP 175

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
           + D W+ G+ ++EM + GQ P+
Sbjct: 176 SVDWWALGVLMYEMMA-GQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 38.8 bits (90), Expect = 3e-04
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 10/98 (10%)

Query: 35  MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK-ATHGGRWPIKWYAPES 92
           MH +   +RDL   NILL      +ISD GL+   + ++ +    THG      + APE 
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG------YMAPEV 166

Query: 93  YNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
              G  + S++D +S G  L+++   G  P+ + K  D
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKD 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 38.5 bits (89), Expect = 3e-04
 Identities = 24/82 (29%), Positives = 39/82 (47%), Gaps = 4/82 (4%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   N++L      KI+DFGL +   ++    K   G     ++ APE      +  
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP---EYLAPEVLEDNDYGR 174

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
           A D W  G+ ++EM   G+ P+
Sbjct: 175 AVDWWGLGVVMYEMMC-GRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 38.4 bits (89), Expect = 4e-04
 Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 5/82 (6%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPES- 92
           +HK    +RDL   NILL +     + DFGLS+A N   N    T  G    ++ APE  
Sbjct: 112 LHKYDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCG--TTEYLAPEVL 168

Query: 93  YNFGRFSSASDVWSFGITLWEM 114
            +   ++   D WS G+ ++EM
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 38.2 bits (89), Expect = 4e-04
 Identities = 26/82 (31%), Positives = 37/82 (45%), Gaps = 7/82 (8%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL   N L+ +    K++DFGLS+ +     Y  +  G   P  + APE      +  
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSVVGS--P-DYMAPEVLRGKGYDF 177

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
             D WS G  L+E    G  P+
Sbjct: 178 TVDYWSLGCMLYEFL-CGFPPF 198

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 38.3 bits (90), Expect = 4e-04
 Identities = 29/79 (36%), Positives = 39/79 (49%), Gaps = 16/79 (20%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE-----SYNF 95
           +RDL   N+LL S    KI+DFG ++ V   R Y   T  G  P ++ APE      Y  
Sbjct: 124 YRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTY---TLCGT-P-EYLAPEIILSKGYG- 176

Query: 96  GRFSSASDVWSFGITLWEM 114
                A D W+ GI ++EM
Sbjct: 177 ----KAVDWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 38.1 bits (88), Expect = 5e-04
 Identities = 24/86 (27%), Positives = 40/86 (46%), Gaps = 4/86 (4%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   +RD+   N++L      KI+DFGL +   S+    K   G     ++ APE     
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP---EYLAPEVLEDN 170

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +  A D W  G+ ++EM   G+ P+
Sbjct: 171 DYGRAVDWWGLGVVMYEMMC-GRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 38.0 bits (89), Expect = 5e-04
 Identities = 32/114 (28%), Positives = 45/114 (39%), Gaps = 28/114 (24%)

Query: 36  HKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNS--ERNYY----------KATHGGR 82
           HK  F HRD+   NIL+ +    K++DFGL + +N   +R YY                R
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177

Query: 83  WPIKWY--------------APESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
              K                APE      +    D WS G+ L+EM  +G  P+
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML-YGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 38.1 bits (88), Expect = 5e-04
 Identities = 28/89 (31%), Positives = 38/89 (42%), Gaps = 9/89 (10%)

Query: 29  VCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSR--AVNSERNYYKATHGGRWPI 85
           +C    +H +   HRDL   NI++ S    KI DFGL+R    N     Y  T   R   
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYR--- 189

Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEM 114
              APE      +    D+WS G  + E+
Sbjct: 190 ---APEVILGMGYKENVDIWSVGCIMGEL 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 37.6 bits (87), Expect = 6e-04
 Identities = 25/100 (25%), Positives = 48/100 (48%), Gaps = 10/100 (10%)

Query: 30  CRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK--ATHGGRWPIK 86
           C  L +H     +RD+   N+LL  +   ++SD GL+  +   +   +   T+G      
Sbjct: 106 CGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG------ 159

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
           + APE      +S   D ++ G +++EM + G+ P+ + K
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVA-GRTPFKDHK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 37.1 bits (86), Expect = 9e-04
 Identities = 24/77 (31%), Positives = 38/77 (49%), Gaps = 9/77 (11%)

Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           +RDL   N+LL +    +ISD GL+   +   S+   Y  T G      + APE      
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPG------FMAPELLQGEE 173

Query: 98  FSSASDVWSFGITLWEM 114
           +  + D ++ G+TL+EM
Sbjct: 174 YDFSVDYFALGVTLYEM 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 37.1 bits (86), Expect = 0.001
 Identities = 18/45 (40%), Positives = 25/45 (55%), Gaps = 3/45 (6%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNS--ERNYYK 76
           +HK  F HRD+   NIL+      K+SDFGLS   +   +  YY+
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 36.7 bits (85), Expect = 0.001
 Identities = 26/102 (25%), Positives = 42/102 (41%), Gaps = 22/102 (21%)

Query: 17  ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFG----LSRAVNSER 72
           AL Y+ G             +   HRD+   NI L     A + DFG    L    ++ +
Sbjct: 197 ALAYLHG-------------RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243

Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEM 114
            Y     G    ++  +PE      + + +D+WS G+ L+EM
Sbjct: 244 CY-----GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 36.9 bits (85), Expect = 0.001
 Identities = 23/87 (26%), Positives = 41/87 (47%), Gaps = 8/87 (9%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN-----F 95
           HRD+   N+LL      +++DFG    +N +     +   G  P  + +PE         
Sbjct: 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGT-P-DYISPEILQAMEDGM 182

Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
           G++    D WS G+ ++EM  +G+ P+
Sbjct: 183 GKYGPECDWWSLGVCMYEML-YGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 37.0 bits (86), Expect = 0.001
 Identities = 14/31 (45%), Positives = 20/31 (64%), Gaps = 1/31 (3%)

Query: 36  HKSSF-HRDLAARNILLASRHQAKISDFGLS 65
           HK  + HRD+   N+LL ++   K+SDFGL 
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLC 148

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 36.4 bits (85), Expect = 0.001
 Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 15/88 (17%)

Query: 42  RDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE-----SYNFG 96
           RDL   N+LL S    K+ DFG ++ + S +  +  T  G  P ++ APE      Y+F 
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFCGT-P-EYVAPEIILNKGYDF- 171

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGE 124
               + D WS GI L+E+ + G+ P+GE
Sbjct: 172 ----SVDYWSLGILLYELLT-GRPPFGE 194

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 36.7 bits (85), Expect = 0.002
 Identities = 24/74 (32%), Positives = 36/74 (48%), Gaps = 3/74 (4%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   N++L      KI+DFGL +   S+    K   G   P ++ APE      +  
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT--P-EYLAPEVLEDNDYGR 174

Query: 101 ASDVWSFGITLWEM 114
           A D W  G+ ++EM
Sbjct: 175 AVDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 36.3 bits (84), Expect = 0.002
 Identities = 34/135 (25%), Positives = 48/135 (35%), Gaps = 42/135 (31%)

Query: 29  VCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHG---- 80
            C    +HK  F HRD+   NIL+      K++DFGL    R  +  + Y K  H     
Sbjct: 111 TCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 81  ----------GRWPIK-----------------------WYAPESYNFGRFSSASDVWSF 107
                      R  +K                       + APE      ++   D WS 
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230

Query: 108 GITLWEMYSFGQQPY 122
           G+ L+EM   GQ P+
Sbjct: 231 GVILYEML-VGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 36.2 bits (83), Expect = 0.002
 Identities = 28/89 (31%), Positives = 38/89 (42%), Gaps = 9/89 (10%)

Query: 29  VCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSE--RNYYKATHGGRWPI 85
           +C    +H +   HRDL   NI++ S    KI DFGL+R   +      Y  T   R   
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR--- 185

Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEM 114
              APE      +    D+WS G  + EM
Sbjct: 186 ---APEVILGMGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 36.2 bits (83), Expect = 0.002
 Identities = 27/95 (28%), Positives = 38/95 (40%), Gaps = 21/95 (22%)

Query: 29  VCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSE--------RNYYKATH 79
           +C    +H +   HRDL   NI++ S    KI DFGL+R   +           YY+   
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR--- 192

Query: 80  GGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEM 114
                    APE      +    D+WS G  + EM
Sbjct: 193 ---------APEVILGMGYKENVDIWSVGCIMGEM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 36.2 bits (83), Expect = 0.002
 Identities = 29/121 (23%), Positives = 46/121 (38%), Gaps = 34/121 (28%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGL----------------------------- 64
           +H+  F HRD+   N+LL S+   K+SDFGL                             
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 65  ---SRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQP 121
               +A   +RN  +          + APE +    ++   D WS G+ ++EM   G  P
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML-IGYPP 235

Query: 122 Y 122
           +
Sbjct: 236 F 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 35.9 bits (83), Expect = 0.002
 Identities = 27/82 (32%), Positives = 40/82 (48%), Gaps = 4/82 (4%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   NILL S+    ++DFGL +    E +   +T  G  P ++ APE      +  
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGT-P-EYLAPEVLRKQPYDR 175

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
             D W  G  L+EM  +G  P+
Sbjct: 176 TVDWWCLGAVLYEML-YGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 36.0 bits (83), Expect = 0.003
 Identities = 15/35 (42%), Positives = 22/35 (62%), Gaps = 1/35 (2%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSR 66
           YL  H    HRDL   N+L+++    K++DFGLS+
Sbjct: 119 YLHRH-GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 35.9 bits (83), Expect = 0.003
 Identities = 23/93 (24%), Positives = 41/93 (44%), Gaps = 15/93 (16%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI---KWYAPE------ 91
           HRD+   N+L+      K++DFG +  + + +         + P+    + APE      
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN-----SKLPVGTPDYIAPEVLTTMN 179

Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE 124
               G +    D WS G+  +EM  +G+ P+ E
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMI-YGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 35.9 bits (83), Expect = 0.003
 Identities = 30/101 (29%), Positives = 42/101 (41%), Gaps = 23/101 (22%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRA--VNSERNYY-------------KATHGGRWPI 85
           HRDL   N+L+ S    K++DFGLS+   ++   N Y             K   G   P 
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT--P- 180

Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEMYS-----FGQQP 121
           ++ APE      +    D W+ GI L+E        FG  P
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 35.7 bits (82), Expect = 0.003
 Identities = 27/82 (32%), Positives = 43/82 (52%), Gaps = 4/82 (4%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   NILL  +    + DFGL + +N + +    T  G  P ++ APE      ++ 
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGT-P-EYLAPELLLGHGYTK 172

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
           A D W+ G+ L+EM + G  P+
Sbjct: 173 AVDWWTLGVLLYEMLT-GLPPF 193

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 35.6 bits (82), Expect = 0.003
 Identities = 25/86 (29%), Positives = 39/86 (45%), Gaps = 4/86 (4%)

Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   +RDL   N+LL      K++DFG+ +          +T  G  P  + APE     
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFCGT-P-DYIAPEILQEM 171

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +  + D W+ G+ L+EM   G  P+
Sbjct: 172 LYGPSVDWWAMGVLLYEMLC-GHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 35.3 bits (82), Expect = 0.004
 Identities = 28/93 (30%), Positives = 37/93 (39%), Gaps = 31/93 (33%)

Query: 40  FHRDLAARNILLAS----RHQAKISDFGLSRAVNSERNYYKATHGGRWPIK--------- 86
            HRDL   NIL+      R   KI D GL+R  N+             P+K         
Sbjct: 130 LHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA-------------PLKPLADLDPVV 176

Query: 87  ---WY-APESYNFGR-FSSASDVWSFGITLWEM 114
              WY APE     R ++ A D+W+ G    E+
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 35.3 bits (81), Expect = 0.004
 Identities = 27/82 (32%), Positives = 39/82 (47%), Gaps = 4/82 (4%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   NILL S+    ++DFGL +    E     +T  G  P ++ APE      +  
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGT-P-EYLAPEVLRKEPYDR 175

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
             D W  G  L+EM  +G  P+
Sbjct: 176 TVDWWCLGAVLYEML-YGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	129
KOG0595|consensus	429		99.97
KOG0616|consensus	355		99.97
KOG0598|consensus	357		99.96
KOG0694|consensus	694		99.96
KOG0592|consensus	604		99.95
KOG0197|consensus	468		99.95
KOG0583|consensus	370		99.95
KOG0581|consensus	364		99.94
KOG0605|consensus	550		99.94
KOG0610|consensus	459		99.94
KOG0192|consensus	362		99.94
KOG0198|consensus	313		99.94
KOG4721|consensus	904		99.94
KOG0575|consensus	592		99.94
KOG0578|consensus	550		99.94
KOG0696|consensus	683		99.93
KOG0615|consensus	475		99.93
KOG0591|consensus	375		99.93
KOG0201|consensus	467		99.93
KOG0588|consensus	786		99.92
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.92
KOG0611|consensus	668		99.92
KOG0593|consensus	396		99.92
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.92
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.92
KOG0594|consensus	323		99.91
KOG1989|consensus	738		99.91
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.91
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.91
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.91
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.91
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.91
KOG0582|consensus	516		99.91
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.91
KOG0690|consensus	516		99.91
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.91
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.91
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.91
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.91
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.91
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.91
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.91
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.91
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.91
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.91
KOG0597|consensus	808		99.91
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.91
KOG0658|consensus	364		99.91
KOG0614|consensus	732		99.91
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.91
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.91
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.9
PTZ00267	478	NIMA-related protein kinase; Provisional	99.9
PTZ00283	496	serine/threonine protein kinase; Provisional	99.9
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.9
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.9
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.9
KOG0193|consensus	678		99.9
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.9
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.9
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.9
KOG0589|consensus	426		99.9
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.9
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.9
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.9
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.9
KOG1095|consensus	1025		99.9
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.9
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.9
KOG0612|consensus	1317		99.9
KOG0660|consensus	359		99.9
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.9
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.9
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.9
KOG0986|consensus	591		99.9
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.9
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.9
KOG0983|consensus	391		99.89
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.89
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.89
KOG0600|consensus	560		99.89
KOG0663|consensus	419		99.89
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.89
KOG4645|consensus	1509		99.89
KOG0585|consensus	576		99.89
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.89
KOG0661|consensus	538		99.89
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.89
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.89
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.89
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.89
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.89
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.89
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.89
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.89
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.89
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.88
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.88
PHA02988	283	hypothetical protein; Provisional	99.88
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.88
KOG0194|consensus	474		99.88
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.88
PHA02882	294	putative serine/threonine kinase; Provisional	99.88
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.88
PTZ00036	440	glycogen synthase kinase; Provisional	99.88
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.88
KOG0659|consensus	318		99.88
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.88
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.88
KOG0599|consensus	411		99.88
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.88
KOG0579|consensus	1187		99.88
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.88
KOG4250|consensus	732		99.88
KOG1026|consensus	774		99.88
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.88
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.88
KOG0580|consensus	281		99.88
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.88
KOG0603|consensus	612		99.88
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.87
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.87
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.87
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.87
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.87
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.87
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.87
PTZ00284	467	protein kinase; Provisional	99.87
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.87
KOG0033|consensus	355		99.87
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.87
KOG0608|consensus	1034		99.87
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.87
KOG0984|consensus	282		99.87
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.87
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.87
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.87
PHA03212	391	serine/threonine kinase US3; Provisional	99.87
KOG0695|consensus	593		99.87
KOG0667|consensus	586		99.87
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.87
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.86
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.86
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.86
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.86
KOG4279|consensus	1226		99.86
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.86
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.86
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.86
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.86
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.86
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.86
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.86
KOG0574|consensus	502		99.86
PHA03207	392	serine/threonine kinase US3; Provisional	99.86
KOG0032|consensus	382		99.86
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.86
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.86
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.86
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.86
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.86
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.86
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.86
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.86
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.86
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.86
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.86
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.86
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.85
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.85
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.85
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.85
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.85
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.85
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.85
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.85
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.85
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.85
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.85
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.85
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.85
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.85
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.85
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.85
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.85
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.85
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.85
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.85
KOG1187|consensus	361		99.85
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.85
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.85
KOG0196|consensus	996		99.85
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.85
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.85
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.85
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.85
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.84
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.84
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.84
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.84
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.84
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.84
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.84
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.84
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.84
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.84
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.84
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.84
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.84
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.84
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.84
KOG0200|consensus	609		99.84
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.84
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.84
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.84
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.84
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.84
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.84
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.84
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.84
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.84
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.84
PHA03210	501	serine/threonine kinase US3; Provisional	99.84
KOG1006|consensus	361		99.84
KOG0577|consensus	948		99.84
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.84
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.84
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.84
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.84
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.84
KOG0199|consensus	1039		99.83
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.83
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.83
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.83
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.83
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.83
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.83
PHA03211	461	serine/threonine kinase US3; Provisional	99.83
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.83
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.83
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.83
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.83
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.83
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.83
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.83
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.83
KOG0586|consensus	596		99.83
PHA03209	357	serine/threonine kinase US3; Provisional	99.83
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.83
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.83
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.83
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.83
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.83
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.83
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.83
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.83
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.83
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.83
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.83
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.83
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.83
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.83
KOG0604|consensus	400		99.83
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.83
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.83
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.83
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.83
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.82
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.82
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.82
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.82
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.82
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.82
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.82
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.82
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.82
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.82
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.82
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.82
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.82
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.82
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.82
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.82
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.82
KOG0596|consensus	677		99.82
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.82
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.82
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.82
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.82
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.82
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.81
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.81
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.81
KOG4257|consensus	974		99.81
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.81
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.81
KOG0664|consensus	449		99.81
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.81
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.81
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.81
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.81
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.81
KOG1035|consensus	1351		99.81
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.81
KOG1025|consensus	1177		99.81
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.81
KOG0587|consensus	953		99.81
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.81
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.81
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.81
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.8
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.8
KOG2345|consensus	302		99.8
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.8
PLN00181	793	protein SPA1-RELATED; Provisional	99.8
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.8
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.8
KOG0671|consensus	415		99.8
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.8
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.8
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.8
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.8
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.8
KOG4278|consensus	1157		99.8
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.8
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.8
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.8
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.8
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.8
KOG4717|consensus	864		99.8
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.8
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.8
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.79
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.79
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.79
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.79
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.79
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.79
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.79
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.79
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.79
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.79
KOG0665|consensus	369		99.79
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.79
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.79
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.79
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.79
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.79
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.79
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.78
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.78
KOG0666|consensus	438		99.78
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.78
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.78
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.78
PLN00009	294	cyclin-dependent kinase A; Provisional	99.78
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.78
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.78
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.77
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.77
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.77
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.77
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.77
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.77
KOG0668|consensus	338		99.77
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.77
KOG1094|consensus	807		99.77
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.77
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.77
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.77
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.77
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.76
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.76
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.76
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.76
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.76
KOG1024|consensus	563		99.76
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.76
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.76
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.76
KOG0669|consensus	376		99.75
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.75
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.75
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.75
KOG4236|consensus	888		99.74
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.74
KOG0607|consensus	463		99.74
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.74
KOG1027|consensus	903		99.73
KOG0584|consensus	632		99.72
KOG1345|consensus	378		99.72
KOG0662|consensus	292		99.72
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.7
KOG1151|consensus	775		99.7
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.69
KOG3653|consensus	534		99.69
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.68
KOG1152|consensus	772		99.67
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.67
KOG0670|consensus	752		99.65
KOG2052|consensus	513		99.63
KOG0576|consensus	829		99.57
KOG0590|consensus	601		99.55
KOG0606|consensus	1205		99.51
KOG1164|consensus	322		99.49
KOG1290|consensus	590		99.48
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.48
PRK09188	365	serine/threonine protein kinase; Provisional	99.45
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.45
KOG0603|consensus	612		99.45
KOG1167|consensus	418		99.4
PRK12274	218	serine/threonine protein kinase; Provisional	99.4
KOG1165|consensus	449		99.32
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.26
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.25
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.25
KOG4158|consensus	598		99.24
KOG1240|consensus	1431		99.24
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.23
KOG1163|consensus	341		99.23
KOG1033|consensus	516		99.21
KOG0195|consensus	448		99.14
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.09
KOG1166|consensus	974		99.03
KOG1023|consensus	484		98.98
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.95
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.95
smart00090	237	RIO RIO-like kinase.	98.95
KOG0590|consensus	601		98.93
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.9
PRK14879	211	serine/threonine protein kinase; Provisional	98.83
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.81
PRK10345	210	hypothetical protein; Provisional	98.76
KOG0606|consensus	1205		98.56
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.53
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.52
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.47
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.33
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.12
KOG3087|consensus	229		97.94
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	97.89
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.85
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	97.83
KOG2137|consensus	700		97.76
COG4248	637	Uncharacterized protein with protein kinase and he	97.65
KOG0601|consensus	524		97.64
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	97.6
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.35
KOG1243|consensus	690		97.18
PRK09902	216	hypothetical protein; Provisional	96.82
COG0478	304	RIO-like serine/threonine protein kinase fused to	96.62
KOG0601|consensus	524		96.55
KOG1266|consensus	458		95.64
COG0661	517	AarF Predicted unusual protein kinase [General fun	94.54
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	93.58
PRK05231	319	homoserine kinase; Provisional	93.03
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	92.62
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	92.56
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	92.09
KOG2268|consensus	465		91.82
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	91.33
PHA03111	444	Ser/Thr kinase; Provisional	91.12
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	91.1
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	90.73
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	90.55
KOG0576|consensus	829		90.4
KOG3741|consensus	655		90.36
KOG1235|consensus	538		90.33
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	90.18
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	90.16
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	89.75
PF01636	239	APH: Phosphotransferase enzyme family This family	89.71
PRK10271	188	thiK thiamine kinase; Provisional	89.69
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	89.26
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	88.23
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	87.71
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	87.56
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	86.85
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	86.16
PLN02236	344	choline kinase	85.98
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	84.91
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	84.5
COG2334	331	Putative homoserine kinase type II (protein kinase	84.14
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	83.79
PRK06148	1013	hypothetical protein; Provisional	82.81
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	81.83
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	80.93

>KOG0595|consensus

Probab=99.97  E-value=1.4e-31  Score=182.20  Aligned_cols=121  Identities=25%  Similarity=0.400  Sum_probs=100.1

Q ss_pred             CCCCCCCCccccCCCC------chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC------CcEEEEeecCcccc
Q psy7529           1 MKSPNGSGVVTPLGSY------ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR------HQAKISDFGLSRAV   68 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~------~~~~l~d~~~~~~~   68 (129)
                      ||||+||+|...+...      ..+.++.|+ +.|+.+||. ++||||||||+|||++..      ..+|++|||++|.+
T Consensus        88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QL-A~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQL-ASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            8999999977766654      356688888 999999999 999999999999999764      45799999999987


Q ss_pred             cCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          69 NSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                      ..... .   ..-++++-|||||++....|+-++|+||+|+++|++++ |+.||...+..
T Consensus       166 ~~~~~-a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~-g~~Pf~a~t~~  220 (429)
T KOG0595|consen  166 QPGSM-A---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLT-GKPPFDAETPK  220 (429)
T ss_pred             CchhH-H---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHh-CCCCccccCHH
Confidence            64321 1   12234567999999998999999999999999999998 99999965543

>KOG0616|consensus

Probab=99.97  E-value=1.2e-30  Score=171.88  Aligned_cols=118  Identities=25%  Similarity=0.400  Sum_probs=103.6

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||.+||.++..|+.      ...+++++|+ +.|++|+|. +.|++||+||+|||++..+++|+.|||+++......  
T Consensus       123 meyv~GGElFS~Lrk~~rF~e~~arFYAAei-vlAleylH~-~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT--  198 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEI-VLALEYLHS-LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT--  198 (355)
T ss_pred             EeccCCccHHHHHHhcCCCCchhHHHHHHHH-HHHHHHHHh-cCeeeccCChHHeeeccCCcEEEEeccceEEecCcE--
Confidence            899999998876664      5588999999 999999999 999999999999999999999999999998765431  


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                       .   .-++++.|+|||.+...+++..+|+||+|+++|||+. |.+||.+.++
T Consensus       199 -~---TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMla-G~pPF~~~~~  246 (355)
T KOG0616|consen  199 -W---TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLA-GYPPFYDDNP  246 (355)
T ss_pred             -E---EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHc-CCCCCcCCCh
Confidence             1   2234578999999999999999999999999999999 9999998764

>KOG0598|consensus

Probab=99.96  E-value=2.9e-30  Score=173.75  Aligned_cols=120  Identities=28%  Similarity=0.398  Sum_probs=102.4

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ++|.+||+|+.-|..      -..+++.+.+ +.||.|||. ++|||||+||+|||++..+++++.|||+++..-.....
T Consensus       104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi-~lAL~~LH~-~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGRFSEDRARFYLAEI-VLALGYLHS-KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             EeccCCccHHHHHHhcCCcchhHHHHHHHHH-HHHHHHHHh-CCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence            478899998887773      3578899999 999999999 99999999999999999999999999999864322211


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         +..-++|+.|+|||.+....|+..+|+||+|+++|+|++ |.+||.+.+
T Consensus       182 ---t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~-G~pPF~~~~  229 (357)
T KOG0598|consen  182 ---TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLT-GKPPFYAED  229 (357)
T ss_pred             ---cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhh-CCCCCcCcc
Confidence               222345678999999999999999999999999999998 999998765

>KOG0694|consensus

Probab=99.96  E-value=1.6e-29  Score=180.92  Aligned_cols=122  Identities=23%  Similarity=0.384  Sum_probs=104.2

Q ss_pred             CCCCCCCCcc-----ccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVV-----TPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++||+++     ..+.+.+.++++|.+ +.||.|+|. ++|||||||.+|||+|..+++|++|||+++..-..... 
T Consensus       448 mey~~Ggdm~~~~~~~~F~e~rarfyaAev-~l~L~fLH~-~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~-  524 (694)
T KOG0694|consen  448 MEYVAGGDLMHHIHTDVFSEPRARFYAAEV-VLGLQFLHE-NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDR-  524 (694)
T ss_pred             EEecCCCcEEEEEecccccHHHHHHHHHHH-HHHHHHHHh-cCceeeecchhheEEcccCcEEecccccccccCCCCCc-
Confidence            8999999944     345567889999999 999999999 99999999999999999999999999999864322222 


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                        +.+-++|+.|+|||.+....|+..+|+|++|+++|||+. |+.||.+-+.+
T Consensus       525 --TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~-Gq~PF~gddEe  574 (694)
T KOG0694|consen  525 --TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLV-GESPFPGDDEE  574 (694)
T ss_pred             --cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHc-CCCCCCCCCHH
Confidence              223345678999999999999999999999999999998 99999976543

>KOG0592|consensus

Probab=99.95  E-value=1.1e-28  Score=173.14  Aligned_cols=123  Identities=24%  Similarity=0.435  Sum_probs=102.0

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+++|++...+..      ...+++++++ .-||.|||. ++||||||||+|||++.+++++|.|||-++.+.+....
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeI-ldAleylH~-~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEI-LDALEYLHS-NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHH-HHHHHHHHh-cCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence            588999997776654      5689999999 999999999 99999999999999999999999999999876432111


Q ss_pred             -------eeec---cCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 -------YKAT---HGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 -------~~~~---~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                             ....   ..-.++..|.+||++.....+..+|+|++||++|+|+. |.+||.+.+
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmla-G~PPFra~N  291 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLA-GQPPFRAAN  291 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhc-CCCCCcccc
Confidence                   0001   11234677999999999888999999999999999998 999998754

>KOG0197|consensus

Probab=99.95  E-value=9.7e-29  Score=172.49  Aligned_cols=125  Identities=45%  Similarity=0.810  Sum_probs=107.7

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||.+.|+|.+.|+.        ....-+++|+ |+|++||.. +++|||||...|||++.+..+||+|||++|...  .
T Consensus       280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qI-aeGM~YLes-~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~--d  355 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQI-AEGMAYLES-KNYIHRDLAARNILVDEDLVVKISDFGLARLIG--D  355 (468)
T ss_pred             EEecccCcHHHHhhhcCCCccchHHHHHHHHHH-HHHHHHHHh-CCccchhhhhhheeeccCceEEEcccccccccC--C
Confidence            688888887777775        2244488888 999999999 999999999999999999999999999999433  2


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD  129 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~e  129 (129)
                      ..+....+...+..|.|||.+..+.++.++|+||+|+++||++|+|+.||..+++.|
T Consensus       356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e  412 (468)
T KOG0197|consen  356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE  412 (468)
T ss_pred             CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH
Confidence            345556667778899999999999999999999999999999999999999998753

>KOG0583|consensus

Probab=99.95  E-value=5.2e-28  Score=168.01  Aligned_cols=120  Identities=28%  Similarity=0.391  Sum_probs=100.6

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC-CcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR-HQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~-~~~~l~d~~~~~~~~~~~~   73 (129)
                      ||||.||++++.+..      -..+.+|.|+ +.|+.|+|. ++|+|||||++|++++.+ +++|++|||++....... 
T Consensus        99 mEy~~gGdL~~~i~~~g~l~E~~ar~~F~Ql-isav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~-  175 (370)
T KOG0583|consen   99 MEYCSGGDLFDYIVNKGRLKEDEARKYFRQL-ISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGED-  175 (370)
T ss_pred             EEecCCccHHHHHHHcCCCChHHHHHHHHHH-HHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCC-
Confidence            899999997766554      3577799999 999999999 999999999999999999 999999999998663111 


Q ss_pred             eeeeccCCCCCceecccccccCCC-CC-ChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGR-FS-SASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~-~~-~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        ......++++.|+|||++.+.. |+ .++|+||+|+++|.|+. |..||.+.+
T Consensus       176 --~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~-G~~PF~d~~  227 (370)
T KOG0583|consen  176 --GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLC-GRLPFDDSN  227 (370)
T ss_pred             --CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHh-CCCCCCCcc
Confidence              1223334567899999998877 84 89999999999999998 999999854

>KOG0581|consensus

Probab=99.94  E-value=4.3e-28  Score=163.50  Aligned_cols=118  Identities=27%  Similarity=0.423  Sum_probs=96.8

Q ss_pred             CCCCCCCCccccCCC---Cc---hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS---YA---LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~---~~---~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||..||+|-..++.   ..   +..++.++ .+||.|||...+|||||+||+|+|++..+.+|++|||.++.+.+.  .
T Consensus       157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~V-L~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~  233 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAV-LRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--I  233 (364)
T ss_pred             hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHH-HHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--h
Confidence            899999996666553   22   33477788 999999997689999999999999999999999999999865332  1


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ..   +-.+|..||+||.+.+..|+.++||||+|..++|+.. |+.||..-
T Consensus       234 a~---tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~-GrfP~~~~  280 (364)
T KOG0581|consen  234 AN---TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAI-GRFPYPPP  280 (364)
T ss_pred             cc---cccccccccChhhhcCCcCCcccceecccHHHHHHhh-CCCCCCCc
Confidence            11   1123446999999999999999999999999999998 99998763

>KOG0605|consensus

Probab=99.94  E-value=6.5e-28  Score=168.83  Aligned_cols=125  Identities=22%  Similarity=0.358  Sum_probs=101.3

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC----
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS----   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~----   70 (129)
                      |||.+||++-+.|..      ...+++++++ ..|+.-+|. .++|||||||+|+|++..|++|++|||++..+-.    
T Consensus       220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~-vlAI~~iH~-~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAET-VLAIESIHQ-LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EEecCCccHHHHHHhcCcCchHHHHHHHHHH-HHHHHHHHH-cCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence            999999996665554      4578899999 889999999 9999999999999999999999999999864211    


Q ss_pred             -----------------CCcee-----eec------------------cCCCCCceecccccccCCCCCChhhHHHHHHH
Q psy7529          71 -----------------ERNYY-----KAT------------------HGGRWPIKWYAPESYNFGRFSSASDVWSFGIT  110 (129)
Q Consensus        71 -----------------~~~~~-----~~~------------------~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~  110 (129)
                                       .....     ...                  ....+++.|+|||++.+..|+...|+||+||+
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I  377 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI  377 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence                             00000     000                  01235788999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCC
Q psy7529         111 LWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus       111 l~~l~~~~~~pf~~~~~~  128 (129)
                      +||++. |.+||.+-++.
T Consensus       378 myEmLv-GyPPF~s~tp~  394 (550)
T KOG0605|consen  378 MYEMLV-GYPPFCSETPQ  394 (550)
T ss_pred             HHHHHh-CCCCCCCCCHH
Confidence            999998 99999987654

>KOG0610|consensus

Probab=99.94  E-value=5.6e-27  Score=160.21  Aligned_cols=126  Identities=26%  Similarity=0.342  Sum_probs=101.3

Q ss_pred             CCCCCCCCccccCCCC--------chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC--
Q psy7529           1 MKSPNGSGVVTPLGSY--------ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS--   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~--   70 (129)
                      ||||+||+|+..+..+        .++++++.+ ..||+|||. .+||+|||||+|||+-.++++.++||-++.....  
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEv-l~ALEYLHm-lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEV-LLALEYLHM-LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHH-HHHHHHHHh-hceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            8999999988777653        488899999 899999999 9999999999999999999999999988753210  


Q ss_pred             -----C---------------------Cceee-e------------------cc------CCCCCceecccccccCCCCC
Q psy7529          71 -----E---------------------RNYYK-A------------------TH------GGRWPIKWYAPESYNFGRFS   99 (129)
Q Consensus        71 -----~---------------------~~~~~-~------------------~~------~~~~~~~~~~pe~~~~~~~~   99 (129)
                           .                     ..... .                  ..      .-.+|-.|+|||++++...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                 0                     00000 0                  00      01235679999999999999


Q ss_pred             ChhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q psy7529         100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD  129 (129)
Q Consensus       100 ~~~di~s~g~~l~~l~~~~~~pf~~~~~~e  129 (129)
                      ..+|+|++|+++|||+. |.+||.+.+++|
T Consensus       314 sAVDWWtfGIflYEmLy-G~TPFKG~~~~~  342 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLY-GTTPFKGSNNKE  342 (459)
T ss_pred             chhhHHHHHHHHHHHHh-CCCCcCCCCchh
Confidence            99999999999999996 999999987764

>KOG0192|consensus

Probab=99.94  E-value=2.9e-27  Score=163.51  Aligned_cols=121  Identities=31%  Similarity=0.512  Sum_probs=97.7

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCC-CccCCCCCCCEEecCCC-cEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKS-SFHRDLAARNILLASRH-QAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~-~ihr~lk~~nil~~~~~-~~~l~d~~~~~~~~~   70 (129)
                      |||.++|++...+..        ..+..++.++ |+|+.|+|. +. |||||||++|+|++... ++||+|||+++....
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldi-ArGm~YLH~-~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDI-ARGMEYLHS-EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHH-HHHHHHHhc-CCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            799999997766633        1234477777 999999999 77 99999999999999997 999999999986543


Q ss_pred             CCceeeeccCCCCCceeccccccc--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYN--FGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ..   .......++..|||||++.  ...|+.++|+||+|+++||+++ ++.||.++.+
T Consensus       197 ~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t-~~~Pf~~~~~  251 (362)
T KOG0192|consen  197 SK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLT-GEIPFEDLAP  251 (362)
T ss_pred             cc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHH-CCCCCCCCCH
Confidence            21   1111123456799999999  5589999999999999999999 9999998874

>KOG0198|consensus

Probab=99.94  E-value=1e-27  Score=162.12  Aligned_cols=121  Identities=29%  Similarity=0.434  Sum_probs=96.5

Q ss_pred             CCCCCCCCccc-------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-CCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVT-------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-RHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+++|+|..       .+++..++.+..|+ ++||.|+|. ++++|||||++|||++. ++.+|++|||+++......
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~i-L~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQI-LEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHH-HHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            89999999666       45566678888999 999999998 99999999999999999 6999999999887654311


Q ss_pred             ceeeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ..........+++.|++||++..+ ..+..+|+||+||++.||++ |+.||.+
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T-g~~PW~~  224 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT-GKPPWSE  224 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC-CCCcchh
Confidence            111112223345679999999853 23458999999999999998 9999987

>KOG4721|consensus

Probab=99.94  E-value=1.2e-27  Score=169.57  Aligned_cols=121  Identities=32%  Similarity=0.514  Sum_probs=100.8

Q ss_pred             CCCCCCCCccccCCCCc------hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGSYA------LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||||..|+|++.|+.-+      ++.--.+| |-|+.|||. +.|||||||..|||+..+..+||+|||-++..... ..
T Consensus       191 MEfCa~GqL~~VLka~~~itp~llv~Wsk~I-A~GM~YLH~-hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-ST  267 (904)
T KOG4721|consen  191 MEFCAQGQLYEVLKAGRPITPSLLVDWSKGI-AGGMNYLHL-HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-ST  267 (904)
T ss_pred             eeccccccHHHHHhccCccCHHHHHHHHHHh-hhhhHHHHH-hhHhhhccCCCceEeeccceEEeccccchHhhhhh-hh
Confidence            99999999999998643      22244566 889999999 89999999999999999999999999988765443 22


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                      ....   .++..|||||++...+.+.++||||+|+++|||++ |+.||.+.+..
T Consensus       268 kMSF---aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT-~EiPYkdVdss  317 (904)
T KOG4721|consen  268 KMSF---AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLT-GEIPYKDVDSS  317 (904)
T ss_pred             hhhh---hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHh-cCCCccccchh
Confidence            2222   23557999999999999999999999999999999 99999987653

>KOG0575|consensus

Probab=99.94  E-value=1.2e-26  Score=164.41  Aligned_cols=118  Identities=26%  Similarity=0.433  Sum_probs=98.7

Q ss_pred             CCCCCCCcc------ccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           2 KSPNGSGVV------TPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         2 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |.|..+.+-      .++.+.+.+++..|| +.|+.|||. ++|||||||..|++++.+.++||+|||++..........
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QI-v~GlkYLH~-~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk  175 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQI-VEGLKYLHS-LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK  175 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHH-HHHHHHHHh-cCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence            456666633      345567789999999 999999999 889999999999999999999999999998776544333


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ...+   +|+-|.|||++.....+..+|+||+||++|.++. |++||...
T Consensus       176 ~TlC---GTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~-G~PPFetk  221 (592)
T KOG0575|consen  176 KTLC---GTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLV-GRPPFETK  221 (592)
T ss_pred             ceec---CCCcccChhHhccCCCCCchhhhhhhhHHHhhhh-CCCCcccc
Confidence            3333   4567999999988888999999999999999997 99999865

>KOG0578|consensus

Probab=99.94  E-value=1.4e-26  Score=162.89  Aligned_cols=119  Identities=26%  Similarity=0.439  Sum_probs=97.1

Q ss_pred             CCCCCCCCccccCCC-----CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLGS-----YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||.+||.|......     ..+..+...+ ++||+|||. ++|+|||||.+||++..++.+|+.|||++..+.......
T Consensus       349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~-l~aL~fLH~-~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKTRMTEGQIAAICREI-LQGLKFLHA-RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             EeecCCCchhhhhhcccccHHHHHHHHHHH-HHHHHHHHh-cceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence            899999985443333     2344455556 889999999 999999999999999999999999999998765544322


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .   ...+++.|||||+.....|+.++||||+|++.+||+. |++||...
T Consensus       427 ~---TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMve-GEPPYlnE  472 (550)
T KOG0578|consen  427 S---TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVE-GEPPYLNE  472 (550)
T ss_pred             c---cccCCCCccchhhhhhcccCccccchhhhhHHHHHhc-CCCCccCC
Confidence            2   2334667999999999999999999999999999998 99999753

>KOG0696|consensus

Probab=99.93  E-value=1.6e-26  Score=159.13  Aligned_cols=122  Identities=26%  Similarity=0.413  Sum_probs=102.5

Q ss_pred             CCCCCCCCcc------ccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVV------TPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++||+|-      -.+++.-..++++.+ +-||.+||. ++||+||||.+|++++..+++|+.|||+++..-.....
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEi-aigLFFLh~-kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T  506 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEI-AIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT  506 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHH-HHHhhhhhc-CCeeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence            8999999942      334456678899999 999999999 99999999999999999999999999999864332222


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                      ...   -++++.|+|||.+...+|+..+|+||+|+++||++. |+.||.+.+..
T Consensus       507 TkT---FCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmla-GQpPFdGeDE~  556 (683)
T KOG0696|consen  507 TKT---FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGEDED  556 (683)
T ss_pred             eee---ecCCCcccccceEEecccccchhHHHHHHHHHHHHc-CCCCCCCCCHH
Confidence            222   234567999999999999999999999999999998 99999987653

>KOG0615|consensus

Probab=99.93  E-value=2.2e-27  Score=162.20  Aligned_cols=119  Identities=26%  Similarity=0.423  Sum_probs=95.3

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC---CcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~---~~~~l~d~~~~~~~~~~   71 (129)
                      |||.+||+|+.-      +++-.-+.++.|+ +.|+.|||. ++|+||||||+|||+...   ..+|+.|||+++..+..
T Consensus       255 lE~v~GGeLfd~vv~nk~l~ed~~K~~f~Ql-l~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~  332 (475)
T KOG0615|consen  255 LEYVEGGELFDKVVANKYLREDLGKLLFKQL-LTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG  332 (475)
T ss_pred             EEEecCccHHHHHHhccccccchhHHHHHHH-HHHHHHHHH-cCcccccCCcceEEeccCCcceEEEecccchhhccccc
Confidence            789999996543      3344567799999 999999999 999999999999999776   67899999999876422


Q ss_pred             CceeeeccCCCCCceecccccccCCC---CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGR---FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~---~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       +..   .+.++++.|.|||++....   +..++|+||+||++|-+++ |.+||.+-.
T Consensus       333 -sfm---~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs-G~pPFS~~~  385 (475)
T KOG0615|consen  333 -SFM---KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS-GYPPFSEEY  385 (475)
T ss_pred             -eeh---hhhcCCccccChhheecCCeecccchheeeeccceEEEEec-cCCCccccc
Confidence             222   2233456799999986653   3458899999999999999 999998754

>KOG0591|consensus

Probab=99.93  E-value=1.1e-26  Score=152.82  Aligned_cols=120  Identities=23%  Similarity=0.369  Sum_probs=96.9

Q ss_pred             CCCCCCCCccccCCCC----------chhhHHhHHHHHHHHHHhcc--C-CCccCCCCCCCEEecCCCcEEEEeecCccc
Q psy7529           1 MKSPNGSGVVTPLGSY----------ALPYIEGQIPAKVCRYLKMH--K-SSFHRDLAARNILLASRHQAKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~~h~~--~-~~ihr~lk~~nil~~~~~~~~l~d~~~~~~   67 (129)
                      ||+|.+|++.+-.+..          ..--++.|+ +.||..+|..  + .++||||||.||.++.++.+|+.|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL-~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQL-CRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHH-HHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            8999999976554422          122288999 9999999972  2 378999999999999999999999999987


Q ss_pred             ccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          68 VNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      +.+.....   ..-.+|+-||+||.+...+|+.++|+||+||++|||+. -..||.+.
T Consensus       178 l~s~~tfA---~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMca-L~~PF~g~  231 (375)
T KOG0591|consen  178 LSSKTTFA---HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCA-LQSPFYGD  231 (375)
T ss_pred             hcchhHHH---HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHh-cCCCcccc
Confidence            75443222   23334567999999999999999999999999999999 78999764

>KOG0201|consensus

Probab=99.93  E-value=5.7e-26  Score=156.10  Aligned_cols=122  Identities=29%  Similarity=0.486  Sum_probs=101.9

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||||.||.+...|..      ..+..+..++ ..|+.|+|. ++.+|||+|+.||++...+.++++|||++..++.....
T Consensus        90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~-l~~l~ylH~-~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNILDEFEIAVILREV-LKGLDYLHS-EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHHhcCcchhhhhccCCCCccceeeeehHHH-HHHhhhhhh-cceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            899999997777664      3345566777 999999999 89999999999999999999999999998776554433


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                      ....   .+++-|||||++++..|+.++||||+|++.+||.+ |++|+.++.++
T Consensus       168 r~tf---vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~-GePP~s~~hPm  217 (467)
T KOG0201|consen  168 RKTF---VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAK-GEPPHSKLHPM  217 (467)
T ss_pred             cccc---cccccccchhhhccccccchhhhhhhhHHHHHHhc-CCCCCcccCcc
Confidence            3333   34556999999998899999999999999999998 99999987653

>KOG0588|consensus

Probab=99.92  E-value=5.2e-26  Score=162.86  Aligned_cols=118  Identities=25%  Similarity=0.372  Sum_probs=99.4

Q ss_pred             CCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           2 KSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         2 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      ||.+||.+|..+      .+.+...++.|| .-|+.|+|+ .+|+|||+||+|++++..+++||+|||++.......   
T Consensus        92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QI-i~gv~yCH~-~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk---  166 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGPLPEREAAHFFRQI-LDGVSYCHA-FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK---  166 (786)
T ss_pred             EecCCchhHHHHHhhCCCCCHHHHHHHHHH-HHHHHHHhh-hcceeccCCchhhhhhcccCEeeeccceeecccCCc---
Confidence            788888877654      456788899999 899999999 899999999999999999999999999986543322   


Q ss_pred             eeccCCCCCceecccccccCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRF-SSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       .....++++.|.+||.+.+.+| +.++|+||+|++++.+++ |+.||+|-+
T Consensus       167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLt-G~LPFdDdN  216 (786)
T KOG0588|consen  167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLT-GKLPFDDDN  216 (786)
T ss_pred             -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHh-CCCCCCCcc
Confidence             2233445678999999999998 578999999999999999 999999754

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.92  E-value=8.1e-26  Score=157.11  Aligned_cols=123  Identities=23%  Similarity=0.384  Sum_probs=96.8

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|+++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi-~~aL~~lH~-~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAET-VLAIDSIHQ-LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            7999999866544      334466688898 899999998 99999999999999999999999999998653211000


Q ss_pred             --------------------------------eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q psy7529          75 --------------------------------YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY  122 (129)
Q Consensus        75 --------------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf  122 (129)
                                                      ........++..|+|||.+.+..++.++|+||+|++++++++ |..||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf  236 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI-GYPPF  236 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh-CCCCC
Confidence                                            000011234567999999988888999999999999999998 99999


Q ss_pred             CCCC
Q psy7529         123 GEMK  126 (129)
Q Consensus       123 ~~~~  126 (129)
                      .+.+
T Consensus       237 ~~~~  240 (363)
T cd05628         237 CSET  240 (363)
T ss_pred             CCCC
Confidence            8654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0611|consensus

Probab=99.92  E-value=8.7e-26  Score=155.20  Aligned_cols=120  Identities=25%  Similarity=0.365  Sum_probs=102.3

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||.++|+|+....      +...+++|.|| ..|..|+|. ++++|||||.+|||++.++++|++|||++..+..... 
T Consensus       132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQI-vSAVhYCHk-nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf-  208 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGSLSEREARHFFRQI-VSAVHYCHK-NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF-  208 (668)
T ss_pred             EEecCCccHHHHHHHhccccHHHHHHHHHHH-HHHHHHHhh-ccceecccchhheeecCCCCeeeeccchhhhhccccH-
Confidence            89999999887655      45688899999 999999999 9999999999999999999999999999977654321 


Q ss_pred             eeeccCCCCCceecccccccCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRF-SSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                         .+.-++++.|.+||.+.+.+| ++.+|.||+|+++|.+.. |.+||++.+.
T Consensus       209 ---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVy-GtMPFDG~Dh  258 (668)
T KOG0611|consen  209 ---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVY-GTMPFDGRDH  258 (668)
T ss_pred             ---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhh-cccccCCchH
Confidence               122233467999999999988 689999999999999996 9999998764

>KOG0593|consensus

Probab=99.92  E-value=1.4e-25  Score=148.77  Aligned_cols=106  Identities=24%  Similarity=0.458  Sum_probs=90.1

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ....+-+.+|+ ++|+.|+|. +.+||||+||+||++..++.+|++|||+++.+..+...+.....++|   |.|||.+.
T Consensus       100 ~~~vk~~l~Q~-l~ai~~cHk-~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRW---YRaPELLv  174 (396)
T KOG0593|consen  100 SELVKKYLYQL-LKAIHFCHK-NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRW---YRAPELLV  174 (396)
T ss_pred             HHHHHHHHHHH-HHHhhhhhh-cCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhh---ccChhhhc
Confidence            34466689999 999999999 89999999999999999999999999999987654444444444444   78999888


Q ss_pred             C-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 F-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 ~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      + ..|+..+|+||+||++.|+++ |++-|.+.+
T Consensus       175 GDtqYG~pVDiWAiGCv~aEl~~-G~pL~PG~S  206 (396)
T KOG0593|consen  175 GDTQYGKPVDIWAIGCVFAELLT-GEPLWPGRS  206 (396)
T ss_pred             ccCcCCCcccchhhhHHHHHHhc-CCcCCCCcc
Confidence            7 589999999999999999998 999888765

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.92  E-value=2.9e-25  Score=152.18  Aligned_cols=120  Identities=26%  Similarity=0.405  Sum_probs=96.2

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi-~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEI-AIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence            7899999875443      333466688888 999999998 89999999999999999999999999998743221111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   ....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       158 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~  205 (323)
T cd05616         158 T---KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGED  205 (323)
T ss_pred             c---ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHh-CCCCCCCCC
Confidence            1   11123457999999988889999999999999999998 999998654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.92  E-value=6.1e-25  Score=150.62  Aligned_cols=120  Identities=25%  Similarity=0.406  Sum_probs=95.1

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi-~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI-AIGLFFLHS-KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence            7999999875443      233455578888 999999999 89999999999999999999999999988643211111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   ...++..|+|||.+.+..++.++|+||+|++++++++ |+.||.+.+
T Consensus       158 ~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~pf~~~~  205 (324)
T cd05587         158 TR---TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGED  205 (324)
T ss_pred             ee---eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCC
Confidence            11   1123457999999988888899999999999999998 999997654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0594|consensus

Probab=99.91  E-value=9e-25  Score=146.76  Aligned_cols=105  Identities=26%  Similarity=0.421  Sum_probs=87.3

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      ..+..++.|+ +.|+.|+|. ++|+||||||.|++++..+.+|++|||+++...-+...+.....   +.-|.|||++.+
T Consensus       120 ~~ik~~m~Ql-l~gl~~~H~-~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evv---TlWYRaPEvLlG  194 (323)
T KOG0594|consen  120 RLIKSFMRQL-LRGLAFLHS-HGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVV---TLWYRAPEVLLG  194 (323)
T ss_pred             HHHHHHHHHH-HHHHHHHHh-CCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEE---EeeccCHHHhcC
Confidence            3467799999 999999999 99999999999999999999999999999866543332322222   233889999887


Q ss_pred             C-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 G-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . .|+..+|+||+||++.||++ ++..|.+.+
T Consensus       195 s~~Ys~~vDiWs~GcIfaEm~~-~~~LFpG~s  225 (323)
T KOG0594|consen  195 STSYSTSVDIWSLGCIFAEMFT-RRPLFPGDS  225 (323)
T ss_pred             CCcCCCCcchHhHHHHHHHHHh-CCCCCCCCc
Confidence            7 68999999999999999998 888888754

>KOG1989|consensus

Probab=99.91  E-value=5.7e-25  Score=160.74  Aligned_cols=123  Identities=23%  Similarity=0.327  Sum_probs=96.4

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccC-CCccCCCCCCCEEecCCCcEEEEeecCccccc-C
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHK-SSFHRDLAARNILLASRHQAKISDFGLSRAVN-S   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~-~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~-~   70 (129)
                      ||||.|+.|..-+.        +..+..|++++ |+|+.+||... .|||||||.+|+|+..+++.|+||||.+.... .
T Consensus       121 mEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv-~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~  199 (738)
T KOG1989|consen  121 MEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDV-CEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILS  199 (738)
T ss_pred             hhhccCCcHHHHHHHHHhccCChHHHHHHHHHH-HHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCC
Confidence            99999988655554        55677899999 99999999832 49999999999999999999999999875421 1


Q ss_pred             CC-----ceeeeccCCCCCceecccccc---cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          71 ER-----NYYKATHGGRWPIKWYAPESY---NFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        71 ~~-----~~~~~~~~~~~~~~~~~pe~~---~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ..     ........+..|+.|.+||++   .+.+.+.++|||++||++|.++- ...||.+-
T Consensus       200 ~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy-~t~PFe~s  261 (738)
T KOG1989|consen  200 PTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCY-FTTPFEES  261 (738)
T ss_pred             CccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHH-hCCCcCcC
Confidence            10     111122233456779999975   55678999999999999999995 89999864

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.91  E-value=1.7e-24  Score=149.03  Aligned_cols=105  Identities=42%  Similarity=0.774  Sum_probs=83.4

Q ss_pred             hhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCCC
Q psy7529          19 PYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRF   98 (129)
Q Consensus        19 ~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~   98 (129)
                      ..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........ ........+..|+|||.+....+
T Consensus       177 ~~~~~qi-~~aL~~LH~-~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~  253 (338)
T cd05102         177 ICYSFQV-ARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLPLKWMAPESIFDKVY  253 (338)
T ss_pred             HHHHHHH-HHHHHHHHH-CCEECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCCccccCcHHhhcCCC
Confidence            3467788 999999998 99999999999999999999999999998754322111 11111122356999999888888


Q ss_pred             CChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          99 SSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        99 ~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +.++|+||+|+++|++++.|..||.+.+
T Consensus       254 ~~~sDiwslG~il~el~~~g~~pf~~~~  281 (338)
T cd05102         254 TTQSDVWSFGVLLWEIFSLGASPYPGVQ  281 (338)
T ss_pred             CcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999966889998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.91  E-value=5.6e-25  Score=150.43  Aligned_cols=120  Identities=26%  Similarity=0.399  Sum_probs=95.8

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|+++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        75 ~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi-~~al~~LH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  152 (316)
T cd05592          75 MEYLNGGDLMFHIQSSGRFDEARARFYAAEI-ICGLQFLHK-KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK  152 (316)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence            7899999875433      333455678888 999999999 99999999999999999999999999998753221111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   ....++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       153 ~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~Pf~~~~  200 (316)
T cd05592         153 A---STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI-GQSPFHGED  200 (316)
T ss_pred             c---ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHh-CCCCCCCCC
Confidence            1   11123457999999988888899999999999999998 999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.91  E-value=4.6e-25  Score=151.22  Aligned_cols=120  Identities=25%  Similarity=0.400  Sum_probs=95.6

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  151 (323)
T cd05571          74 MEYANGGELFFHLSRERVFSEDRARFYGAEI-VSALGYLHS-CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence            7899999875443      233456678888 999999998 89999999999999999999999999998753221111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   ....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       152 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~  199 (323)
T cd05571         152 M---KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQD  199 (323)
T ss_pred             c---cceecCccccChhhhcCCCCCccccCcccchhhhhhhc-CCCCCCCCC
Confidence            1   11123457999999988888999999999999999998 999997644

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.91  E-value=1.2e-24  Score=149.12  Aligned_cols=120  Identities=24%  Similarity=0.413  Sum_probs=96.3

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|+++...      +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi-~~al~~lH~-~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEI-SVGLFFLHR-RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence            799999987644      3344566688888 999999998 89999999999999999999999999998753221111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       158 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~pf~~~~  205 (323)
T cd05615         158 ---TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA-GQPPFDGED  205 (323)
T ss_pred             ---ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Confidence               111123467999999988888899999999999999998 999998754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.91  E-value=4.5e-25  Score=151.60  Aligned_cols=120  Identities=24%  Similarity=0.396  Sum_probs=95.4

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        74 ~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi-~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~  151 (328)
T cd05593          74 MEYVNGGELFFHLSRERVFSEDRTRFYGAEI-VSALDYLHS-GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT  151 (328)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc
Confidence            7899999875433      333456688888 999999998 89999999999999999999999999998653221111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   ....++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       152 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~  199 (328)
T cd05593         152 M---KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQD  199 (328)
T ss_pred             c---ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhh-CCCCCCCCC
Confidence            1   11123457999999988888899999999999999998 999997644

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0582|consensus

Probab=99.91  E-value=1.8e-24  Score=149.23  Aligned_cols=111  Identities=28%  Similarity=0.447  Sum_probs=87.8

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeec-cCCCCCceecccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKAT-HGGRWPIKWYAPESY   93 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~-~~~~~~~~~~~pe~~   93 (129)
                      +..+..|..++ ++||.|+|. ++.||||+|+.|||++.++.++++|||.+..+.......... ..-.+++.|+|||++
T Consensus       125 E~~Ia~iLre~-LkaL~YLH~-~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl  202 (516)
T KOG0582|consen  125 EASIATILREV-LKALDYLHQ-NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVL  202 (516)
T ss_pred             HHHHHHHHHHH-HHHHHHHHh-cCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHh
Confidence            33455566666 999999999 999999999999999999999999999877654322222111 222345779999985


Q ss_pred             cC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          94 NF--GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        94 ~~--~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                      ..  ..|+.++||||+|++..|+.+ |..||.++++.
T Consensus       203 ~q~~~GYdfKaDIwSfGITA~ELA~-G~aPf~k~pPm  238 (516)
T KOG0582|consen  203 MQQLHGYDFKADIWSFGITACELAH-GHAPFSKYPPM  238 (516)
T ss_pred             hhcccCccchhhhhhhhHHHHHHhc-CCCCcccCChH
Confidence            44  369999999999999999998 99999998764

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.91  E-value=1.4e-24  Score=149.01  Aligned_cols=118  Identities=20%  Similarity=0.369  Sum_probs=95.1

Q ss_pred             CCCCCCCCccc------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVT------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++..      .+.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        75 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi-~~al~~lH~-~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  152 (327)
T cd05617          75 IEYVNGGDLMFHMQRQRKLPEEHARFYAAEI-CIALNFLHE-RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT  152 (327)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence            78999998753      34444566788999 999999999 89999999999999999999999999988643211111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .   ....++..|+|||.+.+..++.++|+||+|++++++++ |..||..
T Consensus       153 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~-g~~pf~~  198 (327)
T cd05617         153 T---STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA-GRSPFDI  198 (327)
T ss_pred             e---ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHh-CCCCCCc
Confidence            1   11123457999999988888999999999999999998 9999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0690|consensus

Probab=99.91  E-value=7.3e-25  Score=147.15  Aligned_cols=121  Identities=25%  Similarity=0.388  Sum_probs=102.8

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||.+||.|+--|..      -+.+++.+.| ..||.|+|+ ++|++||+|.+|+++++++++|+.|||+++..-.....
T Consensus       247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEI-vsAL~YLHs-~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERVFSEDRTRFYGAEI-VSALGYLHS-RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEEccCceEeeehhhhhcccchhhhhhhHHH-HHHhhhhhh-CCeeeeechhhhheeccCCceEeeecccchhcccccce
Confidence            899999998877664      4678899999 999999999 99999999999999999999999999999853222222


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .   ..-++++.|+|||++-...|+..+|+|.+|+++|||+. |+.||-..++
T Consensus       325 ~---kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmC-GRLPFyn~dh  373 (516)
T KOG0690|consen  325 T---KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMC-GRLPFYNKDH  373 (516)
T ss_pred             e---ccccCChhhcCchhhccccccceeehhhhhHHHHHHHh-ccCcccccch
Confidence            2   22334678999999999999999999999999999998 9999987654

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.91  E-value=1.4e-24  Score=148.83  Aligned_cols=120  Identities=24%  Similarity=0.412  Sum_probs=95.3

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        74 ~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  151 (323)
T cd05595          74 MEYANGGELFFHLSRERVFTEERARFYGAEI-VSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence            7899999865433      334456688888 999999998 89999999999999999999999999987643221111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   ....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       152 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~  199 (323)
T cd05595         152 M---KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQD  199 (323)
T ss_pred             c---ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHh-CCCCCCCCC
Confidence            1   11123457999999988888999999999999999998 999997654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.91  E-value=1.2e-24  Score=148.73  Aligned_cols=120  Identities=27%  Similarity=0.398  Sum_probs=95.0

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        75 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  152 (316)
T cd05620          75 MEFLNGGDLMFHIQDKGRFDLYRATFYAAEI-VCGLQFLHS-KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR  152 (316)
T ss_pred             ECCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence            7999999875433      333455678888 999999998 89999999999999999999999999988643211111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   ....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       153 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~-g~~Pf~~~~  200 (316)
T cd05620         153 A---STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI-GQSPFHGDD  200 (316)
T ss_pred             e---eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCC
Confidence            1   11123457999999988888999999999999999998 999997654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.91  E-value=6.4e-25  Score=153.50  Aligned_cols=124  Identities=23%  Similarity=0.336  Sum_probs=95.5

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc-
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN-   73 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~-   73 (129)
                      |||++|+++...+      .......+++|+ +.|+.|+|. .+++||||||+||+++..+.++++|||+++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi-~~aL~~LH~-~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAEL-TLAIESVHK-MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            7999999875543      333456678888 999999999 8999999999999999999999999998753210000 


Q ss_pred             ---------------------------------------e----eeeccCCCCCceecccccccCCCCCChhhHHHHHHH
Q psy7529          74 ---------------------------------------Y----YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGIT  110 (129)
Q Consensus        74 ---------------------------------------~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~  110 (129)
                                                             .    ........++..|+|||.+.+..++.++|+||+|++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                   0    000001124567999999988888999999999999


Q ss_pred             HHHHHhCCCCCCCCCCC
Q psy7529         111 LWEMYSFGQQPYGEMKG  127 (129)
Q Consensus       111 l~~l~~~~~~pf~~~~~  127 (129)
                      ++++++ |..||...+.
T Consensus       238 l~ellt-G~~Pf~~~~~  253 (381)
T cd05626         238 LFEMLV-GQPPFLAPTP  253 (381)
T ss_pred             HHHHHh-CCCCCcCCCH
Confidence            999998 9999986543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.91  E-value=1.1e-24  Score=149.30  Aligned_cols=120  Identities=23%  Similarity=0.376  Sum_probs=95.5

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        75 ~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql-~~~L~~lH~-~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~  152 (320)
T cd05590          75 MEFVNGGDLMFHIQKSRRFDEARARFYAAEI-TSALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT  152 (320)
T ss_pred             EcCCCCchHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence            7999999875433      333455678888 999999998 99999999999999999999999999998643211111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~~~~  200 (320)
T cd05590         153 ---TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC-GHAPFEAEN  200 (320)
T ss_pred             ---ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhh-CCCCCCCCC
Confidence               111123467999999988888899999999999999998 999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.91  E-value=1.8e-24  Score=147.99  Aligned_cols=120  Identities=27%  Similarity=0.370  Sum_probs=95.5

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+.      ......++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++........
T Consensus        75 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi-~~al~~LH~-~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  152 (316)
T cd05619          75 MEYLNGGDLMFHIQSCHKFDLPRATFYAAEI-ICGLQFLHS-KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK  152 (316)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence            78999999765443      33455678888 999999998 99999999999999999999999999998643211111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   ...++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       153 ~~---~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-G~~pf~~~~  200 (316)
T cd05619         153 TC---TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI-GQSPFHGHD  200 (316)
T ss_pred             ee---eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCC
Confidence            11   1123456999999988888999999999999999998 999997654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.91  E-value=7.9e-25  Score=149.89  Aligned_cols=120  Identities=22%  Similarity=0.360  Sum_probs=95.5

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        75 ~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~aL~~LH~-~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  152 (321)
T cd05591          75 MEYVNGGDLMFQIQRSRKFDEPRSRFYAAEV-TLALMFLHR-HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT  152 (321)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence            7899999875433      233455678888 999999999 89999999999999999999999999988653221111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   ....++..|+|||.+.+..++.++|+||+|+++|++++ |..||...+
T Consensus       153 ~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~  200 (321)
T cd05591         153 T---TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMA-GQPPFEADN  200 (321)
T ss_pred             c---cccccCccccCHHHHcCCCCCCccceechhHHHHHHhc-CCCCCCCCC
Confidence            1   11123457999999988888999999999999999998 999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.91  E-value=1.2e-24  Score=148.94  Aligned_cols=120  Identities=25%  Similarity=0.361  Sum_probs=95.2

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  152 (321)
T cd05603          75 LDYVNGGELFFHLQRERCFLEPRARFYAAEV-ASAIGYLHS-LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET  152 (321)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc
Confidence            7899999875433      334456678888 999999998 89999999999999999999999999988643221111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  200 (321)
T cd05603         153 ---TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLY-GLPPFYSRD  200 (321)
T ss_pred             ---cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhc-CCCCCCCCC
Confidence               111123457999999988888899999999999999998 999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=9.4e-25  Score=148.99  Aligned_cols=120  Identities=23%  Similarity=0.342  Sum_probs=95.9

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        72 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  149 (312)
T cd05585          72 LAFINGGELFHHLQREGRFDLSRARFYTAEL-LCALENLHK-FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK  149 (312)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc
Confidence            7899999875543      334456688888 999999998 99999999999999999999999999998753221111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       150 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~  197 (312)
T cd05585         150 ---TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT-GLPPFYDEN  197 (312)
T ss_pred             ---cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHh-CCCCcCCCC
Confidence               111123457999999988888999999999999999998 999997643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.91  E-value=4.5e-25  Score=154.26  Aligned_cols=123  Identities=23%  Similarity=0.338  Sum_probs=95.1

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc-
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN-   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~-   73 (129)
                      |||++++++...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi-~~al~~lH~-~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAEL-TCAVESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            79999998765543      23355678888 999999998 8999999999999999999999999998753210000 


Q ss_pred             -------------------------------------------eeeeccCCCCCceecccccccCCCCCChhhHHHHHHH
Q psy7529          74 -------------------------------------------YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGIT  110 (129)
Q Consensus        74 -------------------------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~  110 (129)
                                                                 .........++..|+|||.+.+..++.++|+||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                       0000001124567999999988889999999999999


Q ss_pred             HHHHHhCCCCCCCCCC
Q psy7529         111 LWEMYSFGQQPYGEMK  126 (129)
Q Consensus       111 l~~l~~~~~~pf~~~~  126 (129)
                      ++++++ |..||.+.+
T Consensus       238 l~ellt-G~~Pf~~~~  252 (382)
T cd05625         238 LYEMLV-GQPPFLAQT  252 (382)
T ss_pred             HHHHHh-CCCCCCCCC
Confidence            999998 999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5.5e-25  Score=152.82  Aligned_cols=123  Identities=22%  Similarity=0.360  Sum_probs=96.7

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+++++|...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.+......
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi-~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAET-ILAIDSIHK-LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            7999999876543      334566788899 999999998 89999999999999999999999999998654221100


Q ss_pred             ee-----------------------------------eccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCC
Q psy7529          75 YK-----------------------------------ATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQ  119 (129)
Q Consensus        75 ~~-----------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~  119 (129)
                      ..                                   ......+++.|+|||.+....++.++|+||+|++++++++ |.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-G~  236 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV-GY  236 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc-CC
Confidence            00                                   0001124567999999988888999999999999999998 99


Q ss_pred             CCCCCCC
Q psy7529         120 QPYGEMK  126 (129)
Q Consensus       120 ~pf~~~~  126 (129)
                      .||.+.+
T Consensus       237 ~Pf~~~~  243 (364)
T cd05599         237 PPFCSDN  243 (364)
T ss_pred             CCCCCCC
Confidence            9997654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0597|consensus

Probab=99.91  E-value=1.1e-24  Score=154.42  Aligned_cols=116  Identities=29%  Similarity=0.480  Sum_probs=95.2

Q ss_pred             CCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           2 KSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         2 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||.| ++++.+.      +-..+.+++++ ..||.|+|. ++|+|||+||.||++++.+.+|++|||+++.++......
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~L-VsaL~yLhs-~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDL-VSALYYLHS-NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHH-HHHHHHHHh-cCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence            56666 6555443      33466688888 999999999 999999999999999999999999999999775432211


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                         ..-.+++-|||||...+.+|+..+|+||+||++||+++ |++||..
T Consensus       158 ---tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~-G~PPF~a  202 (808)
T KOG0597|consen  158 ---TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYV-GQPPFYA  202 (808)
T ss_pred             ---eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhc-CCCCchH
Confidence               12234567999999999999999999999999999998 9999974

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.91  E-value=2.2e-24  Score=147.89  Aligned_cols=120  Identities=23%  Similarity=0.356  Sum_probs=95.4

Q ss_pred             CCCCCCCCccccCC-----CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLG-----SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++++...+.     ......++.|+ +.|+.|+|. ++++|||||++||+++.++.++++|||+++........ 
T Consensus        81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi-~~al~~lH~-~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-  157 (324)
T cd05589          81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACV-VLGLQYLHE-NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-  157 (324)
T ss_pred             EcCCCCCcHHHHhhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc-
Confidence            78999998755443     23455588888 999999998 99999999999999999999999999987643221111 


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        .....++..|++||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-G~~pf~~~~  205 (324)
T cd05589         158 --TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLV-GESPFPGDD  205 (324)
T ss_pred             --ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Confidence              111123457999999988888899999999999999998 999998654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0658|consensus

Probab=99.91  E-value=2.1e-24  Score=145.53  Aligned_cols=110  Identities=22%  Similarity=0.318  Sum_probs=90.0

Q ss_pred             ccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC-CcEEEEeecCcccccCCCceeeeccCCCCCceecc
Q psy7529          11 TPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR-HQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYA   89 (129)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (129)
                      +.++...++.+..|+ .+|+.|||. .+|+|||+||+|+|+|.. +.+|++|||.++.+.... .....++.+   -|.|
T Consensus       120 ~~mp~~~iKLYt~Ql-frgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e-pniSYicSR---yYRa  193 (364)
T KOG0658|consen  120 QRMPLLEIKLYTYQL-FRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE-PNISYICSR---YYRA  193 (364)
T ss_pred             CCCceeeeHHHHHHH-HHHHHHHHh-cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC-CceeEEEec---cccC
Confidence            345556788899999 999999999 999999999999999987 667999999998764322 223333333   4899


Q ss_pred             cccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          90 PESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        90 pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ||.+.+. .|+...|+||.||++.|++. |++-|.+.+.
T Consensus       194 PELifga~~Yt~~IDiWSaGCV~aELl~-g~plFpG~s~  231 (364)
T KOG0658|consen  194 PELIFGATEYTTSIDIWSAGCVMAELLK-GQPLFPGDSS  231 (364)
T ss_pred             HHHHcCccccCceeEEhhhhHHHHHHhc-CCcccCCCCH
Confidence            9988776 68999999999999999998 9999988654

>KOG0614|consensus

Probab=99.91  E-value=2.5e-24  Score=151.03  Aligned_cols=121  Identities=26%  Similarity=0.427  Sum_probs=100.8

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||-|-||.+-+-|.      ....+++.+-+ .+|+.|||+ ++||+|||||+|++++.++.+|+.|||+++....... 
T Consensus       499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv-~EAfeYLH~-k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K-  575 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGSFDDYTARFYVACV-LEAFEYLHR-KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK-  575 (732)
T ss_pred             HHhhcCchhhhhhhhcCCcccchhhhhHHHH-HHHHHHHHh-cCceeccCChhheeeccCCceEEeehhhHHHhccCCc-
Confidence            67788888766665      34567777777 899999999 9999999999999999999999999999998754321 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                      ....   ++++.|.|||.+.....+..+|.||+|++++|+++ |.+||.+.+++
T Consensus       576 TwTF---cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~-G~pPFs~~dpm  625 (732)
T KOG0614|consen  576 TWTF---CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLT-GSPPFSGVDPM  625 (732)
T ss_pred             eeee---cCCcccccchhhhccCcchhhHHHHHHHHHHHHHc-CCCCCCCCchH
Confidence            1222   24568999999988888999999999999999998 99999987763

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=6.6e-25  Score=153.18  Aligned_cols=123  Identities=23%  Similarity=0.337  Sum_probs=95.0

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|++|...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql-~~aL~~LH~-~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAEC-VLAIEAVHK-LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            78999998765443      23355678888 999999998 99999999999999999999999999998632110000


Q ss_pred             -----------ee---------------------------------eccCCCCCceecccccccCCCCCChhhHHHHHHH
Q psy7529          75 -----------YK---------------------------------ATHGGRWPIKWYAPESYNFGRFSSASDVWSFGIT  110 (129)
Q Consensus        75 -----------~~---------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~  110 (129)
                                 ..                                 ......++..|+|||.+.+..++.++|+||+|++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                       00                                 0001124567999999988888999999999999


Q ss_pred             HHHHHhCCCCCCCCCC
Q psy7529         111 LWEMYSFGQQPYGEMK  126 (129)
Q Consensus       111 l~~l~~~~~~pf~~~~  126 (129)
                      ++++++ |..||.+.+
T Consensus       238 l~ellt-G~~Pf~~~~  252 (377)
T cd05629         238 MFECLI-GWPPFCSEN  252 (377)
T ss_pred             hhhhhc-CCCCCCCCC
Confidence            999998 999997644

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.91  E-value=9.4e-25  Score=149.74  Aligned_cols=120  Identities=26%  Similarity=0.371  Sum_probs=95.6

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi-~~~L~~lH~-~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~  152 (325)
T cd05602          75 LDYINGGELFYHLQRERCFLEPRARFYAAEI-ASALGYLHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT  152 (325)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC
Confidence            78999988755432      33455678888 999999998 99999999999999999999999999998653221111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  200 (325)
T cd05602         153 ---TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRN  200 (325)
T ss_pred             ---cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhc-CCCCCCCCC
Confidence               111123467999999988888999999999999999998 999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.90  E-value=1e-24  Score=149.46  Aligned_cols=120  Identities=26%  Similarity=0.369  Sum_probs=95.3

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        75 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  152 (323)
T cd05575          75 LDYVNGGELFFHLQRERSFPEPRARFYAAEI-ASALGYLHS-LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT  152 (323)
T ss_pred             EcCCCCCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCc
Confidence            7899999875433      333455678888 999999998 89999999999999999999999999988643221111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~  200 (323)
T cd05575         153 ---TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRD  200 (323)
T ss_pred             ---cccccCChhhcChhhhcCCCCCccccccccchhhhhhhc-CCCCCCCCC
Confidence               111123457999999988888999999999999999998 999998654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.90  E-value=3.5e-24  Score=153.69  Aligned_cols=122  Identities=24%  Similarity=0.398  Sum_probs=96.8

Q ss_pred             CCCCCCCCcccc----------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTP----------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||++|++|...          +.......++.|+ +.|+.|+|. ++++||||||+||+++..+.++++|||+++....
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi-~~aL~~lH~-~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQI-VLALDEVHS-RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHh-CCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            799999997543          3333455688899 999999999 8999999999999999999999999999876533


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..... ......++..|++||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus       222 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~Pf~~~~  275 (478)
T PTZ00267        222 SVSLD-VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT-LHRPFKGPS  275 (478)
T ss_pred             ccccc-cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            21110 1111223567999999988888999999999999999998 999997643

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=6.1e-24  Score=153.00  Aligned_cols=122  Identities=21%  Similarity=0.308  Sum_probs=96.6

Q ss_pred             CCCCCCCCccccCC----------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPLG----------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||+++++|.+.+.          ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++....
T Consensus       118 ~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~ql-l~aL~~lH~-~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~  195 (496)
T PTZ00283        118 LDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV-LLAVHHVHS-KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA  195 (496)
T ss_pred             EeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHH-HHHHHHHHh-CCEecCCCCHHHEEEeCCCCEEEEecccCeeccc
Confidence            68999998765432          23455688899 999999999 8999999999999999999999999999876432


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..... ......++..|++||.+.+..++.++|+||+|+++|++++ |+.||.+.+
T Consensus       196 ~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLlt-G~~Pf~~~~  249 (496)
T PTZ00283        196 TVSDD-VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT-LKRPFDGEN  249 (496)
T ss_pred             ccccc-ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCC
Confidence            21111 0111223467999999988889999999999999999998 999997644

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.90  E-value=4.8e-24  Score=143.82  Aligned_cols=119  Identities=25%  Similarity=0.421  Sum_probs=94.4

Q ss_pred             CCCCCCCCccc--------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVT--------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++..        .+.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++......
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAEL-CCGLEDLQR-ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            67888887632        23333455677888 999999998 999999999999999999999999999987643221


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . .   ....++..|+|||.+.+..++.++|+||+|++++++++ |+.||...+
T Consensus       157 ~-~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~~~  205 (285)
T cd05631         157 T-V---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQ-GQSPFRKRK  205 (285)
T ss_pred             e-e---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHh-CCCCCCCCC
Confidence            1 1   11223467999999988888999999999999999998 999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.90  E-value=5.7e-25  Score=150.83  Aligned_cols=121  Identities=25%  Similarity=0.411  Sum_probs=95.1

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+.      ......++.|+ +.|+.|+|..++++||||||+||+++.++.++++|||+++........
T Consensus        74 ~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi-~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  152 (325)
T cd05594          74 MEYANGGELFFHLSRERVFSEDRARFYGAEI-VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT  152 (325)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence            78999998754432      23455677888 999999996468999999999999999999999999998643221111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   ....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       153 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-G~~Pf~~~~  200 (325)
T cd05594         153 M---KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQD  200 (325)
T ss_pred             c---ccccCCcccCCHHHHccCCCCCccccccccceeeeecc-CCCCCCCCC
Confidence            1   11123457999999988888999999999999999998 999997654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.90  E-value=2.8e-24  Score=147.74  Aligned_cols=118  Identities=19%  Similarity=0.358  Sum_probs=94.4

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...      +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        75 ~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi-~~~l~~lH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~  152 (329)
T cd05588          75 IEFVSGGDLMFHMQRQRKLPEEHARFYSAEI-SLALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT  152 (329)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence            789999987543      3344566688898 999999998 99999999999999999999999999998642211111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .   ....++..|+|||.+.+..++.++|+||+|+++|++++ |..||..
T Consensus       153 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~Pf~~  198 (329)
T cd05588         153 T---STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDI  198 (329)
T ss_pred             c---ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHH-CCCCccc
Confidence            1   11123457999999988888899999999999999998 9999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0193|consensus

Probab=99.90  E-value=2.8e-24  Score=152.70  Aligned_cols=119  Identities=34%  Similarity=0.507  Sum_probs=93.7

Q ss_pred             CCCCCCccccCCCCch-------hhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCccccc--CCCc
Q psy7529           3 SPNGSGVVTPLGSYAL-------PYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVN--SERN   73 (129)
Q Consensus         3 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~--~~~~   73 (129)
                      +|.|++||+-+.-.+.       .-|+.|+ |+|+.|||+ ++|||||||.-||++..+..++|.|||++..-.  ....
T Consensus       468 wCeGsSLY~hlHv~etkfdm~~~idIAqQi-aqGM~YLHA-K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQI-AQGMDYLHA-KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             hccCchhhhhccchhhhhhHHHHHHHHHHH-HHhhhhhhh-hhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence            6899998888776554       4488888 999999999 999999999999999999999999999975321  1111


Q ss_pred             eeeeccCCCCCceeccccccc---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYN---FGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                      ..   ..-.+.+.|+|||++.   ..+|+..+|+||+|++.||+++ |..||. ..+.
T Consensus       546 q~---~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELlt-g~lPys-i~~~  598 (678)
T KOG0193|consen  546 QL---EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLT-GELPYS-IQNR  598 (678)
T ss_pred             cc---CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHh-CcCCcC-CCCh
Confidence            11   1111235699999875   3478899999999999999999 999998 4443

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.90  E-value=5.4e-25  Score=152.81  Aligned_cols=124  Identities=23%  Similarity=0.367  Sum_probs=96.8

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|+++...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++..+.++++|||+++........
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi-~~~L~~lH~-~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAET-VLAIDAIHQ-LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            78999998765443      33456688888 999999998 99999999999999999999999999998643211000


Q ss_pred             --------------------------------eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q psy7529          75 --------------------------------YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY  122 (129)
Q Consensus        75 --------------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf  122 (129)
                                                      ........++..|+|||.+.+..++.++|+||+|++++++++ |..||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t-G~~Pf  236 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI-GYPPF  236 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc-CCCCC
Confidence                                            000011234567999999988889999999999999999998 99999


Q ss_pred             CCCCC
Q psy7529         123 GEMKG  127 (129)
Q Consensus       123 ~~~~~  127 (129)
                      .+.+.
T Consensus       237 ~~~~~  241 (360)
T cd05627         237 CSETP  241 (360)
T ss_pred             CCCCH
Confidence            87543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.90  E-value=1.4e-24  Score=151.47  Aligned_cols=121  Identities=20%  Similarity=0.338  Sum_probs=94.9

Q ss_pred             CCCCCCCCccccCCC-----CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLGS-----YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||+++++|...+..     .....++.|+ +.|+.|+|. ++++||||||+||+++..+.++++|||+++.........
T Consensus       122 ~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qi-l~aL~~LH~-~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         122 MEYMPGGDLVNLMSNYDVPEKWAKFYTAEV-VLALDAIHS-MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             EcCCCCCcHHHHHHhcCCCHHHHHHHHHHH-HHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence            799999987665543     2355578888 999999998 999999999999999999999999999987653221111


Q ss_pred             eeccCCCCCceecccccccCCC----CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGR----FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~----~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        .....++..|+|||.+....    ++.++|+||+|+++|++++ |..||.+.+
T Consensus       200 --~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~-G~~Pf~~~~  251 (370)
T cd05621         200 --CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV-GDTPFYADS  251 (370)
T ss_pred             --cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHh-CCCCCCCCC
Confidence              11223456799999886532    6789999999999999998 999997654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.1e-24  Score=149.71  Aligned_cols=117  Identities=24%  Similarity=0.380  Sum_probs=95.5

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+++++|...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++..+.++++|||+++.....   
T Consensus        80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi-~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~---  154 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEM-FEAVDALHE-LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY---  154 (333)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCccccCCCHHHEEECCCCCEEEEeCcCCcccccc---
Confidence            78999998765543      33455578888 999999998 89999999999999999999999999998754321   


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....++..|++||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~  202 (333)
T cd05600         155 ---ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC-GFPPFSGST  202 (333)
T ss_pred             ---cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhh-CCCCCCCCC
Confidence               111223456999999988888999999999999999998 999997654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0589|consensus

Probab=99.90  E-value=5.3e-25  Score=153.08  Aligned_cols=120  Identities=25%  Similarity=0.390  Sum_probs=101.6

Q ss_pred             CCCCCCCCccccCCCCc--------hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGSYA--------LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |+||+||++.+.+...+        +-..+.|+ +.|+.|+|. +.++|||+|..||++.++..+++.|||+++.++...
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~-~~av~ylH~-~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQI-LLAVNYLHE-NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHH-HHHHHHHHh-hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            89999999887777654        33378888 889999996 999999999999999999999999999999887654


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .......   +++.|++||.+.+.+|+.++|+||+||++||+++ -+.+|...+
T Consensus       161 ~~a~tvv---GTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~-lk~aF~a~~  210 (426)
T KOG0589|consen  161 SLASTVV---GTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCT-LKPAFKASN  210 (426)
T ss_pred             hhhheec---CCCcccCHHHhCCCCCCccCcchhhcchHHHHHh-cccccCccc
Confidence            3333232   3456999999999999999999999999999998 788888654

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.90  E-value=1.2e-24  Score=149.29  Aligned_cols=120  Identities=26%  Similarity=0.366  Sum_probs=95.4

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~al~~lH~-~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  152 (325)
T cd05604          75 LDFVNGGELFFHLQRERSFPEPRARFYAAEI-ASALGYLHS-INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT  152 (325)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC
Confidence            7899998865433      233456688888 999999998 99999999999999999999999999998643221111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-G~~pf~~~~  200 (325)
T cd05604         153 ---TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY-GLPPFYCRD  200 (325)
T ss_pred             ---cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhc-CCCCCCCCC
Confidence               111123457999999988888899999999999999998 999998654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=3.9e-24  Score=144.68  Aligned_cols=117  Identities=26%  Similarity=0.389  Sum_probs=95.1

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++.+.+.      ......++.|+ +.|+.|+|. ++++||||||+||+++..+.++++|||+++....... 
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~-  156 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEI-VCALEYLHS-KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW-  156 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcc-
Confidence            78999988765442      33455678888 999999998 9999999999999999999999999999875432211 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                           ...++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       157 -----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~  202 (291)
T cd05612         157 -----TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV-GYPPFFDDN  202 (291)
T ss_pred             -----cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence                 1123457999999988888899999999999999998 999997654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.90  E-value=1.2e-23  Score=141.61  Aligned_cols=119  Identities=24%  Similarity=0.337  Sum_probs=94.4

Q ss_pred             CCCCCCCCcccc----------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTP----------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||++++++...          +.......++.|+ +.|+.|+|. ++++||||+|+||+++.++.++++|||+++....
T Consensus        72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  149 (280)
T cd05608          72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQI-ISGLEHLHQ-RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD  149 (280)
T ss_pred             EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence            789999886422          2233345578888 999999998 8999999999999999999999999999875433


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .....   ....++..|++||.+.+..++.++|+||+|++++++++ |+.||...
T Consensus       150 ~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~  200 (280)
T cd05608         150 GQSKT---KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIA-ARGPFRAR  200 (280)
T ss_pred             CCccc---cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHh-CCCCCCCC
Confidence            22111   11123457999999988888899999999999999998 99999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.90  E-value=4.2e-24  Score=149.05  Aligned_cols=121  Identities=21%  Similarity=0.349  Sum_probs=94.2

Q ss_pred             CCCCCCCCccccCCC-----CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLGS-----YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||+++++|...+..     .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.........
T Consensus       122 ~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi-~~aL~~LH~-~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~  199 (371)
T cd05622         122 MEYMPGGDLVNLMSNYDVPEKWARFYTAEV-VLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR  199 (371)
T ss_pred             EcCCCCCcHHHHHHhcCCCHHHHHHHHHHH-HHHHHHHHH-CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccc
Confidence            789999987654433     2345577888 999999998 999999999999999999999999999987653221111


Q ss_pred             eeccCCCCCceecccccccCCC----CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGR----FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~----~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        .....++..|+|||.+....    ++.++|+||+|+++|++++ |..||.+.+
T Consensus       200 --~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~  251 (371)
T cd05622         200 --CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADS  251 (371)
T ss_pred             --ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHh-CCCCCCCCC
Confidence              11222456799999886432    6789999999999999998 999997643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG1095|consensus

Probab=99.90  E-value=1.8e-24  Score=162.42  Aligned_cols=126  Identities=40%  Similarity=0.682  Sum_probs=100.6

Q ss_pred             CCCCCCCCccccCCCC-------------chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCccc
Q psy7529           1 MKSPNGSGVVTPLGSY-------------ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~   67 (129)
                      +||..||+|.+-++..             ++..++.++ |+|+.||+. +..|||||..+|+|++.+..+|++|||+++-
T Consensus       774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dv-A~G~~YLe~-~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD  851 (1025)
T KOG1095|consen  774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDV-AKGMNYLES-KHFVHRDLAARNCLLDERRVVKIADFGLARD  851 (1025)
T ss_pred             ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHH-hhhhHHHHh-CCCcCcchhhhheeecccCcEEEcccchhHh
Confidence            5788888866655543             244466777 999999999 9999999999999999999999999999984


Q ss_pred             ccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q psy7529          68 VNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD  129 (129)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~e  129 (129)
                      .-...-...... ..-+.+||+||.++...+..++|+||+|+++||++++|.+||.+.++.|
T Consensus       852 iy~~~yyr~~~~-a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~  912 (1025)
T KOG1095|consen  852 IYDKDYYRKHGE-AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE  912 (1025)
T ss_pred             hhhchheeccCc-cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH
Confidence            322222222111 2235689999999998999999999999999999999999999988743

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.90  E-value=4.3e-24  Score=146.84  Aligned_cols=118  Identities=22%  Similarity=0.379  Sum_probs=93.8

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...      +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        75 ~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi-~~~l~~lH~-~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~  152 (329)
T cd05618          75 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEI-SLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  152 (329)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc
Confidence            789999886543      3333456688888 999999998 89999999999999999999999999998643221111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .   ....++..|+|||.+.+..++.++|+||+|++++++++ |..||..
T Consensus       153 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~~  198 (329)
T cd05618         153 T---STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDI  198 (329)
T ss_pred             c---ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhh-CCCCCcc
Confidence            1   11123457999999988888899999999999999998 9999953

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.90  E-value=2.8e-24  Score=148.40  Aligned_cols=117  Identities=25%  Similarity=0.347  Sum_probs=95.5

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+..      .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++....... 
T Consensus       110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi-~~aL~~LH~-~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~-  186 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI-VLIFEYLQS-LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY-  186 (340)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCcc-
Confidence            789999987655432      2345678888 999999998 9999999999999999999999999999875432211 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                           ...++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       187 -----~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~  232 (340)
T PTZ00426        187 -----TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILV-GCPPFYANE  232 (340)
T ss_pred             -----eecCChhhcCHHHHhCCCCCccccccchhhHHHHHhc-CCCCCCCCC
Confidence                 1123457999999987778899999999999999998 999998754

>KOG0612|consensus

Probab=99.90  E-value=4.4e-24  Score=159.86  Aligned_cols=119  Identities=23%  Similarity=0.425  Sum_probs=100.0

Q ss_pred             CCCCCCCCccccCCCCc------hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGSYA------LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |+|..||++.+.+..+.      .+|+.+.+ ..||.-+|. .+.||||+||+|+|++..|+++++|||.+-.+......
T Consensus       154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEi-VlAldslH~-mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEI-VLALDSLHS-MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             EecccCchHHHHHhhcCCChHHHHHHHHHHH-HHHHHHHHh-ccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence            89999999999988876      56688888 779999999 99999999999999999999999999998776533322


Q ss_pred             eeeccCCCCCceeccccccc----C-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYN----F-GRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~----~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                        ......+|+.|.+||++.    + +.|+...|+||+|+++|||+. |.+||..
T Consensus       232 --~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMly-G~TPFYa  283 (1317)
T KOG0612|consen  232 --RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLY-GETPFYA  283 (1317)
T ss_pred             --EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHc-CCCcchH
Confidence              223445678899999764    2 458899999999999999996 9999964

>KOG0660|consensus

Probab=99.90  E-value=4.6e-24  Score=143.69  Aligned_cols=108  Identities=28%  Similarity=0.336  Sum_probs=85.4

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      -...++++|+ ++||+|+|+ .+++|||+||+|++++.+..+|++|||+++..... ...........|.-|.|||....
T Consensus       125 ~H~q~f~YQi-LrgLKyiHS-AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~  201 (359)
T KOG0660|consen  125 DHAQYFLYQI-LRGLKYIHS-ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-FEDGFMTEYVATRWYRAPELLLN  201 (359)
T ss_pred             HHHHHHHHHH-HHhcchhhc-ccccccccchhheeeccCCCEEeccccceeecccc-CcccchhcceeeeeecCHHHHhc
Confidence            3467799999 999999999 99999999999999999999999999999976432 11011011111223789997644


Q ss_pred             -CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          96 -GRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        96 -~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                       ..|+...|+||+||++.|+++ |++-|.+.+.
T Consensus       202 ~~~Yt~aiDiWSvGCI~AEmL~-gkplFpG~d~  233 (359)
T KOG0660|consen  202 SSEYTKAIDIWSVGCILAEMLT-GKPLFPGKDY  233 (359)
T ss_pred             cccccchhhhhhhhHHHHHHHc-CCCCCCCCch
Confidence             479999999999999999998 9999987654

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.90  E-value=4.8e-24  Score=146.52  Aligned_cols=117  Identities=24%  Similarity=0.407  Sum_probs=95.1

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++....... 
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-  173 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAEL-VLAFEYLHS-KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF-  173 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc-
Confidence            78999988765443      22345577888 999999999 8999999999999999999999999999876533211 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                           ...++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       174 -----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  219 (329)
T PTZ00263        174 -----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIA-GYPPFFDDT  219 (329)
T ss_pred             -----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHc-CCCCCCCCC
Confidence                 1123456999999988888899999999999999998 999997654

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.90  E-value=1.1e-24  Score=151.91  Aligned_cols=123  Identities=23%  Similarity=0.329  Sum_probs=94.6

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc-
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN-   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~-   73 (129)
                      |||++++++...+..      .....++.|+ +.|+.|+|. ++++||||||+||+++..+.++++|||++........ 
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi-~~al~~lH~-~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAEL-TCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            799999987665432      3345577888 999999998 9999999999999999999999999998742210000 


Q ss_pred             ---------------------------------------eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHH
Q psy7529          74 ---------------------------------------YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEM  114 (129)
Q Consensus        74 ---------------------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l  114 (129)
                                                             .........++..|+|||.+.+..++.++|+||+|+++|++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                   00000011245679999999888889999999999999999


Q ss_pred             HhCCCCCCCCCC
Q psy7529         115 YSFGQQPYGEMK  126 (129)
Q Consensus       115 ~~~~~~pf~~~~  126 (129)
                      ++ |..||.+.+
T Consensus       238 l~-G~~Pf~~~~  248 (376)
T cd05598         238 LV-GQPPFLADT  248 (376)
T ss_pred             hh-CCCCCCCCC
Confidence            98 999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.90  E-value=8.9e-24  Score=144.85  Aligned_cols=120  Identities=26%  Similarity=0.395  Sum_probs=94.7

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+..      .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          79 LEYLSGGELFMHLEREGIFMEDTACFYLSEI-SLALEHLHQ-QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             EeCCCCchHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc
Confidence            788988887655432      2345577888 999999998 99999999999999999999999999998643221111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       157 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~pf~~~~  204 (323)
T cd05584         157 ---THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLT-GAPPFTAEN  204 (323)
T ss_pred             ---ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhc-CCCCCCCCC
Confidence               111223467999999988788899999999999999998 999997654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0986|consensus

Probab=99.90  E-value=7.5e-24  Score=146.79  Aligned_cols=108  Identities=25%  Similarity=0.388  Sum_probs=92.8

Q ss_pred             cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccc
Q psy7529          12 PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE   91 (129)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe   91 (129)
                      .+++.+.+++++++ +-||..+|. .+|++||+||+|||+|.+++++|+|+|++..+.......    +..+|..|||||
T Consensus       283 gF~e~ra~FYAAEi-~cGLehlH~-~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~----~rvGT~GYMAPE  356 (591)
T KOG0986|consen  283 GFDEQRARFYAAEI-ICGLEHLHR-RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR----GRVGTVGYMAPE  356 (591)
T ss_pred             CCchHHHHHHHHHH-HhhHHHHHh-cceeeccCChhheeeccCCCeEeeccceEEecCCCCccc----cccCcccccCHH
Confidence            45667899999999 889999999 999999999999999999999999999997665432211    223456799999


Q ss_pred             cccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          92 SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        92 ~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++....|+..+|+|++||++|+|+. |..||....
T Consensus       357 vl~ne~Y~~s~Dwf~lGCllYemi~-G~sPFr~~K  390 (591)
T KOG0986|consen  357 VLQNEVYDFSPDWFSLGCLLYEMIA-GHSPFRQRK  390 (591)
T ss_pred             HHcCCcccCCccHHHHHhHHHHHHc-ccCchhhhh
Confidence            9998899999999999999999998 999998644

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.90  E-value=1.3e-23  Score=144.40  Aligned_cols=122  Identities=23%  Similarity=0.342  Sum_probs=89.9

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+. +++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        83 ~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  159 (338)
T cd07859          83 FELME-SDLHQVIKANDDLTPEHHQFFLYQL-LRALKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT  159 (338)
T ss_pred             EecCC-CCHHHHHHhcccCCHHHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence            56664 3443332      223355578888 999999999 89999999999999999999999999998754221111


Q ss_pred             eeeccCCCCCceecccccccC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNF--GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~--~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ........++..|+|||.+..  ..++.++|+||+|++++++++ |+.||.+.+
T Consensus       160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~t-g~~pf~~~~  212 (338)
T cd07859         160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN  212 (338)
T ss_pred             cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHc-CCCCCCCCC
Confidence            111111223456999998765  467889999999999999998 999997643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.90  E-value=7.9e-24  Score=145.44  Aligned_cols=119  Identities=29%  Similarity=0.402  Sum_probs=92.9

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++|||||++||+++.++.++++|||+++........
T Consensus        84 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~  161 (332)
T cd05614          84 LDYVSGGEMFTHLYQRDNFSEDEVRFYSGEI-ILALEHLHK-LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE  161 (332)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC
Confidence            7899998875543      333455677888 999999998 89999999999999999999999999998754322111


Q ss_pred             eeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .  .....++..|+|||.+.+. .++.++|+||+|++++++++ |..||..
T Consensus       162 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~  209 (332)
T cd05614         162 R--TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT-GASPFTL  209 (332)
T ss_pred             c--cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhc-CCCCCCC
Confidence            1  1112235679999988764 36788999999999999998 9999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0983|consensus

Probab=99.89  E-value=1.5e-23  Score=137.84  Aligned_cols=108  Identities=33%  Similarity=0.496  Sum_probs=83.8

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccc
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPES   92 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~   92 (129)
                      .++..+-.+..-+ .+||.||...+++||||+||+|||++.++++|++|||.+..+.......  ..  .++..||+||.
T Consensus       188 iPE~ilGk~tva~-v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht--rs--AGC~~YMaPER  262 (391)
T KOG0983|consen  188 IPERILGKMTVAI-VKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT--RS--AGCAAYMAPER  262 (391)
T ss_pred             chHHhhhhhHHHH-HHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccc--cc--cCCccccCccc
Confidence            3333344455555 7899999988899999999999999999999999999987654332211  11  22357999997


Q ss_pred             cc---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          93 YN---FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        93 ~~---~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +-   ...|+.++|+||+|+.++|+.+ |..||.+.+
T Consensus       263 idp~~~~kYDiRaDVWSlGITlveLaT-g~yPy~~c~  298 (391)
T KOG0983|consen  263 IDPPDKPKYDIRADVWSLGITLVELAT-GQYPYKGCK  298 (391)
T ss_pred             cCCCCCCccchhhhhhhhccchhhhhc-ccCCCCCCC
Confidence            74   3368999999999999999998 999998743

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.89  E-value=6.5e-24  Score=148.05  Aligned_cols=121  Identities=20%  Similarity=0.341  Sum_probs=93.9

Q ss_pred             CCCCCCCCccccCCC-----CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLGS-----YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++|++|...+..     .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........ 
T Consensus       122 ~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi-~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-  198 (370)
T cd05596         122 MEYMPGGDLVNLMSNYDIPEKWARFYTAEV-VLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-  198 (370)
T ss_pred             EcCCCCCcHHHHHHhcCCCHHHHHHHHHHH-HHHHHHHHH-CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-
Confidence            789999987655433     2344577788 999999998 89999999999999999999999999998754322111 


Q ss_pred             eeccCCCCCceecccccccCC----CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFG----RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~----~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       ......+++.|+|||.+...    .++.++|+||+|++++++++ |..||.+.+
T Consensus       199 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~  251 (370)
T cd05596         199 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADS  251 (370)
T ss_pred             -cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHh-CCCCcCCCC
Confidence             11122245679999987543    36789999999999999998 999998654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.89  E-value=1.7e-23  Score=143.19  Aligned_cols=120  Identities=25%  Similarity=0.396  Sum_probs=94.5

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        75 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi-~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  152 (318)
T cd05570          75 MEYVNGGDLMFHIQRSGRFDEPRARFYAAEI-VLGLQFLHE-RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT  152 (318)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence            7899998865433      333455678888 999999998 99999999999999999999999999988642211111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   ....++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       153 ~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~-G~~pf~~~~  200 (318)
T cd05570         153 T---STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA-GQSPFEGDD  200 (318)
T ss_pred             c---cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhh-CCCCCCCCC
Confidence            1   11123457999999988888999999999999999998 999997654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0600|consensus

Probab=99.89  E-value=9e-24  Score=147.54  Aligned_cols=108  Identities=23%  Similarity=0.331  Sum_probs=88.0

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ...+..++-|+ +.||+|+|. ++++|||||.+|||++.++.+|++|||+++.+.......  ......++=|.+||.+.
T Consensus       217 ~~qIKc~mkQL-l~Gl~~cH~-~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~--~T~rVvTLWYRpPELLL  292 (560)
T KOG0600|consen  217 EPQIKCYMKQL-LEGLEYCHS-RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP--YTSRVVTLWYRPPELLL  292 (560)
T ss_pred             hHHHHHHHHHH-HHHHHHHhh-cCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc--cccceEEeeccChHHhc
Confidence            34566799999 999999999 999999999999999999999999999999764432111  11112233378999988


Q ss_pred             CC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          95 FG-RFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        95 ~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      +. .|+..+|+||+||++.|++. |++.|++.+.
T Consensus       293 G~t~Yg~aVDlWS~GCIl~El~~-gkPI~~G~tE  325 (560)
T KOG0600|consen  293 GATSYGTAVDLWSVGCILAELFL-GKPILQGRTE  325 (560)
T ss_pred             CCcccccceeehhhhHHHHHHHc-CCCCcCCccH
Confidence            76 69999999999999999998 9999987653

>KOG0663|consensus

Probab=99.89  E-value=1.7e-23  Score=140.40  Aligned_cols=109  Identities=27%  Similarity=0.355  Sum_probs=89.7

Q ss_pred             cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccc
Q psy7529          12 PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE   91 (129)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe   91 (129)
                      ++..-..+-++.|+ ++|++|+|. +-|+|||||++|+|+...+-+|++|||++|.+.++.........   ++=|.|||
T Consensus       173 ~F~~~evK~L~~Ql-L~glk~lH~-~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVV---TLWYRaPE  247 (419)
T KOG0663|consen  173 PFLPGEVKTLMLQL-LRGLKHLHD-NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVV---TLWYRAPE  247 (419)
T ss_pred             CCchHHHHHHHHHH-HHHHHHHhh-ceeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEE---EeeecCHH
Confidence            44445567799999 999999999 89999999999999999999999999999988765332222221   23378999


Q ss_pred             cccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          92 SYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        92 ~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .+.+. .|+...|+||+||++.|++. +++-|.+.+
T Consensus       248 LLLG~~tyst~iDMWSvGCI~aE~l~-~kPlf~G~s  282 (419)
T KOG0663|consen  248 LLLGAKTYSTAVDMWSVGCIFAELLT-QKPLFPGKS  282 (419)
T ss_pred             HhcCCcccCcchhhhhHHHHHHHHHh-cCCCCCCCc
Confidence            98877 58999999999999999998 888888754

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.89  E-value=3.6e-24  Score=147.26  Aligned_cols=121  Identities=21%  Similarity=0.385  Sum_probs=94.5

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++|++|...+..       .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi-~~~L~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEM-VLAIHSIHQ-LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            789999987655432       3355677888 999999998 9999999999999999999999999999876543221


Q ss_pred             eeeeccCCCCCceecccccccC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNF-----GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..  .....++..|+|||.+..     ..++.++|+||+|+++|++++ |+.||.+.+
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~  212 (331)
T cd05624         158 VQ--SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY-GETPFYAES  212 (331)
T ss_pred             ee--eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhh-CCCCccCCC
Confidence            11  111223567999998764     356788999999999999998 999997643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG4645|consensus

Probab=99.89  E-value=1.1e-24  Score=164.72  Aligned_cols=125  Identities=24%  Similarity=0.355  Sum_probs=102.7

Q ss_pred             CCCCCCCCccccCCCC------chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC-c
Q psy7529           1 MKSPNGSGVVTPLGSY------ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER-N   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~-~   73 (129)
                      ||||++|+|..++...      -.+.+..|+ +.|+.|||. .+|+|||+|+.||+++.++-+|+.|||.+....... .
T Consensus      1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~ql-l~gla~LH~-~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQL-LEGLAYLHE-HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             HHHhccCcHHHHHHhcchhhhhHHHHHHHHH-HHHHHHHHh-cCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            8999999987776654      356678888 999999999 899999999999999999999999999998765432 1


Q ss_pred             eeeeccCCCCCceecccccccCCC---CCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGR---FSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~---~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                      .........+++-|||||++.+..   ...++||||+||++.||.+ |+-||.+++++
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~t-GkrPW~~~dne 1447 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMAT-GKRPWAELDNE 1447 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeec-CCCchhhccch
Confidence            122333445677899999986653   4578999999999999998 99999988764

>KOG0585|consensus

Probab=99.89  E-value=1.7e-23  Score=145.60  Aligned_cols=121  Identities=26%  Similarity=0.382  Sum_probs=91.7

Q ss_pred             CCCCCCCccc------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC--c
Q psy7529           2 KSPNGSGVVT------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER--N   73 (129)
Q Consensus         2 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~--~   73 (129)
                      |||+.|.+--      .|.....+.++..+ ..||.|||. ++||||||||+|+|++..+.+|++|||.+.......  .
T Consensus       190 ey~s~G~v~w~p~d~~els~~~Ar~ylrDv-v~GLEYLH~-QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~  267 (576)
T KOG0585|consen  190 EYCSKGEVKWCPPDKPELSEQQARKYLRDV-VLGLEYLHY-QGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEG  267 (576)
T ss_pred             EeccCCccccCCCCcccccHHHHHHHHHHH-HHHHHHHHh-cCeeccccchhheEEcCCCcEEeeccceeeecccCCccc
Confidence            6777776321      14445567777777 899999999 999999999999999999999999999986542111  1


Q ss_pred             eeeeccCCCCCceecccccccCC---CC-CChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFG---RF-SSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~---~~-~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .........+|+.|+|||.....   .+ +.+.|+||+|+++|.++ +|+.||.+-
T Consensus       268 ~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll-fG~~PF~~~  322 (576)
T KOG0585|consen  268 SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL-FGQLPFFDD  322 (576)
T ss_pred             cHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh-hccCCcccc
Confidence            11112235567889999988763   23 57899999999999999 599999863

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=4.5e-24  Score=147.36  Aligned_cols=123  Identities=22%  Similarity=0.355  Sum_probs=96.7

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc-
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN-   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~-   73 (129)
                      |||++++++...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++....... 
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi-~~aL~~LH~-~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAEL-VLALDSVHK-LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            78998888655443      33455688888 999999999 9999999999999999999999999999875432210 


Q ss_pred             -------------------------eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 -------------------------YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 -------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                                               .........++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~  234 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY-GFPPFYSDT  234 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc-CCCCCCCCC
Confidence                                     0001111224567999999988888999999999999999998 999998654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0661|consensus

Probab=99.89  E-value=2.9e-23  Score=144.22  Aligned_cols=108  Identities=31%  Similarity=0.477  Sum_probs=87.8

Q ss_pred             cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccc
Q psy7529          12 PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE   91 (129)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe   91 (129)
                      ++.+-.++.|++|+ ++||.++|. +++.|||+||+|||+.....+|++|||++|...+.. .+.....++|   |.|||
T Consensus       106 ~fse~~irnim~Qi-lqGL~hiHk-~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp-PYTeYVSTRW---YRAPE  179 (538)
T KOG0661|consen  106 LFSESDIRNIMYQI-LQGLAHIHK-HGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP-PYTEYVSTRW---YRAPE  179 (538)
T ss_pred             cCCHHHHHHHHHHH-HHHHHHHHh-cCcccccCChhheEecccceeEecccccccccccCC-Ccchhhhccc---ccchH
Confidence            33445577899999 999999999 999999999999999999999999999999765432 2223333444   78999


Q ss_pred             cccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          92 SYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        92 ~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++... .|+.+.|+||+||+++|+.+ -++.|.+-+
T Consensus       180 vLLrs~~Ys~pvD~wA~GcI~aEl~s-LrPLFPG~s  214 (538)
T KOG0661|consen  180 VLLRSGYYSSPVDMWAVGCIMAELYS-LRPLFPGAS  214 (538)
T ss_pred             HhhhccccCCchHHHHHHHHHHHHHH-hcccCCCCc
Confidence            87654 68999999999999999998 677787654

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.89  E-value=2.9e-23  Score=138.12  Aligned_cols=125  Identities=51%  Similarity=0.939  Sum_probs=95.6

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+.       ......++.|+ +.|+.|+|. ++++|+||||+||+++.+..++++|||+++.......
T Consensus        73 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          73 MEMASGGPLNKFLSGKKDEITVSNVVELMHQV-SMGMKYLEG-KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS  150 (257)
T ss_pred             EEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHH-HHHHHHHHh-cCeeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence            67888887654332       23345678888 999999998 8999999999999999999999999999875433222


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ..........+..|++||.+....++.++|+||+|++++++++.|..||.+.+.
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  204 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG  204 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH
Confidence            111122222235699999887777888999999999999998658999987653

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.89  E-value=4.3e-23  Score=144.15  Aligned_cols=106  Identities=43%  Similarity=0.784  Sum_probs=84.0

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++||||||+||+++.+..++++|||+++......... .......+..|+|||.+....
T Consensus       214 ~~~i~~qi-~~aL~yLH~-~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~  290 (374)
T cd05106         214 LLRFSSQV-AQGMDFLAS-KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV-VKGNARLPVKWMAPESIFDCV  290 (374)
T ss_pred             HHHHHHHH-HHHHHHHHH-CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee-eccCCCCccceeCHHHhcCCC
Confidence            34578888 999999998 999999999999999999999999999987543221111 111111234699999988778


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|++++++++.|..||.+..
T Consensus       291 ~~~~~DvwSlGvil~ellt~G~~Pf~~~~  319 (374)
T cd05106         291 YTVQSDVWSYGILLWEIFSLGKSPYPGIL  319 (374)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence            89999999999999999965899997654

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.89  E-value=6.1e-23  Score=136.37  Aligned_cols=124  Identities=48%  Similarity=0.883  Sum_probs=95.3

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||+++........
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi-~~al~~lH~-~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~  151 (257)
T cd05116          74 MELAELGPLNKFLQKNKHVTEKNITELVHQV-SMGMKYLEE-TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY  151 (257)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence            6788888765433      223455577888 999999998 89999999999999999999999999998765433222


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .........+..|++||.+....++.++|+||+|++++++++.|..||.+.+
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  203 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK  203 (257)
T ss_pred             eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            2222222223579999988777788899999999999999965889998654

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=2.3e-24  Score=148.08  Aligned_cols=120  Identities=23%  Similarity=0.324  Sum_probs=94.0

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...      +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        75 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi-l~al~~LH~-~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~  152 (330)
T cd05586          75 TDYMSGGELFWHLQKEGRFSEDRAKFYIAEL-VLALEHLHK-YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT  152 (330)
T ss_pred             EcCCCCChHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence            789999886543      3344566688899 999999998 99999999999999999999999999998653221111


Q ss_pred             eeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....++..|++||.+.+. .++.++|+||+|++++++++ |..||.+.+
T Consensus       153 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ellt-G~~Pf~~~~  201 (330)
T cd05586         153 ---TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCC-GWSPFYAED  201 (330)
T ss_pred             ---ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEecc-CCCCCCCCC
Confidence               1112234679999988654 47889999999999999998 999997643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.89  E-value=6.5e-23  Score=142.32  Aligned_cols=106  Identities=25%  Similarity=0.289  Sum_probs=86.1

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......    .....++..|+|||.+
T Consensus       121 ~~~~~~~~~~qi-~~~L~~LH~-~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~  194 (359)
T cd07876         121 DHERMSYLLYQM-LCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM----MTPYVVTRYYRAPEVI  194 (359)
T ss_pred             CHHHHHHHHHHH-HHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEecCCCccccccCcc----CCCCcccCCCCCchhc
Confidence            334456688888 999999999 8999999999999999999999999999865322111    1111234569999999


Q ss_pred             cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          94 NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        94 ~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       195 ~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~  226 (359)
T cd07876         195 LGMGYKENVDIWSVGCIMGELVK-GSVIFQGTD  226 (359)
T ss_pred             cCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Confidence            88888899999999999999998 999998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.89  E-value=5.8e-23  Score=142.33  Aligned_cols=105  Identities=25%  Similarity=0.273  Sum_probs=85.7

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......    .....++..|+|||.+.
T Consensus       118 ~~~~~~~~~qi-~~aL~~LH~-~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~  191 (355)
T cd07874         118 HERMSYLLYQM-LCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVVTRYYRAPEVIL  191 (355)
T ss_pred             HHHHHHHHHHH-HHHHHHHHh-CCcccCCCChHHEEECCCCCEEEeeCcccccCCCccc----cCCccccCCccCHHHHc
Confidence            34455688888 999999999 9999999999999999999999999999875432211    11112345699999998


Q ss_pred             CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 ~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +..++.++|+||+|++++++++ |+.||.+.+
T Consensus       192 ~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  222 (355)
T cd07874         192 GMGYKENVDIWSVGCIMGEMVR-HKILFPGRD  222 (355)
T ss_pred             CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            8888999999999999999998 999997643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.89  E-value=5.5e-23  Score=140.42  Aligned_cols=123  Identities=37%  Similarity=0.638  Sum_probs=94.7

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+..       .....++.|+ +.|+.|+|. ++++|||||++||+++.++.++++|||+++.......
T Consensus        87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi-~~~L~~LH~-~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  164 (316)
T cd05108          87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-AKGMNYLEE-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK  164 (316)
T ss_pred             eecCCCCCHHHHHHhccccCCHHHHHHHHHHH-HHHHHHHHh-cCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence            467777776554432       2234567788 999999998 8999999999999999999999999999986543221


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .. .......+..|++||.+....++.++|+||+|+++|+++++|..||.+.+
T Consensus       165 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~  216 (316)
T cd05108         165 EY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  216 (316)
T ss_pred             ce-eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            11 11122224569999999888889999999999999999876899998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.89  E-value=1e-23  Score=144.99  Aligned_cols=121  Identities=20%  Similarity=0.360  Sum_probs=93.6

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+..       .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi-~~al~~lH~-~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEM-VIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            789999987665532       2345677888 999999998 9999999999999999999999999999865432211


Q ss_pred             eeeeccCCCCCceeccccccc-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYN-----FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..  .....++..|++||.+.     ...++.++|+||+|+++|++++ |+.||...+
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~-g~~Pf~~~~  212 (332)
T cd05623         158 VQ--SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY-GETPFYAES  212 (332)
T ss_pred             ce--ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhc-CCCCCCCCC
Confidence            11  11122356799999875     2356789999999999999998 999998654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.89  E-value=5.7e-23  Score=142.85  Aligned_cols=104  Identities=26%  Similarity=0.301  Sum_probs=85.5

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      ..+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......    .....++..|+|||.+.+
T Consensus       126 ~~~~~~~~qi-~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~  199 (364)
T cd07875         126 ERMSYLLYQM-LCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVVTRYYRAPEVILG  199 (364)
T ss_pred             HHHHHHHHHH-HHHHHHHhh-CCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCc----ccCCcccCCcCCHHHHhC
Confidence            3455688888 999999998 9999999999999999999999999999875432211    111123456999999988


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..++.++|+||+|++++++++ |+.||.+.+
T Consensus       200 ~~~~~~~DiwSlG~il~ell~-g~~pf~~~~  229 (364)
T cd07875         200 MGYKENVDIWSVGCIMGEMIK-GGVLFPGTD  229 (364)
T ss_pred             CCCCchhhHHhHHHHHHHHHh-CCCCCCCCC
Confidence            888999999999999999998 999997654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.88  E-value=7.5e-23  Score=139.00  Aligned_cols=105  Identities=25%  Similarity=0.431  Sum_probs=83.6

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      ..+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.........   ....++..|+|||.+.+
T Consensus       103 ~~~~~~~~qi-~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~  177 (303)
T cd07869         103 ENVKLFLFQL-LRGLSYIHQ-RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY---SNEVVTLWYRPPDVLLG  177 (303)
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC---CCCcccCCCCChHHHcC
Confidence            3456688888 999999998 999999999999999999999999999986433221111   11223456999998765


Q ss_pred             C-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 G-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . .++.++|+||+|++++++++ |..||.+.+
T Consensus       178 ~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~  208 (303)
T cd07869         178 STEYSTCLDMWGVGCIFVEMIQ-GVAAFPGMK  208 (303)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCc
Confidence            4 57889999999999999998 999998653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.88  E-value=9.9e-23  Score=140.11  Aligned_cols=118  Identities=26%  Similarity=0.395  Sum_probs=93.5

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+++++|...+.      ......++.|+ +.|+.|+|...+++||||||+||+++.++.++++|||+++....... 
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i-~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  159 (331)
T cd06649          82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAV-LRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-  159 (331)
T ss_pred             eecCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc-
Confidence            78999888765443      22345577888 99999999744699999999999999999999999999865432111 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                          ....++..|++||.+.+..++.++|+||+|++++++++ |+.||...
T Consensus       160 ----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~  205 (331)
T cd06649         160 ----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAI-GRYPIPPP  205 (331)
T ss_pred             ----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCC
Confidence                11123457999999988888999999999999999998 99999753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PHA02988 hypothetical protein; Provisional

Probab=99.88  E-value=5.2e-23  Score=138.84  Aligned_cols=119  Identities=16%  Similarity=0.243  Sum_probs=94.2

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+++++|...+..      .....++.++ +.|+.|+|...+++|||+||+|++++.++.++++|||+++....... 
T Consensus       101 ~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i-~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~-  178 (283)
T PHA02988        101 LEYCTRGYLREVLDKEKDLSFKTKLDMAIDC-CKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF-  178 (283)
T ss_pred             EEeCCCCcHHHHHhhCCCCChhHHHHHHHHH-HHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccc-
Confidence            689999987665543      2234477788 99999999745888999999999999999999999999875433211 


Q ss_pred             eeeccCCCCCceecccccccC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNF--GRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~--~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                           ...++..|+|||.+.+  ..++.++|+||+|+++|++++ |..||.+.+.
T Consensus       179 -----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~-g~~Pf~~~~~  227 (283)
T PHA02988        179 -----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFT-GKIPFENLTT  227 (283)
T ss_pred             -----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHH-CCCCCCCCCH
Confidence                 1112356999998865  568899999999999999998 9999987653

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.88  E-value=5.7e-23  Score=138.37  Aligned_cols=121  Identities=20%  Similarity=0.247  Sum_probs=92.9

Q ss_pred             CCCCCCCCccc------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVT------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+.++.+..      .+.......++.|+ +.|+.|+|. .+++||||||+||+++.++.++++|||+++........
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi-~~~L~~lH~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQL-IKAIHWCHK-NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            67877764221      23333456688888 999999998 89999999999999999999999999998764322111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .  .....++..|++||.+.+..++.++|+||+|++++++++ |+.||.+.+
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~-g~~pf~~~~  205 (287)
T cd07848         157 N--YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSD-GQPLFPGES  205 (287)
T ss_pred             c--ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHh-CCCCCCCCC
Confidence            1  011123456999999988788899999999999999998 999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0194|consensus

Probab=99.88  E-value=2e-24  Score=152.40  Aligned_cols=123  Identities=41%  Similarity=0.641  Sum_probs=98.4

Q ss_pred             CCCCCCCCccccCCCCc------hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGSYA------LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||.|+||+|-..|....      .+..++..+|.|+.|||. +.+|||||...|+|+.....+|++|||+++.-..   .
T Consensus       240 mEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~---~  315 (474)
T KOG0194|consen  240 MELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ---Y  315 (474)
T ss_pred             EEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecCCCeEEeCccccccCCcc---e
Confidence            89999999777776543      233444444999999999 9999999999999999999999999999875321   1


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ......+..+.+|+|||.+....|+.++|+||+|+++||+++.|..||.+++.
T Consensus       316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~  368 (474)
T KOG0194|consen  316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN  368 (474)
T ss_pred             eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence            11111223457899999998889999999999999999999988899998764

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.88  E-value=5e-23  Score=139.04  Aligned_cols=104  Identities=23%  Similarity=0.402  Sum_probs=82.9

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC-
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF-   95 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-   95 (129)
                      ....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........   ......+..|+|||.+.+ 
T Consensus       104 ~~~~~~~qi-~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~  178 (288)
T cd07871         104 NVKIFMFQL-LRGLSYCHK-RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT---YSNEVVTLWYRPPDVLLGS  178 (288)
T ss_pred             HHHHHHHHH-HHHHHHHHh-CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc---ccCceecccccChHHhcCC
Confidence            345578888 999999998 99999999999999999999999999998754322111   111123456999998865 


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..++.++|+||+|++++++++ |..||.+.+
T Consensus       179 ~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~  208 (288)
T cd07871         179 TEYSTPIDMWGVGCILYEMAT-GRPMFPGST  208 (288)
T ss_pred             cccCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            457889999999999999998 999997644

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.88  E-value=1.8e-22  Score=136.73  Aligned_cols=106  Identities=14%  Similarity=0.205  Sum_probs=84.8

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee----eeccCCCCCceecccccc
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY----KATHGGRWPIKWYAPESY   93 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~   93 (129)
                      ...++.|+ +.|+.|+|. ++++||||||+||+++..+.++++|||+++.........    .......++..|++||..
T Consensus       128 ~~~i~~qi-~~~l~~lH~-~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~  205 (294)
T PHA02882        128 IKNIMKDM-LTTLEYIHE-HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH  205 (294)
T ss_pred             HHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHh
Confidence            34578888 999999998 899999999999999999999999999987643211100    001111245679999998


Q ss_pred             cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          94 NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        94 ~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .+..++.++|+||+|++++++++ |..||.+.+
T Consensus       206 ~~~~~~~~~DiwSlG~~l~el~~-g~~P~~~~~  237 (294)
T PHA02882        206 NGACVTRRGDLESLGYCMLKWAG-IKLPWKGFG  237 (294)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHh-CCCCCCccc
Confidence            88888999999999999999998 999998763

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.88  E-value=7e-24  Score=145.59  Aligned_cols=121  Identities=21%  Similarity=0.380  Sum_probs=94.0

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+++++|...+.       ......++.|+ +.|+.|+|. ++++||||||+||+++..+.++++|||+++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi-~~aL~~lH~-~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAEL-VLAIHSVHQ-MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            78999998665443       23355577888 999999999 9999999999999999999999999999876543221


Q ss_pred             eeeeccCCCCCceeccccccc------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYN------FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~------~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...  ....++..|+|||.+.      ...++.++|+||+|++++++++ |..||.+.+
T Consensus       158 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~~~~  213 (330)
T cd05601         158 VNS--KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY-GRSPFHEGT  213 (330)
T ss_pred             eee--ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeecc-CCCCCCCCC
Confidence            111  1112345799999875      3456789999999999999998 999997643

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.88  E-value=8.9e-23  Score=145.19  Aligned_cols=103  Identities=22%  Similarity=0.341  Sum_probs=82.0

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC-cEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH-QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      ....++.|+ +.||.|+|. ++++||||||+||+++..+ .++++|||+++........    ....++..|+|||.+.+
T Consensus       171 ~~~~~~~qi-~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~----~~~~~t~~y~aPE~~~~  244 (440)
T PTZ00036        171 LVKLYSYQL-CRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS----VSYICSRFYRAPELMLG  244 (440)
T ss_pred             HHHHHHHHH-HHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCc----ccCCCCcCccCHHHhcC
Confidence            455577788 999999998 8999999999999998765 5899999999765322111    11122456999998765


Q ss_pred             C-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 G-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . .++.++|+||+|++++++++ |..||.+.+
T Consensus       245 ~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~  275 (440)
T PTZ00036        245 ATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQS  275 (440)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            4 58899999999999999998 999998654

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.88  E-value=1.2e-22  Score=134.87  Aligned_cols=125  Identities=55%  Similarity=0.985  Sum_probs=95.6

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++|+|++++|++++.++.++++|||+++........
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~~l~~lh~-~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          74 MELAPLGPLLKYLKKRREIPVSDLKELAHQV-AMGMAYLES-KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHH-HHHHHHHhh-cCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            5778887755433      223345588888 999999998 89999999999999999999999999998765332222


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ........++..|++||.+....++.++|+||+|++++++++.|..||.+.++
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~  204 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG  204 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH
Confidence            21122222234699999988778889999999999999999658899987553

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0659|consensus

Probab=99.88  E-value=1.4e-22  Score=132.33  Aligned_cols=103  Identities=27%  Similarity=0.366  Sum_probs=83.6

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC-
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG-   96 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-   96 (129)
                      ++.++.++ .+|+.|+|. +-|+|||+||.|+|++.++.+|++|||+++...++.........++|   |.|||.+-+. 
T Consensus       103 iK~y~~m~-LkGl~y~H~-~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRW---YRAPELLfGsr  177 (318)
T KOG0659|consen  103 IKSYMLMT-LKGLAYCHS-KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRW---YRAPELLFGSR  177 (318)
T ss_pred             HHHHHHHH-HHHHHHHHh-hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeee---ccChHHhccch
Confidence            55577788 999999999 99999999999999999999999999999987765443332233333   7899977665 


Q ss_pred             CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          97 RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        97 ~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .|+..+|+||.||++.|++- +.+.|.+-+
T Consensus       178 ~Yg~~VDmWavGCI~AELll-r~P~fpG~s  206 (318)
T KOG0659|consen  178 QYGTGVDMWAVGCIFAELLL-RVPFFPGDS  206 (318)
T ss_pred             hcCCcchhhhHHHHHHHHHc-cCCCCCCCc
Confidence            68999999999999999995 766565543

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.88  E-value=1.6e-22  Score=137.97  Aligned_cols=106  Identities=25%  Similarity=0.333  Sum_probs=82.6

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe----cCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccc
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL----ASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE   91 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe   91 (129)
                      .....++.|+ +.|+.|+|. ++++||||||+||++    +..+.++++|||+++................++..|+|||
T Consensus       108 ~~~~~i~~qi-~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE  185 (317)
T cd07868         108 GMVKSLLYQI-LDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE  185 (317)
T ss_pred             HHHHHHHHHH-HHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCH
Confidence            3456688999 999999998 899999999999999    4557899999999876543221111111222345699999


Q ss_pred             cccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          92 SYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        92 ~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .+.+. .++.++|+||+|++++++++ |..||..
T Consensus       186 ~~~~~~~~~~~~DiwslG~il~el~~-g~~~f~~  218 (317)
T cd07868         186 LLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHC  218 (317)
T ss_pred             HHcCCCCcCchhhHHHHHHHHHHHHh-CCCCccC
Confidence            88764 57889999999999999998 9999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.88  E-value=1.9e-22  Score=135.54  Aligned_cols=119  Identities=22%  Similarity=0.319  Sum_probs=93.5

Q ss_pred             CCCCCCCCccccC--------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPL--------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++|+++...+        .......++.|+ +.|+.|+|. .+++||||+|+||+++.++.++++|||++.......
T Consensus        72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi-~~al~~lH~-~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~  149 (277)
T cd05607          72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI-TCGILHLHS-MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK  149 (277)
T ss_pred             EecCCCCCHHHHHHhccccCCCHHHHHHHHHHH-HHHHHHHHH-CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc
Confidence            7888888864322        222344577788 999999998 999999999999999999999999999887543321


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..    ....++..|++||.+....++.++|+||+|++++++++ |..||.+..
T Consensus       150 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~p~~~~~  198 (277)
T cd05607         150 TI----TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVA-GRTPFKDHK  198 (277)
T ss_pred             ee----eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCc
Confidence            11    11123456999999888788999999999999999998 999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0599|consensus

Probab=99.88  E-value=6.3e-23  Score=135.05  Aligned_cols=113  Identities=26%  Similarity=0.407  Sum_probs=89.8

Q ss_pred             CCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeee
Q psy7529           4 PNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA   77 (129)
Q Consensus         4 ~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~   77 (129)
                      +.-|.|+..|.+      -+.+.|+.|+ ..|++|+|+ +.|+||||||+|||++.+-+++++|||++..+..... .. 
T Consensus       105 ~prGELFDyLts~VtlSEK~tR~iMrql-fegVeylHa-~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek-Lr-  180 (411)
T KOG0599|consen  105 MPRGELFDYLTSKVTLSEKETRRIMRQL-FEGVEYLHA-RNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK-LR-  180 (411)
T ss_pred             cccchHHHHhhhheeecHHHHHHHHHHH-HHHHHHHHH-hhhhhcccChhheeeccccceEEeccceeeccCCchh-HH-
Confidence            344555555543      3567799999 999999999 9999999999999999999999999999987654322 11 


Q ss_pred             ccCCCCCceecccccccCC------CCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          78 THGGRWPIKWYAPESYNFG------RFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        78 ~~~~~~~~~~~~pe~~~~~------~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                        .-++++.|+|||.++..      .|+..+|.|++|+++|.++. |.+||-
T Consensus       181 --elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLa-GcpPFw  229 (411)
T KOG0599|consen  181 --ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLA-GCPPFW  229 (411)
T ss_pred             --HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHc-CCCchh
Confidence              22345679999987532      47789999999999999998 999973

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=4.4e-23  Score=141.88  Aligned_cols=121  Identities=21%  Similarity=0.378  Sum_probs=93.4

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++|++|...+.       ......++.|+ +.|+.|+|. ++++|||||++||+++.++.++++|||++........
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEM-VLAIDSVHQ-LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            78999988765443       23456688888 999999998 9999999999999999999999999999865432211


Q ss_pred             eeeeccCCCCCceecccccccC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNF-----GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..  .....++..|++||.+..     ..++.++|+||+|+++|++++ |..||.+.+
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~Pf~~~~  212 (331)
T cd05597         158 VQ--SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY-GETPFYAES  212 (331)
T ss_pred             cc--ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhh-CCCCCCCCC
Confidence            11  011123457999998753     346778999999999999998 999997643

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0579|consensus

Probab=99.88  E-value=7.4e-23  Score=147.25  Aligned_cols=121  Identities=29%  Similarity=0.424  Sum_probs=99.5

Q ss_pred             CCCCCCCC-------ccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSG-------VVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      +|||.||-       |-.+|..-.+..+.+|+ +.||.|||. +.|||||||..|||+..++.++++|||.+........
T Consensus       108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~-ldALn~LHs-~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQV-LDALNWLHS-QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             EeecCCchHhHHHHHhccccchHHHHHHHHHH-HHHHHHHhh-cchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence            47888887       55566666777888888 999999999 9999999999999999999999999999876544433


Q ss_pred             eeeeccCCCCCceecccccc-----cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESY-----NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~-----~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ......+   ++-|||||+.     +..+|+.++|+||+|+++.+|.. +++|..+.++
T Consensus       186 kRDsFIG---TPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAq-iEPPHhelnp  240 (1187)
T KOG0579|consen  186 KRDSFIG---TPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQ-IEPPHHELNP  240 (1187)
T ss_pred             hhccccC---CcccccchheeeccccCCCchhhhhHHhhhhHHHHHhc-cCCCccccch
Confidence            3334444   3459999964     56689999999999999999997 9999888765

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.88  E-value=2.5e-22  Score=139.14  Aligned_cols=118  Identities=28%  Similarity=0.466  Sum_probs=89.8

Q ss_pred             CCCCCCCCccccCC--CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeec
Q psy7529           1 MKSPNGSGVVTPLG--SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKAT   78 (129)
Q Consensus         1 m~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~   78 (129)
                      |||++++++.....  ......++.|+ +.|+.|+|. ++++|||||++||+++.++.++++|||+++........   .
T Consensus       151 ~e~~~~~~L~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~---~  225 (353)
T PLN00034        151 LEFMDGGSLEGTHIADEQFLADVARQI-LSGIAYLHR-RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---C  225 (353)
T ss_pred             EecCCCCcccccccCCHHHHHHHHHHH-HHHHHHHHH-CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc---c
Confidence            78999888754322  22344578888 999999998 89999999999999999999999999998754322111   1


Q ss_pred             cCCCCCceecccccccCC-----CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          79 HGGRWPIKWYAPESYNFG-----RFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        79 ~~~~~~~~~~~pe~~~~~-----~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ....++..|++||.+...     ..+.++|+||+|+++|++++ |+.||..
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~  275 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL-GRFPFGV  275 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHh-CCCCCCC
Confidence            112234579999987432     23468999999999999998 9999974

>KOG4250|consensus

Probab=99.88  E-value=1e-22  Score=146.79  Aligned_cols=118  Identities=27%  Similarity=0.481  Sum_probs=93.0

Q ss_pred             CCCCCCCCccccCCCCc---------hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC--Cc--EEEEeecCccc
Q psy7529           1 MKSPNGSGVVTPLGSYA---------LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR--HQ--AKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~--~~--~~l~d~~~~~~   67 (129)
                      ||||+||+|+..|....         ..-+...+ ..|+.+||. ++|+||||||.||++-..  +.  .|++|||.++.
T Consensus        96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~-~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDL-VSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHH-HHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            89999999988888643         33345555 789999998 999999999999987332  32  49999999997


Q ss_pred             ccCCCceeeeccCCCCCceeccccccc-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          68 VNSERNYYKATHGGRWPIKWYAPESYN-FGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ..... ...   .-.+|..|++|++.. +..|+..+|.||+|+++|++.+ |..||-..
T Consensus       174 l~d~s-~~~---S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caT-G~lPF~p~  227 (732)
T KOG4250|consen  174 LDDNS-LFT---SLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECAT-GELPFIPF  227 (732)
T ss_pred             CCCCC-eee---eecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhc-cCCCCCcC
Confidence            65433 222   223456799999987 4678899999999999999999 99998754

>KOG1026|consensus

Probab=99.88  E-value=4.2e-23  Score=150.92  Aligned_cols=114  Identities=45%  Similarity=0.816  Sum_probs=95.1

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccc
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPES   92 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~   92 (129)
                      |..-....|++|| |.|+.||-. +..+||||...|+|+...-.+||+|||++|-.=+. ..+......--+++||+||.
T Consensus       600 L~~~q~L~iA~QI-AaGM~YLs~-~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYss-DYYk~~~~t~lPIRWMppEs  676 (774)
T KOG1026|consen  600 LSTSQFLHIATQI-AAGMEYLSS-HHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSS-DYYKVRGNTLLPIRWMPPES  676 (774)
T ss_pred             CCHHHHHHHHHHH-HHHHHHHHh-CcccccchhhhhceeccceEEEecccccchhhhhh-hhhcccCCceeeeecCCHHH
Confidence            4445677799999 999999998 89999999999999999999999999999853211 12222212223578999999


Q ss_pred             ccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q psy7529          93 YNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD  129 (129)
Q Consensus        93 ~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~e  129 (129)
                      +..+.|+.++|+||+|+++||++++|+.||.+++++|
T Consensus       677 Ily~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E  713 (774)
T KOG1026|consen  677 ILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE  713 (774)
T ss_pred             hhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence            9999999999999999999999999999999998875

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.88  E-value=2e-22  Score=140.80  Aligned_cols=105  Identities=46%  Similarity=0.784  Sum_probs=82.9

Q ss_pred             hhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCCC
Q psy7529          19 PYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRF   98 (129)
Q Consensus        19 ~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~   98 (129)
                      ..++.|+ +.|+.|+|. ++++||||||+||+++.+..++++|||+++......... .......+..|++||.+.+..+
T Consensus       217 ~~~~~qi-~~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~  293 (375)
T cd05104         217 LSFSYQV-AKGMSFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV-VKGNARLPVKWMAPESIFNCVY  293 (375)
T ss_pred             HHHHHHH-HHHHHHHHH-CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc-ccCCCCCCcceeChhHhcCCCC
Confidence            3467788 999999998 899999999999999999999999999987543221111 0111112346999999988888


Q ss_pred             CChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          99 SSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        99 ~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +.++|+||+|++++++++.|..||.+.+
T Consensus       294 ~~~sDi~slG~~l~ellt~g~~p~~~~~  321 (375)
T cd05104         294 TFESDVWSYGILLWEIFSLGSSPYPGMP  321 (375)
T ss_pred             CCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999976788987654

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.88  E-value=2.7e-22  Score=134.95  Aligned_cols=122  Identities=38%  Similarity=0.581  Sum_probs=93.5

Q ss_pred             CCCCCCCCccccC-----CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPL-----GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++++...+     .......++.|+ +.|+.|+|. ++++|+|+||+||+++.++.++++|||+++.........
T Consensus        87 ~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l-~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  164 (283)
T cd05080          87 MEYVPLGSLRDYLPKHKLNLAQLLLFAQQI-CEGMAYLHS-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY  164 (283)
T ss_pred             ecCCCCCCHHHHHHHcCCCHHHHHHHHHHH-HHHHHHHHH-CCeeccccChheEEEcCCCcEEEeecccccccCCcchhh
Confidence            6888888865533     333455578888 999999998 899999999999999999999999999987653322111


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ........+..|++||......++.++|+||+|++++++++ |..||...
T Consensus       165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~t-g~~p~~~~  213 (283)
T cd05080         165 RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSP  213 (283)
T ss_pred             ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHh-CCCCCCCC
Confidence            11111122345899998877778899999999999999998 99888653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0580|consensus

Probab=99.88  E-value=3.2e-23  Score=133.55  Aligned_cols=119  Identities=24%  Similarity=0.352  Sum_probs=97.4

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      +||...+++++.|..        ...-.+..|+ |.|+-|+|. +++||||+||+|+|++..+.+|++|||.+-....  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~-A~Al~y~h~-k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~--  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQL-ANALLYCHL-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--  176 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHH-HHHHHHhcc-CCcccCCCCHHHhccCCCCCeeccCCCceeecCC--
Confidence            477777887776662        2344488899 999999999 9999999999999999999999999999854331  


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ..   ....+++..|++||+..+..++..+|+|++|++.||++. |.+||.+.+.
T Consensus       177 ~k---R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflv-g~ppFes~~~  227 (281)
T KOG0580|consen  177 NK---RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLV-GLPPFESQSH  227 (281)
T ss_pred             CC---ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHh-cCCchhhhhh
Confidence            11   122234578999999999999999999999999999998 9999987654

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.88  E-value=1.8e-22  Score=135.57  Aligned_cols=107  Identities=43%  Similarity=0.790  Sum_probs=84.5

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++|+|+||+||+++.++.++++|||+++........ ........+..|+|||.+....
T Consensus       126 ~~~~~~~l-~~al~~lH~-~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~  202 (283)
T cd05048         126 FLHIAIQI-AAGMEYLSS-HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY-RVQSKSLLPVRWMPPEAILYGK  202 (283)
T ss_pred             HHHHHHHH-HHHHHHHHh-CCeeccccccceEEEcCCCcEEECCCcceeeccccccc-cccCCCcccccccCHHHhccCc
Confidence            34588888 999999999 89999999999999999999999999998754322111 1111112245699999988778


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ++.++|+||+|++++++++.|..||.+.+.
T Consensus       203 ~~~~sDv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05048         203 FTTESDIWSFGVVLWEIFSYGLQPYYGFSN  232 (283)
T ss_pred             CchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            889999999999999999768889886543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0603|consensus

Probab=99.88  E-value=1.8e-22  Score=144.01  Aligned_cols=104  Identities=24%  Similarity=0.469  Sum_probs=88.0

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe-cCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL-ASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ..+..+++++ +.|+.|||. ++++|||+||+|||+ +..++++++|||.++.....      ....+.+..|.|||+..
T Consensus       415 ~e~~~w~~~l-v~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~------~~tp~~t~~y~APEvl~  486 (612)
T KOG0603|consen  415 SEASQWAAEL-VSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS------CDTPALTLQYVAPEVLA  486 (612)
T ss_pred             HHHHHHHHHH-HHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhhCchh------hcccchhhcccChhhhc
Confidence            3456688999 999999999 999999999999999 58899999999998765433      11223356699999999


Q ss_pred             CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          95 FGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        95 ~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                      ...|+...|+||+|+++|+|++ |..||...+..
T Consensus       487 ~~~yt~acD~WSLGvlLy~ML~-G~tp~~~~P~~  519 (612)
T KOG0603|consen  487 IQEYTEACDWWSLGVLLYEMLT-GRTLFAAHPAG  519 (612)
T ss_pred             cCCCCcchhhHHHHHHHHHHHh-CCCccccCCch
Confidence            8899999999999999999999 99999887653

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.87  E-value=1.8e-22  Score=135.49  Aligned_cols=123  Identities=40%  Similarity=0.660  Sum_probs=94.1

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+..       .....++.|+ +.|+.|+|. ++++|||+||+||+++..+.++++|||+++.......
T Consensus        87 ~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi-~~~L~~lH~-~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~  164 (279)
T cd05109          87 TQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI-AKGMSYLEE-VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET  164 (279)
T ss_pred             EEcCCCCCHHHHHhhccCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence            567777776655433       2344577888 999999998 9999999999999999999999999999876543221


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .. .......+..|++||......++.++|+||+|+++|+++++|..||.+.+
T Consensus       165 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  216 (279)
T cd05109         165 EY-HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP  216 (279)
T ss_pred             ee-ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            11 11122223569999998877888999999999999999876888987643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.87  E-value=1.3e-23  Score=143.76  Aligned_cols=120  Identities=26%  Similarity=0.403  Sum_probs=95.4

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+.      ......++.|+ +.|+.|+|. ++++|||||++||+++.++.++++|||+++........
T Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          77 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL-ALALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence            78999988755432      33456688888 999999998 89999999999999999999999999998754322111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   ....++..|++||.+....++.++|+||+|++++++++ |+.||...+
T Consensus       155 ~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~  202 (318)
T cd05582         155 A---YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GSLPFQGKD  202 (318)
T ss_pred             e---ecccCChhhcCHHHHcCCCCCCccceeccceEeeeecc-CCCCCCCCC
Confidence            1   11123456999999987778889999999999999998 999997654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=2.5e-22  Score=135.43  Aligned_cols=119  Identities=24%  Similarity=0.400  Sum_probs=94.0

Q ss_pred             CCCCCCCCcccc--------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTP--------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+.++++...        +.......++.|+ +.|+.|+|. ++++||||+++||+++.++.++++|||+++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEI-TCGLEDLHR-ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHH-HHHHHHHHH-CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            788888886422        2233455578888 999999998 899999999999999999999999999987543221


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..    ....++..|++||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       157 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~-g~~pf~~~~  205 (285)
T cd05605         157 TI----RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPFRQRK  205 (285)
T ss_pred             cc----ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHH-CCCCCCCCc
Confidence            11    11123456999999987788889999999999999998 999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.87  E-value=2e-22  Score=136.92  Aligned_cols=106  Identities=42%  Similarity=0.731  Sum_probs=82.4

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++......... .......+..|++||.+....
T Consensus       140 ~~~i~~~i-~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~  216 (304)
T cd05096         140 LLHVALQI-ASGMKYLSS-LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR-IQGRAVLPIRWMAWECILMGK  216 (304)
T ss_pred             HHHHHHHH-HHHHHHHHH-CCccccCcchhheEEcCCccEEECCCccceecccCceeE-ecCcCCCCccccCHHHHhcCC
Confidence            34588888 999999998 899999999999999999999999999987543322111 111112245699999988778


Q ss_pred             CCChhhHHHHHHHHHHHHhC-CCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSF-GQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~-~~~pf~~~~  126 (129)
                      ++.++|+||+|++++++++. +..||.+.+
T Consensus       217 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  246 (304)
T cd05096         217 FTTASDVWAFGVTLWEILMLCKEQPYGELT  246 (304)
T ss_pred             CCchhhhHHHHHHHHHHHHccCCCCCCcCC
Confidence            89999999999999999852 456887654

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.87  E-value=3.2e-22  Score=134.55  Aligned_cols=123  Identities=39%  Similarity=0.636  Sum_probs=94.3

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++.+.+..       .....++.|+ +.|+.|+|. ++++|||+|++||+++.++.++++|||.++.......
T Consensus        87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T cd05111          87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI-AKGMYYLEE-HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK  164 (279)
T ss_pred             EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHH-HHHHHHHHH-CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence            567777786655432       2345578888 999999998 8999999999999999999999999999875432211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ... ......+..|++||.+....++.++|+||+|+++|+++++|..||.+..
T Consensus       165 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~  216 (279)
T cd05111         165 KYF-YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR  216 (279)
T ss_pred             ccc-cCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            111 1111223469999998878889999999999999999976889998754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.87  E-value=1.3e-22  Score=136.87  Aligned_cols=103  Identities=26%  Similarity=0.397  Sum_probs=84.8

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++......    ......++..|+|||.+...
T Consensus       111 ~~~~i~~qi-~~aL~~lH~-~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~  184 (290)
T cd07862         111 TIKDMMFQL-LRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQS  184 (290)
T ss_pred             HHHHHHHHH-HHHHHHHHH-CCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCc----ccccccccccccChHHHhCC
Confidence            455688888 999999999 999999999999999999999999999987543221    11112234569999998877


Q ss_pred             CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          97 RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        97 ~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .++.++|+||+|++++++++ |..||.+.+
T Consensus       185 ~~~~~~DiwslG~il~el~~-g~~~f~~~~  213 (290)
T cd07862         185 SYATPVDLWSVGCIFAEMFR-RKPLFRGSS  213 (290)
T ss_pred             CCCCccchHHHHHHHHHHHc-CCCCcCCCC
Confidence            88899999999999999998 999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.87  E-value=2.5e-22  Score=151.03  Aligned_cols=123  Identities=26%  Similarity=0.279  Sum_probs=93.9

Q ss_pred             CCCCCCCCccccCCC-----------------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeec
Q psy7529           1 MKSPNGSGVVTPLGS-----------------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFG   63 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~   63 (129)
                      |||++|+++...+..                 .....++.|+ +.|+.|+|. ++++|||+||+||+++..+.++++|||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QI-a~AL~yLHs-~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI-CATIEYVHS-KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHH-HHHHHHHHH-CCccccCCchheEEEcCCCCEEEEecC
Confidence            788999886554321                 1123467788 999999998 899999999999999999999999999


Q ss_pred             CcccccCCCce---------------eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          64 LSRAVNSERNY---------------YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        64 ~~~~~~~~~~~---------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +++........               ........++..|+|||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLT-G~~PF~~~~  235 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT-LSFPYRRKK  235 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHH-CCCCCCCcc
Confidence            98754111000               000001124567999999988888999999999999999998 999997644

>PTZ00284 protein kinase; Provisional

Probab=99.87  E-value=2.2e-22  Score=144.02  Aligned_cols=104  Identities=23%  Similarity=0.338  Sum_probs=82.7

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC----------------cEEEEeecCcccccCCCceeeec
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH----------------QAKISDFGLSRAVNSERNYYKAT   78 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~----------------~~~l~d~~~~~~~~~~~~~~~~~   78 (129)
                      ...+..++.|+ +.||.|+|...+|+||||||+||+++..+                .+|++|||.+.......      
T Consensus       230 ~~~~~~i~~qi-~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~------  302 (467)
T PTZ00284        230 HRHLAQIIFQT-GVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSR------  302 (467)
T ss_pred             HHHHHHHHHHH-HHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcccc------
Confidence            33456688899 99999999735999999999999997654                48999999875322111      


Q ss_pred             cCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          79 HGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        79 ~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....++..|+|||.+.+..++.++|+||+||++|++++ |+.||...+
T Consensus       303 ~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~  349 (467)
T PTZ00284        303 TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT-GKLLYDTHD  349 (467)
T ss_pred             ccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            11123457999999988889999999999999999998 999997654

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.87  E-value=5.1e-22  Score=133.66  Aligned_cols=118  Identities=23%  Similarity=0.379  Sum_probs=92.9

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+++++|...      +.......++.|+ +.|+.|+|. ++++|||+|++||+++.++.++++|||++........ 
T Consensus        76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi-~~al~~lH~-~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-  152 (279)
T cd05633          76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEI-ILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (279)
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence            788998887533      3334456688888 999999998 8999999999999999999999999998864432111 


Q ss_pred             eeeccCCCCCceecccccccC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNF-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                          ....++..|++||.+.. ..++.++|+||+|++++++++ |..||.+..
T Consensus       153 ----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~  200 (279)
T cd05633         153 ----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR-GHSPFRQHK  200 (279)
T ss_pred             ----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHh-CCCCcCCCC
Confidence                11123457999998753 457889999999999999998 999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0033|consensus

Probab=99.87  E-value=2.6e-22  Score=130.37  Aligned_cols=104  Identities=29%  Similarity=0.447  Sum_probs=87.5

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC---CCcEEEEeecCcccccCCCceeeeccCCCCCceeccccc
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS---RHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPES   92 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~   92 (129)
                      ....+.+.|+ +.++.|.|. ++|+|||+||.|+++.+   ...+|++|||++..+++...    ..+..+++.|++||+
T Consensus       110 a~aSH~~rQi-Leal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~----~~G~~GtP~fmaPEv  183 (355)
T KOG0033|consen  110 ADASHCIQQI-LEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA----WHGFAGTPGYLSPEV  183 (355)
T ss_pred             HHHHHHHHHH-HHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccceEEEeCCccc----cccccCCCcccCHHH
Confidence            4466688888 999999999 99999999999999854   34589999999987764322    234445678999999


Q ss_pred             ccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          93 YNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        93 ~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++..+|+..+|+|++|++++-++. |.+||-+.+
T Consensus       184 vrkdpy~kpvDiW~cGViLfiLL~-G~~PF~~~~  216 (355)
T KOG0033|consen  184 LKKDPYSKPVDIWACGVILYILLV-GYPPFWDED  216 (355)
T ss_pred             hhcCCCCCcchhhhhhHHHHHHHh-CCCCCCCcc
Confidence            999999999999999999999998 999998743

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.87  E-value=2.1e-22  Score=134.48  Aligned_cols=123  Identities=36%  Similarity=0.559  Sum_probs=94.0

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+       .......++.|+ +.|+.|+|. ++++|||++|+||+++.++.++++|||..........
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i-~~al~~lH~-~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGL-ASGMKYLSE-MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHH-HHHHHHHHH-CCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence            7899988865433       223455688888 899999998 8999999999999999999999999997654321111


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                        ........+..|++||.+.+..++.++|+||+|++++++++.|..||.+.+.
T Consensus       163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~  214 (266)
T cd05064         163 --YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG  214 (266)
T ss_pred             --hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence              1111222235699999988888899999999999999987559999987543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0608|consensus

Probab=99.87  E-value=1.9e-22  Score=144.88  Aligned_cols=126  Identities=22%  Similarity=0.334  Sum_probs=97.4

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc-
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN-   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~-   73 (129)
                      |+|++||++-..|-.      ...+++++.+ .-|+++.|. .+.|||||||+|||+|.++++|+.|||++..+..... 
T Consensus       708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEl-tcAiesVHk-mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAEL-TCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             EeccCCccHHHHHHHhccCHHHHHHHHHHHH-HHHHHHHHh-ccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            899999996655543      2366777777 557899998 9999999999999999999999999999864321100 


Q ss_pred             --------------------------------------eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHH
Q psy7529          74 --------------------------------------YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMY  115 (129)
Q Consensus        74 --------------------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~  115 (129)
                                                            ..+..+...++..|+|||++....+....|+|+.|+++++|+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                                                  000011113456699999998888888999999999999999


Q ss_pred             hCCCCCCCCCCCCC
Q psy7529         116 SFGQQPYGEMKGSD  129 (129)
Q Consensus       116 ~~~~~pf~~~~~~e  129 (129)
                      - |++||.+-++.|
T Consensus       866 ~-g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  866 V-GQPPFLADTPGE  878 (1034)
T ss_pred             h-CCCCccCCCCCc
Confidence            6 999999876643

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.87  E-value=5e-22  Score=136.79  Aligned_cols=118  Identities=28%  Similarity=0.405  Sum_probs=92.9

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+++++|...+..      .....++.|+ +.|+.|+|...+++|+||||+||+++.++.++++|||++........ 
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l-~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-  159 (333)
T cd06650          82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAV-IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-  159 (333)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc-
Confidence            789999987665432      2344577787 99999999745799999999999999999999999999865432111 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                          ....++..|++||.+.+..++.++|+||+|++++++++ |+.||...
T Consensus       160 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~  205 (333)
T cd06650         160 ----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI-GRYPIPPP  205 (333)
T ss_pred             ----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCc
Confidence                11123456999999988788899999999999999998 99998753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0984|consensus

Probab=99.87  E-value=1.7e-22  Score=128.19  Aligned_cols=101  Identities=33%  Similarity=0.419  Sum_probs=79.9

Q ss_pred             hHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc----C
Q psy7529          20 YIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN----F   95 (129)
Q Consensus        20 ~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~----~   95 (129)
                      .|+..+ ..|+.+||..-.+||||+||+|||++..+++|++|||.+.-+.+........    ++.+|+|||.+.    .
T Consensus       152 kIa~Sv-v~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~da----GCkpYmaPEri~~e~n~  226 (282)
T KOG0984|consen  152 KIAVSV-VHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDA----GCKPYMAPERINPELNQ  226 (282)
T ss_pred             HhHHHH-HHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhc----CCCccCChhhcCcccCc
Confidence            366666 7899999987789999999999999999999999999986554322111111    123599999763    3


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..|+.++|+||+|+.+.|+.+ +..||..+-
T Consensus       227 ~gY~vksDvWSLGItmiElA~-lr~PY~~w~  256 (282)
T KOG0984|consen  227 KGYSVKSDVWSLGITMIEMAI-LRFPYESWG  256 (282)
T ss_pred             ccceeehhhhhhhhhhhhhhh-ccccccccC
Confidence            368999999999999999998 899988754

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.87  E-value=2.8e-22  Score=134.45  Aligned_cols=123  Identities=38%  Similarity=0.674  Sum_probs=92.5

Q ss_pred             CCCCCCCCccccCCC----------------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecC
Q psy7529           1 MKSPNGSGVVTPLGS----------------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGL   64 (129)
Q Consensus         1 m~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~   64 (129)
                      |||+++++|...+..                .....++.|+ +.|+.|+|. .+++|+|+||+||+++.++.++++|||+
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lH~-~~~vH~dlkp~Nil~~~~~~~~l~dfg~  165 (277)
T cd05062          88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI-ADGMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGM  165 (277)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCcchheEEEcCCCCEEECCCCC
Confidence            678888876543321                1234467788 999999998 8999999999999999999999999999


Q ss_pred             cccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          65 SRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.......... ......+..|++||.+.+..++.++|+||+|++++++++.+..||.+.+
T Consensus       166 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~  226 (277)
T cd05062         166 TRDIYETDYYRK-GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS  226 (277)
T ss_pred             ccccCCcceeec-CCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            875432211111 1111123569999998877888999999999999999975678887654

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.87  E-value=2.3e-22  Score=134.28  Aligned_cols=123  Identities=28%  Similarity=0.492  Sum_probs=90.0

Q ss_pred             CCCCCCCCccccCCCC-----------chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCccccc
Q psy7529           1 MKSPNGSGVVTPLGSY-----------ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVN   69 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~   69 (129)
                      |||+++++|..-+...           ....++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++...
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV-ASGLLWLHQ-ADFIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHH-HHHHHHHHh-cCEecccccHhheEecCCCcEEEeccccccccc
Confidence            6888888865543221           134577888 999999998 899999999999999999999999999886432


Q ss_pred             CCCceeeeccCCCCCceecccccccC-------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          70 SERNYYKATHGGRWPIKWYAPESYNF-------GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .... .........+..|++||....       ..++.++|+||+|++++++++.|..||.+.+
T Consensus       152 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (269)
T cd05042         152 PEDY-YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS  214 (269)
T ss_pred             cchh-eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence            2111 111112222356999997632       3456789999999999999975678887654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.87  E-value=4.3e-22  Score=132.06  Aligned_cols=124  Identities=43%  Similarity=0.687  Sum_probs=94.1

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++.+.+..        .....++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||+++......
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi-~~~L~~lH~-~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~  151 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQI-ANGMRYLES-KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE  151 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHH-HHHHHHHHh-CCccccccCcccEEEecCCEEEeccccccccccccc
Confidence            578888886654322        2234466788 999999998 899999999999999999999999999987654322


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...........+..|++||.+....++.++|+||+|+++++++++|..||...+
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  205 (257)
T cd05040         152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS  205 (257)
T ss_pred             cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence            111111112234569999988877788899999999999999976899986543

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=1.1e-21  Score=137.89  Aligned_cols=104  Identities=27%  Similarity=0.356  Sum_probs=83.2

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ +.||.|+|. ++++||||||+||+++..+.++++|||+++........  ......++..|++||.+.+
T Consensus       182 ~~~~~i~~qi-~~aL~ylH~-~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~  257 (391)
T PHA03212        182 CDILAIERSV-LRAIQYLHE-NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN--KYYGWAGTIATNAPELLAR  257 (391)
T ss_pred             HHHHHHHHHH-HHHHHHHHh-CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc--ccccccCccCCCChhhhcC
Confidence            3455688888 999999999 89999999999999999999999999998643221110  1111224567999999988


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ..++.++|+||+|+++|++++ |..||.+
T Consensus       258 ~~~~~~~DiwSlGvil~ellt-g~~p~~~  285 (391)
T PHA03212        258 DPYGPAVDIWSAGIVLFEMAT-CHDSLFE  285 (391)
T ss_pred             CCCCcHHHHHHHHHHHHHHHH-CCCCcCC
Confidence            889999999999999999998 9877654

>KOG0695|consensus

Probab=99.87  E-value=5.4e-22  Score=134.14  Aligned_cols=117  Identities=21%  Similarity=0.403  Sum_probs=98.0

Q ss_pred             CCCCCCCCcc------ccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVV------TPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      +||.+||+|-      ..|++...+++-+.+ +.||.|+|. ++||+||+|.+|++++..+++|+.|+|+++....+...
T Consensus       330 ieyv~ggdlmfhmqrqrklpeeharfys~ei-~lal~flh~-rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~  407 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEI-CLALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT  407 (593)
T ss_pred             EEEecCcceeeehhhhhcCcHHHhhhhhHHH-HHHHHHHhh-cCeeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence            4788899853      234455678888999 899999999 99999999999999999999999999999865443333


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      ....   ++++.|.|||.+.+..|+..+|+|++|++++||+. |+.||+
T Consensus       408 tstf---cgtpnyiapeilrgeeygfsvdwwalgvlmfemma-grspfd  452 (593)
T KOG0695|consen  408 TSTF---CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA-GRSPFD  452 (593)
T ss_pred             cccc---cCCCcccchhhhcccccCceehHHHHHHHHHHHHc-CCCCcc
Confidence            3323   34567999999999999999999999999999998 999997

>KOG0667|consensus

Probab=99.87  E-value=2.9e-22  Score=143.12  Aligned_cols=105  Identities=28%  Similarity=0.343  Sum_probs=84.8

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC--CCcEEEEeecCcccccCCCceeeeccCCCCCceeccc
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS--RHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP   90 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~p   90 (129)
                      +....++-+..|+ +.||..||. .+|||.||||+|||+..  ...+|++|||.+.......-.+.   .   +.-|.||
T Consensus       286 lsl~~ir~~~~Qi-l~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vytYi---Q---SRfYRAP  357 (586)
T KOG0667|consen  286 LSLPLVRKFAQQI-LTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVYTYI---Q---SRFYRAP  357 (586)
T ss_pred             CCHHHHHHHHHHH-HHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccccccCCcceeee---e---ccccccc
Confidence            3444566688888 999999998 99999999999999954  34689999999876544332221   1   2348999


Q ss_pred             ccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          91 ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        91 e~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      |++.+.+|+.+.|+||+||++.||++ |.+.|.+-+
T Consensus       358 EVILGlpY~~~IDmWSLGCIlAEL~t-G~PLfpG~n  392 (586)
T KOG0667|consen  358 EVILGLPYDTAIDMWSLGCILAELFT-GEPLFPGDN  392 (586)
T ss_pred             hhhccCCCCCccceeehhhhHHhHhc-CccccCCCC
Confidence            99999999999999999999999998 988887654

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.87  E-value=6.8e-22  Score=134.78  Aligned_cols=105  Identities=26%  Similarity=0.345  Sum_probs=81.4

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe----cCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL----ASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      ...++.|+ +.|+.|+|. ++++||||||+||++    +..+.++++|||+++................++..|+|||.+
T Consensus       110 ~~~i~~qi-~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~  187 (317)
T cd07867         110 VKSLLYQI-LDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL  187 (317)
T ss_pred             HHHHHHHH-HHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHh
Confidence            45678888 999999998 899999999999999    456789999999987653322111111122234569999988


Q ss_pred             cCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          94 NFG-RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        94 ~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .+. .++.++|+||+|++++++++ |..||...
T Consensus       188 ~~~~~~~~~~DiwSlG~il~el~t-g~~~f~~~  219 (317)
T cd07867         188 LGARHYTKAIDIWAIGCIFAELLT-SEPIFHCR  219 (317)
T ss_pred             cCCCccCcHHHHHhHHHHHHHHHh-CCCCcccc
Confidence            664 47889999999999999998 99999743

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.86  E-value=9.6e-22  Score=135.65  Aligned_cols=106  Identities=42%  Similarity=0.776  Sum_probs=83.4

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      +..++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++.+....... .......+..|++||.+.+..
T Consensus       175 ~~~~~~qi-~~aL~~lH~-~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~  251 (337)
T cd05054         175 LISYSFQV-ARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKGDARLPLKWMAPESIFDKV  251 (337)
T ss_pred             HHHHHHHH-HHHHHHHHh-CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh-hccCCCCCccccCcHHhcCCC
Confidence            44577888 999999998 899999999999999999999999999987643221111 111112234699999988888


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|++++++++.|..||.+..
T Consensus       252 ~~~~~Di~SlGv~l~el~t~g~~p~~~~~  280 (337)
T cd05054         252 YTTQSDVWSFGVLLWEIFSLGASPYPGVQ  280 (337)
T ss_pred             CCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence            89999999999999999965889997643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=7.2e-22  Score=131.31  Aligned_cols=123  Identities=27%  Similarity=0.382  Sum_probs=92.9

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++.+.+.      ......++.|+ +.|+.|+|. .+++|+|++|+||+++.++.++++|||+++........
T Consensus        83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lH~-~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQI-LEGVEYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEECCCCcHHHHHHHhCCCCHHHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            56777777654432      23345577888 999999998 89999999999999999999999999998654321111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .........+..|++||.+.+..++.++|+||+|+++|++++ |+.||.+.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~  211 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-EKPPWAEFE  211 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHh-CCCCccccc
Confidence            100011112346999999988778899999999999999998 999997654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.86  E-value=7.8e-22  Score=131.51  Aligned_cols=123  Identities=25%  Similarity=0.370  Sum_probs=93.1

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+.      ......++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||.++........
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l-~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~  162 (265)
T cd06652          85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQI-LEGVSYLHS-NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS  162 (265)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHh-CCEecCCCCHHHEEecCCCCEEECcCcccccccccccc
Confidence            57888887654432      22345577888 999999998 89999999999999999999999999988754321111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ........++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~  213 (265)
T cd06652         163 GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT-EKPPWAEFE  213 (265)
T ss_pred             ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhh-CCCCCCccc
Confidence            011111123456999999877778889999999999999998 999997653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.86  E-value=7.7e-22  Score=133.32  Aligned_cols=106  Identities=42%  Similarity=0.753  Sum_probs=83.9

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++|||++|+||+++.++.++++|||+++.......... ......+..|++||.+.+..
T Consensus       125 ~~~i~~~i-~~al~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~  201 (291)
T cd05094         125 MLHIASQI-ASGMVYLAS-QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV-GGHTMLPIRWMPPESIMYRK  201 (291)
T ss_pred             HHHHHHHH-HHHHHHHHh-CCeeecccCcceEEEccCCcEEECCCCcccccCCCceeec-CCCCCcceeecChHHhccCC
Confidence            45578888 999999998 9999999999999999999999999999875433211111 11111235699999988888


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|++++++++.|..||.+.+
T Consensus       202 ~~~~~Di~slG~il~el~t~g~~p~~~~~  230 (291)
T cd05094         202 FTTESDVWSFGVILWEIFTYGKQPWFQLS  230 (291)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            88899999999999999966889987654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG4279|consensus

Probab=99.86  E-value=7e-23  Score=148.44  Aligned_cols=121  Identities=31%  Similarity=0.518  Sum_probs=97.7

Q ss_pred             CCCCCCCCccccCCC---------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-CCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPLGS---------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-RHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-~~~~~l~d~~~~~~~~~   70 (129)
                      ||-.+||+|...|.+         ....++.-|| ++||+|+|. +.|+|||+|-+|++++. ++.+|++|||-++.+..
T Consensus       651 MEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQI-LeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  651 MEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQI-LEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             eecCCCCcHHHHHHhccCCCccchhHHHHHHHHH-HHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence            778889997776653         3467788899 999999999 99999999999999965 67889999998886533


Q ss_pred             CCceeeeccCCCCCceecccccccCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFG--RFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      -.   ..+..-.+++.|||||++-.+  .|+..+||||+||+..||.+ |++||-++-.
T Consensus       729 in---P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMAT-GrPPF~Elgs  783 (1226)
T KOG4279|consen  729 IN---PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMAT-GRPPFVELGS  783 (1226)
T ss_pred             CC---ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeecc-CCCCeeecCC
Confidence            21   112223346789999998665  58899999999999999998 9999987654

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.86  E-value=1.3e-21  Score=131.43  Aligned_cols=117  Identities=27%  Similarity=0.406  Sum_probs=93.4

Q ss_pred             CCCCCCCCcc--ccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeec
Q psy7529           1 MKSPNGSGVV--TPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKAT   78 (129)
Q Consensus         1 m~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~   78 (129)
                      |||++++.+.  ..++......++.|+ +.|+.|+|. .+++|+|++++||+++.++.++++|||++........     
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~-----  150 (279)
T cd06619          78 TEFMDGGSLDVYRKIPEHVLGRIAVAV-VKGLTYLWS-LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA-----  150 (279)
T ss_pred             EecCCCCChHHhhcCCHHHHHHHHHHH-HHHHHHHHH-CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc-----
Confidence            6888888753  233344456688888 999999998 9999999999999999999999999999875432211     


Q ss_pred             cCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          79 HGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        79 ~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ....++..|++||.+.+..++.++|+||+|++++++++ |..||...
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~  196 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELAL-GRFPYPQI  196 (279)
T ss_pred             cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHh-CCCCchhh
Confidence            11123456999999988788899999999999999998 99999653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.86  E-value=8.3e-22  Score=132.98  Aligned_cols=107  Identities=40%  Similarity=0.732  Sum_probs=84.0

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++........... .....+..|++||.+.+.
T Consensus       121 ~~~~~~~ql-~~aL~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~  197 (288)
T cd05093         121 QMLHIAQQI-AAGMVYLAS-QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG-GHTMLPIRWMPPESIMYR  197 (288)
T ss_pred             HHHHHHHHH-HHHHHHHHh-CCeeecccCcceEEEccCCcEEeccCCccccccCCceeecC-CCCCccccccCHHHhccC
Confidence            345578888 999999998 89999999999999999999999999998754322111111 111123469999998877


Q ss_pred             CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          97 RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        97 ~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .++.++|+||+|++++++++.|..||...+
T Consensus       198 ~~~~~sDiwslG~il~~l~t~g~~p~~~~~  227 (288)
T cd05093         198 KFTTESDVWSLGVVLWEIFTYGKQPWYQLS  227 (288)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            888999999999999999975788887654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.86  E-value=7.4e-22  Score=133.22  Aligned_cols=119  Identities=27%  Similarity=0.415  Sum_probs=93.8

Q ss_pred             CCCCCCCCcccc--------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTP--------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...        +.......++.|+ +.|+.|+|. .+++|||+|++||+++..+.++++|||++.......
T Consensus        79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi-~~~l~~lH~-~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI-CCGLEDLHQ-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHH-HHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            678888876433        2233455678888 999999998 999999999999999999999999999886543221


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..    ....++..|+|||.+.+..++.++|+||+|++++++++ |..||....
T Consensus       157 ~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~  205 (285)
T cd05630         157 TI----KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRK  205 (285)
T ss_pred             cc----cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHh-CCCCCCCCC
Confidence            11    11123457999999988888899999999999999998 999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.86  E-value=9.8e-22  Score=131.32  Aligned_cols=106  Identities=40%  Similarity=0.655  Sum_probs=83.4

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++......... .......+..|++||......
T Consensus       114 ~~~~~~~i-~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~  190 (272)
T cd05075         114 LVKFMTDI-ASGMEYLSS-KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR-QGRIAKMPVKWIAIESLADRV  190 (272)
T ss_pred             HHHHHHHH-HHHHHHHHH-CCeeccccchhheEEcCCCCEEECCCCcccccCccccee-cCCcccCCcccCCHHHccCCC
Confidence            44577788 999999998 899999999999999999999999999987653322111 111112245699999988888


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|++++++++.|..||.+.+
T Consensus       191 ~~~~~Di~slG~il~el~~~g~~p~~~~~  219 (272)
T cd05075         191 YTTKSDVWSFGVTMWEIATRGQTPYPGVE  219 (272)
T ss_pred             cChHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            88999999999999999964678887643

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.86  E-value=8.5e-22  Score=132.86  Aligned_cols=119  Identities=26%  Similarity=0.416  Sum_probs=93.4

Q ss_pred             CCCCCCCCccc--------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVT--------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++..        .+.......++.|+ +.|+.|+|. ++++|||++++|++++..+.++++|||++.......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql-~~~l~~lH~-~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEI-LCGLEDLHR-ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            57777777532        23334566688888 999999998 899999999999999999999999999886543211


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..    ....++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       157 ~~----~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~P~~~~~  205 (285)
T cd05632         157 SI----RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRGRK  205 (285)
T ss_pred             cc----cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Confidence            11    11123467999999887788899999999999999998 999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.86  E-value=6.5e-22  Score=133.01  Aligned_cols=106  Identities=41%  Similarity=0.761  Sum_probs=83.4

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++|||+||+||+++.+..++++|||+++........ ........+..|++||.+....
T Consensus       126 ~~~~~~ql-~~aL~~lH~-~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~  202 (283)
T cd05091         126 FVHIVTQI-AAGMEFLSS-HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMYGK  202 (283)
T ss_pred             HHHHHHHH-HHHHHHHHH-cCccccccchhheEecCCCceEecccccccccccchhe-eeccCccCCccccCHHHHhcCC
Confidence            44577888 999999998 89999999999999999999999999998754322111 1111111235699999987777


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|++++++++.|..||.+.+
T Consensus       203 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~  231 (283)
T cd05091         203 FSIDSDIWSYGVVLWEVFSYGLQPYCGYS  231 (283)
T ss_pred             CCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            88899999999999999975778887654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.86  E-value=8.7e-22  Score=132.16  Aligned_cols=123  Identities=38%  Similarity=0.700  Sum_probs=91.4

Q ss_pred             CCCCCCCCccccCC-------------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC---cEEEEeecC
Q psy7529           1 MKSPNGSGVVTPLG-------------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH---QAKISDFGL   64 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~---~~~l~d~~~   64 (129)
                      |||++++++...+.             ......++.|+ +.|+.|+|. ++++|+|++|+||+++..+   .++++|||+
T Consensus        88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi-~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV-AKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHH-HHHHHHHHH-CCEeecccchheEEEeccCCCcceEeccCcc
Confidence            67888887665332             22344578888 999999999 8999999999999998654   589999999


Q ss_pred             cccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          65 SRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++......... .......+..|++||.+....++.++|+||+|++++++++.|..||.+.+
T Consensus       166 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~  226 (277)
T cd05036         166 ARDIYRASYYR-KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT  226 (277)
T ss_pred             ccccCCcccee-cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            87653221111 01111113469999998877889999999999999999965889998654

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0574|consensus

Probab=99.86  E-value=5.8e-23  Score=137.00  Aligned_cols=121  Identities=27%  Similarity=0.453  Sum_probs=98.4

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      ||||-.|++..-++       +..+.-+...+ ++||.|+|. .+-||||+|..|||+...++.|++|||.+..+++...
T Consensus       107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~T-LKGL~YLH~-~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDT-LKGLQYLHD-LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHH-HhHHHHHHH-HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            89999998655443       33444455566 889999998 7889999999999999999999999999877665443


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ......+   ++-|+|||++..-.|+..+|+||+|++..|+.. |++||.++-+
T Consensus       185 KRNTVIG---TPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAE-G~PPYsDIHP  234 (502)
T KOG0574|consen  185 KRNTVIG---TPFWMAPEVIEEIGYDTKADIWSLGITAIEMAE-GRPPYSDIHP  234 (502)
T ss_pred             hhCcccc---CcccccHHHHHHhccchhhhHhhhcchhhhhhc-CCCCcccccc
Confidence            3333333   345999999988889999999999999999998 9999998654

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.86  E-value=1.6e-21  Score=136.88  Aligned_cols=108  Identities=21%  Similarity=0.341  Sum_probs=86.8

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ......++.|+ +.|+.|+|. ++++||||||+||+++..+.++++|||+++......... ......++..|++||.+.
T Consensus       184 ~~~~~~i~~ql-~~aL~~LH~-~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~  260 (392)
T PHA03207        184 LEQAITIQRRL-LEALAYLHG-RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP-QCYGWSGTLETNSPELLA  260 (392)
T ss_pred             HHHHHHHHHHH-HHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc-cccccccccCccCHhHhc
Confidence            34456688888 999999998 899999999999999999999999999987543221111 111222356799999998


Q ss_pred             CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 ~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...++.++|+||+|+++|++++ |..||.+.+
T Consensus       261 ~~~~~~~~DvwslGvil~el~~-g~~pf~~~~  291 (392)
T PHA03207        261 LDPYCAKTDIWSAGLVLFEMSV-KNVTLFGKQ  291 (392)
T ss_pred             CCCCCchhhHHHHHHHHHHHHH-CCCCCCCCC
Confidence            8888999999999999999998 999997654

>KOG0032|consensus

Probab=99.86  E-value=8.1e-22  Score=137.44  Aligned_cols=120  Identities=28%  Similarity=0.436  Sum_probs=98.2

Q ss_pred             CCCCCCCCccccC-----CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC----CcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPL-----GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR----HQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~----~~~~l~d~~~~~~~~~~   71 (129)
                      ||.|+||+++..+     .+.....++.|+ +.++.|+|. .+++|||+||+|+++...    ..++++|||++..... 
T Consensus       115 mEL~~GGeLfd~i~~~~~sE~da~~~~~~i-l~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-  191 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKKHYSERDAAGIIRQI-LEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-  191 (382)
T ss_pred             EEecCCchHHHHHHHccCCHHHHHHHHHHH-HHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence            7899999966554     444567788999 999999999 999999999999998654    3699999999987655 


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ....   ....+++.|+|||++....|+..+|+||+|+++|.++. |.+||.+.+.
T Consensus       192 ~~~~---~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~-G~~PF~~~~~  243 (382)
T KOG0032|consen  192 GERL---HTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLS-GVPPFWGETE  243 (382)
T ss_pred             CceE---eeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhh-CCCCCcCCCh
Confidence            2222   22234567999999998899999999999999999998 9999987653

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.86  E-value=1.6e-21  Score=130.81  Aligned_cols=107  Identities=41%  Similarity=0.746  Sum_probs=83.9

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++|||++|+||+++.++.++++|||+++........ ........+..|+|||.+.+..
T Consensus       124 ~~~~~~~i-~~~l~~lH~-~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~  200 (280)
T cd05049         124 LLQIAVQI-ASGMVYLAS-QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRK  200 (280)
T ss_pred             HHHHHHHH-HHHHHHHhh-CCeeccccccceEEEcCCCeEEECCcccceecccCcce-ecCCCCcccceecChhhhccCC
Confidence            34477888 999999998 89999999999999999999999999998754221110 0011111235699999998888


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ++.++|+||+|++++++++.|..||.+.+.
T Consensus       201 ~~~~~Di~slG~il~e~~~~g~~p~~~~~~  230 (280)
T cd05049         201 FTTESDVWSFGVVLWEIFTYGKQPWYGLSN  230 (280)
T ss_pred             cchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            899999999999999999768899876543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.86  E-value=9.2e-22  Score=132.34  Aligned_cols=106  Identities=46%  Similarity=0.790  Sum_probs=83.6

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++|+|+||+|++++....++++|||+++.......... ......+..|++||.+.+..
T Consensus       126 ~~~i~~~i-~~al~~lH~-~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~  202 (283)
T cd05090         126 FLHIAIQI-AAGMEYLSS-HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV-QPKSLLPIRWMPPEAIMYGK  202 (283)
T ss_pred             HHHHHHHH-HHHHHHHHh-cCeehhccccceEEEcCCCcEEeccccccccccCCcceec-ccCCCccceecChHHhccCC
Confidence            34578888 999999998 8999999999999999999999999999876533211111 11111234699999988777


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|++++++++.|..||.+.+
T Consensus       203 ~~~~~Dv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05090         203 FSSDSDIWSFGVVLWEIFSFGLQPYYGFS  231 (283)
T ss_pred             CCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            88999999999999999976888987654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.86  E-value=1.2e-21  Score=130.80  Aligned_cols=123  Identities=27%  Similarity=0.370  Sum_probs=92.3

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||+++........
T Consensus        85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi-~~~l~~LH~-~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd06651          85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQI-LEGMSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS  162 (266)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence            5777777754333      223344577888 999999998 89999999999999999999999999998754321111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .........+..|++||.+.+..++.++|+||+|++++++++ |+.||.+.+
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~-g~~pf~~~~  213 (266)
T cd06651         163 GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-EKPPWAEYE  213 (266)
T ss_pred             CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHH-CCCCccccc
Confidence            001111112456999999887778889999999999999998 999998654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.86  E-value=2e-21  Score=130.68  Aligned_cols=117  Identities=24%  Similarity=0.405  Sum_probs=92.8

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|+++...+      ....+..++.|+ ++|+.|+|. .+++|||++++||+++.++.++++|||+++....... 
T Consensus        76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql-~~~l~~lH~-~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-  152 (278)
T cd05606          76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEI-ILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (278)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence            6888888865433      333456688888 999999998 8999999999999999999999999998865432111 


Q ss_pred             eeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                          ....++..|++||.+... .++.++|+||+|++++++++ |..||.+.
T Consensus       153 ----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~-g~~p~~~~  199 (278)
T cd05606         153 ----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQH  199 (278)
T ss_pred             ----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCC
Confidence                111234569999988644 57888999999999999998 99999765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.86  E-value=2e-21  Score=129.64  Aligned_cols=124  Identities=44%  Similarity=0.742  Sum_probs=92.7

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+.       ......++.|+ +.|+.|+|. .+++|+|++++||+++.+..++++|||++........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l-~~al~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGI-AAGMKYLSD-MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence            67888887654432       22344577777 999999998 8999999999999999999999999999875432211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..........+..|++||.+....++.++|+||+|+++|++++.|..||...+
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~  215 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS  215 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence            11111111223469999988877788999999999999998865889987544

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.86  E-value=2.1e-21  Score=129.93  Aligned_cols=116  Identities=18%  Similarity=0.381  Sum_probs=93.8

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC-cEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH-QAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~-~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+++++|...+      .......++.|+ ++|+.|+|. .+++|||++|+||+++.++ .++++|||.++.......
T Consensus        88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  165 (267)
T PHA03390         88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQL-VEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC  165 (267)
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCcc
Confidence            7888888875433      333456688888 999999998 8899999999999999888 899999998875432211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                             ..++..|++||.+.+..++.++|+||+|++++++++ |..||.+..
T Consensus       166 -------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~  210 (267)
T PHA03390        166 -------YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLT-GKHPFKEDE  210 (267)
T ss_pred             -------CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCC
Confidence                   112356999999988788899999999999999998 999998544

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.86  E-value=1.3e-21  Score=131.40  Aligned_cols=124  Identities=39%  Similarity=0.658  Sum_probs=95.3

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+       .......++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||.++.......
T Consensus        87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi-~~~l~~LH~-~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~  164 (279)
T cd05057          87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI-AKGMSYLEE-KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK  164 (279)
T ss_pred             EecCCCCcHHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHh-CCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence            6788888755433       233455577888 999999998 9999999999999999999999999999876543221


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .. .......+..|++||.+....++.++|+||+|+++++++++|..||.+.+.
T Consensus       165 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  217 (279)
T cd05057         165 EY-HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA  217 (279)
T ss_pred             ce-ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence            11 111222235699999887777889999999999999999768999987543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.86  E-value=1.1e-21  Score=133.27  Aligned_cols=123  Identities=38%  Similarity=0.695  Sum_probs=93.0

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+..       .....++.|+ +.|+.|+|. ++++|+|+||+||+++.++.++++|||+++.......
T Consensus        87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi-~~~L~~LH~-~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~  164 (303)
T cd05110          87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI-AKGMMYLEE-RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK  164 (303)
T ss_pred             ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHH-HHHHHHHhh-cCeeccccccceeeecCCCceEEccccccccccCccc
Confidence            567777775544332       2344567788 999999998 8999999999999999999999999999876532211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .. .......+..|++||.+.+..++.++|+||+|+++++++++|..||.+.+
T Consensus       165 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~  216 (303)
T cd05110         165 EY-NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP  216 (303)
T ss_pred             cc-ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            11 11112224569999998877888999999999999999876889987653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.86  E-value=1.5e-21  Score=129.19  Aligned_cols=123  Identities=45%  Similarity=0.747  Sum_probs=94.6

Q ss_pred             CCCCCCCCccccCC---------------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCc
Q psy7529           1 MKSPNGSGVVTPLG---------------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLS   65 (129)
Q Consensus         1 m~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~   65 (129)
                      |||++++++...+.               ......++.|+ +.|+.++|. ++++|+|++|+||+++.++.++++|||.+
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~al~~lH~-~~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI-AKGMEYLAS-KKFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHH-HHHHHHHHc-CCcccCccCcceEEECCCCcEEEcccccc
Confidence            57777777554433               23355688888 999999999 99999999999999999999999999998


Q ss_pred             ccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          66 RAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +....... .........+..|++||.+....++.++|+||+|++++++++.|..||.+.+
T Consensus       153 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  212 (262)
T cd00192         153 RDVYDDDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS  212 (262)
T ss_pred             cccccccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence            76543221 1111122234569999988877888999999999999999984588998764

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.86  E-value=5e-22  Score=135.07  Aligned_cols=104  Identities=44%  Similarity=0.758  Sum_probs=81.9

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ +.|+.|+|. ++++|||+||+|++++.++.++++|||+++......    .......+..|++||.+...
T Consensus       125 ~~~~~~~qi-~~al~~LH~-~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~  198 (303)
T cd05088         125 QLLHFAADV-ARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYS  198 (303)
T ss_pred             HHHHHHHHH-HHHHHHHHh-CCccccccchheEEecCCCcEEeCccccCcccchhh----hcccCCCcccccCHHHHhcc
Confidence            345578888 999999998 999999999999999999999999999886321110    01111123459999988777


Q ss_pred             CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          97 RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        97 ~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .++.++|+||+|++++++++.|..||...+
T Consensus       199 ~~~~~~Di~slG~il~ellt~g~~p~~~~~  228 (303)
T cd05088         199 VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  228 (303)
T ss_pred             CCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence            788899999999999999965888987654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.86  E-value=1.4e-21  Score=132.38  Aligned_cols=103  Identities=45%  Similarity=0.779  Sum_probs=81.8

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++||||||+|++++.+..++++|||++......   .. ......+..|++||......
T Consensus       121 ~~~i~~qi-~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~-~~~~~~~~~y~aPE~~~~~~  194 (297)
T cd05089         121 LLQFASDV-ATGMQYLSE-KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY---VK-KTMGRLPVRWMAIESLNYSV  194 (297)
T ss_pred             HHHHHHHH-HHHHHHHHH-CCcccCcCCcceEEECCCCeEEECCcCCCccccce---ec-cCCCCcCccccCchhhccCC
Confidence            45578888 999999998 89999999999999999999999999987532111   00 11111134599999988778


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|++++++++.|..||.+.+
T Consensus       195 ~~~~~DvwSlG~il~el~t~g~~pf~~~~  223 (297)
T cd05089         195 YTTKSDVWSFGVLLWEIVSLGGTPYCGMT  223 (297)
T ss_pred             CCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            88999999999999999965889997654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.86  E-value=2.2e-21  Score=136.58  Aligned_cols=105  Identities=44%  Similarity=0.746  Sum_probs=82.9

Q ss_pred             hhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCCC
Q psy7529          19 PYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRF   98 (129)
Q Consensus        19 ~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~   98 (129)
                      ..++.|+ +.|+.|+|. ++++|||+||+||+++.+..++++|||+++........ ........+..|++||.+.+..+
T Consensus       240 ~~~~~qi-~~aL~~LH~-~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~  316 (400)
T cd05105         240 LSFTYQV-ARGMEFLAS-KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFDNLY  316 (400)
T ss_pred             HHHHHHH-HHHHHHHHh-CCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcCCCC
Confidence            4577788 999999998 89999999999999999999999999998754322111 11111112356999999887788


Q ss_pred             CChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          99 SSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        99 ~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +.++|+||+|++++++++.|..||....
T Consensus       317 ~~~~DiwSlGvil~ellt~g~~P~~~~~  344 (400)
T cd05105         317 TTLSDVWSYGILLWEIFSLGGTPYPGMI  344 (400)
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence            8999999999999999976888987653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.85  E-value=9.2e-22  Score=131.34  Aligned_cols=107  Identities=38%  Similarity=0.630  Sum_probs=83.7

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++.......... ......+..|++||.+....
T Consensus       115 ~~~~~~~i-~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~  191 (273)
T cd05035         115 LLKFMVDI-ALGMEYLSN-RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ-GRIAKMPVKWIAIESLADRV  191 (273)
T ss_pred             HHHHHHHH-HHHHHHHHh-CCeeccccchheEEECCCCeEEECCccceeeccccccccc-cccccCCccccCHhhcccCC
Confidence            44477888 999999998 8999999999999999999999999999876533221111 11111234699999987777


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ++.++|+||+|++++++++.|..||.+.++
T Consensus       192 ~~~~~Dv~SlG~il~el~~~g~~p~~~~~~  221 (273)
T cd05035         192 YTSKSDVWAFGVTMWEIATRGQTPYPGVEN  221 (273)
T ss_pred             CCcccchHHHHHHHHHHHhCCCCCCCCCCH
Confidence            889999999999999999757788876543

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.85  E-value=1.4e-21  Score=131.93  Aligned_cols=123  Identities=38%  Similarity=0.668  Sum_probs=93.1

Q ss_pred             CCCCCCCCccccCCC----------------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecC
Q psy7529           1 MKSPNGSGVVTPLGS----------------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGL   64 (129)
Q Consensus         1 m~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~   64 (129)
                      |||+.+++|...+..                .....++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lH~-~~i~H~dikp~nili~~~~~~~L~Dfg~  165 (288)
T cd05061          88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI-ADGMAYLNA-KKFVHRDLAARNCMVAHDFTVKIGDFGM  165 (288)
T ss_pred             EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCCcCCCCChheEEEcCCCcEEECcCCc
Confidence            688888886655532                1234477888 999999998 9999999999999999999999999999


Q ss_pred             cccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          65 SRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.......... ......+..|++||.+....++.++|+||+|++++++++.+..||.+.+
T Consensus       166 ~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~  226 (288)
T cd05061         166 TRDIYETDYYRK-GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS  226 (288)
T ss_pred             cccccccccccc-cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            875432211111 1111123469999998877888999999999999999975788887644

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.85  E-value=1.3e-21  Score=130.66  Aligned_cols=124  Identities=42%  Similarity=0.702  Sum_probs=93.9

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++.+.+..       .....++.|+ +.|+.++|. ++++|||++|+|++++.++.++++|||+++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i-~~~l~~lH~-~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGI-ASGMKYLSD-MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence            688888876544332       2345577788 999999998 8999999999999999999999999999876543221


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..........+..|++||.+.+..++.++|+||+|++++++++.|..||.+.+
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~  214 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS  214 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence            11111111113469999999877888999999999999998865899997754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.85  E-value=2.8e-21  Score=128.56  Aligned_cols=122  Identities=39%  Similarity=0.662  Sum_probs=93.3

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+.++++...+.        ......++.|+ +.|+.++|. ++++|+|++|+||+++.++.++++|||+++......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV-ASGMAYLEA-QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            67777777544332        22345577888 999999998 899999999999999999999999999987654221


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .  ....+...+..|++||......++.++|+||+|++++++++.|+.||.+.+
T Consensus       158 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  209 (261)
T cd05068         158 Y--EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT  209 (261)
T ss_pred             c--cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            1  111111223469999998877888999999999999999976888997654

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.85  E-value=1.7e-21  Score=132.67  Aligned_cols=104  Identities=26%  Similarity=0.444  Sum_probs=82.4

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++..........   ....+..|++||.+.+.
T Consensus       105 ~~~~~~~qi-~~aL~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~  179 (309)
T cd07872         105 NVKIFLYQI-LRGLAYCHR-RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS---NEVVTLWYRPPDVLLGS  179 (309)
T ss_pred             HHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc---cccccccccCCHHHhCC
Confidence            455577788 999999998 9999999999999999999999999999865432211111   11224569999987653


Q ss_pred             -CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          97 -RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        97 -~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       .++.++|+||+|++++++++ |..||.+.+
T Consensus       180 ~~~~~~~DiwslG~il~el~t-g~~pf~~~~  209 (309)
T cd07872         180 SEYSTQIDMWGVGCIFFEMAS-GRPLFPGST  209 (309)
T ss_pred             CCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence             57889999999999999998 999997654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.85  E-value=2e-21  Score=129.00  Aligned_cols=122  Identities=36%  Similarity=0.702  Sum_probs=93.1

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+.       ......++.|+ +.|+.|+|. ++++|||++|+||+++.++.++++|||+++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDV-CEAMEYLES-NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHH-HHHHHHHHH-CCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            67888887655432       22345577888 999999999 8999999999999999999999999998875432211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        ........+..|++||.+.+..++.++|+||+|+++|++++.|..||...+
T Consensus       156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  206 (256)
T cd05059         156 --TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS  206 (256)
T ss_pred             --cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence              111111223469999998877888999999999999999975788987654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.85  E-value=1.8e-21  Score=132.26  Aligned_cols=105  Identities=43%  Similarity=0.790  Sum_probs=82.6

Q ss_pred             hhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCCC
Q psy7529          19 PYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRF   98 (129)
Q Consensus        19 ~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~   98 (129)
                      ..++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++........ ........+..|++||.+.+..+
T Consensus       140 ~~~~~qi-~~al~~LH~-~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~  216 (304)
T cd05101         140 VSCTYQV-ARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVY  216 (304)
T ss_pred             HHHHHHH-HHHHHHHHH-CCeeecccccceEEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCC
Confidence            4467788 999999998 89999999999999999999999999998765332111 11111222356999999877778


Q ss_pred             CChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          99 SSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        99 ~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +.++|+||+|++++++++.|..||.+.+
T Consensus       217 ~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         217 THQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             CchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            8999999999999999975678887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.85  E-value=1.8e-21  Score=129.66  Aligned_cols=122  Identities=40%  Similarity=0.745  Sum_probs=92.5

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+.++++...+.        ......++.|+ ++|+.|+|. ++++|+|++|+||+++.++.++++|||+++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql-~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI-SSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            67777777654332        22244577888 999999998 899999999999999999999999999987653321


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..  .......+..|++||.+.+..++.++|+||+|++++++++.|..||.+.+
T Consensus       159 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~  210 (263)
T cd05052         159 YT--AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  210 (263)
T ss_pred             ee--ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            11  11111123469999988877888899999999999999976888987643

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.85  E-value=2.8e-21  Score=129.13  Aligned_cols=124  Identities=32%  Similarity=0.490  Sum_probs=90.5

Q ss_pred             CCCCCCCCccccCCC-----------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCccccc
Q psy7529           1 MKSPNGSGVVTPLGS-----------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVN   69 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~   69 (129)
                      |||+++++|...+..           .....++.|+ +.|+.|+|. ++++|+|+||+||+++.+..++++|||.++...
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi-~~al~~lH~-~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI-ALGLLHLHK-NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHH-HHHHHHHHH-CCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence            788988887654321           1223467788 999999998 899999999999999999999999999886432


Q ss_pred             CCCceeeeccCCCCCceecccccccCC-------CCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          70 SERNYYKATHGGRWPIKWYAPESYNFG-------RFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~pe~~~~~-------~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .... .........+..|++||.+...       .++.++|+||+|+++++++++|..||...+.
T Consensus       152 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~  215 (269)
T cd05087         152 KEDY-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD  215 (269)
T ss_pred             Ccce-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh
Confidence            2211 1111111223569999987432       2467899999999999998558999976543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.85  E-value=1.8e-21  Score=131.35  Aligned_cols=106  Identities=46%  Similarity=0.748  Sum_probs=83.4

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++|||++|+||+++.++.++++|||+++.......... ......+..|++||.+.+..
T Consensus       129 ~~~i~~~i-~~~l~~LH~-~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~  205 (290)
T cd05045         129 LISFAWQI-SRGMQYLAE-MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK-RSKGRIPVKWMAIESLFDHI  205 (290)
T ss_pred             HHHHHHHH-HHHHHHHHH-CCeehhhhhhheEEEcCCCcEEeccccccccccCccchhc-ccCCCCCccccCHHHHccCC
Confidence            34577788 999999998 9999999999999999999999999999875432221111 11112235699999887777


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|+++++++++|..||.+.+
T Consensus       206 ~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         206 YTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             cchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            88999999999999999976888997654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.85  E-value=2.4e-21  Score=129.47  Aligned_cols=120  Identities=28%  Similarity=0.411  Sum_probs=90.1

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+.++++...+..        .....++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||+++......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi-~~~l~~LH~-~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~  165 (272)
T cd06637          88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI-LRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  165 (272)
T ss_pred             EEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHH-HHHHHHHHH-CCCccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence            678888775543332        2234477888 999999998 899999999999999999999999999987542211


Q ss_pred             ceeeeccCCCCCceeccccccc-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYN-----FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   .....++..|++||.+.     ...++.++|+||+|++++++++ |..||.+.+
T Consensus       166 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~-g~~p~~~~~  220 (272)
T cd06637         166 GR---RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPPLCDMH  220 (272)
T ss_pred             cc---CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHh-CCCCccccC
Confidence            11   11111234699999875     2356788999999999999998 999997643

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.85  E-value=4e-21  Score=128.38  Aligned_cols=123  Identities=43%  Similarity=0.728  Sum_probs=94.0

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+.       ...+..++.++ +.|+.|+|. ++++|+|++|+||+++..+.+++.|||+++.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l-~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQL-STALAYLES-KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence            67888888655433       22344577788 999999998 8999999999999999999999999998875533211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      . ... ....+..|++||.+....++.++|+||+|++++++++.|..||.+.+.
T Consensus       163 ~-~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~  214 (270)
T cd05056         163 Y-KAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN  214 (270)
T ss_pred             e-ecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence            1 111 111234699999887777888999999999999988658999977653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.85  E-value=2.6e-21  Score=130.08  Aligned_cols=107  Identities=39%  Similarity=0.736  Sum_probs=83.7

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ +.|+.|+|. ++++|+|++|+||+++..+.++++|||+++......... .......+..|++||.+.+.
T Consensus       123 ~~~~~~~qi-~~al~~LH~-~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~  199 (280)
T cd05092         123 QMLAIASQI-ASGMVYLAS-LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-VGGRTMLPIRWMPPESILYR  199 (280)
T ss_pred             HHHHHHHHH-HHHHHHHHH-CCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceee-cCCCccccccccCHHHhccC
Confidence            345577888 999999998 999999999999999999999999999987543221111 11111123569999998888


Q ss_pred             CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          97 RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        97 ~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .++.++|+||+|++++++++.|..||.+.+
T Consensus       200 ~~~~~~Di~slG~il~el~~~g~~p~~~~~  229 (280)
T cd05092         200 KFTTESDIWSFGVVLWEIFTYGKQPWYQLS  229 (280)
T ss_pred             CcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence            888999999999999999976888987654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.85  E-value=2.9e-21  Score=128.86  Aligned_cols=123  Identities=43%  Similarity=0.725  Sum_probs=94.4

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+.       ......++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||+++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l-~~~l~~Lh~-~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGI-ASGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHh-CCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            67888877554332       22344577888 999999998 9999999999999999999999999999886542111


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ... ......+..|++||.+....++.++|+||+|+++++++++|..||.+.+
T Consensus       162 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~  213 (266)
T cd05033         162 TYT-TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS  213 (266)
T ss_pred             cee-ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence            111 1122234569999998877888999999999999999877889997654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.85  E-value=2.5e-21  Score=128.70  Aligned_cols=124  Identities=36%  Similarity=0.614  Sum_probs=89.4

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+.++++...+..       .....++.|+ +.|+.|+|. .+++|||++++||+++.++.++++|||+++.......
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV-AKGMEYLAS-KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHh-CCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            567777775543321       2234466788 999999998 8999999999999999999999999999875432211


Q ss_pred             eeee-ccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKA-THGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .... ......+..|++||......++.++|+||+|++++++++.+.+||.+.+
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~  207 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD  207 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            1101 1111223469999988777888999999999999999983456676543

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.85  E-value=1.2e-21  Score=131.15  Aligned_cols=103  Identities=45%  Similarity=0.770  Sum_probs=81.6

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++|+|+||+|++++.++.++++|||+++.......    ......+..|++||.+....
T Consensus       114 ~~~~~~~i-~~al~~lH~-~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~----~~~~~~~~~y~apE~~~~~~  187 (270)
T cd05047         114 LLHFAADV-ARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNYSV  187 (270)
T ss_pred             HHHHHHHH-HHHHHHHHH-CCEeecccccceEEEcCCCeEEECCCCCccccchhhh----ccCCCCccccCChHHHccCC
Confidence            45578888 899999998 9999999999999999999999999998753211100    01111234599999887777


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|++++++++.|..||.+.+
T Consensus       188 ~~~~~Di~slG~il~el~~~g~~pf~~~~  216 (270)
T cd05047         188 YTTNSDVWSYGVLLWEIVSLGGTPYCGMT  216 (270)
T ss_pred             CCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence            88999999999999999965889997654

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.85  E-value=1.6e-21  Score=129.41  Aligned_cols=118  Identities=42%  Similarity=0.745  Sum_probs=91.5

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++.+.+..        .....++.|+ +.|+.|+|. ++++|||++|+||+++.++.++++|||+++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV-CEAMEYLEA-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            678888776654322        2234577788 899999998 899999999999999999999999999887543211


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .      ....+..|++||......++.++|+||+|++++++++.|+.||...+
T Consensus       157 ~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~  204 (256)
T cd05082         157 D------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  204 (256)
T ss_pred             C------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence            1      11123469999988777788899999999999999966888987543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.85  E-value=1.4e-21  Score=131.88  Aligned_cols=106  Identities=42%  Similarity=0.788  Sum_probs=83.7

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||+++......... .......+..|++||......
T Consensus       134 ~~~i~~qi-~~al~~LH~-~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~  210 (293)
T cd05053         134 LVSFAYQV-ARGMEFLAS-KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFDRV  210 (293)
T ss_pred             HHHHHHHH-HHHHHHHHH-CCccccccceeeEEEcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhccCC
Confidence            34478888 999999998 999999999999999999999999999987653321111 111112234699999887777


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|+++++++++|..||...+
T Consensus       211 ~~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         211 YTHQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             cCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            88999999999999999976888987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.85  E-value=4.5e-21  Score=132.33  Aligned_cols=102  Identities=24%  Similarity=0.392  Sum_probs=83.6

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......      ...++..|+|||.+.
T Consensus       117 ~~~~~~i~~qi-~~aL~~LH~-~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------~~~~t~~y~aPE~~~  188 (343)
T cd07878         117 DEHVQFLIYQL-LRGLKYIHS-AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT------GYVATRWYRAPEIML  188 (343)
T ss_pred             HHHHHHHHHHH-HHHHHHHHH-CCeecccCChhhEEECCCCCEEEcCCccceecCCCcC------CccccccccCchHhc
Confidence            34456688899 999999998 9999999999999999999999999999875432211      112345699999886


Q ss_pred             C-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          95 F-GRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        95 ~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      + ..++.++|+||+|++++++++ |..||.+.
T Consensus       189 ~~~~~~~~~DiwslG~il~el~~-g~~pf~~~  219 (343)
T cd07878         189 NWMHYNQTVDIWSVGCIMAELLK-GKALFPGN  219 (343)
T ss_pred             CCccCCchhhhHhHHHHHHHHHH-CCCCCCCC
Confidence            6 357889999999999999998 99999754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.85  E-value=2.6e-21  Score=129.06  Aligned_cols=120  Identities=26%  Similarity=0.421  Sum_probs=91.7

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||++.........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRET-LQGLYYLHS-KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK  162 (267)
T ss_pred             EeccCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence            6888888876533      334456688888 999999998 89999999999999999999999999987654322111


Q ss_pred             eeeccCCCCCceeccccccc---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYN---FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~---~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....++..|++||.+.   ...++.++|+||+|++++++++ +..||.+..
T Consensus       163 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~-~~~p~~~~~  213 (267)
T cd06645         163 ---RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAE-LQPPMFDLH  213 (267)
T ss_pred             ---cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhc-CCCCccccc
Confidence               11112345699999864   3457789999999999999998 999986543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG1187|consensus

Probab=99.85  E-value=2.4e-21  Score=134.53  Aligned_cols=106  Identities=30%  Similarity=0.447  Sum_probs=82.5

Q ss_pred             CCchhh-HHhHHHHHHHHHHhccC--CCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccc
Q psy7529          15 SYALPY-IEGQIPAKVCRYLKMHK--SSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE   91 (129)
Q Consensus        15 ~~~~~~-~~~~~~~~~l~~~h~~~--~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe   91 (129)
                      .|..+. |+..+ |+||.|||...  .|||||+|++||++|.+...|++|||+++............ . .++..|++||
T Consensus       172 ~W~~R~kIa~g~-A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~-~-~gt~gY~~PE  248 (361)
T KOG1187|consen  172 DWETRLKIALGA-ARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTT-V-MGTFGYLAPE  248 (361)
T ss_pred             CHHHHHHHHHHH-HHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeee-c-CCCCccCChh
Confidence            565555 55555 99999999855  49999999999999999999999999996543311111111 0 3345699999


Q ss_pred             cccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          92 SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        92 ~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      +...+....++|+||+|+++.|+++ |+.|.+.
T Consensus       249 y~~~g~lt~KsDVySFGVvllElit-gr~~~d~  280 (361)
T KOG1187|consen  249 YASTGKLTEKSDVYSFGVVLLELIT-GRKAVDQ  280 (361)
T ss_pred             hhccCCcCcccccccchHHHHHHHh-CCcccCC
Confidence            9987778899999999999999998 9877664

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.85  E-value=2.2e-21  Score=132.42  Aligned_cols=105  Identities=43%  Similarity=0.793  Sum_probs=82.4

Q ss_pred             hhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCCC
Q psy7529          19 PYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRF   98 (129)
Q Consensus        19 ~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~   98 (129)
                      ..++.|+ +.|+.|+|. ++++|+|+||+||+++.++.++++|||+++........ ........+..|++||.+....+
T Consensus       137 ~~~~~qi-~~aL~~lH~-~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~  213 (314)
T cd05099         137 VSCAYQV-ARGMEYLES-RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFDRVY  213 (314)
T ss_pred             HHHHHHH-HHHHHHHHH-CCeeeccccceeEEEcCCCcEEEccccccccccccccc-cccccCCCCccccCHHHHccCCc
Confidence            3467888 999999998 99999999999999999999999999998754322111 11111112245999999887778


Q ss_pred             CChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          99 SSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        99 ~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +.++|+||+|++++++++.|..||...+
T Consensus       214 ~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         214 THQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             CccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            8999999999999999976788887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.85  E-value=1.6e-21  Score=130.55  Aligned_cols=123  Identities=38%  Similarity=0.652  Sum_probs=92.8

Q ss_pred             CCCCCCCCccccCCC----------------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecC
Q psy7529           1 MKSPNGSGVVTPLGS----------------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGL   64 (129)
Q Consensus         1 m~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~   64 (129)
                      |||++++++...+..                .....++.|+ +.|+.|+|. ++++|||++|+||+++.++.++++|||+
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~di~p~nill~~~~~~kl~dfg~  165 (277)
T cd05032          88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI-ADGMAYLAA-KKFVHRDLAARNCMVAEDLTVKIGDFGM  165 (277)
T ss_pred             EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCccccccChheEEEcCCCCEEECCccc
Confidence            678888776544321                1234477888 999999998 8999999999999999999999999999


Q ss_pred             cccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          65 SRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++......... .......+..|++||.+....++.++|+||+|++++++++.|..||.+.+
T Consensus       166 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  226 (277)
T cd05032         166 TRDIYETDYYR-KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS  226 (277)
T ss_pred             chhhccCcccc-cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence            87543221110 01111123569999998777788899999999999999976888987654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0196|consensus

Probab=99.85  E-value=7.7e-23  Score=149.00  Aligned_cols=110  Identities=46%  Similarity=0.810  Sum_probs=95.7

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ++-+..-| +.|++||.. .+.+||||...|||++.+-.+|++|||++|.+.+.....-.+.++..+.+|.|||.+...+
T Consensus       733 LVgMLrGI-AsGMkYLsd-m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK  810 (996)
T KOG0196|consen  733 LVGMLRGI-ASGMKYLSD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK  810 (996)
T ss_pred             HHHHHHHH-HHHhHHHhh-cCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcc
Confidence            33355566 899999998 9999999999999999999999999999998755444444556677789999999999999


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD  129 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~e  129 (129)
                      +...+|+||+|+++||++++|+-||-+|++.|
T Consensus       811 FTsASDVWSyGIVmWEVmSyGERPYWdmSNQd  842 (996)
T KOG0196|consen  811 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQD  842 (996)
T ss_pred             cCchhhccccceEEEEecccCCCcccccchHH
Confidence            99999999999999999999999999998764

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.85  E-value=4.9e-21  Score=127.10  Aligned_cols=122  Identities=35%  Similarity=0.681  Sum_probs=93.5

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+..       .....++.|+ +.|+.|+|. ++++|+|++++|++++.++.++++|||.++.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDV-CEGMEYLER-NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHH-HHHHHHHHH-CCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            688888886654431       2234577777 899999998 8999999999999999999999999998875432211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        ........+..|++||.+.+..++.++|+||+|++++++++.|+.||...+
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~  206 (256)
T cd05114         156 --TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS  206 (256)
T ss_pred             --eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence              111122233569999998877888999999999999999975788997654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=3.4e-21  Score=131.45  Aligned_cols=123  Identities=26%  Similarity=0.358  Sum_probs=92.7

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...+.        ......++.|+ ++|+.|+|. .+++|+|||++||+++.++.+++.|||++.......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEV-LLALEYLHL-LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHH-HHHHHHHHH-CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            67888888655433        22344577788 999999998 899999999999999999999999999876432111


Q ss_pred             ceee--------------------------eccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYK--------------------------ATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~--------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....                          ......++..|++||...+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~  236 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY-GTTPFKGSN  236 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh-CCCCCCCCc
Confidence            0000                          0000112456999999888778889999999999999998 999997654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.85  E-value=4.5e-21  Score=129.84  Aligned_cols=120  Identities=28%  Similarity=0.433  Sum_probs=92.8

Q ss_pred             CCCCCCCCccccC-----CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPL-----GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++++..-+     .......++.|+ +.|+.|+|. ++++|||++|+||+++.++.++++|||++..........
T Consensus        98 ~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi-~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~  175 (292)
T cd06658          98 MEFLEGGALTDIVTHTRMNEEQIATVCLSV-LRALSYLHN-QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR  175 (292)
T ss_pred             EeCCCCCcHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence            6788888754432     333455678888 999999998 899999999999999999999999999886543221111


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   ...++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       176 ~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~  222 (292)
T cd06658         176 K---SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMID-GEPPYFNEP  222 (292)
T ss_pred             c---eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            1   1112356999999887778899999999999999998 999997644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.85  E-value=4e-21  Score=129.39  Aligned_cols=103  Identities=25%  Similarity=0.386  Sum_probs=84.0

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++........    ....++..|++||.+.+
T Consensus       108 ~~~~~~~~qi-~~al~~lH~-~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~  181 (288)
T cd07863         108 ETIKDLMRQF-LRGLDFLHA-NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL----TPVVVTLWYRAPEVLLQ  181 (288)
T ss_pred             HHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECccCccccccCcccC----CCccccccccCchHhhC
Confidence            3456688888 999999998 89999999999999999999999999998754322111    11122456999999988


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ..++.++|+||+|++++++++ |..||...
T Consensus       182 ~~~~~~~DiwslG~~l~~l~~-g~~~f~~~  210 (288)
T cd07863         182 STYATPVDMWSVGCIFAEMFR-RKPLFCGN  210 (288)
T ss_pred             CCCCCcchhhhHHHHHHHHHh-CCcCcCCC
Confidence            788899999999999999998 99998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.84  E-value=5.7e-21  Score=126.44  Aligned_cols=123  Identities=42%  Similarity=0.686  Sum_probs=91.8

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+.++++...+.       ......++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||+++.......
T Consensus        72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi-~~~L~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  149 (252)
T cd05084          72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENA-AAGMEYLES-KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY  149 (252)
T ss_pred             EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCccccccchheEEEcCCCcEEECccccCcccccccc
Confidence            67888887654432       22334577888 999999998 8999999999999999999999999999865332110


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .. .......+..|++||.+....++.++|+||+|++++++++.|..||...+
T Consensus       150 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~  201 (252)
T cd05084         150 AS-TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS  201 (252)
T ss_pred             cc-cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence            00 00001112459999998877888999999999999999965788887654

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.84  E-value=3.9e-21  Score=128.15  Aligned_cols=122  Identities=38%  Similarity=0.612  Sum_probs=93.3

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++.+.+..        .....++.|+ ++|+.|+|. ++++|+|++|+||+++.++.++++|||.++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l-~~aL~~lH~-~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI-ASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHH-HHHHHHHHH-CCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            678888886555432        2345577888 999999998 999999999999999999999999999987543221


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..  .......+..|++||......++.++|+||+|++++++++.|..||.+.+
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~  208 (262)
T cd05071         157 YT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  208 (262)
T ss_pred             cc--cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            11  11111223469999988777788999999999999999974677887654

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.84  E-value=6e-21  Score=127.63  Aligned_cols=123  Identities=26%  Similarity=0.475  Sum_probs=88.5

Q ss_pred             CCCCCCCCccccCCC----------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPLGS----------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||+++++|...+..          .....++.|+ +.|+.|+|. ++++|||+|++||+++.++.++++|||++.....
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i-~~al~~lH~-~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~  151 (268)
T cd05086          74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI-AAGVTHMHK-HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK  151 (268)
T ss_pred             EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHH-HHHHHHHHH-CCeeccCCccceEEEcCCccEEecccccccccCc
Confidence            789998887654432          1234577788 999999998 8999999999999999999999999998753211


Q ss_pred             CCceeeeccCCCCCceecccccccC-------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNF-------GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ... ........++..|++||....       ..++.++|+||+|++++++++.+..||.+.+
T Consensus       152 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  213 (268)
T cd05086         152 EDY-IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS  213 (268)
T ss_pred             chh-hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence            100 000111123456999997642       2345789999999999999974577887654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.84  E-value=5.6e-21  Score=131.15  Aligned_cols=123  Identities=20%  Similarity=0.318  Sum_probs=89.7

Q ss_pred             CCCCCCCCccccC--------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPL--------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...+        ....+..++.|+ +.|+.|+|. ++++|||+||+||+++.++.+++.||+.........
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi-~~~L~~LH~-~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGV-LKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHH-HHHHHHHHH-CCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            6788887754332        233455688888 999999998 899999999999999999999999987644322111


Q ss_pred             ceee----eccCCCCCceecccccccC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYK----ATHGGRWPIKWYAPESYNF--GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~----~~~~~~~~~~~~~pe~~~~--~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....    .......+..|++||.+..  ..++.++|+||+|++++++++ |..||.+.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  214 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN-GHVPFKDMP  214 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHH-CCCCCCCcc
Confidence            0000    0001112345999998865  357889999999999999998 999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=2.7e-21  Score=128.93  Aligned_cols=123  Identities=24%  Similarity=0.349  Sum_probs=91.9

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.++|. ++++|+|++++||+++.++.+++.|||+++........
T Consensus        85 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i-~~al~~LH~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  162 (264)
T cd06653          85 VEYMPGGSIKDQLKAYGALTENVTRRYTRQI-LQGVSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS  162 (264)
T ss_pred             EEeCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEECcccccccccccccc
Confidence            4667777654332      233455577888 999999998 89999999999999999999999999998754321100


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ........++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~  213 (264)
T cd06653         163 GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT-EKPPWAEYE  213 (264)
T ss_pred             CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHh-CCCCCCccC
Confidence            000011113456999999887778889999999999999998 999998654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.84  E-value=4.5e-21  Score=127.47  Aligned_cols=122  Identities=36%  Similarity=0.682  Sum_probs=93.7

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++.+.+.       ......++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||.++.......
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDV-CEGMAYLES-KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            68888887554432       22345588888 999999998 8999999999999999999999999998875433211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        ........+..|++||......++.++|+||+|++++++++.|..||...+
T Consensus       156 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~  206 (256)
T cd05113         156 --TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN  206 (256)
T ss_pred             --eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence              111122223469999998877788899999999999999975888987654

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.84  E-value=3.7e-21  Score=130.92  Aligned_cols=106  Identities=43%  Similarity=0.786  Sum_probs=82.1

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++|||++|+||+++.++.++++|||.++........ ........+..|++||.+.+..
T Consensus       142 ~~~~~~qi-~~aL~~lH~-~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~  218 (307)
T cd05098         142 LVSCAYQV-ARGMEYLAS-KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRI  218 (307)
T ss_pred             HHHHHHHH-HHHHHHHHH-CCcccccccHHheEEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhccCC
Confidence            34578888 999999998 89999999999999999999999999988654321110 1111111234699999888777


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|++++++++.|..||.+.+
T Consensus       219 ~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         219 YTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             CCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            88999999999999999975778886543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.84  E-value=1.3e-20  Score=124.96  Aligned_cols=120  Identities=23%  Similarity=0.365  Sum_probs=92.7

Q ss_pred             CCCCCCCCccccC--------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPL--------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++..-+        .......++.++ +.|+.++|. ++++|+|++|+||+++..+.++++|||++.......
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l-~~~l~~lH~-~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI-AMALQYLHE-KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            6788888754332        223345678888 999999998 899999999999999999999999999987553221


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...   ....++..|++||...+..++.++|+||+|++++++++ |..||...+
T Consensus       157 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~~~~~~~  206 (257)
T cd08223         157 DMA---STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT-LKHAFNAKD  206 (257)
T ss_pred             Ccc---ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCC
Confidence            111   11122356999999887788889999999999999998 999987543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.84  E-value=6.7e-21  Score=128.68  Aligned_cols=117  Identities=26%  Similarity=0.399  Sum_probs=93.4

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++.+.+      .......++.|+ ++|+.|+|. ++++|+|++|+||+++.++.++++|||+++......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi-l~~l~~lH~-~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~--  155 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQV-VLALEYLHS-LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--  155 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC--
Confidence            6888888765443      333455577888 999999999 999999999999999999999999999987653321  


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                          ....++..|++||.+.....+.++|+||+|++++++++ |..||...+
T Consensus       156 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~  202 (290)
T cd05580         156 ----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLA-GYPPFFDDN  202 (290)
T ss_pred             ----CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCC
Confidence                11123456999998877777888999999999999998 999997654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.84  E-value=4.5e-21  Score=130.00  Aligned_cols=120  Identities=24%  Similarity=0.423  Sum_probs=92.8

Q ss_pred             CCCCCCCCccccC-----CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPL-----GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||+.++++...+     .......++.|+ +.|+.|+|. ++++|+||+|+||+++.++.++++|||+++........ 
T Consensus        96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql-~~aL~~LH~-~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-  172 (296)
T cd06654          96 MEYLAGGSLTDVVTETCMDEGQIAAVCREC-LQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  172 (296)
T ss_pred             ecccCCCCHHHHHHhcCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence            6788888765433     233455677888 999999998 89999999999999999999999999987654321111 


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        .....++..|++||.+....++.++|+||+|++++++++ |+.||.+.+
T Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~-g~~pf~~~~  220 (296)
T cd06654         173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNEN  220 (296)
T ss_pred             --cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Confidence              011123356999999887777889999999999999998 999997644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.84  E-value=8.6e-21  Score=128.19  Aligned_cols=120  Identities=29%  Similarity=0.368  Sum_probs=90.3

Q ss_pred             CCCCCCCCccc-------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVT-------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++.+..       .+.......++.|+ ++++.|+|. .+++|+|++++||+++.++.++++|||++........
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql-~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQM-LEALQYLHS-MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHH-HHHHHHHhc-CCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence            68888887532       23334456688888 999999998 8999999999999999999999999998764322111


Q ss_pred             eeeeccCCCCCceeccccccc-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYN-----FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...   ....+..|++||.+.     ...++.++|+||+|+++|++++ |..||.+.+
T Consensus       166 ~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~  219 (292)
T cd06644         166 RRD---SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ-IEPPHHELN  219 (292)
T ss_pred             ccc---eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhc-CCCCCcccc
Confidence            111   111234699999874     3346778999999999999998 999987643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.84  E-value=9e-21  Score=126.52  Aligned_cols=117  Identities=31%  Similarity=0.378  Sum_probs=86.9

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc-------EEEEeecCcc
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ-------AKISDFGLSR   66 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~-------~~l~d~~~~~   66 (129)
                      |||++++.+...       +.......++.|+ +.|+.|+|. ++++|||+||+||+++..+.       ++++|||++.
T Consensus        83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~  160 (262)
T cd05077          83 EEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQL-ASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI  160 (262)
T ss_pred             EecccCCCHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence            677777763322       2333445688888 999999998 99999999999999976553       7899999876


Q ss_pred             cccCCCceeeeccCCCCCceeccccccc-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          67 AVNSERNYYKATHGGRWPIKWYAPESYN-FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ......       ....+..|++||.+. ...++.++|+||+|+++|+++..|..||.+.+
T Consensus       161 ~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (262)
T cd05077         161 TVLSRQ-------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT  214 (262)
T ss_pred             cccCcc-------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            543211       111234699999876 35678899999999999999743888887654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.84  E-value=5.1e-21  Score=128.67  Aligned_cols=120  Identities=30%  Similarity=0.387  Sum_probs=90.4

Q ss_pred             CCCCCCCCccc-------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVT-------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++.+..       ++.......++.|+ ++|+.|+|. .+++|+|++++||+++.++.++++|||+++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi-~~~L~~LH~-~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQT-LEALNYLHE-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence            57777777533       23334456678888 999999998 8999999999999999999999999999865432211


Q ss_pred             eeeeccCCCCCceeccccccc-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYN-----FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   ....++..|++||.+.     ...++.++|+||+|++++++++ |..||.+.+
T Consensus       159 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~  212 (282)
T cd06643         159 RR---DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ-IEPPHHELN  212 (282)
T ss_pred             cc---ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc-CCCCccccC
Confidence            11   1112345699999873     3346778999999999999998 999998654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.84  E-value=4.8e-21  Score=133.58  Aligned_cols=106  Identities=25%  Similarity=0.350  Sum_probs=83.7

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.........  ......+..|++||.+.+
T Consensus       103 ~~~~~~~~qi-~~aL~~LH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~--~~~~~~~~~y~aPE~~~~  178 (372)
T cd07853         103 DHVKVFLYQI-LRGLKYLHS-AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH--MTQEVVTQYYRAPEILMG  178 (372)
T ss_pred             HHHHHHHHHH-HHHHHHHHh-CCeeCCCCChHHEEECCCCCEEeccccceeecccCcccc--CCCCCcCCCcCCHHHHcC
Confidence            3455678888 999999998 899999999999999999999999999987543221111  111122456999998876


Q ss_pred             C-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 G-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . .++.++|+||+|++++++++ |+.||.+.+
T Consensus       179 ~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  209 (372)
T cd07853         179 SRHYTSAVDIWSVGCIFAELLG-RRILFQAQS  209 (372)
T ss_pred             CCCCCcHHHHHhHHHHHHHHHc-CCCCCCCCC
Confidence            4 46889999999999999998 999997654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=6.8e-21  Score=126.46  Aligned_cols=120  Identities=27%  Similarity=0.419  Sum_probs=91.4

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+.++.+...       +.......++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||.+........
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql-~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRET-LKGLAYLHE-TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHH-HHHHHHHHh-CCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            677777775432       2333345578888 999999998 8999999999999999999999999998865432211


Q ss_pred             eeeeccCCCCCceecccccccCC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFG---RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...   ....+..|++||.+...   .++.++|+||+|++++++++ |..||.+.+
T Consensus       157 ~~~---~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~t-g~~p~~~~~  208 (262)
T cd06613         157 KRK---SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAE-LQPPMFDLH  208 (262)
T ss_pred             ccc---cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHh-CCCCCCCCC
Confidence            111   11123459999988665   67889999999999999998 999998654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0200|consensus

Probab=99.84  E-value=3.3e-21  Score=141.59  Aligned_cols=109  Identities=43%  Similarity=0.726  Sum_probs=88.8

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      -.+.-++.|+ |+|+.|+.. ..++|||+...||++..+..+|++|||+++................-+..|+|||.+..
T Consensus       418 ~dLlsfa~QI-a~GMe~L~~-~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~  495 (609)
T KOG0200|consen  418 KDLLSFAYQI-ANGMEYLAS-VPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD  495 (609)
T ss_pred             HHHHHHHHHH-HHHHHHHhh-CCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc
Confidence            3455588899 999999998 88999999999999999999999999999864433222111111113456999999988


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..|..++|+||+|+++||++++|..||.++.
T Consensus       496 ~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  496 RVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             CcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            8899999999999999999999999999865

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.84  E-value=6.7e-21  Score=127.06  Aligned_cols=120  Identities=25%  Similarity=0.420  Sum_probs=90.9

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||+++........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRET-LQGLAYLHS-KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK  162 (267)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence            6788888765432      333456677888 999999998 89999999999999999999999999998754322111


Q ss_pred             eeeccCCCCCceeccccccc---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYN---FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~---~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....++..|++||.+.   ...++.++|+||+|++++++++ |..||.+.+
T Consensus       163 ---~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~-g~~p~~~~~  213 (267)
T cd06646         163 ---RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE-LQPPMFDLH  213 (267)
T ss_pred             ---cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHh-CCCCccccc
Confidence               11112235699999774   2346778999999999999998 999986554

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.84  E-value=6.7e-21  Score=128.28  Aligned_cols=118  Identities=39%  Similarity=0.607  Sum_probs=89.5

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++|++|.+.+.       ......++.|+ +.|+.|+|. ++++|||++|+||+++.++.++++|||+++.......
T Consensus        87 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i-~~aL~~lH~-~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~  164 (284)
T cd05079          87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI-CKGMDYLGS-RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE  164 (284)
T ss_pred             EEccCCCCHHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeecccchheEEEcCCCCEEECCCccccccccCcc
Confidence            68888888754432       22345577888 999999998 9999999999999999999999999999876543222


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQP  121 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~p  121 (129)
                      ..........+..|++||.+.+..++.++|+||+|++++++++ +..|
T Consensus       165 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt-~~~~  211 (284)
T cd05079         165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT-YCDS  211 (284)
T ss_pred             ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhc-CCCC
Confidence            1111111222346899998877778889999999999999997 6554

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.84  E-value=6.7e-21  Score=125.47  Aligned_cols=115  Identities=21%  Similarity=0.309  Sum_probs=90.6

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|+++...+      .......++.|+ +.|+.|+|. ++++|||+||+||+++.++.+++.|||.+........ 
T Consensus        64 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql-~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~-  140 (237)
T cd05576          64 LQHAEGGKLWSHISKFLNIPEECVKRWAAEM-VVALDALHR-EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD-  140 (237)
T ss_pred             EecCCCCCHHHHHHHhcCCCHHHHHHHHHHH-HHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEecccchhccccccc-
Confidence            6889998875543      223345578888 999999998 8999999999999999999999999997754432211 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                           ....+..|++||......++.++|+||+|++++++++ |..||..
T Consensus       141 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~~~~~  184 (237)
T cd05576         141 -----GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLT-GKTLVEC  184 (237)
T ss_pred             -----cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHH-Ccchhhc
Confidence                 1112345999998877778889999999999999998 9877654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.84  E-value=1.1e-20  Score=128.57  Aligned_cols=123  Identities=24%  Similarity=0.286  Sum_probs=91.9

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc-
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN-   73 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~-   73 (129)
                      |||++|+++...+      .......++.|+ +.|+.|+|. ++++|+|++|+||+++..+.++++|||+++....... 
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAET-VLALEYLHN-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            6888888765443      223345577888 899999998 8999999999999999999999999998763110000 


Q ss_pred             -e----------eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 -Y----------YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 -~----------~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       .          ........++..|++||.+....++.++|+||+|++++++++ |..||.+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~-g~~pf~~~~  220 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV-GCVPFFGDT  220 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence             0          000001112346999999887788899999999999999998 999997654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.84  E-value=8.1e-21  Score=129.14  Aligned_cols=123  Identities=40%  Similarity=0.644  Sum_probs=93.3

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+.++++...+..        .....++.|+ +.|+.|+|. ++++|+|++|+||+++.+..++++|||+++......
T Consensus       118 ~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i-~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  195 (302)
T cd05055         118 TEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV-AKGMAFLAS-KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS  195 (302)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeehhhhccceEEEcCCCeEEECCCcccccccCCC
Confidence            678888886544322        2334477788 999999998 899999999999999999999999999987543322


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ... .......+..|++||.+....++.++|+||+|++++++++.|..||.+.+
T Consensus       196 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~  248 (302)
T cd05055         196 NYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP  248 (302)
T ss_pred             cee-ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence            111 11111123469999998877888999999999999999965889987654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.84  E-value=1.5e-20  Score=129.98  Aligned_cols=105  Identities=43%  Similarity=0.770  Sum_probs=81.8

Q ss_pred             hhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCCC
Q psy7529          19 PYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRF   98 (129)
Q Consensus        19 ~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~   98 (129)
                      ..++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++......... .......+..|++||.+....+
T Consensus       182 ~~~~~qi-~~al~~lH~-~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~  258 (343)
T cd05103         182 ICYSFQV-AKGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKGDARLPLKWMAPETIFDRVY  258 (343)
T ss_pred             HHHHHHH-HHHHHHHHh-CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh-hcCCCCCCcceECcHHhcCCCC
Confidence            3467788 999999998 999999999999999999999999999987543221111 1111122346999998877778


Q ss_pred             CChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          99 SSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        99 ~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +.++|+||+|++++++++.|..||....
T Consensus       259 ~~~~Di~slG~~l~el~~~g~~p~~~~~  286 (343)
T cd05103         259 TIQSDVWSFGVLLWEIFSLGASPYPGVK  286 (343)
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence            8899999999999999965888987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.84  E-value=5.6e-21  Score=131.48  Aligned_cols=104  Identities=43%  Similarity=0.797  Sum_probs=82.4

Q ss_pred             hHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCCCC
Q psy7529          20 YIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS   99 (129)
Q Consensus        20 ~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~   99 (129)
                      .++.|+ +.|+.|+|. ++++|||++|+||+++.++.++++|||+++........ ........+..|++||.+.+..++
T Consensus       138 ~~~~qi-~~al~~LH~-~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~  214 (334)
T cd05100         138 SCAYQV-ARGMEYLAS-QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFDRVYT  214 (334)
T ss_pred             HHHHHH-HHHHHHHHH-CCeeccccccceEEEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhccCCcC
Confidence            367788 999999998 99999999999999999999999999998754322111 111112223469999999888888


Q ss_pred             ChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529         100 SASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus       100 ~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .++|+||+|++++++++.|..||.+.+
T Consensus       215 ~~~Di~slG~il~el~~~g~~p~~~~~  241 (334)
T cd05100         215 HQSDVWSFGVLLWEIFTLGGSPYPGIP  241 (334)
T ss_pred             chhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            999999999999999975788887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.84  E-value=5.2e-21  Score=127.21  Aligned_cols=123  Identities=37%  Similarity=0.608  Sum_probs=93.2

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++.+.+.        ......++.++ +.|+.|+|. ++++|+|++++||+++.++.+++.|||.+.......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l-~~al~~lH~-~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQV-AAGMAYIER-MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            67888887655432        22355678888 999999998 899999999999999999999999999987543221


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ..  .......+..|++||......++.++|+||+|++++++++.|..||.+.+.
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~  209 (260)
T cd05070         157 YT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN  209 (260)
T ss_pred             cc--cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            11  111111234699999887777888999999999999999647788877543

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.84  E-value=6.5e-21  Score=126.75  Aligned_cols=122  Identities=40%  Similarity=0.694  Sum_probs=92.6

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...+..        .....++.|+ +.|+.|+|. ++++|+|++|+||+++..+.+++.|||+++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l-~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI-AEGMAYIER-KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            578888876544321        2234467788 999999998 899999999999999999999999999987653321


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..  .......+..|++||......++.++|+||+|++++++++.|..||.+.+
T Consensus       158 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~  209 (261)
T cd05072         158 YT--AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS  209 (261)
T ss_pred             ee--ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC
Confidence            11  11111223469999998777788899999999999999965888997643

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.84  E-value=4.2e-21  Score=129.00  Aligned_cols=120  Identities=28%  Similarity=0.413  Sum_probs=89.6

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...+..        .....++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||+++......
T Consensus        98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi-~~al~~LH~-~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~  175 (282)
T cd06636          98 MEFCGAGSVTDLVKNTKGNALKEDWIAYICREI-LRGLAHLHA-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  175 (282)
T ss_pred             EEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc
Confidence            678888775544322        1234467788 999999998 899999999999999999999999999876542211


Q ss_pred             ceeeeccCCCCCceeccccccc-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYN-----FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   .....++..|++||.+.     ...++.++|+||+|++++++++ |..||.+..
T Consensus       176 ~~---~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~  230 (282)
T cd06636         176 GR---RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE-GAPPLCDMH  230 (282)
T ss_pred             cC---CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHh-CCCCccccC
Confidence            11   11112345699999875     2356778999999999999998 999997654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.84  E-value=1.6e-20  Score=135.61  Aligned_cols=102  Identities=26%  Similarity=0.427  Sum_probs=81.8

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.||.|+|. ++++||||||+||+++.++.++++|||+++.........  .....++..|++||.+.+..
T Consensus       269 ~~~i~~ql-~~aL~yLH~-~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~  344 (501)
T PHA03210        269 TRAIMKQL-LCAVEYIHD-KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF--DYGWVGTVATNSPEILAGDG  344 (501)
T ss_pred             HHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccc--cccccCCcCCCCchhhcCCC
Confidence            44578888 999999998 899999999999999999999999999987654322111  11122356799999998888


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCC-CCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQ-PYGE  124 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~-pf~~  124 (129)
                      ++.++|+||+|++++++++ +.. ||.+
T Consensus       345 ~~~~~DiwSlGvil~ell~-~~~~p~~~  371 (501)
T PHA03210        345 YCEITDIWSCGLILLDMLS-HDFCPIGD  371 (501)
T ss_pred             CCcHHHHHHHHHHHHHHHH-CCCCCccC
Confidence            9999999999999999998 664 5543

>KOG1006|consensus

Probab=99.84  E-value=3.2e-22  Score=131.07  Aligned_cols=96  Identities=32%  Similarity=0.525  Sum_probs=76.5

Q ss_pred             HHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC--CCCChhhH
Q psy7529          27 AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG--RFSSASDV  104 (129)
Q Consensus        27 ~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~di  104 (129)
                      ..||.||.....|||||+||+|||++..+.+|++|||.+..+...-.  ...  -.++.+|+|||.+-..  .|+.++|+
T Consensus       177 V~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--kT~--daGCrpYmAPERi~p~~~gyDiRSDv  252 (361)
T KOG1006|consen  177 VDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--KTV--DAGCRPYMAPERIDPSDKGYDIRSDV  252 (361)
T ss_pred             hhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--hhh--ccCCccccChhccCCccCCcchhhhh
Confidence            45999999877899999999999999999999999999865432111  111  1123469999987433  58999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCC
Q psy7529         105 WSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus       105 ~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ||+|++++|+.+ |..||..++.
T Consensus       253 WSLGITL~EvAt-G~fPyr~w~s  274 (361)
T KOG1006|consen  253 WSLGITLYEVAT-GNFPYRKWDS  274 (361)
T ss_pred             hhhcceEeeeec-CCCCcchHHH
Confidence            999999999998 9999988753

>KOG0577|consensus

Probab=99.84  E-value=7.4e-22  Score=141.00  Aligned_cols=117  Identities=30%  Similarity=0.453  Sum_probs=89.7

Q ss_pred             CCCCCCC--Cccc----cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGS--GVVT----PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~--~~~~----~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||||-|+  ++..    ||.+-.+--|..+. +.||.|+|+ ...||||+|..|||+...+.+|++|||.+....+..+ 
T Consensus       105 MEYClGSAsDlleVhkKplqEvEIAAi~~ga-L~gLaYLHS-~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns-  181 (948)
T KOG0577|consen  105 MEYCLGSASDLLEVHKKPLQEVEIAAITHGA-LQGLAYLHS-HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS-  181 (948)
T ss_pred             HHHHhccHHHHHHHHhccchHHHHHHHHHHH-HHHHHHHHH-hhHHhhhccccceEecCCCeeeeccccchhhcCchhc-
Confidence            8898554  4443    34344444444444 889999999 7899999999999999999999999998754433221 


Q ss_pred             eeeccCCCCCceecccccccC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNF---GRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~---~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                         ..   +++-|||||++..   +.|+.++|+||+|+++.++.. .++|+..|+.
T Consensus       182 ---Fv---GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAE-RkPPlFnMNA  230 (948)
T KOG0577|consen  182 ---FV---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNA  230 (948)
T ss_pred             ---cc---CCccccchhHheeccccccCCccceeeccchhhhhhh-cCCCccCchH
Confidence               22   3456999998753   468999999999999999998 9999888764

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.84  E-value=8.2e-21  Score=126.18  Aligned_cols=121  Identities=40%  Similarity=0.687  Sum_probs=93.8

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...+..        .....++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i-~~al~~lH~-~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQV-AEGMAYLEE-QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            688888886654432        2345577888 999999998 899999999999999999999999999887543221


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   ......+..|++||......++.++|+||+|++++++++.|..||...+
T Consensus       159 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~  209 (261)
T cd05148         159 YL---SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN  209 (261)
T ss_pred             cc---ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence            11   1122234569999988777788899999999999999975788997654

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.84  E-value=1.6e-20  Score=125.42  Aligned_cols=124  Identities=41%  Similarity=0.718  Sum_probs=92.7

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+.       ......++.|+ +.|+.|+|. ++++|+|++|+||+++.+..+++.|||+++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l-~~al~~lH~-~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGI-AAGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHH-HHHHHHHHH-CCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            67888877654332       22345577788 999999998 8999999999999999999999999998865432111


Q ss_pred             e--eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 Y--YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .  ......+..+..|++||.+.+..++.++|+||+|++++++++.|..||.+.+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~  216 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS  216 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence            1  1111111123469999998877888999999999999998866889987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.84  E-value=1.7e-20  Score=124.19  Aligned_cols=120  Identities=23%  Similarity=0.350  Sum_probs=92.2

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...+..        .....++.++ +.|+.|+|. ++++|+|++++||+++..+.++++|||+++......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l-~~al~~lH~-~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQI-LLGLAHLHS-KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            577888776543322        2233467788 999999998 899999999999999999999999999887554322


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....   ...++..|++||......++.++|+||+|++++++++ |+.||...+
T Consensus       156 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~  205 (256)
T cd08529         156 NFAN---TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCT-GKHPFDANN  205 (256)
T ss_pred             chhh---ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Confidence            1111   1112346999999887778889999999999999998 999997654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=8.2e-21  Score=126.21  Aligned_cols=116  Identities=23%  Similarity=0.304  Sum_probs=92.3

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ ++|+.|+|. .+++|+|++|+||+++.++.++++|||+++......  
T Consensus        76 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi-~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  151 (260)
T cd05611          76 MEYLNGGDCASLIKTLGGLPEDWAKQYIAEV-VLGVEDLHQ-RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK--  151 (260)
T ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHeEECCCCcEEEeecccceeccccc--
Confidence            6788888865443      333456688888 999999998 899999999999999999999999999876532211  


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                           ....+..|++||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus       152 -----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~  197 (260)
T cd05611         152 -----KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF-GYPPFHAET  197 (260)
T ss_pred             -----cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHH-CCCCCCCCC
Confidence                 0112345999999877777889999999999999998 999997644

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.84  E-value=1.3e-20  Score=127.86  Aligned_cols=120  Identities=23%  Similarity=0.425  Sum_probs=92.4

Q ss_pred             CCCCCCCCcccc-----CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTP-----LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++++...     +.......++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||++..........
T Consensus        95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l-~~al~~LH~-~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  172 (296)
T cd06655          95 MEYLAGGSLTDVVTETCMDEAQIAAVCREC-LQALEFLHA-NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR  172 (296)
T ss_pred             EEecCCCcHHHHHHhcCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence            467777775432     3333455677888 899999998 899999999999999999999999999876543221111


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+..|++||.+....++.++|+||+|++++++++ |..||...+
T Consensus       173 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~llt-g~~pf~~~~  219 (296)
T cd06655         173 ---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNEN  219 (296)
T ss_pred             ---CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence               11123356999999887778889999999999999998 999997643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0199|consensus

Probab=99.83  E-value=2.8e-21  Score=139.96  Aligned_cols=125  Identities=41%  Similarity=0.707  Sum_probs=100.4

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      ||-+.+|+|..-|..        ..+-.++.|+ |.|+.||.. +++|||||...|+++.....+||+|||+.+.+....
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~Qi-A~aM~YLes-krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQI-AKAMQYLES-KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHH-HHHHHHHhh-hhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            455677775554443        1233478888 999999998 999999999999999999999999999999876544


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ..+.-......+..|.+||.+....++.++|+|++|+++|||+++|+.||-+..+
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g  321 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG  321 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence            4443223334456799999999999999999999999999999999999987653

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.83  E-value=1.1e-20  Score=127.15  Aligned_cols=120  Identities=28%  Similarity=0.464  Sum_probs=90.7

Q ss_pred             CCCCCCCCccccC----------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPL----------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||+++++|...+          .......++.|+ ++|+.|+|. ++++|||++++||+++.++.++++|||+++....
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  176 (286)
T cd06638          99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA-LMGLQHLHV-NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  176 (286)
T ss_pred             EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHH-HHHHHHHHh-CCccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence            6888888865432          112244477888 999999998 8999999999999999999999999999875432


Q ss_pred             CCceeeeccCCCCCceecccccccC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNF-----GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....   .....++..|++||.+..     ..++.++|+||+|++++++++ |+.||.+.+
T Consensus       177 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~-g~~p~~~~~  233 (286)
T cd06638         177 TRLR---RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD-GDPPLADLH  233 (286)
T ss_pred             CCCc---cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhc-CCCCCCCCc
Confidence            2111   111123456999998742     346789999999999999998 999987654

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.83  E-value=1.9e-20  Score=125.94  Aligned_cols=120  Identities=41%  Similarity=0.654  Sum_probs=89.8

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+.       ......++.|+ +.|+.|+|. ++++|+|+||+||+++.++.++++|||+++.......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l-~~aL~~LH~-~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  163 (284)
T cd05081          86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQI-CKGMEYLGS-KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE  163 (284)
T ss_pred             EEecCCCCHHHHHHhcCcCCCHHHHHHHHHHH-HHHHHHHHH-CCceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence            57788887665442       22334577888 999999998 8999999999999999999999999999876543222


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      ..........+..|++||...+..++.++|+||+|++++++++ +..|+.
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-~~~~~~  212 (284)
T cd05081         164 YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YSDKSC  212 (284)
T ss_pred             ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhh-cCCcCC
Confidence            1111111122345899999887788899999999999999998 655543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.83  E-value=1.1e-20  Score=125.30  Aligned_cols=118  Identities=42%  Similarity=0.724  Sum_probs=91.5

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+.++++.+.+..        .....++.|+ +.|+.|+|. ++++|||++|+||+++.++.++++|||.++......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi-~~al~~lH~-~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDV-AEGMEYLES-KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence            688888886544322        1234467788 999999998 999999999999999999999999999886532211


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .      ....+..|++||.+....++.+.|+||+|++++++++.|..||.+.+
T Consensus       155 ~------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  202 (254)
T cd05083         155 D------NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS  202 (254)
T ss_pred             C------CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence            1      11123469999988877888899999999999999965888987654

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.83  E-value=1.1e-20  Score=130.84  Aligned_cols=106  Identities=25%  Similarity=0.297  Sum_probs=85.7

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......    .....++..|++||.+
T Consensus       116 ~~~~~~~~~~ql-~~aL~~LH~-~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~  189 (353)
T cd07850         116 DHERMSYLLYQM-LCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVVTRYYRAPEVI  189 (353)
T ss_pred             CHHHHHHHHHHH-HHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC----CCCCcccccccCHHHH
Confidence            334455678888 999999998 8999999999999999999999999999876432211    1111123469999999


Q ss_pred             cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          94 NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        94 ~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .+..++.++|+||+|++++++++ |+.||...+
T Consensus       190 ~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~  221 (353)
T cd07850         190 LGMGYKENVDIWSVGCIMGEMIR-GTVLFPGTD  221 (353)
T ss_pred             hCCCCCCchhhHhHHHHHHHHHH-CCCCCCCCC
Confidence            88888999999999999999998 999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.83  E-value=1.7e-20  Score=127.31  Aligned_cols=120  Identities=24%  Similarity=0.416  Sum_probs=92.9

Q ss_pred             CCCCCCCCccccC-----CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPL-----GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++++...+     .......++.|+ +.|+.|+|. .+++|+||+++||+++.++.++++|||++..........
T Consensus        95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l-~~~L~~LH~-~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  172 (297)
T cd06656          95 MEYLAGGSLTDVVTETCMDEGQIAAVCREC-LQALDFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (297)
T ss_pred             ecccCCCCHHHHHHhCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence            6788888765433     223455677788 899999998 899999999999999999999999999886543221110


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ....++..|++||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus       173 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~t-g~~pf~~~~  219 (297)
T cd06656         173 ---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNEN  219 (297)
T ss_pred             ---CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence               11122346999999887778899999999999999998 999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.83  E-value=1.8e-20  Score=132.10  Aligned_cols=104  Identities=42%  Similarity=0.764  Sum_probs=81.5

Q ss_pred             hHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCCCC
Q psy7529          20 YIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS   99 (129)
Q Consensus        20 ~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~   99 (129)
                      .++.|+ +.|+.|+|. ++++|||+|++||+++....++++|||+++......... .......+..|++||.+....++
T Consensus       243 ~~~~qi-~~aL~~LH~-~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~  319 (401)
T cd05107         243 GFSYQV-ANGMEFLAS-KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYI-SKGSTFLPLKWMAPESIFNNLYT  319 (401)
T ss_pred             HHHHHH-HHHHHHHhc-CCcCcccCCcceEEEeCCCEEEEEecCcceecccccccc-cCCCcCCCCceeChHHhcCCCCC
Confidence            366688 999999998 899999999999999999999999999987543211110 01111223569999998877788


Q ss_pred             ChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529         100 SASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus       100 ~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .++|+||+|++++++++.|..||...+
T Consensus       320 ~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         320 TLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             cHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999999975788987654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.83  E-value=1.5e-20  Score=134.30  Aligned_cols=104  Identities=18%  Similarity=0.282  Sum_probs=82.2

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      ..+..++.|+ +.||.|+|. ++++|||||++||+++..+.++++|||+++......... ......++..|++||++.+
T Consensus       260 ~~~~~i~~qi-~~aL~yLH~-~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~~GT~~Y~APE~~~~  336 (461)
T PHA03211        260 AQVTAVARQL-LSAIDYIHG-EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP-FHYGIAGTVDTNAPEVLAG  336 (461)
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc-cccccCCCcCCcCHHHHcC
Confidence            3456688888 999999998 899999999999999999999999999987543211110 0111224567999999988


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      ..++.++|+||+|+++|+++. +..|+.
T Consensus       337 ~~~~~~sDvwSlGviL~El~~-g~~~lf  363 (461)
T PHA03211        337 DPYTPSVDIWSAGLVIFEAAV-HTASLF  363 (461)
T ss_pred             CCCCchHHHHHHHHHHHHHHH-cCCCcc
Confidence            888999999999999999997 765543

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.83  E-value=9.4e-21  Score=127.89  Aligned_cols=120  Identities=30%  Similarity=0.419  Sum_probs=89.8

Q ss_pred             CCCCCCCCcccc----------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTP----------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||++++++...          +.......++.|+ +.|+.|+|. ++++|+|++++|++++..+.++++|||+++....
T Consensus       103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi-~~al~~lH~-~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~  180 (291)
T cd06639         103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGA-LLGLQHLHN-NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  180 (291)
T ss_pred             EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence            577777776532          2223345577888 999999998 8999999999999999999999999998875432


Q ss_pred             CCceeeeccCCCCCceecccccccCC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFG-----RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .....   ....++..|++||.+...     .++.++|+||+|++++++++ |..||...+
T Consensus       181 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~-g~~p~~~~~  237 (291)
T cd06639         181 TRLRR---NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD-GDPPLFDMH  237 (291)
T ss_pred             ccccc---cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhh-CCCCCCCCc
Confidence            11110   111223469999987533     25688999999999999998 999998764

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.83  E-value=1e-20  Score=125.85  Aligned_cols=122  Identities=39%  Similarity=0.620  Sum_probs=92.6

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+.++++.+.+..        .....++.|+ +.|+.|+|. .+++|+|++++|++++.++.++++|||.++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l-~~al~~lH~-~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQI-ADGMAYIER-MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            678888876554422        2234577788 999999998 899999999999999999999999999987543221


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..  .......+..|++||...+..++.++|+||+|++++++++.|..||.+.+
T Consensus       157 ~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  208 (260)
T cd05069         157 YT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV  208 (260)
T ss_pred             cc--ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            11  11111223469999988777788999999999999999964788987654

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.83  E-value=5.7e-21  Score=127.43  Aligned_cols=123  Identities=41%  Similarity=0.727  Sum_probs=91.2

Q ss_pred             CCCCCCCCccccCC-------------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC-----cEEEEee
Q psy7529           1 MKSPNGSGVVTPLG-------------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH-----QAKISDF   62 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~-----~~~l~d~   62 (129)
                      |||.+++++...+.             ......++.|+ +.|+.|+|. ++++|+|++|+||+++...     .++++||
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV-AKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHH-HHHHHHHHh-CCcccCCCChheEEEecCCCCCCcceEECCc
Confidence            57777777654432             12234477788 999999998 8999999999999998877     7899999


Q ss_pred             cCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          63 GLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        63 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      |+++........ ........+..|++||.+....++.++|+||+|++++++++.|..||...+
T Consensus       156 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~  218 (269)
T cd05044         156 GLARDIYKSDYY-RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN  218 (269)
T ss_pred             cccccccccccc-ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC
Confidence            998754322110 001111123569999998877888999999999999999976888987643

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.83  E-value=1.4e-20  Score=124.84  Aligned_cols=117  Identities=30%  Similarity=0.374  Sum_probs=89.0

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC-------cEEEEeecCcc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH-------QAKISDFGLSR   66 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~-------~~~l~d~~~~~   66 (129)
                      |||+.++++...+..       .....++.|+ +.|+.|+|. ++++|||+||+||+++..+       .++++|||+++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i-~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL-ASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHH-HHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            678888886544332       2344466788 999999998 9999999999999998877       78999999887


Q ss_pred             cccCCCceeeeccCCCCCceecccccccCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          67 AVNSERNYYKATHGGRWPIKWYAPESYNFG--RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ......       .......|++||.+...  .++.++|+||+|++++++++.+..||.+.+
T Consensus       157 ~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~  211 (259)
T cd05037         157 TVLSRE-------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS  211 (259)
T ss_pred             cccccc-------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence            543211       11122459999988766  678899999999999999973467887664

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.83  E-value=7.4e-21  Score=129.07  Aligned_cols=120  Identities=24%  Similarity=0.421  Sum_probs=91.8

Q ss_pred             CCCCCCCCccccCC-----CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLG-----SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++.+...+.     ......++.|+ +.|+.++|. ++++|+|++++||+++.++.++++|||+++.........
T Consensus        97 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi-~~~L~~LH~-~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~  174 (297)
T cd06659          97 MEFLQGGALTDIVSQTRLNEEQIATVCESV-LQALCYLHS-QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR  174 (297)
T ss_pred             EecCCCCCHHHHHhhcCCCHHHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence            57777777544332     23345577888 999999998 899999999999999999999999999886543221111


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+..|++||.+....++.++|+||+|++++++++ |+.||...+
T Consensus       175 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~  221 (297)
T cd06659         175 ---KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD-GEPPYFSDS  221 (297)
T ss_pred             ---cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence               11112356999999887778899999999999999998 999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.83  E-value=1.1e-20  Score=128.81  Aligned_cols=118  Identities=27%  Similarity=0.405  Sum_probs=92.5

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+++++|...+..      .....++.|+ ++|+.|+|...+++|+|++++||+++.++.++++|||++........ 
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i-~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAV-LRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-  155 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccccc-
Confidence            688888887655432      2345688888 99999999745899999999999999999999999998765422111 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                          ....++..|++||.+.+..++.++|+||+|++++++++ |..||...
T Consensus       156 ----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~  201 (308)
T cd06615         156 ----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI-GRYPIPPP  201 (308)
T ss_pred             ----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCc
Confidence                11123456999998877778889999999999999998 99998643

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.83  E-value=1.7e-20  Score=125.89  Aligned_cols=120  Identities=28%  Similarity=0.482  Sum_probs=93.2

Q ss_pred             CCCCCCCCccccCCC-----CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLGS-----YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++++...+..     .....++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||++..........
T Consensus        81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l-~~~l~~lh~-~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06640          81 MEYLGGGSALDLLRAGPFDEFQIATMLKEI-LKGLDYLHS-EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EecCCCCcHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence            678888886554432     2344577888 899999998 999999999999999999999999999986543221111


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       159 ---~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~  205 (277)
T cd06640         159 ---NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAK-GEPPNSDMH  205 (277)
T ss_pred             ---ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHH-CCCCCCCcC
Confidence               01112345899999877778899999999999999998 999998654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.83  E-value=1.1e-20  Score=142.96  Aligned_cols=120  Identities=27%  Similarity=0.466  Sum_probs=90.2

Q ss_pred             CCCCCCCCccccC----------CCCchhhHHhHHHHHHHHHHhcc------CCCccCCCCCCCEEecCC----------
Q psy7529           1 MKSPNGSGVVTPL----------GSYALPYIEGQIPAKVCRYLKMH------KSSFHRDLAARNILLASR----------   54 (129)
Q Consensus         1 m~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~h~~------~~~ihr~lk~~nil~~~~----------   54 (129)
                      |||+++++|...+          ....+..++.|+ +.||.|+|..      ++|+||||||+||+++..          
T Consensus        93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QI-L~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL-LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHH-HHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            7899998875433          334456688899 9999999972      349999999999999542          


Q ss_pred             -------CcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          55 -------HQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG--RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        55 -------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                             ..++++|||+++.......    .....+++.|+|||.+.+.  .++.++|+||+||++|++++ |..||...
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT-Gk~PF~~~  246 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS-GKTPFHKA  246 (1021)
T ss_pred             ccccCCCCceEEccCCcccccccccc----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH-CCCCCCcC
Confidence                   3489999999875432211    1112235679999988543  47889999999999999998 99999754


Q ss_pred             C
Q psy7529         126 K  126 (129)
Q Consensus       126 ~  126 (129)
                      +
T Consensus       247 ~  247 (1021)
T PTZ00266        247 N  247 (1021)
T ss_pred             C
Confidence            3

>KOG0586|consensus

Probab=99.83  E-value=1.3e-21  Score=139.12  Aligned_cols=120  Identities=28%  Similarity=0.388  Sum_probs=100.3

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+.++.++..+..      ...+.+|.|+ ..|+.|+|. +.++|||||.+|++++.+.++||+|||++..+..... 
T Consensus       134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~-vsaveYcH~-k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~-  210 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRMKEKEARAKFRQI-VSAVEYCHS-KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM-  210 (596)
T ss_pred             EEeccCchhHHHHHhcccchhhhhhhhhHHH-HHHHHHHhh-cceeccccchhhcccccccceeeeccccceeeccccc-
Confidence            799999998877764      3466689998 999999999 9999999999999999999999999999987643211 


Q ss_pred             eeeccCCCCCceecccccccCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRF-SSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                         ....+++++|.|||++.+..| ++.+|+|++|+++|.+.. |..||++-+-
T Consensus       211 ---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~-GsLPFDG~~l  260 (596)
T KOG0586|consen  211 ---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVE-GSLPFDGQNL  260 (596)
T ss_pred             ---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeee-cccccCCccc
Confidence               122334567999999998877 588999999999999998 9999997554

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.83  E-value=2.3e-20  Score=129.66  Aligned_cols=102  Identities=28%  Similarity=0.431  Sum_probs=81.4

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ +.|+.|+|. ++++||||||+||+++..+.++++|||+++.......    .....++..|++||.+.+.
T Consensus       158 ~~~~i~~qi-~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~  231 (357)
T PHA03209        158 QALIIEKQI-LEGLRYLHA-QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA----FLGLAGTVETNAPEVLARD  231 (357)
T ss_pred             HHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc----cccccccccccCCeecCCC
Confidence            455678888 999999999 8999999999999999999999999999864321111    1112234579999999888


Q ss_pred             CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          97 RFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        97 ~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .++.++|+||+|+++|++++++..+|.+
T Consensus       232 ~~~~~~DiwSlGvvl~ell~~~~~~f~~  259 (357)
T PHA03209        232 KYNSKADIWSAGIVLFEMLAYPSTIFED  259 (357)
T ss_pred             CCCchhhHHHHHHHHHHHHHcCCccccC
Confidence            8899999999999999999855555554

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.83  E-value=1.7e-20  Score=126.26  Aligned_cols=118  Identities=27%  Similarity=0.430  Sum_probs=89.9

Q ss_pred             CCCCCCCCcccc---------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTP---------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~   71 (129)
                      |||++++++...         +.......++.|+ +.|+.|+|...+++|+||+|+||+++.++.++++|||.++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i-~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV-VKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHH-HHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            688888885432         3333456688888 999999996468999999999999999999999999988654322


Q ss_pred             CceeeeccCCCCCceecccccccCC------CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFG------RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~------~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ..     .....+..|++||.+.+.      .++.++|+||+|++++++++ |..||...
T Consensus       157 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~  210 (286)
T cd06622         157 LA-----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMAL-GRYPYPPE  210 (286)
T ss_pred             cc-----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHh-CCCCCCCc
Confidence            11     111123469999987543      24678999999999999998 99999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.83  E-value=1.4e-20  Score=124.81  Aligned_cols=118  Identities=40%  Similarity=0.691  Sum_probs=91.8

Q ss_pred             CCCCCCCCccccC--------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPL--------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...+        .......++.|+ +.|+.|+|. ++++|+|++|+||+++.++.+++.|||.++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi-~~~l~~lh~-~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV-CEGMEYLEE-KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            5777777755433        223345577888 999999998 999999999999999999999999999987653211


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .      ....+..|++||.+....++.++|+||+|+++++++++|..||...+
T Consensus       157 ~------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  204 (256)
T cd05039         157 D------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  204 (256)
T ss_pred             c------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            1      11123459999988777788899999999999999976888987654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.83  E-value=1.2e-20  Score=127.79  Aligned_cols=123  Identities=37%  Similarity=0.632  Sum_probs=90.6

Q ss_pred             CCCCCCCCccccCCC-----------------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeec
Q psy7529           1 MKSPNGSGVVTPLGS-----------------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFG   63 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~   63 (129)
                      |||+.++++...+..                 .....++.|+ +.|+.|+|. ++++|+|+||+||+++.++.++++|||
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i-~~al~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg  175 (296)
T cd05095          98 TEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQI-ASGMKYLSS-LNFVHRDLATRNCLVGKNYTIKIADFG  175 (296)
T ss_pred             EEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHH-HHHHHHHHH-CCeecccCChheEEEcCCCCEEeccCc
Confidence            577777775443322                 1245578888 999999998 899999999999999999999999999


Q ss_pred             CcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCC
Q psy7529          64 LSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYS-FGQQPYGEMK  126 (129)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~-~~~~pf~~~~  126 (129)
                      +++......... .......+..|++||......++.++|+||+|+++|++++ .+..||...+
T Consensus       176 ~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         176 MSRNLYSGDYYR-IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             ccccccCCccee-ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            987543221111 0111111346899998777778899999999999999986 2567887554

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.83  E-value=2.8e-20  Score=123.17  Aligned_cols=120  Identities=31%  Similarity=0.437  Sum_probs=93.0

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+       .......++.|+ +.|+.|+|. .+++|+|++++||+++.++.+++.|||++........
T Consensus        77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l-~~~l~~lh~-~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQT-LKGLEYLHS-NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             EecCCCCcHHHHHHhCccCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            5778877755433       233455688888 899999998 8999999999999999999999999999875533221


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   .....+..|++||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus       155 ~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~-g~~p~~~~~  203 (256)
T cd06612         155 KR---NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAE-GKPPYSDIH  203 (256)
T ss_pred             cc---ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCcc
Confidence            10   01112346999999887788889999999999999998 999997654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.83  E-value=2.1e-20  Score=127.42  Aligned_cols=123  Identities=21%  Similarity=0.337  Sum_probs=91.1

Q ss_pred             CCCCCCCCccccC--------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPL--------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...+        .......++.|+ +.|+.|+|. ++++|||++++||+++.++.+++.||+.+.......
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l-~~~L~~LH~-~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~  155 (314)
T cd08216          78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDV-LNALDYIHS-KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG  155 (314)
T ss_pred             EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence            6788887754433        233455678888 999999998 899999999999999999999999999876442211


Q ss_pred             ce----eeeccCCCCCceecccccccCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NY----YKATHGGRWPIKWYAPESYNFG--RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~----~~~~~~~~~~~~~~~pe~~~~~--~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..    .........+..|++||.+...  .++.++|+||+|++++++++ |..||.+.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~-g~~pf~~~~  214 (314)
T cd08216         156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN-GHVPFKDMP  214 (314)
T ss_pred             ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            10    0001111123469999987653  47788999999999999998 999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.83  E-value=2.1e-20  Score=124.64  Aligned_cols=123  Identities=28%  Similarity=0.471  Sum_probs=93.0

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+.      ......++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||.++........
T Consensus        85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l-~~~l~~lH~-~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06628          85 LEYVPGGSVAALLNNYGAFEETLVRNFVRQI-LKGLNYLHN-RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS  162 (267)
T ss_pred             EEecCCCCHHHHHHhccCccHHHHHHHHHHH-HHHHHHHHh-cCcccccCCHHHEEEcCCCCEEecccCCCccccccccc
Confidence            57787877644432      23344578888 999999998 89999999999999999999999999988765321100


Q ss_pred             ---eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 ---YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ---~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ........++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       163 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~  216 (267)
T cd06628         163 TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT-GKHPFPDCT  216 (267)
T ss_pred             CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhh-CCCCCCCcc
Confidence               000001112356999999887778889999999999999998 999998654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.83  E-value=2e-20  Score=125.53  Aligned_cols=120  Identities=27%  Similarity=0.441  Sum_probs=92.4

Q ss_pred             CCCCCCCCccccCC-----CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLG-----SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++++...+.     ......++.|+ +.|+.|+|. ++++|+|++++||+++.++.+++.|||++..........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          81 MEYLGGGSALDLLKPGPLEETYIATILREI-LKGLDYLHS-ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EEccCCCcHHHHhhcCCCCHHHHHHHHHHH-HHHHHHHhc-CCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence            67888887654433     23344577788 999999998 899999999999999999999999999886543221110


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+..|++||.+.+..++.++|+||+|++++++++ |..||.+..
T Consensus       159 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~  205 (277)
T cd06642         159 ---NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAK-GEPPNSDLH  205 (277)
T ss_pred             ---hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHh-CCCCCcccc
Confidence               01112345899999887778889999999999999998 999987654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.83  E-value=1e-20  Score=125.37  Aligned_cols=120  Identities=23%  Similarity=0.373  Sum_probs=93.0

Q ss_pred             CCCCCCCCccccC--------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPL--------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...+        .......++.|+ +.|+.++|. ++++|+|++|+||+++.++.++++|||.++......
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i-~~al~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM-CLGVQHIHE-KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHH-HHHHHHHhh-CCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            6788888765433        222344577888 999999998 899999999999999999999999999987543221


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....   ...++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       155 ~~~~---~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~p~~~~~  204 (255)
T cd08219         155 AYAC---TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT-LKHPFQANS  204 (255)
T ss_pred             cccc---cccCCccccCHHHHccCCcCchhhhhhhchhheehhh-ccCCCCCCC
Confidence            1111   1122346999999887778889999999999999998 999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.83  E-value=3.3e-20  Score=122.57  Aligned_cols=122  Identities=43%  Similarity=0.664  Sum_probs=91.8

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+..       .....+..++ +.++.|+|. ++++|+|++|+||+++.++.++++|||++........
T Consensus        71 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  148 (250)
T cd05085          71 MELVPGGDFLSFLRKKKDELKTKQLVKFALDA-AAGMAYLES-KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY  148 (250)
T ss_pred             EECCCCCcHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeecccChheEEEcCCCeEEECCCccceecccccc
Confidence            688888886654322       2234467777 899999998 8999999999999999999999999998864322111


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..  ......+..|++||.+....++.++|+||+|++++++++.|..||.+..
T Consensus       149 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~  199 (250)
T cd05085         149 SS--SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT  199 (250)
T ss_pred             cc--CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence            11  1111123459999998877788899999999999999976888997653

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.83  E-value=9.1e-21  Score=127.80  Aligned_cols=105  Identities=44%  Similarity=0.813  Sum_probs=82.1

Q ss_pred             hhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCCC
Q psy7529          19 PYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRF   98 (129)
Q Consensus        19 ~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~   98 (129)
                      ..++.|+ +.|+.|+|. ++++|||++|+||+++.++.++++|||+++....... .........+..|++||.+.+..+
T Consensus       133 ~~~~~~i-~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~  209 (288)
T cd05050         133 LCIAKQV-AAGMAYLSE-RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIFYNRY  209 (288)
T ss_pred             HHHHHHH-HHHHHHHHh-CCeecccccHhheEecCCCceEECccccceecccCcc-ccccCCCccChhhcCHHHHhcCCC
Confidence            4577888 999999998 8999999999999999999999999998875432211 011111112346999998887788


Q ss_pred             CChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          99 SSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        99 ~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +.++|+||+|+++++++++|..||.+.+
T Consensus       210 ~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         210 TTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             CchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            8999999999999999976778887654

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.83  E-value=1.9e-20  Score=125.77  Aligned_cols=120  Identities=21%  Similarity=0.311  Sum_probs=90.6

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++.+...      +.......++.|+ +.++.|+|. .+++|+|++++||+++.++.++++|||++.........
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql-~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQT-LQAVNFCHK-HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             EeccCccHHHHHHhCCCCCCHHHHHHHHHHH-HHHHHHHHH-CCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence            577777654332      2223355688888 999999999 99999999999999999999999999998765432211


Q ss_pred             eeeccCCCCCceecccccccC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNF-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   ....+..|++||.+.+ ..++.++|+||+|++++++++ |..||.+.+
T Consensus       157 ~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~-g~~p~~~~~  205 (286)
T cd07847         157 YT---DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT-GQPLWPGKS  205 (286)
T ss_pred             cc---CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHh-CCCCCCCCC
Confidence            10   1112345899998765 346789999999999999998 999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.83  E-value=1.6e-20  Score=126.14  Aligned_cols=106  Identities=41%  Similarity=0.615  Sum_probs=83.9

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++|+|++|+|++++.++.++++|||+++.+........ ......+..|++||.+....
T Consensus       119 ~~~i~~~i-~~~l~~LH~-~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~  195 (280)
T cd05043         119 LVHMAIQI-ACGMSYLHK-RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL-GDNENRPVKWMALESLVNKE  195 (280)
T ss_pred             HHHHHHHH-HHHHHHHHH-CCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEe-CCCCCcchhccCHHHHhcCC
Confidence            44577788 999999998 8999999999999999999999999999876533221111 11111234699999988777


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|++++++++.|+.||.+.+
T Consensus       196 ~~~~~Di~slG~~l~el~~~g~~p~~~~~  224 (280)
T cd05043         196 YSSASDVWSFGVLLWELMTLGQTPYVEID  224 (280)
T ss_pred             CCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence            88999999999999999976889997654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.83  E-value=1.6e-20  Score=124.85  Aligned_cols=122  Identities=39%  Similarity=0.671  Sum_probs=92.6

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+.++++...+.        ......++.|+ +.|+.|+|. .+++|+|++|+|++++.++.+++.|||+++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i-~~al~~LH~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQI-AEGMAFIER-KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHH-HHHHHHHhc-CCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            57788888654432        12234467788 999999998 899999999999999999999999999986543211


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .  ........+..|++||.+....++.++|+||+|++++++++.|..||.+.+
T Consensus       157 ~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  208 (260)
T cd05067         157 Y--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT  208 (260)
T ss_pred             c--ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            1  111111223469999998877788899999999999999965889997654

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.83  E-value=2.1e-20  Score=126.32  Aligned_cols=107  Identities=43%  Similarity=0.775  Sum_probs=82.2

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ +.|+.|+|. ++++|+|+||+||+++.++.++++|||+++........ ........+..|++||.+...
T Consensus       131 ~~~~~~~~i-~~al~~LH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~  207 (296)
T cd05051         131 TLLYMATQI-ASGMRYLES-LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLLG  207 (296)
T ss_pred             HHHHHHHHH-HHHHHHHHH-cCccccccchhceeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhcC
Confidence            445578888 999999998 89999999999999999999999999998754322111 111111223569999988777


Q ss_pred             CCCChhhHHHHHHHHHHHHhC-CCCCCCCCC
Q psy7529          97 RFSSASDVWSFGITLWEMYSF-GQQPYGEMK  126 (129)
Q Consensus        97 ~~~~~~di~s~g~~l~~l~~~-~~~pf~~~~  126 (129)
                      .++.++|+||+|++++++++. +..||...+
T Consensus       208 ~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         208 KFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             CCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            788999999999999999863 456776544

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0604|consensus

Probab=99.83  E-value=5.4e-21  Score=127.09  Aligned_cols=119  Identities=23%  Similarity=0.431  Sum_probs=95.9

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC---CCcEEEEeecCccccc
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS---RHQAKISDFGLSRAVN   69 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~---~~~~~l~d~~~~~~~~   69 (129)
                      ||+.+||+|+.-+..        -....|+-|| +.|+.|+|. ..|-|||+||+|+|...   +..+|+.|||+++...
T Consensus       138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI-~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQI-GLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             eecccchHHHHHHHHcccccchHHHHHHHHHHH-HHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            788899998876553        3456699999 999999999 89999999999999854   4567999999998654


Q ss_pred             CCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          70 SERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...    ....-++++-|.|||++....|+...|+||+|+++|-++- |.+||-+..
T Consensus       216 ~~~----~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLC-GyPPFYS~h  267 (400)
T KOG0604|consen  216 EPG----DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNH  267 (400)
T ss_pred             CCc----cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhc-CCCcccccC
Confidence            321    1222234566899999988889999999999999999998 999997654

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.83  E-value=2.4e-20  Score=124.30  Aligned_cols=119  Identities=20%  Similarity=0.310  Sum_probs=90.6

Q ss_pred             CCCCCCCCccccC----------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPL----------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||++++++...+          .......++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||+++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i-~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL-CSALEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            5677777754432          222344567788 999999998 9999999999999999999999999998765432


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .....   ....++..|++||......++.++|+||+|++++++++ |..||.+.
T Consensus       159 ~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~  209 (267)
T cd08229         159 KTTAA---HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGD  209 (267)
T ss_pred             CCccc---ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHh-CCCCcccc
Confidence            21111   11122346999999877778889999999999999998 99998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=2.2e-20  Score=125.39  Aligned_cols=120  Identities=28%  Similarity=0.411  Sum_probs=91.6

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...       +.......++.|+ +.|+.|+|. ++++|+|++++|++++.++.++++|||++........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql-~~~l~~lh~-~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQM-LEALNFLHS-HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            688888875433       3344566688888 999999998 8999999999999999999999999998765432211


Q ss_pred             eeeeccCCCCCceeccccccc-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYN-----FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   .....+..|++||.+.     ...++.++|+||+|+++|++++ |..||.+.+
T Consensus       159 ~~---~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~-g~~p~~~~~  212 (280)
T cd06611         159 KR---DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQ-MEPPHHELN  212 (280)
T ss_pred             cc---ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHh-CCCCcccCC
Confidence            11   1111234689999764     3346778999999999999998 999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.83  E-value=3.3e-20  Score=123.48  Aligned_cols=118  Identities=21%  Similarity=0.324  Sum_probs=90.9

Q ss_pred             CCCCCCCCccccC----------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPL----------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||++++++...+          .......++.++ ++|+.|+|. .+++|+|++|+||+++.++.++++|||+++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lh~-~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL-CSALEHMHS-KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHH-HHHHHHHHh-CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            6888888865433          222344567788 999999998 8999999999999999999999999998765432


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .....   .....+..|.+||.+.+..++.++|+||+|++++++++ |..||..
T Consensus       159 ~~~~~---~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~  208 (267)
T cd08224         159 KTTAA---HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYG  208 (267)
T ss_pred             CCccc---ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHH-CCCCccc
Confidence            21110   11112345999998887778889999999999999998 9999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.83  E-value=2.8e-20  Score=123.93  Aligned_cols=123  Identities=27%  Similarity=0.400  Sum_probs=93.4

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc-
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN-   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~-   73 (129)
                      |||++++++...+.      ......++.|+ +.|+.|+|. .+++|+|++|+||+++.++.++++|||.++....... 
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQI-LDGVAYLHN-NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            67888888655443      23345577888 999999998 8999999999999999999999999998865421110 


Q ss_pred             --eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 --YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 --~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        .........++..|++||.+....++.++|+||+|++++++++ |..||...+
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~  212 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMAT-GKPPLASMD  212 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHh-CCCccccCC
Confidence              0000111123456999999887778899999999999999998 999997654

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.82  E-value=1.8e-20  Score=124.53  Aligned_cols=122  Identities=43%  Similarity=0.735  Sum_probs=92.7

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++.+.+.        ......++.++ +.|+.|+|. ++++|+|++|+||+++.++.++++|||.++......
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i-~~al~~lh~-~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI-AEGMAYLES-RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHH-HHHHHHHHh-CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            57778877654432        22345577888 999999998 899999999999999999999999999887543211


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        .........+..|++||.+.+..++.++|+||+|++++++++.|..||.+.+
T Consensus       158 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  209 (261)
T cd05034         158 --YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT  209 (261)
T ss_pred             --hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence              0111111123469999998877788899999999999999976889997654

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.82  E-value=2.4e-20  Score=124.90  Aligned_cols=122  Identities=32%  Similarity=0.522  Sum_probs=91.8

Q ss_pred             CCCCCCCCccccC---------------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCc
Q psy7529           1 MKSPNGSGVVTPL---------------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLS   65 (129)
Q Consensus         1 m~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~   65 (129)
                      |||+++++|...+               .......++.|+ ++|+.|+|. ++++|+|+||+|++++..+.++++||+++
T Consensus        87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l-~~~l~~LH~-~~i~H~dlkp~Nili~~~~~~~l~~~~~~  164 (275)
T cd05046          87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI-ALGMDHLSN-ARFVHRDLAARNCLVSSQREVKVSLLSLS  164 (275)
T ss_pred             EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHH-HHHHHHhhh-cCcccCcCccceEEEeCCCcEEEcccccc
Confidence            6788888865433               333455688888 999999998 89999999999999999999999999987


Q ss_pred             ccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          66 RAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +......  .........+..|++||.+.....+.++|+||+|++++++++.|..||.+.+
T Consensus       165 ~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~  223 (275)
T cd05046         165 KDVYNSE--YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS  223 (275)
T ss_pred             cccCccc--ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc
Confidence            6432111  0111111223459999988777778899999999999999975678887654

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.82  E-value=3.4e-20  Score=124.65  Aligned_cols=104  Identities=26%  Similarity=0.372  Sum_probs=81.9

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ +.||.|+|. ++++|+|++|+||+++.++.++++|||++...........   ....+..|++||.+.+
T Consensus       101 ~~~~~~~~qi-~~~L~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~  175 (285)
T cd07861         101 ELVKSYLYQI-LQGILFCHS-RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT---HEVVTLWYRAPEVLLG  175 (285)
T ss_pred             HHHHHHHHHH-HHHHHHHHh-CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc---CCcccccccChHHhcC
Confidence            3455578899 999999998 8999999999999999999999999999865432211111   1112346999998765


Q ss_pred             C-CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          96 G-RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        96 ~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      . .++.++|+||+|++++++++ |..||.+.
T Consensus       176 ~~~~~~~~Dv~slG~il~~l~t-g~~~~~~~  205 (285)
T cd07861         176 SPRYSTPVDIWSIGTIFAEMAT-KKPLFHGD  205 (285)
T ss_pred             CCCcCcHHHHHHHHHHHHHHHH-CCCCCCCC
Confidence            4 46789999999999999998 99999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.82  E-value=1.7e-20  Score=125.91  Aligned_cols=122  Identities=42%  Similarity=0.673  Sum_probs=92.7

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+..       .....++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||.+........
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l-~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  164 (284)
T cd05038          87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI-CKGMDYLGS-QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD  164 (284)
T ss_pred             EecCCCCCHHHHHHhCccccCHHHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHhEEEcCCCCEEEcccccccccccCCc
Confidence            678888886554432       2345577888 999999998 8999999999999999999999999999876542222


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ..........+..|.+||......++.++|+||+|++++++++ |..||...
T Consensus       165 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~t-g~~p~~~~  215 (284)
T cd05038         165 YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT-YGDPSQSP  215 (284)
T ss_pred             ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeec-cCCCcccc
Confidence            1111111122345899998877778889999999999999998 98887653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.82  E-value=6.2e-20  Score=123.24  Aligned_cols=118  Identities=31%  Similarity=0.333  Sum_probs=86.7

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC-------cEEEEeecCcc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH-------QAKISDFGLSR   66 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~-------~~~l~d~~~~~   66 (129)
                      |||++++.+..-+.       ...+..++.|+ ++|+.|+|. ++++||||||+||+++..+       .++++|||.+.
T Consensus        95 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~  172 (274)
T cd05076          95 EEFVEHGPLDVCLRKEKGRVPVAWKITVAQQL-ASALSYLED-KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF  172 (274)
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHc-CCccCCCCCcccEEEeccCcccCccceeeecCCcccc
Confidence            78999888544332       22234477888 999999998 8999999999999997543       37899999875


Q ss_pred             cccCCCceeeeccCCCCCceecccccccC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          67 AVNSERNYYKATHGGRWPIKWYAPESYNF-GRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .......       ...+..|++||.+.. ..++.++|+||+|+++++++..|..||.+.+.
T Consensus       173 ~~~~~~~-------~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         173 TALSREE-------RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             ccccccc-------cccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            4322111       112346999998865 45788999999999999985338899876543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.82  E-value=2.3e-20  Score=123.72  Aligned_cols=120  Identities=23%  Similarity=0.383  Sum_probs=92.7

Q ss_pred             CCCCCCCCccccCCCC--------chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGSY--------ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...+...        ....++.|+ +.++.|+|. .+++|+|++++||+++.++.++++|||+++......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lh~-~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI-VSAVSYIHK-AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHH-HHHHHHHHh-CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            6888888866544332        234467788 999999998 899999999999999999999999999887543222


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   ......+..|.+||...+..++.++|+||+|++++++++ |..||...+
T Consensus       156 ~~---~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~-g~~~~~~~~  205 (256)
T cd08221         156 SM---AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT-LKRTFDATN  205 (256)
T ss_pred             cc---ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHH-CCCCCCCCC
Confidence            10   111122456999998877777888999999999999998 999987643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.82  E-value=3.1e-20  Score=124.84  Aligned_cols=103  Identities=23%  Similarity=0.350  Sum_probs=80.5

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ ++|+.|+|. ++++|+|++++||+++.++.++++|||+++.........   .....+..|++||.+.+
T Consensus        99 ~~~~~~~~qi-~~al~~LH~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~  173 (284)
T cd07839          99 EIVKSFMFQL-LKGLAFCHS-HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY---SAEVVTLWYRPPDVLFG  173 (284)
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc---CCCccccCCcChHHHhC
Confidence            3455688888 999999998 899999999999999999999999999887543221111   11122356999998765


Q ss_pred             C-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          96 G-RFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        96 ~-~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      . .++.++|+||+|++++++++ |..||..
T Consensus       174 ~~~~~~~~DiwslG~il~~l~t-g~~p~~~  202 (284)
T cd07839         174 AKLYSTSIDMWSAGCIFAELAN-AGRPLFP  202 (284)
T ss_pred             CcccCcHHHHHHHHHHHHHHHh-cCCCCcC
Confidence            4 46889999999999999998 8887543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.82  E-value=4.2e-20  Score=125.04  Aligned_cols=123  Identities=39%  Similarity=0.663  Sum_probs=90.3

Q ss_pred             CCCCCCCCccccCCC------------------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEee
Q psy7529           1 MKSPNGSGVVTPLGS------------------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDF   62 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~   62 (129)
                      |||+.++++...+..                  .....++.|+ +.|+.|+|. ++++|+|++|+|++++.++.++++||
T Consensus        96 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i-~~al~~lH~-~~i~H~dlkp~Nill~~~~~~kl~df  173 (295)
T cd05097          96 TEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQI-ASGMKYLAS-LNFVHRDLATRNCLVGNHYTIKIADF  173 (295)
T ss_pred             EecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHH-HHHHHHHHh-cCeeccccChhhEEEcCCCcEEeccc
Confidence            678888776443321                  1234477888 999999998 89999999999999999999999999


Q ss_pred             cCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCC
Q psy7529          63 GLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF-GQQPYGEMK  126 (129)
Q Consensus        63 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~-~~~pf~~~~  126 (129)
                      |+++....... .........+..|++||......++.++|+||+|++++++++. +..||...+
T Consensus       174 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         174 GMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             ccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            99875432211 1111111123569999988877888999999999999999862 456777543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.82  E-value=2.7e-20  Score=124.60  Aligned_cols=120  Identities=28%  Similarity=0.465  Sum_probs=92.8

Q ss_pred             CCCCCCCCccccC-----CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPL-----GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||+.++++...+     .......++.|+ +.|+.|+|. ++++|+|++|+|++++.++.++++|||+++.........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql-~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  155 (274)
T cd06609          78 MEYCGGGSCLDLLKPGKLDETYIAFILREV-LLGLEYLHE-EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR  155 (274)
T ss_pred             EEeeCCCcHHHHHhhcCCCHHHHHHHHHHH-HHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence            4667777654333     333455688888 899999998 899999999999999999999999999987654321111


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ....++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       156 ---~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~t-g~~p~~~~~  202 (274)
T cd06609         156 ---NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK-GEPPLSDLH  202 (274)
T ss_pred             ---ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccCc
Confidence               11112345999999887778899999999999999998 999997643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.82  E-value=4.7e-20  Score=121.93  Aligned_cols=123  Identities=42%  Similarity=0.677  Sum_probs=90.5

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+       .......++.++ +.++.|+|. ++++|||++|+||+++.++.++++|||+++.......
T Consensus        71 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~-~~~l~~lH~-~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  148 (251)
T cd05041          71 MELVPGGSLLTFLRKKKNRLTVKKLLQMSLDA-AAGMEYLES-KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY  148 (251)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHh-CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc
Confidence            5777777754433       122234466777 899999998 8999999999999999999999999998875432111


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . ........+..|++||.+.+..++.++|+||+|++++++++.+..||.+.+
T Consensus       149 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~  200 (251)
T cd05041         149 T-VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS  200 (251)
T ss_pred             e-eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence            1 010111123459999998877888999999999999999975678887654

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.82  E-value=3.2e-20  Score=123.74  Aligned_cols=119  Identities=20%  Similarity=0.323  Sum_probs=90.7

Q ss_pred             CCCCCCCCccccC----------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPL----------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||++++++...+          .......++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||+++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i-~~~l~~LH~-~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL-CSAVEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHH-HHHHHHHhh-CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            5777777764332          222234577788 999999998 8999999999999999999999999998875432


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ....   .....++..|++||.+....++.++|+||+|++++++++ |..||.+.
T Consensus       159 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~  209 (267)
T cd08228         159 KTTA---AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGD  209 (267)
T ss_pred             hhHH---HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhc-CCCCCccc
Confidence            2111   111123356999999887778889999999999999998 99998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.82  E-value=2.3e-20  Score=126.67  Aligned_cols=104  Identities=24%  Similarity=0.433  Sum_probs=81.9

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ ++|+.|+|. ++++|+|++|+||+++.++.++++|||+++.........   .....+..|++||.+.+.
T Consensus       105 ~~~~~~~qi-~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~  179 (301)
T cd07873         105 NVKLFLFQL-LRGLNYCHR-RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY---SNEVVTLWYRPPDILLGS  179 (301)
T ss_pred             HHHHHHHHH-HHHHHHHHh-CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc---cccceeecccCcHHHhCC
Confidence            455577888 999999998 999999999999999999999999999886533211111   111123569999987654


Q ss_pred             -CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          97 -RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        97 -~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       .++.++|+||+|++++++++ |..||...+
T Consensus       180 ~~~~~~~Dv~slG~~l~el~t-g~~~f~~~~  209 (301)
T cd07873         180 TDYSTQIDMWGVGCIFYEMST-GRPLFPGST  209 (301)
T ss_pred             CCCccHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence             46788999999999999998 999997654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.82  E-value=3.1e-20  Score=122.91  Aligned_cols=122  Identities=46%  Similarity=0.784  Sum_probs=92.9

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...+.        ......++.|+ +.|+.++|. .+++|+|++++||+++..+.++++|||+++......
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql-~~~l~~lh~-~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQI-ARGMEYLES-KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHH-HHHHHHHhc-CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            67888877544332        23345578888 999999998 899999999999999999999999999987654321


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .... . ....+..|++||......++.++|+|++|++++++++.|..||.+.+
T Consensus       158 ~~~~-~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~  209 (258)
T smart00219      158 YYKK-K-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS  209 (258)
T ss_pred             cccc-c-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            1111 0 11234569999988777788999999999999999975778887543

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.82  E-value=5.3e-20  Score=122.32  Aligned_cols=123  Identities=24%  Similarity=0.395  Sum_probs=92.1

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+.++++...+.      ......++.++ +.|+.|+|. .+++|+|++++||+++..+.++++|||++.........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i-~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQL-LEGLAYLHS-HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            46777777554432      22344477888 999999998 89999999999999999999999999988765432221


Q ss_pred             eee-ccCCCCCceecccccccCCC---CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKA-THGGRWPIKWYAPESYNFGR---FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~-~~~~~~~~~~~~pe~~~~~~---~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ... ......+..|++||.+....   ...++|+|++|++++++++ |..||.+.+
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~-g~~pf~~~~  210 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT-GKRPWSELD  210 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHh-CCCCccCCc
Confidence            111 01112345699999887655   6789999999999999998 999997653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.82  E-value=3.3e-20  Score=126.28  Aligned_cols=108  Identities=26%  Similarity=0.334  Sum_probs=83.4

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC----CCcEEEEeecCcccccCCCceeeeccCCCCCceeccccc
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS----RHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPES   92 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~----~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~   92 (129)
                      ....++.|+ +.|+.|+|. ++++|||++++||+++.    .+.++++|||+++.................+..|++||.
T Consensus       109 ~~~~i~~qi-~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  186 (316)
T cd07842         109 MVKSLLWQI-LNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPEL  186 (316)
T ss_pred             HHHHHHHHH-HHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHH
Confidence            455688888 999999998 89999999999999999    889999999988754322211111111122456999998


Q ss_pred             ccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          93 YNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        93 ~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      +.+. .++.++|+||+|++++++++ |..||.+.+.
T Consensus       187 ~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~  221 (316)
T cd07842         187 LLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREA  221 (316)
T ss_pred             HhCCCCCCcHHHHHHHHHHHHHHHh-cCCCCcCCcc
Confidence            7654 57889999999999999998 9999986543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.82  E-value=3.9e-20  Score=123.09  Aligned_cols=122  Identities=39%  Similarity=0.680  Sum_probs=92.2

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...+..        ..+..++.|+ +.|+.|+|. .+++|+|++|+|++++..+.+++.|||.++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l-~~aL~~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI-AEGMAFIEQ-RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHH-HHHHHHHHh-CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            678888876544322        1234467788 999999998 899999999999999999999999999886543211


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .  ........+..|++||.+....++.++|+||+|++++++++.|..||.+.+
T Consensus       157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~  208 (260)
T cd05073         157 Y--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS  208 (260)
T ss_pred             c--ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence            1  111111223459999998877788899999999999999975788997654

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.82  E-value=9.2e-20  Score=123.07  Aligned_cols=104  Identities=26%  Similarity=0.422  Sum_probs=81.5

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ +.|+.|+|. ++++|+||+|+||+++.++.++++|||+++.........   .....+..|++||.+.+.
T Consensus       104 ~~~~~~~qi-~~~L~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~  178 (291)
T cd07870         104 NVRLFMFQL-LRGLAYIHG-QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY---SSEVVTLWYRPPDVLLGA  178 (291)
T ss_pred             HHHHHHHHH-HHHHHHHHh-CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC---CCccccccccCCceeecC
Confidence            455577788 999999998 899999999999999999999999999886532221111   111123569999988654


Q ss_pred             -CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          97 -RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        97 -~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       .++.++|+||+|++++++++ |..||.+.+
T Consensus       179 ~~~~~~~Dv~slG~~l~~l~~-g~~~f~~~~  208 (291)
T cd07870         179 TDYSSALDIWGAGCIFIEMLQ-GQPAFPGVS  208 (291)
T ss_pred             CCCCcHHHHHHHHHHHHHHHh-CCCCCCCch
Confidence             46788999999999999998 999997643

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0596|consensus

Probab=99.82  E-value=2.5e-20  Score=131.91  Aligned_cols=106  Identities=25%  Similarity=0.476  Sum_probs=84.4

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      |-++++..|+ +.|+.++|. ++|||.||||.|.++-. +.+|++|||.+..+...... .......++..||+||.+..
T Consensus       460 ~~lk~ywkqM-L~aV~~IH~-~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTs-I~kdsQvGT~NYMsPEAl~~  535 (677)
T KOG0596|consen  460 WFLKFYWKQM-LLAVKTIHQ-HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTS-IVKDSQVGTVNYMSPEALTD  535 (677)
T ss_pred             HHHHHHHHHH-HHHHHHHHH-hceeecCCCcccEEEEe-eeEEeeeechhcccCccccc-eeeccccCcccccCHHHHhh
Confidence            4577889999 999999999 99999999999998765 77999999999877544322 22223345678999997643


Q ss_pred             CC-----------CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 GR-----------FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~~-----------~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..           .+.++|+||+||++|+|+. |++||++..
T Consensus       536 ~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY-gktPf~~~~  576 (677)
T KOG0596|consen  536 MSSSRENGKSKIKISRKSDVWSLGCILYQMVY-GKTPFGQII  576 (677)
T ss_pred             ccccccCCCcceeecCccchhhhhhHHHHHHh-cCCchHHHH
Confidence            22           4578999999999999996 999998754

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.82  E-value=5e-20  Score=122.20  Aligned_cols=120  Identities=23%  Similarity=0.374  Sum_probs=92.9

Q ss_pred             CCCCCCCCccccC----------CCCchhhHHhHHHHHHHHHHh-----ccCCCccCCCCCCCEEecCCCcEEEEeecCc
Q psy7529           1 MKSPNGSGVVTPL----------GSYALPYIEGQIPAKVCRYLK-----MHKSSFHRDLAARNILLASRHQAKISDFGLS   65 (129)
Q Consensus         1 m~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~h-----~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~   65 (129)
                      |||++++++...+          .......++.|+ +.|+.|+|     . .+++|+|++++||+++.++.++++|||++
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i-~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL-LLALYECHNRSDPG-NTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHH-HHHHHHHhcCcccc-CcceecCCCHHHEEEecCCCEEEeccccc
Confidence            6788887754333          223345578888 99999999     6 88999999999999999999999999998


Q ss_pred             ccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          66 RAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +..........   ....+..|++||.+....++.++|+||+|++++++++ |..||...+
T Consensus       158 ~~~~~~~~~~~---~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~  214 (265)
T cd08217         158 KILGHDSSFAK---TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA-LSPPFTARN  214 (265)
T ss_pred             ccccCCccccc---ccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHH-CCCcccCcC
Confidence            76543221111   1122356999999887778889999999999999998 999997653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.82  E-value=1.5e-20  Score=124.58  Aligned_cols=119  Identities=30%  Similarity=0.480  Sum_probs=91.6

Q ss_pred             CCCCCCCCccc------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVT------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||++.++++..      .+....+..++.|+ +.||.++|. ++++|+||+|+||+++.++.++++|||.+.........
T Consensus        77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~~L~~Lh~-~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~  154 (260)
T PF00069_consen   77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQI-LEALAYLHS-KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN  154 (260)
T ss_dssp             EEEETTEBHHHHHHHHSSBBHHHHHHHHHHH-HHHHHHHHH-TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred             ccccccccccccccccccccccccccccccc-ccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence            45666655432      23334456688888 999999999 89999999999999999999999999998653111111


Q ss_pred             eeeccCCCCCceeccccccc-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYN-FGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~-~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                         ......+..|.+||... ....+.++|+||+|++++++++ |..||.+.
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-~~~p~~~~  202 (260)
T PF00069_consen  155 ---FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLT-GKLPFEES  202 (260)
T ss_dssp             ---BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHH-SSSSSTTS
T ss_pred             ---cccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence               11222345699999987 6677899999999999999999 99999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.82  E-value=5.3e-20  Score=124.64  Aligned_cols=120  Identities=24%  Similarity=0.414  Sum_probs=92.7

Q ss_pred             CCCCCCCCccccCC-----CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLG-----SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++++...+.     ...+..++.|+ +.|+.|+|. ++++|+|++++|++++.++.++++|||++..........
T Consensus        95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l-~~al~~LH~-~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          95 MEYLAGGSLTDVVTETCMDEGQIAAVCREC-LQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             EecCCCCcHHHHHhhcCCCHHHHHHHHHHH-HHHHHHHHh-CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence            57788887654333     23455678888 999999998 899999999999999999999999999876443221111


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+..|++||.+....++.++|+||+|++++++++ |..||...+
T Consensus       173 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~-g~~pf~~~~  219 (293)
T cd06647         173 ---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNEN  219 (293)
T ss_pred             ---ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence               11122346999998877778889999999999999998 999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.82  E-value=5e-20  Score=124.30  Aligned_cols=104  Identities=24%  Similarity=0.441  Sum_probs=81.3

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC-
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF-   95 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-   95 (129)
                      ....++.|+ ++|+.|+|. ++++|+||+++||+++.++.++++|||+++..........   ....+..|++||.+.+ 
T Consensus       104 ~~~~~~~ql-~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~  178 (291)
T cd07844         104 NVRLFLFQL-LRGLAYCHQ-RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS---NEVVTLWYRPPDVLLGS  178 (291)
T ss_pred             HHHHHHHHH-HHHHHHHHh-CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccc---ccccccccCCcHHhhcC
Confidence            455577888 999999998 8999999999999999999999999998865322111110   1112346899998765 


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..++.++|+||+|++++++++ |..||.+.+
T Consensus       179 ~~~~~~~Dv~slG~il~~l~~-g~~~~~~~~  208 (291)
T cd07844         179 TEYSTSLDMWGVGCIFYEMAT-GRPLFPGST  208 (291)
T ss_pred             cccCcHHHHHHHHHHHHHHHh-CCCCCCCCc
Confidence            357889999999999999998 999997543

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.82  E-value=6.7e-20  Score=121.90  Aligned_cols=116  Identities=30%  Similarity=0.421  Sum_probs=86.8

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc--------EEEEeecCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ--------AKISDFGLS   65 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~--------~~l~d~~~~   65 (129)
                      |||++++++...+..       .....++.|+ +.|+.|+|. ++++|||+|++||+++.++.        ++++|||.+
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQL-AWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            789999886554432       2234467888 999999998 99999999999999977654        589999987


Q ss_pred             ccccCCCceeeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCC-CCCCCCCC
Q psy7529          66 RAVNSERNYYKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFG-QQPYGEMK  126 (129)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~-~~pf~~~~  126 (129)
                      ........       ...+..|++||.+... .++.++|+||+|+++|++++ | ..||...+
T Consensus       156 ~~~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~~~~~~~~  210 (258)
T cd05078         156 ITVLPKEI-------LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS-GGDKPLSALD  210 (258)
T ss_pred             cccCCchh-------ccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHc-CCCCChhhcc
Confidence            64432111       1123469999988764 46788999999999999998 7 46766543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.81  E-value=5.8e-20  Score=123.33  Aligned_cols=119  Identities=25%  Similarity=0.369  Sum_probs=91.8

Q ss_pred             CCCCCCCCcccc--------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTP--------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...        +.......++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||.++......
T Consensus        72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql-~~~l~~lH~-~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~  149 (277)
T cd05577          72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQI-ICGLEHLHQ-RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK  149 (277)
T ss_pred             EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHH-HHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC
Confidence            678888775432        2233345577788 999999998 899999999999999999999999999876543211


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .    .........|++||...+..++.++|+||+|++++++++ |+.||...+
T Consensus       150 ~----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~  198 (277)
T cd05577         150 K----IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA-GRSPFRQRK  198 (277)
T ss_pred             c----cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhh-CCCCCCCCc
Confidence            1    111122346999999877778889999999999999998 999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.81  E-value=6.6e-21  Score=127.04  Aligned_cols=124  Identities=34%  Similarity=0.577  Sum_probs=91.0

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+++++|...+.        ...+..++.|+ +.|+.|+|. ++++|++|+++||+++.++.+|++|||+.+......
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i-~~~l~~Lh~-~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQI-AEALSYLHS-NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHH-HHHHHHHHH-TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccccccccccccccccccccccc-ccccccccc-cccccccccccccccccccccccccccccccccccc
Confidence            57787777543322        23344478888 999999998 899999999999999999999999999987653222


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .. ...........|++||.+....++.++|+||+|++++|+++.++.||.+.+.
T Consensus       158 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~  211 (259)
T PF07714_consen  158 KY-KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN  211 (259)
T ss_dssp             SE-EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred             cc-cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            11 1112222345699999988777889999999999999999856789987643

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.81  E-value=9.2e-20  Score=121.28  Aligned_cols=119  Identities=28%  Similarity=0.431  Sum_probs=93.2

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||.+++++...+.      ......++.|+ ++|+.|+|. ++++|+|++++||+++.++.++++|||.++........
T Consensus        72 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i-~~~l~~lH~-~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~  149 (262)
T cd05572          72 MEYCLGGELWTILRDRGLFDEYTARFYIACV-VLAFEYLHN-RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT  149 (262)
T ss_pred             EecCCCCcHHHHHhhcCCCCHHHHHHHHHHH-HHHHHHHhh-CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccc
Confidence            57778887654433      23344577788 999999998 99999999999999999999999999998765432111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                          .....+..|++||.+....++.++|+|++|+++|++++ |..||...+
T Consensus       150 ----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~  196 (262)
T cd05572         150 ----WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLT-GRPPFGEDD  196 (262)
T ss_pred             ----ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHh-CCCCcCCCC
Confidence                11112346999999877778889999999999999998 999998655

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG4257|consensus

Probab=99.81  E-value=2.6e-20  Score=133.81  Aligned_cols=125  Identities=46%  Similarity=0.772  Sum_probs=102.3

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      ||-+..|.|...|..       ..+..+.+|+ +.|+.|+|+ ++.+|||+...|||+.+..=+|++|||+++.+.... 
T Consensus       469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi-~talaYLeS-krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~-  545 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQI-CTALAYLES-KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA-  545 (974)
T ss_pred             EecccchhHHHHHHhccccchHHHHHHHHHHH-HHHHHHHHh-hchhhhhhhhhheeecCcceeeecccchhhhccccc-
Confidence            566666665555443       2355588899 999999998 999999999999999999999999999999776543 


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD  129 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~e  129 (129)
                      .+.+. .+.-++.|++||.+....+...+|+|=+|+.+||++++|..||++.++.+
T Consensus       546 yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD  600 (974)
T KOG4257|consen  546 YYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD  600 (974)
T ss_pred             hhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence            33333 33335789999999999999999999999999999999999999988764

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.81  E-value=4.6e-20  Score=123.30  Aligned_cols=106  Identities=39%  Similarity=0.683  Sum_probs=82.7

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++|||+||+||+++.+..++++|||+++........ ........+..|++||......
T Consensus       115 ~~~~~~~i-~~~l~~lH~-~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~  191 (273)
T cd05074         115 LVRFMIDI-ASGMEYLSS-KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY-RQGCASKLPVKWLALESLADNV  191 (273)
T ss_pred             HHHHHHHH-HHHHHHHHh-CCEeecccchhhEEEcCCCCEEECcccccccccCCcce-ecCCCccCchhhcCHhHHhcCc
Confidence            45588888 999999998 89999999999999999999999999988754322111 1111111234689999887777


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|++++++++.|..||.+.+
T Consensus       192 ~~~~sDi~slG~il~el~~~g~~p~~~~~  220 (273)
T cd05074         192 YTTHSDVWAFGVTMWEIMTRGQTPYAGVE  220 (273)
T ss_pred             cchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence            88899999999999999875778887654

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.81  E-value=6.9e-20  Score=126.17  Aligned_cols=106  Identities=29%  Similarity=0.399  Sum_probs=82.3

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC-
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF-   95 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-   95 (129)
                      ....++.|+ +.|+.++|. ++++||||+++||+++..+.++++|||+++................++..|+|||.+.. 
T Consensus       107 ~~~~i~~ql-~~aL~~LH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  184 (336)
T cd07849         107 HIQYFLYQI-LRGLKYIHS-ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS  184 (336)
T ss_pred             HHHHHHHHH-HHHHHHHHh-CCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCC
Confidence            355578888 999999999 89999999999999999999999999998754322111111111123456999997654 


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ..++.++|+||+|++++++++ |..||.+.
T Consensus       185 ~~~~~~~DvwslGvil~el~~-G~~~f~~~  213 (336)
T cd07849         185 KGYTKAIDIWSVGCILAEMLS-NRPLFPGK  213 (336)
T ss_pred             CCCCcHHHHHHHHHHHHHHHh-CCCCCCCC
Confidence            457889999999999999998 99999754

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0664|consensus

Probab=99.81  E-value=8.4e-21  Score=125.33  Aligned_cols=106  Identities=25%  Similarity=0.362  Sum_probs=83.3

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      -...-+.+|| ++||+|+|. .+|+|||+||.|.+++++..+|++|||+++............  ...+--|.+||.+.+
T Consensus       156 DHvKVFlYQI-LRGLKYLHs-A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTq--EVVTQYYRAPEiLMG  231 (449)
T KOG0664|consen  156 DHVKVFVYQI-LRGLKYLHT-ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTH--EVVTQYYRAPELLMG  231 (449)
T ss_pred             chhhhhHHHH-HhhhHHHhh-cchhhccCCCccEEeccCceEEecccccccccchhhhhhhHH--HHHHHHhccHHHhhc
Confidence            3456688899 999999999 999999999999999999999999999998654322211111  011234889999887


Q ss_pred             C-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 G-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . .|+...|+||+||++.|++- .+..|+.-+
T Consensus       232 aRhYs~AvDiWSVGCIFaELLg-RrILFQAq~  262 (449)
T KOG0664|consen  232 ARRYTGAVDIWSVGCIFAELLQ-RKILFQAAG  262 (449)
T ss_pred             chhhcCccceehhhHHHHHHHh-hhhhhhccC
Confidence            6 58899999999999999997 777776543

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.81  E-value=6.1e-20  Score=123.83  Aligned_cols=120  Identities=27%  Similarity=0.421  Sum_probs=90.9

Q ss_pred             CCCCCCCCccccCC-----CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLG-----SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||+.++++...+.     ......++.|+ +.|+.++|. ++++|||++|+||+++.++.++++|||.+..........
T Consensus        95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql-~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~  172 (285)
T cd06648          95 MEFLEGGALTDIVTHTRMNEEQIATVCLAV-LKALSFLHA-QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR  172 (285)
T ss_pred             EeccCCCCHHHHHHhCCCCHHHHHHHHHHH-HHHHHHHHh-CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence            46777777554332     23344577888 999999998 899999999999999999999999999876433211111


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ....++..|++||......++.++|+||+|++++++++ |..||.+.+
T Consensus       173 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~-g~~p~~~~~  219 (285)
T cd06648         173 ---KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD-GEPPYFNEP  219 (285)
T ss_pred             ---ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHh-CCCCCcCCC
Confidence               11112346999999887778889999999999999998 999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.81  E-value=1.1e-19  Score=122.84  Aligned_cols=104  Identities=26%  Similarity=0.333  Sum_probs=81.1

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-CCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-RHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      .....++.|+ ++||.|+|. ++++|||++++||+++. ++.++++|||+++...........   ...+..|++||.+.
T Consensus       110 ~~~~~~~~qi-~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~---~~~~~~~~aPE~~~  184 (295)
T cd07837         110 KTIKSFMYQL-LKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---EIVTLWYRAPEVLL  184 (295)
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCC---cccccCCCChHHhh
Confidence            3455678888 999999998 89999999999999998 788999999988754322111111   11234599999876


Q ss_pred             CC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          95 FG-RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        95 ~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      +. .++.++|+||+|++++++++ |..||.+.
T Consensus       185 ~~~~~~~~~Di~slG~~l~~l~~-g~~~~~~~  215 (295)
T cd07837         185 GSTHYSTPVDIWSVGCIFAEMSR-KQPLFPGD  215 (295)
T ss_pred             CCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Confidence            53 46889999999999999998 99999754

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.81  E-value=4.1e-20  Score=122.91  Aligned_cols=124  Identities=28%  Similarity=0.450  Sum_probs=93.2

Q ss_pred             CCCCCCCCccccC---------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPL---------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~   71 (129)
                      ||+++++++...+         .......++.|+ +.|+.++|. ++++|+|++++||+++.++.+++.|||++......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql-~~al~~lh~-~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEV-LKGLEYLHS-NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            5778887755443         222345578888 999999998 99999999999999999999999999988765432


Q ss_pred             Ccee-eeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          72 RNYY-KATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        72 ~~~~-~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .... .......++..|++||.+... .++.++|+||+|++++++++ |+.||.+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~-g~~p~~~~~~  212 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT-GAAPYSKYPP  212 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHh-CCCCccccCh
Confidence            2111 000111234569999987665 67888999999999999998 9999987654

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.81  E-value=1e-19  Score=121.29  Aligned_cols=123  Identities=24%  Similarity=0.350  Sum_probs=91.8

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC-cEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH-QAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~-~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+      .......++.|+ +.|+.++|. ++++|+|++++||+++..+ .++++|||.++.......
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql-~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQL-LRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EeccCCCcHHHHHHHhCCCCHHHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            5778887764433      334456678888 999999999 8999999999999998765 589999999876543211


Q ss_pred             eeee-ccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKA-THGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .... .....++..|++||.+.+..++.++|+|++|++++++++ |..||...+
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~  212 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT-AKPPWNAEK  212 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Confidence            1000 001112456999999877778889999999999999998 999997543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.81  E-value=1.1e-19  Score=121.40  Aligned_cols=119  Identities=28%  Similarity=0.418  Sum_probs=91.8

Q ss_pred             CCCCCCCCccccC----------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPL----------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||++++++...+          .......++.|+ +.++.++|...+++|+|+++.||+++.++.++++|||.+.....
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  166 (269)
T cd08528          88 MDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM-VLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP  166 (269)
T ss_pred             EecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHH-HHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccc
Confidence            6788887764332          122334467788 99999999646799999999999999999999999999876443


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ...    ......+..|++||.+.+..++.++|+||+|+++|++++ |+.||...
T Consensus       167 ~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~-g~~p~~~~  216 (269)
T cd08528         167 ESK----LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYST  216 (269)
T ss_pred             ccc----cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHh-CCCccccc
Confidence            221    111223456999999987778899999999999999998 99998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1035|consensus

Probab=99.81  E-value=2.2e-20  Score=141.08  Aligned_cols=114  Identities=26%  Similarity=0.343  Sum_probs=86.4

Q ss_pred             CCCCCCCCccccCCCC-------chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCccccc----
Q psy7529           1 MKSPNGSGVVTPLGSY-------ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVN----   69 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~----   69 (129)
                      ||||+...+......-       ..-.+|.+| +.|+.|+|. +++||||+||.||.++.+..+|+.|||++....    
T Consensus       675 MEyCE~~ll~~iI~~N~~~~~~d~~wrLFreI-lEGLaYIH~-~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~  752 (1351)
T KOG1035|consen  675 MEYCEKTLLRDIIRRNHFNSQRDEAWRLFREI-LEGLAYIHD-QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLE  752 (1351)
T ss_pred             HhhhhhhHHHHHHHhcccchhhHHHHHHHHHH-HHHHHHHHh-CceeeccCCcceeEEcCCCCeeecccccchhhhhhhh
Confidence            8888887755444432       234589999 999999999 999999999999999999999999999987511    


Q ss_pred             --CCC---------ceeeeccCCCCCceecccccccCC---CCCChhhHHHHHHHHHHHHh
Q psy7529          70 --SER---------NYYKATHGGRWPIKWYAPESYNFG---RFSSASDVWSFGITLWEMYS  116 (129)
Q Consensus        70 --~~~---------~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~di~s~g~~l~~l~~  116 (129)
                        ...         .......+..+|.-|+|||.+...   .|+.++|+||+|++++||+.
T Consensus       753 ~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  753 SIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             hHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc
Confidence              000         001111222345679999988655   49999999999999999874

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=8.4e-20  Score=122.35  Aligned_cols=120  Identities=28%  Similarity=0.524  Sum_probs=91.0

Q ss_pred             CCCCCCCCccccCCC-----CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLGS-----YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++++...+..     .....++.|+ +.|+.|+|. .+++|+|++|+||+++..+.++++|||.+..........
T Consensus        81 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i-~~~l~~lh~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          81 MEYAEGGSVRTLMKAGPIAEKYISVIIREV-LVALKYIHK-VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EecCCCCcHHHHHHccCCCHHHHHHHHHHH-HHHHHHHHh-CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            678888775543322     2344577788 999999998 899999999999999999999999999887553322111


Q ss_pred             eeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ....++..|++||.+... .++.++|+||+|+++|++++ |..||.+.+
T Consensus       159 ---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~-g~~p~~~~~  206 (277)
T cd06917         159 ---STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT-GNPPYSDVD  206 (277)
T ss_pred             ---ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHh-CCCCCCCCC
Confidence               111233469999987643 46789999999999999998 999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG1025|consensus

Probab=99.81  E-value=3e-20  Score=136.54  Aligned_cols=113  Identities=44%  Similarity=0.807  Sum_probs=97.7

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      +......+.+|| ++|+.|||. ++++||||...|+|+....++|+.|||+++........+... ++..++.|+|-|.+
T Consensus       796 gsq~lLnw~~QI-AkgM~YLe~-qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~-~gK~pikwmale~i  872 (1177)
T KOG1025|consen  796 GSQDLLNWCYQI-AKGMKYLEE-QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAP-GGKVPIKWMALESI  872 (1177)
T ss_pred             cHHHHHHHHHHH-HHHHHHHHh-cchhhhhhhhhheeecCCCeEEEEecchhhccCccccccccc-ccccCcHHHHHHHh
Confidence            344566688999 999999998 999999999999999999999999999999877665555443 34446789999999


Q ss_pred             cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q psy7529          94 NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD  129 (129)
Q Consensus        94 ~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~e  129 (129)
                      ....|.+++|+||+|+++||+++||..|+++++.+|
T Consensus       873 ~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e  908 (1177)
T KOG1025|consen  873 RIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE  908 (1177)
T ss_pred             hccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence            999999999999999999999999999999987654

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.81  E-value=1.3e-19  Score=121.19  Aligned_cols=122  Identities=27%  Similarity=0.494  Sum_probs=91.8

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+.++++...+..      ..+..++.|+ +.|+.++|. ++++|+|++++||+++.++.++++|||+++........
T Consensus        87 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  164 (272)
T cd06629          87 LEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV-LEGLAYLHS-KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN  164 (272)
T ss_pred             EecCCCCcHHHHHhhccCCCHHHHHHHHHHH-HHHHHHHhh-CCeeecCCChhhEEEcCCCeEEEeeccccccccccccc
Confidence            688888886554332      3345577788 999999998 89999999999999999999999999998754321111


Q ss_pred             eeeccCCCCCceecccccccCCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGR--FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~--~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . ......++..|++||.+....  ++.++|+||+|++++++++ |..||.+.+
T Consensus       165 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~  216 (272)
T cd06629         165 D-QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA-GRRPWSDEE  216 (272)
T ss_pred             c-ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh-CCCCCcCcc
Confidence            1 011112345699999876543  6788999999999999998 999997644

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0587|consensus

Probab=99.81  E-value=2.8e-20  Score=136.83  Aligned_cols=121  Identities=29%  Similarity=0.455  Sum_probs=92.2

Q ss_pred             CCCCCCCCccccCCC-----Cc---hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS-----YA---LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----~~---~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      ||||.||++...-+-     ++   +.+|...+ +.|+..+|. +.+||||+|-.|||+..++.+|+.|||++..+....
T Consensus       100 MEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~-lrgl~HLH~-nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~  177 (953)
T KOG0587|consen  100 MEFCGGGSVTDLVKNTKGNRLKEEWIAYILREI-LRGLAHLHN-NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV  177 (953)
T ss_pred             eeccCCccHHHHHhhhcccchhhHHHHHHHHHH-HHHHHHHhh-cceeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence            899999994333221     22   33344444 778888888 889999999999999999999999999988765443


Q ss_pred             ceeeeccCCCCCceecccccccCC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFG-----RFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ......   .+++-|||||++...     .|+.++|+||+|++..|+.. |.+|+.++=+
T Consensus       178 grRnT~---iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIElad-G~PPl~DmHP  233 (953)
T KOG0587|consen  178 GRRNTF---IGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAE-GAPPLCDMHP  233 (953)
T ss_pred             ccccCc---CCCcccccceeeecccCCCCCcccccchhhccceeehhcC-CCCCccCcch
Confidence            332222   345569999987543     36789999999999999998 9999998743

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.81  E-value=8.6e-20  Score=122.89  Aligned_cols=119  Identities=27%  Similarity=0.371  Sum_probs=91.9

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+..      .....++.++ +.++.|+|...+++|+|++++|++++.++.++++|||++........ 
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i-~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~-  159 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAV-VEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA-  159 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHH-HHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc-
Confidence            688888886543322      2344577777 89999999746899999999999999999999999998764322111 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                          ....++..|++||.+....++.++|+||+|++++++++ |..||...+
T Consensus       160 ----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~  206 (284)
T cd06620         160 ----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL-GKFPFAFSN  206 (284)
T ss_pred             ----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHh-CCCCCcccc
Confidence                11123456999999877778889999999999999998 999998644

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.81  E-value=7.8e-20  Score=124.48  Aligned_cols=105  Identities=25%  Similarity=0.326  Sum_probs=82.9

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ ++|+.|+|. .+++|+||+++||+++..+.++++|||+++.........   .....+..|++||.+.+
T Consensus       108 ~~~~~~~~qi-~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~  182 (309)
T cd07845         108 SQVKCLMLQL-LRGLQYLHE-NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM---TPKVVTLWYRAPELLLG  182 (309)
T ss_pred             HHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCC---CcccccccccChhhhcC
Confidence            3455588888 999999999 899999999999999999999999999987654321111   11112345999998765


Q ss_pred             -CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 -GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 -~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       ..++.++|+||+|++++++++ |..||.+.+
T Consensus       183 ~~~~~~~~DvwslG~il~el~~-g~~~f~~~~  213 (309)
T cd07845         183 CTTYTTAIDMWAVGCILAELLA-HKPLLPGKS  213 (309)
T ss_pred             CCCcCchHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence             357889999999999999998 999997654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.81  E-value=1.3e-19  Score=120.19  Aligned_cols=122  Identities=34%  Similarity=0.663  Sum_probs=90.7

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++.+...+.       ......++.|+ +.++.++|. ++++|+|++++||+++.++.++++|||.++.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lH~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDV-CEGMAYLES-SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHH-HHHHHHHHH-CCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            57788877543332       22234466677 899999998 8999999999999999999999999998865432211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        ........+..|++||.+.+..++.++|+||+|++++++++.|..||.+.+
T Consensus       156 --~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  206 (256)
T cd05112         156 --TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS  206 (256)
T ss_pred             --cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence              111111223469999988877788899999999999999965788987543

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.80  E-value=1.2e-19  Score=122.80  Aligned_cols=119  Identities=21%  Similarity=0.221  Sum_probs=88.5

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+ ++++...+       .......++.|+ ++|+.|+|. ++++|+|++++||+++.++.++++|||+++.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi-~~al~~lH~-~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMT-LRGLEYLHS-NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            5666 55544333       223355688888 999999998 8999999999999999999999999999876543221


Q ss_pred             eeeeccCCCCCceecccccccC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNF-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   .....+..|++||.+.+ ..++.++|+||+|++++++++ |..||.+.+
T Consensus       158 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~-g~~~~~~~~  207 (298)
T cd07841         158 KM---THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDS  207 (298)
T ss_pred             cc---cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHc-CCccccCCc
Confidence            11   11112346999998754 356789999999999999998 877776543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.80  E-value=1.1e-19  Score=120.58  Aligned_cols=123  Identities=28%  Similarity=0.356  Sum_probs=91.8

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+.++++...      +....+..++.|+ ++|+.|+|. ++++|+|++++||+++.++.++++|||++.........
T Consensus        72 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi-~~~L~~lH~-~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          72 MEYLPGGDLASLLENVGSLDEDVARIYIAEI-VLALEYLHS-NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence            577777775433      2333455688888 999999998 99999999999999999999999999987643221100


Q ss_pred             -----eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 -----YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 -----~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                           .........+..|++||.......+.++|+||+|++++++++ |..||...+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~  205 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV-GIPPFHGET  205 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Confidence                 000111112346999998877777889999999999999998 999997554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG2345|consensus

Probab=99.80  E-value=3.8e-20  Score=120.06  Aligned_cols=107  Identities=26%  Similarity=0.403  Sum_probs=82.2

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCC--CccCCCCCCCEEecCCCcEEEEeecCcccccCC------CceeeeccCCCCCce
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKS--SFHRDLAARNILLASRHQAKISDFGLSRAVNSE------RNYYKATHGGRWPIK   86 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~--~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~------~~~~~~~~~~~~~~~   86 (129)
                      +.+...++.++ ++||.++|. ..  ..|||+||.||++...+...+.|||.+.....+      ....+......++..
T Consensus       126 E~~iL~if~gi-c~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~p  203 (302)
T KOG2345|consen  126 EAQILWIFLGI-CRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIP  203 (302)
T ss_pred             HHHHHHHHHHH-HHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCc
Confidence            34566788999 999999998 66  889999999999999999999999987653211      111111112234677


Q ss_pred             ecccccccCC---CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          87 WYAPESYNFG---RFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        87 ~~~pe~~~~~---~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      |.|||.+...   ..+.++|+||+||++|+++- |..||..
T Consensus       204 yRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf-~~sPfe~  243 (302)
T KOG2345|consen  204 YRAPELFNVKSHCTITERTDIWSLGCTLYAMMF-GESPFER  243 (302)
T ss_pred             ccCchheecccCcccccccchhhhhHHHHHHHH-cCCcchH
Confidence            9999988543   45789999999999999995 9999974

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.80  E-value=1.3e-19  Score=122.23  Aligned_cols=119  Identities=26%  Similarity=0.406  Sum_probs=89.2

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ ++|+.|+|. .+++|||++++||+++.++.++++|||+++........
T Consensus        84 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi-~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (290)
T cd05613          84 LDYINGGELFTHLSQRERFKEQEVQIYSGEI-VLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE  161 (290)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeccCCCHHHeEECCCCCEEEeeCccceeccccccc
Confidence            6788888765543      223344466688 999999998 99999999999999999999999999988754321111


Q ss_pred             eeeccCCCCCceecccccccCC--CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFG--RFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~--~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .  .....++..|++||.+...  .++.++|+||+|++++++++ |..||..
T Consensus       162 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~-g~~p~~~  210 (290)
T cd05613         162 R--AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT-GASPFTV  210 (290)
T ss_pred             c--cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhc-CCCCCCc
Confidence            0  1111123569999987643  35678999999999999998 9999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.80  E-value=7.9e-20  Score=137.96  Aligned_cols=106  Identities=17%  Similarity=0.178  Sum_probs=76.0

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc-------------------EEEEeecCcccccCCCc---
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ-------------------AKISDFGLSRAVNSERN---   73 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~-------------------~~l~d~~~~~~~~~~~~---   73 (129)
                      .....++.|+ +.|+.|+|. ++|+||||||+||+++..+.                   ++++|||+++.......   
T Consensus        80 ~~~~~i~~qi-~~al~~lH~-~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~  157 (793)
T PLN00181         80 FECFHVFRQI-VEIVNAAHS-QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRI  157 (793)
T ss_pred             HHHHHHHHHH-HHHHHHHHh-CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccch
Confidence            3456688999 999999998 99999999999999965444                   45555555543210000   


Q ss_pred             -eeee---------ccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          74 -YYKA---------THGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        74 -~~~~---------~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                       ....         .....+++.|+|||.+.+..++.++|+||+||+++|+++ +..|+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~-~~~~~~~  217 (793)
T PLN00181        158 EKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFC-PVSSREE  217 (793)
T ss_pred             hhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhh-CCCchhh
Confidence             0000         000123456999999988889999999999999999998 8887653

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.80  E-value=7.6e-20  Score=122.01  Aligned_cols=120  Identities=31%  Similarity=0.478  Sum_probs=88.7

Q ss_pred             CCCCCCCCcccc----------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTP----------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||++++++...          +.......++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||.+.....
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql-~~al~~lH~-~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  165 (275)
T cd06608          88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET-LRGLAYLHE-NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS  165 (275)
T ss_pred             EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHH-HHHHHHHhc-CCcccCCCCHHHEEEccCCeEEECCCccceeccc
Confidence            577777764332          2233345578888 999999998 8999999999999999999999999998765432


Q ss_pred             CCceeeeccCCCCCceecccccccC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNF-----GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....   .....++..|++||.+..     ..++.++|+||+|++++++++ |..||.+..
T Consensus       166 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~  222 (275)
T cd06608         166 TLGR---RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD-GKPPLCDMH  222 (275)
T ss_pred             chhh---hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh-CCCCccccc
Confidence            1111   111122346999997643     235678999999999999998 999997643

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.80  E-value=9.6e-20  Score=120.62  Aligned_cols=119  Identities=26%  Similarity=0.458  Sum_probs=91.0

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+.      ......++.|+ +.|+.|+|. .+++|+|++++||+++.++.++++|||++........ 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~-  157 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQI-LLGLEYLHD-RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF-  157 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEccCccceecccccc-
Confidence            57777777654432      23344467778 999999998 8999999999999999999999999998865432210 


Q ss_pred             eeeccCCCCCceecccccccCCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGR-FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~-~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ......+..|++||.+.... ++.++|+||+|++++++++ |..||.+.+
T Consensus       158 ---~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~-g~~pf~~~~  206 (258)
T cd06632         158 ---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT-GKPPWSQLE  206 (258)
T ss_pred             ---ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHh-CCCCcccCc
Confidence               11111234699999876655 7889999999999999998 999997754

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0671|consensus

Probab=99.80  E-value=1.2e-20  Score=128.30  Aligned_cols=108  Identities=24%  Similarity=0.316  Sum_probs=87.1

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC--------------------CCcEEEEeecCcccccCCC
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS--------------------RHQAKISDFGLSRAVNSER   72 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~--------------------~~~~~l~d~~~~~~~~~~~   72 (129)
                      ++.-.++.+.+|+ ++++++||. .+++|-||||+||++.+                    +..++++|||.++......
T Consensus       189 fpi~~ir~m~~QL-~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h  266 (415)
T KOG0671|consen  189 FPIDHIRHMGYQL-LESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH  266 (415)
T ss_pred             cchHHHHHHHHHH-HHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc
Confidence            3334567789999 999999999 99999999999999842                    2357899999887644333


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD  129 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~e  129 (129)
                      ....      .|..|.|||++.+..++.+.|+||+||++.|+.+ |...|+..++.|
T Consensus       267 s~iV------sTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt-G~~LFqtHen~E  316 (415)
T KOG0671|consen  267 STIV------STRHYRAPEVILGLGWSQPCDVWSIGCILVELYT-GETLFQTHENLE  316 (415)
T ss_pred             ceee------eccccCCchheeccCcCCccCceeeeeEEEEeec-cceecccCCcHH
Confidence            2221      2356999999999999999999999999999998 999999877654

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.80  E-value=9.6e-20  Score=125.82  Aligned_cols=110  Identities=22%  Similarity=0.347  Sum_probs=81.3

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC-CcEEEEeecCcccccCCCceeeeccCCCCCceeccccc
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR-HQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPES   92 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~   92 (129)
                      .......++.|+ +.|+.|+|. .+++|||++++||+++.. ..++++|||.++................++..|+|||.
T Consensus       112 ~~~~~~~~~~qi-~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  189 (342)
T cd07854         112 SEEHARLFMYQL-LRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRL  189 (342)
T ss_pred             CHHHHHHHHHHH-HHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHH
Confidence            334456688888 999999998 899999999999999754 56799999998754322111110111122346999997


Q ss_pred             ccC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          93 YNF-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        93 ~~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +.. ..++.++|+||+|++++++++ |..||.+.+
T Consensus       190 ~~~~~~~~~~~DiwSlGvil~el~~-g~~pf~~~~  223 (342)
T cd07854         190 LLSPNNYTKAIDMWAAGCIFAEMLT-GKPLFAGAH  223 (342)
T ss_pred             HhCccccCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            654 356789999999999999998 999997543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.80  E-value=2e-19  Score=121.81  Aligned_cols=119  Identities=26%  Similarity=0.399  Sum_probs=91.0

Q ss_pred             CCCCCCCCccccC-----CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPL-----GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++++...+     .......++.|+ +.++.|+|. ++++|+|++++||+++.++.++++|||++..........
T Consensus        96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql-~~~l~~lH~-~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657          96 MEFLEGGALTDIVTHTRMNEEQIAAVCLAV-LKALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             EecCCCCcHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence            6788888765433     222344577788 999999998 899999999999999999999999999876543221111


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                         ....++..|++||.+....++.++|+||+|++++++++ |..||...
T Consensus       174 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~t-g~~p~~~~  219 (292)
T cd06657         174 ---KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNE  219 (292)
T ss_pred             ---cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Confidence               11112346999998877777889999999999999998 99998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.80  E-value=1.4e-19  Score=120.11  Aligned_cols=120  Identities=25%  Similarity=0.391  Sum_probs=94.0

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+.++++...      +.......++.|+ ++|+.|+|. ++++|+|++++||+++.++.++++|||.+.........
T Consensus        79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i-~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEI-VLALEYLHS-KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHH-HHHHHHHHh-CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccc
Confidence            577888775433      3334456688888 999999998 89999999999999999999999999988654332111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                          ....++..|++||.+....++.++|+||+|++++++++ |..||...+.
T Consensus       157 ----~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~  204 (258)
T cd05578         157 ----TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR-GKRPYRGHSR  204 (258)
T ss_pred             ----cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHh-CCCCCCCCCc
Confidence                11112346999998877778899999999999999998 9999987653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.80  E-value=8.1e-20  Score=133.34  Aligned_cols=99  Identities=23%  Similarity=0.285  Sum_probs=72.0

Q ss_pred             hHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-CCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC--
Q psy7529          20 YIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-RHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG--   96 (129)
Q Consensus        20 ~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--   96 (129)
                      .++.|+ +.||.|+|. ++++||||||+||+++. .+.++++|||+++.........  ......++.|++||.+...  
T Consensus       259 ~i~~ql-l~aL~yLH~-~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~--~~~~~~t~~Y~APE~~~~~~~  334 (566)
T PLN03225        259 TIMRQI-LFALDGLHS-TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQ  334 (566)
T ss_pred             HHHHHH-HHHHHHHHH-CCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccC--CcccccCCCccChHHhhccCC
Confidence            477888 999999998 89999999999999986 5789999999997543221110  1111234569999955322  


Q ss_pred             --------------------CCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          97 --------------------RFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        97 --------------------~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                                          .++.++|+||+||++++++. +..++.
T Consensus       335 ~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~-~~~~~~  380 (566)
T PLN03225        335 TPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAF-PNLRSD  380 (566)
T ss_pred             CCCCccccccccccchhccccCCCCcccHHHHHHHHHHHh-CcCCCc
Confidence                                12345699999999999996 665543

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.80  E-value=2.4e-19  Score=119.74  Aligned_cols=120  Identities=28%  Similarity=0.472  Sum_probs=88.3

Q ss_pred             CCCCCCCCccccCC---------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-CCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPLG---------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-RHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-~~~~~l~d~~~~~~~~~   70 (129)
                      |||+.+++|...+.         ......++.|+ +.|+.|+|. ++++|||++++||+++. .+.++++|||.+.....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi-~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI-LEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHH-HHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            56777777554332         12234567788 999999998 99999999999999976 56899999998865432


Q ss_pred             CCceeeeccCCCCCceecccccccCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFG--RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .....   ....++..|++||.+...  .++.++|+||+|++++++++ |..||....
T Consensus       162 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~-g~~p~~~~~  215 (268)
T cd06624         162 INPCT---ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT-GKPPFIELG  215 (268)
T ss_pred             CCCcc---ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHh-CCCCCcccc
Confidence            11111   111224569999987554  36789999999999999998 999997643

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG4278|consensus

Probab=99.80  E-value=7.5e-20  Score=131.77  Aligned_cols=105  Identities=47%  Similarity=0.902  Sum_probs=91.7

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      +.+++.|| ..|+.||.. +..|||||...|+|+..+..+|++|||+++.+....  +..-.+...++.|.|||.+..+.
T Consensus       367 LlyMAtQI-sSaMeYLEk-knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT--YTAHAGAKFPIKWTAPEsLAyNt  442 (1157)
T KOG4278|consen  367 LLYMATQI-SSAMEYLEK-KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNT  442 (1157)
T ss_pred             HHHHHHHH-HHHHHHHHH-hhhhhhhhhhhhccccccceEEeeccchhhhhcCCc--eecccCccCcccccCcccccccc
Confidence            55688888 999999998 899999999999999999999999999999886532  33333445678899999998889


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+|++|+++||+.++|-.||.+++
T Consensus       443 FSiKSDVWAFGVLLWEIATYGMsPYPGid  471 (1157)
T KOG4278|consen  443 FSIKSDVWAFGVLLWEIATYGMSPYPGID  471 (1157)
T ss_pred             cccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence            99999999999999999999989999865

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.80  E-value=1.5e-19  Score=124.45  Aligned_cols=107  Identities=30%  Similarity=0.411  Sum_probs=81.9

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee--eeccCCCCCceeccccccc
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY--KATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~   94 (129)
                      ....++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||+++.........  .....-.++..|++||.+.
T Consensus       108 ~~~~i~~qi-~~~L~~LH~-~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  185 (337)
T cd07852         108 HKRYIMYQL-LKALKYIHS-GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILL  185 (337)
T ss_pred             HHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeee
Confidence            445578888 999999998 899999999999999999999999999887543221110  0000111234699999875


Q ss_pred             CC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 FG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 ~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +. .++.++|+||+|++++++++ |..||.+.+
T Consensus       186 ~~~~~~~~sDi~slG~~l~el~t-g~~pf~~~~  217 (337)
T cd07852         186 GSTRYTKGVDMWSVGCILGEMLL-GKPLFPGTS  217 (337)
T ss_pred             ccccccccchHHHHHHHHHHHHh-CCCCCCCCC
Confidence            43 46788999999999999998 999997543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.80  E-value=3e-19  Score=120.15  Aligned_cols=120  Identities=21%  Similarity=0.264  Sum_probs=89.7

Q ss_pred             CCCCCCCCccc------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVT------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+.++.+..      .+.......++.|+ ++|+.|+|. ++++|+|++++||+++.++.++++|||++.........
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i-~~~l~~LH~-~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          79 FEYVERTLLELLEASPGGLPPDAVRSYIWQL-LQAIAYCHS-HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            56776654321      12233455578888 999999998 89999999999999999999999999998764332210


Q ss_pred             eeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ...  ....+..|++||.+... .++.++|+||+|++++++++ |..||.+.
T Consensus       157 ~~~--~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~~~~~  205 (288)
T cd07833         157 PLT--DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD-GEPLFPGD  205 (288)
T ss_pred             ccc--CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh-CCCCCCCC
Confidence            000  11123458999998777 67889999999999999998 99998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.80  E-value=1.7e-19  Score=121.90  Aligned_cols=106  Identities=27%  Similarity=0.335  Sum_probs=83.4

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ......++.|+ +.|+.|+|. ++++|+||+++||+++.++.++++|||+++..........   ....+..|++||.+.
T Consensus       105 ~~~~~~i~~qi-~~aL~~LH~-~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~---~~~~~~~~~aPE~~~  179 (293)
T cd07843         105 QSEVKCLMLQL-LSGVAHLHD-NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT---QLVVTLWYRAPELLL  179 (293)
T ss_pred             HHHHHHHHHHH-HHHHHHHHH-CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccc---cccccccccCchhhc
Confidence            33455688888 999999998 8999999999999999999999999998876543211111   111234699999876


Q ss_pred             CC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 FG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 ~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +. .++.++|+||+|++++++++ |..||...+
T Consensus       180 ~~~~~~~~~Di~slG~~l~~l~~-g~~~f~~~~  211 (293)
T cd07843         180 GAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKS  211 (293)
T ss_pred             CCccccchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            54 35788999999999999998 999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.80  E-value=8.8e-20  Score=121.40  Aligned_cols=118  Identities=31%  Similarity=0.419  Sum_probs=91.2

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+.+.+|...+.       ......++.|+ +.|+.|+|...+++|+|++++||+++.++.+++.|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAV-LKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHH-HHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            46677666554333       23345578888 99999999757899999999999999999999999998765432211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ..     ...+..|++||.+.+..++.++|+||+|++++++++ |..||.+.
T Consensus       157 ~~-----~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~  202 (265)
T cd06605         157 KT-----FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELAT-GRFPYPPE  202 (265)
T ss_pred             hc-----ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCcc
Confidence            11     122346999999887788899999999999999998 99999765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.80  E-value=2e-19  Score=122.06  Aligned_cols=110  Identities=21%  Similarity=0.296  Sum_probs=83.3

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee-eeccCCCCCceeccccc
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY-KATHGGRWPIKWYAPES   92 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe~   92 (129)
                      .......++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||++.......... ........+..|++||.
T Consensus       117 ~~~~~~~i~~qi-~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  194 (310)
T cd07865         117 TLSEIKKVMKML-LNGLYYIHR-NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL  194 (310)
T ss_pred             CHHHHHHHHHHH-HHHHHHHHH-CCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHH
Confidence            334455688888 999999998 899999999999999999999999999987543221110 00011122356999998


Q ss_pred             ccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          93 YNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        93 ~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +.+. .++.++|+||+|++++++++ |..||.+.+
T Consensus       195 ~~~~~~~~~~~Di~slG~~l~el~t-~~~~~~~~~  228 (310)
T cd07865         195 LLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNT  228 (310)
T ss_pred             hcCCcccCchhhhHHHHHHHHHHHh-CCCCCCCCC
Confidence            7654 36788999999999999998 999986543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG4717|consensus

Probab=99.80  E-value=1.9e-19  Score=127.27  Aligned_cols=106  Identities=25%  Similarity=0.438  Sum_probs=87.7

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe-cCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL-ASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      ..+.+|+|| ..|+-|+|. -.++||||||+|+++ .+-+-+|+.|||++..+.+...    ....++++.|-|||.+.+
T Consensus       119 La~kYF~QI-~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k----L~TsCGSLAYSAPEILLG  192 (864)
T KOG4717|consen  119 LAKKYFAQI-VHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK----LTTSCGSLAYSAPEILLG  192 (864)
T ss_pred             HHHHHHHHH-HHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccccCCCcch----hhcccchhhccCchhhhc
Confidence            356699999 999999998 789999999999986 5678899999999877654432    222334577999999999


Q ss_pred             CCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q psy7529          96 GRFS-SASDVWSFGITLWEMYSFGQQPYGEMKGSD  129 (129)
Q Consensus        96 ~~~~-~~~di~s~g~~l~~l~~~~~~pf~~~~~~e  129 (129)
                      ..|+ +.+||||+|+++|.+.. |+.||++-+..|
T Consensus       193 DsYDAPAVDiWSLGVILyMLVC-Gq~PFqeANDSE  226 (864)
T KOG4717|consen  193 DSYDAPAVDIWSLGVILYMLVC-GQPPFQEANDSE  226 (864)
T ss_pred             CccCCcchhhhHHHHHHHHHHh-CCCccccccchh
Confidence            8885 78999999999999998 999999876654

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.80  E-value=2.9e-19  Score=122.89  Aligned_cols=109  Identities=25%  Similarity=0.303  Sum_probs=84.1

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee-eeccCCCCCceecccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY-KATHGGRWPIKWYAPESY   93 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~   93 (129)
                      ......++.|+ +.||.|+|. ++++|||+||+||+++.++.++++|||+++......... .......++..|++||..
T Consensus       104 ~~~~~~~~~qi-~~aL~~LH~-~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~  181 (332)
T cd07857         104 DAHFQSFIYQI-LCGLKYIHS-ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM  181 (332)
T ss_pred             HHHHHHHHHHH-HHHHHHHHh-CCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHH
Confidence            34456688888 999999998 899999999999999999999999999987543221110 001111234569999987


Q ss_pred             cC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          94 NF-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        94 ~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .+ ..++.++|+||+|++++++++ |..||...+
T Consensus       182 ~~~~~~~~~~Di~slGv~l~~l~~-g~~pf~~~~  214 (332)
T cd07857         182 LSFQSYTKAIDVWSVGCILAELLG-RKPVFKGKD  214 (332)
T ss_pred             hCCCCCCcHHHHHHHHHHHHHHHh-CCcCCCCCC
Confidence            65 457889999999999999998 999997643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.80  E-value=3.1e-19  Score=120.39  Aligned_cols=117  Identities=30%  Similarity=0.411  Sum_probs=91.2

Q ss_pred             CCCCCCCCccccC----------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPL----------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||+++++|...+          .......++.|+ +.|+.|+|. .+++|+|++++||+++.++.++++|||++.....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i-~~~L~~lH~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESV-LKGLSYLHS-RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            5788887764322          222344588888 999999998 8999999999999999999999999998764332


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ....     ....+..|++||.+....++.+.|+|++|+++|++++ |..||...
T Consensus       158 ~~~~-----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~  206 (287)
T cd06621         158 SLAG-----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ-NRFPFPPE  206 (287)
T ss_pred             cccc-----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCcc
Confidence            1111     1112346999999887788889999999999999998 99999765

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.79  E-value=2e-19  Score=120.61  Aligned_cols=104  Identities=24%  Similarity=0.349  Sum_probs=81.2

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ......++.|+ +.|+.|+|. ++++|+|++|+||+++. +.++++|||+++.........    ....+..|++||.+.
T Consensus        99 ~~~~~~~~~qi-~~~L~~LH~-~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~----~~~~~~~y~aPE~~~  171 (282)
T cd07831          99 EKRVKSYMYQL-LKSLDHMHR-NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT----EYISTRWYRAPECLL  171 (282)
T ss_pred             HHHHHHHHHHH-HHHHHHHHH-CCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC----CCCCCcccCChhHhh
Confidence            33456688888 999999998 89999999999999999 999999999987653221111    011234699999764


Q ss_pred             C-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 F-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 ~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . ..++.++|+||+|++++++++ |..||.+.+
T Consensus       172 ~~~~~~~~~Di~slGv~l~el~~-~~~p~~~~~  203 (282)
T cd07831         172 TDGYYGPKMDIWAVGCVFFEILS-LFPLFPGTN  203 (282)
T ss_pred             cCCCCCcchhHHHHHHHHHHHHc-CCcCCCCCC
Confidence            4 346788999999999999998 999997643

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.79  E-value=1.3e-19  Score=122.11  Aligned_cols=120  Identities=26%  Similarity=0.473  Sum_probs=91.9

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+++++|...+..       .....++.|+ +.|+.++|. .+++|+|++|+||+++.++.++++|||++........
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i-~~~L~~lH~-~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREV-LQGLEYLHS-QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHH-HHHHHHHHh-CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            567777775544332       3455588888 999999998 9999999999999999999999999998754332211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...   ...++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       172 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~-g~~p~~~~~  220 (286)
T cd06614         172 KRN---SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAE-GEPPYLREP  220 (286)
T ss_pred             hhc---cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHh-CCCCCCCCC
Confidence            111   1112345999998877778899999999999999998 999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.79  E-value=1.9e-19  Score=121.25  Aligned_cols=105  Identities=32%  Similarity=0.461  Sum_probs=82.9

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ......++.|+ +.|+.|+|...+++|||++|+||+++.++.++++|||+++........    ....++..|++||.+.
T Consensus       106 ~~~~~~i~~~i-~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~  180 (288)
T cd06616         106 EEILGKIAVAT-VKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMAPERID  180 (288)
T ss_pred             HHHHHHHHHHH-HHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc----ccccCccCccCHHHhc
Confidence            34455688888 999999997458999999999999999999999999998654322111    1112245699999886


Q ss_pred             CC---CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          95 FG---RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        95 ~~---~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ..   .++.++|+||+|++++++++ |+.||...
T Consensus       181 ~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~  213 (288)
T cd06616         181 PSARDGYDVRSDVWSLGITLYEVAT-GKFPYPKW  213 (288)
T ss_pred             cccccCCcchhhhhHHHHHHHHHHh-CCCCchhc
Confidence            65   57889999999999999998 99999754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.79  E-value=2.6e-19  Score=120.17  Aligned_cols=120  Identities=28%  Similarity=0.461  Sum_probs=91.8

Q ss_pred             CCCCCCCCccccCCC-----CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLGS-----YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++++...+..     .....++.++ +.++.++|. ++++|+|++++||+++.++.+++.|||++..........
T Consensus        81 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l-~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06641          81 MEYLGGGSALDLLEPGPLDETQIATILREI-LKGLDYLHS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EEeCCCCcHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHcc-CCeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence            678888876554432     2345577777 999999998 999999999999999999999999999886543221111


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   ....+..|++||.+....++.++|+||+|++++++++ |..||.+.+
T Consensus       159 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~  205 (277)
T cd06641         159 N---TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPHSELH  205 (277)
T ss_pred             c---cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCccc
Confidence            0   1112345899998877777889999999999999998 999997654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.79  E-value=1.8e-19  Score=123.97  Aligned_cols=108  Identities=25%  Similarity=0.362  Sum_probs=83.3

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeee-ccCCCCCceeccccccc
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA-THGGRWPIKWYAPESYN   94 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~   94 (129)
                      .....++.|+ +.|+.|+|. ++++|||++++||+++.++.++++|||+++........... .....++..|++||.+.
T Consensus       107 ~~~~~i~~qi-~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  184 (334)
T cd07855         107 EHIRYFLYQL-LRGLKYIHS-ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL  184 (334)
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhc
Confidence            3456688888 999999998 89999999999999999999999999998764322111000 01112234689999875


Q ss_pred             C-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 F-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 ~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . ..++.++|+||+|++++++++ |..||.+.+
T Consensus       185 ~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~  216 (334)
T cd07855         185 SLPEYTTAIDMWSVGCIFAEMLG-RRQLFPGKN  216 (334)
T ss_pred             CCcccccccchHHHHHHHHHHHc-CCCccCCCC
Confidence            5 357889999999999999998 999997654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.79  E-value=2.4e-19  Score=120.45  Aligned_cols=119  Identities=23%  Similarity=0.315  Sum_probs=88.9

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+ ++++...+       .......++.|+ ++|+.|+|. ++++|+|++++||+++.++.++++|||.+........
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRML-LKGVAYMHA-NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            5677 77654433       233455678888 999999998 8999999999999999999999999998876533221


Q ss_pred             eeeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .  ......++..|++||.+... .++.++|+||+|++++++++ |..||.+.
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~~~~~~  204 (286)
T cd07832         155 R--LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN-GSPLFPGE  204 (286)
T ss_pred             C--ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHc-CCcCcCCC
Confidence            0  01111234569999987654 45789999999999999998 98777653

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.79  E-value=4.7e-19  Score=121.20  Aligned_cols=100  Identities=31%  Similarity=0.453  Sum_probs=80.1

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc--
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN--   94 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--   94 (129)
                      ....++.++ +.|+.|+|. ++++|+|++++||+++.++.++++|||++.......       ...++..|++||.+.  
T Consensus       126 ~~~~i~~~i-~~~l~~lH~-~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~y~aPE~~~~~  196 (317)
T cd06635         126 EIAAITHGA-LQGLAYLHS-HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-------SFVGTPYWMAPEVILAM  196 (317)
T ss_pred             HHHHHHHHH-HHHHHHHHH-CCcccCCCCcccEEECCCCCEEEecCCCccccCCcc-------cccCCccccChhhhhcC
Confidence            445577888 999999998 899999999999999999999999999876433211       111234599999863  


Q ss_pred             -CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 -FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 -~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       ...++.++|+||+|++++++++ |..||.+.+
T Consensus       197 ~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~  228 (317)
T cd06635         197 DEGQYDGKVDVWSLGITCIELAE-RKPPLFNMN  228 (317)
T ss_pred             CCCCCCccccHHHHHHHHHHHHh-CCCCCCCcc
Confidence             3456788999999999999998 999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.79  E-value=3e-19  Score=122.65  Aligned_cols=123  Identities=20%  Similarity=0.272  Sum_probs=87.0

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+.++++...+.        ......++.|+ +.||.|+|. ++++|||+||+||+++..+.+++.||+.........
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi-~~aL~~lH~-~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGA-LRGLNYLHQ-NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             EecccCCCHHHHHHhhcccCCCHHHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence            46666666443332        22234578888 999999998 899999999999999999999999987543221110


Q ss_pred             c----eeeeccCCCCCceecccccccCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 N----YYKATHGGRWPIKWYAPESYNFG--RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~----~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .    .............|++||.+.+.  .++.++|+||+|++++++++ |..||.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~  214 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELAT-GRVPFQDML  214 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcC
Confidence            0    00000011123459999988653  46789999999999999998 999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.79  E-value=6.3e-19  Score=118.48  Aligned_cols=103  Identities=25%  Similarity=0.371  Sum_probs=80.3

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ +.|+.|+|. .+++|+|++|+||+++.++.++++|||+++..........   ....+..|++||.+.+.
T Consensus       101 ~~~~~~~~i-~~~l~~lh~-~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~  175 (284)
T cd07860         101 LIKSYLFQL-LQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEILLGC  175 (284)
T ss_pred             HHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc---cccccccccCCeEEecC
Confidence            345577788 999999998 8999999999999999999999999998865432211111   11123459999987654


Q ss_pred             C-CCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          97 R-FSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        97 ~-~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      . ++.++|+||+|++++++++ |+.||.+.
T Consensus       176 ~~~~~~~Dv~slG~il~~l~t-g~~p~~~~  204 (284)
T cd07860         176 KYYSTAVDIWSLGCIFAEMVT-RRALFPGD  204 (284)
T ss_pred             CCCCcHHHHHHHHHHHHHHHH-CCCCCCCC
Confidence            3 5788999999999999998 99998653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.79  E-value=4.7e-19  Score=122.42  Aligned_cols=101  Identities=27%  Similarity=0.416  Sum_probs=81.3

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC-
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF-   95 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-   95 (129)
                      ....++.|+ +.|+.|+|. ++++|||++++||+++.++.++++|||+++.......      ...++..|++||.+.+ 
T Consensus       118 ~~~~~~~qi-~~aL~~LH~-~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~~------~~~~~~~y~aPE~~~~~  189 (342)
T cd07879         118 KVQYLVYQM-LCGLKYIHS-AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT------GYVVTRWYRAPEVILNW  189 (342)
T ss_pred             HHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCCC------CceeeecccChhhhcCc
Confidence            445577888 999999998 8999999999999999999999999999865422111      1112345899998765 


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..++.++|+||+|++++++++ |+.||.+.+
T Consensus       190 ~~~~~~~Dv~slGvil~el~~-g~~pf~~~~  219 (342)
T cd07879         190 MHYNQTVDIWSVGCIMAEMLT-GKTLFKGKD  219 (342)
T ss_pred             cccCchHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            357889999999999999998 999998643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0665|consensus

Probab=99.79  E-value=1.7e-19  Score=120.54  Aligned_cols=101  Identities=28%  Similarity=0.374  Sum_probs=84.1

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCC--CceeeeccCCCCCceeccccccc
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSE--RNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ..+.+.+|. +.|++++|+ .+|+||||||+||++..+..+|+.|||+++.....  .+.+.      .+.-|.|||.+.
T Consensus       119 tis~i~yq~-~~~ik~lhs-~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyV------vtRyyrapevil  190 (369)
T KOG0665|consen  119 TISYILYQM-LCGIKHLHS-AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYV------VTRYYRAPEVIL  190 (369)
T ss_pred             HHHHHHHHH-HHHHHHHHh-cceeecccCcccceecchhheeeccchhhcccCcccccCchh------heeeccCchhee
Confidence            467799999 889999999 99999999999999999999999999999754321  11111      123488999999


Q ss_pred             CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 ~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +..+...+|+||+||++.|++. |..-|.+.+
T Consensus       191 ~~~~ke~vdiwSvGci~gEli~-~~Vlf~g~d  221 (369)
T KOG0665|consen  191 GMGYKENVDIWSVGCIMGELIL-GTVLFPGKD  221 (369)
T ss_pred             ccCCcccchhhhhhhHHHHHhh-ceEEecCch
Confidence            8889999999999999999998 998887644

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.79  E-value=5e-19  Score=117.08  Aligned_cols=119  Identities=25%  Similarity=0.341  Sum_probs=91.8

Q ss_pred             CCCCCCCCccccC----------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPL----------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||.+++++...+          .......++.|+ ++|+.|+|. .+++|+|++++||+++..+.+++.|||+++....
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l-~~al~~lh~-~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL-LRGLQALHE-QKILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHH-HHHHHHHhh-CCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            5677777754332          222344577788 999999998 8999999999999999999999999999876543


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ...     .....+..|++||......++.++|+||+|++++++++ |..||...+.
T Consensus       156 ~~~-----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~-g~~p~~~~~~  206 (256)
T cd08530         156 NMA-----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT-FAPPFEARSM  206 (256)
T ss_pred             CCc-----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Confidence            311     11122346999999887778889999999999999998 9999986553

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.79  E-value=6e-19  Score=118.63  Aligned_cols=119  Identities=21%  Similarity=0.300  Sum_probs=88.5

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++.+...      +.......++.|+ ++|+.|+|. .+++|+|++++||+++.++.++++|||++.........
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i-~~~l~~LH~-~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQI-LRGIEFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             EecCCccHHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHH-CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence            567776654322      2333455578888 999999998 89999999999999999999999999988754322111


Q ss_pred             eeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ..   ....+..|++||.+.+. .++.++|+||+|++++++++ |..||...
T Consensus       157 ~~---~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~-g~~~~~~~  204 (286)
T cd07846         157 YT---DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT-GEPLFPGD  204 (286)
T ss_pred             cC---cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHc-CCCCCCCC
Confidence            10   11123468999987653 46778999999999999998 99888653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.79  E-value=7e-19  Score=119.75  Aligned_cols=103  Identities=30%  Similarity=0.429  Sum_probs=81.7

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      ....+..++.|+ +.|+.|+|. .+++|+|++|+||+++.++.+++.|||+++.......       ...+..|++||.+
T Consensus       113 ~~~~~~~~~~ql-~~~L~~LH~-~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~-------~~~~~~y~aPE~~  183 (307)
T cd06607         113 QEVEIAAICHGA-LQGLAYLHS-HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-------FVGTPYWMAPEVI  183 (307)
T ss_pred             CHHHHHHHHHHH-HHHHHHHHH-CCceecCCCcccEEECCCCCEEEeecCcceecCCCCC-------ccCCccccCceee
Confidence            333455578888 999999998 8999999999999999999999999998865432211       1123459999987


Q ss_pred             c---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          94 N---FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        94 ~---~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   ...++.++|+||+|+++|++++ |..||.+.+
T Consensus       184 ~~~~~~~~~~~sDv~s~G~il~el~t-g~~p~~~~~  218 (307)
T cd06607         184 LAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMN  218 (307)
T ss_pred             eccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCcc
Confidence            4   3457789999999999999998 999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.79  E-value=3.6e-19  Score=117.07  Aligned_cols=118  Identities=32%  Similarity=0.520  Sum_probs=91.4

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+.+.++...+       .......++.|+ ++|+.++|. ++++|+|++|+||+++..+.+++.|||.+........
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i-~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKEL-LKGLEYLHS-NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHH-HHHHHHhhc-CCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            4677777755433       223445578888 999999999 9999999999999999999999999998876543221


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                       .   ....++..|++||......++.+.|+||+|++++++++ |..||...
T Consensus       154 -~---~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~  200 (253)
T cd05122         154 -R---NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAE-GKPPYSEL  200 (253)
T ss_pred             -c---cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHh-CCCCCCCC
Confidence             0   11112346999998877777889999999999999998 99999765

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.79  E-value=3e-19  Score=122.53  Aligned_cols=108  Identities=29%  Similarity=0.401  Sum_probs=84.6

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ ++|+.++|. ++++|+|++++||+++.++.++++|||.+..................+..|++||.+.+
T Consensus       103 ~~~~~i~~~l-~~~l~~LH~-~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  180 (330)
T cd07834         103 DHIQYFLYQI-LRGLKYLHS-ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS  180 (330)
T ss_pred             HHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeec
Confidence            3345578888 999999998 89999999999999999999999999998765433210001111122345899999877


Q ss_pred             C-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 G-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . .++.++|+||+|++++++++ |..||.+.+
T Consensus       181 ~~~~~~~sDi~slG~il~~l~~-g~~pf~~~~  211 (330)
T cd07834         181 SSRYTKAIDIWSVGCIFAELLT-RKPLFPGRD  211 (330)
T ss_pred             ccCCCcchhHHHHHHHHHHHHc-CCCCcCCCC
Confidence            6 67889999999999999998 999997654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.79  E-value=5.8e-19  Score=119.01  Aligned_cols=119  Identities=27%  Similarity=0.370  Sum_probs=90.1

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+.      ......++.|+ ++++.|+|. .+++|+|++++||+++.++.++++|||+++........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql-~~~l~~lH~-~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  161 (288)
T cd05583          84 LDYVNGGELFTHLYQREHFTESEVRVYIAEI-VLALDHLHQ-LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE  161 (288)
T ss_pred             EecCCCCcHHHHHhhcCCcCHHHHHHHHHHH-HHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEEECcccccccccccc
Confidence            67888887654432      23455567788 999999998 89999999999999999999999999988654322111


Q ss_pred             eeeccCCCCCceecccccccCCC--CCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGR--FSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~--~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .  .....++..|++||...+..  .+.++|+||+|++++++++ |..||..
T Consensus       162 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~  210 (288)
T cd05583         162 R--AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT-GASPFTV  210 (288)
T ss_pred             c--cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHh-CCCCccc
Confidence            1  11112245699999876554  5788999999999999998 9999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.78  E-value=5.5e-19  Score=117.36  Aligned_cols=121  Identities=29%  Similarity=0.480  Sum_probs=93.0

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+.      ......++.|+ +.|+.|+|..++++|+|++++||+++.++.++++|||.+.........
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l-~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQI-LKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            56777777554443      23345578888 999999996578999999999999999999999999988765322211


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   ....+..|++||.+....++.++|+|++|++++++++ |..||.+..
T Consensus       157 ~~---~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~  204 (264)
T cd06623         157 CN---TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECAL-GKFPFLPPG  204 (264)
T ss_pred             cc---ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCcccc
Confidence            10   1112346999999887778889999999999999998 999997764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.78  E-value=1.6e-18  Score=114.41  Aligned_cols=120  Identities=28%  Similarity=0.441  Sum_probs=92.3

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.++|. .+++|+|++++||+++.++.++++|||.+........ 
T Consensus        72 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi-~~~l~~lh~-~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-  148 (250)
T cd05123          72 LEYAPGGELFSHLSKEGRFSEERARFYAAEI-VLALEYLHS-LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-  148 (250)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-
Confidence            5777777765433      333455577788 999999999 9999999999999999999999999998865432210 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        .......+..|++||.......+.++|+|++|++++++++ |..||...+
T Consensus       149 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~-g~~p~~~~~  197 (250)
T cd05123         149 --RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT-GKPPFYAED  197 (250)
T ss_pred             --cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCC
Confidence              0111122346999998877777889999999999999998 999997544

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0666|consensus

Probab=99.78  E-value=2.7e-19  Score=119.77  Aligned_cols=104  Identities=28%  Similarity=0.353  Sum_probs=81.2

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC----CcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR----HQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      .+-|..|+ +.|+.|+|. +=++||||||.||++-.+    +.+|++|+|+++.+.++....-..-.-..+.=|.|||.+
T Consensus       134 vKsilwQi-l~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELL  211 (438)
T KOG0666|consen  134 VKSILWQI-LDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELL  211 (438)
T ss_pred             HHHHHHHH-HhhhHHHhh-hheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHh
Confidence            45588999 999999998 889999999999999766    899999999999775543221111111113347899998


Q ss_pred             cCC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          94 NFG-RFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        94 ~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .+. .|.+..|+|++||++.|+++ -++.|..
T Consensus       212 LGa~hYT~AiDvWAiGCIfaElLt-l~PlF~g  242 (438)
T KOG0666|consen  212 LGARHYTKAIDVWAIGCIFAELLT-LEPLFKG  242 (438)
T ss_pred             cccccccchhhhHHHHHHHHHHHc-cCccccc
Confidence            877 58899999999999999998 6776664

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.78  E-value=4.8e-19  Score=118.79  Aligned_cols=105  Identities=24%  Similarity=0.315  Sum_probs=82.9

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||.+...........   ....+..|.+||.+.+
T Consensus        98 ~~~~~~~~~i-~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~~~~~PE~~~~  172 (283)
T cd05118          98 SLIKSYLYQL-LQGLAFCHS-HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT---HYVVTRWYRAPELLLG  172 (283)
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc---CccCcccccCcHHHhc
Confidence            3455688888 999999998 8999999999999999999999999998865543221111   1112345899998766


Q ss_pred             C-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 G-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . .++.++|+||+|++++++++ |..||.+.+
T Consensus       173 ~~~~~~~~Di~slG~~l~~l~t-g~~~~~~~~  203 (283)
T cd05118         173 DKGYSTPVDIWSVGCIFAELLS-RRPLFPGKS  203 (283)
T ss_pred             CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            5 67889999999999999998 999987644

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.78  E-value=7.5e-19  Score=116.32  Aligned_cols=119  Identities=24%  Similarity=0.346  Sum_probs=89.8

Q ss_pred             CCCCCCCCccccC--------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC-cEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPL--------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH-QAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~-~~~l~d~~~~~~~~~~   71 (129)
                      |||++++++...+        .......++.++ +.++.|+|. ++++|+|++++||+++.+. .++++|||.++.....
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i-~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI-LLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            5777777754333        223345577788 999999998 8999999999999997654 4799999998765322


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...    ....++..|++||.+....++.++|+||+|++++++++ |..||...+
T Consensus       156 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~  205 (256)
T cd08220         156 SKA----YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS-LKRAFEAAN  205 (256)
T ss_pred             ccc----cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHh-CCCCcccCc
Confidence            111    01112346999999887777889999999999999998 999997654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.78  E-value=5.6e-19  Score=121.77  Aligned_cols=103  Identities=26%  Similarity=0.419  Sum_probs=81.5

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC-
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF-   95 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-   95 (129)
                      ....++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||+++.........   ....++..|++||.+.. 
T Consensus       109 ~~~~i~~qi-~~aL~~LH~-~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~  183 (337)
T cd07858         109 HCQYFLYQL-LRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM---TEYVVTRWYRAPELLLNC  183 (337)
T ss_pred             HHHHHHHHH-HHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccc---cccccccCccChHHHhcC
Confidence            345578888 999999998 899999999999999999999999999987653321110   11112346999998754 


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ..++.++|+||+|++++++++ |..||.+.
T Consensus       184 ~~~~~~~DiwslG~il~~l~~-g~~pf~~~  212 (337)
T cd07858         184 SEYTTAIDVWSVGCIFAELLG-RKPLFPGK  212 (337)
T ss_pred             CCCCCcccHHHHHHHHHHHHc-CCCCCCCC
Confidence            357889999999999999998 99999754

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.78  E-value=7.9e-19  Score=118.67  Aligned_cols=102  Identities=25%  Similarity=0.366  Sum_probs=77.9

Q ss_pred             hhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-CCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC-
Q psy7529          19 PYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-RHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG-   96 (129)
Q Consensus        19 ~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-   96 (129)
                      ..++.|+ +.|+.|+|. ++++|+|++++||+++. ...++++|||+++..........   ...++..|++||.+.+. 
T Consensus       105 ~~~~~qi-~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~~y~~PE~~~~~~  179 (294)
T PLN00009        105 KTYLYQI-LRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT---HEVVTLWYRAPEILLGSR  179 (294)
T ss_pred             HHHHHHH-HHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccc---cCceeecccCHHHHhCCC
Confidence            3467788 999999998 89999999999999985 45689999999865432211111   11123469999987553 


Q ss_pred             CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          97 RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        97 ~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .++.++|+||+|++++++++ |..||.+.+
T Consensus       180 ~~~~~~Dv~slG~i~~~l~t-g~~pf~~~~  208 (294)
T PLN00009        180 HYSTPVDIWSVGCIFAEMVN-QKPLFPGDS  208 (294)
T ss_pred             CCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            46789999999999999998 999997543

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.78  E-value=3.2e-19  Score=118.23  Aligned_cols=119  Identities=22%  Similarity=0.357  Sum_probs=90.7

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+.++++...+..        .....++.|+ +.|+.|+|. ++++|+|++++||+++.++.+++.|||++.......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lh~-~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQI-CLALKHVHD-RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHH-HHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            578888776544322        2234467788 999999998 899999999999999999999999999887543221


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ...   ....++..|++||...+...+.++|+||+|++++++++ |..||...
T Consensus       156 ~~~---~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~-g~~~~~~~  204 (256)
T cd08218         156 ELA---RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT-LKHAFEAG  204 (256)
T ss_pred             hhh---hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHc-CCCCccCC
Confidence            111   01112345999999877777889999999999999998 99998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.78  E-value=1.9e-18  Score=118.06  Aligned_cols=101  Identities=31%  Similarity=0.443  Sum_probs=80.5

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc-
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN-   94 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-   94 (129)
                      .....++.|+ +.++.|+|. ++++|+|++|+||+++.++.++++|||++.......       ...++..|++||.+. 
T Consensus       121 ~~~~~~~~qi-~~al~~LH~-~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~-------~~~~~~~y~aPE~~~~  191 (313)
T cd06633         121 VEIAAITHGA-LQGLAYLHS-HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN-------SFVGTPYWMAPEVILA  191 (313)
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCeecCCCChhhEEECCCCCEEEeecCCCcccCCCC-------CccccccccChhhccc
Confidence            3445578888 999999998 899999999999999999999999999875432111       111234699999874 


Q ss_pred             --CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 --FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 --~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        ...++.++|+||+|++++++++ |..||.+.+
T Consensus       192 ~~~~~~~~~sDv~slGvil~el~~-g~~p~~~~~  224 (313)
T cd06633         192 MDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMN  224 (313)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence              3457789999999999999998 999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.77  E-value=8.1e-19  Score=117.42  Aligned_cols=123  Identities=22%  Similarity=0.399  Sum_probs=93.9

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||+++++++.+.+..      .....++.|+ +.|+.++|. ++++|+|++++||+++.++.++++|||++.........
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql-~~~l~~Lh~-~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEI-LLALEYLHS-KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            678888886554433      3456688888 999999998 89999999999999999999999999988754322110


Q ss_pred             e-----------------eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 Y-----------------KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~-----------------~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .                 ........+..|++||.......+.++|+|++|++++++++ |..||...+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~  226 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT-GKPPFRGSN  226 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHh-CCCCCCCcc
Confidence            0                 00011112356899998877777889999999999999998 999997643

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.77  E-value=9.1e-19  Score=117.64  Aligned_cols=106  Identities=25%  Similarity=0.395  Sum_probs=85.1

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      +......++.|+ ++|+.|+|. ++++|+|++++|++++.++.++++|||.++........    .....+..|++||.+
T Consensus       105 ~~~~~~~~~~~i-~~al~~LH~-~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~PE~~  178 (287)
T cd07838         105 PPETIKDLMRQL-LRGVDFLHS-HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL----TSVVVTLWYRAPEVL  178 (287)
T ss_pred             CHHHHHHHHHHH-HHHHHHHHH-CCeeeccCChhhEEEccCCCEEEeccCcceeccCCccc----ccccccccccChHHh
Confidence            334456688888 999999999 89999999999999999999999999988765322111    111123569999998


Q ss_pred             cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          94 NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        94 ~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .+..++.++|+||+|++++++++ |..||.+.+
T Consensus       179 ~~~~~~~~~Di~s~G~~l~~l~~-~~~~~~~~~  210 (287)
T cd07838         179 LQSSYATPVDMWSVGCIFAELFR-RRPLFRGTS  210 (287)
T ss_pred             ccCCCCCcchhhhHHHHHHHHHh-CCCcccCCC
Confidence            87788889999999999999998 999987654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.77  E-value=1.2e-18  Score=120.54  Aligned_cols=101  Identities=26%  Similarity=0.418  Sum_probs=81.1

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC-
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF-   95 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-   95 (129)
                      ....++.|+ ++|+.|+|. ++++|||++++||+++.++.++++|||+++.......      ...++..|++||.+.+ 
T Consensus       121 ~~~~i~~qi-~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~y~aPE~~~~~  192 (345)
T cd07877         121 HVQFLIYQI-LRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT------GYVATRWYRAPEIMLNW  192 (345)
T ss_pred             HHHHHHHHH-HHHHHHHHH-CCeeecCCChHHEEEcCCCCEEEeccccccccccccc------ccccCCCccCHHHHhCc
Confidence            455588888 999999998 8999999999999999999999999999865422111      1112345899998765 


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..++.++|+||+|++++++++ |+.||...+
T Consensus       193 ~~~~~~~DvwslG~il~el~~-g~~pf~~~~  222 (345)
T cd07877         193 MHYNQTVDIWSVGCIMAELLT-GRTLFPGTD  222 (345)
T ss_pred             cCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            357789999999999999998 999997543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.77  E-value=8.1e-19  Score=117.88  Aligned_cols=106  Identities=25%  Similarity=0.424  Sum_probs=82.4

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ......++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||+++.........   .....+..|++||.+.
T Consensus        99 ~~~~~~~~~qi-~~~l~~lH~-~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~---~~~~~~~~y~~PE~~~  173 (284)
T cd07836          99 PNTVKSFTYQL-LKGIAFCHE-NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF---SNEVVTLWYRAPDVLL  173 (284)
T ss_pred             HHHHHHHHHHH-HHHHHHHHH-CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc---ccccccccccChHHhc
Confidence            33455688888 999999998 899999999999999999999999999886543211100   1111234599999876


Q ss_pred             CC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 FG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 ~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +. .++.++|+|++|++++++++ |..||.+.+
T Consensus       174 ~~~~~~~~~Dv~slG~~l~~l~~-g~~~~~~~~  205 (284)
T cd07836         174 GSRTYSTSIDIWSVGCIMAEMIT-GRPLFPGTN  205 (284)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            54 46789999999999999998 999997654

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.77  E-value=1.6e-18  Score=114.42  Aligned_cols=120  Identities=26%  Similarity=0.421  Sum_probs=91.2

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.++.++|. ++++|+|++++||+++..+.+++.|||.+.........
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQV-LQGLAYLHE-QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHH-HHHHHHHhh-CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            4667776654433      223345577888 999999998 89999999999999999999999999988765332211


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ......+..|++||.......+.++|+|++|++++++++ |..||.+.+
T Consensus       156 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~-g~~p~~~~~  203 (254)
T cd06627         156 ---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLT-GNPPYYDLN  203 (254)
T ss_pred             ---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCcc
Confidence               111122356999998876677889999999999999998 999997654

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.77  E-value=1.2e-18  Score=117.04  Aligned_cols=103  Identities=33%  Similarity=0.469  Sum_probs=80.2

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC-
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF-   95 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-   95 (129)
                      ....++.|+ +.|+.|+|...+++|||++|+||+++.++.++++|||+++........    .....+..|++||.+.+ 
T Consensus       104 ~~~~~~~qi-~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~  178 (283)
T cd06617         104 ILGKIAVSI-VKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK----TIDAGCKPYMAPERINPE  178 (283)
T ss_pred             HHHHHHHHH-HHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc----ccccCCccccChhhcCCc
Confidence            345678888 999999998338999999999999999999999999998754321111    00112345999998754 


Q ss_pred             ---CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          96 ---GRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        96 ---~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                         ..++.++|+||+|++++++++ |..||.+.
T Consensus       179 ~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~  210 (283)
T cd06617         179 LNQKGYDVKSDVWSLGITMIELAT-GRFPYDSW  210 (283)
T ss_pred             ccccccCccccchhhHHHHHHHHh-CCCCCCcc
Confidence               345788999999999999998 99999754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0668|consensus

Probab=99.77  E-value=1.1e-18  Score=112.69  Aligned_cols=119  Identities=20%  Similarity=0.383  Sum_probs=92.0

Q ss_pred             CCCCCCC---ccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC-CcEEEEeecCcccccCCCceeee
Q psy7529           2 KSPNGSG---VVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR-HQAKISDFGLSRAVNSERNYYKA   77 (129)
Q Consensus         2 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~   77 (129)
                      ||.++.+   +++.|.-+.+++++.++ +.||.|+|+ .+|+|||+||.|++++.. ..++++|+|++....+.......
T Consensus       115 E~v~n~Dfk~ly~tl~d~dIryY~~el-LkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVR  192 (338)
T KOG0668|consen  115 EYVNNTDFKQLYPTLTDYDIRYYIYEL-LKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR  192 (338)
T ss_pred             hhhccccHHHHhhhhchhhHHHHHHHH-HHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeee
Confidence            5566666   67777788999999999 999999999 999999999999999865 56899999999877655443322


Q ss_pred             ccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCC-CCCCC
Q psy7529          78 THGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPY-GEMKG  127 (129)
Q Consensus        78 ~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf-~~~~~  127 (129)
                      ..    +.-|--||.+..- .|+...|+||+||++..++ |.+-|| .+.++
T Consensus       193 VA----SRyfKGPELLVdy~~YDYSLD~WS~GcmlA~mi-FrkepFFhG~dN  239 (338)
T KOG0668|consen  193 VA----SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI-FRKEPFFHGHDN  239 (338)
T ss_pred             ee----hhhcCCchheeechhccccHHHHHHHHHHHHHH-hccCcccCCCCC
Confidence            21    1225678877654 5788899999999999988 477665 44443

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.77  E-value=1.5e-18  Score=119.96  Aligned_cols=102  Identities=27%  Similarity=0.425  Sum_probs=81.7

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ +.|+.|+|. .+++|||++|+||+++.++.++++|||+++.......      ....+..|++||.+..
T Consensus       118 ~~~~~i~~qi-~~al~~LH~-~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~y~aPE~~~~  189 (343)
T cd07880         118 DRIQFLVYQM-LKGLKYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT------GYVVTRWYRAPEVILN  189 (343)
T ss_pred             HHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccccccccCcc------ccccCCcccCHHHHhC
Confidence            3455578888 999999998 8999999999999999999999999998875432111      1112346899998765


Q ss_pred             -CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 -GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 -~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       ..++.++|+||+|++++++++ |..||.+.+
T Consensus       190 ~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~  220 (343)
T cd07880         190 WMHYTQTVDIWSVGCIMAEMLT-GKPLFKGHD  220 (343)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence             346789999999999999998 999997643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1094|consensus

Probab=99.77  E-value=1.4e-19  Score=129.09  Aligned_cols=125  Identities=37%  Similarity=0.606  Sum_probs=95.8

Q ss_pred             CCCCCCCCccccCCCC--------chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGSY--------ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||.+.|+|-+-+...        ....|..|+ +.|++||.. -.++|||+.+.|+|++.++++|++|||+++-+-+..
T Consensus       614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqi-asgmaYLes-~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQI-ASGMAYLES-LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcccccchhHHHHHHH-HHHHHHHHh-hchhhccccccceeecCcccEEecCcccccccccCC
Confidence            4666667754444332        234499999 999999998 899999999999999999999999999998542222


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCC-CCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFG-QQPYGEMKGS  128 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~-~~pf~~~~~~  128 (129)
                      . +.......-+++|+|+|.+..+++..++|+|++|+++||+++++ +.||.+++.+
T Consensus       692 y-y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e  747 (807)
T KOG1094|consen  692 Y-YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE  747 (807)
T ss_pred             c-eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence            1 11111112357899999998899999999999999999988754 4799887754

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.77  E-value=8.3e-19  Score=115.85  Aligned_cols=120  Identities=23%  Similarity=0.404  Sum_probs=92.2

Q ss_pred             CCCCCCCCccccC----------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPL----------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      ||+++++++...+          .......++.++ ++|+.++|. ++++|+|++++||+++..+.++++|||.+.....
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i-~~~l~~lh~-~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL-CLALKYLHS-RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHH-HHHHHHHHh-CCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            5677777754333          333455688888 999999998 8999999999999999999999999998865433


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .....   ....++..|++||......++.++|+|++|++++++++ |..||...+
T Consensus       156 ~~~~~---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~  207 (258)
T cd08215         156 TVDLA---KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT-LKHPFEGEN  207 (258)
T ss_pred             Cccee---cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHc-CCCCCCCCc
Confidence            22111   11122346999998877778889999999999999998 999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.77  E-value=2.1e-18  Score=116.90  Aligned_cols=105  Identities=30%  Similarity=0.410  Sum_probs=81.5

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ +.|+.|+|. .+++|+|++++||+++.++.++++|||.+..........  ......+..|++||.+..
T Consensus       116 ~~~~~i~~qi-~~aL~~LH~-~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~  191 (302)
T cd07864         116 DHIKSFMKQL-LEGLNYCHK-KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP--YTNKVITLWYRPPELLLG  191 (302)
T ss_pred             HHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccc--cccceeccCccChHHhcC
Confidence            3456688888 999999999 899999999999999999999999999887543221100  001112345999997754


Q ss_pred             C-CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          96 G-RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        96 ~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      . .++.++|+||+|++++++++ |..||...
T Consensus       192 ~~~~~~~~Di~slG~~~~el~~-g~~~~~~~  221 (302)
T cd07864         192 EERYGPAIDVWSCGCILGELFT-KKPIFQAN  221 (302)
T ss_pred             CCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Confidence            3 46788999999999999998 99999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.77  E-value=9.2e-19  Score=119.32  Aligned_cols=102  Identities=28%  Similarity=0.419  Sum_probs=80.9

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ......++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||++........       ...+..|++||.+.
T Consensus       114 ~~~~~~~~~~l-~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~y~aPE~~~  184 (308)
T cd06634         114 EVEIAAVTHGA-LQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMAPEVIL  184 (308)
T ss_pred             HHHHHHHHHHH-HHHHHHHHh-CCcccCCCCHHhEEECCCCcEEECCcccceeecCccc-------ccCCccccCHHHHh
Confidence            33455577888 999999998 8999999999999999999999999998765432111       11234699999864


Q ss_pred             ---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 ---FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 ---~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ...++.++|+||+|++++++++ |..||.+.+
T Consensus       185 ~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~  218 (308)
T cd06634         185 AMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMN  218 (308)
T ss_pred             hcccCCCCcccchHHHHHHHHHHHc-CCCCCcccc
Confidence               2356788999999999999998 999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.77  E-value=2.5e-18  Score=108.46  Aligned_cols=94  Identities=27%  Similarity=0.306  Sum_probs=77.0

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccc
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPES   92 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~   92 (129)
                      +....+..++.|+ +.|+.|+|. ++      |++||+++.++.+++  ||.++.......        .++..|+|||.
T Consensus        14 l~~~~~~~i~~qi-~~~L~~lH~-~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~--------~g~~~y~aPE~   75 (176)
T smart00750       14 LNEEEIWAVCLQC-LRALRELHR-QA------KSGNILLTWDGLLKL--DGSVAFKTPEQS--------RVDPYFMAPEV   75 (176)
T ss_pred             CCHHHHHHHHHHH-HHHHHHHHh-cC------CcccEeEcCccceee--ccceEeeccccC--------CCcccccChHH
Confidence            4555667788999 999999998 44      999999999999988  998765432211        23457999999


Q ss_pred             ccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          93 YNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        93 ~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      +.+..++.++|+||+|+++|++++ |+.||.+.
T Consensus        76 ~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~  107 (176)
T smart00750       76 IQGQSYTEKADIYSLGITLYEALD-YELPYNEE  107 (176)
T ss_pred             hcCCCCcchhhHHHHHHHHHHHHh-CCCCcccc
Confidence            988889999999999999999998 99999754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.76  E-value=3.9e-18  Score=114.31  Aligned_cols=106  Identities=28%  Similarity=0.397  Sum_probs=83.0

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      .......++.|+ ++|+.++|. ++++|+|++++||+++.++.++++|||.++..........   ....+..|++||.+
T Consensus        96 ~~~~~~~~~~~i-~~~l~~LH~-~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~---~~~~~~~~~aPE~~  170 (282)
T cd07829          96 SPNLIKSIMYQL-LRGLAYCHS-HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT---HEVVTLWYRAPEIL  170 (282)
T ss_pred             CHHHHHHHHHHH-HHHHHHHHH-CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC---ccccCcCcCChHHh
Confidence            334455678888 999999999 8999999999999999999999999998876433221111   11123458999987


Q ss_pred             cCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          94 NFG-RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        94 ~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ... .++.++|+|++|++++++++ |..||...
T Consensus       171 ~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~  202 (282)
T cd07829         171 LGSKHYSTAVDIWSVGCIFAEMIT-GKPLFPGD  202 (282)
T ss_pred             cCCcCCCccccHHHHHHHHHHHHh-CCCCCCCc
Confidence            665 67888999999999999998 99998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.76  E-value=1.9e-18  Score=117.05  Aligned_cols=103  Identities=32%  Similarity=0.497  Sum_probs=80.7

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ ++|+.|+|...+++|+|++++||+++.++.++++|||++..........    ....+..|++||.+...
T Consensus       115 ~~~~i~~~i-~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~----~~~~~~~y~aPE~~~~~  189 (296)
T cd06618         115 ILGKMTVAI-VKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT----RSAGCAAYMAPERIDPP  189 (296)
T ss_pred             HHHHHHHHH-HHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCccc----CCCCCccccCHhhcCCC
Confidence            345688888 9999999974589999999999999999999999999886543221111    11123469999987644


Q ss_pred             C----CCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          97 R----FSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        97 ~----~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .    ++.++|+||+|++++++++ |+.||...
T Consensus       190 ~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~  221 (296)
T cd06618         190 DPNPKYDIRADVWSLGISLVELAT-GQFPYKNC  221 (296)
T ss_pred             CCccccccchhHHHHHHHHHHHHh-CCCCCCcc
Confidence            3    6788999999999999998 99999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.76  E-value=3.8e-18  Score=114.60  Aligned_cols=102  Identities=28%  Similarity=0.404  Sum_probs=80.5

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC-
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF-   95 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-   95 (129)
                      ....++.|+ +.++.|+|. ++++|+|++++||+++.++.++++|||.++.........    ....+..|++||.+.. 
T Consensus       100 ~~~~~~~~l-~~~l~~Lh~-~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~  173 (283)
T cd07830         100 VIRSIIYQI-LQGLAHIHK-HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT----DYVSTRWYRAPEILLRS  173 (283)
T ss_pred             HHHHHHHHH-HHHHHHHHH-CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC----CCCCcccccCceeeecC
Confidence            445578888 999999998 899999999999999999999999999887543221110    1112345899997744 


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ..++.++|+||+|++++++++ |..||...
T Consensus       174 ~~~~~~~Di~s~G~~l~el~~-g~~~~~~~  202 (283)
T cd07830         174 TSYSSPVDIWALGCIMAELYT-LRPLFPGS  202 (283)
T ss_pred             cCcCCccchhhHHHHHHHHHh-CCCccCCC
Confidence            356789999999999999998 99998654

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.76  E-value=1.4e-18  Score=115.04  Aligned_cols=120  Identities=22%  Similarity=0.380  Sum_probs=89.8

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc-EEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ-AKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~-~~l~d~~~~~~~~~~   71 (129)
                      |||+.++++...+.        ......++.|+ +.|+.|+|. ++++|+|++++||+++.++. ++++|||.+......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI-SLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            46777777544332        22345577888 999999998 89999999999999988754 599999988654332


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .....   ...++..|++||......++.++|+||+|++++++++ |..||...+
T Consensus       156 ~~~~~---~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~  206 (257)
T cd08225         156 MELAY---TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT-LKHPFEGNN  206 (257)
T ss_pred             ccccc---ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcc
Confidence            11111   1123456999998877778889999999999999998 999987543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.76  E-value=2.3e-18  Score=116.95  Aligned_cols=108  Identities=25%  Similarity=0.337  Sum_probs=82.2

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeee--------ccCCCCCcee
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA--------THGGRWPIKW   87 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~--------~~~~~~~~~~   87 (129)
                      .....++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||+++...........        .....++..|
T Consensus       115 ~~~~~i~~~l-~~al~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  192 (311)
T cd07866         115 SQIKCYMLQL-LEGINYLHE-NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWY  192 (311)
T ss_pred             HHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCc
Confidence            3455688888 999999998 89999999999999999999999999998754322111000        0000123459


Q ss_pred             cccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          88 YAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        88 ~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++||.+.+. .++.++|+||+|++++++++ |..||.+.+
T Consensus       193 ~aPE~~~~~~~~~~~~Dv~slG~il~el~~-g~~~~~~~~  231 (311)
T cd07866         193 RPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPILQGKS  231 (311)
T ss_pred             CChHHhhCCCccCchhHhHHHHHHHHHHHh-CCCCCCCCC
Confidence            999987654 46788999999999999998 999987543

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG1024|consensus

Probab=99.76  E-value=6.9e-19  Score=120.82  Aligned_cols=112  Identities=33%  Similarity=0.595  Sum_probs=92.7

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ...++.++.|+ +-|+.++|. .++||.|+...|++++.--.+|++|=.++|-+.+.+-...+... .-+..||++|.+.
T Consensus       395 t~qlV~masQl-a~am~hlh~-~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnE-nRPvkWMslEal~  471 (563)
T KOG1024|consen  395 TIQLVLMASQL-AMAMEHLHN-HGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNE-NRPVKWMSLEALQ  471 (563)
T ss_pred             HHHHHHHHHHH-HHHHHHHHh-cCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCC-CCcccccCHHHHh
Confidence            34567788999 889999999 99999999999999999999999999888865443322222211 2246799999999


Q ss_pred             CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q psy7529          95 FGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD  129 (129)
Q Consensus        95 ~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~e  129 (129)
                      ...|+..+|+||+|+++||+++.|+.|+.+.++.|
T Consensus       472 n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE  506 (563)
T KOG1024|consen  472 NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE  506 (563)
T ss_pred             hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence            88999999999999999999999999999988754

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.76  E-value=1.8e-18  Score=119.58  Aligned_cols=103  Identities=26%  Similarity=0.408  Sum_probs=82.1

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ......++.|+ ++|+.|+|. .+++|+|++++||+++.++.++++|||++........      ....+..|++||...
T Consensus       117 ~~~~~~~~~ql-~~aL~~LH~-~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~------~~~~~~~y~aPE~~~  188 (343)
T cd07851         117 DDHIQFLVYQI-LRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT------GYVATRWYRAPEIML  188 (343)
T ss_pred             HHHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEcccccccccccccc------CCcccccccCHHHHh
Confidence            34455688888 999999998 8999999999999999999999999999875432211      111234599999875


Q ss_pred             CC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 FG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 ~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .. .++.++|+||+|++++++++ |..||.+.+
T Consensus       189 ~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~  220 (343)
T cd07851         189 NWMHYNQTVDIWSVGCIMAELLT-GKTLFPGSD  220 (343)
T ss_pred             CCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            43 56789999999999999998 999997543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.76  E-value=5.3e-18  Score=113.95  Aligned_cols=103  Identities=25%  Similarity=0.370  Sum_probs=80.3

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ ++|+.|+|. ++++|+|++++||+++.++.++++|||.++..........   ....+..|++||.+.+.
T Consensus       100 ~~~~~~~~i-~~~L~~lH~-~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~  174 (283)
T cd07835         100 LIKSYLYQL-LQGIAYCHS-HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEILLGS  174 (283)
T ss_pred             HHHHHHHHH-HHHHHHHHH-CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC---ccccccCCCCCceeecC
Confidence            344577788 999999998 8999999999999999999999999999865422111111   11123469999987654


Q ss_pred             -CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          97 -RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        97 -~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                       .++.++|+||+|++++++++ |..||...
T Consensus       175 ~~~~~~~Di~slG~~l~~l~~-g~~pf~~~  203 (283)
T cd07835         175 RQYSTPVDIWSIGCIFAEMVN-RRPLFPGD  203 (283)
T ss_pred             cccCcHHHHHHHHHHHHHHHh-CCCCCCCC
Confidence             46789999999999999998 99998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.76  E-value=3.5e-18  Score=112.76  Aligned_cols=122  Identities=28%  Similarity=0.450  Sum_probs=92.0

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++.+.+      .......++.|+ +.++.|+|. ++++|+|++++||+++.++.++++|||.+.........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lh~-~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI-LEGLAYLHS-NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            4666666654433      223345578888 999999999 99999999999999999999999999988754332210


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       ........+..|.+||.......+.++|+|++|++++++++ |..||...+
T Consensus       158 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~  207 (260)
T cd06606         158 -EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT-GKPPWSELG  207 (260)
T ss_pred             -ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence             00111122356999999877778899999999999999998 999997654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0669|consensus

Probab=99.75  E-value=1.5e-18  Score=113.47  Aligned_cols=107  Identities=21%  Similarity=0.353  Sum_probs=82.5

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceee-eccCCCCCceecccccccC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK-ATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~   95 (129)
                      .+.-++-++ .+||.|+|+ ..|+|||+|+.|++++.++.++++|||+++.++....... +......++.|.+||.+.+
T Consensus       125 ~Ikk~Mk~L-m~GL~~iHr-~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG  202 (376)
T KOG0669|consen  125 EIKKVMKGL-MNGLYYIHR-NKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG  202 (376)
T ss_pred             HHHHHHHHH-HHHHHHHHH-hhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhc
Confidence            344466677 999999999 9999999999999999999999999999986543221111 1111122456899998876


Q ss_pred             C-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 G-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . .|+++.|+|+.||++.++++ +.+-|++.+
T Consensus       203 ~r~yg~~iDiWgAgCimaeMwt-rspimqgnt  233 (376)
T KOG0669|consen  203 DREYGPPIDIWGAGCIMAEMWT-RSPIMQGNT  233 (376)
T ss_pred             ccccCCcchhHhHHHHHHHHHc-cCccccCCh
Confidence            5 68999999999999999998 777776544

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.75  E-value=4.3e-18  Score=117.12  Aligned_cols=107  Identities=26%  Similarity=0.327  Sum_probs=81.5

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc-----------eeeeccCCCCCc
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN-----------YYKATHGGRWPI   85 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~~   85 (129)
                      ....++.|+ +.|+.|+|. .+++|+||+++||+++.++.++++|||.++.......           ..........+.
T Consensus       120 ~~~~~~~ql-~~aL~~LH~-~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (335)
T PTZ00024        120 QVKCILLQI-LNGLNVLHK-WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTL  197 (335)
T ss_pred             HHHHHHHHH-HHHHHHHHh-CCeecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccccccccccccc
Confidence            345578888 999999998 8999999999999999999999999998875431000           000001111234


Q ss_pred             eecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          86 KWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        86 ~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .|++||.+.+. .++.++|+||+|++++++++ |..||.+.+
T Consensus       198 ~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~  238 (335)
T PTZ00024        198 WYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-GKPLFPGEN  238 (335)
T ss_pred             CCCCChhcccCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            69999988654 46789999999999999998 999997543

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.75  E-value=6.4e-18  Score=112.31  Aligned_cols=117  Identities=26%  Similarity=0.366  Sum_probs=87.3

Q ss_pred             CCCCCCCCcccc----------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTP----------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||++++++...          +.......++.|+ +.|+.|+|. ++++|+|++++|++++. +.++++|||.++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lH~-~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL-LLGVHYMHQ-RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHH-HHHHHHHHH-cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence            567777775432          2233455678888 999999998 89999999999999975 5699999998865432


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ......   ...++..|++||......++.++|+||+|++++++++ +..||.+
T Consensus       158 ~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~  207 (260)
T cd08222         158 SCDLAT---TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC-LAHAFEG  207 (260)
T ss_pred             Cccccc---CCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Confidence            211111   1112345999998877777889999999999999998 9999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.75  E-value=7.8e-18  Score=113.04  Aligned_cols=106  Identities=24%  Similarity=0.385  Sum_probs=82.6

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ +.|+.++|. ++++|+|++++||+++.++.++++|||.+..........  ......+..|++||.+.+
T Consensus       100 ~~~~~i~~~i-~~al~~LH~-~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~  175 (287)
T cd07840         100 SQIKCYMKQL-LEGLQYLHS-NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD--YTNRVITLWYRPPELLLG  175 (287)
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc--ccccccccccCCceeeEc
Confidence            3455688888 999999998 899999999999999999999999999987654322100  111122345999997654


Q ss_pred             C-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 G-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . .++.++|+||+|++++++++ |..||.+.+
T Consensus       176 ~~~~~~~~Dv~slG~~l~el~t-~~~p~~~~~  206 (287)
T cd07840         176 ATRYGPEVDMWSVGCILAELFL-GKPIFQGST  206 (287)
T ss_pred             cccCChHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            3 56789999999999999998 999997644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG4236|consensus

Probab=99.74  E-value=1.2e-19  Score=128.64  Aligned_cols=104  Identities=30%  Similarity=0.515  Sum_probs=85.6

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC---CcEEEEeecCcccccCCCceeeeccCCCCCceecccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE   91 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe   91 (129)
                      +....++..|| +.||+|+|. ++|+|.||||+|+|+...   ..+|++|||+++...... ....   -.+++.|+|||
T Consensus       663 er~TkFlvtQI-L~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-FRrs---VVGTPAYLaPE  736 (888)
T KOG4236|consen  663 ERITKFLVTQI-LVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-FRRS---VVGTPAYLAPE  736 (888)
T ss_pred             HHHHHHHHHHH-HHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccceeecchhh-hhhh---hcCCccccCHH
Confidence            34567899999 999999999 999999999999999654   458999999998764321 1111   12456799999


Q ss_pred             cccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          92 SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        92 ~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ++....|+...|+||+|+++|-.++ |..||.+-
T Consensus       737 VLrnkGyNrSLDMWSVGVIiYVsLS-GTFPFNEd  769 (888)
T KOG4236|consen  737 VLRNKGYNRSLDMWSVGVIIYVSLS-GTFPFNED  769 (888)
T ss_pred             HHhhccccccccceeeeEEEEEEec-ccccCCCc
Confidence            9999899999999999999999998 99999863

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.74  E-value=7e-18  Score=129.62  Aligned_cols=114  Identities=19%  Similarity=0.325  Sum_probs=87.2

Q ss_pred             CCCCCCCCccccCCC---CchhhHHhHHHHHHHHHHhcc--CCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLGS---YALPYIEGQIPAKVCRYLKMH--KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~h~~--~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++++...+..   ..+..++.|+ +.|+.|+|..  .+++|||+||+||+++.....++. ++........    
T Consensus       762 ~Ey~~~g~L~~~l~~l~~~~~~~i~~~i-a~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----  835 (968)
T PLN00113        762 HEYIEGKNLSEVLRNLSWERRRKIAIGI-AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----  835 (968)
T ss_pred             EeCCCCCcHHHHHhcCCHHHHHHHHHHH-HHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence            799999987666543   3455678888 9999999942  689999999999999988877665 5543322111    


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                         ....++..|+|||.+.+..++.++|+||+|+++||+++ |+.||..
T Consensus       836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~t-g~~p~~~  880 (968)
T PLN00113        836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLT-GKSPADA  880 (968)
T ss_pred             ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHh-CCCCCCc
Confidence               01122456999999988888999999999999999998 9999853

>KOG0607|consensus

Probab=99.74  E-value=9.2e-18  Score=112.86  Aligned_cols=124  Identities=25%  Similarity=0.376  Sum_probs=86.0

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC---cEEEEeecCccccc--
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH---QAKISDFGLSRAVN--   69 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~---~~~l~d~~~~~~~~--   69 (129)
                      ||..+||.+..-      +.+.+...+.-.+ +.||.+||. ++|-|||+||+|||-....   .+|++||-+.....  
T Consensus       155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdi-a~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~  232 (463)
T KOG0607|consen  155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDI-ASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN  232 (463)
T ss_pred             EecccCchHHHHHHHhhhccHHHHHHHHHHH-HHHHHHHhh-cCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence            455566664332      3344566677777 999999999 9999999999999986544   46999987754321  


Q ss_pred             CCCce--eeeccCCCCCceecccccc---cC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          70 SERNY--YKATHGGRWPIKWYAPESY---NF--GRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        70 ~~~~~--~~~~~~~~~~~~~~~pe~~---~~--~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ...+.  ......-.++..|||||+.   .+  ..|+.+.|.||+|+++|-|++ |.+||.++=+
T Consensus       233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs-GYpPFvG~Cg  296 (463)
T KOG0607|consen  233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS-GYPPFVGHCG  296 (463)
T ss_pred             CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh-CCCCccCccC
Confidence            11110  0011112234579999964   33  258999999999999999999 9999987543

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.74  E-value=1.4e-17  Score=114.53  Aligned_cols=101  Identities=29%  Similarity=0.438  Sum_probs=80.9

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC-
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF-   95 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-   95 (129)
                      ....++.|+ +.|+.|+|. ++++|+|++++|++++.++.++++|||.++.......      ...++..|++||.+.. 
T Consensus       109 ~~~~~~~ql-~~aL~~LH~-~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~y~aPE~~~~~  180 (328)
T cd07856         109 FIQYFLYQI-LRGLKYVHS-AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT------GYVSTRYYRAPEIMLTW  180 (328)
T ss_pred             HHHHHHHHH-HHHHHHHHh-CCcccCCCCHHHEeECCCCCEEeCccccccccCCCcC------CCcccccccCceeeecc
Confidence            345577888 999999999 8999999999999999999999999998865422111      1112345999998755 


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..++.++|+||+|++++++++ |..||...+
T Consensus       181 ~~~~~~~Dv~slG~il~el~t-g~~~f~~~~  210 (328)
T cd07856         181 QKYDVEVDIWSAGCIFAEMLE-GKPLFPGKD  210 (328)
T ss_pred             CCcCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            457889999999999999998 999997543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1027|consensus

Probab=99.73  E-value=6.4e-19  Score=129.28  Aligned_cols=110  Identities=31%  Similarity=0.468  Sum_probs=89.9

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC-----CcEEEEeecCcccccCCCceeeeccCCCCCceeccc
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR-----HQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP   90 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~-----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~p   90 (129)
                      .....+..|+ +.|+..||. -+|+||||||.|||+...     ..++++|||+++.+...........+..++-.|.||
T Consensus       606 i~~~~~l~q~-~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~AP  683 (903)
T KOG1027|consen  606 IDPISVLSQI-ASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAP  683 (903)
T ss_pred             ccHHHHHHHH-HHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCH
Confidence            3455677888 999999999 899999999999999762     457899999999887665555555555667789999


Q ss_pred             ccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          91 ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        91 e~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      |++....-...+|++|+||++|++++-|.-||++.-.
T Consensus       684 E~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~  720 (903)
T KOG1027|consen  684 EQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE  720 (903)
T ss_pred             HHHhccccCcccchhhcCceEEEEecCCccCCCchHH
Confidence            9998776667899999999999999855789997543

>KOG0584|consensus

Probab=99.72  E-value=4.4e-18  Score=121.70  Aligned_cols=114  Identities=26%  Similarity=0.413  Sum_probs=87.2

Q ss_pred             CCCccccCCCCc------hhhHHhHHHHHHHHHHhccC-CCccCCCCCCCEEecCC-CcEEEEeecCcccccCCCceeee
Q psy7529           6 GSGVVTPLGSYA------LPYIEGQIPAKVCRYLKMHK-SSFHRDLAARNILLASR-HQAKISDFGLSRAVNSERNYYKA   77 (129)
Q Consensus         6 ~~~~~~~~~~~~------~~~~~~~~~~~~l~~~h~~~-~~ihr~lk~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~   77 (129)
                      .|+|.+..+..+      ++.-..|| ++||.|||.+. .|||||||-+||.+..+ +.+||.|+|++........  ..
T Consensus       127 SGtLr~Y~kk~~~vn~kaik~W~RQI-LkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a--ks  203 (632)
T KOG0584|consen  127 SGTLREYRKKHRRVNIKAIKSWCRQI-LKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA--KS  203 (632)
T ss_pred             CCcHHHHHHHhccCCHHHHHHHHHHH-HHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc--ce
Confidence            344555444433      22356677 99999999743 58999999999999765 7899999999986543211  11


Q ss_pred             ccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          78 THGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        78 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .   .+|+.|||||+.- ..|+..+|+||||.++.||.+ ++.||.+..+
T Consensus       204 v---IGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT-~eYPYsEC~n  248 (632)
T KOG0584|consen  204 V---IGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVT-SEYPYSECTN  248 (632)
T ss_pred             e---ccCccccChHHHh-hhcchhhhhhhhhHHHHHHHh-ccCChhhhCC
Confidence            1   2467899999986 679999999999999999999 9999988654

>KOG1345|consensus

Probab=99.72  E-value=2.5e-18  Score=113.28  Aligned_cols=115  Identities=24%  Similarity=0.438  Sum_probs=86.5

Q ss_pred             CCCCCCCCccccCCC-----CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEec--CCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-----YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLA--SRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~--~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++-|+|......     -....++.|+ +.|+.|+|. +.++|||||.+|||+-  ...++|++|||..+.......
T Consensus       101 qE~aP~gdL~snv~~~GigE~~~K~v~~ql-~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAGIGEANTKKVFAQL-LSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             eccCccchhhhhcCcccccHHHHHHHHHHH-HHHHHHhhc-cchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence            688888886655443     3466799999 999999999 9999999999999984  345789999999876543332


Q ss_pred             eeeeccCCCCCceecccccc---cCCC--CCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESY---NFGR--FSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~---~~~~--~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ....      ...|-+||..   ....  .++..|+|.+|++++.+++ |..||+.
T Consensus       179 ~~~~------~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~clt-G~~PWQk  227 (378)
T KOG1345|consen  179 YLEY------VNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLT-GKFPWQK  227 (378)
T ss_pred             hhhh------hcccCCcHHHhhccccceEecccccchheeeeeeeeec-CCCcchh
Confidence            2211      1246677743   2222  3577899999999999998 9999984

>KOG0662|consensus

Probab=99.72  E-value=1.4e-17  Score=104.36  Aligned_cols=104  Identities=23%  Similarity=0.365  Sum_probs=81.9

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ..+-++.|+ .+|+.+.|+ +.++|||+||.|.++..++.+|++|||+++...-+..-+....   .+.-|.+|.++-+.
T Consensus       102 ~~rsfmlql-lrgl~fchs-hnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaev---vtlwyrppdvlfga  176 (292)
T KOG0662|consen  102 IVRSFMLQL-LRGLGFCHS-HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEV---VTLWYRPPDVLFGA  176 (292)
T ss_pred             HHHHHHHHH-Hhhhhhhhh-hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeecee---eeeeccCcceeeee
Confidence            345577888 999999999 8899999999999999999999999999987765432222222   23336788877665


Q ss_pred             -CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          97 -RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        97 -~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                       .|+...|+||.||++.|+..-|.+.|.+.
T Consensus       177 kly~tsidmwsagcifaelanagrplfpg~  206 (292)
T KOG0662|consen  177 KLYSTSIDMWSAGCIFAELANAGRPLFPGN  206 (292)
T ss_pred             ehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence             47889999999999999998666767654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.70  E-value=4.7e-17  Score=117.19  Aligned_cols=101  Identities=23%  Similarity=0.302  Sum_probs=74.1

Q ss_pred             hhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC-
Q psy7529          19 PYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-   97 (129)
Q Consensus        19 ~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-   97 (129)
                      ..++.|+ +.++.|+|. ++++|||+||+||+++.+..++++|||+++.......  ........++.|++||.+.... 
T Consensus       312 ~~i~~ql-~~aL~~lH~-~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~g~~tp~Y~aPE~l~~~~~  387 (507)
T PLN03224        312 KGVMRQV-LTGLRKLHR-IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN--FNPLYGMLDPRYSPPEELVMPQS  387 (507)
T ss_pred             HHHHHHH-HHHHHHHHH-CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc--cCccccCCCcceeChhhhcCCCC
Confidence            3467777 899999998 8999999999999999999999999999865432111  1111122245799999764321 


Q ss_pred             -------------------CC--ChhhHHHHHHHHHHHHhCCCC-CCCC
Q psy7529          98 -------------------FS--SASDVWSFGITLWEMYSFGQQ-PYGE  124 (129)
Q Consensus        98 -------------------~~--~~~di~s~g~~l~~l~~~~~~-pf~~  124 (129)
                                         ++  ...|+||+|+++++++. +.. ||.+
T Consensus       388 ~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~-~~l~p~~~  435 (507)
T PLN03224        388 CPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCV-PELRPVAN  435 (507)
T ss_pred             CCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHh-CCCCCccc
Confidence                               11  24699999999999997 764 7754

>KOG1151|consensus

Probab=99.70  E-value=2e-17  Score=115.59  Aligned_cols=122  Identities=29%  Similarity=0.472  Sum_probs=89.8

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhcc-CCCccCCCCCCCEEecC---CCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMH-KSSFHRDLAARNILLAS---RHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~-~~~ihr~lk~~nil~~~---~~~~~l~d~~~~~~~~~   70 (129)
                      +|||+|.+|--.|+.      -..+-|.+|+ .+||.||..- ..|||.||||.|||+..   .+.+|+.|||+++.+.+
T Consensus       547 LEYceGNDLDFYLKQhklmSEKEARSIiMQi-VnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdd  625 (775)
T KOG1151|consen  547 LEYCEGNDLDFYLKQHKLMSEKEARSIIMQI-VNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDD  625 (775)
T ss_pred             eeecCCCchhHHHHhhhhhhHHHHHHHHHHH-HHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccC
Confidence            489999985444443      3467799999 9999999863 46899999999999854   46789999999987643


Q ss_pred             CCc----eeeeccCCCCCceecccccccCC----CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          71 ERN----YYKATHGGRWPIKWYAPESYNFG----RFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        71 ~~~----~~~~~~~~~~~~~~~~pe~~~~~----~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ...    ....+..+.++.=|++||.+...    ..+.++|+||+|+++|+++. |+.||+.
T Consensus       626 dSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY-GrKPFGh  686 (775)
T KOG1151|consen  626 DSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY-GRKPFGH  686 (775)
T ss_pred             CccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc-cCCCCCC
Confidence            211    11111222233347899987544    25678999999999999996 9999985

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.69  E-value=5.9e-17  Score=105.82  Aligned_cols=117  Identities=29%  Similarity=0.469  Sum_probs=89.1

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||+..++++...+.      ......++.++ ++++.++|. .+++|+|++++||+++.++.++++|||.+........ 
T Consensus        66 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lh~-~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-  142 (244)
T smart00220       66 MEYCDGGDLFDLLKKRGRLSEDEARFYARQI-LSALEYLHS-NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL-  142 (244)
T ss_pred             EeCCCCCCHHHHHHhccCCCHHHHHHHHHHH-HHHHHHHHH-cCeecCCcCHHHeEECCCCcEEEccccceeeeccccc-
Confidence            45666666444332      22344577777 899999999 8999999999999999999999999999876543210 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                         .........|++||......++.++|+|++|++++++++ +..||..
T Consensus       143 ---~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~  188 (244)
T smart00220      143 ---LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLT-GKPPFPG  188 (244)
T ss_pred             ---cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Confidence               111112346999998877777889999999999999998 9999876

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG3653|consensus

Probab=99.69  E-value=6.7e-17  Score=112.83  Aligned_cols=113  Identities=26%  Similarity=0.377  Sum_probs=84.1

Q ss_pred             CCCCCCCccccCCCCc-----hhhHHhHHHHHHHHHHhcc--------CCCccCCCCCCCEEecCCCcEEEEeecCcccc
Q psy7529           2 KSPNGSGVVTPLGSYA-----LPYIEGQIPAKVCRYLKMH--------KSSFHRDLAARNILLASRHQAKISDFGLSRAV   68 (129)
Q Consensus         2 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~~h~~--------~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~   68 (129)
                      ||=+.|+|...|....     ...++.-+ ++||.|||..        ..|.|||+|..|||+.++..+-|+|||++..+
T Consensus       288 ~fh~kGsL~dyL~~ntisw~~~cria~Sm-arGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKANTISWNSLCRIAESM-ARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             eeccCCcHHHHHHhccccHHHHHHHHHHH-HHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            3445666666666543     33356666 9999999973        23789999999999999999999999999876


Q ss_pred             cCCCceeeeccCCCCCceecccccccCC-CCC-----ChhhHHHHHHHHHHHHh
Q psy7529          69 NSERNYYKATHGGRWPIKWYAPESYNFG-RFS-----SASDVWSFGITLWEMYS  116 (129)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~-----~~~di~s~g~~l~~l~~  116 (129)
                      ..... .....+..+|.+|||||++-+. .+.     .+.|+||+|.++||+++
T Consensus       367 ~p~~~-~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~S  419 (534)
T KOG3653|consen  367 EPGKP-QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIAS  419 (534)
T ss_pred             cCCCC-CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHh
Confidence            53322 2223345667899999988554 222     57899999999999998

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.68  E-value=1.4e-16  Score=103.21  Aligned_cols=119  Identities=28%  Similarity=0.442  Sum_probs=88.0

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      ||++.++++...+..       .....++.++ +.++.++|. ++++|+|++++|++++....++++|||.+........
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lh~-~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQI-LEALEYLHS-LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             EeccCCCCHHHHHHhcccCCCHHHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            456666664443332       2244577777 899999998 8999999999999999999999999998876543210


Q ss_pred             eeeeccCCCCCceecccccc-cCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESY-NFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ..  .........|++||.. ....++.++|+|++|++++++++ |+.||..
T Consensus       154 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~-g~~pf~~  202 (225)
T smart00221      154 AL--LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLW-GPEPFSG  202 (225)
T ss_pred             cc--ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHH-CCCCccc
Confidence            00  0011122458999987 55567789999999999999999 9999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152|consensus

Probab=99.67  E-value=3e-17  Score=117.15  Aligned_cols=106  Identities=22%  Similarity=0.385  Sum_probs=85.9

Q ss_pred             ccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccc
Q psy7529          11 TPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP   90 (129)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~p   90 (129)
                      +.+.+.....||.|+ +.|++.+|. ++|+|||+|.+|++++.++-+|++|||.+....+..  ....   .++..|.||
T Consensus       665 p~m~E~eAk~IFkQV-~agi~hlh~-~~ivhrdikdenvivd~~g~~klidfgsaa~~ksgp--fd~f---~gtv~~aap  737 (772)
T KOG1152|consen  665 PRMDEPEAKLIFKQV-VAGIKHLHD-QGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP--FDVF---VGTVDYAAP  737 (772)
T ss_pred             CccchHHHHHHHHHH-Hhccccccc-cCceecccccccEEEecCCeEEEeeccchhhhcCCC--ccee---eeeccccch
Confidence            344556788899999 999999999 999999999999999999999999999875432211  1111   124569999


Q ss_pred             ccccCCCC-CChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          91 ESYNFGRF-SSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        91 e~~~~~~~-~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      |++.+.+| +.+.|||++|+++|.+.. .+.||-.
T Consensus       738 evl~g~~y~gk~qdiwalgillytivy-kenpyyn  771 (772)
T KOG1152|consen  738 EVLGGEKYLGKPQDIWALGILLYTIVY-KENPYYN  771 (772)
T ss_pred             hhhCCCccCCCcchhhhhhheeeEEEe-ccCCCcC
Confidence            99999887 678999999999999884 8889854

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.67  E-value=1.3e-16  Score=118.65  Aligned_cols=64  Identities=30%  Similarity=0.419  Sum_probs=54.1

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      |||+.|++|...+.      ......++.|+ +.||.|+|. ++++||||||+||+++..+.++++|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qi-l~aL~yLH~-~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEV-ALALDYLHR-HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            78888888655443      33456688888 999999998 899999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0670|consensus

Probab=99.65  E-value=2.4e-17  Score=116.64  Aligned_cols=102  Identities=25%  Similarity=0.361  Sum_probs=81.3

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc-EEEEeecCcccccCCC-ceeeeccCCCCCceecccccccC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ-AKISDFGLSRAVNSER-NYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~-~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .+-++.|+ .-||..|.. .+++|.||||+|||+..... +|+||||.+-...... +.+.      .+.-|.|||.+.+
T Consensus       538 VRsYaqQL-flALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitPYL------VSRFYRaPEIiLG  609 (752)
T KOG0670|consen  538 VRSYAQQL-FLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSASFASENEITPYL------VSRFYRAPEIILG  609 (752)
T ss_pred             HHHHHHHH-HHHHHHHHh-cCeeecccCccceEeccCcceeeeccCccccccccccccHHH------HHHhccCcceeec
Confidence            44466777 788999998 89999999999999987665 5999999875433211 1111      0123889999999


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                      .+|+...|+||+||++||+.+ |+.-|.+.++.
T Consensus       610 ~~yd~~iD~WSvgctLYElYt-GkIlFpG~TNN  641 (752)
T KOG0670|consen  610 LPYDYPIDTWSVGCTLYELYT-GKILFPGRTNN  641 (752)
T ss_pred             CcccCCccceeeceeeEEeec-cceecCCCCcH
Confidence            999999999999999999998 99999987764

>KOG2052|consensus

Probab=99.63  E-value=1.6e-15  Score=105.48  Aligned_cols=126  Identities=25%  Similarity=0.343  Sum_probs=89.7

Q ss_pred             CCCCCCCccccCCCCc-----hhhHHhHHHHHHHHHHhcc----C---CCccCCCCCCCEEecCCCcEEEEeecCccccc
Q psy7529           2 KSPNGSGVVTPLGSYA-----LPYIEGQIPAKVCRYLKMH----K---SSFHRDLAARNILLASRHQAKISDFGLSRAVN   69 (129)
Q Consensus         2 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~~h~~----~---~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~   69 (129)
                      +|=+.|+|+..|....     ...++..+ |.||+.||..    +   .|-|||||+.||++.+++.+-|+|+|++-...
T Consensus       289 dYHe~GSL~DyL~r~tv~~~~ml~LalS~-AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~  367 (513)
T KOG2052|consen  289 DYHEHGSLYDYLNRNTVTTEGMLKLALSI-ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  367 (513)
T ss_pred             ecccCCcHHHHHhhccCCHHHHHHHHHHH-hhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence            3557788888887754     33366666 8899999973    1   25699999999999999999999999986543


Q ss_pred             CC-CceeeeccCCCCCceecccccccCC----CC--CChhhHHHHHHHHHHHHhC---------CCCCCCCCCCC
Q psy7529          70 SE-RNYYKATHGGRWPIKWYAPESYNFG----RF--SSASDVWSFGITLWEMYSF---------GQQPYGEMKGS  128 (129)
Q Consensus        70 ~~-~~~~~~~~~~~~~~~~~~pe~~~~~----~~--~~~~di~s~g~~l~~l~~~---------~~~pf~~~~~~  128 (129)
                      .. ...........++.+|||||++...    .+  -..+||||+|.++||+...         -+.||.++.++
T Consensus       368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            22 2222223334467789999987432    12  1579999999999997641         14688877654

>KOG0576|consensus

Probab=99.57  E-value=8.7e-16  Score=111.15  Aligned_cols=117  Identities=30%  Similarity=0.512  Sum_probs=91.0

Q ss_pred             CCCCCCCC------ccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSG------VVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||||-|++      +.-++.+..+.+..... .++++|+|. .+-+|||+|-.||++...+.+++.|||.+..++.....
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRet-l~gl~ylhs-~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRET-LQGLKYLHS-QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhh-hccchhhhc-CCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence            89998887      44455555666666666 889999998 89999999999999999999999999998766544433


Q ss_pred             eeeccCCCCCceecccccc---cCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESY---NFGRFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~---~~~~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      .+...+   ++.|++||+.   +...|+...|+|+.|+...++.. -++|-.
T Consensus       169 rksfiG---tpywmapEvaaverkggynqlcdiwa~gitAiel~e-Lqpplf  216 (829)
T KOG0576|consen  169 RKSFIG---TPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGE-LQPPLF  216 (829)
T ss_pred             hhcccC---CccccchhHHHHHhcccccccccccccccchhhhhh-cCCccc
Confidence            344444   4459999975   34568899999999999888887 556643

>KOG0590|consensus

Probab=99.55  E-value=1.8e-15  Score=111.01  Aligned_cols=120  Identities=25%  Similarity=0.293  Sum_probs=93.2

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||||+. +++..+..      .++--++-|+ ..|++|+|. .++-|||+|++|+++..++.+|++|||.+....-+...
T Consensus       400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL-~~Gv~y~h~-~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQL-LRGVKYLHS-MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             hhcccH-HHHHHHhcccccchhhhhHHHHHH-HHHHHHHHh-cCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            899999 87766655      3445578888 999999999 99999999999999999999999999988654322111


Q ss_pred             -eeeccCCCCCceecccccccCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          75 -YKATHGGRWPIKWYAPESYNFGRFS-SASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        75 -~~~~~~~~~~~~~~~pe~~~~~~~~-~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                       .....+-.++.+|+|||.+.+..|+ ..+|+||+|+++..|.. ++.||.-
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~-~~~~Wk~  527 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL-GRFPWKV  527 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec-CCCcccc
Confidence             0112222344579999999988886 56899999999998887 8888864

>KOG0606|consensus

Probab=99.51  E-value=8.5e-15  Score=110.43  Aligned_cols=101  Identities=27%  Similarity=0.370  Sum_probs=80.7

Q ss_pred             HHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCccccc--CCCce----------eeeccCCCCCceeccccccc
Q psy7529          27 AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVN--SERNY----------YKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        27 ~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~--~~~~~----------~~~~~~~~~~~~~~~pe~~~   94 (129)
                      +.+++|+|. -+|+|||+|++|.++..-+++|+.|||+.+...  .....          ......-++++.|.+||++.
T Consensus       153 vla~Eylh~-ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil  231 (1205)
T KOG0606|consen  153 VLAVEYLHS-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL  231 (1205)
T ss_pred             hHHhHhhcc-CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence            568899998 999999999999999999999999999987421  00000          00011123467899999999


Q ss_pred             CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q psy7529          95 FGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD  129 (129)
Q Consensus        95 ~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~e  129 (129)
                      ...|+..+|+|++|+++|+.+. |..||++-+++|
T Consensus       232 rqgygkpvdwwamGiIlyeFLV-gcvpffGdtpee  265 (1205)
T KOG0606|consen  232 RQGYGKPVDWWAMGIILYEFLV-GCVPFFGDTPEE  265 (1205)
T ss_pred             hhccCCCccHHHHHHHHHHHhe-eeeeccCCCHHH
Confidence            8899999999999999999997 999998876654

>KOG1164|consensus

Probab=99.49  E-value=1e-13  Score=95.41  Aligned_cols=109  Identities=18%  Similarity=0.143  Sum_probs=83.4

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC-----CcEEEEeecCcc--cccCCCce---eee--ccCCCC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR-----HQAKISDFGLSR--AVNSERNY---YKA--THGGRW   83 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~-----~~~~l~d~~~~~--~~~~~~~~---~~~--~~~~~~   83 (129)
                      .....++.|+ ..+|+++|. .+++|||+||+|+++...     ..+.+.|||+++  ........   ...  .....+
T Consensus       122 ~T~l~ia~q~-l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rG  199 (322)
T KOG1164|consen  122 KTVLRIAIQN-LNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRG  199 (322)
T ss_pred             hHHHHHHHHH-HHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCC
Confidence            3455588888 999999999 999999999999999765     357899999998  33221110   111  112235


Q ss_pred             CceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          84 PIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        84 ~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      +.+|.++....+...+.+.|+||++.++.++.. |..||...+.
T Consensus       200 T~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~-g~LPW~~~~~  242 (322)
T KOG1164|consen  200 TLRYASINVHLGIEQGRRDDLESLFYMLLELLK-GSLPWEALEM  242 (322)
T ss_pred             ccccccHHHhCCCccCCchhhhhHHHHHHHHhc-CCCCCccccc
Confidence            678999988888888899999999999999997 8899976553

>KOG1290|consensus

Probab=99.48  E-value=1.2e-13  Score=97.23  Aligned_cols=44  Identities=23%  Similarity=0.441  Sum_probs=39.2

Q ss_pred             CceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          84 PIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        84 ~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                      |..|.+||++.+..|+..+|+||++|+.+|+.| |...|...+.+
T Consensus       414 TRQYRapEVllGsgY~~~ADiWS~AC~~FELaT-GDyLFePhsG~  457 (590)
T KOG1290|consen  414 TRQYRAPEVLLGSGYSTSADIWSTACMAFELAT-GDYLFEPHSGE  457 (590)
T ss_pred             hhhccCcceeecCCCCCchhHHHHHHHHHHhhc-CceeecCCCCC
Confidence            455999999999999999999999999999998 99988876553

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.48  E-value=2.5e-13  Score=91.42  Aligned_cols=108  Identities=32%  Similarity=0.464  Sum_probs=83.1

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC-cEEEEeecCcccccCCCceee---eccCCCCCceecccc
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH-QAKISDFGLSRAVNSERNYYK---ATHGGRWPIKWYAPE   91 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~---~~~~~~~~~~~~~pe   91 (129)
                      .....+..|+ +.++.++|. .+++|||+||+|++++... .+++.|||.++..........   ......++..|.+||
T Consensus       101 ~~~~~~~~~~-~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe  178 (384)
T COG0515         101 SEALFILAQI-LSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE  178 (384)
T ss_pred             HHHHHHHHHH-HHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHH
Confidence            3456688888 888999999 8899999999999999988 699999999875433221110   112223345699999


Q ss_pred             cccC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          92 SYNF---GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        92 ~~~~---~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....   .......|+|++|+.+++++. +..||....
T Consensus       179 ~~~~~~~~~~~~~~D~~s~g~~~~~~~~-~~~p~~~~~  215 (384)
T COG0515         179 VLLGLSLAYASSSSDIWSLGITLYELLT-GLPPFEGEK  215 (384)
T ss_pred             HhcCCCCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            8876   467789999999999999997 999976654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.45  E-value=1.2e-13  Score=96.16  Aligned_cols=67  Identities=19%  Similarity=0.174  Sum_probs=54.7

Q ss_pred             CCCCCCCCccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCC-CCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDL-AARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~l-k~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||+.|++|.. ........++.|+ ++++.|+|. ++++|||| ||+||+++.++.++++|||+++....
T Consensus        97 mE~~~G~~L~~-~~~~~~~~~~~~i-~~aL~~lH~-~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         97 RGWTEGVPLHL-ARPHGDPAWFRSA-HRALRDLHR-AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             EEccCCCCHHH-hCccchHHHHHHH-HHHHHHHHH-CCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            79999988763 2222234567777 899999999 99999999 99999999888999999999986543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.45  E-value=2.5e-13  Score=86.61  Aligned_cols=109  Identities=32%  Similarity=0.447  Sum_probs=78.7

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-CCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-RHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-~~~~~l~d~~~~~~~~~~~   72 (129)
                      ||++.+.++...+.       ......++.++ ++++.++|. .+++|+|+++.||+++. ...++++||+.........
T Consensus        70 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l-~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~  147 (215)
T cd00180          70 MEYCEGGSLKDLLKENEGKLSEDEILRILLQI-LEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK  147 (215)
T ss_pred             EecCCCCcHHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence            46666666444332       22345577788 999999999 89999999999999999 8999999999886543321


Q ss_pred             ceeeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHH
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEM  114 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l  114 (129)
                      .   ..........|.+||..... ..+.+.|+|++|++++++
T Consensus       148 ~---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         148 S---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             c---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            0   00111123458999988765 667889999999988765

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0603|consensus

Probab=99.45  E-value=4.1e-14  Score=101.84  Aligned_cols=111  Identities=29%  Similarity=0.432  Sum_probs=88.3

Q ss_pred             CCCCCCCccccCCCCc------hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           2 KSPNGSGVVTPLGSYA------LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         2 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      ++..|+++++-+....      ...+.+.+ +.++..+|. .++++||+|++||+++.++++++.|||+++..-..... 
T Consensus        77 d~~rgg~lft~l~~~~~f~~~~~~~~~ael-aLald~lh~-l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   77 DFLRGGDLFTRLSKEVMFDELDVAFYLAEL-ALALDHLHK-LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             hhcccchhhhccccCCchHHHHHHHHHHHH-HHHHhhcch-hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            5677888888777643      34455666 667888888 89999999999999999999999999998764322211 


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                            +++..|++||.+.  .....+|+||+|++.+++++ |..||..
T Consensus       154 ------cgt~eymApEI~~--gh~~a~D~ws~gvl~fellt-g~~pf~~  193 (612)
T KOG0603|consen  154 ------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLT-GTLPFGG  193 (612)
T ss_pred             ------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhh-CCCCCch
Confidence                  3346799999987  34577899999999999998 9999986

>KOG1167|consensus

Probab=99.40  E-value=1.8e-13  Score=94.44  Aligned_cols=114  Identities=25%  Similarity=0.392  Sum_probs=79.5

Q ss_pred             ccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC-cEEEEeecCccccc---------C-------C
Q psy7529           9 VVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH-QAKISDFGLSRAVN---------S-------E   71 (129)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~-~~~l~d~~~~~~~~---------~-------~   71 (129)
                      ++..++...++.++.-+ .+|+.++|. ++|+|||+||+|++.+... +-.+.|||++....         .       +
T Consensus       125 l~~~l~~~~i~~Yl~~l-l~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~  202 (418)
T KOG1167|consen  125 LYRSLSLAEIRWYLRNL-LKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATP  202 (418)
T ss_pred             HHhcCCHHHHHHHHHHH-HHHhhhhhc-cCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCc
Confidence            33444444555566667 889999999 9999999999999998764 45788999986210         0       0


Q ss_pred             -----------------Cceeeecc--------CCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          72 -----------------RNYYKATH--------GGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        72 -----------------~~~~~~~~--------~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                                       ........        ...+++.|.+||++... ....+.|+||.|+++.-+++ +..||..-
T Consensus       203 ~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls-~~~PFf~a  281 (418)
T KOG1167|consen  203 AMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLS-RRYPFFKA  281 (418)
T ss_pred             cccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhc-cccccccC
Confidence                             00000000        01246678999987554 35678999999999999998 88888753

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.40  E-value=7.5e-13  Score=85.55  Aligned_cols=122  Identities=14%  Similarity=0.079  Sum_probs=79.4

Q ss_pred             CCCCCCCCccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCC-CCCCEEecCCCcEEEEeecCcccccCCCcee--ee
Q psy7529           1 MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDL-AARNILLASRHQAKISDFGLSRAVNSERNYY--KA   77 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~l-k~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~   77 (129)
                      |||+.|..+....... ...++.|+ +.++.++|. ++++|||+ |+.||+++.++.++++|||++..........  ..
T Consensus        77 meyI~G~~L~~~~~~~-~~~~~~qi-~~~L~~lH~-~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~  153 (218)
T PRK12274         77 RSYLAGAAMYQRPPRG-DLAYFRAA-RRLLQQLHR-CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLA  153 (218)
T ss_pred             EeeecCccHHhhhhhh-hHHHHHHH-HHHHHHHHH-CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHH
Confidence            7888888876544322 23466777 889999999 99999999 7999999999999999999997433221100  00


Q ss_pred             --------ccCCCCCceecccccccCC-CCC-ChhhHHHHHHHHHHHHhCCCCC-CCCCC
Q psy7529          78 --------THGGRWPIKWYAPESYNFG-RFS-SASDVWSFGITLWEMYSFGQQP-YGEMK  126 (129)
Q Consensus        78 --------~~~~~~~~~~~~pe~~~~~-~~~-~~~di~s~g~~l~~l~~~~~~p-f~~~~  126 (129)
                              ..-...++.++.|+.-... ..+ .+.++.+.|.-+|.+.+ +..+ |.|..
T Consensus       154 ~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~-~~~~~~~~~~  212 (218)
T PRK12274        154 REDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVT-RRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHh-ccCCccccCC
Confidence                    0001123345555532221 223 44556689999999998 6554 55544

>KOG1165|consensus

Probab=99.32  E-value=1.1e-11  Score=84.28  Aligned_cols=105  Identities=18%  Similarity=0.289  Sum_probs=82.3

Q ss_pred             hHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC-----CcEEEEeecCcccccCCCc----eeeeccCCCCCceeccc
Q psy7529          20 YIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR-----HQAKISDFGLSRAVNSERN----YYKATHGGRWPIKWYAP   90 (129)
Q Consensus        20 ~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~-----~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~~~~p   90 (129)
                      .++.|. ..-+.|+|. +.+|+||+||+|.|+...     ..+.++|||+++.+-++.+    .+.......++.+||+.
T Consensus       128 miA~Qm-i~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSI  205 (449)
T KOG1165|consen  128 MIAKQM-ITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSI  205 (449)
T ss_pred             HHHHHH-HHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEe
Confidence            366666 778899999 899999999999999643     3468999999998755432    22222333456789998


Q ss_pred             ccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          91 ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        91 e~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ....+..-+.+.|+-|+|=++.+.+. |..||+++..
T Consensus       206 NTHlGrEQSRRDDLEaLGHvFmYFLR-GsLPWQGLKA  241 (449)
T KOG1165|consen  206 NTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKA  241 (449)
T ss_pred             eccccchhhhhhhHHHhhhhhhhhcc-CCCccccccC
Confidence            88888877889999999998888887 9999998764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.26  E-value=1.4e-12  Score=85.57  Aligned_cols=93  Identities=11%  Similarity=0.085  Sum_probs=65.6

Q ss_pred             CCCCCCCCccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccC
Q psy7529           1 MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHG   80 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~   80 (129)
                      |||++|.++.+.....  .....++ +.++..+|. .+++|+|++|+|++++..+ ++++|||.........        
T Consensus       122 mEyi~G~tL~~~~~~~--~~~~~~i-~~~l~~lH~-~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~--------  188 (232)
T PRK10359        122 IEYIEGVELNDMPEIS--EDVKAKI-KASIESLHQ-HGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRK--------  188 (232)
T ss_pred             EEEECCccHHHhhhcc--HHHHHHH-HHHHHHHHH-cCCccCCCChHHEEEeCCC-EEEEECCCcccccchh--------
Confidence            7889998875543221  2345566 889999999 9999999999999998888 9999999765331110        


Q ss_pred             CCCCceecccccccCCCCCChhhHHHHHHHHHH
Q psy7529          81 GRWPIKWYAPESYNFGRFSSASDVWSFGITLWE  113 (129)
Q Consensus        81 ~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~  113 (129)
                             ..-.......++.++|+|++|+.+..
T Consensus       189 -------a~d~~vler~y~~~~di~~lg~~~~~  214 (232)
T PRK10359        189 -------AKDRIDLERHYGIKNEIKDLGYYLLI  214 (232)
T ss_pred             -------hHHHHHHHhHhcccccccceeEeehH
Confidence                   00112334456678999999986543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.25  E-value=5.8e-12  Score=80.79  Aligned_cols=63  Identities=24%  Similarity=0.227  Sum_probs=49.1

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHH-hccCCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYL-KMHKSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~-h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      |||++|+.+...      ++......++.|+ +.++.++ |. .+++|||+||+||+++ .+.++++|||++.
T Consensus        96 mE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi-~~~L~~l~H~-~giiHrDlkP~NIli~-~~~v~LiDFG~a~  165 (190)
T cd05147          96 MEFIGDDGWAAPRLKDAPLSESKARELYLQV-IQIMRILYQD-CRLVHADLSEYNLLYH-DGKLYIIDVSQSV  165 (190)
T ss_pred             EEEeCCCCCcchhhhcCCCCHHHHHHHHHHH-HHHHHHHHHh-CCcccCCCCHHHEEEE-CCcEEEEEccccc
Confidence            889988764322      2222345577888 8999999 56 8999999999999998 4789999999875

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.25  E-value=7.7e-12  Score=80.13  Aligned_cols=66  Identities=23%  Similarity=0.226  Sum_probs=51.9

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccc
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAV   68 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~   68 (129)
                      |||++|+.+...      +.......++.|+ +.++.++|..++++|||+||.||+++ .+.++++|||++...
T Consensus        96 mE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l-~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145          96 MEFIGDDGSPAPRLKDVPLEEEEAEELYEQV-VEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             EEEecCCCchhhhhhhccCCHHHHHHHHHHH-HHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceec
Confidence            788888743221      2223456688888 89999999767999999999999998 788999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158|consensus

Probab=99.24  E-value=4.3e-11  Score=83.31  Aligned_cols=104  Identities=25%  Similarity=0.305  Sum_probs=70.3

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC----CcEEEEeecCcccccC---CCceeeeccCCCCCceeccc
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR----HQAKISDFGLSRAVNS---ERNYYKATHGGRWPIKWYAP   90 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~----~~~~l~d~~~~~~~~~---~~~~~~~~~~~~~~~~~~~p   90 (129)
                      ...+.+|+ ++|+.++|. +++-|||+|.+||++.-+    .++.++|||.+-.-..   +...........+.-..++|
T Consensus       343 ~~~~laQl-LEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAP  420 (598)
T KOG4158|consen  343 GRVILAQL-LEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAP  420 (598)
T ss_pred             HHHHHHHH-HHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecch
Confidence            45588999 999999999 899999999999998432    3467889997632111   00000000011112247899


Q ss_pred             ccccCCC-----C-CChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          91 ESYNFGR-----F-SSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        91 e~~~~~~-----~-~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      |.....+     . -.++|.|++|.+.||++. ...||-.
T Consensus       421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg-~~NPFY~  459 (598)
T KOG4158|consen  421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFG-RSNPFYK  459 (598)
T ss_pred             hhhhcCCCCceeeccchhhhhhhhhhHHHHhc-cCCcccc
Confidence            9764322     1 157899999999999997 7788864

>KOG1240|consensus

Probab=99.24  E-value=2.2e-11  Score=92.99  Aligned_cols=103  Identities=23%  Similarity=0.335  Sum_probs=77.5

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccc-cCCCc-----eeeeccCCCCCceeccc
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAV-NSERN-----YYKATHGGRWPIKWYAP   90 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~p   90 (129)
                      +.++|+.|+ ..|+.-+|. .+++|+|||.+|||+..=+++.+.||...+.. .+.+.     ..--+...+  ..|.||
T Consensus       121 EKkWiaFQL-L~al~qcH~-~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRR--tCYiAP  196 (1431)
T KOG1240|consen  121 EKKWIAFQL-LKALSQCHK-LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRR--TCYIAP  196 (1431)
T ss_pred             HHHHHHHHH-HHHHHHHHH-cCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCce--eeecCh
Confidence            456799999 999999999 99999999999999999999999999877642 11111     111111111  249999


Q ss_pred             ccccCC----------C-CCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          91 ESYNFG----------R-FSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        91 e~~~~~----------~-~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      |.+...          + ..++.||+|.||++.|++.-|.+||.
T Consensus       197 ERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  197 ERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             HhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            977431          1 34789999999999999986777775

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.23  E-value=5.6e-12  Score=85.03  Aligned_cols=98  Identities=23%  Similarity=0.503  Sum_probs=65.6

Q ss_pred             HHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC-----
Q psy7529          21 IEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF-----   95 (129)
Q Consensus        21 ~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----   95 (129)
                      +..|. .+..+++|. .+++|.|++++|++++.++.+.+.||+.....+..   ...   ...+..+.+||....     
T Consensus       150 lT~Q~-I~lvA~Lh~-~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~---~~~~~~~~PPe~~~~~~~~~  221 (288)
T PF14531_consen  150 LTVQM-IRLVANLHS-YGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRC---SEFPVAFTPPELESCAGQFG  221 (288)
T ss_dssp             HHHHH-HHHHHHHHH-TTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEG---GGS-TTTS-HHHHHHHTSCH
T ss_pred             HHHHH-HHHHHHHhh-cceEecccceeeEEEcCCCCEEEcChHHHeecCce---eec---cCCCcccCChhhhhhhcccC
Confidence            34555 788899999 99999999999999999999999999865443211   110   111234677875422     


Q ss_pred             ---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          96 ---GRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        96 ---~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                         ..+..+.|.|++|+++|.++. +..||...++
T Consensus       222 ~~~~~~t~~~DaW~LG~~ly~lWC-~~lPf~~~~~  255 (288)
T PF14531_consen  222 QNNAPYTFATDAWQLGITLYSLWC-GRLPFGLSSP  255 (288)
T ss_dssp             HSEEEE-HHHHHHHHHHHHHHHHH-SS-STCCCGG
T ss_pred             cccceeeeccCHHHHHHHHHHHHH-ccCCCCCCCc
Confidence               235678999999999999999 9999986543

>KOG1163|consensus

Probab=99.23  E-value=1e-11  Score=81.35  Aligned_cols=104  Identities=20%  Similarity=0.311  Sum_probs=74.3

Q ss_pred             HHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC---CcEEEEeecCcccccCCCce----eeeccCCCCCceecccccc
Q psy7529          21 IEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNY----YKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        21 ~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~---~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~   93 (129)
                      ++-|+ ..-++|+|. +..||||+||+|.|..-.   ..+-++|||+++...+..+.    +.......++.+|.+-...
T Consensus       116 LaDQm-l~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh  193 (341)
T KOG1163|consen  116 LADQM-LSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAH  193 (341)
T ss_pred             HHHHH-HHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhh
Confidence            44555 778999999 999999999999998654   45679999999876443221    1111112234567665555


Q ss_pred             cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          94 NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        94 ~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .+..-+.+.|+-|+|.++...-. |..||+++..
T Consensus       194 ~g~eqSRRDDmeSvgYvLmYfnr-G~LPWQglka  226 (341)
T KOG1163|consen  194 LGIEQSRRDDMESVGYVLMYFNR-GSLPWQGLKA  226 (341)
T ss_pred             hhhhhhhhhhhhhhcceeeeeec-CCCcccccch
Confidence            44445677899999988888876 9999998764

>KOG1033|consensus

Probab=99.21  E-value=1.9e-12  Score=91.78  Aligned_cols=92  Identities=28%  Similarity=0.434  Sum_probs=70.6

Q ss_pred             hHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce--ee-eccCCCCCceecccccccCC
Q psy7529          20 YIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY--YK-ATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        20 ~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~pe~~~~~   96 (129)
                      .++-|+ +.++.|    ++.+|||+||.||....+..+++.|||+........+.  .. ......++..|++||.+.+.
T Consensus       363 ~~~~q~-~~~~~y----k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~  437 (516)
T KOG1033|consen  363 DIFKQI-APAVEY----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ  437 (516)
T ss_pred             HHHHhh-ccchhh----ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhh
Confidence            366666 667777    78999999999999999999999999987654322200  00 01112245679999999999


Q ss_pred             CCCChhhHHHHHHHHHHHHh
Q psy7529          97 RFSSASDVWSFGITLWEMYS  116 (129)
Q Consensus        97 ~~~~~~di~s~g~~l~~l~~  116 (129)
                      .|+.++|||++|.+++|++.
T Consensus       438 ~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  438 QYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhhhcchhhHHHHHHHHHH
Confidence            99999999999999999887

>KOG0195|consensus

Probab=99.14  E-value=8.4e-11  Score=78.45  Aligned_cols=100  Identities=23%  Similarity=0.435  Sum_probs=72.4

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCc-cCCCCCCCEEecCCCcEEEE--eecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKIS--DFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~i-hr~lk~~nil~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      .+.++..+ ++|+.|+|....++ ...+...+++++.+-..++.  |--++..          ..+..+.+.|++||.+.
T Consensus       291 av~faldi-argmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq----------e~gr~y~pawmspealq  359 (448)
T KOG0195|consen  291 AVRFALDI-ARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----------EVGRAYSPAWMSPEALQ  359 (448)
T ss_pred             HHHHHHHH-HhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee----------ccccccCcccCCHHHHh
Confidence            44466666 99999999865554 55678888888887665544  4322211          12333456799999886


Q ss_pred             CCCCC---ChhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q psy7529          95 FGRFS---SASDVWSFGITLWEMYSFGQQPYGEMKGSD  129 (129)
Q Consensus        95 ~~~~~---~~~di~s~g~~l~~l~~~~~~pf~~~~~~e  129 (129)
                      ..+-+   ..+|+||+.+++||+-+ .+.||.++++.|
T Consensus       360 rkped~n~raadmwsfaillwel~t-revpfadlspme  396 (448)
T KOG0195|consen  360 RKPEDLNIRAADMWSFAILLWELNT-REVPFADLSPME  396 (448)
T ss_pred             cCchhcchhhhhHHHHHHHHHHhhc-cccccccCCchh
Confidence            65433   56899999999999998 999999999876

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.09  E-value=2.6e-10  Score=73.46  Aligned_cols=66  Identities=17%  Similarity=0.074  Sum_probs=53.6

Q ss_pred             CCCCCCCCccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccc
Q psy7529           1 MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAV   68 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~   68 (129)
                      |||+.|.++...........++.++ +.++.++|. .+++|+|++|.|++++..+.++++|||.+...
T Consensus       110 ~e~~~g~~L~~~~~~~~~~~~~~~i-~~~l~~lh~-~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         110 MEYIDGVELYRVRVLEDPEEVLDEI-LEEIVKAYK-HGIIHGDLSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             EEEeCCcchhhccccccHHHHHHHH-HHHHHHHHH-CCCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence            6788887765544334455677777 889999999 89999999999999999999999999988543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1166|consensus

Probab=99.03  E-value=1e-09  Score=83.85  Aligned_cols=113  Identities=18%  Similarity=0.253  Sum_probs=81.3

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-------CCcEEEEeecCccc
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-------RHQAKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-------~~~~~l~d~~~~~~   67 (129)
                      |+|.+-|+|.....      .+...++.+|+ +..+..+|. .+|||.||||+|.++-.       +..++++|||.+.-
T Consensus       773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qm-l~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD  850 (974)
T KOG1166|consen  773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQM-LRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID  850 (974)
T ss_pred             eeccccccHHHhhccCCCCCchhhhHHHHHH-HHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence            35555555444333      34466788888 999999999 89999999999999843       34579999998764


Q ss_pred             cc--CCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCC
Q psy7529          68 VN--SERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQ  119 (129)
Q Consensus        68 ~~--~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~  119 (129)
                      +.  ..........   .+-.+.++|+..+.++...+|.+.++.+++-|+ +|+
T Consensus       851 m~lfp~~~~F~~~~---~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mL-FG~  900 (974)
T KOG1166|consen  851 MKLFPDGTKFKAVW---HTDLFDCIEMREGRPWTYQIDYFGLAATVHVML-FGK  900 (974)
T ss_pred             eeEcCCCcEEeeee---ccccchhHHHhcCCCCchhhhhHHHHHHHHHHH-HHH
Confidence            32  2222222221   223478999999999999999999998888877 364

>KOG1023|consensus

Probab=98.98  E-value=3.8e-10  Score=80.82  Aligned_cols=122  Identities=25%  Similarity=0.372  Sum_probs=83.0

Q ss_pred             CCCCCCCccccCCCC----c--hhh-HHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           2 KSPNGSGVVTPLGSY----A--LPY-IEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         2 ~~~~~~~~~~~~~~~----~--~~~-~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      +||+-+++...+...    .  ... +...+ ..|+.|+|.+.-..|..++..|++++.++.+|+.|||+....... ..
T Consensus        27 ~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi-~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~-~~  104 (484)
T KOG1023|consen   27 EYCSRGSLLDILSNEDIKLDYFFILSFIRDI-SKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEET-AE  104 (484)
T ss_pred             eeecCccHHhHHhccccCccHHHHHHHHHHH-HHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhccccccc-cc
Confidence            456666654444431    1  222 34444 889999998554589999999999999999999999987654321 00


Q ss_pred             eeeccCCCCCceecccccccCCC-------CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGR-------FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~-------~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ........-...|.+||.+....       ...+.|+||+|++++|++. .+.||....
T Consensus       105 ~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~-r~~~~~~~~  162 (484)
T KOG1023|consen  105 PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF-RSGPFDLRN  162 (484)
T ss_pred             ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh-ccCcccccc
Confidence            01011111124589999876531       3567899999999999997 899998743

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.95  E-value=1e-09  Score=72.79  Aligned_cols=66  Identities=21%  Similarity=0.221  Sum_probs=48.2

Q ss_pred             CCCCCC-CCccccCCCCc-hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccc
Q psy7529           1 MKSPNG-SGVVTPLGSYA-LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAV   68 (129)
Q Consensus         1 m~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~   68 (129)
                      ||+++| .++...+.... ....+.++ +.++.++|. ++++|+|++|.||+++.++.++++||+.+...
T Consensus       125 ~e~l~G~~~L~~~l~~~~l~~~~~~~i-~~~l~~lH~-~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        125 IERIEGARDLVALLQEAPLSEEQWQAI-GQLIARFHD-AGVYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             EEecCCCCCHHHHHhcCCCCHHHHHHH-HHHHHHHHH-CCCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence            455665 34433322221 12245667 899999999 99999999999999998889999999987653

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.95  E-value=4.4e-10  Score=82.28  Aligned_cols=63  Identities=21%  Similarity=0.348  Sum_probs=52.5

Q ss_pred             CCCCCCCCccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccc
Q psy7529           1 MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAV   68 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~   68 (129)
                      |||++|+++...+.  ....++.++ ++++.++|. .+++|||+||+||++ ..+.++++|||+++..
T Consensus       415 ~E~~~g~~L~~~l~--~~~~~~~~i-~~~L~~lH~-~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        415 MEYIGGKDLKDVLE--GNPELVRKV-GEIVAKLHK-AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEecCCCcHHHHHH--HHHHHHHHH-HHHHHHHHh-CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            68888888766554  345577888 999999999 999999999999999 5778999999998753

>smart00090 RIO RIO-like kinase

Probab=98.95  E-value=9.4e-10  Score=72.86  Aligned_cols=65  Identities=25%  Similarity=0.228  Sum_probs=50.1

Q ss_pred             CCCCCCCCccccC-C-----CCchhhHHhHHHHHHHHHHhccCC-CccCCCCCCCEEecCCCcEEEEeecCcccc
Q psy7529           1 MKSPNGSGVVTPL-G-----SYALPYIEGQIPAKVCRYLKMHKS-SFHRDLAARNILLASRHQAKISDFGLSRAV   68 (129)
Q Consensus         1 m~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~l~~~h~~~~-~ihr~lk~~nil~~~~~~~~l~d~~~~~~~   68 (129)
                      |||+.|..+.... .     ......++.|+ +.++.++|. ++ ++|+|++|+||+++ .+.++++|||.+...
T Consensus       127 ~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi-~~~l~~LH~-~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      127 MEFIGGDGLPAPRLKDVEPEEEEEFELYDDI-LEEMRKLYK-EGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEEecCCcccccccccCCcchHHHHHHHHHH-HHHHHHHHh-cCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            6777776643322 1     12234677888 899999999 77 99999999999998 788999999987643

>KOG0590|consensus

Probab=98.93  E-value=3.8e-10  Score=83.35  Aligned_cols=122  Identities=26%  Similarity=0.349  Sum_probs=90.1

Q ss_pred             CCCCCCCccccC-C-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC-cEEEEeecCcccccC--
Q psy7529           2 KSPNGSGVVTPL-G-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH-QAKISDFGLSRAVNS--   70 (129)
Q Consensus         2 ~~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~-~~~l~d~~~~~~~~~--   70 (129)
                      ++..|++++... .       ......++.|+ ..++.|+|...++.|||++|+|.+++.++ ..+..|||++.....  
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql-~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~  179 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQL-NSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN  179 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhh-ccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence            455666666655 1       23355578888 88999999438999999999999999999 899999999986544  


Q ss_pred             CCceeeeccCCCCCceecccccccCCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGR-FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..........+ .+..|.+||...+.. .....|+||+|+++..+++ |..|+....
T Consensus       180 g~~~~~~~~~g-~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~-g~~p~~~~~  234 (601)
T KOG0590|consen  180 GAERSLKDRCG-SSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLT-GELPWDFPS  234 (601)
T ss_pred             CcceeeecccC-CCCCCCCcccccchhhcCCCccccccccccccccc-CCCCccccc
Confidence            22222111222 267899999887743 4678899999999999998 999876543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.90  E-value=1.2e-09  Score=70.20  Aligned_cols=63  Identities=21%  Similarity=0.285  Sum_probs=51.4

Q ss_pred             CCCCCCCCccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCccc
Q psy7529           1 MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~   67 (129)
                      |||++|.++...+..... .++.++ +.++.++|. .+++|+|+++.|++++ .+.+++.|||.++.
T Consensus        76 ~e~~~g~~l~~~~~~~~~-~~~~~i-~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        76 MEYIEGKPLKDVIEEGND-ELLREI-GRLVGKLHK-AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEECCccHHHHHhhcHH-HHHHHH-HHHHHHHHH-CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            677888876655443222 677777 899999999 9999999999999999 78899999998765

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.83  E-value=3.7e-09  Score=68.47  Aligned_cols=64  Identities=22%  Similarity=0.318  Sum_probs=51.1

Q ss_pred             CCCCCCCCccccCCCC--chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCccc
Q psy7529           1 MKSPNGSGVVTPLGSY--ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~   67 (129)
                      |||++|.++...+...  ....++.++ +.++.++|. .+++|+|++|.|++++ .+.++++|||.++.
T Consensus        78 ~e~~~G~~L~~~~~~~~~~~~~i~~~i-~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         78 MEYIEGEPLKDLINSNGMEELELSREI-GRLVGKLHS-AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEeCCcCHHHHHHhccHHHHHHHHHH-HHHHHHHHh-CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            6788887765444322  234567777 889999999 8999999999999999 78899999998764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.81  E-value=7.5e-09  Score=65.83  Aligned_cols=51  Identities=24%  Similarity=0.202  Sum_probs=43.1

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccc
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAV   68 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~   68 (129)
                      .....++.++ +.++.++|...+++|+|++|+|++++ .+.++++|||.+...
T Consensus       114 ~~~~~~~~~~-~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         114 EDPEELYDQI-LELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             ccHHHHHHHH-HHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence            3455577777 88999999767899999999999999 888999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK10345 hypothetical protein; Provisional

Probab=98.76  E-value=7.4e-09  Score=67.42  Aligned_cols=63  Identities=16%  Similarity=-0.018  Sum_probs=42.9

Q ss_pred             CCC--CCCCCccccCCCCc---hhhHHhHHHHHHH-HHHhccCCCccCCCCCCCEEecC----CCcEEEEeecCc
Q psy7529           1 MKS--PNGSGVVTPLGSYA---LPYIEGQIPAKVC-RYLKMHKSSFHRDLAARNILLAS----RHQAKISDFGLS   65 (129)
Q Consensus         1 m~~--~~~~~~~~~~~~~~---~~~~~~~~~~~~l-~~~h~~~~~ihr~lk~~nil~~~----~~~~~l~d~~~~   65 (129)
                      |||  +.+++|...+....   ....+.++ +.++ .|+|. ++|+|||+||+||+++.    ...++++|++.+
T Consensus        84 ~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~-L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQCRYEEDVAQLRQL-LKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ecCCCCcchhHHHHHHcccccHhHHHHHHH-HHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            456  44566655554321   12235566 5455 89999 99999999999999974    347999995443

>KOG0606|consensus

Probab=98.56  E-value=7.7e-08  Score=73.90  Aligned_cols=125  Identities=23%  Similarity=0.276  Sum_probs=85.8

Q ss_pred             CCCCCCCCccccCCCC------chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCccccc---C-
Q psy7529           1 MKSPNGSGVVTPLGSY------ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVN---S-   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~---~-   70 (129)
                      |+|.++++++..|...      ..+=..... .+++.++|. ..+.|||+++.+++....++.++.+++......   . 
T Consensus       883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~-vqs~e~L~s-~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSGCLSAEPARSPILER-VQSLESLHS-SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             hHHhccCCchhhhhcCCCcccccccchhHHH-Hhhhhcccc-chhhcccccccchhhcccCCcccCccccccccccccCc
Confidence            4566666666654432      222233444 667899997 558999999999999999999999887322110   0 


Q ss_pred             --C---------------Cc--ee-----eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 --E---------------RN--YY-----KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 --~---------------~~--~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        .               ..  ..     ........++.|.+||...+......+|+|+.|+.+.+.++ |.+||.+-.
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~-g~pp~na~t 1039 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT-GIPPFNAET 1039 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc-CCCCCCCcc
Confidence              0               00  00     00111234567999999988888889999999999999998 999998765


Q ss_pred             CC
Q psy7529         127 GS  128 (129)
Q Consensus       127 ~~  128 (129)
                      ++
T Consensus      1040 pq 1041 (1205)
T KOG0606|consen 1040 PQ 1041 (1205)
T ss_pred             hh
Confidence            43

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.53  E-value=1.2e-07  Score=57.62  Aligned_cols=64  Identities=22%  Similarity=0.171  Sum_probs=47.8

Q ss_pred             CCCCCCCCccccCCCCchhhHHhHHHHHHHHHHhcc--CCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529           1 MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMH--KSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~h~~--~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      |||++|..+... .......++.++ +.++..+|..  .+++|+|+++.|++++..+.+++.||+.++
T Consensus        72 ~e~~~g~~~~~~-~~~~~~~~~~~~-~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          72 MEWIEGETLDEV-SEEEKEDIAEQL-AELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             EEecCCeecccC-CHHHHHHHHHHH-HHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            455555554332 223445567777 8899999974  269999999999999998889999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.52  E-value=3e-07  Score=57.45  Aligned_cols=61  Identities=25%  Similarity=0.305  Sum_probs=46.7

Q ss_pred             CCCCCCCCccccCCCCchhhHHhHHHHHHHHHHhccCC-----CccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529           1 MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKS-----SFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~-----~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      |||++|.++...  ....+....++ ++++..+|. ..     ++|+|+++.|++++ .+.++++||+.+.
T Consensus        70 ~e~i~G~~l~~~--~~~~~~~~~~l-~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          70 TEFIEGSELLTE--DFSDPENLEKI-AKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             EEecCCCccccc--cccCHHHHHHH-HHHHHHHhC-CCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            678888776543  12234456677 899999998 55     49999999999998 5678999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.47  E-value=2e-07  Score=66.97  Aligned_cols=68  Identities=16%  Similarity=0.193  Sum_probs=51.1

Q ss_pred             CCCCCCCCccccCCC----CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCccccc
Q psy7529           1 MKSPNGSGVVTPLGS----YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVN   69 (129)
Q Consensus         1 m~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~   69 (129)
                      |||++|..+.+....    .....++.+++...+..+|. .+++|+|++|.||++..++.+++.|||++..+.
T Consensus       237 mE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~-~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       237 MEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLR-DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             EEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHh-CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            789998887654321    12334555553335677887 899999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.33  E-value=5.3e-07  Score=57.31  Aligned_cols=63  Identities=24%  Similarity=0.336  Sum_probs=49.4

Q ss_pred             CCCCCCCCccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCccc
Q psy7529           1 MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~   67 (129)
                      |||++|..+...+... .+-+...+ -.-+.-||. .+++|.|+.++|+++.... +-++|||+...
T Consensus        78 me~I~G~~lkd~l~~~-~~~~~r~v-G~~vg~lH~-~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          78 MEYIEGELLKDALEEA-RPDLLREV-GRLVGKLHK-AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEeCChhHHHHHHhc-chHHHHHH-HHHHHHHHh-cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            7888888777666665 23445555 556789998 9999999999999998765 88999999864

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.12  E-value=4.5e-06  Score=53.86  Aligned_cols=45  Identities=22%  Similarity=0.149  Sum_probs=36.0

Q ss_pred             hhHHhHHHHHHHHHH-hccCCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          19 PYIEGQIPAKVCRYL-KMHKSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        19 ~~~~~~~~~~~l~~~-h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      ..+..++ ..++..+ |. .+++|+|+++.||++. .+.+.++||+-+-
T Consensus       127 ~~i~~~i-~~~l~~l~H~-~glVHGDLs~~NIL~~-~~~v~iIDF~qav  172 (197)
T cd05146         127 KNAYYQV-LSMMKQLYKE-CNLVHADLSEYNMLWH-DGKVWFIDVSQSV  172 (197)
T ss_pred             HHHHHHH-HHHHHHHHHh-CCeecCCCCHHHEEEE-CCcEEEEECCCce
Confidence            3455666 7778877 66 8999999999999996 4679999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087|consensus

Probab=97.94  E-value=2e-05  Score=50.41  Aligned_cols=48  Identities=31%  Similarity=0.418  Sum_probs=38.1

Q ss_pred             hhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc---EEEEeecCcccc
Q psy7529          19 PYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ---AKISDFGLSRAV   68 (129)
Q Consensus        19 ~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~---~~l~d~~~~~~~   68 (129)
                      ..++.++ -+.+.-||. +.++|.||..+||++..++.   +-++|||++...
T Consensus       116 ~~~~~~i-G~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  116 AELARRI-GELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             HHHHHHH-HHHHHHhhh-CCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            3455566 778899999 99999999999999865543   478899997643

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=97.89  E-value=1.9e-05  Score=58.17  Aligned_cols=68  Identities=19%  Similarity=0.223  Sum_probs=45.9

Q ss_pred             CCCCCCCCcccc--CCC--CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC----cEEEEeecCccccc
Q psy7529           1 MKSPNGSGVVTP--LGS--YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH----QAKISDFGLSRAVN   69 (129)
Q Consensus         1 m~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~----~~~l~d~~~~~~~~   69 (129)
                      |||++|..+.+.  +..  .....+....+..-+.-+.. .+++|+|++|.||+++.++    .+.+.|||+...+.
T Consensus       240 mE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        240 MERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             EeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            899999887542  221  12223333332223333444 8899999999999998887    89999999987553

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.85  E-value=1.7e-05  Score=50.86  Aligned_cols=47  Identities=26%  Similarity=0.338  Sum_probs=33.1

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      ...++.++.......+|. .+++|.|+...||++... .+.++||+-+.
T Consensus       108 ~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~-~~~iIDf~qav  154 (188)
T PF01163_consen  108 PKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG-KVYIIDFGQAV  154 (188)
T ss_dssp             HHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred             HHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-eEEEEecCcce
Confidence            444666663334555677 899999999999999887 89999998654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=97.83  E-value=3.7e-05  Score=52.02  Aligned_cols=45  Identities=18%  Similarity=0.212  Sum_probs=38.2

Q ss_pred             hHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-------CCcEEEEeecCcc
Q psy7529          20 YIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-------RHQAKISDFGLSR   66 (129)
Q Consensus        20 ~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-------~~~~~l~d~~~~~   66 (129)
                      .++.++ ++.+.-||. ++++|+|+++.||+++.       ...+.++||+.++
T Consensus       142 ~ll~~l-a~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        142 MLIKRV-ATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHH-HHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            456666 889999999 99999999999999975       4568899999774

>KOG2137|consensus

Probab=97.76  E-value=5.9e-06  Score=61.35  Aligned_cols=94  Identities=20%  Similarity=0.311  Sum_probs=66.4

Q ss_pred             HHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccC------CCCCceecccccccCCCCCC
Q psy7529          27 AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHG------GRWPIKWYAPESYNFGRFSS  100 (129)
Q Consensus        27 ~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~------~~~~~~~~~pe~~~~~~~~~  100 (129)
                      +.|+.++|.+.+++|+++.|+.|.++..+..|+..|+.+.-.............      ..-...|.+||.+.+.....
T Consensus       109 ~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~  188 (700)
T KOG2137|consen  109 ADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTP  188 (700)
T ss_pred             cchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccccc
Confidence            357899999899999999999999999999999988876543321111100000      00123589999887766678


Q ss_pred             hhhHHHHHHHHHHHHhCCCC
Q psy7529         101 ASDVWSFGITLWEMYSFGQQ  120 (129)
Q Consensus       101 ~~di~s~g~~l~~l~~~~~~  120 (129)
                      .+|++|+|++.+.+..-|+.
T Consensus       189 ~sd~fSlG~li~~i~~~gk~  208 (700)
T KOG2137|consen  189 ASDVFSLGVLIYTIYNGGKS  208 (700)
T ss_pred             cccceeeeeEEEEEecCCcc
Confidence            89999999988877642433

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.65  E-value=0.00089  Score=48.21  Aligned_cols=100  Identities=12%  Similarity=0.184  Sum_probs=67.6

Q ss_pred             HHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc-----C
Q psy7529          21 IEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN-----F   95 (129)
Q Consensus        21 ~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~   95 (129)
                      ....+ +.+..-+|. .+..-.|+.++|++++....+.+.|--..+ +........+.   .+...|++||...     +
T Consensus       122 vaRnl-A~aFA~lH~-~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq-i~~ng~~~~cp---Vg~~eftPPElQ~~~sf~g  195 (637)
T COG4248         122 VARNL-ASAFATLHE-HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ-INANGTLHLCP---VGVSEFTPPELQTLPSFVG  195 (637)
T ss_pred             HHHHH-HHHHHHHHh-cCCcccccCccceeeecCceEEEEccccee-eccCCceEecc---cCccccCCHHHhccccccc
Confidence            33444 778899998 777789999999999999999888632211 11111111111   2234699999654     2


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..-+...|.+.+++++++++--|.-||.++.
T Consensus       196 ~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         196 FERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             cCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence            2334678999999999998863478998753

>KOG0601|consensus

Probab=97.64  E-value=2e-05  Score=57.37  Aligned_cols=108  Identities=19%  Similarity=0.167  Sum_probs=70.0

Q ss_pred             CCCCCCC------ccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC-CcEEEEeecCcccccCCCce
Q psy7529           2 KSPNGSG------VVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR-HQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         2 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~-~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++      +...+++-++..+..|+ ..++.++|. ...+|+|++++||++..+ +..++.|++....+..... 
T Consensus       346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~-~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~-  422 (524)
T KOG0601|consen  346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQI-LTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG-  422 (524)
T ss_pred             hhhcCcchhhhhHHHHhcCcchhhhhHHHH-Hhccccccc-hhhhcccccccceeeccchhhhhccccccccccceecc-
Confidence            5666655      23334444566678888 899999998 999999999999999886 6667888887643211000 


Q ss_pred             eeeccCCCCCcee-cccccccCCCCCChhhHHHHHHHHHHHHh
Q psy7529          75 YKATHGGRWPIKW-YAPESYNFGRFSSASDVWSFGITLWEMYS  116 (129)
Q Consensus        75 ~~~~~~~~~~~~~-~~pe~~~~~~~~~~~di~s~g~~l~~l~~  116 (129)
                      ...    .....| .++.......+..++|++++|..+.+..+
T Consensus       423 ~~~----~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~  461 (524)
T KOG0601|consen  423 VFH----HIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAIT  461 (524)
T ss_pred             ccc----ccccccccchhhcccccccccccccccccccccccc
Confidence            000    001112 23333444466788899999988777765

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.60  E-value=0.00016  Score=47.05  Aligned_cols=49  Identities=20%  Similarity=0.237  Sum_probs=41.3

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC---cEEEEeecCccc
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH---QAKISDFGLSRA   67 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~---~~~l~d~~~~~~   67 (129)
                      ....+..++ ++.+.-||. ++++|+|+++.||++....   .+.++||...+.
T Consensus       119 ~~~~ll~~l-~~~i~~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  119 QRRELLRAL-ARLIAKLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hHHHHHHHH-HHHHHHHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            344566777 888999999 9999999999999998877   788999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.35  E-value=0.00046  Score=45.38  Aligned_cols=61  Identities=18%  Similarity=0.186  Sum_probs=44.5

Q ss_pred             CCCCCCCCccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529           1 MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      |||++|-.+........  .+.-.+ .+++.-+|. .+..|.|..|.|+++.. +.++++|++..+
T Consensus       122 ~EYIeG~~l~d~~~i~e--~~~~ki-~~~ikqlH~-~G~~HGD~hpgNFlv~~-~~i~iID~~~k~  182 (229)
T PF06176_consen  122 MEYIEGVELNDIEDIDE--DLAEKI-VEAIKQLHK-HGFYHGDPHPGNFLVSN-NGIRIIDTQGKR  182 (229)
T ss_pred             EEEecCeecccchhcCH--HHHHHH-HHHHHHHHH-cCCccCCCCcCcEEEEC-CcEEEEECcccc
Confidence            67888877554332221  233344 678999999 89999999999999885 449999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1243|consensus

Probab=97.18  E-value=0.0022  Score=48.16  Aligned_cols=94  Identities=14%  Similarity=0.164  Sum_probs=62.2

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ..+-+.|+ ++||-+||....++|.++.-+.+.++..+.-++.+|.+...........   ........+..|+.+....
T Consensus       106 v~~Gl~qI-l~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~---~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQI-LAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA---KSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHH-HHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc---ccchhhhcccChhhcCccc
Confidence            34466778 8999999976889999999999999999999999887654322111000   0000001234444322111


Q ss_pred             CCChhhHHHHHHHHHHHHhCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFG  118 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~  118 (129)
                        -..|.|.+|+++++++. |
T Consensus       182 --~s~D~~~Lg~li~el~n-g  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFN-G  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhC-c
Confidence              23699999999999997 7

>PRK09902 hypothetical protein; Provisional

Probab=96.82  E-value=0.003  Score=41.37  Aligned_cols=46  Identities=17%  Similarity=0.145  Sum_probs=38.9

Q ss_pred             hHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc--EEEEeecCccc
Q psy7529          20 YIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ--AKISDFGLSRA   67 (129)
Q Consensus        20 ~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~--~~l~d~~~~~~   67 (129)
                      .+..++ ++.++-||. .++.|+|+-+.||+++..+.  ++++||..++.
T Consensus       132 ~il~~v-a~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        132 AMLKAV-ALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             HHHHHH-HHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            566666 999999999 99999999999999986666  89999986653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=96.62  E-value=0.0068  Score=41.24  Aligned_cols=61  Identities=20%  Similarity=0.153  Sum_probs=40.7

Q ss_pred             CCCCCCCCccccC-CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeec
Q psy7529           1 MKSPNGSGVVTPL-GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFG   63 (129)
Q Consensus         1 m~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~   63 (129)
                      ||+++|..++..- ..-...-+...+ ..-+.-+-. .+++|.|++.=||+++.++.+.++||.
T Consensus       186 Me~ieG~eL~~~r~~~en~~~il~~i-l~~~~~~~~-~GiVHGDlSefNIlV~~dg~~~vIDwP  247 (304)
T COG0478         186 MEYIEGVELYRLRLDVENPDEILDKI-LEEVRKAYR-RGIVHGDLSEFNILVTEDGDIVVIDWP  247 (304)
T ss_pred             eehcccceeecccCcccCHHHHHHHH-HHHHHHHHH-cCccccCCchheEEEecCCCEEEEeCc
Confidence            8888887766554 122222233333 222222223 789999999999999999999999985

>KOG0601|consensus

Probab=96.55  E-value=0.0021  Score=47.26  Aligned_cols=86  Identities=26%  Similarity=0.298  Sum_probs=62.2

Q ss_pred             HHHHHhccCCCccCCCCCCCEEecCC-CcEEEEeecCcccccCCCce--eeeccCCCCCceecccccccCCCCCChhhHH
Q psy7529          29 VCRYLKMHKSSFHRDLAARNILLASR-HQAKISDFGLSRAVNSERNY--YKATHGGRWPIKWYAPESYNFGRFSSASDVW  105 (129)
Q Consensus        29 ~l~~~h~~~~~ihr~lk~~nil~~~~-~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~  105 (129)
                      |+..+|. ..++|-++++.|+....+ ..+++.||++...+....-.  ........+...|++||...+ .+....|++
T Consensus       234 al~~~hs-~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~  311 (524)
T KOG0601|consen  234 ALSHLHS-NNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIF  311 (524)
T ss_pred             cccccCC-CcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhc
Confidence            8889998 899999999999999888 77889999988766543211  110011112235999997764 456788999


Q ss_pred             HHHHHHHHHHh
Q psy7529         106 SFGITLWEMYS  116 (129)
Q Consensus       106 s~g~~l~~l~~  116 (129)
                      ++|-+..+...
T Consensus       312 sl~ev~l~~~l  322 (524)
T KOG0601|consen  312 SLGEVILEAIL  322 (524)
T ss_pred             chhhhhHhhHh
Confidence            99988777665

>KOG1266|consensus

Probab=95.64  E-value=0.017  Score=40.55  Aligned_cols=98  Identities=21%  Similarity=0.193  Sum_probs=58.0

Q ss_pred             hhhHHhHHHHHHHHHHhccC-CCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee-eeccCCCCCceecccccccC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHK-SSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY-KATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~-~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~   95 (129)
                      +.....|+ ..||.|||... .++|.++.-+.+.+..++-+|+..-.....-....... .......+-+.|.+|+.-.-
T Consensus       178 wkkw~tqI-lsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~  256 (458)
T KOG1266|consen  178 WKKWCTQI-LSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT  256 (458)
T ss_pred             HHHHHHHH-HhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc
Confidence            44577888 99999999854 47899999999988877777754321111000000000 00001111234666665443


Q ss_pred             CCCCChhhHHHHHHHHHHHHh
Q psy7529          96 GRFSSASDVWSFGITLWEMYS  116 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~  116 (129)
                      ......+|||++|....++.-
T Consensus       257 tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  257 TNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             cccccchhhhhhhHHHHHHHH
Confidence            344567899999977777765

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=94.54  E-value=0.077  Score=39.44  Aligned_cols=68  Identities=21%  Similarity=0.255  Sum_probs=47.0

Q ss_pred             CCCCCCCCcccc--CCC--CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCccccc
Q psy7529           1 MKSPNGSGVVTP--LGS--YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVN   69 (129)
Q Consensus         1 m~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~   69 (129)
                      |||.+|..+.+.  ++.  .....+...+ .++....-...+.+|.|.-|.|+++..++.+-+.|||+.....
T Consensus       245 mE~i~Gi~i~d~~~l~~~g~d~k~ia~~~-~~~f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         245 MEWIDGIKISDIAALKSAGIDRKELAELL-VRAFLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             EEeeCCEecccHHHHHhcCCCHHHHHHHH-HHHHHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            788888776655  333  2334454444 4433322222789999999999999999999999999876543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=93.58  E-value=0.073  Score=34.32  Aligned_cols=30  Identities=20%  Similarity=0.318  Sum_probs=24.4

Q ss_pred             CCCccCCCCCCCEEecC--CCcEEEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLAS--RHQAKISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~--~~~~~l~d~~~~~   66 (129)
                      ..++|+|+.+.|++++.  ...+.++||+.+.
T Consensus       174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             cEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence            34689999999999988  4557899998653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK05231 homoserine kinase; Provisional

Probab=93.03  E-value=0.12  Score=35.73  Aligned_cols=30  Identities=23%  Similarity=0.377  Sum_probs=25.3

Q ss_pred             CCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .+++|+|+.+.|++++......++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            478999999999999866556899998764

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=92.62  E-value=0.38  Score=32.59  Aligned_cols=38  Identities=26%  Similarity=0.282  Sum_probs=30.8

Q ss_pred             HHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCc
Q psy7529          27 AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLS   65 (129)
Q Consensus        27 ~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~   65 (129)
                      .+.+.-|-...+++|.||+.=|||+. .+.+.++|++=+
T Consensus       176 v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~Qa  213 (268)
T COG1718         176 VEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQA  213 (268)
T ss_pred             HHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccc
Confidence            66566555447899999999999999 788999999754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=92.56  E-value=0.17  Score=33.92  Aligned_cols=37  Identities=19%  Similarity=0.103  Sum_probs=31.4

Q ss_pred             HHHHHHHhc-cCCCccCCCCCCCEEecCCCcEEEEeec
Q psy7529          27 AKVCRYLKM-HKSSFHRDLAARNILLASRHQAKISDFG   63 (129)
Q Consensus        27 ~~~l~~~h~-~~~~ihr~lk~~nil~~~~~~~~l~d~~   63 (129)
                      .++|..+|+ +...+|.|..|+||+-++.+.+|+.|-+
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~  188 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV  188 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence            467788884 3568999999999999999999999854

The function of this family is unknown.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=92.09  E-value=0.16  Score=34.76  Aligned_cols=29  Identities=31%  Similarity=0.413  Sum_probs=25.4

Q ss_pred             CCccCCCCCCCEEecCC----CcEEEEeecCcc
Q psy7529          38 SSFHRDLAARNILLASR----HQAKISDFGLSR   66 (129)
Q Consensus        38 ~~ihr~lk~~nil~~~~----~~~~l~d~~~~~   66 (129)
                      .++|.|+.+.||+++.+    +.+.++||..+.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            46899999999999875    789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268|consensus

Probab=91.82  E-value=0.4  Score=34.10  Aligned_cols=61  Identities=16%  Similarity=0.178  Sum_probs=40.4

Q ss_pred             CCCCCCCCccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeec
Q psy7529           1 MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFG   63 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~   63 (129)
                      ||.+.|-.+++.-.....+-+...+ ...+.-+-. +++||.|-.-=||++..+..++++||.
T Consensus       187 melv~g~Pl~~v~~v~d~~~ly~~l-m~~Iv~la~-~GlIHgDFNEFNimv~dd~~i~vIDFP  247 (465)
T KOG2268|consen  187 MELVDGYPLRQVRHVEDPPTLYDDL-MGLIVRLAN-HGLIHGDFNEFNIMVKDDDKIVVIDFP  247 (465)
T ss_pred             HHhhcccceeeeeecCChHHHHHHH-HHHHHHHHH-cCceecccchheeEEecCCCEEEeech
Confidence            3444444444444334444444444 444444545 899999999999999999999999985

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=91.33  E-value=0.24  Score=32.50  Aligned_cols=29  Identities=24%  Similarity=0.409  Sum_probs=24.8

Q ss_pred             CCccCCCCCCCEEecC-CCcEEEEeecCcc
Q psy7529          38 SSFHRDLAARNILLAS-RHQAKISDFGLSR   66 (129)
Q Consensus        38 ~~ihr~lk~~nil~~~-~~~~~l~d~~~~~   66 (129)
                      .++|.|+.+.||+++. ...+.++||..+.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            4789999999999997 5779999997653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PHA03111 Ser/Thr kinase; Provisional

Probab=91.12  E-value=0.55  Score=33.43  Aligned_cols=38  Identities=24%  Similarity=0.309  Sum_probs=24.8

Q ss_pred             hhhHHhHHHHHHHHHHhc--cCCCccCCCCCCCEEecCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKM--HKSSFHRDLAARNILLASRH   55 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~--~~~~ihr~lk~~nil~~~~~   55 (129)
                      .++++.|+++--+++-..  ....+|-||||+|||+-.+.
T Consensus       281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~  320 (444)
T PHA03111        281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD  320 (444)
T ss_pred             HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence            566888884444343222  24568999999999985443

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=91.10  E-value=0.24  Score=32.73  Aligned_cols=29  Identities=34%  Similarity=0.512  Sum_probs=23.8

Q ss_pred             CCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          38 SSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        38 ~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .++|.|+.+.|++++......++||+.+.
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            47899999999999876555799998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=90.73  E-value=0.31  Score=33.54  Aligned_cols=30  Identities=23%  Similarity=0.382  Sum_probs=26.0

Q ss_pred             CCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .+++|.|+.+.|++++.+....++||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            568999999999999887766899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=90.55  E-value=0.77  Score=33.19  Aligned_cols=30  Identities=37%  Similarity=0.492  Sum_probs=26.7

Q ss_pred             CCccCCCCCCCEEecCCCcEEEEeecCcccc
Q psy7529          38 SSFHRDLAARNILLASRHQAKISDFGLSRAV   68 (129)
Q Consensus        38 ~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~   68 (129)
                      ..=||++...||+++ .+++.++||.++|..
T Consensus       342 ~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         342 PFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             Ccccccccccceeee-cCceEEEEeeeeecc
Confidence            456999999999999 899999999999853

>KOG0576|consensus

Probab=90.40  E-value=0.14  Score=39.13  Aligned_cols=84  Identities=21%  Similarity=0.253  Sum_probs=51.9

Q ss_pred             HHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHH
Q psy7529          27 AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWS  106 (129)
Q Consensus        27 ~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s  106 (129)
                      .+++.++|. -.-+|||    ||+... ...+..+++....+....    .......+..|++||+.....+....|.|+
T Consensus       346 t~~l~~l~~-~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~  415 (829)
T KOG0576|consen  346 TRPLAELHS-SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM----KPRTAIGTPEPLAPEVIQENTIDGCPDSGS  415 (829)
T ss_pred             ccccccccc-ccccCcc----cccccc-cccccccccCCcccCccc----ccccCCCCCCCCCchhhcccccccCCCccC
Confidence            346677776 3346776    554433 556777887765544332    111222346799999888888888889999


Q ss_pred             HHHHHHHHHhCCCCC
Q psy7529         107 FGITLWEMYSFGQQP  121 (129)
Q Consensus       107 ~g~~l~~l~~~~~~p  121 (129)
                      .+.-..++.. +..|
T Consensus       416 ~~~~~~~~ap-~~pP  429 (829)
T KOG0576|consen  416 LAVSAIQMAP-GLPP  429 (829)
T ss_pred             CCcchhhcCC-CCCC
Confidence            8865555554 4444

>KOG3741|consensus

Probab=90.36  E-value=1.3  Score=33.37  Aligned_cols=44  Identities=16%  Similarity=0.243  Sum_probs=35.6

Q ss_pred             HHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          21 IEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        21 ~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      ++.|+ ..||.++|+ .++--+-|.+.+|++...-++++...|.-.
T Consensus       398 y~~QL-taaL~sIHs-sGLAck~L~~~kIlv~G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  398 YISQL-TAALYSIHS-SGLACKTLDLKKILVTGKMRIRISGCGIMD  441 (655)
T ss_pred             HHHHH-HHHHHHHHh-cCceeecccHhHeEeeCcceEEEeccccee
Confidence            67788 889999998 676568899999999988888877665543

>KOG1235|consensus

Probab=90.33  E-value=0.45  Score=35.65  Aligned_cols=67  Identities=18%  Similarity=0.163  Sum_probs=41.5

Q ss_pred             CCCCCCCCccccCCC--C--chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC----CCcEEEEeecCcccc
Q psy7529           1 MKSPNGSGVVTPLGS--Y--ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS----RHQAKISDFGLSRAV   68 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~----~~~~~l~d~~~~~~~   68 (129)
                      |||+.|..+-.....  .  ....+...+.-.-+.-+-. .+.+|.|--|.||++..    ...+.+.|+|+....
T Consensus       281 ME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~-~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  281 MEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFK-TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             EEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHh-cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            889988886544221  1  1111222221112223333 78999999999999984    566889999987644

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=90.18  E-value=0.33  Score=32.12  Aligned_cols=29  Identities=21%  Similarity=0.225  Sum_probs=24.7

Q ss_pred             CCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          38 SSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        38 ~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .++|+|+.+.|++++......++||+.+.
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            36899999999999987667899998663

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=90.16  E-value=0.32  Score=33.15  Aligned_cols=30  Identities=23%  Similarity=0.395  Sum_probs=25.5

Q ss_pred             CCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .+++|+|+.+.|++++....+.++||..+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            458999999999999987667899998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=89.75  E-value=0.34  Score=32.37  Aligned_cols=28  Identities=21%  Similarity=0.439  Sum_probs=24.0

Q ss_pred             CCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          38 SSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        38 ~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .++|+|+.+.|++++..+ +.++||..+.
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            468999999999998766 7899998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=89.71  E-value=0.21  Score=32.34  Aligned_cols=30  Identities=33%  Similarity=0.358  Sum_probs=20.1

Q ss_pred             CCCccCCCCCCCEEec-CCCcEEEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLA-SRHQAKISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~-~~~~~~l~d~~~~~   66 (129)
                      ..++|.|+.+.|++++ .++.+.++||+.+.
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             cEEEEeccccccceeeeccceeEEEecccce
Confidence            4578999999999999 55666799998653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PRK10271 thiK thiamine kinase; Provisional

Probab=89.69  E-value=0.44  Score=30.74  Aligned_cols=27  Identities=19%  Similarity=0.384  Sum_probs=23.2

Q ss_pred             CccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          39 SFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        39 ~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .+|.|+-+.|+++...+ ++++|++.+.
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCccc
Confidence            47999999999987766 8899998764

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=89.26  E-value=0.7  Score=33.04  Aligned_cols=37  Identities=24%  Similarity=0.301  Sum_probs=23.0

Q ss_pred             hhhHHhHHHHHHHHHHhc--cCCCccCCCCCCCEEecCC
Q psy7529          18 LPYIEGQIPAKVCRYLKM--HKSSFHRDLAARNILLASR   54 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~--~~~~ihr~lk~~nil~~~~   54 (129)
                      .++++.|+++--+++-..  ....+|-||||+|||+-.+
T Consensus       277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  315 (434)
T PF05445_consen  277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDS  315 (434)
T ss_pred             HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecC
Confidence            456777773333222121  2446899999999998543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=88.23  E-value=0.32  Score=31.55  Aligned_cols=29  Identities=31%  Similarity=0.450  Sum_probs=19.9

Q ss_pred             CCccCCCCCCCEEe-cCCCcEEEEeecCcc
Q psy7529          38 SSFHRDLAARNILL-ASRHQAKISDFGLSR   66 (129)
Q Consensus        38 ~~ihr~lk~~nil~-~~~~~~~l~d~~~~~   66 (129)
                      ...|.|+.+.||++ ...+.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            35799999999999 888999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=87.71  E-value=0.62  Score=31.93  Aligned_cols=29  Identities=31%  Similarity=0.487  Sum_probs=24.5

Q ss_pred             CCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .+++|+|+.+.|++++. +.+.++||..+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            46799999999999987 668899998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=87.56  E-value=0.59  Score=30.90  Aligned_cols=28  Identities=18%  Similarity=0.294  Sum_probs=23.9

Q ss_pred             CCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          38 SSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        38 ~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .++|.|+.+.|++++..+ +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            357999999999998877 8999998653

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=86.85  E-value=0.8  Score=31.23  Aligned_cols=29  Identities=24%  Similarity=0.377  Sum_probs=26.4

Q ss_pred             CCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          38 SSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        38 ~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      ..+|.|+.+.|++.+..+.+.++||..+.
T Consensus       154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             eeecCCCCccceEEcCCCcEEEEecccCC
Confidence            47899999999999999999999998774

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=86.16  E-value=0.78  Score=29.56  Aligned_cols=30  Identities=33%  Similarity=0.411  Sum_probs=24.0

Q ss_pred             CCCccCCCCCCCEEecCCC-----cEEEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLASRH-----QAKISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~~~-----~~~l~d~~~~~   66 (129)
                      ..++|+|+.+.|+++..+.     .+.+.||..++
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            3568999999999997543     57899998764

subfamily of choline kinases

>PLN02236 choline kinase

Probab=85.98  E-value=0.83  Score=32.23  Aligned_cols=29  Identities=24%  Similarity=0.384  Sum_probs=24.6

Q ss_pred             CCccCCCCCCCEEecC-CCcEEEEeecCcc
Q psy7529          38 SSFHRDLAARNILLAS-RHQAKISDFGLSR   66 (129)
Q Consensus        38 ~~ihr~lk~~nil~~~-~~~~~l~d~~~~~   66 (129)
                      .++|+|+.+.||+++. ...+.++||..+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            4689999999999976 4679999998775

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=84.91  E-value=0.92  Score=30.99  Aligned_cols=29  Identities=21%  Similarity=0.349  Sum_probs=23.7

Q ss_pred             CCccCCCCCCCEEecCCCc-EEEEeecCcc
Q psy7529          38 SSFHRDLAARNILLASRHQ-AKISDFGLSR   66 (129)
Q Consensus        38 ~~ihr~lk~~nil~~~~~~-~~l~d~~~~~   66 (129)
                      .++|.|+.+.|++++..+. ..++||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            4789999999999987455 4699998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=84.50  E-value=0.76  Score=31.74  Aligned_cols=30  Identities=13%  Similarity=0.186  Sum_probs=26.1

Q ss_pred             CCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .+++|+|+.+.|++++.++.+.++||-.+.
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            368999999999999988888999987654

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=84.14  E-value=1.1  Score=31.59  Aligned_cols=28  Identities=25%  Similarity=0.389  Sum_probs=24.8

Q ss_pred             CccCCCCCCCEEecCCCc-EEEEeecCcc
Q psy7529          39 SFHRDLAARNILLASRHQ-AKISDFGLSR   66 (129)
Q Consensus        39 ~ihr~lk~~nil~~~~~~-~~l~d~~~~~   66 (129)
                      +||.|+.+.|++++.... +.+.||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            899999999999998885 7899998764

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=83.79  E-value=1.2  Score=31.20  Aligned_cols=29  Identities=17%  Similarity=0.346  Sum_probs=26.2

Q ss_pred             CCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          38 SSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        38 ~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .++|.|..+.|++++....+-+.||+++.
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~  227 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELAT  227 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccc
Confidence            36899999999999998889999999875

>PRK06148 hypothetical protein; Provisional

Probab=82.81  E-value=1.4  Score=35.68  Aligned_cols=30  Identities=27%  Similarity=0.398  Sum_probs=24.8

Q ss_pred             CCCccCCCCCCCEEecCCC--cE-EEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLASRH--QA-KISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~~~--~~-~l~d~~~~~   66 (129)
                      +++||.|+.+.||+++...  .+ .++|||-+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            5689999999999998775  44 599999764

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=81.83  E-value=3.1  Score=26.77  Aligned_cols=46  Identities=15%  Similarity=0.064  Sum_probs=34.7

Q ss_pred             hHHhHHHHHHHHHHhcc--CCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          20 YIEGQIPAKVCRYLKMH--KSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        20 ~~~~~~~~~~l~~~h~~--~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .|+.++ .+.+..++..  ..+.-.|++++|+.+..++++++.|.....
T Consensus        63 ~iA~~l-L~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   63 KIALQL-LELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             HHHHHH-HHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence            366666 6667777652  236678999999999999999999987553

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=80.93  E-value=1.6  Score=30.58  Aligned_cols=28  Identities=25%  Similarity=0.354  Sum_probs=24.1

Q ss_pred             CccCCCCCCCEEecC-CCcEEEEeecCcc
Q psy7529          39 SFHRDLAARNILLAS-RHQAKISDFGLSR   66 (129)
Q Consensus        39 ~ihr~lk~~nil~~~-~~~~~l~d~~~~~   66 (129)
                      .+|.|+.+.||++.. .+.++++||..+.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            579999999999974 4679999998874

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	129
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-33
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-33
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-33
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-33
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-33
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-33
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-33
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-32
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-32
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-32
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-32
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-32
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-25
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-24
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-24
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-24
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-24
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-24
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-24
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-24
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-24
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-24
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-24
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-24
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-24
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-24
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-24
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-24
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-24
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-24
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-24
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-24
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-24
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-24
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-24
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-23
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-23
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-23
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-23
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-23
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-23
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-22
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-22
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-22
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-22
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-22
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-22
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-22
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-22
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-22
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-22
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-22
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-22
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-22
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-22
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-22
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-22
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-22
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-22
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-22
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-22
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-22
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-22
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-22
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-22
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-22
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-22
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-22
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-22
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-22
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-22
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-22
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-22
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-21
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-21
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-21
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-21
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-21
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-21
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-21
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-21
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-21
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-21
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-21
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-21
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-21
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-21
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-21
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-21
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-21
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-21
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-21
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-21
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-21
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-21
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-21
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-21
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-21
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-21
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-21
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-21
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-21
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-21
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-21
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-21
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-21
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-21
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-21
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		9e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-20
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-20
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-20
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-20
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-20
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-20
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-20
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-20
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-20
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-20
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-20
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-20
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-20
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-20
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-20
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-20
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-20
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-20
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-20
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-20
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-20
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-20
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-20
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-20
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-20
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-20
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-20
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-20
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-20
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-20
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-20
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-20
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-20
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-20
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-20
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-20
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-20
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-20
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-20
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-20
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-20
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-20
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-20
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-20
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-20
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-19
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-19
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-19
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-19
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-19
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-19
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-19
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-19
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-19
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-19
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-19
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-19
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-19
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-19
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-19
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-19
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-19
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-19
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-19
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-19
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-19
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-19
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-19
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-19
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-19
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-19
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-19
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-19
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-19
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-19
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-19
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-19
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-19
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-19
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-19
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-19
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-19
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-19
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-19
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-19
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-19
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-19
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-19
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-19
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-19
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		9e-19
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-18
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-18
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-18
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-18
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-18
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-18
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-18
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-18
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-18
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-18
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-18
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-18
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-18
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-18
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-18
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-18
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-17
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-17
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-17
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-17
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-17
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-17
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-17
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-17
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-17
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-17
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-17
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-17
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-17
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-16
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-09
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-08
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-08
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-08
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-08
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-08
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-07
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-07
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-07
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-06
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		9e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-05
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-05
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-05
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-05
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-05
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-05
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-05
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-05
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-05
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-05
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-05
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-05
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-05
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-05
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-05
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-05
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-05
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-05
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-05
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		8e-05
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-05
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-05
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-05
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-04
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-04
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-04
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-04
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-04
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-04
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-04
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-04
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-04
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-04
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-04
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-04
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-04
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-04
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-04
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-04
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-04
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-04
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-04
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-04
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-04
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-04
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-04
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-04
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-04
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-04
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-04
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-04
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-04
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-04
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-04
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-04
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-04
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-04
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-04
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-04
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-04
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-04
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-04
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-04
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		6e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-04
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-04
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-04
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-04
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		8e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-04

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score =  135 bits (340), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 59/96 (61%), Positives = 79/96 (82%), Gaps = 1/96 (1%)
Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           + +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYAPE  
Sbjct: 143 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 238

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score =  135 bits (340), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 59/96 (61%), Positives = 79/96 (82%), Gaps = 1/96 (1%)
Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           + +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYAPE  
Sbjct: 143 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 238

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score =  135 bits (339), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 59/96 (61%), Positives = 79/96 (82%), Gaps = 1/96 (1%)
Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           + +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYAPE  
Sbjct: 133 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score =  135 bits (339), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 59/96 (61%), Positives = 79/96 (82%), Gaps = 1/96 (1%)
Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           + +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYAPE  
Sbjct: 123 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score =  135 bits (339), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 59/96 (61%), Positives = 79/96 (82%), Gaps = 1/96 (1%)
Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           + +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYAPE  
Sbjct: 121 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 180
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 216

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  135 bits (339), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 59/96 (61%), Positives = 79/96 (82%), Gaps = 1/96 (1%)
Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           + +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYAPE  
Sbjct: 127 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 186
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 222

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score =  135 bits (339), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 59/96 (61%), Positives = 79/96 (82%), Gaps = 1/96 (1%)
Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           + +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYAPE  
Sbjct: 141 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 200
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 236

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score =  134 bits (337), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 59/96 (61%), Positives = 79/96 (82%), Gaps = 1/96 (1%)
Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           + +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYAPE  
Sbjct: 485 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 544
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 580

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score =  134 bits (337), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 59/96 (61%), Positives = 79/96 (82%), Gaps = 1/96 (1%)
Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           + +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+KWYAPE  
Sbjct: 486 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 545
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 581

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score =  134 bits (336), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 59/99 (59%), Positives = 79/99 (79%), Gaps = 1/99 (1%)
Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           +YL+  K+  HRDLAARN+LL +RH AKISDFGLS+A+ ++ +YY A   G+WP+KWYAP
Sbjct: 124 KYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182
Query: 91  ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           E  NF +FSS SDVWS+G+T+WE  S+GQ+PY +MKG +
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  132 bits (332), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 58/96 (60%), Positives = 78/96 (81%), Gaps = 1/96 (1%)
Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           + +S+F HRDLAARN+LL ++H AKISDFGLS+A+ ++ N YKA   G+WP+KWYAPE  
Sbjct: 127 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI 186
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 222

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score =  131 bits (330), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 58/99 (58%), Positives = 79/99 (79%), Gaps = 1/99 (1%)
Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           +YL+  K+  HR+LAARN+LL +RH AKISDFGLS+A+ ++ +YY A   G+WP+KWYAP
Sbjct: 450 KYLE-EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508
Query: 91  ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           E  NF +FSS SDVWS+G+T+WE  S+GQ+PY +MKG +
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  108 bits (271), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 48/90 (53%), Positives = 63/90 (70%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ PI+W APE+  F +F+
Sbjct: 146 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFT 205
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           SASDVWS+GI +WE+ S+G++PY EM   D
Sbjct: 206 SASDVWSYGIVMWEVVSYGERPYWEMTNQD 235

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  107 bits (266), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 47/90 (52%), Positives = 63/90 (70%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ PI+W +PE+  + +F+
Sbjct: 157 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 216
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           SASDVWS+GI LWE+ S+G++PY EM   D
Sbjct: 217 SASDVWSYGIVLWEVMSYGERPYWEMSNQD 246

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  107 bits (266), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 47/90 (52%), Positives = 63/90 (70%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ PI+W +PE+  + +F+
Sbjct: 140 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 199
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           SASDVWS+GI LWE+ S+G++PY EM   D
Sbjct: 200 SASDVWSYGIVLWEVMSYGERPYWEMSNQD 229

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  107 bits (266), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 47/91 (51%), Positives = 64/91 (70%)
Query: 39  SFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRF 98
           + HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ PI+W +PE+  + +F
Sbjct: 168 AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 99  SSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +SASDVWS+GI LWE+ S+G++PY EM   D
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  107 bits (266), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 47/90 (52%), Positives = 63/90 (70%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ PI+W +PE+  + +F+
Sbjct: 140 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 199
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           SASDVWS+GI LWE+ S+G++PY EM   D
Sbjct: 200 SASDVWSYGIVLWEVMSYGERPYWEMSNQD 229

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 47/90 (52%), Positives = 63/90 (70%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ PI+W +PE+  + +F+
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           SASDVWS+GI LWE+ S+G++PY EM   D
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 47/90 (52%), Positives = 63/90 (70%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ PI+W +PE+  + +F+
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           SASDVWS+GI LWE+ S+G++PY EM   D
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  106 bits (265), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 46/92 (50%), Positives = 65/92 (70%)
Query: 38  SSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           S+ HRDLAARNIL+ S    K+SDFG+SR +  +      T GG+ PI+W APE+  + +
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 98  FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           F+SASDVWS+GI +WE+ S+G++PY +M   D
Sbjct: 211 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 242

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 47/89 (52%), Positives = 63/89 (70%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ PI+W +PE+  + +F+S
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ASDVWS+GI LWE+ S+G++PY EM   D
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  106 bits (265), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 47/90 (52%), Positives = 63/90 (70%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ PI+W +PE+  + +F+
Sbjct: 167 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 226
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           SASDVWS+GI LWE+ S+G++PY EM   D
Sbjct: 227 SASDVWSYGIVLWEVMSYGERPYWEMSNQD 256

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 47/90 (52%), Positives = 63/90 (70%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ PI+W +PE+  + +F+
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           SASDVWS+GI LWE+ S+G++PY EM   D
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 47/90 (52%), Positives = 63/90 (70%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ PI+W +PE+  + +F+
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           SASDVWS+GI LWE+ S+G++PY EM   D
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 47/90 (52%), Positives = 63/90 (70%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ PI+W +PE+  + +F+
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           SASDVWS+GI LWE+ S+G++PY EM   D
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  106 bits (264), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 53/101 (52%), Positives = 69/101 (68%), Gaps = 3/101 (2%)
Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAV--NSERNYYKATHGGRWPIKWY 88
           RYL    S  HRDLAARNIL+ S    K+SDFGLSR +  NS    Y ++ GG+ PI+W 
Sbjct: 130 RYLA-EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 89  APESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           APE+  F +F+SASD WS+GI +WE+ SFG++PY +M   D
Sbjct: 189 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD 229

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  105 bits (263), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 45/89 (50%), Positives = 63/89 (70%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ P++W APE+  + +F+S
Sbjct: 168 HRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTS 227
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ASDVWS+GI +WE+ S+G++PY +M   D
Sbjct: 228 ASDVWSYGIVMWEVMSYGERPYWDMSNQD 256

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  105 bits (263), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 46/90 (51%), Positives = 63/90 (70%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARNIL+ S    K+SDFGL+R +  +      T GG+ PI+W +PE+  + +F+
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           SASDVWS+GI LWE+ S+G++PY EM   D
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score =  105 bits (262), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 50/104 (48%), Positives = 71/104 (68%), Gaps = 4/104 (3%)
Query: 28  KVCRYLKMHKS--SFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++C+ +   +S    HRD+A RNIL+AS    K+ DFGLSR +  E +YYKA+   R PI
Sbjct: 117 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKAS-VTRLPI 174
Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           KW +PES NF RF++ASDVW F + +WE+ SFG+QP+  ++  D
Sbjct: 175 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 218

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score =  105 bits (262), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 50/104 (48%), Positives = 71/104 (68%), Gaps = 4/104 (3%)
Query: 28  KVCRYLKMHKS--SFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++C+ +   +S    HRD+A RNIL+AS    K+ DFGLSR +  E +YYKA+   R PI
Sbjct: 133 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKAS-VTRLPI 190
Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           KW +PES NF RF++ASDVW F + +WE+ SFG+QP+  ++  D
Sbjct: 191 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 234

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score =  105 bits (262), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 50/104 (48%), Positives = 71/104 (68%), Gaps = 4/104 (3%)
Query: 28  KVCRYLKMHKS--SFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++C+ +   +S    HRD+A RNIL+AS    K+ DFGLSR +  E +YYKA+   R PI
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKAS-VTRLPI 178
Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           KW +PES NF RF++ASDVW F + +WE+ SFG+QP+  ++  D
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  105 bits (262), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 46/92 (50%), Positives = 64/92 (69%)
Query: 38  SSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           S  HRDLAARNIL+ S    K+SDFG+SR +  +      T GG+ PI+W APE+  + +
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 98  FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           F+SASDVWS+GI +WE+ S+G++PY +M   D
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 227

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  105 bits (261), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 46/92 (50%), Positives = 64/92 (69%)
Query: 38  SSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           S  HRDLAARNIL+ S    K+SDFG+SR +  +      T GG+ PI+W APE+  + +
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 98  FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           F+SASDVWS+GI +WE+ S+G++PY +M   D
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 221

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  105 bits (261), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 46/90 (51%), Positives = 62/90 (68%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARN+L+ S    K+SDFGLSR +  + +    T GG+ PI+W APE+  F  FS
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           SASDVWSFG+ +WE+ ++G++PY  M   D
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPYWNMTNRD 262

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  105 bits (261), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 45/85 (52%), Positives = 63/85 (74%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ PI+W APE+ ++ +F+S
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS 229
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
           ASDVWSFGI +WE+ ++G++PY E+
Sbjct: 230 ASDVWSFGIVMWEVMTYGERPYWEL 254

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 46/90 (51%), Positives = 62/90 (68%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARNIL+ S    K+SDFGL R +  +      T GG+ PI+W +PE+  + +F+
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           SASDVWS+GI LWE+ S+G++PY EM   D
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  104 bits (259), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 46/90 (51%), Positives = 62/90 (68%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARN+L+ S    K+SDFGLSR +  + +    T GG+ PI+W APE+  F  FS
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           SASDVWSFG+ +WE+ ++G++PY  M   D
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPYWNMTNRD 262

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  103 bits (257), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 52/101 (51%), Positives = 68/101 (67%), Gaps = 3/101 (2%)
Query: 31  RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAV--NSERNYYKATHGGRWPIKWY 88
           RYL    S  HRDLAARNIL+ S    K+SDFGLSR +  NS      ++ GG+ PI+W 
Sbjct: 132 RYLA-EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT 190
Query: 89  APESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           APE+  F +F+SASD WS+GI +WE+ SFG++PY +M   D
Sbjct: 191 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD 231

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score =  102 bits (255), Expect = 4e-23,   Method: Composition-based stats.
 Identities = 48/93 (51%), Positives = 65/93 (69%), Gaps = 2/93 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+AARN+L++S    K+ DFGLSR +  +  YYKA+ G + PIKW APES NF 
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKG-KLPIKWMAPESINFR 567
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           RF+SASDVW FG+ +WE+   G +P+  +K +D
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  102 bits (254), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 46/91 (50%), Positives = 65/91 (71%), Gaps = 2/91 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERN--YYKATHGGRWPIKWYAPESYNFGRF 98
           HRDLAARNIL+ S    K+SDFGLSR +  + +   Y +  GG+ PI+W APE+  + +F
Sbjct: 158 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF 217
Query: 99  SSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +SASDVWS+GI +WE+ S+G++PY +M   D
Sbjct: 218 TSASDVWSYGIVMWEVMSYGERPYWDMTNQD 248

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score =  101 bits (252), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 48/93 (51%), Positives = 65/93 (69%), Gaps = 2/93 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+AARN+L++S    K+ DFGLSR +  +  YYKA+ G + PIKW APES NF 
Sbjct: 158 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKG-KLPIKWMAPESINFR 215
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           RF+SASDVW FG+ +WE+   G +P+  +K +D
Sbjct: 216 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 248

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 48/93 (51%), Positives = 65/93 (69%), Gaps = 2/93 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+AARN+L++S    K+ DFGLSR +  +  YYKA+ G + PIKW APES NF 
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKG-KLPIKWMAPESINFR 184
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           RF+SASDVW FG+ +WE+   G +P+  +K +D
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 48/93 (51%), Positives = 65/93 (69%), Gaps = 2/93 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+AARN+L++S    K+ DFGLSR +  +  YYKA+ G + PIKW APES NF 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKG-KLPIKWMAPESINFR 187
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           RF+SASDVW FG+ +WE+   G +P+  +K +D
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score =  101 bits (252), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 48/93 (51%), Positives = 65/93 (69%), Gaps = 2/93 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+AARN+L++S    K+ DFGLSR +  +  YYKA+ G + PIKW APES NF 
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKG-KLPIKWMAPESINFR 189
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           RF+SASDVW FG+ +WE+   G +P+  +K +D
Sbjct: 190 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 222

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score =  101 bits (252), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 48/93 (51%), Positives = 65/93 (69%), Gaps = 2/93 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+AARN+L++S    K+ DFGLSR +  +  YYKA+ G + PIKW APES NF 
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKG-KLPIKWMAPESINFR 192
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           RF+SASDVW FG+ +WE+   G +P+  +K +D
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 48/93 (51%), Positives = 65/93 (69%), Gaps = 2/93 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+AARN+L++S    K+ DFGLSR +  +  YYKA+ G + PIKW APES NF 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKG-KLPIKWMAPESINFR 187
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           RF+SASDVW FG+ +WE+   G +P+  +K +D
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score =  101 bits (252), Expect = 1e-22,   Method: Composition-based stats.
 Identities = 47/93 (50%), Positives = 65/93 (69%), Gaps = 2/93 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+AARN+L+++    K+ DFGLSR +  +  YYKA+ G + PIKW APES NF 
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKG-KLPIKWMAPESINFR 567
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           RF+SASDVW FG+ +WE+   G +P+  +K +D
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score =  101 bits (252), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 48/93 (51%), Positives = 65/93 (69%), Gaps = 2/93 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+AARN+L++S    K+ DFGLSR +  +  YYKA+ G + PIKW APES NF 
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKG-KLPIKWMAPESINFR 190
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           RF+SASDVW FG+ +WE+   G +P+  +K +D
Sbjct: 191 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 223

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score =  100 bits (250), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 54/128 (42%), Positives = 73/128 (57%), Gaps = 7/128 (5%)
Query: 1   MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKIS 60
           ++   G  ++  L  YA+   EG        YL+  K   HRDLAARN+LLA+R   KI 
Sbjct: 101 LRKHQGHFLLGTLSRYAVQVAEGM------GYLE-SKRFIHRDLAARNLLLATRDLVKIG 153
Query: 61  DFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
           DFGL RA+    ++Y      + P  W APES     FS ASD W FG+TLWEM+++GQ+
Sbjct: 154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
Query: 121 PYGEMKGS 128
           P+  + GS
Sbjct: 214 PWIGLNGS 221

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score =  100 bits (250), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 54/128 (42%), Positives = 73/128 (57%), Gaps = 7/128 (5%)
Query: 1   MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKIS 60
           ++   G  ++  L  YA+   EG        YL+  K   HRDLAARN+LLA+R   KI 
Sbjct: 101 LRKHQGHFLLGTLSRYAVQVAEGM------GYLE-SKRFIHRDLAARNLLLATRDLVKIG 153
Query: 61  DFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
           DFGL RA+    ++Y      + P  W APES     FS ASD W FG+TLWEM+++GQ+
Sbjct: 154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
Query: 121 PYGEMKGS 128
           P+  + GS
Sbjct: 214 PWIGLNGS 221

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score =  100 bits (250), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 54/128 (42%), Positives = 73/128 (57%), Gaps = 7/128 (5%)
Query: 1   MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKIS 60
           ++   G  ++  L  YA+   EG        YL+  K   HRDLAARN+LLA+R   KI 
Sbjct: 105 LRKHQGHFLLGTLSRYAVQVAEGM------GYLE-SKRFIHRDLAARNLLLATRDLVKIG 157
Query: 61  DFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
           DFGL RA+    ++Y      + P  W APES     FS ASD W FG+TLWEM+++GQ+
Sbjct: 158 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 217
Query: 121 PYGEMKGS 128
           P+  + GS
Sbjct: 218 PWIGLNGS 225

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 54/128 (42%), Positives = 73/128 (57%), Gaps = 7/128 (5%)
Query: 1   MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKIS 60
           ++   G  ++  L  YA+   EG        YL+  K   HRDLAARN+LLA+R   KI 
Sbjct: 105 LRKHQGHFLLGTLSRYAVQVAEGM------GYLE-SKRFIHRDLAARNLLLATRDLVKIG 157
Query: 61  DFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
           DFGL RA+    ++Y      + P  W APES     FS ASD W FG+TLWEM+++GQ+
Sbjct: 158 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 217
Query: 121 PYGEMKGS 128
           P+  + GS
Sbjct: 218 PWIGLNGS 225

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score =  100 bits (249), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 54/128 (42%), Positives = 73/128 (57%), Gaps = 7/128 (5%)
Query: 1   MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKIS 60
           ++   G  ++  L  YA+   EG        YL+  K   HRDLAARN+LLA+R   KI 
Sbjct: 111 LRKHQGHFLLGTLSRYAVQVAEGM------GYLE-SKRFIHRDLAARNLLLATRDLVKIG 163
Query: 61  DFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
           DFGL RA+    ++Y      + P  W APES     FS ASD W FG+TLWEM+++GQ+
Sbjct: 164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
Query: 121 PYGEMKGS 128
           P+  + GS
Sbjct: 224 PWIGLNGS 231

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  100 bits (249), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 47/93 (50%), Positives = 65/93 (69%), Gaps = 2/93 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+AARN+L+++    K+ DFGLSR +  +  YYKA+ G + PIKW APES NF 
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKG-KLPIKWMAPESINFR 187
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           RF+SASDVW FG+ +WE+   G +P+  +K +D
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 45/92 (48%), Positives = 64/92 (69%), Gaps = 2/92 (2%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERN--YYKATHGGRWPIKWYAPESYNFGR 97
            HR LAARNIL+ S    K+SDFGLSR +  + +   Y +  GG+ PI+W APE+  + +
Sbjct: 131 VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 190
Query: 98  FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           F+SASDVWS+GI +WE+ S+G++PY +M   D
Sbjct: 191 FTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 222

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 109 VNAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 166
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 167 --YTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 110 VNAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 167
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 168 --YTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 113 VNAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 171 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 110 VNAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 167
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 168 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 110 VNAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 167
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 168 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 121 VNAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 178
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 179 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 108 VNAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 166 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 113 VNAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 171 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 113 VSAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 171 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 113 VNAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 171 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 108 VNAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 166 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 108 VSAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 166 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 112 VNAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 170 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 108 VSAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 166 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 108 VSAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 166 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 108 VSAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 166 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 53/123 (43%), Positives = 75/123 (60%), Gaps = 10/123 (8%)
Query: 1   MKSPNGSGVVTP-LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKI 59
           +KS  G  V+ P L  ++    EG        Y++  K+  HRDL A N+L++     KI
Sbjct: 99  LKSDEGGKVLLPKLIDFSAQIAEGM------AYIE-RKNYIHRDLRAANVLVSESLMCKI 151
Query: 60  SDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQ 119
           +DFGL+R +  E N Y A  G ++PIKW APE+ NFG F+  SDVWSFGI L+E+ ++G+
Sbjct: 152 ADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGK 209
Query: 120 QPY 122
            PY
Sbjct: 210 IPY 212

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 48/88 (54%), Positives = 59/88 (67%), Gaps = 5/88 (5%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG--RWPIKWYAPESYN 94
           K   HRDLAARN L+  ++  KISDFG+SR    E +   A  GG  + P+KW APE+ N
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGGLRQVPVKWTAPEALN 288
Query: 95  FGRFSSASDVWSFGITLWEMYSFGQQPY 122
           +GR+SS SDVWSFGI LWE +S G  PY
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 48/87 (55%), Positives = 58/87 (66%), Gaps = 3/87 (3%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW-PIKWYAPESYNF 95
           K   HRDLAARN L+  ++  KISDFG+SR        Y A+ G R  P+KW APE+ N+
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
           GR+SS SDVWSFGI LWE +S G  PY
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/128 (41%), Positives = 72/128 (56%), Gaps = 7/128 (5%)
Query: 1   MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKIS 60
           ++   G  ++  L  YA+   EG        YL+  K   HRDLAARN+LLA+R   KI 
Sbjct: 101 LRKHQGHFLLGTLSRYAVQVAEGM------GYLE-SKRFIHRDLAARNLLLATRDLVKIG 153
Query: 61  DFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
           DFGL RA+    ++       + P  W APES     FS ASD W FG+TLWEM+++GQ+
Sbjct: 154 DFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
Query: 121 PYGEMKGS 128
           P+  + GS
Sbjct: 214 PWIGLNGS 221

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/128 (41%), Positives = 72/128 (56%), Gaps = 7/128 (5%)
Query: 1   MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKIS 60
           ++   G  ++  L  YA+   EG        YL+  K   HRDLAARN+LLA+R   KI 
Sbjct: 111 LRKHQGHFLLGTLSRYAVQVAEGM------GYLE-SKRFIHRDLAARNLLLATRDLVKIG 163
Query: 61  DFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
           DFGL RA+    ++       + P  W APES     FS ASD W FG+TLWEM+++GQ+
Sbjct: 164 DFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
Query: 121 PYGEMKGS 128
           P+  + GS
Sbjct: 224 PWIGLNGS 231

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 48/110 (43%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +    
Sbjct: 106 VSAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-- 161
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           + + A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 162 DTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 49/110 (44%), Positives = 69/110 (62%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 127 VTAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDT 184
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  +  FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 185 --YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 65/96 (67%), Gaps = 2/96 (2%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ S +  KI+DFGL+R +  +   Y A  GG+ PIK
Sbjct: 150 AKGMMYLE-ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA-DGGKMPIK 207
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W A E  ++ +F+  SDVWS+G+T+WE+ +FG +PY
Sbjct: 208 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 243

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 41/86 (47%), Positives = 59/86 (68%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARN+L+   +  KI+DFGL+R +N+  +YYK T  GR P+KW APE+    
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINN-IDYYKKTTNGRLPVKWMAPEALFDR 280
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWSFG+ +WE+++ G  PY
Sbjct: 281 VYTHQSDVWSFGVLMWEIFTLGGSPY 306

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 52/123 (42%), Positives = 75/123 (60%), Gaps = 10/123 (8%)
Query: 1   MKSPNGSGVVTP-LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKI 59
           +KS  G  V+ P L  ++    EG        Y++  K+  HRDL A N+L++     KI
Sbjct: 98  LKSDEGGKVLLPKLIDFSAQIAEGM------AYIE-RKNYIHRDLRAANVLVSESLMCKI 150
Query: 60  SDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQ 119
           +DFGL+R +  E N Y A  G ++PIKW APE+ NFG F+  S+VWSFGI L+E+ ++G+
Sbjct: 151 ADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGK 208
Query: 120 QPY 122
            PY
Sbjct: 209 IPY 211

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 63/96 (65%), Gaps = 2/96 (2%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A+   YL   K   HRDLAARN+L+   +  KI+DFGL+R +N+  +YYK T  GR P+K
Sbjct: 167 ARGMEYLASQKC-IHRDLAARNVLVTENNVMKIADFGLARDINN-IDYYKKTTNGRLPVK 224
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+     ++  SDVWSFG+ +WE+++ G  PY
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 41/86 (47%), Positives = 59/86 (68%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARN+L+   +  KI+DFGL+R +N+  +YYK T  GR P+KW APE+    
Sbjct: 168 QKCIHRDLAARNVLVTENNVMKIADFGLARDINN-IDYYKKTTNGRLPVKWMAPEALFDR 226
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWSFG+ +WE+++ G  PY
Sbjct: 227 VYTHQSDVWSFGVLMWEIFTLGGSPY 252

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 63/96 (65%), Gaps = 2/96 (2%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A+   YL   K   HRDLAARN+L+   +  KI+DFGL+R +N+  +YYK T  GR P+K
Sbjct: 167 ARGMEYLASQKC-IHRDLAARNVLVTENNVMKIADFGLARDINN-IDYYKKTTNGRLPVK 224
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+     ++  SDVWSFG+ +WE+++ G  PY
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 63/96 (65%), Gaps = 2/96 (2%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A+   YL   K   HRDLAARN+L+   +  KI+DFGL+R +N+  +YYK T  GR P+K
Sbjct: 167 ARGMEYLASQKC-IHRDLAARNVLVTENNVMKIADFGLARDINN-IDYYKKTTNGRLPVK 224
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+     ++  SDVWSFG+ +WE+++ G  PY
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 63/96 (65%), Gaps = 2/96 (2%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A+   YL   K   HRDLAARN+L+   +  KI+DFGL+R +N+  +YYK T  GR P+K
Sbjct: 156 ARGMEYLASQKC-IHRDLAARNVLVTENNVMKIADFGLARDINN-IDYYKKTTNGRLPVK 213
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+     ++  SDVWSFG+ +WE+++ G  PY
Sbjct: 214 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 249

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 63/96 (65%), Gaps = 2/96 (2%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A+   YL   K   HRDLAARN+L+   +  KI+DFGL+R +N+  +YYK T  GR P+K
Sbjct: 167 ARGMEYLASQKC-IHRDLAARNVLVTENNVMKIADFGLARDINN-IDYYKKTTNGRLPVK 224
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+     ++  SDVWSFG+ +WE+++ G  PY
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-21,   Method: Composition-based stats.
 Identities = 43/82 (52%), Positives = 60/82 (73%), Gaps = 6/82 (7%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN+L++  + AK+SDFGL++  +S ++       G+ P+KW APE+    +FS+
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------TGKLPVKWTAPEALREKKFST 365
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFGI LWE+YSFG+ PY
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPY 387

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 63/96 (65%), Gaps = 2/96 (2%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A+   YL   K   HRDLAARN+L+   +  KI+DFGL+R +N+  +YYK T  GR P+K
Sbjct: 167 ARGMEYLASQKC-IHRDLAARNVLVTENNVMKIADFGLARDINN-IDYYKKTTNGRLPVK 224
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+     ++  SDVWSFG+ +WE+++ G  PY
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 65/96 (67%), Gaps = 2/96 (2%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ S +  KI+DFGL+R +  +   Y A  GG+ PIK
Sbjct: 127 AKGMMYLE-ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD-GGKMPIK 184
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W A E  ++ +F+  SDVWS+G+T+WE+ +FG +PY
Sbjct: 185 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 220

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 63/96 (65%), Gaps = 2/96 (2%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A+   YL   K   HRDLAARN+L+   +  KI+DFGL+R +N+  +YYK T  GR P+K
Sbjct: 167 ARGMEYLASQKC-IHRDLAARNVLVTENNVMKIADFGLARDINN-IDYYKNTTNGRLPVK 224
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+     ++  SDVWSFG+ +WE+++ G  PY
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 46/96 (47%), Positives = 68/96 (70%), Gaps = 8/96 (8%)
Query: 29  VCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           VC  ++ +  ++F HRDLAARN+L++  + AK+SDFGL++  +S ++       G+ P+K
Sbjct: 111 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------TGKLPVK 164
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+    +FS+ SDVWSFGI LWE+YSFG+ PY
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 46/96 (47%), Positives = 68/96 (70%), Gaps = 8/96 (8%)
Query: 29  VCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           VC  ++ +  ++F HRDLAARN+L++  + AK+SDFGL++  +S ++       G+ P+K
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT------GKLPVK 179
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+    +FS+ SDVWSFGI LWE+YSFG+ PY
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 45/94 (47%), Positives = 62/94 (65%), Gaps = 2/94 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL+++    KI+DFGL+R +  E N Y A  G ++PIKW APE+ NF
Sbjct: 129 QRNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINF 186
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           G F+  SDVWSFGI L E+ ++G+ PY  M   +
Sbjct: 187 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 220

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 45/93 (48%), Positives = 61/93 (65%), Gaps = 2/93 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+AARN+L++S    K+ DFGLSR +  E +       G+ PIKW APES NF 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTXXKASKGKLPIKWMAPESINFR 187
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           RF+SASDVW FG+ +WE+   G +P+  +K +D
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 48/110 (43%), Positives = 69/110 (62%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 106 VSAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 163
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 164 X--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 48/110 (43%), Positives = 69/110 (62%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 109 VNAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 166
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 167 X--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 48/110 (43%), Positives = 69/110 (62%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 113 VNAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 171 X--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 48/110 (43%), Positives = 69/110 (62%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HRDLAARN L+   H  K++DFGLSR +  + 
Sbjct: 106 VSAVVLLYMATQISSAM-EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 163
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 164 X--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 48/110 (43%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HR+LAARN L+   H  K++DFGLSR +  + 
Sbjct: 315 VSAVVLLYMATQISSAM-EYLE-KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 373 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 44/96 (45%), Positives = 63/96 (65%), Gaps = 2/96 (2%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A+   YL   K   HRDLAARN+L+   +  +I+DFGL+R +N+  +YYK T  GR P+K
Sbjct: 167 ARGMEYLASQKC-IHRDLAARNVLVTENNVMRIADFGLARDINN-IDYYKKTTNGRLPVK 224
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+     ++  SDVWSFG+ +WE+++ G  PY
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 45/90 (50%), Positives = 61/90 (67%), Gaps = 2/90 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL+++    KI+DFGL+R +  E N Y A  G ++PIKW APE+ NF
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINF 359
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           G F+  SDVWSFGI L E+ ++G+ PY  M
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 46/96 (47%), Positives = 67/96 (69%), Gaps = 8/96 (8%)
Query: 29  VCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           VC  ++ +  ++F HRDLAARN+L++  + AK+SDFGL++  +S ++       G+ P+K
Sbjct: 117 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT------GKLPVK 170
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+     FS+ SDVWSFGI LWE+YSFG+ PY
Sbjct: 171 WTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 48/110 (43%), Positives = 70/110 (63%), Gaps = 4/110 (3%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           + +  L Y+  QI + +  YL+  K+  HR+LAARN L+   H  K++DFGLSR +  + 
Sbjct: 354 VNAVVLLYMATQISSAM-EYLE-KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 411
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             Y A  G ++PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY
Sbjct: 412 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 459

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 43/83 (51%), Positives = 59/83 (71%), Gaps = 1/83 (1%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARN+L+ S +  KI+DFGL+R ++ +   Y A  GG+ PIKW A ES    RF+
Sbjct: 141 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA-DGGKVPIKWMALESILRRRFT 199
Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
             SDVWS+G+T+WE+ +FG +PY
Sbjct: 200 HQSDVWSYGVTVWELMTFGAKPY 222

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 50/122 (40%), Positives = 75/122 (61%), Gaps = 7/122 (5%)
Query: 11  TPLGSYALPYIEGQIPAKVCR---YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRA 67
           T  G +A   + G +   VC    YL+   S  HRDLAARN L+      K+SDFG++R 
Sbjct: 95  TQRGLFAAETLLG-MCLDVCEGMAYLE-EASVIHRDLAARNCLVGENQVIKVSDFGMTRF 152
Query: 68  VNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG 127
           V  ++  Y ++ G ++P+KW +PE ++F R+SS SDVWSFG+ +WE++S G+ PY     
Sbjct: 153 VLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 210
Query: 128 SD 129
           S+
Sbjct: 211 SE 212

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 40/86 (46%), Positives = 58/86 (67%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDL ARN+L+   +  KI+DFGL+R +N+  +YYK T  GR P+KW APE+    
Sbjct: 163 QKCIHRDLTARNVLVTENNVMKIADFGLARDINN-IDYYKKTTNGRLPVKWMAPEALFDR 221
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWSFG+ +WE+++ G  PY
Sbjct: 222 VYTHQSDVWSFGVLMWEIFTLGGSPY 247

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 42/86 (48%), Positives = 58/86 (67%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN+L+   +  KI+DFGL+R ++   +YYK T  GR P+KW APE+    
Sbjct: 169 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPEALFDR 227
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWSFG+ LWE+++ G  PY
Sbjct: 228 IYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 42/86 (48%), Positives = 58/86 (67%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN+L+   +  KI+DFGL+R ++   +YYK T  GR P+KW APE+    
Sbjct: 169 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPEALFDR 227
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWSFG+ LWE+++ G  PY
Sbjct: 228 IYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 42/86 (48%), Positives = 58/86 (67%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN+L+   +  KI+DFGL+R ++   +YYK T  GR P+KW APE+    
Sbjct: 162 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPEALFDR 220
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWSFG+ LWE+++ G  PY
Sbjct: 221 IYTHQSDVWSFGVLLWEIFTLGGSPY 246

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 42/86 (48%), Positives = 58/86 (67%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN+L+   +  KI+DFGL+R ++   +YYK T  GR P+KW APE+    
Sbjct: 169 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPEALFDR 227
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWSFG+ LWE+++ G  PY
Sbjct: 228 IYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 42/86 (48%), Positives = 58/86 (67%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN+L+   +  KI+DFGL+R ++   +YYK T  GR P+KW APE+    
Sbjct: 154 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPEALFDR 212
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWSFG+ LWE+++ G  PY
Sbjct: 213 IYTHQSDVWSFGVLLWEIFTLGGSPY 238

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 42/86 (48%), Positives = 58/86 (67%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN+L+   +  KI+DFGL+R ++   +YYK T  GR P+KW APE+    
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPEALFDR 268
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWSFG+ LWE+++ G  PY
Sbjct: 269 IYTHQSDVWSFGVLLWEIFTLGGSPY 294

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 42/86 (48%), Positives = 58/86 (67%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN+L+   +  KI+DFGL+R ++   +YYK T  GR P+KW APE+    
Sbjct: 161 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPEALFDR 219
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWSFG+ LWE+++ G  PY
Sbjct: 220 IYTHQSDVWSFGVLLWEIFTLGGSPY 245

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 42/86 (48%), Positives = 58/86 (67%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN+L+   +  KI+DFGL+R ++   +YYK T  GR P+KW APE+    
Sbjct: 158 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPEALFDR 216
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWSFG+ LWE+++ G  PY
Sbjct: 217 IYTHQSDVWSFGVLLWEIFTLGGSPY 242

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 62/90 (68%), Gaps = 2/90 (2%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARN L+      K+SDFG++R V  ++  Y ++ G ++P+KW +PE ++F R+S
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           S SDVWSFG+ +WE++S G+ PY     S+
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 40/83 (48%), Positives = 60/83 (72%), Gaps = 2/83 (2%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARN L+      K+SDFG++R V  ++  Y ++ G ++P+KW +PE ++F R+S
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYS 202
Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
           S SDVWSFG+ +WE++S G+ PY
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPY 225

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 62/90 (68%), Gaps = 2/90 (2%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARN L+      K+SDFG++R V  ++  Y ++ G ++P+KW +PE ++F R+S
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           S SDVWSFG+ +WE++S G+ PY     S+
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE 212

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 43/108 (39%), Positives = 67/108 (62%), Gaps = 4/108 (3%)
Query: 24  QIPAKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++   VC  ++  +S    HRDLAARN L+  +   K+SDFGLSR V  +   Y ++ G 
Sbjct: 109 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSRGS 166
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ++P++W  PE   + +FSS SD+W+FG+ +WE+YS G+ PY     S+
Sbjct: 167 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 214

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 62/90 (68%), Gaps = 2/90 (2%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARN L+      K+SDFG++R V  ++  Y ++ G ++P+KW +PE ++F R+S
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           S SDVWSFG+ +WE++S G+ PY     S+
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 62/90 (68%), Gaps = 2/90 (2%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARN L+      K+SDFG++R V  ++  Y ++ G ++P+KW +PE ++F R+S
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYS 185
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           S SDVWSFG+ +WE++S G+ PY     S+
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE 215

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 43/108 (39%), Positives = 67/108 (62%), Gaps = 4/108 (3%)
Query: 24  QIPAKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++   VC  ++  +S    HRDLAARN L+  +   K+SDFGLSR V  +   Y ++ G 
Sbjct: 104 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGS 161
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ++P++W  PE   + +FSS SD+W+FG+ +WE+YS G+ PY     S+
Sbjct: 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 43/86 (50%), Positives = 57/86 (66%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRD+AARN+LL + H AKI DFGL+R + ++ NY       R P+KW APES    
Sbjct: 177 KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-VKGNARLPVKWMAPESIFDC 235
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWS+GI LWE++S G  PY
Sbjct: 236 VYTVQSDVWSYGILLWEIFSLGLNPY 261

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 43/86 (50%), Positives = 57/86 (66%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRD+AARN+LL + H AKI DFGL+R + ++ NY       R P+KW APES    
Sbjct: 171 KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-VKGNARLPVKWMAPESIFDC 229
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWS+GI LWE++S G  PY
Sbjct: 230 VYTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 43/108 (39%), Positives = 67/108 (62%), Gaps = 4/108 (3%)
Query: 24  QIPAKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++   VC  ++  +S    HRDLAARN L+  +   K+SDFGLSR V  +   Y ++ G 
Sbjct: 115 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGS 172
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ++P++W  PE   + +FSS SD+W+FG+ +WE+YS G+ PY     S+
Sbjct: 173 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 220

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 43/108 (39%), Positives = 67/108 (62%), Gaps = 4/108 (3%)
Query: 24  QIPAKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++   VC  ++  +S    HRDLAARN L+  +   K+SDFGLSR V  +   Y ++ G 
Sbjct: 124 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGS 181
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ++P++W  PE   + +FSS SD+W+FG+ +WE+YS G+ PY     S+
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 43/86 (50%), Positives = 57/86 (66%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRD+AARN+LL + H AKI DFGL+R + ++ NY       R P+KW APES    
Sbjct: 183 KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-VKGNARLPVKWMAPESIFDC 241
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWS+GI LWE++S G  PY
Sbjct: 242 VYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 43/108 (39%), Positives = 67/108 (62%), Gaps = 4/108 (3%)
Query: 24  QIPAKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++   VC  ++  +S    HRDLAARN L+  +   K+SDFGLSR V  +   Y ++ G 
Sbjct: 108 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGS 165
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ++P++W  PE   + +FSS SD+W+FG+ +WE+YS G+ PY     S+
Sbjct: 166 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 213

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 43/86 (50%), Positives = 57/86 (66%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRD+AARN+LL + H AKI DFGL+R + ++ NY       R P+KW APES    
Sbjct: 183 KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-VKGNARLPVKWMAPESIFDC 241
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWS+GI LWE++S G  PY
Sbjct: 242 VYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 43/86 (50%), Positives = 57/86 (66%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRD+AARN+LL + H AKI DFGL+R + ++ NY       R P+KW APES    
Sbjct: 179 KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-VKGNARLPVKWMAPESIFDC 237
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWS+GI LWE++S G  PY
Sbjct: 238 VYTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 43/108 (39%), Positives = 67/108 (62%), Gaps = 4/108 (3%)
Query: 24  QIPAKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++   VC  ++  +S    HRDLAARN L+  +   K+SDFGLSR V  +   Y ++ G 
Sbjct: 109 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGS 166
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ++P++W  PE   + +FSS SD+W+FG+ +WE+YS G+ PY     S+
Sbjct: 167 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 214

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 64/96 (66%), Gaps = 2/96 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HR+LA RNIL+ + ++ KI DFGL++ +  ++ YYK    G
Sbjct: 119 QYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 178
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
             PI WYAPES    +FS ASDVWSFG+ L+E++++
Sbjct: 179 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 214

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 41/86 (47%), Positives = 57/86 (66%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN ++A     KI DFG++R +  E +YY+    G  P++W APES   G
Sbjct: 148 KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPESLKDG 206
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            F+++SD+WSFG+ LWE+ S  +QPY
Sbjct: 207 VFTTSSDMWSFGVVLWEITSLAEQPY 232

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 43/86 (50%), Positives = 57/86 (66%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRD+AARN+LL + H AKI DFGL+R + ++ NY       R P+KW APES    
Sbjct: 185 KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-VKGNARLPVKWMAPESIFDC 243
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWS+GI LWE++S G  PY
Sbjct: 244 VYTVQSDVWSYGILLWEIFSLGLNPY 269

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 64/96 (66%), Gaps = 2/96 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HRDLA RNIL+ + ++ KI DFGL++ +  ++ ++K    G
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
             PI WYAPES    +FS ASDVWSFG+ L+E++++
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 213

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 41/82 (50%), Positives = 56/82 (68%), Gaps = 1/82 (1%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLA RN L+      KI+DFGLSR + S  +YYKA      PI+W  PES  + R+++
Sbjct: 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSA-DYYKADGNDAIPIRWMPPESIFYNRYTT 255
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVW++G+ LWE++S+G QPY
Sbjct: 256 ESDVWAYGVVLWEIFSYGLQPY 277

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 41/86 (47%), Positives = 57/86 (66%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN ++A     KI DFG++R +  E +YY+    G  P++W APES   G
Sbjct: 149 KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPESLKDG 207
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            F+++SD+WSFG+ LWE+ S  +QPY
Sbjct: 208 VFTTSSDMWSFGVVLWEITSLAEQPY 233

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 44/94 (46%), Positives = 60/94 (63%), Gaps = 2/94 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL++     KI+DFGL+R +  E N Y A  G ++PIKW APE+ N+
Sbjct: 122 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINY 179
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 180 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 213

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 44/86 (51%), Positives = 55/86 (63%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           KS  HRDLAARN+L+      KI DFGL+R + S+ NY       R P+KW APES   G
Sbjct: 191 KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV-VRGNARLPVKWMAPESLFEG 249
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWS+GI LWE++S G  PY
Sbjct: 250 IYTIKSDVWSYGILLWEIFSLGVNPY 275

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 161 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 218
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 219 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 261

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 44/94 (46%), Positives = 60/94 (63%), Gaps = 2/94 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL++     KI+DFGL+R +  E N Y A  G ++PIKW APE+ N+
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINY 190
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 224

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 44/94 (46%), Positives = 60/94 (63%), Gaps = 2/94 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL++     KI+DFGL+R +  E N Y A  G ++PIKW APE+ N+
Sbjct: 132 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINY 189
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 190 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 223

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 130 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 187
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 131 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 188
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 231

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 130 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 187
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 130 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 187
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 128 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 185
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 228

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 133 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 190
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 191 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 233

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 128 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 185
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 228

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 44/94 (46%), Positives = 60/94 (63%), Gaps = 2/94 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL++     KI+DFGL+R +  E N Y A  G ++PIKW APE+ N+
Sbjct: 137 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINY 194
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 195 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 228

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 44/94 (46%), Positives = 60/94 (63%), Gaps = 2/94 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL++     KI+DFGL+R +  E N Y A  G ++PIKW APE+ N+
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINY 184
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 127 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 184
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 127 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 184
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 134 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 191
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 129 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 186
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 137 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 194
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 195 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 237

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 127 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 184
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 134 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 191
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 134 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 191
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 129 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 186
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 152 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 209
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 210 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 252

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 127 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 184
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 127 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 184
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 121 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 178
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 45/103 (43%), Positives = 66/103 (64%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIK
Sbjct: 130 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIK 187
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 60/90 (66%), Gaps = 1/90 (1%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+ PIKW A ES     ++
Sbjct: 136 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESILHRIYT 194
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 195 HQSDVWSYGVTVWELMTFGSKPYDGIPASE 224

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 46/103 (44%), Positives = 65/103 (63%), Gaps = 3/103 (2%)
Query: 20  YIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH 79
           ++  QI A +  YL  H    H+DLA RN+L+  +   KISD GL R V +  +YYK   
Sbjct: 149 HLVAQIAAGM-EYLSSHHV-VHKDLATRNVLVYDKLNVKISDLGLFREVYAA-DYYKLLG 205
Query: 80  GGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               PI+W APE+  +G+FS  SD+WS+G+ LWE++S+G QPY
Sbjct: 206 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 248

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 43/96 (44%), Positives = 61/96 (63%), Gaps = 2/96 (2%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A+   YL   K   HRDLAARN+L+   +  KI+DFGL+R +N+  +  K T  GR P+K
Sbjct: 167 ARGMEYLASQKC-IHRDLAARNVLVTENNVMKIADFGLARDINN-IDXXKKTTNGRLPVK 224
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+     ++  SDVWSFG+ +WE+++ G  PY
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 46/103 (44%), Positives = 65/103 (63%), Gaps = 3/103 (2%)
Query: 20  YIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH 79
           ++  QI A +  YL  H    H+DLA RN+L+  +   KISD GL R V +  +YYK   
Sbjct: 132 HLVAQIAAGM-EYLSSHHV-VHKDLATRNVLVYDKLNVKISDLGLFREVYAA-DYYKLLG 188
Query: 80  GGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               PI+W APE+  +G+FS  SD+WS+G+ LWE++S+G QPY
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 43/96 (44%), Positives = 61/96 (63%), Gaps = 2/96 (2%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A+   YL   K   HRDLAARN+L+   +  KI+DFGL+R +N+  +  K T  GR P+K
Sbjct: 167 ARGMEYLASQKC-IHRDLAARNVLVTENNVMKIADFGLARDINN-IDXXKKTTNGRLPVK 224
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W APE+     ++  SDVWSFG+ +WE+++ G  PY
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 41/86 (47%), Positives = 56/86 (65%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN ++A     KI DFG++R +  E  YY+    G  P++W APES   G
Sbjct: 149 KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETAYYRKGGKGLLPVRWMAPESLKDG 207
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            F+++SD+WSFG+ LWE+ S  +QPY
Sbjct: 208 VFTTSSDMWSFGVVLWEITSLAEQPY 233

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 42/108 (38%), Positives = 66/108 (61%), Gaps = 4/108 (3%)
Query: 24  QIPAKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++   VC  ++  +S    HRDLAARN L+  +   K+SDFGLSR V  +     ++ G 
Sbjct: 124 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEE--TSSVGS 181
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ++P++W  PE   + +FSS SD+W+FG+ +WE+YS G+ PY     S+
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 48/120 (40%), Positives = 73/120 (60%), Gaps = 7/120 (5%)
Query: 12  PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSE 71
           PLG   L  +  Q+ A +     +H    HRDLA RN L+      KI DFG+SR + S 
Sbjct: 131 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 188
Query: 72  RNYYKATHGGR--WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            +YY+   GGR   PI+W  PES  + +F++ SDVWSFG+ LWE++++G+QP+ ++  ++
Sbjct: 189 -DYYRV--GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 245

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 39/82 (47%), Positives = 55/82 (67%), Gaps = 1/82 (1%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN ++A     KI DFG++R +  E +YY+    G  P++W +PES   G F++
Sbjct: 154 HRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTT 212
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWE+ +  +QPY
Sbjct: 213 YSDVWSFGVVLWEIATLAEQPY 234

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 48/120 (40%), Positives = 73/120 (60%), Gaps = 7/120 (5%)
Query: 12  PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSE 71
           PLG   L  +  Q+ A +     +H    HRDLA RN L+      KI DFG+SR + S 
Sbjct: 125 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 182
Query: 72  RNYYKATHGGR--WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            +YY+   GGR   PI+W  PES  + +F++ SDVWSFG+ LWE++++G+QP+ ++  ++
Sbjct: 183 -DYYRV--GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 239

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 44/89 (49%), Positives = 55/89 (61%), Gaps = 1/89 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRDLAARNILL      KI DFGL+R + ++ NY       R P+KW APES    
Sbjct: 180 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNC 238
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            ++  SDVWS+GI LWE++S G  PY  M
Sbjct: 239 VYTFESDVWSYGIFLWELFSLGSSPYPGM 267

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 48/120 (40%), Positives = 73/120 (60%), Gaps = 7/120 (5%)
Query: 12  PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSE 71
           PLG   L  +  Q+ A +     +H    HRDLA RN L+      KI DFG+SR + S 
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 72  RNYYKATHGGR--WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            +YY+   GGR   PI+W  PES  + +F++ SDVWSFG+ LWE++++G+QP+ ++  ++
Sbjct: 212 -DYYRV--GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 45/82 (54%), Positives = 56/82 (68%), Gaps = 1/82 (1%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARNIL+A   + KISDFGLSR V  E +Y K + G R P+KW A ES     +++
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQG-RIPVKWMAIESLFDHIYTT 231
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWE+ + G  PY
Sbjct: 232 QSDVWSFGVLLWEIVTLGGNPY 253

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 45/117 (38%), Positives = 70/117 (59%), Gaps = 3/117 (2%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER 72
           LG   + +I  QI + +      H    HRDLA RN L+ +    KI DFG+SR V S  
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYST- 186
Query: 73  NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +YY+       PI+W  PES  + +F++ SDVWSFG+ LWE++++G+QP+ ++  ++
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 39/82 (47%), Positives = 55/82 (67%), Gaps = 1/82 (1%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN ++A     KI DFG++R +  E +YY+    G  P++W +PES   G F++
Sbjct: 154 HRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTT 212
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWE+ +  +QPY
Sbjct: 213 YSDVWSFGVVLWEIATLAEQPY 234

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 44/85 (51%), Positives = 57/85 (67%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAA NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 44/89 (49%), Positives = 55/89 (61%), Gaps = 1/89 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRDLAARNILL      KI DFGL+R + ++ NY       R P+KW APES    
Sbjct: 164 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNC 222
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            ++  SDVWS+GI LWE++S G  PY  M
Sbjct: 223 VYTFESDVWSYGIFLWELFSLGSSPYPGM 251

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 39/82 (47%), Positives = 55/82 (67%), Gaps = 1/82 (1%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN ++A     KI DFG++R +  E +YY+    G  P++W +PES   G F++
Sbjct: 161 HRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTT 219
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWE+ +  +QPY
Sbjct: 220 YSDVWSFGVVLWEIATLAEQPY 241

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 39/82 (47%), Positives = 55/82 (67%), Gaps = 1/82 (1%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN ++A     KI DFG++R +  E +YY+    G  P++W +PES   G F++
Sbjct: 152 HRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTT 210
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWE+ +  +QPY
Sbjct: 211 YSDVWSFGVVLWEIATLAEQPY 232

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 39/82 (47%), Positives = 55/82 (67%), Gaps = 1/82 (1%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN ++A     KI DFG++R +  E +YY+    G  P++W +PES   G F++
Sbjct: 151 HRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTT 209
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWE+ +  +QPY
Sbjct: 210 YSDVWSFGVVLWEIATLAEQPY 231

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 39/82 (47%), Positives = 55/82 (67%), Gaps = 1/82 (1%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN ++A     KI DFG++R +  E +YY+    G  P++W +PES   G F++
Sbjct: 155 HRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTT 213
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWE+ +  +QPY
Sbjct: 214 YSDVWSFGVVLWEIATLAEQPY 235

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 45/94 (47%), Positives = 60/94 (63%), Gaps = 4/94 (4%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            K   HRDLAARNIL+   + AKI+DFGLSR    +  Y K T G R P++W A ES N+
Sbjct: 160 QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMG-RLPVRWMAIESLNY 215
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             +++ SDVWS+G+ LWE+ S G  PY  M  ++
Sbjct: 216 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 39/82 (47%), Positives = 55/82 (67%), Gaps = 1/82 (1%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN ++A     KI DFG++R +  E +YY+    G  P++W +PES   G F++
Sbjct: 148 HRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTT 206
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWE+ +  +QPY
Sbjct: 207 YSDVWSFGVVLWEIATLAEQPY 228

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 39/82 (47%), Positives = 55/82 (67%), Gaps = 1/82 (1%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN ++A     KI DFG++R +  E +YY+    G  P++W +PES   G F++
Sbjct: 161 HRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTT 219
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWE+ +  +QPY
Sbjct: 220 YSDVWSFGVVLWEIATLAEQPY 241

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 44/89 (49%), Positives = 55/89 (61%), Gaps = 1/89 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRDLAARNILL      KI DFGL+R + ++ NY       R P+KW APES    
Sbjct: 187 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNC 245
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            ++  SDVWS+GI LWE++S G  PY  M
Sbjct: 246 VYTFESDVWSYGIFLWELFSLGSSPYPGM 274

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 44/89 (49%), Positives = 55/89 (61%), Gaps = 1/89 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRDLAARNILL      KI DFGL+R + ++ NY       R P+KW APES    
Sbjct: 182 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNC 240
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            ++  SDVWS+GI LWE++S G  PY  M
Sbjct: 241 VYTFESDVWSYGIFLWELFSLGSSPYPGM 269

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 45/94 (47%), Positives = 60/94 (63%), Gaps = 4/94 (4%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            K   HRDLAARNIL+   + AKI+DFGLSR    +  Y K T G R P++W A ES N+
Sbjct: 150 QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMG-RLPVRWMAIESLNY 205
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             +++ SDVWS+G+ LWE+ S G  PY  M  ++
Sbjct: 206 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 239

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 39/82 (47%), Positives = 55/82 (67%), Gaps = 1/82 (1%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN ++A     KI DFG++R +  E +YY+    G  P++W +PES   G F++
Sbjct: 183 HRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTT 241
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWE+ +  +QPY
Sbjct: 242 YSDVWSFGVVLWEIATLAEQPY 263

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 40/86 (46%), Positives = 57/86 (66%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HR+LAARN ++A     KI DFG++R +  E +YY+    G  P++W APES   G
Sbjct: 150 KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPESLKDG 208
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            F+++SD+WSFG+ LWE+ S  +QPY
Sbjct: 209 VFTTSSDMWSFGVVLWEITSLAEQPY 234

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 40/86 (46%), Positives = 57/86 (66%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HR+LAARN ++A     KI DFG++R +  E +YY+    G  P++W APES   G
Sbjct: 149 KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPESLKDG 207
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            F+++SD+WSFG+ LWE+ S  +QPY
Sbjct: 208 VFTTSSDMWSFGVVLWEITSLAEQPY 233

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 44/89 (49%), Positives = 55/89 (61%), Gaps = 1/89 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRDLAARNILL      KI DFGL+R + ++ NY       R P+KW APES    
Sbjct: 187 KNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYV-VKGNARLPVKWMAPESIFNC 245
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            ++  SDVWS+GI LWE++S G  PY  M
Sbjct: 246 VYTFESDVWSYGIFLWELFSLGSSPYPGM 274

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 43/97 (44%), Positives = 67/97 (69%), Gaps = 6/97 (6%)
Query: 29  VCR---YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           VC    +L+ H+   HRDLAARN L+      K+SDFG++R V  ++  Y ++ G ++P+
Sbjct: 113 VCEGMAFLESHQF-IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSSVGTKFPV 169
Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           KW APE +++ ++SS SDVW+FGI +WE++S G+ PY
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 43/94 (45%), Positives = 60/94 (63%), Gaps = 2/94 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HR+L A NIL++     KI+DFGL+R +  E N Y A  G ++PIKW APE+ N+
Sbjct: 123 ERNYIHRNLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINY 180
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 181 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 214

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 58/90 (64%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +Y +     R P+KW APE+    
Sbjct: 204 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-DARLPLKWMAPETIFDR 262
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 263 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 62/96 (64%), Gaps = 2/96 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HRDLA RNIL+ + ++ KI DFGL++ +  ++   K    G
Sbjct: 149 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 208
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
             PI WYAPES    +FS ASDVWSFG+ L+E++++
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 244

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 58/90 (64%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +Y +     R P+KW APE+    
Sbjct: 167 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-DARLPLKWMAPETIFDR 225
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 62/96 (64%), Gaps = 2/96 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HRDLA RNIL+ + ++ KI DFGL++ +  ++   K    G
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
             PI WYAPES    +FS ASDVWSFG+ L+E++++
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 213

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 40/99 (40%), Positives = 64/99 (64%), Gaps = 2/99 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HRDLA RNIL+ + ++ KI DFGL++ +  ++   K    G
Sbjct: 122 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 181
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
             PI WYAPES    +FS ASDVWSFG+ L+E++++ ++
Sbjct: 182 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 220

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 62/96 (64%), Gaps = 2/96 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HRDLA RNIL+ + ++ KI DFGL++ +  ++   K    G
Sbjct: 116 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 175
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
             PI WYAPES    +FS ASDVWSFG+ L+E++++
Sbjct: 176 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 62/96 (64%), Gaps = 2/96 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HRDLA RNIL+ + ++ KI DFGL++ +  ++   K    G
Sbjct: 121 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
             PI WYAPES    +FS ASDVWSFG+ L+E++++
Sbjct: 181 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 216

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 58/90 (64%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +Y +     R P+KW APE+    
Sbjct: 169 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-DARLPLKWMAPETIFDR 227
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 228 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 257

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 58/90 (64%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +Y +     R P+KW APE+    
Sbjct: 217 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-DARLPLKWMAPETIFDR 275
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 276 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 305

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 62/96 (64%), Gaps = 2/96 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HRDLA RNIL+ + ++ KI DFGL++ +  ++   K    G
Sbjct: 136 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
             PI WYAPES    +FS ASDVWSFG+ L+E++++
Sbjct: 196 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 231

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 62/96 (64%), Gaps = 2/96 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HRDLA RNIL+ + ++ KI DFGL++ +  ++   K    G
Sbjct: 125 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 184
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
             PI WYAPES    +FS ASDVWSFG+ L+E++++
Sbjct: 185 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 220

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 62/96 (64%), Gaps = 2/96 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HRDLA RNIL+ + ++ KI DFGL++ +  ++   K    G
Sbjct: 136 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
             PI WYAPES    +FS ASDVWSFG+ L+E++++
Sbjct: 196 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 231

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 39/82 (47%), Positives = 54/82 (65%), Gaps = 1/82 (1%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN  +A     KI DFG++R +  E +YY+    G  P++W +PES   G F++
Sbjct: 148 HRDLAARNCXVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTT 206
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWE+ +  +QPY
Sbjct: 207 YSDVWSFGVVLWEIATLAEQPY 228

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 62/96 (64%), Gaps = 2/96 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HRDLA RNIL+ + ++ KI DFGL++ +  ++   K    G
Sbjct: 123 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 182
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
             PI WYAPES    +FS ASDVWSFG+ L+E++++
Sbjct: 183 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 218

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 58/90 (64%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +Y +     R P+KW APE+    
Sbjct: 219 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-DARLPLKWMAPETIFDR 277
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 278 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 307

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 62/96 (64%), Gaps = 2/96 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HRDLA RNIL+ + ++ KI DFGL++ +  ++   K    G
Sbjct: 121 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
             PI WYAPES    +FS ASDVWSFG+ L+E++++
Sbjct: 181 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 62/96 (64%), Gaps = 2/96 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HRDLA RNIL+ + ++ KI DFGL++ +  ++   K    G
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
             PI WYAPES    +FS ASDVWSFG+ L+E++++
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 213

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 40/86 (46%), Positives = 56/86 (65%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN+L+   +  KI+DFGL+R ++   +  K T  GR P+KW APE+    
Sbjct: 169 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDXXKKTTNGRLPVKWMAPEALFDR 227
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            ++  SDVWSFG+ LWE+++ G  PY
Sbjct: 228 IYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 40/99 (40%), Positives = 64/99 (64%), Gaps = 2/99 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HRDLA RNIL+ + ++ KI DFGL++ +  ++   K    G
Sbjct: 117 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 176
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
             PI WYAPES    +FS ASDVWSFG+ L+E++++ ++
Sbjct: 177 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 215

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 58/90 (64%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +Y +     R P+KW APE+    
Sbjct: 210 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-DARLPLKWMAPETIFDR 268
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 269 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 298

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 62/96 (64%), Gaps = 2/96 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HRDLA RNIL+ + ++ KI DFGL++ +  ++   K    G
Sbjct: 124 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 183
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
             PI WYAPES    +FS ASDVWSFG+ L+E++++
Sbjct: 184 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 219

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 40/99 (40%), Positives = 64/99 (64%), Gaps = 2/99 (2%)
Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q  +++C+ ++    K   HRDLA RNIL+ + ++ KI DFGL++ +  ++   K    G
Sbjct: 121 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
             PI WYAPES    +FS ASDVWSFG+ L+E++++ ++
Sbjct: 181 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 219

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 58/90 (64%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +Y +     R P+KW APE+    
Sbjct: 212 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-DARLPLKWMAPETIFDR 270
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 271 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 58/90 (64%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +Y +     R P+KW APE+    
Sbjct: 158 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-DARLPLKWMAPETIFDR 216
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 217 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 246

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 58/90 (64%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +Y +     R P+KW APE+    
Sbjct: 158 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-DARLPLKWMAPETIFDR 216
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 217 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 246

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 43/94 (45%), Positives = 59/94 (62%), Gaps = 2/94 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL++     KI+DFGL+R +  E N   A  G ++PIKW APE+ N+
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINY 190
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 224

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 43/94 (45%), Positives = 59/94 (62%), Gaps = 2/94 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL++     KI+DFGL+R +  E N   A  G ++PIKW APE+ N+
Sbjct: 135 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINY 192
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 193 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 226

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 43/94 (45%), Positives = 59/94 (62%), Gaps = 2/94 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL++     KI+DFGL+R +  E N   A  G ++PIKW APE+ N+
Sbjct: 129 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINY 186
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 187 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 220

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 43/94 (45%), Positives = 59/94 (62%), Gaps = 2/94 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL++     KI+DFGL+R +  E N   A  G ++PIKW APE+ N+
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINY 184
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 43/94 (45%), Positives = 59/94 (62%), Gaps = 2/94 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL++     KI+DFGL+R +  E N   A  G ++PIKW APE+ N+
Sbjct: 136 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINY 193
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 194 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 227

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 58/90 (64%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +Y +     R P+KW APE+    
Sbjct: 163 RKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-DARLPLKWMAPETIFDR 221
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 222 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 251

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 43/94 (45%), Positives = 59/94 (62%), Gaps = 2/94 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL++     KI+DFGL+R +  E N   A  G ++PIKW APE+ N+
Sbjct: 128 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINY 185
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 186 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 219

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 43/94 (45%), Positives = 59/94 (62%), Gaps = 2/94 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL++     KI+DFGL+R +  E N   A  G ++PIKW APE+ N+
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINY 184
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 39/81 (48%), Positives = 56/81 (69%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNIL+ S    KI+DFGL++ +  +++YY     G+ PI WYAPES +  
Sbjct: 134 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 193
Query: 97  RFSSASDVWSFGITLWEMYSF 117
            FS  SDVWSFG+ L+E++++
Sbjct: 194 IFSRQSDVWSFGVVLYELFTY 214

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 44/94 (46%), Positives = 60/94 (63%), Gaps = 4/94 (4%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            K   HR+LAARNIL+   + AKI+DFGLSR    +  Y K T G R P++W A ES N+
Sbjct: 157 QKQFIHRNLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMG-RLPVRWMAIESLNY 212
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             +++ SDVWS+G+ LWE+ S G  PY  M  ++
Sbjct: 213 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 246

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 44/103 (42%), Positives = 65/103 (63%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFG ++ + +E   Y A  GG+ PIK
Sbjct: 129 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIK 186
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 45/85 (52%), Positives = 56/85 (65%), Gaps = 1/85 (1%)
Query: 38  SSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           S  HRDLAARNIL+A   + KISDFGLSR V  E +  K + G R P+KW A ES     
Sbjct: 170 SLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQG-RIPVKWMAIESLFDHI 228
Query: 98  FSSASDVWSFGITLWEMYSFGQQPY 122
           +++ SDVWSFG+ LWE+ + G  PY
Sbjct: 229 YTTQSDVWSFGVLLWEIVTLGGNPY 253

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 39/81 (48%), Positives = 56/81 (69%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNIL+ S    KI+DFGL++ +  +++YY     G+ PI WYAPES +  
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 97  RFSSASDVWSFGITLWEMYSF 117
            FS  SDVWSFG+ L+E++++
Sbjct: 206 IFSRQSDVWSFGVVLYELFTY 226

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 192 KSDVWSFGILLTELTTKGRVPYPGM 216

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 45/119 (37%), Positives = 68/119 (57%), Gaps = 3/119 (2%)
Query: 11  TPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS 70
           T L    + +I  QI A +      H    HRDLA RN L+      KI DFG+SR V S
Sbjct: 123 TELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYS 180
Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             +YY+       PI+W  PES  + +F++ SDVWS G+ LWE++++G+QP+ ++  ++
Sbjct: 181 T-DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 238

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 44/103 (42%), Positives = 65/103 (63%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFG ++ + +E   Y A  GG+ PIK
Sbjct: 131 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIK 188
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 231

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 44/103 (42%), Positives = 65/103 (63%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFG ++ + +E   Y A  GG+ PIK
Sbjct: 134 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIK 191
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 44/103 (42%), Positives = 65/103 (63%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFG ++ + +E   Y A  GG+ PIK
Sbjct: 127 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIK 184
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 40/93 (43%), Positives = 63/93 (67%), Gaps = 2/93 (2%)
Query: 27  AKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWP 84
           +++C+ ++    +   HRDLAARNIL+ S    KI+DFGL++ +  +++YY     G+ P
Sbjct: 121 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 180
Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
           I WYAPES +   FS  SDVWSFG+ L+E++++
Sbjct: 181 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY 213

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 187
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 188 KSDVWSFGILLTELTTKGRVPYPGM 212

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 44/103 (42%), Positives = 65/103 (63%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFG ++ + +E   Y A  GG+ PIK
Sbjct: 129 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIK 186
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 186 KSDVWSFGILLTELTTKGRVPYPGM 210

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 183
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 184 KSDVWSFGILLTELTTKGRVPYPGM 208

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 44/103 (42%), Positives = 65/103 (63%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+  +   HRDLAARN+L+ +    KI+DFG ++ + +E   Y A  GG+ PIK
Sbjct: 129 AKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIK 186
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 58/90 (64%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +Y +     R P+KW APE+    
Sbjct: 163 RKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKG-DARLPLKWMAPETIFDR 221
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 222 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 251

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGM 468

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 39/86 (45%), Positives = 55/86 (63%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN ++A     KI DFG++R +  E +  +    G  P++W APES   G
Sbjct: 146 KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-XETDXXRKGGKGLLPVRWMAPESLKDG 204
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            F+++SD+WSFG+ LWE+ S  +QPY
Sbjct: 205 VFTTSSDMWSFGVVLWEITSLAEQPY 230

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 39/86 (45%), Positives = 55/86 (63%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN ++A     KI DFG++R +  E +  +    G  P++W APES   G
Sbjct: 149 KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-XETDXXRKGGKGLLPVRWMAPESLKDG 207
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            F+++SD+WSFG+ LWE+ S  +QPY
Sbjct: 208 VFTTSSDMWSFGVVLWEITSLAEQPY 233

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 39/86 (45%), Positives = 55/86 (63%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDLAARN ++A     KI DFG++R +  E +  +    G  P++W APES   G
Sbjct: 149 KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-XETDXXRKGGKGLLPVRWMAPESLKDG 207
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            F+++SD+WSFG+ LWE+ S  +QPY
Sbjct: 208 VFTTSSDMWSFGVVLWEITSLAEQPY 233

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 44/82 (53%), Positives = 55/82 (67%), Gaps = 1/82 (1%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARNIL+A   + KISDFGLSR V  E +  K + G R P+KW A ES     +++
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQG-RIPVKWMAIESLFDHIYTT 231
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWE+ + G  PY
Sbjct: 232 QSDVWSFGVLLWEIVTLGGNPY 253

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 41/86 (47%), Positives = 55/86 (63%), Gaps = 1/86 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+  +  KI DFGL+R +    +Y +     R P+KW APES    
Sbjct: 218 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT-RLPLKWMAPESIFDK 276
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +S+ SDVWS+G+ LWE++S G  PY
Sbjct: 277 IYSTKSDVWSYGVLLWEIFSLGGSPY 302

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 40/90 (44%), Positives = 57/90 (63%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +  +     R P+KW APE+    
Sbjct: 167 RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG-DARLPLKWMAPETIFDR 225
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 40/90 (44%), Positives = 57/90 (63%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +  +     R P+KW APE+    
Sbjct: 167 RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG-DARLPLKWMAPETIFDR 225
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 40/90 (44%), Positives = 57/90 (63%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +  +     R P+KW APE+    
Sbjct: 158 RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG-DARLPLKWMAPETIFDR 216
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 217 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 246

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 40/90 (44%), Positives = 57/90 (63%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +  +     R P+KW APE+    
Sbjct: 158 RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG-DARLPLKWMAPETIFDR 216
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 217 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 246

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 40/90 (44%), Positives = 57/90 (63%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +  +     R P+KW APE+    
Sbjct: 167 RKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG-DARLPLKWMAPETIFDR 225
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 37/77 (48%), Positives = 51/77 (66%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN+L+ S HQ KI DFGL++A+ +++           P+ WYAPE     +F  
Sbjct: 149 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYI 208
Query: 101 ASDVWSFGITLWEMYSF 117
           ASDVWSFG+TL E+ ++
Sbjct: 209 ASDVWSFGVTLHELLTY 225

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 40/90 (44%), Positives = 57/90 (63%), Gaps = 1/90 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNILL+ ++  KI DFGL+R +  + +  +     R P+KW APE+    
Sbjct: 167 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG-DARLPLKWMAPETIFDR 225
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 37/77 (48%), Positives = 51/77 (66%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN+L+ S HQ KI DFGL++A+ +++           P+ WYAPE     +F  
Sbjct: 137 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYI 196
Query: 101 ASDVWSFGITLWEMYSF 117
           ASDVWSFG+TL E+ ++
Sbjct: 197 ASDVWSFGVTLHELLTY 213

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/131 (38%), Positives = 68/131 (51%), Gaps = 10/131 (7%)
Query: 1   MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKIS 60
           ++SP  +  V  L S+ L    G        YL   K   HRDLAARN +L      K++
Sbjct: 114 IRSPQRNPTVKDLISFGLQVARGM------EYLAEQKF-VHRDLAARNCMLDESFTVKVA 166
Query: 61  DFGLSRAVNSERNYYKATHG--GRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFG 118
           DFGL+R +  +R YY        R P+KW A ES    RF++ SDVWSFG+ LWE+ + G
Sbjct: 167 DFGLARDI-LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRG 225
Query: 119 QQPYGEMKGSD 129
             PY  +   D
Sbjct: 226 APPYRHIDPFD 236

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 42/85 (49%), Positives = 56/85 (65%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N + A  G ++PIKW APE+  +GRF+ 
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 192 KSDVWSFGILLTELTTKGRVPYPGM 216

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGM 385

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 41/100 (41%), Positives = 65/100 (65%), Gaps = 2/100 (2%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+ H    HR+LAARN+LL S  Q +++DFG++  +  +      +   + PIK
Sbjct: 143 AKGMYYLEEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA-KTPIK 200
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
           W A ES +FG+++  SDVWS+G+T+WE+ +FG +PY  ++
Sbjct: 201 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 240

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGM 385

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 43/85 (50%), Positives = 56/85 (65%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGM 385

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 67/103 (65%), Gaps = 2/103 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   YL+ H    HR+LAARN+LL S  Q +++DFG++  +  +      +   + PIK
Sbjct: 125 AKGMYYLEEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA-KTPIK 182
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W A ES +FG+++  SDVWS+G+T+WE+ +FG +PY  ++ ++
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 37/82 (45%), Positives = 53/82 (64%), Gaps = 1/82 (1%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN ++A     KI DFG++R +  E +  +    G  P++W +PES   G F++
Sbjct: 146 HRDLAARNCMVAEDFTVKIGDFGMTRDI-XETDXXRKGGKGLLPVRWMSPESLKDGVFTT 204
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
            SDVWSFG+ LWE+ +  +QPY
Sbjct: 205 YSDVWSFGVVLWEIATLAEQPY 226

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 45/114 (39%), Positives = 66/114 (57%), Gaps = 3/114 (2%)
Query: 9   VVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAV 68
           V+ P     +  + G+I A    YL  +K   HRDLAARN ++A     KI DFG++R +
Sbjct: 125 VLAPPSLSKMIQMAGEI-ADGMAYLNANKF-VHRDLAARNCMVAEDFTVKIGDFGMTRDI 182
Query: 69  NSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             E +  +    G  P++W +PES   G F++ SDVWSFG+ LWE+ +  +QPY
Sbjct: 183 -XETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 235

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 42/85 (49%), Positives = 55/85 (64%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N   A  G ++PIKW APE+  +GRF+ 
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTI 184
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 185 KSDVWSFGILLTELTTKGRVPYPGM 209

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 42/94 (44%), Positives = 58/94 (61%), Gaps = 2/94 (2%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL++     KI+DFGL+R +  E     A  G ++PIKW APE+ N+
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDAEXTAREGAKFPIKWTAPEAINY 184
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 42/85 (49%), Positives = 55/85 (64%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +  E N   A  G ++PIKW APE+  +GRF+ 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 44/105 (41%), Positives = 64/105 (60%), Gaps = 4/105 (3%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH--GGRWP 84
           AK  +YL   K   HRDLAARN +L  +   K++DFGL+R +  ++ YY   +  G + P
Sbjct: 161 AKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLP 218
Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +KW A ES    +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 219 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 263

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 44/105 (41%), Positives = 64/105 (60%), Gaps = 4/105 (3%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH--GGRWP 84
           AK  +YL   K   HRDLAARN +L  +   K++DFGL+R +  ++ YY   +  G + P
Sbjct: 162 AKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLP 219
Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +KW A ES    +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 220 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 264

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 44/105 (41%), Positives = 64/105 (60%), Gaps = 4/105 (3%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH--GGRWP 84
           AK  +YL   K   HRDLAARN +L  +   K++DFGL+R +  ++ YY   +  G + P
Sbjct: 143 AKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLP 200
Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +KW A ES    +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 44/105 (41%), Positives = 64/105 (60%), Gaps = 4/105 (3%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH--GGRWP 84
           AK  +YL   K   HRDLAARN +L  +   K++DFGL+R +  ++ YY   +  G + P
Sbjct: 140 AKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLP 197
Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +KW A ES    +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 43/85 (50%), Positives = 55/85 (64%), Gaps = 2/85 (2%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL R +  E N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 361
Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SDVWSFGI L E+ + G+ PY  M
Sbjct: 362 KSDVWSFGILLTELTTKGRVPYPGM 386

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 44/105 (41%), Positives = 64/105 (60%), Gaps = 4/105 (3%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH--GGRWP 84
           AK  +YL   K   HRDLAARN +L  +   K++DFGL+R +  ++ YY   +  G + P
Sbjct: 135 AKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLP 192
Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +KW A ES    +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 193 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 237

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 44/105 (41%), Positives = 64/105 (60%), Gaps = 4/105 (3%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH--GGRWP 84
           AK  +YL   K   HRDLAARN +L  +   K++DFGL+R +  ++ YY   +  G + P
Sbjct: 143 AKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLP 200
Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +KW A ES    +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 44/105 (41%), Positives = 64/105 (60%), Gaps = 4/105 (3%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH--GGRWP 84
           AK  +YL   K   HRDLAARN +L  +   K++DFGL+R +  ++ YY   +  G + P
Sbjct: 142 AKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLP 199
Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +KW A ES    +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 200 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 244

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 44/105 (41%), Positives = 64/105 (60%), Gaps = 4/105 (3%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH--GGRWP 84
           AK  +YL   K   HRDLAARN +L  +   K++DFGL+R +  ++ YY   +  G + P
Sbjct: 141 AKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLP 198
Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +KW A ES    +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 199 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 243

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 44/105 (41%), Positives = 64/105 (60%), Gaps = 4/105 (3%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH--GGRWP 84
           AK  +YL   K   HRDLAARN +L  +   K++DFGL+R +  ++ YY   +  G + P
Sbjct: 138 AKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLP 195
Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +KW A ES    +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 196 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 57/94 (60%), Gaps = 1/94 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSR-AVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRDLAARN +L  +   K++DFGL+R  ++ E +      G + P+KW A ES   
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 246

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 42/90 (46%), Positives = 57/90 (63%), Gaps = 2/90 (2%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDL + NIL+ +    KI+DFGL+R +  E N   A  G ++PIKW APE+  +GRF+
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFT 184
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 185 IKSDVWSFGILLTELVTKGRVPYPGMNNRE 214

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 61/104 (58%), Gaps = 2/104 (1%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAV-NSERNYYKATHGGRWPI 85
           AK  +YL   K   HRDLAARN +L  +   K++DFGL+R + + E        G + P+
Sbjct: 142 AKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV 200
Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           KW A ES    +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 244

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 57/94 (60%), Gaps = 1/94 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAV-NSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRDLAARN +L  +   K++DFGL+R + + E +      G + P+KW A ES   
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 57/94 (60%), Gaps = 1/94 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAV-NSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRDLAARN +L  +   K++DFGL+R + + E +      G + P+KW A ES   
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 246

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 57/94 (60%), Gaps = 1/94 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAV-NSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRDLAARN +L  +   K++DFGL+R + + E +      G + P+KW A ES   
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 57/94 (60%), Gaps = 1/94 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAV-NSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRDLAARN +L  +   K++DFGL+R + + E +      G + P+KW A ES   
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 57/94 (60%), Gaps = 1/94 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAV-NSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRDLAARN +L  +   K++DFGL+R + + E +      G + P+KW A ES   
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 243

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 57/94 (60%), Gaps = 1/94 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAV-NSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRDLAARN +L  +   K++DFGL+R + + E +      G + P+KW A ES   
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 250

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 38/93 (40%), Positives = 59/93 (63%), Gaps = 1/93 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           ++  HRDLAARN +LA      ++DFGLSR + S  +YY+     + P+KW A ES    
Sbjct: 156 RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS-GDYYRQGCASKLPVKWLALESLADN 214
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            ++  SDVW+FG+T+WE+ + GQ PY  ++ ++
Sbjct: 215 LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 38/78 (48%), Positives = 50/78 (64%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HR LAARN+LL +    KI DFGL++AV     YY+    G  P+ WYAPE     +F 
Sbjct: 133 IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFY 192
Query: 100 SASDVWSFGITLWEMYSF 117
            ASDVWSFG+TL+E+ ++
Sbjct: 193 YASDVWSFGVTLYELLTY 210

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 38/78 (48%), Positives = 50/78 (64%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HR LAARN+LL +    KI DFGL++AV     YY+    G  P+ WYAPE     +F 
Sbjct: 134 IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFY 193
Query: 100 SASDVWSFGITLWEMYSF 117
            ASDVWSFG+TL+E+ ++
Sbjct: 194 YASDVWSFGVTLYELLTY 211

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 41/90 (45%), Positives = 56/90 (62%), Gaps = 12/90 (13%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            ++  HRDL A NIL+++    KI+DFGL+R             G ++PIKW APE+ NF
Sbjct: 296 QRNYIHRDLRAANILVSASLVCKIADFGLARV------------GAKFPIKWTAPEAINF 343
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           G F+  SDVWSFGI L E+ ++G+ PY  M
Sbjct: 344 GSFTIKSDVWSFGILLMEIVTYGRIPYPGM 373

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 37/81 (45%), Positives = 54/81 (66%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDLAARNIL+ S    KI+DFGL++ +  +++       G+ PI WYAPES +  
Sbjct: 130 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDN 189
Query: 97  RFSSASDVWSFGITLWEMYSF 117
            FS  SDVWSFG+ L+E++++
Sbjct: 190 IFSRQSDVWSFGVVLYELFTY 210

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           C+YL+      HRD+AARN LL        AKI DFG++R +    +YY+       P+K
Sbjct: 153 CQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVK 210
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W  PE++  G F+S +D WSFG+ LWE++S G  PY
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           C+YL+      HRD+AARN LL        AKI DFG++R +    +YY+       P+K
Sbjct: 170 CQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVK 227
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W  PE++  G F+S +D WSFG+ LWE++S G  PY
Sbjct: 228 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 263

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           C+YL+      HRD+AARN LL        AKI DFG++R +    +YY+       P+K
Sbjct: 153 CQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVK 210
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W  PE++  G F+S +D WSFG+ LWE++S G  PY
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           C+YL+      HRD+AARN LL        AKI DFG++R +    +YY+       P+K
Sbjct: 168 CQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVK 225
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W  PE++  G F+S +D WSFG+ LWE++S G  PY
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 38/77 (49%), Positives = 50/77 (64%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HR+LAARN+LL +    KI DFGL++AV     YY+    G  P+ WYAPE     +F 
Sbjct: 139 IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY 198
Query: 100 SASDVWSFGITLWEMYS 116
            ASDVWSFG+TL+E+ +
Sbjct: 199 YASDVWSFGVTLYELLT 215

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           C+YL+      HRD+AARN LL        AKI DFG++R +    +YY+       P+K
Sbjct: 168 CQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVK 225
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W  PE++  G F+S +D WSFG+ LWE++S G  PY
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           C+YL+      HRD+AARN LL        AKI DFG++R +    +YY+       P+K
Sbjct: 168 CQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVK 225
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W  PE++  G F+S +D WSFG+ LWE++S G  PY
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 38/77 (49%), Positives = 50/77 (64%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HR+LAARN+LL +    KI DFGL++AV     YY+    G  P+ WYAPE     +F 
Sbjct: 139 IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY 198
Query: 100 SASDVWSFGITLWEMYS 116
            ASDVWSFG+TL+E+ +
Sbjct: 199 YASDVWSFGVTLYELLT 215

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           C+YL+      HRD+AARN LL        AKI DFG++R +    +YY+       P+K
Sbjct: 145 CQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVK 202
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W  PE++  G F+S +D WSFG+ LWE++S G  PY
Sbjct: 203 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 238

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           C+YL+      HRD+AARN LL        AKI DFG++R +    +YY+       P+K
Sbjct: 154 CQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVK 211
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W  PE++  G F+S +D WSFG+ LWE++S G  PY
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 247

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           C+YL+      HRD+AARN LL        AKI DFG++R +    +YY+       P+K
Sbjct: 160 CQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVK 217
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W  PE++  G F+S +D WSFG+ LWE++S G  PY
Sbjct: 218 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 253

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           C+YL+      HRD+AARN LL        AKI DFG++R +    +YY+       P+K
Sbjct: 154 CQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVK 211
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W  PE++  G F+S +D WSFG+ LWE++S G  PY
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 247

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           C+YL+      HRD+AARN LL        AKI DFG++R +    +YY+       P+K
Sbjct: 180 CQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVK 237
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W  PE++  G F+S +D WSFG+ LWE++S G  PY
Sbjct: 238 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 273

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 56/96 (58%), Gaps = 5/96 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           C+YL+      HRD+AARN LL        AKI DFG++R +     YY+       P+K
Sbjct: 171 CQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRAGYYRKGGCAMLPVK 228
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W  PE++  G F+S +D WSFG+ LWE++S G  PY
Sbjct: 229 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 264

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 56/96 (58%), Gaps = 5/96 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           C+YL+      HRD+AARN LL        AKI DFG++R +     YY+       P+K
Sbjct: 194 CQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRAGYYRKGGCAMLPVK 251
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W  PE++  G F+S +D WSFG+ LWE++S G  PY
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 38/77 (49%), Positives = 49/77 (63%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDLAARN+LL +    KI DFGL++AV      Y+    G  P+ WYAPE     +F 
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFY 215
Query: 100 SASDVWSFGITLWEMYS 116
            ASDVWSFG+TL+E+ +
Sbjct: 216 YASDVWSFGVTLYELLT 232

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           C+YL+      HRD+AARN LL        AKI DFG+++ +    +YY+       P+K
Sbjct: 154 CQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDI-YRASYYRKGGCAMLPVK 211
Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W  PE++  G F+S +D WSFG+ LWE++S G  PY
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 247

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 55/87 (63%), Gaps = 1/87 (1%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           +++  HRDLAARN +L       ++DFGLS+ + S  +YY+     + P+KW A ES   
Sbjct: 165 NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS-GDYYRQGRIAKMPVKWIAIESLAD 223
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
             ++S SDVW+FG+T+WE+ + G  PY
Sbjct: 224 RVYTSKSDVWAFGVTMWEIATRGMTPY 250

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/86 (38%), Positives = 47/86 (54%), Gaps = 4/86 (4%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDL + N+L+  ++  K+ DFGLSR   S     K   G     +W APE       +
Sbjct: 161 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTP---EWMAPEVLRDEPSN 217
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEM 125
             SDV+SFG+ LWE+ +  QQP+G +
Sbjct: 218 EKSDVYSFGVILWELATL-QQPWGNL 242

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 59/117 (50%), Gaps = 14/117 (11%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSE 71
           LG  ++  I+G        YL+      HRD+   NIL+ SR + K+ DFG+S + ++S 
Sbjct: 125 LGKVSIAVIKG------LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 178
Query: 72  RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS 128
            N +  T        + +PE      +S  SD+WS G++L EM + G+ P G   GS
Sbjct: 179 ANSFVGTRS------YMSPERLQGTHYSVQSDIWSMGLSLVEM-AVGRYPIGSGSGS 228

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 32/86 (37%), Positives = 48/86 (55%), Gaps = 4/86 (4%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HR+L + N+L+  ++  K+ DFGLSR   S     K+  G     +W APE       +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTP---EWMAPEVLRDEPSN 217
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEM 125
             SDV+SFG+ LWE+ +  QQP+G +
Sbjct: 218 EKSDVYSFGVILWELATL-QQPWGNL 242

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 44/80 (55%), Gaps = 3/80 (3%)
Query: 38  SSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           +  HRDL   N+ L  +   K+ DFGL+R +N + ++ KA  G  +   + +PE  N   
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPY---YMSPEQMNRMS 192
Query: 98  FSSASDVWSFGITLWEMYSF 117
           ++  SD+WS G  L+E+ + 
Sbjct: 193 YNEKSDIWSLGCLLYELCAL 212

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 25/80 (31%), Positives = 43/80 (53%), Gaps = 3/80 (3%)
Query: 38  SSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           +  HRDL   N+ L  +   K+ DFGL+R +N + ++ K   G  +   + +PE  N   
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPY---YMSPEQMNRMS 192
Query: 98  FSSASDVWSFGITLWEMYSF 117
           ++  SD+WS G  L+E+ + 
Sbjct: 193 YNEKSDIWSLGCLLYELCAL 212

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 59/115 (51%), Gaps = 15/115 (13%)
Query: 19  PYIEGQIPAKVCRYLK----MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNS--- 70
           P  E QI   +   LK    +H +   HRD+ A N+LL+   + K++DFG++  +     
Sbjct: 115 PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174
Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +RN +  T     P  W APE      + S +D+WS GIT  E+ + G+ P+ E+
Sbjct: 175 KRNXFVGT-----PF-WMAPEVIKQSAYDSKADIWSLGITAIEL-ARGEPPHSEL 222

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 59/115 (51%), Gaps = 15/115 (13%)
Query: 19  PYIEGQIPAKVCRYLK----MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNS--- 70
           P  E QI   +   LK    +H +   HRD+ A N+LL+   + K++DFG++  +     
Sbjct: 120 PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 179
Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +RN +  T     P  W APE      + S +D+WS GIT  E+ + G+ P+ E+
Sbjct: 180 KRNTFVGT-----PF-WMAPEVIKQSAYDSKADIWSLGITAIEL-ARGEPPHSEL 227

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 59/115 (51%), Gaps = 15/115 (13%)
Query: 19  PYIEGQIPAKVCRYLK----MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNS--- 70
           P  E QI   +   LK    +H +   HRD+ A N+LL+   + K++DFG++  +     
Sbjct: 100 PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 159
Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +RN +  T     P  W APE      + S +D+WS GIT  E+ + G+ P+ E+
Sbjct: 160 KRNXFVGT-----PF-WMAPEVIKQSAYDSKADIWSLGITAIEL-ARGEPPHSEL 207

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 59/115 (51%), Gaps = 15/115 (13%)
Query: 19  PYIEGQIPAKVCRYLK----MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNS--- 70
           P  E QI   +   LK    +H +   HRD+ A N+LL+   + K++DFG++  +     
Sbjct: 100 PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 159
Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +RN +  T     P  W APE      + S +D+WS GIT  E+ + G+ P+ E+
Sbjct: 160 KRNTFVGT-----PF-WMAPEVIKQSAYDSKADIWSLGITAIEL-ARGEPPHSEL 207

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 49/96 (51%), Gaps = 14/96 (14%)
Query: 40  FHRDLAARNILLASRHQ--------AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
            HRDL + NIL+  + +         KI+DFGL+R         K +  G +   W APE
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAGAY--AWMAPE 184
Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG 127
                 FS  SDVWS+G+ LWE+ + G+ P+  + G
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLT-GEVPFRGIDG 219

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 15/115 (13%)
Query: 19  PYIEGQIPAKVCRYLK----MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNS--- 70
           P+ E QI   +   LK    +H +   HRD+ A N+LL+ +   K++DFG++  +     
Sbjct: 116 PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 175
Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +RN +  T     P  W APE      + S +D+WS GIT  E+   G+ P  +M
Sbjct: 176 KRNTFVGT-----PF-WMAPEVIQQSAYDSKADIWSLGITAIELAK-GEPPNSDM 223

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 25/80 (31%), Positives = 43/80 (53%), Gaps = 3/80 (3%)
Query: 38  SSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           +  HRDL   N+ L  +   K+ DFGL+R +N + ++ K   G  +   + +PE  N   
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY---YMSPEQMNRMS 192
Query: 98  FSSASDVWSFGITLWEMYSF 117
           ++  SD+WS G  L+E+ + 
Sbjct: 193 YNEKSDIWSLGCLLYELCAL 212

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 11/99 (11%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW---PIKWYAPESY 93
           KS  HRDL + NI L   +  KI DFGL+    +E++ +  +H        I W APE  
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 94  NFGR---FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                  +S  SDV++FGI L+E+ + GQ PY  +   D
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRD 232

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 11/99 (11%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW---PIKWYAPESY 93
           KS  HRDL + NI L   +  KI DFGL+    +E++ +  +H        I W APE  
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 94  NFGR---FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                  +S  SDV++FGI L+E+ + GQ PY  +   D
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRD 232

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 13/103 (12%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSE 71
           LG  ++  I+G        YL+      HRD+   NIL+ SR + K+ DFG+S + ++S 
Sbjct: 168 LGKVSIAVIKG------LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 221
Query: 72  RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEM 114
            N +  T        + +PE      +S  SD+WS G++L EM
Sbjct: 222 ANSFVGTRS------YMSPERLQGTHYSVQSDIWSMGLSLVEM 258

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 49/107 (45%), Gaps = 11/107 (10%)
Query: 22  EGQIPAKVCRYLK-----MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY 75
           EGQI A VCR        +H +   HRD+ + NILL      K++DFG    +  E++  
Sbjct: 115 EGQI-AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 76  KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               G  +   W APE      +    D+WS GI   EM   G+ PY
Sbjct: 174 STMVGTPY---WMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPY 216

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 21  IEGQIPAKVCR---YLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYK 76
           I G++   V R   YL+      HRD+   NIL+ SR + K+ DFG+S + ++S  N + 
Sbjct: 115 ILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 174
Query: 77  ATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEM 114
            T        + APE      +S  SD+WS G++L E+
Sbjct: 175 GTRS------YMAPERLQGTHYSVQSDIWSMGLSLVEL 206

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW---PIKWYAPESY 93
           KS  HRDL + NI L      KI DFGL+    +E++ +  +H        I W APE  
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 94  NFGR---FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                  +S  SDV++FGI L+E+ + GQ PY  +   D
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRD 216

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW---PIKWYAPESY 93
           KS  HRDL + NI L      KI DFGL+    +E++ +  +H        I W APE  
Sbjct: 143 KSIIHRDLKSNNIFLHEDLTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVI 198
Query: 94  NFGR---FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                  +S  SDV++FGI L+E+ + GQ PY  +   D
Sbjct: 199 RMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRD 236

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 13/103 (12%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSE 71
           LG  ++  I+G        YL+      HRD+   NIL+ SR + K+ DFG+S + ++S 
Sbjct: 133 LGKVSIAVIKG------LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186
Query: 72  RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEM 114
            N +  T        + +PE      +S  SD+WS G++L EM
Sbjct: 187 ANSFVGTRS------YMSPERLQGTHYSVQSDIWSMGLSLVEM 223

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 13/103 (12%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSE 71
           LG  ++  I+G        YL+      HRD+   NIL+ SR + K+ DFG+S + ++S 
Sbjct: 106 LGKVSIAVIKG------LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 72  RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEM 114
            N +  T        + +PE      +S  SD+WS G++L EM
Sbjct: 160 ANSFVGTR------SYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 53/101 (52%), Gaps = 3/101 (2%)
Query: 24  QIPAKVCRYLKM-HKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++ A  C+ L   H++   HRD+   NIL+++ +  K+ DFG++RA+    N    T   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAV 179
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               ++ +PE        + SDV+S G  L+E+ + G+ P+
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPF 219

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 13/103 (12%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSE 71
           LG  ++  I+G        YL+      HRD+   NIL+ SR + K+ DFG+S + ++S 
Sbjct: 106 LGKVSIAVIKG------LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 72  RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEM 114
            N +  T        + +PE      +S  SD+WS G++L EM
Sbjct: 160 ANSFVGTR------SYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 49/107 (45%), Gaps = 11/107 (10%)
Query: 22  EGQIPAKVCRYLK-----MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY 75
           EGQI A VCR        +H +   HRD+ + NILL      K++DFG    +  E++  
Sbjct: 116 EGQI-AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 174
Query: 76  KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               G  +   W APE      +    D+WS GI   EM   G+ PY
Sbjct: 175 SXMVGTPY---WMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPY 217

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 13/103 (12%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSE 71
           LG  ++  I+G        YL+      HRD+   NIL+ SR + K+ DFG+S + ++S 
Sbjct: 106 LGKVSIAVIKG------LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 72  RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEM 114
            N +  T        + +PE      +S  SD+WS G++L EM
Sbjct: 160 ANSFVGTRS------YMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 49/107 (45%), Gaps = 11/107 (10%)
Query: 22  EGQIPAKVCRYLK-----MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY 75
           EGQI A VCR        +H +   HRD+ + NILL      K++DFG    +  E++  
Sbjct: 115 EGQI-AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 76  KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               G  +   W APE      +    D+WS GI   EM   G+ PY
Sbjct: 174 SXMVGTPY---WMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPY 216

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 49/107 (45%), Gaps = 11/107 (10%)
Query: 22  EGQIPAKVCRYLK-----MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY 75
           EGQI A VCR        +H +   HRD+ + NILL      K++DFG    +  E++  
Sbjct: 115 EGQI-AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 76  KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               G  +   W APE      +    D+WS GI   EM   G+ PY
Sbjct: 174 SEMVGTPY---WMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPY 216

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 13/103 (12%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSE 71
           LG  ++  I+G        YL+      HRD+   NIL+ SR + K+ DFG+S + ++S 
Sbjct: 106 LGKVSIAVIKG------LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 72  RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEM 114
            N +  T        + +PE      +S  SD+WS G++L EM
Sbjct: 160 ANSFVGTR------SYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 13/103 (12%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSE 71
           LG  ++  I+G        YL+      HRD+   NIL+ SR + K+ DFG+S + ++S 
Sbjct: 106 LGKVSIAVIKG------LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 72  RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEM 114
            N +  T        + +PE      +S  SD+WS G++L EM
Sbjct: 160 ANSFVGTR------SYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW---PIKWYAPESY 93
           KS  HRDL + NI L      KI DFGL+    +E++ +  +H        I W APE  
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVI 206
Query: 94  NFGR---FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                  +S  SDV++FGI L+E+ + GQ PY  +   D
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRD 244

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 53/101 (52%), Gaps = 3/101 (2%)
Query: 24  QIPAKVCRYLKM-HKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++ A  C+ L   H++   HRD+   NI++++ +  K+ DFG++RA+    N    T   
Sbjct: 137 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 196
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               ++ +PE        + SDV+S G  L+E+ + G+ P+
Sbjct: 197 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPF 236

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 53/101 (52%), Gaps = 3/101 (2%)
Query: 24  QIPAKVCRYLKM-HKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++ A  C+ L   H++   HRD+   NI++++ +  K+ DFG++RA+    N    T   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               ++ +PE        + SDV+S G  L+E+ + G+ P+
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPF 219

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVN--SERNYYKATHGGRWPIKWYAPESYN 94
           KS  HRDL + NI L   +  KI DFGL+   +  S  + ++   G    I W APE   
Sbjct: 127 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGS---ILWMAPEVIR 183
Query: 95  FGR---FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                 +S  SDV++FGI L+E+ + GQ PY  +   D
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRD 220

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 53/101 (52%), Gaps = 3/101 (2%)
Query: 24  QIPAKVCRYLKM-HKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++ A  C+ L   H++   HRD+   NI++++ +  K+ DFG++RA+    N    T   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               ++ +PE        + SDV+S G  L+E+ + G+ P+
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPF 219

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 53/101 (52%), Gaps = 3/101 (2%)
Query: 24  QIPAKVCRYLKM-HKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++ A  C+ L   H++   HRD+   NI++++ +  K+ DFG++RA+    N    T   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               ++ +PE        + SDV+S G  L+E+ + G+ P+
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPF 219

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 53/101 (52%), Gaps = 3/101 (2%)
Query: 24  QIPAKVCRYLKM-HKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++ A  C+ L   H++   HRD+   NI++++ +  K+ DFG++RA+    N    T   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               ++ +PE        + SDV+S G  L+E+ + G+ P+
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPF 219

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 4/86 (4%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRD+ A NILL +   AK++DFG++  +           G  +   W APE      ++
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPF---WMAPEVIQEIGYN 203
Query: 100 SASDVWSFGITLWEMYSFGQQPYGEM 125
             +D+WS GIT  EM   G+ PY ++
Sbjct: 204 CVADIWSLGITAIEMAE-GKPPYADI 228

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 49/98 (50%), Gaps = 9/98 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVN--SERNYYKATHGGRWPIKWYAPESYN 94
           KS  HRDL + NI L      KI DFGL+   +  S  + ++   G    I W APE   
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS---ILWMAPEVIR 179
Query: 95  FGR---FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                 +S  SDV++FGI L+E+ + GQ PY  +   D
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRD 216

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 49/98 (50%), Gaps = 9/98 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVN--SERNYYKATHGGRWPIKWYAPESYN 94
           KS  HRDL + NI L      KI DFGL+   +  S  + ++   G    I W APE   
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS---ILWMAPEVIR 179
Query: 95  FGR---FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                 +S  SDV++FGI L+E+ + GQ PY  +   D
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRD 216

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 47/84 (55%), Gaps = 3/84 (3%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRD+  +NIL+ S    KI DFG+++A+ SE +  +  H     +++++PE        
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNH-VLGTVQYFSPEQAKGEATD 190
Query: 100 SASDVWSFGITLWEMYSFGQQPYG 123
             +D++S GI L+EM   G+ P+ 
Sbjct: 191 ECTDIYSIGIVLYEML-VGEPPFN 213

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 49/98 (50%), Gaps = 9/98 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVN--SERNYYKATHGGRWPIKWYAPESYN 94
           KS  HRDL + NI L      KI DFGL+   +  S  + ++   G    I W APE   
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS---ILWMAPEVIR 184
Query: 95  FGR---FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                 +S  SDV++FGI L+E+ + GQ PY  +   D
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRD 221

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 13/103 (12%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSE 71
           LG  ++  I+G        YL+      HRD+   NIL+ SR + K+ DFG+S + ++  
Sbjct: 109 LGKVSIAVIKG------LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEM 162
Query: 72  RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEM 114
            N +  T        + +PE      +S  SD+WS G++L EM
Sbjct: 163 ANEFVGTR------SYMSPERLQGTHYSVQSDIWSMGLSLVEM 199

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 49/98 (50%), Gaps = 9/98 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVN--SERNYYKATHGGRWPIKWYAPESYN 94
           KS  HRDL + NI L      KI DFGL+   +  S  + ++   G    I W APE   
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS---ILWMAPEVIR 181
Query: 95  FGR---FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                 +S  SDV++FGI L+E+ + GQ PY  +   D
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRD 218

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 49/98 (50%), Gaps = 9/98 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVN--SERNYYKATHGGRWPIKWYAPESYN 94
           KS  HRDL + NI L      KI DFGL+   +  S  + ++   G    I W APE   
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS---ILWMAPEVIR 184
Query: 95  FGR---FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                 +S  SDV++FGI L+E+ + GQ PY  +   D
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRD 221

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 49/98 (50%), Gaps = 9/98 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVN--SERNYYKATHGGRWPIKWYAPESYN 94
           KS  HRDL + NI L      KI DFGL+   +  S  + ++   G    I W APE   
Sbjct: 150 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS---ILWMAPEVIR 206
Query: 95  FGR---FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                 +S  SDV++FGI L+E+ + GQ PY  +   D
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRD 243

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 49/98 (50%), Gaps = 9/98 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVN--SERNYYKATHGGRWPIKWYAPESYN 94
           KS  HRDL + NI L      KI DFGL+   +  S  + ++   G    I W APE   
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS---ILWMAPEVIR 207
Query: 95  FGR---FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                 +S  SDV++FGI L+E+ + GQ PY  +   D
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRD 244

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 49/107 (45%), Gaps = 11/107 (10%)
Query: 22  EGQIPAKVCRYLK-----MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY 75
           EGQI A VCR        +H +   HR++ + NILL      K++DFG    +  E++  
Sbjct: 116 EGQI-AAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 174
Query: 76  KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               G  +   W APE      +    D+WS GI   EM   G+ PY
Sbjct: 175 STMVGTPY---WMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPY 217

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 26/93 (27%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 27  AKVCRYLK-MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWP 84
            ++C  LK +H +   HRD+ ++NI L      ++ DFG++R +NS     +A  G  + 
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY- 190
Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
             + +PE      +++ SD+W+ G  L+E+ + 
Sbjct: 191 --YLSPEICENKPYNNKSDIWALGCVLYELCTL 221

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRD+ + +ILL S  + K+SDFG    V+ E    K   G  +   W APE  +   + 
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPY---WMAPEVISRLPYG 219
Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
           +  D+WS GI + EM   G+ PY
Sbjct: 220 TEVDIWSLGIMVIEMID-GEPPY 241

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 45/79 (56%), Gaps = 6/79 (7%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW--PIKWYAPESYNFGR 97
            HRD+ + NILL     AKISDFGL+RA  SE+ + +     R      + APE+   G 
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARA--SEK-FAQTVMXSRIVGTTAYMAPEALR-GE 210
Query: 98  FSSASDVWSFGITLWEMYS 116
            +  SD++SFG+ L E+ +
Sbjct: 211 ITPKSDIYSFGVVLLEIIT 229

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 45/96 (46%), Gaps = 2/96 (2%)
Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAP 90
           YLK      HRD+   NILL  R Q K+ DFG+S R V+ +     A        +   P
Sbjct: 139 YLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDP 198
Query: 91  ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
                  +   +DVWS GI+L E+ + GQ PY   K
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELAT-GQFPYKNCK 233

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 45/79 (56%), Gaps = 6/79 (7%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW--PIKWYAPESYNFGR 97
            HRD+ + NILL     AKISDFGL+RA  SE+ + +     R      + APE+   G 
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARA--SEK-FAQTVMXXRIVGTTAYMAPEALR-GE 210
Query: 98  FSSASDVWSFGITLWEMYS 116
            +  SD++SFG+ L E+ +
Sbjct: 211 ITPKSDIYSFGVVLLEIIT 229

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 45/79 (56%), Gaps = 6/79 (7%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW--PIKWYAPESYNFGR 97
            HRD+ + NILL     AKISDFGL+RA  SE+ + +     R      + APE+   G 
Sbjct: 149 IHRDIKSANILLDEAFTAKISDFGLARA--SEK-FAQXVMXXRIVGTTAYMAPEALR-GE 204
Query: 98  FSSASDVWSFGITLWEMYS 116
            +  SD++SFG+ L E+ +
Sbjct: 205 ITPKSDIYSFGVVLLEIIT 223

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 45/79 (56%), Gaps = 6/79 (7%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW--PIKWYAPESYNFGR 97
            HRD+ + NILL     AKISDFGL+RA  SE+ + +     R      + APE+   G 
Sbjct: 146 IHRDIKSANILLDEAFTAKISDFGLARA--SEK-FAQXVXXSRIVGTTAYXAPEALR-GE 201
Query: 98  FSSASDVWSFGITLWEMYS 116
            +  SD++SFG+ L E+ +
Sbjct: 202 ITPKSDIYSFGVVLLEIIT 220

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRD+ + +ILL    + K+SDFG    ++ +    K   G  +   W APE  +   ++
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPY---WMAPEVISRSLYA 219
Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
           +  D+WS GI + EM   G+ PY
Sbjct: 220 TEVDIWSLGIMVIEMVD-GEPPY 241

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 35  MHKS-SFHRDLAARNILLASRHQAKISDFGLSRAV----NSERNYYKATHGGRWPIKWYA 89
           +HK+   HRD+ A NILL      +I+DFG+S  +    +  RN  + T  G  P  W A
Sbjct: 132 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT-PC-WMA 189
Query: 90  PESYNFGR-FSSASDVWSFGITLWEMYSFGQQPY 122
           PE     R +   +D+WSFGIT  E+ + G  PY
Sbjct: 190 PEVMEQVRGYDFKADIWSFGITAIELAT-GAAPY 222

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 9/86 (10%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH---GGRWPIKWYAPESYNFG 96
            HRD+ A NILL    +A + DFGL++ ++     YK  H     R  I   APE  + G
Sbjct: 164 IHRDVKAANILLDEEFEAVVGDFGLAKLMD-----YKDXHVXXAVRGTIGHIAPEYLSTG 218
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
           + S  +DV+ +G+ L E+ + GQ+ +
Sbjct: 219 KSSEKTDVFGYGVMLLELIT-GQRAF 243

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 9/86 (10%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH---GGRWPIKWYAPESYNFG 96
            HRD+ A NILL    +A + DFGL++ ++     YK  H     R  I   APE  + G
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLAKLMD-----YKDXHVXXAVRGXIGHIAPEYLSTG 210
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
           + S  +DV+ +G+ L E+ + GQ+ +
Sbjct: 211 KSSEKTDVFGYGVMLLELIT-GQRAF 235

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           ++  HRD+ + NILL      KI+DFG+S+   +E +        +  + +  PE +  G
Sbjct: 158 RAIIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHLXXVVKGTLGYIDPEYFIKG 216
Query: 97  RFSSASDVWSFGITLWEM 114
           R +  SDV+SFG+ L+E+
Sbjct: 217 RLTEKSDVYSFGVVLFEV 234

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRD+ + +ILL    + K+SDFG    V+ E    K   G  +   W APE  +   + 
Sbjct: 192 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY---WMAPELISRLPYG 248
Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
              D+WS GI + EM   G+ PY
Sbjct: 249 PEVDIWSLGIMVIEMVD-GEPPY 270

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 35  MHKS-SFHRDLAARNILLASRHQAKISDFGLSRAV----NSERNYYKATHGGRWPIKWYA 89
           +HK+   HRD+ A NILL      +I+DFG+S  +    +  RN  + T  G  P  W A
Sbjct: 137 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT-PC-WMA 194
Query: 90  PESYNFGR-FSSASDVWSFGITLWEMYSFGQQPY 122
           PE     R +   +D+WSFGIT  E+ + G  PY
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELAT-GAAPY 227

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 37  KSSFHRDLAARNILL-ASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K+  HRDL   N+LL A     KI DFG +  + +     K +        W APE +  
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAA------WMAPEVFEG 178
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKG 127
             +S   DV+S+GI LWE+ +  ++P+ E+ G
Sbjct: 179 SNYSEKCDVFSWGIILWEVIT-RRKPFDEIGG 209

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 37  KSSFHRDLAARNILL-ASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K+  HRDL   N+LL A     KI DFG +  + +     K +        W APE +  
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAA------WMAPEVFEG 177
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEMKG 127
             +S   DV+S+GI LWE+ +  ++P+ E+ G
Sbjct: 178 SNYSEKCDVFSWGIILWEVIT-RRKPFDEIGG 208

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRD+ + +ILL    + K+SDFG    V+ E    K   G  +   W APE  +   + 
Sbjct: 149 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY---WMAPELISRLPYG 205
Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
              D+WS GI + EM   G+ PY
Sbjct: 206 PEVDIWSLGIMVIEMVD-GEPPY 227

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRD+ + +ILL    + K+SDFG    V+ E    K   G  +   W APE  +   + 
Sbjct: 142 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY---WMAPELISRLPYG 198
Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
              D+WS GI + EM   G+ PY
Sbjct: 199 PEVDIWSLGIMVIEMVD-GEPPY 220

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRD+ + +ILL    + K+SDFG    V+ E    K   G  +   W APE  +   + 
Sbjct: 147 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY---WMAPELISRLPYG 203
Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
              D+WS GI + EM   G+ PY
Sbjct: 204 PEVDIWSLGIMVIEMVD-GEPPY 225

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 5/96 (5%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K+  HRD+ + NI L      KI DFGL+  V S  +  +        + W APE     
Sbjct: 151 KNIIHRDMKSNNIFLHEGLTVKIGDFGLA-TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209
Query: 97  R---FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
               FS  SDV+S+GI L+E+ + G+ PY  +   D
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMT-GELPYSHINNRD 244

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRD+ + +ILL    + K+SDFG    V+ E    K   G  +   W APE  +   + 
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY---WMAPELISRLPYG 194
Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
              D+WS GI + EM   G+ PY
Sbjct: 195 PEVDIWSLGIMVIEMVD-GEPPY 216

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+  R Q K+ DFGL+RA     N + +     W   + AP+     R +
Sbjct: 130 LHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW---YRAPDVLMGSRTY 186
Query: 99  SSASDVWSFGITLWEMYS 116
           S++ D+WS G  L EM +
Sbjct: 187 STSIDIWSCGCILAEMIT 204

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 47/84 (55%), Gaps = 6/84 (7%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSR-AVNSERNYYKATHGGRWPIKWYAPESYNFGRF 98
            +RDL   NILL      K++DFGLS+ A++ E+  Y         +++ APE  N    
Sbjct: 152 IYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC----GTVEYMAPEVVNRQGH 207
Query: 99  SSASDVWSFGITLWEMYSFGQQPY 122
           S ++D WS+G+ ++EM + G  P+
Sbjct: 208 SHSADWWSYGVLMFEMLT-GSLPF 230

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 6/84 (7%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSR-AVNSERNYYKATHGGRWPIKWYAPESYNFGRF 98
            +RDL   NILL      K++DFGLS+ +++ E+  Y         +++ APE  N    
Sbjct: 149 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC----GTVEYMAPEVVNRRGH 204
Query: 99  SSASDVWSFGITLWEMYSFGQQPY 122
           + ++D WSFG+ ++EM + G  P+
Sbjct: 205 TQSADWWSFGVLMFEMLT-GTLPF 227

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 6/84 (7%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSR-AVNSERNYYKATHGGRWPIKWYAPESYNFGRF 98
            +RDL   NILL      K++DFGLS+ +++ E+  Y         +++ APE  N    
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC----GTVEYMAPEVVNRRGH 203
Query: 99  SSASDVWSFGITLWEMYSFGQQPY 122
           + ++D WSFG+ ++EM + G  P+
Sbjct: 204 TQSADWWSFGVLMFEMLT-GTLPF 226

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 43/78 (55%), Gaps = 1/78 (1%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           ++  HRD+ + NILL      KI+DFG+S+   +E          +  + +  PE +  G
Sbjct: 158 RAIIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHLXXVVKGTLGYIDPEYFIKG 216
Query: 97  RFSSASDVWSFGITLWEM 114
           R +  SDV+SFG+ L+E+
Sbjct: 217 RLTEKSDVYSFGVVLFEV 234

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 6/84 (7%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSR-AVNSERNYYKATHGGRWPIKWYAPESYNFGRF 98
            +RDL   NILL      K++DFGLS+ +++ E+  Y         +++ APE  N    
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC----GTVEYMAPEVVNRRGH 203
Query: 99  SSASDVWSFGITLWEMYSFGQQPY 122
           + ++D WSFG+ ++EM + G  P+
Sbjct: 204 TQSADWWSFGVLMFEMLT-GTLPF 226

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 29  VC--RYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           +C   Y   HK   HRDL   N+LL      KI+DFGLS  + ++ N+ K + G      
Sbjct: 118 ICAIEYCHRHKI-VHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFLKTSCGSP---N 172
Query: 87  WYAPESYNFGRFSSAS-DVWSFGITLWEMYSFGQQPYGE 124
           + APE  N   ++    DVWS GI L+ M   G+ P+ +
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVML-VGRLPFDD 210

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 44/94 (46%), Gaps = 10/94 (10%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK--------ATHGGRWPIKWY 88
           K   HRDL   NI        K+ DFGL  A++ +             ATH G+   K Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLY 242
Query: 89  -APESYNFGRFSSASDVWSFGITLWE-MYSFGQQ 120
            +PE  +   +S   D++S G+ L+E +YSF  Q
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERN---YYKATHGGR 82
           ++ R LK +H ++  HRDL   N+L+ +    KI DFGL+R  + E +   +       R
Sbjct: 152 QILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 83  WPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
           W   + APE   N   ++ + D+WS G  L EM S
Sbjct: 212 W---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 152 QILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT- 210
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 211 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 132 QILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT- 190
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 191 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 132 QILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT- 190
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 191 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT- 194
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 195 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT- 194
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 195 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 134 QILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT- 192
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 193 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 8/84 (9%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAV------NSERNYYKATHGGRWPIKWY-APES 92
            HRDL   N+L+ S    K+ DFGL+R +      NSE    ++        +WY APE 
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEV 193
Query: 93  -YNFGRFSSASDVWSFGITLWEMY 115
                ++S A DVWS G  L E++
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 152 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT- 210
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 211 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 132 QILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVAT- 190
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 191 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 140 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT- 198
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 199 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 231

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 132 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT- 190
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 191 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 10/89 (11%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNS---ERNYYKATHGGRWPIKWYAPESYNFG 96
            HRD+ A N+LL+ +   K++DFG++  +     +RN +  T     P  W APE     
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGT-----PF-WMAPEVIKQS 191
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            +   +D+WS GIT  E+   G+ P  ++
Sbjct: 192 AYDFKADIWSLGITAIELAK-GEPPNSDL 219

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 134 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT- 192
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 193 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 134 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT- 192
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 193 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 132 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT- 190
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 191 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERN---YYKATHGGR 82
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + +   +       R
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 195
Query: 83  WPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
           W   + APE   N   ++ + D+WS G  L EM S
Sbjct: 196 W---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 43/84 (51%), Gaps = 13/84 (15%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATHGGRWPIKWYAPE-S 92
            HRDL   N+LL +    KI DFGL+R  + + ++      Y AT   RW   + APE  
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT---RW---YRAPEIM 203
Query: 93  YNFGRFSSASDVWSFGITLWEMYS 116
            N   ++ + D+WS G  L EM S
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERN---YYKATHGGR 82
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + +   +       R
Sbjct: 137 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 196
Query: 83  WPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
           W   + APE   N   ++ + D+WS G  L EM S
Sbjct: 197 W---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 137 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT- 195
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 196 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 138 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT- 196
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 197 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 229

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 129 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT- 187
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 188 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 220

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT- 194
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 195 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT- 194
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 195 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 130 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT- 188
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 189 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATH 79
           ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT 
Sbjct: 130 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT- 188
Query: 80  GGRWPIKWYAPE-SYNFGRFSSASDVWSFGITLWEMYS 116
             RW   + APE   N   ++ + D+WS G  L EM S
Sbjct: 189 --RW---YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 50/101 (49%), Gaps = 11/101 (10%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPI 85
            K   +LK +    HRD+   NILL      K+ DFG+S + V+S     K    G  P 
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRP- 190
Query: 86  KWYAPESYNFGR----FSSASDVWSFGITLWEMYSFGQQPY 122
            + APE  +       +   SDVWS GITL+E+ + G+ PY
Sbjct: 191 -YMAPERIDPSASRQGYDVRSDVWSLGITLYELAT-GRFPY 229

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 40/86 (46%), Gaps = 11/86 (12%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSE-------RNYYKATHGGRWPIK----WY 88
            HRDL + N L+       ++DFGL+R +  E       R+  K     R+ +     W 
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 89  APESYNFGRFSSASDVWSFGITLWEM 114
           APE  N   +    DV+SFGI L E+
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 8/84 (9%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAV------NSERNYYKATHGGRWPIKWY-APES 92
            HRDL   N+L+ S    K+ DFGL+R +      NSE    ++        +WY APE 
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEV 193
Query: 93  -YNFGRFSSASDVWSFGITLWEMY 115
                ++S A DVWS G  L E++
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 39/77 (50%), Gaps = 6/77 (7%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG--R 97
            HRDL  +N+L+  R + K++DFGL+RA    ++    T+       WY P     G   
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARA----KSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 98  FSSASDVWSFGITLWEM 114
           +S+  D+W  G   +EM
Sbjct: 178 YSTQIDMWGVGCIFYEM 194

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 13/92 (14%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APES-YNFGR 97
            HRDL   N+ +    + KI DFGL+R  +SE         G    +WY APE   N+ R
Sbjct: 150 IHRDLKPGNLAVNEDCELKILDFGLARQADSEMX-------GXVVTRWYRAPEVILNWMR 202
Query: 98  FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ++   D+WS G  + EM + G+  +   KGSD
Sbjct: 203 YTQTVDIWSVGCIMAEMIT-GKTLF---KGSD 230

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 13/102 (12%)
Query: 21  IEGQIPAKVCRYLK-MHK--SSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYK 76
           I G+I   + + L+ +H   S  HRD+   N+L+ +  Q K+ DFG+S   V+S     K
Sbjct: 154 ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDS---VAK 210
Query: 77  ATHGGRWPIKWYAPE----SYNFGRFSSASDVWSFGITLWEM 114
               G  P  + APE      N   +S  SD+WS GIT+ E+
Sbjct: 211 TIDAGCKP--YMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 11/101 (10%)
Query: 21  IEGQIPAKVCRYLK-MHK--SSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA 77
           I G+I   + + L+ +H   S  HRD+   N+L+ +  Q K+ DFG+S  +    +  K 
Sbjct: 110 ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKD 167
Query: 78  THGGRWPIKWYAPE----SYNFGRFSSASDVWSFGITLWEM 114
              G  P  + APE      N   +S  SD+WS GIT+ E+
Sbjct: 168 IDAGCKP--YMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 7/90 (7%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           ++   HRD+   N+L+      KI+DFG+S            T G      + APES + 
Sbjct: 155 YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTP---AFMAPESLSE 211
Query: 96  GR--FS-SASDVWSFGITLWEMYSFGQQPY 122
            R  FS  A DVW+ G+TL+  + FGQ P+
Sbjct: 212 TRKIFSGKALDVWAMGVTLY-CFVFGQCPF 240

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 182
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 183
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 210

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 182
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 183
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 210

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 182
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 183
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 183
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 183
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 210

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 182
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 182
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 209

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 183
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 210

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 182
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 181
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 208

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 29/82 (35%), Positives = 41/82 (50%), Gaps = 4/82 (4%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRD+ + +ILL    + K+SDFG    V+ E    K   G  +   W APE  +   +  
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY---WMAPELISRLPYGP 326
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
             D+WS GI + EM   G+ PY
Sbjct: 327 EVDIWSLGIMVIEMVD-GEPPY 347

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 182
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 209

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 8/84 (9%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAV------NSERNYYKATHGGRWPIKWY-APES 92
            HRDL   N+L+ S    K+ DFGL+R +      NSE    ++        +WY APE 
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV 193
Query: 93  -YNFGRFSSASDVWSFGITLWEMY 115
                ++S A DVWS G  L E++
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAELF 217

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX--GTLP--YVAPELLKRRE 182
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 209

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 49/105 (46%), Gaps = 16/105 (15%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP-----ESYNF 95
           HRDL ++NIL+       I+D GL+    S+ N        R   K Y P     ES N 
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224
Query: 96  GRFSS--ASDVWSFGITLWEM----YSFG-----QQPYGEMKGSD 129
             F S   +D++SFG+ LWE+     S G     Q PY ++  SD
Sbjct: 225 NHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 183
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 210

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 144 QILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVAT------- 196
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 197 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 42/85 (49%), Gaps = 3/85 (3%)
Query: 35  MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           +H++   HRD+ A N+L+      K++DFGL+RA +  +N     +  R    WY P   
Sbjct: 141 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 94  NFGR--FSSASDVWSFGITLWEMYS 116
             G   +    D+W  G  + EM++
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX--GTLP--YVAPELLKRRE 183
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 210

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/114 (33%), Positives = 51/114 (44%), Gaps = 23/114 (20%)
Query: 27  AKVCR-------YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS---ERNYYK 76
           A +CR       +L  HK   HRD+  +N+LL    + K+ DFG+S  ++     RN + 
Sbjct: 132 AYICREILRGLSHLHQHKV-IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 190
Query: 77  ATHGGRWPIKWYAPESYNFGRFSSA-----SDVWSFGITLWEMYSFGQQPYGEM 125
            T     P  W APE         A     SD+WS GIT  EM   G  P  +M
Sbjct: 191 GT-----PY-WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPPLCDM 237

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX--GTLP--YVAPELLKRRE 182
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX--GTLP--YVAPELLKRRE 182
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP--YVAPELLKRRE 182
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 41  HRDLAARNILLASRHQAKISDFGLS---RAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+LL  R   KISDFGL+   R  N ER   K    G  P  + APE      
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX--GTLP--YVAPELLKRRE 182
Query: 98  F-SSASDVWSFGITLWEMYSFGQQPYGE 124
           F +   DVWS GI L  M + G+ P+ +
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA-GELPWDQ 209

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVAT------- 187
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 27  AKVCRYLK-MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWP 84
           A+VC  L+ +H K   +RDL   NILL      KI+DFG ++ V         T+     
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYXLCGT 166
Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             + APE  +   ++ + D WSFGI ++EM + G  P+
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPF 203

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVAT------- 190
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVAT------- 190
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVAT------- 191
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 42/85 (49%), Gaps = 3/85 (3%)
Query: 35  MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           +H++   HRD+ A N+L+      K++DFGL+RA +  +N     +  R    WY P   
Sbjct: 141 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 94  NFGR--FSSASDVWSFGITLWEMYS 116
             G   +    D+W  G  + EM++
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 42/85 (49%), Gaps = 3/85 (3%)
Query: 35  MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           +H++   HRD+ A N+L+      K++DFGL+RA +  +N     +  R    WY P   
Sbjct: 141 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 94  NFGR--FSSASDVWSFGITLWEMYS 116
             G   +    D+W  G  + EM++
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/79 (30%), Positives = 38/79 (48%), Gaps = 2/79 (2%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-- 97
            HRD+ A N+L+      K++DFGL+RA +  +N     +  R    WY P     G   
Sbjct: 146 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERD 205
Query: 98  FSSASDVWSFGITLWEMYS 116
           +    D+W  G  + EM++
Sbjct: 206 YGPPIDLWGAGCIMAEMWT 224

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 152 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 204
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 205 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 153 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 205
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 153 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 205
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 156 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 208
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 152 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 204
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 205 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 187
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 145 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 197
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 144 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 196
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 197 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 145 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 197
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 145 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 197
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 187
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 187
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 190
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 132 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 184
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 185 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 191
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 192
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 190
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 143 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 195
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 196 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 131 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 183
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 181
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 130 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 182
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 183 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 41/79 (51%), Gaps = 9/79 (11%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERN-YYKATHGGRWPIKWY-APE-SYNFGR 97
           HRDL   NILLA  +   I DF L+R   ++ N  +  TH      +WY APE    F  
Sbjct: 157 HRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH------RWYRAPELVMQFKG 210
Query: 98  FSSASDVWSFGITLWEMYS 116
           F+   D+WS G  + EM++
Sbjct: 211 FTKLVDMWSAGCVMAEMFN 229

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 181
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 181
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 130 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 182
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 183 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 191
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 41/79 (51%), Gaps = 9/79 (11%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERN-YYKATHGGRWPIKWY-APE-SYNFGR 97
           HRDL   NILLA  +   I DF L+R   ++ N  +  TH      +WY APE    F  
Sbjct: 157 HRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH------RWYRAPELVMQFKG 210
Query: 98  FSSASDVWSFGITLWEMYS 116
           F+   D+WS G  + EM++
Sbjct: 211 FTKLVDMWSAGCVMAEMFN 229

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 7/102 (6%)
Query: 27  AKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWP 84
           A++C  L+ +H+    +RDL   NILL      +ISD GL+  V  E    K   G    
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVG---T 348
Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
           + + APE     R++ + D W+ G  L+EM + GQ P+ + K
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRK 389

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 191
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 156 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVAT------- 208
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-AP 90
           +L  H+   HRDL  +NIL+ S  Q K++DFGL+R  +     ++          WY AP
Sbjct: 135 FLHSHRV-VHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMALTSVVVTLWYRAP 188
Query: 91  ESYNFGRFSSASDVWSFGITLWEMY 115
           E      +++  D+WS G    EM+
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-AP 90
           +L  H+   HRDL  +NIL+ S  Q K++DFGL+R  +     ++          WY AP
Sbjct: 135 FLHSHRV-VHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMALTSVVVTLWYRAP 188
Query: 91  ESYNFGRFSSASDVWSFGITLWEMY 115
           E      +++  D+WS G    EM+
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-AP 90
           +L  H+   HRDL  +NIL+ S  Q K++DFGL+R  +     ++          WY AP
Sbjct: 135 FLHSHRV-VHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMALTSVVVTLWYRAP 188
Query: 91  ESYNFGRFSSASDVWSFGITLWEMY 115
           E      +++  D+WS G    EM+
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 7/85 (8%)
Query: 41  HRDLAARNILLASRH---QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRDL   N+L    +   + KI DFG +R    +    K      + + + APE  N   
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP---CFTLHYAAPELLNQNG 185
Query: 98  FSSASDVWSFGITLWEMYSFGQQPY 122
           +  + D+WS G+ L+ M S GQ P+
Sbjct: 186 YDESCDLWSLGVILYTMLS-GQVPF 209

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N   ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 7/102 (6%)
Query: 27  AKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWP 84
           A++C  L+ +H+    +RDL   NILL      +ISD GL+  V  E    K   G    
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVG---T 348
Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
           + + APE     R++ + D W+ G  L+EM + GQ P+ + K
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRK 389

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 9/77 (11%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE-SYNFGR 97
            HRDL   N+ +    + +I DFGL+R  + E   Y AT       +WY APE   N+  
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVAT-------RWYRAPEIMLNWMH 205
Query: 98  FSSASDVWSFGITLWEM 114
           ++   D+WS G  + E+
Sbjct: 206 YNQTVDIWSVGCIMAEL 222

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 9/77 (11%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE-SYNFGR 97
            HRDL   N+ +    + +I DFGL+R  + E   Y AT       +WY APE   N+  
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVAT-------RWYRAPEIMLNWMH 205
Query: 98  FSSASDVWSFGITLWEM 114
           ++   D+WS G  + E+
Sbjct: 206 YNQTVDIWSVGCIMAEL 222

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 132 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW---YRAPEILLGCKYY 188
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 189 STAVDIWSLGCIFAEMVT 206

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 184
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 185 STAVDIWSLGCIFAEMVT 202

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 184
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 185 STAVDIWSLGCIFAEMVT 202

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 132 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW---YRAPEILLGXKYY 188
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 189 STAVDIWSLGCIFAEMVT 206

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 129 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 185
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 186 STAVDIWSLGCIFAEMVT 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 183
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 184 STAVDIWSLGCIFAEMVT 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW---YRAPEILLGCKYY 181
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW---YRAPEILLGCKYY 182
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 183 STAVDIWSLGCIFAEMVT 200

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 184
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 185 STAVDIWSLGCIFAEMVT 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 184
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 185 STAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 183
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 184 STAVDIWSLGCIFAEMVT 201

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW---YRAPEILLGCKYY 181
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW---YRAPEILLGCKYY 181
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW---YRAPEILLGCKYY 180
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 181 STAVDIWSLGCIFAEMVT 198

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW---YRAPEILLGCKYY 180
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 181 STAVDIWSLGCIFAEMVT 198

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 129 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW---YRAPEILLGCKYY 185
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 186 STAVDIWSLGCIFAEMVT 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 182
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 183 STAVDIWSLGCIFAEMVT 200

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 183
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 184 STAVDIWSLGCIFAEMVT 201

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 184
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 185 STAVDIWSLGCIFAEMVT 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW---YRAPEILLGCKYY 181
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 181
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW---YRAPEILLGCKYY 180
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 181 STAVDIWSLGCIFAEMVT 198

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 180
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 181 STAVDIWSLGCIFAEMVT 198

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 181
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 181
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW---YRAPEILLGCKYY 180
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 181 STAVDIWSLGCIFAEMVT 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 182
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 183 STAVDIWSLGCIFAEMVT 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 180
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 181 STAVDIWSLGCIFAEMVT 198

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 40/80 (50%), Gaps = 6/80 (7%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           ++  HRDL  +N+L+    + K++DFGL+RA       Y A         WY P    FG
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA----EVVTLWYRPPDVLFG 175
Query: 97  --RFSSASDVWSFGITLWEM 114
              +S++ D+WS G    E+
Sbjct: 176 AKLYSTSIDMWSAGCIFAEL 195

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW---YRAPEILLGXKYY 181
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 9/77 (11%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE-SYNFGR 97
            HRDL   N+ +    + +I DFGL+R  + E   Y AT       +WY APE   N+  
Sbjct: 145 IHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVAT-------RWYRAPEIMLNWMH 197
Query: 98  FSSASDVWSFGITLWEM 114
           ++   D+WS G  + E+
Sbjct: 198 YNQTVDIWSVGCIMAEL 214

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 42/94 (44%), Gaps = 10/94 (10%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK--------ATHGGRWPIKWY 88
           K   HRDL   NI        K+ DFGL  A++ +             A H G+   K Y
Sbjct: 137 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLY 196
Query: 89  -APESYNFGRFSSASDVWSFGITLWE-MYSFGQQ 120
            +PE  +   +S   D++S G+ L+E +Y F  Q
Sbjct: 197 MSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQ 230

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 4/77 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY-NFGRF 98
            HRD+   NIL++     K+ DFG +R + +    Y      RW   + APE      ++
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW---YRAPELLVGDVKY 202
Query: 99  SSASDVWSFGITLWEMY 115
             A DVW+ G  + EM+
Sbjct: 203 GKAVDVWAIGCLVTEMF 219

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 7/81 (8%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFGRFS 99
           HRD  +RN+L+ S  Q  I+D GL+   +   +Y    +  R   K Y APE  +    +
Sbjct: 136 HRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRT 195
Query: 100 SA------SDVWSFGITLWEM 114
                   +D+W+FG+ LWE+
Sbjct: 196 DCFESYKWTDIWAFGLVLWEI 216

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R    E   Y AT       
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT------- 192
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 38/78 (48%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL   N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 128 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 184
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 185 STAVDIWSLGCIFAEMVT 202

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R    E   Y AT       
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT------- 192
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL  +N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 181
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 38/78 (48%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL   N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 126 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 182
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 183 STAVDIWSLGCIFAEMVT 200

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 38/78 (48%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL   N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 127 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 183
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 184 STAVDIWSLGCIFAEMVT 201

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R    E   Y AT       
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT------- 192
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 38/78 (48%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL   N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 126 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 182
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 183 STAVDIWSLGCIFAEMVT 200

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 38/78 (48%), Gaps = 4/78 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-F 98
            HRDL   N+L+ +    K++DFGL+RA       Y       W   + APE     + +
Sbjct: 125 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW---YRAPEILLGCKYY 181
Query: 99  SSASDVWSFGITLWEMYS 116
           S+A D+WS G    EM +
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 7/81 (8%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-AP----ESYNF 95
           HRDL ++NIL+    Q  I+D GL+   +   N     +  R   K Y AP    E+   
Sbjct: 165 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 224
Query: 96  GRFSS--ASDVWSFGITLWEM 114
             F S    D+W+FG+ LWE+
Sbjct: 225 DCFDSYKRVDIWAFGLVLWEV 245

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 23/80 (28%), Positives = 36/80 (45%), Gaps = 4/80 (5%)
Query: 38  SSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY-NFG 96
           +  HRD+   NIL+      K+ DFG +R +    +YY      RW   + +PE      
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW---YRSPELLVGDT 178
Query: 97  RFSSASDVWSFGITLWEMYS 116
           ++    DVW+ G    E+ S
Sbjct: 179 QYGPPVDVWAIGCVFAELLS 198

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 58/132 (43%), Gaps = 18/132 (13%)
Query: 6   GSGVVTPLGSYALPYIEGQIPAKVCR-------YLKMHKSSFHRDLAARNILLASRHQAK 58
           G  V   +     P  E QI   VC+       YL  +K   HRDL A NIL       K
Sbjct: 118 GGAVDAVMLELERPLTESQIQV-VCKQTLDALNYLHDNKI-IHRDLKAGNILFTLDGDIK 175
Query: 59  ISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-----FSSASDVWSFGITLWE 113
           ++DFG+S A N+     + +  G  P  W APE           +   +DVWS GITL E
Sbjct: 176 LADFGVS-AKNTRTIQRRDSFIGT-PY-WMAPEVVMCETSKDRPYDYKADVWSLGITLIE 232
Query: 114 MYSFGQQPYGEM 125
           M    + P+ E+
Sbjct: 233 MAEI-EPPHHEL 243

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 49/100 (49%), Gaps = 5/100 (5%)
Query: 27  AKVCRYLK-MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWP 84
            ++C  L+ MH +   HRD+   N+ + +    K+ D GL R  +S+     +  G  + 
Sbjct: 143 VQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY- 201
Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE 124
             + +PE  +   ++  SD+WS G  L+EM +     YG+
Sbjct: 202 --YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI D+GL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 58/132 (43%), Gaps = 18/132 (13%)
Query: 6   GSGVVTPLGSYALPYIEGQIPAKVCR-------YLKMHKSSFHRDLAARNILLASRHQAK 58
           G  V   +     P  E QI   VC+       YL  +K   HRDL A NIL       K
Sbjct: 118 GGAVDAVMLELERPLTESQIQV-VCKQTLDALNYLHDNKI-IHRDLKAGNILFTLDGDIK 175
Query: 59  ISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-----FSSASDVWSFGITLWE 113
           ++DFG+S A N+     + +  G  P  W APE           +   +DVWS GITL E
Sbjct: 176 LADFGVS-AKNTRXIQRRDSFIGT-PY-WMAPEVVMCETSKDRPYDYKADVWSLGITLIE 232
Query: 114 MYSFGQQPYGEM 125
           M    + P+ E+
Sbjct: 233 MAEI-EPPHHEL 243

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYA 89
             Y   HK   HRDL   N+LL      KI+DFGLS  + ++ N+ K + G      + A
Sbjct: 120 VEYCHRHKI-VHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKTSCGSP---NYAA 174
Query: 90  PESYNFGRFSSAS-DVWSFGITLWEM 114
           PE  +   ++    DVWS G+ L+ M
Sbjct: 175 PEVISGKLYAGPEVDVWSCGVILYVM 200

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NI L    Q KI DFGL   V S +N  K T   +  +++ +PE  +  
Sbjct: 155 KKLIHRDLKPSNIFLVDTKQVKIGDFGL---VTSLKNDGKRTR-SKGTLRYMSPEQISSQ 210
Query: 97  RFSSASDVWSFGITLWEM 114
            +    D+++ G+ L E+
Sbjct: 211 DYGKEVDLYALGLILAEL 228

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYA 89
             Y   HK   HRDL   N+LL      KI+DFGLS  + ++ N+ K + G      + A
Sbjct: 116 VEYCHRHKI-VHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKTSCGSP---NYAA 170
Query: 90  PESYNFGRFSSAS-DVWSFGITLWEM 114
           PE  +   ++    DVWS G+ L+ M
Sbjct: 171 PEVISGKLYAGPEVDVWSCGVILYVM 196

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 14/101 (13%)
Query: 35  MHKSSF-HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           MHK +  HRDL   NILL S+ +    KI DFGLS     +    K   G  +   + AP
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAY---YIAP 192
Query: 91  ESYNFGRFSSASDVWSFGITLWEMYS-----FGQQPYGEMK 126
           E    G +    DVWS G+ L+ + S     +G+  Y  +K
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYA 89
             Y   HK   HRDL   N+LL      KI+DFGLS  + ++ N+ K + G      + A
Sbjct: 126 VEYCHRHKI-VHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKTSCGSP---NYAA 180
Query: 90  PESYNFGRFSSAS-DVWSFGITLWEM 114
           PE  +   ++    DVWS G+ L+ M
Sbjct: 181 PEVISGKLYAGPEVDVWSCGVILYVM 206

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 6/85 (7%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           ++  HRDL  +N+L+    + K+++FGL+RA       Y A         WY P    FG
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA----EVVTLWYRPPDVLFG 175
Query: 97  --RFSSASDVWSFGITLWEMYSFGQ 119
              +S++ D+WS G    E+ + G+
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 44/86 (51%), Gaps = 11/86 (12%)
Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL  H +  HRD+ A NILL+     K+ DFG S ++ +  N +  T        W APE
Sbjct: 169 YLHSH-NMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXFVGTP------YWMAPE 220
Query: 92  ---SYNFGRFSSASDVWSFGITLWEM 114
              + + G++    DVWS GIT  E+
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 43/93 (46%), Gaps = 5/93 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYA 89
           C+YL  ++   HRDL   N+ L    + KI DFGL+  V  +    K   G      + A
Sbjct: 154 CQYLHRNRV-IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP---NYIA 209
Query: 90  PESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           PE  +    S   DVWS G  ++ +   G+ P+
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPF 241

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 14/101 (13%)
Query: 35  MHKSSF-HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           MHK +  HRDL   NILL S+ +    KI DFGLS     +    K   G  +   + AP
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAY---YIAP 192
Query: 91  ESYNFGRFSSASDVWSFGITLWEMYS-----FGQQPYGEMK 126
           E    G +    DVWS G+ L+ + S     +G+  Y  +K
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 21  IEGQIPAKVCRYLK-MHK--SSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA 77
           I G+I   + + L+ +H   S  HRD+   N+L+ +  Q K  DFG+S  +    +  K 
Sbjct: 137 ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVD--DVAKD 194
Query: 78  THGGRWPIKWYAPE----SYNFGRFSSASDVWSFGITLWEM 114
              G  P  + APE      N   +S  SD+WS GIT  E+
Sbjct: 195 IDAGCKP--YXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 7/81 (8%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-AP----ESYNF 95
           HRDL ++NIL+    Q  I+D GL+   +   N     +  R   K Y AP    E+   
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 96  GRFSS--ASDVWSFGITLWEM 114
             F S    D+W+FG+ LWE+
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEV 216

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYA 89
             Y   HK   HRDL   N+LL      KI+DFGLS  + ++ N+ K + G      + A
Sbjct: 125 VEYCHRHKI-VHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKTSCGSP---NYAA 179
Query: 90  PESYNFGRFSSAS-DVWSFGITLWEM 114
           PE  +   ++    DVWS G+ L+ M
Sbjct: 180 PEVISGKLYAGPEVDVWSCGVILYVM 205

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 7/81 (8%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-AP----ESYNF 95
           HRDL ++NIL+    Q  I+D GL+   +   N     +  R   K Y AP    E+   
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 96  GRFSS--ASDVWSFGITLWEM 114
             F S    D+W+FG+ LWE+
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEV 216

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 43/93 (46%), Gaps = 5/93 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYA 89
           C+YL  ++   HRDL   N+ L    + KI DFGL+  V  +    K   G      + A
Sbjct: 152 CQYLHRNRV-IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP---NYIA 207
Query: 90  PESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           PE  +    S   DVWS G  ++ +   G+ P+
Sbjct: 208 PEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPF 239

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   + AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   + AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E   + AT       
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVAT------- 181
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 45/89 (50%), Gaps = 10/89 (11%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAV---NSERNYYKATHGGRWPIKWYAPESY 93
           K   +RDL   NILL      KI+DFG+ +     +++ N +  T        + APE  
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPD------YIAPEIL 190
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPY 122
              +++ + D WSFG+ L+EM   GQ P+
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEML-IGQSPF 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 43/93 (46%), Gaps = 5/93 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYA 89
           C+YL  ++   HRDL   N+ L    + KI DFGL+  V  +    K   G      + A
Sbjct: 130 CQYLHRNRV-IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP---NYIA 185
Query: 90  PESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           PE  +    S   DVWS G  ++ +   G+ P+
Sbjct: 186 PEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPF 217

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 16/93 (17%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI-----KWYAP 90
            K   HRDL A N+LL +    KI+DFG S          + T GG+         + AP
Sbjct: 129 QKRIVHRDLKAENLLLDADMNIKIADFGFSN---------EFTVGGKLDTFCGSPPYAAP 179
Query: 91  ESYNFGRFSSAS-DVWSFGITLWEMYSFGQQPY 122
           E +   ++     DVWS G+ L+ + S G  P+
Sbjct: 180 ELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPF 211

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 57/132 (43%), Gaps = 18/132 (13%)
Query: 6   GSGVVTPLGSYALPYIEGQIPAKVCR-------YLKMHKSSFHRDLAARNILLASRHQAK 58
           G  V   +     P  E QI   VC+       YL  +K   HRDL A NIL       K
Sbjct: 118 GGAVDAVMLELERPLTESQIQV-VCKQTLDALNYLHDNKI-IHRDLKAGNILFTLDGDIK 175
Query: 59  ISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-----FSSASDVWSFGITLWE 113
           ++DFG+S A N+     +    G  P  W APE           +   +DVWS GITL E
Sbjct: 176 LADFGVS-AKNTRXIQRRDXFIGT-PY-WMAPEVVMCETSKDRPYDYKADVWSLGITLIE 232
Query: 114 MYSFGQQPYGEM 125
           M    + P+ E+
Sbjct: 233 MAEI-EPPHHEL 243

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 43/93 (46%), Gaps = 5/93 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYA 89
           C+YL  ++   HRDL   N+ L    + KI DFGL+  V  +    K   G      + A
Sbjct: 130 CQYLHRNRV-IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP---NYIA 185
Query: 90  PESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           PE  +    S   DVWS G  ++ +   G+ P+
Sbjct: 186 PEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPF 217

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 43/93 (46%), Gaps = 5/93 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYA 89
           C+YL  ++   HRDL   N+ L    + KI DFGL+  V  +    K   G      + A
Sbjct: 134 CQYLHRNRV-IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP---NYIA 189
Query: 90  PESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           PE  +    S   DVWS G  ++ +   G+ P+
Sbjct: 190 PEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPF 221

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 8/86 (9%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL   N+LL +   AKI+DFGLS  + S+  + + + G      + APE  + GR  +
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSCGSP---NYAAPEVIS-GRLYA 188
Query: 101 A--SDVWSFGITLWEMYSFGQQPYGE 124
               D+WS G+ L+ +   G  P+ +
Sbjct: 189 GPEVDIWSCGVILYALLC-GTLPFDD 213

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 43/93 (46%), Gaps = 5/93 (5%)
Query: 30  CRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYA 89
           C+YL  ++   HRDL   N+ L    + KI DFGL+  V  +    K   G      + A
Sbjct: 128 CQYLHRNRV-IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP---NYIA 183
Query: 90  PESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           PE  +    S   DVWS G  ++ +   G+ P+
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPF 215

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 52/113 (46%), Gaps = 13/113 (11%)
Query: 5   NGSGVVTP--LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDF 62
           + S V+TP  + +Y L  ++G        YL  H    HRDL   N+LL      K++DF
Sbjct: 104 DNSLVLTPSHIKAYMLMTLQG------LEYLHQH-WILHRDLKPNNLLLDENGVLKLADF 156
Query: 63  GLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-FSSASDVWSFGITLWEM 114
           GL+++  S    Y      RW   + APE     R +    D+W+ G  L E+
Sbjct: 157 GLAKSFGSPNRAYXHQVVTRW---YRAPELLFGARMYGVGVDMWAVGCILAEL 206

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 7/87 (8%)
Query: 36  HKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE--- 91
           HK +  HRD+ ++N+LL +   A I+DFGL+    + ++    THG     ++ APE   
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS-AGDTHGQVGTRRYMAPEVLE 206
Query: 92  -SYNFGRFSSAS-DVWSFGITLWEMYS 116
            + NF R +    D+++ G+ LWE+ S
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 28  KVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK   S+   HRDL   N+ +    + KI DFGL+R  + E   Y AT       
Sbjct: 162 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT------- 214
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 215 RWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 55/113 (48%), Gaps = 10/113 (8%)
Query: 15  SYALPYIEGQIPAK-VCRYLK-MHKS-SFHRDLAARNILLASRH--QAKISDFGLSRAVN 69
           SY L  ++  +  K +C  ++ MH+    H DL   NIL  +R   Q KI DFGL+R   
Sbjct: 181 SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240
Query: 70  SERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             R   K   G     ++ APE  N+   S  +D+WS G+  + + S G  P+
Sbjct: 241 P-REKLKVNFGTP---EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS-GLSPF 288

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 37/76 (48%), Gaps = 6/76 (7%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFGRFS 99
           HRDL   NIL+ S    K++DFGL+R  +     Y+          WY APE      ++
Sbjct: 135 HRDLKPENILVTSGGTVKLADFGLARIYS-----YQMALAPVVVTLWYRAPEVLLQSTYA 189
Query: 100 SASDVWSFGITLWEMY 115
           +  D+WS G    EM+
Sbjct: 190 TPVDMWSVGCIFAEMF 205

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 39/82 (47%), Gaps = 6/82 (7%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDL  +N+L+    + KI+DFGL+RA       Y  TH       WY       G
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--TH--EIVTLWYRAPDVLMG 174
Query: 97  --RFSSASDVWSFGITLWEMYS 116
             ++S+  D+WS G    EM +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVN 196

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 45/89 (50%), Gaps = 10/89 (11%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAV---NSERNYYKATHGGRWPIKWYAPESY 93
           K   +RDL   NILL      KI+DFG+ +     +++ N +  T        + APE  
Sbjct: 138 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPD------YIAPEIL 191
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPY 122
              +++ + D WSFG+ L+EM   GQ P+
Sbjct: 192 LGQKYNHSVDWWSFGVLLYEML-IGQSPF 219

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 4/86 (4%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   +RDL   N++L S    KI+DFG+ +    +    K   G      + APE   + 
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTP---DYIAPEIIAYQ 196
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +  + D W+FG+ L+EM + GQ P+
Sbjct: 197 PYGKSVDWWAFGVLLYEMLA-GQAPF 221

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 44/86 (51%), Gaps = 11/86 (12%)
Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL  H +  HRD+ A NILL+     K+ DFG S ++ +  N +  T        W APE
Sbjct: 130 YLHSH-NMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXFVGTP------YWMAPE 181
Query: 92  ---SYNFGRFSSASDVWSFGITLWEM 114
              + + G++    DVWS GIT  E+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 39/82 (47%), Gaps = 6/82 (7%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDL  +N+L+    + KI+DFGL+RA       Y  TH       WY       G
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--TH--EVVTLWYRAPDVLMG 174
Query: 97  --RFSSASDVWSFGITLWEMYS 116
             ++S+  D+WS G    EM +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVN 196

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 39/82 (47%), Gaps = 6/82 (7%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   HRDL  +N+L+    + KI+DFGL+RA       Y  TH       WY       G
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--TH--EVVTLWYRAPDVLMG 174
Query: 97  --RFSSASDVWSFGITLWEMYS 116
             ++S+  D+WS G    EM +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVN 196

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 39/79 (49%), Gaps = 6/79 (7%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG--R 97
            HRDL  +N+L+ S    K++DFGL+RA       Y  TH       WY       G  +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--TH--EVVTLWYRAPDVLMGSKK 196
Query: 98  FSSASDVWSFGITLWEMYS 116
           +S++ D+WS G    EM +
Sbjct: 197 YSTSVDIWSIGCIFAEMIT 215

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 16/93 (17%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI-----KWYAP 90
            K   HRDL A N+LL +    KI+DFG S          + T GG+         + AP
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSN---------EFTVGGKLDAFCGAPPYAAP 182
Query: 91  ESYNFGRFSSAS-DVWSFGITLWEMYSFGQQPY 122
           E +   ++     DVWS G+ L+ + S G  P+
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPF 214

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 39/79 (49%), Gaps = 6/79 (7%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG--R 97
            HRDL  +N+L+ S    K++DFGL+RA       Y  TH       WY       G  +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--TH--EVVTLWYRAPDVLMGSKK 196
Query: 98  FSSASDVWSFGITLWEMYS 116
           +S++ D+WS G    EM +
Sbjct: 197 YSTSVDIWSIGCIFAEMIT 215

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 53/108 (49%), Gaps = 10/108 (9%)
Query: 15  SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY 74
           S  L Y+   +P   CR      S  HRD  ++N+LL S   A ++DFGL  AV  E   
Sbjct: 122 SRGLSYLHEDVPW--CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGL--AVRFEPGK 177
Query: 75  YKA-THGGRWPIKWYAPE----SYNFGRFSSAS-DVWSFGITLWEMYS 116
               THG     ++ APE    + NF R +    D+++ G+ LWE+ S
Sbjct: 178 PPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 37/76 (48%), Gaps = 6/76 (7%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFGRFS 99
           HRDL   NIL+ S    K++DFGL+R  + +   +           WY APE      ++
Sbjct: 135 HRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-----TLWYRAPEVLLQSTYA 189
Query: 100 SASDVWSFGITLWEMY 115
           +  D+WS G    EM+
Sbjct: 190 TPVDMWSVGCIFAEMF 205

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E     AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 42/95 (44%), Gaps = 16/95 (16%)
Query: 40  FHRDLAARNILLASRHQ--------AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
            H ++ A+NILL              K+SD G+S  V       K     R P  W  PE
Sbjct: 135 IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-----LPKDILQERIP--WVPPE 187
Query: 92  SY-NFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
              N    + A+D WSFG TLWE+ S G +P   +
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 37/76 (48%), Gaps = 6/76 (7%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFGRFS 99
           HRDL   NIL+ S    K++DFGL+R  +     Y+          WY APE      ++
Sbjct: 135 HRDLKPENILVTSGGTVKLADFGLARIYS-----YQMALDPVVVTLWYRAPEVLLQSTYA 189
Query: 100 SASDVWSFGITLWEMY 115
           +  D+WS G    EM+
Sbjct: 190 TPVDMWSVGCIFAEMF 205

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 13/91 (14%)
Query: 41  HRDLAARNILLASRHQA-KISDFGLSR---AVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           HRD+   N+L+ +     KISDFG S+    +N     +  T      +++ APE  + G
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT------LQYMAPEIIDKG 198
Query: 97  R--FSSASDVWSFGITLWEMYSFGQQPYGEM 125
              +  A+D+WS G T+ EM + G+ P+ E+
Sbjct: 199 PRGYGKAADIWSLGCTIIEMAT-GKPPFYEL 228

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 8/86 (9%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL   N+LL +   AKI+DFGLS  + S+  + + + G      + APE  + GR  +
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDSCGSP---NYAAPEVIS-GRLYA 188
Query: 101 A--SDVWSFGITLWEMYSFGQQPYGE 124
               D+WS G+ L+ +   G  P+ +
Sbjct: 189 GPEVDIWSCGVILYALLC-GTLPFDD 213

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/86 (27%), Positives = 44/86 (51%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NSFVGTAQYVSPELLTEK 209
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
             S +SD+W+ G  ++++ + G  P+
Sbjct: 210 SASKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 37/76 (48%), Gaps = 6/76 (7%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFGRFS 99
           HRDL   NIL+ S    K++DFGL+R  +     Y+          WY APE      ++
Sbjct: 143 HRDLKPENILVTSGGTVKLADFGLARIYS-----YQMALTPVVVTLWYRAPEVLLQSTYA 197
Query: 100 SASDVWSFGITLWEMY 115
           +  D+WS G    EM+
Sbjct: 198 TPVDMWSVGCIFAEMF 213

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 13/91 (14%)
Query: 41  HRDLAARNILLASRHQA-KISDFGLSR---AVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           HRD+   N+L+ +     KISDFG S+    +N     +  T      +++ APE  + G
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT------LQYMAPEIIDKG 184
Query: 97  R--FSSASDVWSFGITLWEMYSFGQQPYGEM 125
              +  A+D+WS G T+ EM + G+ P+ E+
Sbjct: 185 PRGYGKAADIWSLGCTIIEMAT-GKPPFYEL 214

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 4/82 (4%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   NILL S+    ++DFGL +  N E N   +T  G    ++ APE  +   +  
Sbjct: 162 YRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTP--EYLAPEVLHKQPYDR 218
Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
             D W  G  L+EM  +G  P+
Sbjct: 219 TVDWWCLGAVLYEML-YGLPPF 239

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 43/86 (50%), Gaps = 7/86 (8%)
Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           Y+   K+  HRD+   NIL+    + K+SDFG      SE    K   G R   ++  PE
Sbjct: 166 YIHNEKNICHRDVKPSNILMDKNGRVKLSDFG-----ESEYMVDKKIKGSRGTYEFMPPE 220
Query: 92  SY-NFGRFSSAS-DVWSFGITLWEMY 115
            + N   ++ A  D+WS GI L+ M+
Sbjct: 221 FFSNESSYNGAKVDIWSLGICLYVMF 246

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI DFGL+R  + E     AT       
Sbjct: 153 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVAT------- 205
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 41/88 (46%), Gaps = 6/88 (6%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            K   HRDL A N+LL +    KI+DFG S            T  G  P  + APE +  
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPP--YAAPELFQG 186
Query: 96  GRFSSAS-DVWSFGITLWEMYSFGQQPY 122
            ++     DVWS G+ L+ + S G  P+
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVS-GSLPF 213

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 41/88 (46%), Gaps = 6/88 (6%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            K   HRDL A N+LL +    KI+DFG S            T  G  P  + APE +  
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPP--YAAPELFQG 186
Query: 96  GRFSSAS-DVWSFGITLWEMYSFGQQPY 122
            ++     DVWS G+ L+ + S G  P+
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVS-GSLPF 213

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 10/99 (10%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAV---NSERNYYKATHGGR 82
           ++ R LK MH +   HRDL   N+L+    + KI DFG++R +    +E  Y+   +   
Sbjct: 166 QLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA- 224
Query: 83  WPIKWY-APE-SYNFGRFSSASDVWSFGITLWEMYSFGQ 119
              +WY APE   +   ++ A D+WS G    EM +  Q
Sbjct: 225 --TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 47/108 (43%), Gaps = 15/108 (13%)
Query: 29  VCRYLK-----MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           VCR +      +H K   HRDL A N+L+      +++DFG+S           +  G  
Sbjct: 114 VCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP 173
Query: 83  WPIKWYAPESYNFGRFSSA-----SDVWSFGITLWEMYSFGQQPYGEM 125
           +   W APE               +D+WS GITL EM    + P+ E+
Sbjct: 174 Y---WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI-EPPHHEL 217

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 41/88 (46%), Gaps = 6/88 (6%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            K   HRDL A N+LL +    KI+DFG S            T  G  P  + APE +  
Sbjct: 124 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPP--YAAPELFQG 179
Query: 96  GRFSSAS-DVWSFGITLWEMYSFGQQPY 122
            ++     DVWS G+ L+ + S G  P+
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVS-GSLPF 206

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 41/88 (46%), Gaps = 6/88 (6%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            K   HRDL A N+LL +    KI+DFG S            T  G  P  + APE +  
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPP--YAAPELFQG 186
Query: 96  GRFSSAS-DVWSFGITLWEMYSFGQQPY 122
            ++     DVWS G+ L+ + S G  P+
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVS-GSLPF 213

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 40/78 (51%), Gaps = 9/78 (11%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APES-YNFGRF 98
           HRDL   N+ +    + KI DFGL+R  ++E   Y  T       +WY APE   ++  +
Sbjct: 167 HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT-------RWYRAPEVILSWMHY 219
Query: 99  SSASDVWSFGITLWEMYS 116
           +   D+WS G  + EM +
Sbjct: 220 NQTVDIWSVGCIMAEMLT 237

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 42/95 (44%), Gaps = 16/95 (16%)
Query: 40  FHRDLAARNILLASRHQ--------AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
            H ++ A+NILL              K+SD G+S  V       K     R P  W  PE
Sbjct: 135 IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-----LPKDILQERIP--WVPPE 187
Query: 92  SY-NFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
              N    + A+D WSFG TLWE+ S G +P   +
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            K   HRDL A N+LL      KI+DFG S            T  G  P  + APE +  
Sbjct: 132 QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKL--DTFCGSPP--YAAPELFQG 187
Query: 96  GRFSSAS-DVWSFGITLWEMYSFGQQPY 122
            ++     DVWS G+ L+ + S G  P+
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVS-GSLPF 214

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 4/91 (4%)
Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL   K+  +RDL   N++L      KI+DFGL +    +    K   G     ++ APE
Sbjct: 125 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTP---EYLAPE 181
Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                 +  A D W  G+ ++EM   G+ P+
Sbjct: 182 VLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 211

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 4/91 (4%)
Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL   K+  +RDL   N++L      KI+DFGL +    +    K   G     ++ APE
Sbjct: 123 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTP---EYLAPE 179
Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                 +  A D W  G+ ++EM   G+ P+
Sbjct: 180 VLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 209

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 4/91 (4%)
Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL   K+  +RDL   N++L      KI+DFGL +    +    K   G     ++ APE
Sbjct: 124 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTP---EYLAPE 180
Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                 +  A D W  G+ ++EM   G+ P+
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 210

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI D GL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 50/115 (43%), Gaps = 16/115 (13%)
Query: 22  EGQIPAKVCRYLK-----MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY 75
           E QI   VCR +      +H K   HRDL A N+L+      +++DFG+S          
Sbjct: 116 EPQIQV-VCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174
Query: 76  KATHGGRWPIKWYAPESYNFGRFSSA-----SDVWSFGITLWEMYSFGQQPYGEM 125
            +  G  +   W APE               +D+WS GITL EM    + P+ E+
Sbjct: 175 DSFIGTPY---WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI-EPPHHEL 225

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI  FGL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 40/78 (51%), Gaps = 9/78 (11%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APES-YNFGRF 98
           HRDL   N+ +    + KI DFGL+R  ++E   Y  T       +WY APE   ++  +
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT-------RWYRAPEVILSWMHY 201
Query: 99  SSASDVWSFGITLWEMYS 116
           +   D+WS G  + EM +
Sbjct: 202 NQTVDIWSVGCIMAEMLT 219

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 10/93 (10%)
Query: 35  MHKSSF-HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           +HK +  HRDL   N+LL S+ +    KI DFGLS AV   +   K   G  + I   AP
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS-AVFENQKKMKERLGTAYYI---AP 207
Query: 91  ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYG 123
           E     ++    DVWS G+ L+ + + G  P+G
Sbjct: 208 EVLR-KKYDEKCDVWSIGVILFILLA-GYPPFG 238

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI D GL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 35  MHKSSF-HRDLAARNILLASRH---QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           +H+++  H DL  +NILL+S +     KI DFG+SR +       +         ++ AP
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP----EYLAP 202
Query: 91  ESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE 124
           E  N+   ++A+D+W+ GI  + + +      GE
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 10/99 (10%)
Query: 28  KVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAV---NSERNYYKATHGGR 82
           ++ R LK MH +   HRDL   N+L+    + KI DFG++R +    +E  Y+   +   
Sbjct: 167 QLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA- 225
Query: 83  WPIKWY-APE-SYNFGRFSSASDVWSFGITLWEMYSFGQ 119
              +WY APE   +   ++ A D+WS G    EM +  Q
Sbjct: 226 --TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 4/86 (4%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   +RDL   N++L S    KI+DFG+ +    +    K   G      + APE   + 
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTP---DYIAPEIIAYQ 517
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +  + D W+FG+ L+EM + GQ P+
Sbjct: 518 PYGKSVDWWAFGVLLYEMLA-GQAPF 542

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL++ K   HRD+   NI++A     K+ DFG +  +   + +Y  T  G   I++ APE
Sbjct: 145 YLRL-KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY--TFCGT--IEYCAPE 199
Query: 92  SYNFGRFSSAS-DVWSFGITLWEMYSFGQQPYGEMKGS 128
                 +     ++WS G+TL+ +  F + P+ E++ +
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLV-FEENPFCELEET 236

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           +HK    +RDL   N++L S    KI+DFG+ +    +    +   G      + APE  
Sbjct: 136 LHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTP---DYIAPEII 192
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPY 122
            +  +  + D W++G+ L+EM + GQ P+
Sbjct: 193 AYQPYGKSVDWWAYGVLLYEMLA-GQPPF 220

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 8/86 (9%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL   N+LL +   AKI+DFGLS  + S+  + + + G      + APE  + GR  +
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXSCGSP---NYAAPEVIS-GRLYA 193
Query: 101 AS--DVWSFGITLWEMYSFGQQPYGE 124
               D+WS G+ L+ +   G  P+ +
Sbjct: 194 GPEVDIWSSGVILYALLC-GTLPFDD 218

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 28  KVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           ++ R LK +H +   HRDL   N+ +    + KI D GL+R  + E   Y AT       
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVAT------- 185
Query: 86  KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           +WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NAFVGTAQYVSPELLTEK 207
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 208 SACKSSDLWALGCIIYQLVA-GLPPF 232

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 35/92 (38%), Positives = 45/92 (48%), Gaps = 10/92 (10%)
Query: 35  MHKSSF-HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           MHK +  HRDL   NILL S+ +    KI DFGLS     +    K   G  + I   AP
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYI---AP 192
Query: 91  ESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           E    G +    DVWS G+ L+ + S G  P+
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLS-GTPPF 222

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 9/86 (10%)
Query: 35  MHKSSF-HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           MHK+   HRDL   N+LL S+ +    +I DFGLS    + +   K   G  +   + AP
Sbjct: 148 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAY---YIAP 203
Query: 91  ESYNFGRFSSASDVWSFGITLWEMYS 116
           E  + G +    DVWS G+ L+ + S
Sbjct: 204 EVLH-GTYDEKCDVWSTGVILYILLS 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 152 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NSFVGTAQYVSPELLTEK 210
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 211 SACKSSDLWALGCIIYQLVA-GLPPF 235

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 8/86 (9%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-- 97
            HRD+   NILL       I+DF ++  +  E      T  G  P  + APE ++  +  
Sbjct: 137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMAGTKP--YMAPEMFSSRKGA 192
Query: 98  -FSSASDVWSFGITLWEMYSFGQQPY 122
            +S A D WS G+T +E+   G++PY
Sbjct: 193 GYSFAVDWWSLGVTAYELLR-GRRPY 217

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 154 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 212
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 213 SACKSSDLWALGCIIYQLVA-GLPPF 237

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 209
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 210 SACKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 156 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 214
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 215 SACKSSDLWALGCIIYQLVA-GLPPF 239

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 209
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 210 SACKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 152 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 210
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 211 SACKSSDLWALGCIIYQLVA-GLPPF 235

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 41/88 (46%), Gaps = 6/88 (6%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            K   HRDL A N+LL +    KI+DFG S    +E  +            + APE +  
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDAFCGAPPYAAPELFQG 186
Query: 96  GRFSSAS-DVWSFGITLWEMYSFGQQPY 122
            ++     DVWS G+ L+ + S G  P+
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVS-GSLPF 213

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 4/91 (4%)
Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL   K+  +RDL   N++L      KI+DFGL +    +    K   G     ++ APE
Sbjct: 266 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP---EYLAPE 322
Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                 +  A D W  G+ ++EM   G+ P+
Sbjct: 323 VLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 352

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 209
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 210 SACKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 207
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 208 SACKSSDLWALGCIIYQLVA-GLPPF 232

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 207
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 208 SACKSSDLWALGCIIYQLVA-GLPPF 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 207
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 208 SACKSSDLWALGCIIYQLVA-GLPPF 232

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 209
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 210 SACKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 40  FHRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
            HR+L   N+LLAS+ +    K++DFGL+  VN      +A HG      + +PE     
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS----EAWHGFAGTPGYLSPEVLKKD 205
Query: 97  RFSSASDVWSFGITLW 112
            +S   D+W+ G+ L+
Sbjct: 206 PYSKPVDIWACGVILY 221

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 129 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 187
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 188 SACKSSDLWALGCIIYQLVA-GLPPF 212

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 4/91 (4%)
Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL   K+  +RDL   N++L      KI+DFGL +    +    K   G     ++ APE
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP---EYLAPE 319
Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                 +  A D W  G+ ++EM   G+ P+
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 349

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 25/75 (33%), Positives = 40/75 (53%), Gaps = 7/75 (9%)
Query: 41  HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HR+L   N+LLAS+ +    K++DFGL+  VN      +A HG      + +PE      
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS----EAWHGFAGTPGYLSPEVLKKDP 183
Query: 98  FSSASDVWSFGITLW 112
           +S   D+W+ G+ L+
Sbjct: 184 YSKPVDIWACGVILY 198

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 48/105 (45%), Gaps = 12/105 (11%)
Query: 29  VCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFG-LSRAVNSERNYYKATHGGRW-- 83
           +CR L+ +H   + HRDL   NILL    Q  + D G +++A        +A     W  
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 84  ---PIKWYAPESYNFGR---FSSASDVWSFGITLWEMYSFGQQPY 122
               I + APE ++          +DVWS G  L+ M  FG+ PY
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM-FGEGPY 246

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 209
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 210 SAXKSSDLWALGCIIYQLVA-GLPPF 234

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 148 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NSFVGTAQYVSPELLTEK 206
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 207 SACKSSDLWALGCIIYQLVA-GLPPF 231

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 126 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 184
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 185 SACKSSDLWALGCIIYQLVA-GLPPF 209

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 41/88 (46%), Gaps = 6/88 (6%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            K   HRDL A N+LL +    KI+DFG S    +E  +            + APE +  
Sbjct: 131 QKFIVHRDLKAENLLLDADXNIKIADFGFS----NEFTFGNKLDAFCGAPPYAAPELFQG 186
Query: 96  GRFSSAS-DVWSFGITLWEMYSFGQQPY 122
            ++     DVWS G+ L+ + S G  P+
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVS-GSLPF 213

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 128 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 186
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 187 SACKSSDLWALGCIIYQLVA-GLPPF 211

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 185
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 186 SACKSSDLWALGCIIYQLVA-GLPPF 210

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 25/75 (33%), Positives = 40/75 (53%), Gaps = 7/75 (9%)
Query: 41  HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HR+L   N+LLAS+ +    K++DFGL+  VN      +A HG      + +PE      
Sbjct: 127 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS----EAWHGFAGTPGYLSPEVLKKDP 182
Query: 98  FSSASDVWSFGITLW 112
           +S   D+W+ G+ L+
Sbjct: 183 YSKPVDIWACGVILY 197

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 133 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 191
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 192 SACKSSDLWALGCIIYQLVA-GLPPF 216

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 25/75 (33%), Positives = 40/75 (53%), Gaps = 7/75 (9%)
Query: 41  HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HR+L   N+LLAS+ +    K++DFGL+  VN      +A HG      + +PE      
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS----EAWHGFAGTPGYLSPEVLKKDP 183
Query: 98  FSSASDVWSFGITLW 112
           +S   D+W+ G+ L+
Sbjct: 184 YSKPVDIWACGVILY 198

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            K   +RDL   NI+L  +   K++DFGL +    +      TH     I++ APE    
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT---VTHXFCGTIEYMAPEILMR 195
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
              + A D WS G  +++M + G  P+
Sbjct: 196 SGHNRAVDWWSLGALMYDMLT-GAPPF 221

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 36/107 (33%), Positives = 48/107 (44%), Gaps = 22/107 (20%)
Query: 28  KVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRA-VNSER---------NYYK 76
           KV +YL  H     HRD+   NILL +    K++DFGLSR+ VN  R         N   
Sbjct: 120 KVIKYL--HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 77  ATHGGRWPI-------KWY-APES-YNFGRFSSASDVWSFGITLWEM 114
                  PI       +WY APE      +++   D+WS G  L E+
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            K   +RDL   NI+L  +   K++DFGL +    +      TH     I++ APE    
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT---VTHTFCGTIEYMAPEILMR 195
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
              + A D WS G  +++M + G  P+
Sbjct: 196 SGHNRAVDWWSLGALMYDMLT-GAPPF 221

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 36  HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            K   HRDL A N+LL +    KI+DFG S               G  P  + APE +  
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DEFCGSPP--YAAPELFQG 186
Query: 96  GRFSSAS-DVWSFGITLWEMYSFGQQPY 122
            ++     DVWS G+ L+ + S G  P+
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVS-GSLPF 213

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRDL   NILL      +I+DFG ++ ++ E    +A +      ++ +PE     
Sbjct: 148 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQYVSPELLTEK 206
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
               +SD+W+ G  ++++ + G  P+
Sbjct: 207 SACKSSDLWALGCIIYQLVA-GLPPF 231

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/101 (26%), Positives = 42/101 (41%), Gaps = 9/101 (8%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASR----HQAKISDFGLSRAVNSERNYYKATHGGR 82
            K   YL   +   HRDL   NIL           +I DFG ++ + +E           
Sbjct: 126 TKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC--- 181
Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYG 123
           +   + APE      + +A D+WS G+ L+ M + G  P+ 
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT-GYTPFA 221

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 10/92 (10%)
Query: 35  MHKSSF-HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           MHK+   HRDL   N+LL S+ +    +I DFGLS    + +   K   G  + I   AP
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYI---AP 197
Query: 91  ESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           E  + G +    DVWS G+ L+ + S G  P+
Sbjct: 198 EVLH-GTYDEKCDVWSTGVILYILLS-GCPPF 227

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   + T  G   + +  PE     
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCG--TLDYLPPEXIEGR 186
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 187 XHDEKVDLWSLGVLCYE-FLVGKPPF 211

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   + T  G   + +  PE     
Sbjct: 131 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCG--TLDYLPPEMIEGR 185
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 186 MHDEKVDLWSLGVLCYE-FLVGKPPF 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   + T  G   + +  PE     
Sbjct: 126 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCG--TLDYLPPEMIEGR 180
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 181 MHDEKVDLWSLGVLCYE-FLVGKPPF 205

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   + T  G   + +  PE     
Sbjct: 153 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT--LDYLPPEMIEGR 207
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 208 MHDEKVDLWSLGVLCYE-FLVGKPPF 232

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   + T  G   + +  PE     
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCG--TLDYLPPEMIEGR 181
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 182 MHDEKVDLWSLGVLCYE-FLVGKPPF 206

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   + T  G   + +  PE     
Sbjct: 124 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCG--TLDYLPPEMIEGR 178
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 179 MHDEKVDLWSLGVLCYE-FLVGKPPF 203

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 10/92 (10%)
Query: 35  MHKSSF-HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           MHK+   HRDL   N+LL S+ +    +I DFGLS    + +   K   G  + I   AP
Sbjct: 165 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYI---AP 220
Query: 91  ESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           E  + G +    DVWS G+ L+ + S G  P+
Sbjct: 221 EVLH-GTYDEKCDVWSTGVILYILLS-GCPPF 250

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   + T  G   + +  PE     
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCG--TLDYLPPEMIEGR 184
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 185 MHDEKVDLWSLGVLCYE-FLVGKPPF 209

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 10/92 (10%)
Query: 35  MHKSSF-HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           MHK+   HRDL   N+LL S+ +    +I DFGLS    + +   K   G  + I   AP
Sbjct: 166 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYI---AP 221
Query: 91  ESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           E  + G +    DVWS G+ L+ + S G  P+
Sbjct: 222 EVLH-GTYDEKCDVWSTGVILYILLS-GCPPF 251

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/86 (27%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   +RD+   N++L      KI+DFGL +   S+    K   G     ++ APE     
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP---EYLAPEVLEDN 180
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +  A D W  G+ ++EM   G+ P+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMC-GRLPF 205

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 11/91 (12%)
Query: 40  FHRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE---SY 93
            HRDL   N+LL+S+ +    KI+DFG S+ +  E +  +   G      + APE   S 
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP---TYLAPEVLVSV 191
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGE 124
               ++ A D WS G+ L+   S G  P+ E
Sbjct: 192 GTAGYNRAVDCWSLGVILFICLS-GYPPFSE 221

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   + T  G   + +  PE     
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCG--TLDYLPPEMIEGR 186
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 187 MHDEKVDLWSLGVLCYE-FLVGKPPF 211

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 11/91 (12%)
Query: 40  FHRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE---SY 93
            HRDL   N+LL+S+ +    KI+DFG S+ +  E +  +   G      + APE   S 
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP---TYLAPEVLVSV 191
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGE 124
               ++ A D WS G+ L+   S G  P+ E
Sbjct: 192 GTAGYNRAVDCWSLGVILFICLS-GYPPFSE 221

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   + T  G   + +  PE     
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCG--TLDYLPPEMIEGR 184
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 185 MHDEKVDLWSLGVLCYE-FLVGKPPF 209

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 11/91 (12%)
Query: 40  FHRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE---SY 93
            HRDL   N+LL+S+ +    KI+DFG S+ +  E +  +   G      + APE   S 
Sbjct: 135 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP---TYLAPEVLVSV 190
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGE 124
               ++ A D WS G+ L+   S G  P+ E
Sbjct: 191 GTAGYNRAVDCWSLGVILFICLS-GYPPFSE 220

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 11/91 (12%)
Query: 40  FHRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE---SY 93
            HRDL   N+LL+S+ +    KI+DFG S+ +  E +  +   G      + APE   S 
Sbjct: 142 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP---TYLAPEVLVSV 197
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGE 124
               ++ A D WS G+ L+   S G  P+ E
Sbjct: 198 GTAGYNRAVDCWSLGVILFICLS-GYPPFSE 227

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 8/87 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRD+   N+LL S  + KI+DFG S  A +S R+    T      + +  PE    
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGT------LDYLPPEMIEG 183
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
                  D+WS G+  +E +  G+ P+
Sbjct: 184 RMHDEKVDLWSLGVLCYE-FLVGKPPF 209

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   + T  G   + +  PE     
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCG--TLDYLPPEMIEGR 186
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 187 MHDEKVDLWSLGVLCYE-FLVGKPPF 211

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 11/91 (12%)
Query: 40  FHRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE---SY 93
            HRDL   N+LL+S+ +    KI+DFG S+ +  E +  +   G      + APE   S 
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP---TYLAPEVLVSV 191
Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGE 124
               ++ A D WS G+ L+   S G  P+ E
Sbjct: 192 GTAGYNRAVDCWSLGVILFICLS-GYPPFSE 221

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/83 (30%), Positives = 35/83 (42%), Gaps = 4/83 (4%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDL   N+ L      KI DFGL+  +  +    K   G      + APE       S
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTP---NYIAPEVLCKKGHS 220
Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
              D+WS G  L+ +   G+ P+
Sbjct: 221 FEVDIWSLGCILYTLL-VGKPPF 242

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRD+   N+LL S  + KI+DFG S  A +S R+    T      + +  PE    
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGT------LDYLPPEMIEG 184
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
                  D+WS G+  +E +  G  P+
Sbjct: 185 RMHDEKVDLWSLGVLCYE-FLVGMPPF 210

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 8/87 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRD+   N+LL S  + KI+DFG S  A +S R+    T      + +  PE    
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGT------LDYLPPEMIEG 181
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
                  D+WS G+  +E +  G+ P+
Sbjct: 182 RMHDEKVDLWSLGVLCYE-FLVGKPPF 207

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   + T  G   + +  PE     
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR---RTTLSG--TLDYLPPEMIEGR 182
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 183 MHDEKVDLWSLGVLCYE-FLVGKPPF 207

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 39/86 (45%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   + T  G   + +  PE     
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RTTLCG--TLDYLPPEMIEGR 185
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G  P+
Sbjct: 186 MHDEKVDLWSLGVLCYE-FLVGMPPF 210

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 5/84 (5%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            H D+   NI L  R + K+ DFGL      E     A        ++ APE    G + 
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLL----VELGTAGAGEVQEGDPRYMAPELLQ-GSYG 233
Query: 100 SASDVWSFGITLWEMYSFGQQPYG 123
           +A+DV+S G+T+ E+    + P+G
Sbjct: 234 TAADVFSLGLTILEVACNMELPHG 257

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   +A   G   + +  PE     
Sbjct: 127 KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCG--TLDYLPPEMIEGR 181
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 182 MHDEKVDLWSLGVLCYE-FLVGKPPF 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 8/87 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRD+   N+LL S  + KI+DFG S  A +S R+    T      + +  PE    
Sbjct: 153 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGT------LDYLPPEMIEG 206
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
                  D+WS G+  +E +  G+ P+
Sbjct: 207 RMHDEKVDLWSLGVLCYE-FLVGKPPF 232

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   + T  G   + +  PE     
Sbjct: 144 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCG--TLDYLPPEMIEGR 198
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 199 MHDEKVDLWSLGVLCYE-FLVGKPPF 223

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRD+   N+LL S  + KI+DFG S  A +S R     T      + +  PE    
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGT------LDYLPPEMIEG 180
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
                  D+WS G+  +E +  G+ P+
Sbjct: 181 RMHDEKVDLWSLGVLCYE-FLVGKPPF 206

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/86 (27%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   +RD+   N++L      KI+DFGL +   S+    K   G     ++ APE     
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP---EYLAPEVLEDN 180
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +  A D W  G+ ++EM   G+ P+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMC-GRLPF 205

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/87 (28%), Positives = 37/87 (42%), Gaps = 12/87 (13%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI----KWYAPESYNF 95
            HRDL   N+LL      KI+DFGL+  +       K  H   + +     + +PE    
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQL-------KMPHEKHYTLCGTPNYISPEIATR 186
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
                 SDVWS G   + +   G+ P+
Sbjct: 187 SAHGLESDVWSLGCMFYTLL-IGRPPF 212

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRD+   N+LL S  + KI+DFG S  A +S R     T      + +  PE    
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGT------LDYLPPEMIEG 185
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
                  D+WS G+  +E +  G+ P+
Sbjct: 186 RMHDEKVDLWSLGVLCYE-FLVGKPPF 211

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/86 (27%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   +RD+   N++L      KI+DFGL +   S+    K   G     ++ APE     
Sbjct: 129 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTP---EYLAPEVLEDN 185
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +  A D W  G+ ++EM   G+ P+
Sbjct: 186 DYGRAVDWWGLGVVMYEMMC-GRLPF 210

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   +A   G   + +  PE     
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCG--TLDYLPPEMIEGR 181
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 182 MHDEKVDLWSLGVLCYE-FLVGKPPF 206

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/83 (30%), Positives = 35/83 (42%), Gaps = 4/83 (4%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDL   N+ L      KI DFGL+  +  +    K   G      + APE       S
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTP---NYIAPEVLCKKGHS 220
Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
              D+WS G  L+ +   G+ P+
Sbjct: 221 FEVDIWSLGCILYTLL-VGKPPF 242

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI+DFG S    S R   +A   G   + +  PE     
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCG--TLDYLPPEMIEGR 184
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 185 MHDEKVDLWSLGVLCYE-FLVGKPPF 209

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 14/95 (14%)
Query: 35  MHK-SSFHRDLAARNILLASRHQAKISDFGLSR---AVNSERNY-YKATHGGRWPIKWYA 89
           +HK    +RD+   NILL S     ++DFGLS+   A  +ER Y +  T      I++ A
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT------IEYMA 228
Query: 90  PESYNFGR--FSSASDVWSFGITLWEMYSFGQQPY 122
           P+    G      A D WS G+ ++E+ + G  P+
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPF 262

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/86 (27%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   +RD+   N++L      KI+DFGL +   S+    K   G     ++ APE     
Sbjct: 127 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP---EYLAPEVLEDN 183
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +  A D W  G+ ++EM   G+ P+
Sbjct: 184 DYGRAVDWWGLGVVMYEMMC-GRLPF 208

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/86 (27%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   +RD+   N++L      KI+DFGL +   S+    K   G     ++ APE     
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTP---EYLAPEVLEDN 180
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +  A D W  G+ ++EM   G+ P+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMC-GRLPF 205

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/83 (30%), Positives = 35/83 (42%), Gaps = 4/83 (4%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDL   N+ L      KI DFGL+  +  +    K   G      + APE       S
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP---NYIAPEVLCKKGHS 204
Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
              D+WS G  L+ +   G+ P+
Sbjct: 205 FEVDIWSLGCILYTLL-VGKPPF 226

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 41  HRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           H DL   NI+L  R+    + KI DFGL+  ++   N +K   G     ++ APE  N+ 
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTP---EFVAPEIVNYE 192
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                +D+WS G+  + + S G  P+
Sbjct: 193 PLGLEADMWSIGVITYILLS-GASPF 217

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 20/78 (25%), Positives = 39/78 (50%), Gaps = 4/78 (5%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   +RDL   NI L    Q KI DFGL  ++ ++    ++    +  +++ +PE  +  
Sbjct: 141 KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS----KGTLRYMSPEQISSQ 196
Query: 97  RFSSASDVWSFGITLWEM 114
            +    D+++ G+ L E+
Sbjct: 197 DYGKEVDLYALGLILAEL 214

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRD+   N+LL S  + KI+DFG S  A +S R     T      + +  PE    
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGT------LDYLPPEMIEG 180
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
                  D+WS G+  +E +  G+ P+
Sbjct: 181 RMHDEKVDLWSLGVLCYE-FLVGKPPF 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 41  HRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           H DL   NI+L  R+    + KI DFGL+  ++   N +K   G     ++ APE  N+ 
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTP---EFVAPEIVNYE 192
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                +D+WS G+  + + S G  P+
Sbjct: 193 PLGLEADMWSIGVITYILLS-GASPF 217

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/86 (27%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   +RD+   N++L      KI+DFGL +   S+    K   G     ++ APE     
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTP---EYLAPEVLEDN 180
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +  A D W  G+ ++EM   G+ P+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMC-GRLPF 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 24/86 (27%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           +   +RD+   N++L      KI+DFGL +   S+    K   G     ++ APE     
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTP---EYLAPEVLEDN 180
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +  A D W  G+ ++EM   G+ P+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMC-GRLPF 205

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 41  HRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           H DL   NI+L  R+    + KI DFGL+  ++   N +K   G     ++ APE  N+ 
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTP---EFVAPEIVNYE 192
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                +D+WS G+  + + S G  P+
Sbjct: 193 PLGLEADMWSIGVITYILLS-GASPF 217

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/83 (30%), Positives = 35/83 (42%), Gaps = 4/83 (4%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFS 99
            HRDL   N+ L      KI DFGL+  +  +    K   G      + APE       S
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP---NYIAPEVLCKKGHS 220
Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
              D+WS G  L+ +   G+ P+
Sbjct: 221 FEVDIWSLGCILYTLL-VGKPPF 242

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRD+   N+LL S  + KI+DFG S  A +S R     T      + +  PE    
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGT------LDYLPPEMIEG 180
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
                  D+WS G+  +E +  G+ P+
Sbjct: 181 RMHDEKVDLWSLGVLCYE-FLVGKPPF 206

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 41  HRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           H DL   NI+L  R+    + KI DFGL+  ++   N +K   G     ++ APE  N+ 
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTP---EFVAPEIVNYE 192
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                +D+WS G+  + + S G  P+
Sbjct: 193 PLGLEADMWSIGVITYILLS-GASPF 217

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 41  HRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           H DL   NI+L  R+    + KI DFGL+  ++   N +K   G     ++ APE  N+ 
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTP---EFVAPEIVNYE 192
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                +D+WS G+  + + S G  P+
Sbjct: 193 PLGLEADMWSIGVITYILLS-GASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 41  HRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           H DL   NI+L  R+    + KI DFGL+  ++   N +K   G     ++ APE  N+ 
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTP---EFVAPEIVNYE 192
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                +D+WS G+  + + S G  P+
Sbjct: 193 PLGLEADMWSIGVITYILLS-GASPF 217

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 41  HRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           H DL   NI+L  R+    + KI DFGL+  ++   N +K   G     ++ APE  N+ 
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTP---EFVAPEIVNYE 192
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                +D+WS G+  + + S G  P+
Sbjct: 193 PLGLEADMWSIGVITYILLS-GASPF 217

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRD+   N+LL S  + KI+DFG S  A +S R     T      + +  PE    
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGT------LDYLPPEMIEG 183
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
                  D+WS G+  +E +  G+ P+
Sbjct: 184 RMHDEKVDLWSLGVLCYE-FLVGKPPF 209

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 41  HRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           H DL   NI+L  R+    + KI DFGL+  ++   N +K   G     ++ APE  N+ 
Sbjct: 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTP---EFVAPEIVNYE 191
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                +D+WS G+  + + S G  P+
Sbjct: 192 PLGLEADMWSIGVITYILLS-GASPF 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 41  HRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           H DL   NI+L  R+    + KI DFGL+  ++   N +K   G     ++ APE  N+ 
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTP---EFVAPEIVNYE 192
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                +D+WS G+  + + S G  P+
Sbjct: 193 PLGLEADMWSIGVITYILLS-GASPF 217

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 41  HRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           H DL   NI+L  R+    + KI DFGL+  ++   N +K   G     ++ APE  N+ 
Sbjct: 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTP---EFVAPEIVNYE 191
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                +D+WS G+  + + S G  P+
Sbjct: 192 PLGLEADMWSIGVITYILLS-GASPF 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 41  HRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           H DL   NI+L  R+    + KI DFGL+  ++   N +K   G     ++ APE  N+ 
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTP---EFVAPEIVNYE 192
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                +D+WS G+  + + S G  P+
Sbjct: 193 PLGLEADMWSIGVITYILLS-GASPF 217

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRD+   N+LL S  + KI+DFG S  A +S R     T      + +  PE    
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGT------LDYLPPEMIEG 180
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
                  D+WS G+  +E +  G+ P+
Sbjct: 181 RMHDEKVDLWSLGVLCYE-FLVGKPPF 206

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRD+   N+LL S  + KI+DFG S  A +S R     T      + +  PE    
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGT------LDYLPPEMIEG 185
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
                  D+WS G+  +E +  G+ P+
Sbjct: 186 RMHDEKVDLWSLGVLCYE-FLVGKPPF 211

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRD+   N+LL S  + KI+DFG S  A +S R     T      + +  PE    
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGT------LDYLPPEMIEG 182
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
                  D+WS G+  +E +  G+ P+
Sbjct: 183 RMHDEKVDLWSLGVLCYE-FLVGKPPF 208

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 48/105 (45%), Gaps = 16/105 (15%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE----SYNF 95
           HRDL ++NIL+       I+D GL+   +S  +        R   K Y APE    S N 
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
Query: 96  GRFSS--ASDVWSFGITLWEM---YSFG------QQPYGEMKGSD 129
             F S   +D+++ G+  WE+    S G      Q PY ++  SD
Sbjct: 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRD+   N+LL S  + KI+DFG S  A +S R     T      + +  PE    
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGT------LDYLPPEMIEG 180
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
                  D+WS G+  +E +  G+ P+
Sbjct: 181 RMHDEKVDLWSLGVLCYE-FLVGKPPF 206

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 41  HRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           H DL   NI+L  R+    + KI DFGL+  ++   N +K   G     ++ APE  N+ 
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTP---EFVAPEIVNYE 192
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                +D+WS G+  + + S G  P+
Sbjct: 193 PLGLEADMWSIGVITYILLS-GASPF 217

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 41  HRDLAARNILLA-----SRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           HRDL   NIL++      + +A ISDFGL + +   R+ +    G      W APE  + 
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 96  GRFSSAS---DVWSFGITLWEMYSFGQQPYGE 124
               + +   D++S G   + + S G  P+G+
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERNYYKATHGGRWPIKWYAPESYNF 95
           K   HRD+   N+LL S  + KI+DFG S  A +S R     T      + +  PE    
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGT------LDYLPPEMIEG 181
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
                  D+WS G+  +E +  G+ P+
Sbjct: 182 RMHDEKVDLWSLGVLCYE-FLVGKPPF 207

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 44/86 (51%), Gaps = 9/86 (10%)
Query: 41  HRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           H DL   NI+L  R+    + KI DFGL+  ++   N +K   G   P ++ APE  N+ 
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGT--P-EFVAPEIVNYE 192
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                +D+WS G+  + + S G  P+
Sbjct: 193 PLGLEADMWSIGVITYILLS-GASPF 217

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 48/105 (45%), Gaps = 16/105 (15%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE----SYNF 95
           HRDL ++NIL+       I+D GL+   +S  +        R   K Y APE    S N 
Sbjct: 157 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 216
Query: 96  GRFSS--ASDVWSFGITLWEM---YSFG------QQPYGEMKGSD 129
             F S   +D+++ G+  WE+    S G      Q PY ++  SD
Sbjct: 217 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 261

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 35/81 (43%), Gaps = 8/81 (9%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSE--RNYYKATHGGRWPIKWYAPESYNFGR 97
            HRDL   NI++ S    KI DFGL+R   +      Y  T   R      APE      
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYR------APEVILGMG 201
Query: 98  FSSASDVWSFGITLWEMYSFG 118
           +    D+WS G+ + EM   G
Sbjct: 202 YKENVDIWSVGVIMGEMIKGG 222

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 35/81 (43%), Gaps = 8/81 (9%)
Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSE--RNYYKATHGGRWPIKWYAPESYNFGR 97
            HRDL   NI++ S    KI DFGL+R   +      Y  T   R      APE      
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYR------APEVILGMG 201
Query: 98  FSSASDVWSFGITLWEMYSFG 118
           +    D+WS G+ + EM   G
Sbjct: 202 YKENVDIWSVGVIMGEMIKGG 222

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/88 (27%), Positives = 36/88 (40%), Gaps = 8/88 (9%)
Query: 40  FHRDLAARNILLASR----HQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            HRDL   NIL           +I DFG ++ + +E           +   + APE    
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC---YTANFVAPEVLKR 199
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYG 123
             +    D+WS GI L+ M + G  P+ 
Sbjct: 200 QGYDEGCDIWSLGILLYTMLA-GYTPFA 226

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/88 (27%), Positives = 36/88 (40%), Gaps = 8/88 (9%)
Query: 40  FHRDLAARNILLASR----HQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF 95
            HRDL   NIL           +I DFG ++ + +E           +   + APE    
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC---YTANFVAPEVLKR 199
Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYG 123
             +    D+WS GI L+ M + G  P+ 
Sbjct: 200 QGYDEGCDIWSLGILLYTMLA-GYTPFA 226

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 48/105 (45%), Gaps = 16/105 (15%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE----SYNF 95
           HRDL ++NIL+       I+D GL+   +S  +        R   K Y APE    S N 
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 96  GRFSS--ASDVWSFGITLWEM---YSFG------QQPYGEMKGSD 129
             F S   +D+++ G+  WE+    S G      Q PY ++  SD
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 12/87 (13%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSER-----NYYKATHGGRWPIKWYAPE---- 91
           HRDL +RN+L+ +     ISDFGLS  +   R         A       I++ APE    
Sbjct: 143 HRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202
Query: 92  SYNFGRFSSA---SDVWSFGITLWEMY 115
           + N     SA    D+++ G+  WE++
Sbjct: 203 AVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 48/105 (45%), Gaps = 16/105 (15%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE----SYNF 95
           HRDL ++NIL+       I+D GL+   +S  +        R   K Y APE    S N 
Sbjct: 132 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 191
Query: 96  GRFSS--ASDVWSFGITLWEM---YSFG------QQPYGEMKGSD 129
             F S   +D+++ G+  WE+    S G      Q PY ++  SD
Sbjct: 192 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 236

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 48/105 (45%), Gaps = 16/105 (15%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE----SYNF 95
           HRDL ++NIL+       I+D GL+   +S  +        R   K Y APE    S N 
Sbjct: 137 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 196
Query: 96  GRFSS--ASDVWSFGITLWEM---YSFG------QQPYGEMKGSD 129
             F S   +D+++ G+  WE+    S G      Q PY ++  SD
Sbjct: 197 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 241

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 48/105 (45%), Gaps = 16/105 (15%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE----SYNF 95
           HRDL ++NIL+       I+D GL+   +S  +        R   K Y APE    S N 
Sbjct: 134 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 193
Query: 96  GRFSS--ASDVWSFGITLWEM---YSFG------QQPYGEMKGSD 129
             F S   +D+++ G+  WE+    S G      Q PY ++  SD
Sbjct: 194 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 238

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 39.3 bits (90), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 31/106 (29%), Positives = 44/106 (41%), Gaps = 21/106 (19%)
Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSER----------NYYKATHGGRW 83
           +H+S   HRDL   N LL      K+ DFGL+R +NSE+          N     H    
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 84  P--------IKWY-APESYNFGR-FSSASDVWSFGITLWEMYSFGQ 119
                     +WY APE       ++ + D+WS G    E+ +  Q
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 39/78 (50%), Gaps = 12/78 (15%)
Query: 41  HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNY---YKATHGGRWPIKWYAPESYN 94
           HRDL   N+LLAS+ +    K++DFGL+  V  E+     +  T G      + +PE   
Sbjct: 153 HRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPG------YLSPEVLR 206
Query: 95  FGRFSSASDVWSFGITLW 112
              +    D+W+ G+ L+
Sbjct: 207 KDPYGKPVDIWACGVILY 224

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 11/92 (11%)
Query: 41  HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE---SYN 94
           HRDL   N+LL+S+ +    KI+DFG S+ +  E +  +   G      + APE   S  
Sbjct: 276 HRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTP---TYLAPEVLVSVG 331
Query: 95  FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
              ++ A D WS G+ L+   S G  P+ E +
Sbjct: 332 TAGYNRAVDCWSLGVILFICLS-GYPPFSEHR 362

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/119 (23%), Positives = 53/119 (44%), Gaps = 20/119 (16%)
Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSE 71
           +G ++ P+        V  +  +H     +RDL   N+++  +   K++DFGL++ V   
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK-- 192
Query: 72  RNYYKATHGGRWPI----KWYAPESYNFGRFSSASDVWSFGITLWEMYS-----FGQQP 121
                   G  W +    ++ APE      ++ A D W+ G+ ++EM +     F  QP
Sbjct: 193 --------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 9/91 (9%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK-ATHGGRWPIKWYAPESYNFG-RF 98
           +RDL   NILL      +ISD GL+   + ++ +    THG      + APE    G  +
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG------YMAPEVLQKGVAY 368
Query: 99  SSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            S++D +S G  L+++   G  P+ + K  D
Sbjct: 369 DSSADWFSLGCMLFKLLR-GHSPFRQHKTKD 398

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 60/125 (48%), Gaps = 12/125 (9%)
Query: 5   NGSGVVTPLGSYALPYIEGQIPA---KVCRYLK-MHKSSF-HRDLAARNILLASRHQA-- 57
           +G  +   + + A    E +I +   +VC  L+ +H  +  H D+   NI+  +R  +  
Sbjct: 84  SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTI 143
Query: 58  KISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF 117
           KI +FG +R +    N+           ++YAPE +     S+A+D+WS G  ++ + S 
Sbjct: 144 KIIEFGQARQLKPGDNFRLLFTAP----EYYAPEVHQHDVVSTATDMWSLGTLVYVLLS- 198
Query: 118 GQQPY 122
           G  P+
Sbjct: 199 GINPF 203

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 9/91 (9%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK-ATHGGRWPIKWYAPESYNFG-RF 98
           +RDL   NILL      +ISD GL+   + ++ +    THG      + APE    G  +
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG------YMAPEVLQKGVAY 368
Query: 99  SSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            S++D +S G  L+++   G  P+ + K  D
Sbjct: 369 DSSADWFSLGCMLFKLLR-GHSPFRQHKTKD 398

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI++FG S    S R   + T  G   + +  PE     
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCG--TLDYLPPEMIEGR 184
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 185 MHDEKVDLWSLGVLCYE-FLVGKPPF 209

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 11/92 (11%)
Query: 41  HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE---SYN 94
           HRDL   N+LL+S+ +    KI+DFG S+ +  E +  +   G      + APE   S  
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTP---TYLAPEVLVSVG 317
Query: 95  FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
              ++ A D WS G+ L+   S G  P+ E +
Sbjct: 318 TAGYNRAVDCWSLGVILFICLS-GYPPFSEHR 348

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 41/101 (40%), Gaps = 9/101 (8%)
Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASR----HQAKISDFGLSRAVNSERNYYKATHGGR 82
            K   YL   +   HRDL   NIL           +I DFG ++ + +E           
Sbjct: 126 TKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPC--- 181
Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYG 123
           +   + APE      + +A D+WS G+ L+   + G  P+ 
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTXLT-GYTPFA 221

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 39.3 bits (90), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 38/86 (44%), Gaps = 4/86 (4%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   +RDL   N+LL      K++DFG+ +          AT  G     + APE     
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTTATFCGTP--DYIAPEILQEM 199
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +  A D W+ G+ L+EM   G  P+
Sbjct: 200 LYGPAVDWWAMGVLLYEMLC-GHAPF 224

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 37  KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           K   HRD+   N+LL S  + KI++FG S    S R   + T  G   + +  PE     
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCG--TLDYLPPEMIEGR 183
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                 D+WS G+  +E +  G+ P+
Sbjct: 184 MHDEKVDLWSLGVLCYE-FLVGKPPF 208

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 10/91 (10%)
Query: 36  HKSSF-HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           HK+   HRDL   N+LL S+ +    +I DFGLS    + +   K   G  + I   APE
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-XKDKIGTAYYI---APE 198
Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             + G +    DVWS G+ L+ + S G  P+
Sbjct: 199 VLH-GTYDEKCDVWSTGVILYILLS-GCPPF 227

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 27/120 (22%), Positives = 52/120 (43%), Gaps = 18/120 (15%)
Query: 18  LPYIEGQIPAKVCRYL---------KMHKSSF-HRDLAARNILLASRHQAKISDFGLSRA 67
           L   E ++P  + R+           +H+  + HRD+   N+LL      +++DFG    
Sbjct: 165 LSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLK 224
Query: 68  VNSERNYYKATHGGRWPIKWYAPESYN-----FGRFSSASDVWSFGITLWEMYSFGQQPY 122
           +N +     +   G     + +PE         G++    D WS G+ ++EM  +G+ P+
Sbjct: 225 MNDDGTVQSSVAVG--TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML-YGETPF 281

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 9/91 (9%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK-ATHGGRWPIKWYAPESYNFG-RF 98
           +RDL   NILL      +ISD GL+   + ++ +    THG      + APE    G  +
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG------YMAPEVLQKGVAY 368
Query: 99  SSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            S++D +S G  L+++   G  P+ + K  D
Sbjct: 369 DSSADWFSLGCMLFKLLR-GHSPFRQHKTKD 398

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 9/91 (9%)
Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK-ATHGGRWPIKWYAPESYNFG-RF 98
           +RDL   NILL      +ISD GL+   + ++ +    THG      + APE    G  +
Sbjct: 314 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG------YMAPEVLQKGVAY 367
Query: 99  SSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            S++D +S G  L+++   G  P+ + K  D
Sbjct: 368 DSSADWFSLGCMLFKLLR-GHSPFRQHKTKD 397

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 41  HRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG 96
           H DL   NI+L  R+    + KI DFGL+  ++   N +K   G   P  + APE  N+ 
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGT--P-AFVAPEIVNYE 192
Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
                +D+WS G+  + + S G  P+
Sbjct: 193 PLGLEADMWSIGVITYILLS-GASPF 217

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 45/98 (45%), Gaps = 20/98 (20%)
Query: 35  MHKSSF-HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKATHGGRWPIK---- 86
           +HK +  HRDL   N+LL S+ +    KI DFGLS              GG+   +    
Sbjct: 137 LHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV---------GGKMKERLGTA 187
Query: 87  -WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYG 123
            + APE     ++    DVWS G+ L+ +   G  P+G
Sbjct: 188 YYIAPEVLR-KKYDEKCDVWSCGVILYILLC-GYPPFG 223

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 38.5 bits (88), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 27/120 (22%), Positives = 52/120 (43%), Gaps = 18/120 (15%)
Query: 18  LPYIEGQIPAKVCRYL---------KMHKSSF-HRDLAARNILLASRHQAKISDFGLSRA 67
           L   E ++P  + R+           +H+  + HRD+   N+LL      +++DFG    
Sbjct: 181 LSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLK 240
Query: 68  VNSERNYYKATHGGRWPIKWYAPESYN-----FGRFSSASDVWSFGITLWEMYSFGQQPY 122
           +N +     +   G     + +PE         G++    D WS G+ ++EM  +G+ P+
Sbjct: 241 MNDDGTVQSSVAVG--TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML-YGETPF 297

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	129
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-59
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-59
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-58
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-58
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-56
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-54
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-54
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-54
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-54
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-53
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-53
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-52
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-52
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-51
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-51
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-51
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-50
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-50
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-49
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-49
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-49
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-48
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-48
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-48
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-48
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-48
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-48
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-47
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-47
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-47
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-47
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-46
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-46
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-46
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-46
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-46
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-45
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-45
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-45
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-45
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-45
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-45
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-45
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-45
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-44
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-44
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-44
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-43
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-43
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-43
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-43
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-42
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-39
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-30
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-29
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-28
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-26
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-25
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-23
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-23
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-23
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-20
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-18
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-18
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-18
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-18
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-17
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-16
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-16
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-16
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-15
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-15
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-14
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-14
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-14
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-14
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-14
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-14
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-14
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-13
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-13
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-13
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-13
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-13
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-13
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-13
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-13
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-13
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-12
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-12
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-12
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-12
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-12
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-12
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-12
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-12
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-11
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-11
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-11
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-11
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-11
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-11
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-11
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-11
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-11
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-10
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-10
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-10
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-10
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-10
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-10
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-10
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-10
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-10
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-10
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-10
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-10
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-10
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-09
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-09
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-09
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-09
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-09
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-09
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-09
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-09
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-09
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-09
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-09
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-09
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-09
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-09
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-09
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-09
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-09
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-08
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-08
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-08
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-08
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-08
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-08
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-08
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-08
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-08
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-08
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-08
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-08
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-08
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-08
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-08
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-08
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-08
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-08
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-08
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-08
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-08
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-08
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-08
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-07
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-07
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-07
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-07
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-07
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-07
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-07
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-07
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-07
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-07
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-07
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-07
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-07
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-07
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-07
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-07
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-07
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-06
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-06
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-06
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-06
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-06
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-06
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-06
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-06
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-06
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-06
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-06
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-06
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-06
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-06
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-06
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-05
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-05
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-05
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-04
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-04
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-04
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-04
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-04
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-04
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-04
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-04
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-04

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  184 bits (470), Expect = 2e-59
 Identities = 47/107 (43%), Positives = 68/107 (63%), Gaps = 5/107 (4%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           QI AK   YL+  +    HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+
Sbjct: 125 QI-AKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGK 180

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            PIKW A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  182 bits (464), Expect = 6e-59
 Identities = 61/107 (57%), Positives = 82/107 (76%), Gaps = 4/107 (3%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           Q+ +   +YL+     F HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+
Sbjct: 125 QV-SMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           WP+KWYAPE  N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  181 bits (462), Expect = 1e-58
 Identities = 60/106 (56%), Positives = 82/106 (77%), Gaps = 2/106 (1%)

Query: 24  QIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW 83
           Q+ +   +YL+  K+  HRDLAARN+LL +RH AKISDFGLS+A+ ++ +YY A   G+W
Sbjct: 118 QV-SMGMKYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175

Query: 84  PIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           P+KWYAPE  NF +FSS SDVWS+G+T+WE  S+GQ+PY +MKG +
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  181 bits (461), Expect = 2e-58
 Identities = 50/107 (46%), Positives = 67/107 (62%), Gaps = 4/107 (3%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           Q+ A+   YL+  +  F HRDLAARN+LLA+R   KI DFGL RA+    ++Y      +
Sbjct: 129 QV-AEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            P  W APES     FS ASD W FG+TLWEM+++GQ+P+  + GS 
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  176 bits (449), Expect = 4e-56
 Identities = 47/107 (43%), Positives = 68/107 (63%), Gaps = 5/107 (4%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           QI AK   YL+  +    HRDLAARN+L+ +    KI+DFGL++ + +E   Y A  GG+
Sbjct: 125 QI-AKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGK 180

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            PIKW A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  172 bits (439), Expect = 1e-54
 Identities = 43/107 (40%), Positives = 69/107 (64%), Gaps = 5/107 (4%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           QI AK   YL+ H     HR+LAARN+LL S  Q +++DFG++  +  + +        +
Sbjct: 123 QI-AKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-DKQLLYSEAK 178

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            PIKW A ES +FG+++  SDVWS+G+T+WE+ +FG +PY  ++ ++
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  171 bits (435), Expect = 1e-54
 Identities = 55/118 (46%), Positives = 72/118 (61%), Gaps = 6/118 (5%)

Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSE 71
           L    L     QI  K   YL+       HRD+A RNIL+AS    K+ DFGLSR +  E
Sbjct: 110 LKVLTLVLYSLQI-CKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166

Query: 72  RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            +YYKA+   R PIKW +PES NF RF++ASDVW F + +WE+ SFG+QP+  ++  D
Sbjct: 167 -DYYKAS-VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  171 bits (435), Expect = 4e-54
 Identities = 44/100 (44%), Positives = 62/100 (62%), Gaps = 4/100 (4%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           QI  K   YL   +    HRDLAARNIL+ S    KI+DFGL++ +  +++YY     G+
Sbjct: 135 QI-CKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
            PI WYAPES +   FS  SDVWSFG+ L+E++++  +  
Sbjct: 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  177 bits (449), Expect = 8e-54
 Identities = 55/89 (61%), Positives = 73/89 (82%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HR+LAARN+LL +RH AKISDFGLS+A+ ++ +YY A   G+WP+KWYAPE  NF +FSS
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            SDVWS+G+T+WE  S+GQ+PY +MKG +
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  169 bits (429), Expect = 3e-53
 Identities = 49/107 (45%), Positives = 67/107 (62%), Gaps = 4/107 (3%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
            +     RYL      + HRDLAARN+L+ S    K+SDFGLSR +  + +    T GG+
Sbjct: 159 GV-GAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            PI+W APE+  F  FSSASDVWSFG+ +WE+ ++G++PY  M   D
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  167 bits (424), Expect = 8e-53
 Identities = 46/132 (34%), Positives = 66/132 (50%), Gaps = 18/132 (13%)

Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSE 71
           +          QI  K   YL   +  + HRDLAARN+L+ S HQ KI DFGL++A+ ++
Sbjct: 123 INLKQQLKYAVQI-CKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179

Query: 72  RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ----------- 120
           + YY        P+ WYAPE     +F  ASDVWSFG+TL E+ ++              
Sbjct: 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239

Query: 121 ---PYGEMKGSD 129
               +G+M  + 
Sbjct: 240 IGPTHGQMTVTR 251

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  165 bits (421), Expect = 2e-52
 Identities = 51/107 (47%), Positives = 71/107 (66%), Gaps = 6/107 (5%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           Q+ +    YL+  +  F HRD+AARN+L++S    K+ DFGLSR +     YYKA+  G+
Sbjct: 124 QL-STALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKAS-KGK 178

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            PIKW APES NF RF+SASDVW FG+ +WE+   G +P+  +K +D
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  166 bits (422), Expect = 3e-52
 Identities = 45/121 (37%), Positives = 59/121 (48%), Gaps = 18/121 (14%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           QI  +   YL      + HRDLAARN+LL +    KI DFGL++AV     YY+    G 
Sbjct: 142 QI-CEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ--------------PYGEMKGS 128
            P+ WYAPE     +F  ASDVWSFG+TL+E+ +                    G+M   
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258

Query: 129 D 129
            
Sbjct: 259 R 259

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  163 bits (416), Expect = 1e-51
 Identities = 46/133 (34%), Positives = 68/133 (51%), Gaps = 19/133 (14%)

Query: 13  LGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSE 71
           +    L     QI  K   YL   +  + HRDLA RNIL+ + ++ KI DFGL++ +  +
Sbjct: 111 IDHIKLLQYTSQI-CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167

Query: 72  RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSF-------------- 117
           + ++K    G  PI WYAPES    +FS ASDVWSFG+ L+E++++              
Sbjct: 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227

Query: 118 -GQQPYGEMKGSD 129
            G    G+M    
Sbjct: 228 IGNDKQGQMIVFH 240

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  164 bits (417), Expect = 6e-51
 Identities = 50/107 (46%), Positives = 68/107 (63%), Gaps = 4/107 (3%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
            I A   +YL      + HRDLAARNIL+ S    K+SDFGL R +  +      T GG+
Sbjct: 155 GI-ASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            PI+W +PE+  + +F+SASDVWS+GI LWE+ S+G++PY EM   D
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  162 bits (413), Expect = 7e-51
 Identities = 42/104 (40%), Positives = 59/104 (56%), Gaps = 15/104 (14%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLA RNIL+ + ++ KI DFGL++ +  ++ YYK    G  PI WYAPES    +FS 
Sbjct: 168 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSV 227

Query: 101 ASDVWSFGITLWEMYSF---------------GQQPYGEMKGSD 129
           ASDVWSFG+ L+E++++               G    G+M    
Sbjct: 228 ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  162 bits (411), Expect = 2e-50
 Identities = 49/107 (45%), Positives = 70/107 (65%), Gaps = 4/107 (3%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
            I A   +YL      + HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+
Sbjct: 155 GI-AAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            PI+W APE+ ++ +F+SASDVWSFGI +WE+ ++G++PY E+   +
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  158 bits (402), Expect = 9e-50
 Identities = 43/106 (40%), Positives = 66/106 (62%), Gaps = 4/106 (3%)

Query: 24  QIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW 83
            +  +   YL+      HRDLAARN L+      K+SDFG++R V    + Y ++ G ++
Sbjct: 112 DV-CEGMAYLE-EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKF 167

Query: 84  PIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           P+KW +PE ++F R+SS SDVWSFG+ +WE++S G+ PY     S+
Sbjct: 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  158 bits (403), Expect = 1e-49
 Identities = 48/125 (38%), Positives = 69/125 (55%), Gaps = 5/125 (4%)

Query: 2   KSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKIS 60
            + +   V + L      ++  QI A    YL  H     H+DLA RN+L+  +   KIS
Sbjct: 114 STDDDRTVKSALEPPDFVHLVAQI-AAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKIS 170

Query: 61  DFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
           D GL R V +  +YYK       PI+W APE+  +G+FS  SD+WS+G+ LWE++S+G Q
Sbjct: 171 DLGLFREVYAA-DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229

Query: 121 PYGEM 125
           PY   
Sbjct: 230 PYCGY 234

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  156 bits (397), Expect = 5e-49
 Identities = 43/107 (40%), Positives = 69/107 (64%), Gaps = 6/107 (5%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
            +  +   +L+ H+  F HRDLAARN L+      K+SDFG++R V    + Y ++ G +
Sbjct: 112 DV-CEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGTK 166

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +P+KW APE +++ ++SS SDVW+FGI +WE++S G+ PY     S+
Sbjct: 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  156 bits (397), Expect = 7e-49
 Identities = 43/107 (40%), Positives = 66/107 (61%), Gaps = 6/107 (5%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
            +  +   YL+  +  F HRDLAARN L+  +   K+SDFGLSR V    + Y ++ G +
Sbjct: 128 DV-CEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSK 182

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +P++W  PE   + +FSS SD+W+FG+ +WE+YS G+ PY     S+
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  157 bits (400), Expect = 1e-48
 Identities = 51/119 (42%), Positives = 68/119 (57%), Gaps = 5/119 (4%)

Query: 12  PLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNS 70
           PL       I  Q+ A    YL   K  F HRDLA RN L+      KI+DFGLSR + S
Sbjct: 170 PLSCAEQLCIARQV-AAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             +YYKA      PI+W  PES  + R+++ SDVW++G+ LWE++S+G QPY  M   +
Sbjct: 227 A-DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  163 bits (414), Expect = 2e-48
 Identities = 51/107 (47%), Positives = 71/107 (66%), Gaps = 6/107 (5%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           Q+ +    YL+  +  F HRD+AARN+L++S    K+ DFGLSR +     YYKA+  G+
Sbjct: 499 QL-STALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKAS-KGK 553

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            PIKW APES NF RF+SASDVW FG+ +WE+   G +P+  +K +D
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  156 bits (397), Expect = 2e-48
 Identities = 40/107 (37%), Positives = 59/107 (55%), Gaps = 5/107 (4%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
            I A    YL      F HRDLAARN +L       ++DFGLS+ +    +YY+     +
Sbjct: 155 DI-ALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIY-SGDYYRQGRIAK 210

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            P+KW A ES     ++S SDVW+FG+T+WE+ + G  PY  ++  +
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  157 bits (398), Expect = 2e-48
 Identities = 47/124 (37%), Positives = 69/124 (55%), Gaps = 5/124 (4%)

Query: 3   SPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISD 61
           +        PLG   L  +  Q+ A    YL      F HRDLA RN L+      KI D
Sbjct: 145 AGGEDVAPGPLGLGQLLAVASQV-AAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGD 201

Query: 62  FGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQP 121
           FG+SR + S  +YY+       PI+W  PES  + +F++ SDVWSFG+ LWE++++G+QP
Sbjct: 202 FGMSRDIYST-DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

Query: 122 YGEM 125
           + ++
Sbjct: 261 WYQL 264

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  155 bits (394), Expect = 3e-48
 Identities = 48/124 (38%), Positives = 69/124 (55%), Gaps = 5/124 (4%)

Query: 3   SPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISD 61
                     LG   + +I  QI A    YL      F HRDLA RN L+ +    KI D
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQI-ASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGD 176

Query: 62  FGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQP 121
           FG+SR V S  +YY+       PI+W  PES  + +F++ SDVWSFG+ LWE++++G+QP
Sbjct: 177 FGMSRDVYST-DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

Query: 122 YGEM 125
           + ++
Sbjct: 236 WFQL 239

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  155 bits (393), Expect = 8e-48
 Identities = 42/107 (39%), Positives = 61/107 (57%), Gaps = 5/107 (4%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
            I A    YL      F HRDLAARN +LA      ++DFGLSR +    +YY+     +
Sbjct: 145 DI-ACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIY-SGDYYRQGCASK 200

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            P+KW A ES     ++  SDVW+FG+T+WE+ + GQ PY  ++ ++
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  153 bits (389), Expect = 1e-47
 Identities = 47/106 (44%), Positives = 65/106 (61%), Gaps = 4/106 (3%)

Query: 24  QIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW 83
           QI A+   +++      HRDL A NIL++     KI+DFGL+R +  E N Y A  G ++
Sbjct: 117 QI-AEGMAFIEERNY-IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKF 172

Query: 84  PIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           PIKW APE+ N+G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  153 bits (389), Expect = 1e-47
 Identities = 47/106 (44%), Positives = 64/106 (60%), Gaps = 4/106 (3%)

Query: 24  QIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW 83
           QI +    YL+      HRDLAARN L+   H  K++DFGLSR +    + Y A  G ++
Sbjct: 119 QI-SSAMEYLEKKNF-IHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKF 174

Query: 84  PIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           PIKW APES  + +FS  SDVW+FG+ LWE+ ++G  PY  +  S 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  155 bits (394), Expect = 2e-47
 Identities = 46/101 (45%), Positives = 60/101 (59%), Gaps = 4/101 (3%)

Query: 30  CRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY 88
             YL        HRDLAARN L+  ++  KISDFG+SR   ++  Y  +    + P+KW 
Sbjct: 226 MEYL--ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWT 282

Query: 89  APESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           APE+ N+GR+SS SDVWSFGI LWE +S G  PY  +    
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  151 bits (385), Expect = 4e-47
 Identities = 45/106 (42%), Positives = 64/106 (60%), Gaps = 8/106 (7%)

Query: 24  QIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW 83
            +  +   YL+ +    HRDLAARN+L++  + AK+SDFGL++              G+ 
Sbjct: 125 DV-CEAMEYLEGNNF-VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKL 176

Query: 84  PIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           P+KW APE+    +FS+ SDVWSFGI LWE+YSFG+ PY  +   D
Sbjct: 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  151 bits (383), Expect = 1e-46
 Identities = 46/109 (42%), Positives = 66/109 (60%), Gaps = 7/109 (6%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA--THG 80
           Q+ AK  +YL   K  F HRDLAARN +L  +   K++DFGL+R +  ++ YY      G
Sbjct: 136 QV-AKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTG 191

Query: 81  GRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            + P+KW A ES    +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  151 bits (384), Expect = 1e-46
 Identities = 49/107 (45%), Positives = 63/107 (58%), Gaps = 5/107 (4%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           QI ++  +YL   K    HRDLAARNIL+A   + KISDFGLSR V  E + Y     GR
Sbjct: 158 QI-SQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEE-DSYVKRSQGR 213

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            P+KW A ES     +++ SDVWSFG+ LWE+ + G  PY  +    
Sbjct: 214 IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  154 bits (391), Expect = 2e-46
 Identities = 44/89 (49%), Positives = 59/89 (66%), Gaps = 2/89 (2%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+++    KI+DFGL+R +    N Y A  G ++PIKW APE+ NFG F+ 
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINFGSFTI 364

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            SDVWSFGI L E+ ++G+ PY  M   +
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPE 393

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  151 bits (383), Expect = 2e-46
 Identities = 47/125 (37%), Positives = 71/125 (56%), Gaps = 5/125 (4%)

Query: 2   KSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKIS 60
            +   + V+ P     +  + G+I A    YL  +K  F HRDLAARN ++A     KI 
Sbjct: 124 PAMANNPVLAPPSLSKMIQMAGEI-ADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIG 180

Query: 61  DFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
           DFG++R +    +YY+    G  P++W +PES   G F++ SDVWSFG+ LWE+ +  +Q
Sbjct: 181 DFGMTRDIYET-DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 239

Query: 121 PYGEM 125
           PY  +
Sbjct: 240 PYQGL 244

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  149 bits (378), Expect = 8e-46
 Identities = 47/109 (43%), Positives = 62/109 (56%), Gaps = 7/109 (6%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA--THG 80
           Q+ A+   YL   K  F HRDLAARN +L      K++DFGL+R +  +R YY       
Sbjct: 132 QV-ARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHRH 187

Query: 81  GRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            R P+KW A ES    RF++ SDVWSFG+ LWE+ + G  PY  +   D
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  149 bits (379), Expect = 1e-45
 Identities = 46/107 (42%), Positives = 64/107 (59%), Gaps = 8/107 (7%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
            + A+   YL   +  F HRDLAARNIL+   + AKI+DFGLSR     +  Y     GR
Sbjct: 150 DV-ARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 202

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            P++W A ES N+  +++ SDVWS+G+ LWE+ S G  PY  M  ++
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  152 bits (386), Expect = 1e-45
 Identities = 43/89 (48%), Positives = 58/89 (65%), Gaps = 6/89 (6%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDLAARN+L++  + AK+SDFGL++              G+ P+KW APE+    +FS+
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFST 365

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            SDVWSFGI LWE+YSFG+ PY  +   D
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPYPRIPLKD 394

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  148 bits (377), Expect = 1e-45
 Identities = 49/126 (38%), Positives = 65/126 (51%), Gaps = 5/126 (3%)

Query: 2   KSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKIS 60
           K          L    L     Q+ AK   +L   K    HRDLAARNILL+ ++  KI 
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQV-AKGMEFLASRK--CIHRDLAARNILLSEKNVVKIC 190

Query: 61  DFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
           DFGL+R +  +   Y      R P+KW APE+     ++  SDVWSFG+ LWE++S G  
Sbjct: 191 DFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249

Query: 121 PYGEMK 126
           PY  +K
Sbjct: 250 PYPGVK 255

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  150 bits (380), Expect = 2e-45
 Identities = 44/108 (40%), Positives = 65/108 (60%), Gaps = 5/108 (4%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAV-NSERNYYKATHGG 81
           Q+ AK  ++L   K  F HRDLAARN +L  +   K++DFGL+R + + E +      G 
Sbjct: 200 QV-AKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           + P+KW A ES    +F++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  148 bits (376), Expect = 3e-45
 Identities = 47/128 (36%), Positives = 69/128 (53%), Gaps = 5/128 (3%)

Query: 3   SPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISD 61
                     +    L     Q+ A+   YL   K    HRDLAARN+L+   +  KI+D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQL-ARGMEYLASQK--CIHRDLAARNVLVTENNVMKIAD 200

Query: 62  FGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQP 121
           FGL+R +N+  +YYK T  GR P+KW APE+     ++  SDVWSFG+ +WE+++ G  P
Sbjct: 201 FGLARDINNI-DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

Query: 122 YGEMKGSD 129
           Y  +   +
Sbjct: 260 YPGIPVEE 267

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  148 bits (376), Expect = 3e-45
 Identities = 46/121 (38%), Positives = 67/121 (55%), Gaps = 5/121 (4%)

Query: 3   SPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISD 61
            P  +   +   +  L +   Q+ A+   +L        HRD+AARN+LL + H AKI D
Sbjct: 151 DPAFAIANSTASTRDLLHFSSQV-AQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGD 207

Query: 62  FGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQP 121
           FGL+R + ++ + Y      R P+KW APES     ++  SDVWS+GI LWE++S G  P
Sbjct: 208 FGLARDIMND-SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

Query: 122 Y 122
           Y
Sbjct: 267 Y 267

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  148 bits (375), Expect = 3e-45
 Identities = 48/125 (38%), Positives = 61/125 (48%), Gaps = 5/125 (4%)

Query: 2   KSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKIS 60
                      L    L     Q+ AK   +L        HRDLAARNILL      KI 
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQV-AKGMAFLASKN--CIHRDLAARNILLTHGRITKIC 187

Query: 61  DFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
           DFGL+R + ++ + Y      R P+KW APES     ++  SDVWS+GI LWE++S G  
Sbjct: 188 DFGLARDIKND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246

Query: 121 PYGEM 125
           PY  M
Sbjct: 247 PYPGM 251

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  149 bits (378), Expect = 4e-45
 Identities = 47/119 (39%), Positives = 69/119 (57%), Gaps = 5/119 (4%)

Query: 12  PLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNS 70
            +    L     Q+ A+   YL   K    HRDLAARN+L+   +  KI+DFGL+R +N+
Sbjct: 199 QMTFKDLVSCTYQL-ARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINN 255

Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             +YYK T  GR P+KW APE+     ++  SDVWSFG+ +WE+++ G  PY  +   +
Sbjct: 256 I-DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  147 bits (373), Expect = 1e-44
 Identities = 45/104 (43%), Positives = 61/104 (58%), Gaps = 5/104 (4%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           Q+ AK   +L+       HRDLAARN+L+      KI DFGL+R + S+ + Y      R
Sbjct: 180 QV-AKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD-SNYVVRGNAR 235

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            P+KW APES   G ++  SDVWS+GI LWE++S G  PY  + 
Sbjct: 236 LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  145 bits (367), Expect = 6e-44
 Identities = 46/118 (38%), Positives = 65/118 (55%), Gaps = 8/118 (6%)

Query: 12  PLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILL---ASRHQAKISDFGLSRA 67
            L    L ++   I A  C+YL+ +   F HRD+AARN LL        AKI DFG++R 
Sbjct: 136 SLAMLDLLHVARDI-ACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192

Query: 68  VNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +    +YY+       P+KW  PE++  G F+S +D WSFG+ LWE++S G  PY   
Sbjct: 193 IY-RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  145 bits (369), Expect = 9e-44
 Identities = 49/119 (41%), Positives = 69/119 (57%), Gaps = 5/119 (4%)

Query: 12  PLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNS 70
            L S  L     Q+ A+   YL   K    HRDLAARN+L+   +  KI+DFGL+R ++ 
Sbjct: 187 QLSSKDLVSCAYQV-ARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243

Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             +YYK T  GR P+KW APE+     ++  SDVWSFG+ LWE+++ G  PY  +   +
Sbjct: 244 I-DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  143 bits (363), Expect = 1e-43
 Identities = 33/116 (28%), Positives = 50/116 (43%), Gaps = 20/116 (17%)

Query: 24  QIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQ--------AKISDFGLSRAVNSERNY 74
           Q+ A    +L+ +     H ++ A+NILL              K+SD G+S  V  + + 
Sbjct: 121 QL-AAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-DI 176

Query: 75  YKATHGGRWPIKWYAPES-YNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            +        I W  PE   N    + A+D WSFG TLWE+ S G +P   +    
Sbjct: 177 LQ------ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  144 bits (365), Expect = 3e-43
 Identities = 46/118 (38%), Positives = 64/118 (54%), Gaps = 8/118 (6%)

Query: 12  PLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILL---ASRHQAKISDFGLSRA 67
            L    L ++   I A  C+YL+ +   F HRD+AARN LL        AKI DFG++R 
Sbjct: 177 SLAMLDLLHVARDI-ACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 233

Query: 68  VNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +     YY+       P+KW  PE++  G F+S +D WSFG+ LWE++S G  PY   
Sbjct: 234 IY-RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  145 bits (368), Expect = 5e-43
 Identities = 46/106 (43%), Positives = 63/106 (59%), Gaps = 4/106 (3%)

Query: 24  QIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW 83
           QI A    Y++   +  HRDL A NIL+      K++DFGL+R +    N Y A  G ++
Sbjct: 288 QI-ASGMAYVE-RMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKF 343

Query: 84  PIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           PIKW APE+  +GRF+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 389

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  146 bits (369), Expect = 5e-43
 Identities = 42/89 (47%), Positives = 58/89 (65%), Gaps = 2/89 (2%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HR+LAARN L+   H  K++DFGLSR +    + Y A  G ++PIKW APES  + +FS 
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYNKFSI 398

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            SDVW+FG+ LWE+ ++G  PY  +  S 
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  144 bits (364), Expect = 5e-42
 Identities = 42/89 (47%), Positives = 56/89 (62%), Gaps = 2/89 (2%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL A NIL+      K++DFGL+R +    N Y A  G ++PIKW APE+  +GRF+ 
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRFTI 443

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNRE 472

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  132 bits (334), Expect = 8e-39
 Identities = 45/103 (43%), Positives = 62/103 (60%), Gaps = 3/103 (2%)

Query: 24  QIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW 83
           Q+ AK   +L   +   HRDLAARNILL+ ++  KI DFGL+R +  +   Y      R 
Sbjct: 201 QV-AKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARL 257

Query: 84  PIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
           P+KW APE+     ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  106 bits (267), Expect = 3e-29
 Identities = 29/107 (27%), Positives = 44/107 (41%), Gaps = 15/107 (14%)

Query: 31  RYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK--- 86
            YL  H  +  HRDL + N L+       ++DFGL+R +  E+   +     + P +   
Sbjct: 122 AYL--HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179

Query: 87  --------WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
                   W APE  N   +    DV+SFGI L E+         + 
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG-RVNADPDY 225

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  102 bits (257), Expect = 6e-28
 Identities = 37/102 (36%), Positives = 49/102 (48%), Gaps = 8/102 (7%)

Query: 32  YLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP 90
           YL  H  S  HRDL + NI L   +  KI DFGL+    S  +           I W AP
Sbjct: 135 YL--HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT-EKSRWSGSHQFEQLSGSILWMAP 191

Query: 91  E---SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           E     +   +S  SDV++FGI L+E+ + GQ PY  +   D
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRD 232

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 98.5 bits (246), Expect = 2e-26
 Identities = 38/111 (34%), Positives = 51/111 (45%), Gaps = 16/111 (14%)

Query: 27  AKVCRYLKMHKSSF--HRDLAARNILL--------ASRHQAKISDFGLSRAVNSERNYYK 76
           A+   YL         HRDL + NIL+         S    KI+DFGL+R     R    
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKM 172

Query: 77  ATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG 127
           +  G      W APE      FS  SDVWS+G+ LWE+ + G+ P+  + G
Sbjct: 173 SAAG---AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT-GEVPFRGIDG 219

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 96.6 bits (241), Expect = 2e-25
 Identities = 36/104 (34%), Positives = 53/104 (50%), Gaps = 5/104 (4%)

Query: 27  AKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
           AK   YL        HR+L + N+L+  ++  K+ DFGLSR   S     K+  G     
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG---TP 203

Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +W APE       +  SDV+SFG+ LWE+ +  QQP+G +  + 
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQ 246

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 90.9 bits (226), Expect = 2e-23
 Identities = 31/107 (28%), Positives = 49/107 (45%), Gaps = 14/107 (13%)

Query: 27  AKVCRYLKMHKSSF----HRDLAARNILLASRHQ-AKISDFGLSRAVNSERNYYKATHGG 81
           ++   YL  H        HRDL   N+LL +     KI DFG +  + +           
Sbjct: 112 SQGVAYL--HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT------NN 163

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS 128
           +    W APE +    +S   DV+S+GI LWE+ +  ++P+ E+ G 
Sbjct: 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT-RRKPFDEIGGP 209

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 89.6 bits (223), Expect = 5e-23
 Identities = 19/92 (20%), Positives = 40/92 (43%), Gaps = 12/92 (13%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN---FGR 97
              L +R++++     A+IS   +  +  S         G  +   W APE+        
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSFQSP--------GRMYAPAWVAPEALQKKPEDT 187

Query: 98  FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
              ++D+WSF + LWE+ +  + P+ ++   +
Sbjct: 188 NRRSADMWSFAVLLWELVT-REVPFADLSNME 218

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 89.3 bits (222), Expect = 8e-23
 Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 14/96 (14%)

Query: 41  HRDLAARNILLASRHQ-----AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE--SY 93
           HRDL + NI L S  +     AK++DFGLS+             G     +W APE    
Sbjct: 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS------VSGLLGNFQWMAPETIGA 200

Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
               ++  +D +SF + L+ + + G+ P+ E     
Sbjct: 201 EEESYTEKADTYSFAMILYTILT-GEGPFDEYSYGK 235

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 83.9 bits (208), Expect = 1e-20
 Identities = 25/107 (23%), Positives = 43/107 (40%), Gaps = 18/107 (16%)

Query: 32  YLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-- 88
           YL  H     H+DL ++N+      +  I+DFGL   ++      +     R    W   
Sbjct: 145 YL--HAKGILHKDLKSKNVFY-DNGKVVITDFGLFS-ISGVLQAGRREDKLRIQNGWLCH 200

Query: 89  -APE---------SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            APE           +   FS  SDV++ G   +E+++  + P+   
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA-REWPFKTQ 246

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 76.6 bits (189), Expect = 5e-18
 Identities = 25/105 (23%), Positives = 44/105 (41%), Gaps = 16/105 (15%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK-ATHGGRWPIKWYAPE------SY 93
           HRDL ++NIL+    Q  I+D GL+   +   N      +      ++ APE        
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195

Query: 94  NFGRFSSASDVWSFGITLWEMYS---------FGQQPYGEMKGSD 129
           +        D+W+FG+ LWE+             + P+ ++  +D
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 76.7 bits (189), Expect = 7e-18
 Identities = 29/105 (27%), Positives = 47/105 (44%), Gaps = 16/105 (15%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK-ATHGGRWPIKWYAPE----SYNF 95
           HRDL ++NIL+       I+D GL+   +S  +    A +      ++ APE    S N 
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229

Query: 96  GRFSS--ASDVWSFGITLWEMYSFG---------QQPYGEMKGSD 129
             F S   +D+++ G+  WE+             Q PY ++  SD
Sbjct: 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 76.3 bits (188), Expect = 9e-18
 Identities = 31/105 (29%), Positives = 47/105 (44%), Gaps = 16/105 (15%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNY-YKATHGGRWPIKWYAPE----SYNF 95
           HRDL ++NIL+       I+D GL+    S+ N      +      ++  PE    S N 
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224

Query: 96  GRFSS--ASDVWSFGITLWEMYS---------FGQQPYGEMKGSD 129
             F S   +D++SFG+ LWE+             Q PY ++  SD
Sbjct: 225 NHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 76.4 bits (188), Expect = 1e-17
 Identities = 34/109 (31%), Positives = 52/109 (47%), Gaps = 16/109 (14%)

Query: 22  EGQIPAKVCR-------YLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERN 73
           E  +  KV         YL+      HRD+   NIL+ SR + K+ DFG+S + ++S  N
Sbjct: 130 EQIL-GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188

Query: 74  YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               +  G     + +PE      +S  SD+WS G++L EM   G+ P 
Sbjct: 189 ----SFVGTRS--YMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPI 230

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 71.7 bits (176), Expect = 5e-16
 Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 8/92 (8%)

Query: 41  HRDLAARNILLA-----SRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN- 94
           HRDL   NIL++      + +A ISDFGL + +   R+ +    G      W APE  + 
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 95  --FGRFSSASDVWSFGITLWEMYSFGQQPYGE 124
                 +   D++S G   + + S G  P+G+
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 70.5 bits (173), Expect = 9e-16
 Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 20/106 (18%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH--GGRWPIKWYAPE----SYN 94
           HRD+ ++N+LL +   A I+DFGL+    + ++        G R   ++ APE    + N
Sbjct: 154 HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR---RYMAPEVLEGAIN 210

Query: 95  FGRFSS-ASDVWSFGITLWEMYS----------FGQQPYGEMKGSD 129
           F R +    D+++ G+ LWE+ S              P+ E  G  
Sbjct: 211 FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 69.6 bits (171), Expect = 2e-15
 Identities = 34/118 (28%), Positives = 50/118 (42%), Gaps = 19/118 (16%)

Query: 22  EGQIPAKVCR-------YLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERN 73
           E  +  K+         +L    S  HRD+   N+L+ +  Q K+ DFG+S   V+    
Sbjct: 108 EDIL-GKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA- 165

Query: 74  YYKATHGGRWPIKWYAPE----SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG 127
             K    G  P  + APE      N   +S  SD+WS GIT+ E+    + PY     
Sbjct: 166 --KDIDAGCKP--YMAPERINPELNQKGYSVKSDIWSLGITMIELAI-LRFPYDSWGT 218

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 68.5 bits (168), Expect = 6e-15
 Identities = 38/118 (32%), Positives = 55/118 (46%), Gaps = 19/118 (16%)

Query: 22  EGQIPAKVCR-------YLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERN 73
           E  +  K+         +LK +    HRD+   NILL      K+ DFG+S + V+S   
Sbjct: 124 EEIL-GKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA- 181

Query: 74  YYKATHGGRWPIKWYAPE----SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG 127
             K    G  P  + APE    S +   +   SDVWS GITL+E+ + G+ PY +   
Sbjct: 182 --KTRDAGCRP--YMAPERIDPSASRQGYDVRSDVWSLGITLYELAT-GRFPYPKWNS 234

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 67.8 bits (166), Expect = 8e-15
 Identities = 39/119 (32%), Positives = 52/119 (43%), Gaps = 20/119 (16%)

Query: 22  EGQIPAKVCR-------YLKMHKSSFHRDLAARNILLASRHQAKISDFGLS-RAVNSERN 73
           E  +  K+         YLK      HRD+   NILL  R Q K+ DFG+S R V+ +  
Sbjct: 123 ERIL-GKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA- 180

Query: 74  YYKATHGGRWPIKWYAPE-----SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG 127
             K    G     + APE           +   +DVWS GI+L E+ + GQ PY   K 
Sbjct: 181 --KDRSAGCAA--YMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT-GQFPYKNCKT 234

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 67.6 bits (166), Expect = 1e-14
 Identities = 32/97 (32%), Positives = 46/97 (47%), Gaps = 17/97 (17%)

Query: 32  YLKMHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY-----KATHGGRWPI 85
           YL  H  +  HRD+ + NILL      KI+DFG+S+        +     K T G     
Sbjct: 154 YL--HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLG----- 206

Query: 86  KWY-APESYNFGRFSSASDVWSFGITLWEMYSFGQQP 121
             Y  PE +  GR +  SDV+SFG+ L+E+    +  
Sbjct: 207 --YIDPEYFIKGRLTEKSDVYSFGVVLFEVLC-ARSA 240

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 67.2 bits (165), Expect = 1e-14
 Identities = 33/97 (34%), Positives = 45/97 (46%), Gaps = 18/97 (18%)

Query: 32  YLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYY-----KATHGGRWPI 85
           +L  H++   HRD+ + NILL     AKISDFGL+RA               T       
Sbjct: 148 FL--HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTA----- 200

Query: 86  KWY-APESYNFGRFSSASDVWSFGITLWEMYSFGQQP 121
             Y APE    G  +  SD++SFG+ L E+ + G   
Sbjct: 201 --YMAPE-ALRGEITPKSDIYSFGVVLLEIIT-GLPA 233

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 67.2 bits (164), Expect = 2e-14
 Identities = 27/123 (21%), Positives = 49/123 (39%), Gaps = 28/123 (22%)

Query: 22  EGQIPAKVCR-------YLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERN 73
           E  I A + +       Y+  H   + HR + A +IL++   +  +S    + ++ S   
Sbjct: 127 ELAI-AYILQGVLKALDYI--HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183

Query: 74  YYKATHGGRWPIK----WYAPE-------SYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
             +  H           W +PE        Y+       SD++S GIT  E+ + G  P+
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA-----KSDIYSVGITACELAN-GHVPF 237

Query: 123 GEM 125
            +M
Sbjct: 238 KDM 240

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 66.4 bits (162), Expect = 3e-14
 Identities = 26/113 (23%), Positives = 42/113 (37%), Gaps = 24/113 (21%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK-----ATHGGRWPIKWYAPE---- 91
           HRDL +RN+L+ +     ISDFGLS  +   R         A       I++ APE    
Sbjct: 143 HRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202

Query: 92  ---SYNFGRFSSASDVWSFGITLWEMYSFG------------QQPYGEMKGSD 129
                +        D+++ G+  WE++               Q  +    G+ 
Sbjct: 203 AVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNH 255

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 66.2 bits (162), Expect = 4e-14
 Identities = 39/118 (33%), Positives = 50/118 (42%), Gaps = 21/118 (17%)

Query: 19  PYIEGQIPAKVCR-------YLKMHKSS-FHRDLAARNILLASRHQAKISDFGLS---RA 67
              EGQI A VCR       +L  H +   HRD+ + NILL      K++DFG       
Sbjct: 112 CMDEGQI-AAVCRECLQALEFL--HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168

Query: 68  VNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
             S+R+    T     P  W APE      +    D+WS GI   EM   G+ PY   
Sbjct: 169 EQSKRSTMVGT-----PY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNE 219

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 65.8 bits (161), Expect = 4e-14
 Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 21/115 (18%)

Query: 22  EGQIPAKVCR-------YLKMHKSS-FHRDLAARNILLASRHQAKISDFGLS---RAVNS 70
           E QI A + R       YL  H     HRD+ A N+LL+   + K++DFG++        
Sbjct: 118 ETQI-ATILREILKGLDYL--HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174

Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +RN +  T     P  W APE      + S +D+WS GIT  E+   G+ P+ E+
Sbjct: 175 KRNTFVGT-----PF-WMAPEVIKQSAYDSKADIWSLGITAIELAR-GEPPHSEL 222

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 65.8 bits (161), Expect = 5e-14
 Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 21/115 (18%)

Query: 22  EGQIPAKVCR-------YLKMHKSS-FHRDLAARNILLASRHQAKISDFGLS---RAVNS 70
           E +I A + +       YL  H     HRD+ A NILL +   AK++DFG++       +
Sbjct: 124 EDEI-ATILQSTLKGLEYL--HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180

Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +RN    T     P  W APE      ++  +D+WS GIT  EM   G+ PY ++
Sbjct: 181 KRNTVIGT-----PF-WMAPEVIQEIGYNCVADIWSLGITAIEMAE-GKPPYADI 228

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 65.9 bits (161), Expect = 6e-14
 Identities = 38/115 (33%), Positives = 53/115 (46%), Gaps = 15/115 (13%)

Query: 19  PYIEGQIPAKVCR-------YLKMHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNS 70
              E QI A VC        YL  H     HRD+ + +ILL    + K+SDFG   A  S
Sbjct: 137 RLNEEQI-ATVCEAVLQALAYL--HAQGVIHRDIKSDSILLTLDGRVKLSDFGFC-AQIS 192

Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +    + +  G  P  W APE  +   +++  D+WS GI + EM   G+ PY   
Sbjct: 193 KDVPKRKSLVGT-PY-WMAPEVISRSLYATEVDIWSLGIMVIEM-VDGEPPYFSD 244

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 65.8 bits (161), Expect = 6e-14
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 11/92 (11%)

Query: 29  VCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           + + L+ +H +   HRDL   N+ +    + KI DFGL+R  +SE   Y  T       +
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT-------R 189

Query: 87  WY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
           WY APE   N+ R++   D+WS G  + EM +
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 64.3 bits (157), Expect = 1e-13
 Identities = 26/89 (29%), Positives = 39/89 (43%), Gaps = 10/89 (11%)

Query: 41  HRDLAARNILLASRH-QAKISDFGLSRAVN-SERNYYKATHGGRWPIKWYAPESYNFGRF 98
           HRDL   NI +       KI D GL+     S       T       ++ APE Y    +
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP------EFMAPEMYEEK-Y 206

Query: 99  SSASDVWSFGITLWEMYSFGQQPYGEMKG 127
             + DV++FG+ + EM +  + PY E + 
Sbjct: 207 DESVDVYAFGMCMLEMAT-SEYPYSECQN 234

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 64.2 bits (157), Expect = 2e-13
 Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 11/92 (11%)

Query: 29  VCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           + + LK +H +   HRDL   N+ +    + KI DFGL+R  ++E   Y  T       +
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT-------R 187

Query: 87  WY-APES-YNFGRFSSASDVWSFGITLWEMYS 116
           WY APE   ++  ++   D+WS G  + EM +
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 63.9 bits (156), Expect = 2e-13
 Identities = 43/122 (35%), Positives = 57/122 (46%), Gaps = 29/122 (23%)

Query: 22  EGQIPAKVCR-------YLKMHKSSF-HRDLAARNILLASRHQAKISDFG----LSRAVN 69
           E  I A + R       YL  HK+   HRD+ A NILL      +I+DFG    L+   +
Sbjct: 120 ESTI-ATILREVLEGLEYL--HKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176

Query: 70  SERNYYKATHGGRWPIKWYAPE------SYNFGRFSSASDVWSFGITLWEMYSFGQQPYG 123
             RN  + T  G  P  W APE       Y+F      +D+WSFGIT  E+ + G  PY 
Sbjct: 177 ITRNKVRKTFVGT-PC-WMAPEVMEQVRGYDF-----KADIWSFGITAIELAT-GAAPYH 228

Query: 124 EM 125
           + 
Sbjct: 229 KY 230

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 64.1 bits (156), Expect = 2e-13
 Identities = 22/91 (24%), Positives = 35/91 (38%), Gaps = 10/91 (10%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKW------ 87
           +H     HRDL   NI        K+ DFGL  A++ +                      
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 88  --Y-APESYNFGRFSSASDVWSFGITLWEMY 115
             Y +PE  +   +S   D++S G+ L+E+ 
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 64.3 bits (156), Expect = 2e-13
 Identities = 18/118 (15%), Positives = 38/118 (32%), Gaps = 15/118 (12%)

Query: 12  PLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNS 70
             G  AL  +  Q+  ++   L        H      N+ +    +  + D      V +
Sbjct: 190 DEGILALHILTAQL-IRLAANL--QSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

Query: 71  ERNYYKATHGGRWPIKWYAPESYNFGR---FSSASDVWSFGITLWEMYSFGQQPYGEM 125
                            YAP  +       F+ A + W  G++++ ++     P+G +
Sbjct: 247 RGPASSVPV-------TYAPREFLNASTATFTHALNAWQLGLSIYRVWC-LFLPFGLV 296

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 63.5 bits (155), Expect = 3e-13
 Identities = 20/83 (24%), Positives = 33/83 (39%), Gaps = 9/83 (10%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY---------APE 91
           HRDL   NI        K+ DFGL  A++ +              +           +PE
Sbjct: 141 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE 200

Query: 92  SYNFGRFSSASDVWSFGITLWEM 114
             +   +S   D++S G+ L+E+
Sbjct: 201 QIHGNSYSHKVDIFSLGLILFEL 223

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 63.6 bits (155), Expect = 3e-13
 Identities = 38/118 (32%), Positives = 54/118 (45%), Gaps = 22/118 (18%)

Query: 19  PYIEGQIPAKVCR-------YLKMHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNS 70
           P  E +I A V         YL  H  +  HRD+ A NILL+     K+ DFG + ++ +
Sbjct: 150 PLQEVEI-AAVTHGALQGLAYL--HSHNMIHRDVKAGNILLSEPGLVKLGDFGSA-SIMA 205

Query: 71  ERNYYKATHGGRWPIKWYAPE---SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
             N +  T     P  W APE   + + G++    DVWS GIT  E+    + P   M
Sbjct: 206 PANSFVGT-----PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNM 256

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 63.5 bits (155), Expect = 3e-13
 Identities = 38/117 (32%), Positives = 55/117 (47%), Gaps = 20/117 (17%)

Query: 22  EGQIPAKVCR-------YLKMHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERN 73
           E QI   VCR       +L  H     HRDL A N+L+      +++DFG+S A N +  
Sbjct: 116 EPQI-QVVCRQMLEALNFL--HSKRIIHRDLKAGNVLMTLEGDIRLADFGVS-AKNLKTL 171

Query: 74  YYKATHGGRWPIKWYAPE-----SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
             + +  G  P  W APE     +     +   +D+WS GITL EM    + P+ E+
Sbjct: 172 QKRDSFIGT-PY-WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ-IEPPHHEL 225

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 63.1 bits (154), Expect = 4e-13
 Identities = 24/91 (26%), Positives = 33/91 (36%), Gaps = 22/91 (24%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK-----------WYA 89
           HRDL   NI +      KI DFGL++ V+   +  K                     + A
Sbjct: 139 HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA 198

Query: 90  PE------SYNFGRFSSASDVWSFGITLWEM 114
            E       YN        D++S GI  +EM
Sbjct: 199 TEVLDGTGHYN-----EKIDMYSLGIIFFEM 224

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 63.5 bits (155), Expect = 4e-13
 Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 11/92 (11%)

Query: 29  VCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           + R LK +H +   HRDL   N+ +    + KI DFGL+R    E   Y AT       +
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT-------R 193

Query: 87  WY-APES-YNFGRFSSASDVWSFGITLWEMYS 116
           WY APE   N+  ++   D+WS G  + E+ +
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 62.3 bits (152), Expect = 7e-13
 Identities = 21/85 (24%), Positives = 37/85 (43%), Gaps = 10/85 (11%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA--THGGRWPIKWY-APESYNFGR 97
           +RDL   NI L    Q KI DFGL  ++ ++    ++  T         Y +PE  +   
Sbjct: 145 NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT-----L--RYMSPEQISSQD 197

Query: 98  FSSASDVWSFGITLWEMYSFGQQPY 122
           +    D+++ G+ L E+       +
Sbjct: 198 YGKEVDLYALGLILAELLHVCDTAF 222

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 62.4 bits (152), Expect = 1e-12
 Identities = 40/125 (32%), Positives = 54/125 (43%), Gaps = 36/125 (28%)

Query: 22  EGQIPAKVCR-------YLKMHKSS-FHRDLAARNILLASRHQAKISDFGLSR---AVNS 70
           E  I A +CR       +L  H+    HRD+  +N+LL    + K+ DFG+S        
Sbjct: 128 EEWI-AYICREILRGLSHL--HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184

Query: 71  ERNYYKATHGGRWPIKWYAPE----------SYNFGRFSSASDVWSFGITLWEMYSFGQQ 120
            RN +  T     P  W APE          +Y+F      SD+WS GIT  EM   G  
Sbjct: 185 RRNTFIGT-----P-YWMAPEVIACDENPDATYDF-----KSDLWSLGITAIEMAE-GAP 232

Query: 121 PYGEM 125
           P  +M
Sbjct: 233 PLCDM 237

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 62.1 bits (151), Expect = 1e-12
 Identities = 21/90 (23%), Positives = 36/90 (40%), Gaps = 8/90 (8%)

Query: 41  HRDLAARNILLASR-HQAKISDFGLSRAVNSERNYYKATHGGRWPIK----WYAPESYNF 95
           H D+ A N+LL+S   +A + DFG +  +    +    +      I       APE    
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQP--DGLGKSLLTGDYIPGTETHMAPEVVMG 230

Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
               +  D+WS    +  M + G  P+ + 
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLN-GCHPWTQY 259

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 61.1 bits (149), Expect = 2e-12
 Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 17/98 (17%)

Query: 29  VCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------YKATHG 80
           + R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++      Y AT  
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT-- 194

Query: 81  GRWPIKWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
                +WY APE   N   ++ + D+WS G  L EM S
Sbjct: 195 -----RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 60.8 bits (148), Expect = 3e-12
 Identities = 25/79 (31%), Positives = 37/79 (46%), Gaps = 13/79 (16%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE-----SYNF 95
           HRD+   N+ + +    K+ D GL R  +S+     +  G   P  + +PE      YNF
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT--PY-YMSPERIHENGYNF 215

Query: 96  GRFSSASDVWSFGITLWEM 114
                 SD+WS G  L+EM
Sbjct: 216 -----KSDIWSLGCLLYEM 229

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 60.4 bits (147), Expect = 3e-12
 Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 7/88 (7%)

Query: 41  HRDLAARNILLASRH-QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR-- 97
           HRD+   N+L+ +     KISDFG S+ +       +   G    +++ APE  + G   
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG---TLQYMAPEIIDKGPRG 201

Query: 98  FSSASDVWSFGITLWEMYSFGQQPYGEM 125
           +  A+D+WS G T+ EM + G+ P+ E+
Sbjct: 202 YGKAADIWSLGCTIIEMAT-GKPPFYEL 228

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 60.4 bits (147), Expect = 3e-12
 Identities = 27/75 (36%), Positives = 42/75 (56%), Gaps = 5/75 (6%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFGRFS 99
           HRDL   N+ L  +   K+ DFGL+R +N + ++ K   G   P  +Y +PE  N   ++
Sbjct: 139 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT--P--YYMSPEQMNRMSYN 194

Query: 100 SASDVWSFGITLWEM 114
             SD+WS G  L+E+
Sbjct: 195 EKSDIWSLGCLLYEL 209

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 60.8 bits (148), Expect = 4e-12
 Identities = 31/94 (32%), Positives = 45/94 (47%), Gaps = 13/94 (13%)

Query: 29  VCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY--YKATHGGRWP 84
           +   L  +H++   HRDL   NILLA  +   I DF L+R   ++ N   Y         
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH------ 196

Query: 85  IKWY-APES-YNFGRFSSASDVWSFGITLWEMYS 116
            +WY APE    F  F+   D+WS G  + EM++
Sbjct: 197 -RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 60.6 bits (147), Expect = 4e-12
 Identities = 26/106 (24%), Positives = 47/106 (44%), Gaps = 23/106 (21%)

Query: 41  HRDLAARNILLASRH-------------QAKISDFGLSRAVNSERNYYKATHGGRW--PI 85
           HRDL  +NIL+++               +  ISDFGL + ++S ++ ++           
Sbjct: 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197

Query: 86  KWYAPE-------SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE 124
            W APE            R + + D++S G   + + S G+ P+G+
Sbjct: 198 -WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 60.3 bits (147), Expect = 5e-12
 Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 10/98 (10%)

Query: 29  VCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPI- 85
             R +K +H S+  HRDL   N+L+ S    K+ DFGL+R ++          G +  + 
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 86  -----KWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
                +WY APE      ++S A DVWS G  L E++ 
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 60.1 bits (146), Expect = 6e-12
 Identities = 25/79 (31%), Positives = 40/79 (50%), Gaps = 13/79 (16%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE-----SYNF 95
           HRD+ ++NI L      ++ DFG++R +NS     +A  G   P  + +PE      YN 
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGT--PY-YLSPEICENKPYNN 204

Query: 96  GRFSSASDVWSFGITLWEM 114
                 SD+W+ G  L+E+
Sbjct: 205 -----KSDIWALGCVLYEL 218

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 59.6 bits (145), Expect = 7e-12
 Identities = 27/99 (27%), Positives = 45/99 (45%), Gaps = 18/99 (18%)

Query: 27  AKVCRYLK--------MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNS--ERNYY 75
           A+V  YL+        +H     H D+   NI L  R + K+ DFGL   + +       
Sbjct: 157 AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ 216

Query: 76  KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEM 114
           +         ++ APE    G + +A+DV+S G+T+ E+
Sbjct: 217 EGD------PRYMAPELLQ-GSYGTAADVFSLGLTILEV 248

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 59.5 bits (145), Expect = 9e-12
 Identities = 27/87 (31%), Positives = 48/87 (55%), Gaps = 13/87 (14%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNY----YKATHGGRWPIKWY-APESYNF 95
           HRD+ A NILL    +A + DFGL++ ++ +  +     + T G       + APE  + 
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG-------HIAPEYLST 209

Query: 96  GRFSSASDVWSFGITLWEMYSFGQQPY 122
           G+ S  +DV+ +G+ L E+ + GQ+ +
Sbjct: 210 GKSSEKTDVFGYGVMLLELIT-GQRAF 235

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 59.2 bits (144), Expect = 1e-11
 Identities = 27/99 (27%), Positives = 46/99 (46%), Gaps = 18/99 (18%)

Query: 29  VCRYLK-MHKSS-FHRDLAARNILLASRH-QAKISDFGLSRAVNSERNY------YKATH 79
           + R LK +H ++  HRDL   N+ + +     KI DFGL+R ++   ++         T 
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT- 187

Query: 80  GGRWPIKWY-APE-SYNFGRFSSASDVWSFGITLWEMYS 116
                 KWY +P    +   ++ A D+W+ G    EM +
Sbjct: 188 ------KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 59.3 bits (143), Expect = 1e-11
 Identities = 20/111 (18%), Positives = 38/111 (34%), Gaps = 15/111 (13%)

Query: 12  PLGSYALPYIEGQIPAKVCRYLKMHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNS 70
            L  +A   +  Q+  ++   L  H     H  L   +I+L  R    ++ F       +
Sbjct: 207 SLVHHARLQLTLQV-IRLLASL--HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263

Query: 71  ERNYYKATHGGRW--PIKWYAPESYNF-----GRFSSASDVWSFGITLWEM 114
                  +  GR   P +  A     F        + A D W+ G+ ++ +
Sbjct: 264 SA----VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 58.7 bits (142), Expect = 2e-11
 Identities = 24/100 (24%), Positives = 40/100 (40%), Gaps = 16/100 (16%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNS-ERNYYKATHGGRWPIKWYAPE-------- 91
           H DL   N L+      K+ DFG++  +     +  K +  G     +  PE        
Sbjct: 178 HSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN--YMPPEAIKDMSSS 234

Query: 92  ---SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS 128
                +  + S  SDVWS G  L+ M  +G+ P+ ++   
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIINQ 273

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 58.2 bits (141), Expect = 2e-11
 Identities = 24/100 (24%), Positives = 40/100 (40%), Gaps = 16/100 (16%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNS-ERNYYKATHGGRWPIKWYAPE-------- 91
           H DL   N L+      K+ DFG++  +     +  K +  G     +  PE        
Sbjct: 131 HSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN--YMPPEAIKDMSSS 187

Query: 92  ---SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS 128
                +  + S  SDVWS G  L+ M  +G+ P+ ++   
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIINQ 226

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 58.1 bits (141), Expect = 3e-11
 Identities = 24/100 (24%), Positives = 40/100 (40%), Gaps = 16/100 (16%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNS-ERNYYKATHGGRWPIKWYAPE-------- 91
           H DL   N L+      K+ DFG++  +     +  K +  G     +  PE        
Sbjct: 150 HSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN--YMPPEAIKDMSSS 206

Query: 92  ---SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS 128
                +  + S  SDVWS G  L+ M  +G+ P+ ++   
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIINQ 245

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 58.1 bits (141), Expect = 3e-11
 Identities = 25/101 (24%), Positives = 45/101 (44%), Gaps = 18/101 (17%)

Query: 30  CRYLK-MHKSS---FHRDLAARNILL-ASRHQAKISDFGLSRAVNSERNY--YKATHGGR 82
            R +  +H  S    HRD+   N+L+  +    K+ DFG ++ ++       Y  +    
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS---- 194

Query: 83  WPIKWY-APES-YNFGRFSSASDVWSFGITLWEMYSFGQQP 121
              ++Y APE  +    +++A D+WS G    EM     +P
Sbjct: 195 ---RYYRAPELIFGNQHYTTAVDIWSVGCIFAEM--MLGEP 230

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 57.0 bits (138), Expect = 7e-11
 Identities = 28/88 (31%), Positives = 40/88 (45%), Gaps = 10/88 (11%)

Query: 31  RYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY--YKATHGGRWPIK 86
             +K +H +   HRDL   NI++ S    KI DFGL+R   +      Y  T   R+   
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT---RY--- 191

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEM 114
           + APE      +    D+WS G  + EM
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEM 219

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 57.0 bits (137), Expect = 9e-11
 Identities = 24/93 (25%), Positives = 36/93 (38%), Gaps = 24/93 (25%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERN--------YYKATHGGRWPIKWYA 89
           HRDL   NI+L    Q    KI D G ++ ++             Y             A
Sbjct: 144 HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQY------------LA 191

Query: 90  PESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           PE     +++   D WSFG   +E  + G +P+
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECIT-GFRPF 223

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 56.4 bits (137), Expect = 9e-11
 Identities = 25/86 (29%), Positives = 43/86 (50%), Gaps = 16/86 (18%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK----WY-APESYNF 95
           HRDL  +N+L+    + K+++FGL+RA       Y  +       +    WY  P+   F
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SA------EVVTLWYRPPDVL-F 174

Query: 96  G--RFSSASDVWSFGITLWEMYSFGQ 119
           G   +S++ D+WS G    E+ + G+
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 56.6 bits (137), Expect = 1e-10
 Identities = 29/105 (27%), Positives = 40/105 (38%), Gaps = 12/105 (11%)

Query: 29  VCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           +CR L+ +H   + HRDL   NILL    Q  + D G            +     +    
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 87  WY------APE---SYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                   APE     +       +DVWS G  L+ M  FG+ PY
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM-MFGEGPY 246

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 56.7 bits (137), Expect = 1e-10
 Identities = 29/119 (24%), Positives = 43/119 (36%), Gaps = 22/119 (18%)

Query: 31  RYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK-- 86
                +H+S   HRDL   N LL      K+ DFGL+R +NSE++               
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199

Query: 87  ----------------WY-APE-SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG 127
                           WY APE       ++ + D+WS G    E+ +  Q    +   
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 56.4 bits (137), Expect = 1e-10
 Identities = 27/82 (32%), Positives = 39/82 (47%), Gaps = 16/82 (19%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK----WY-APESYNF 95
           HRDL  +NIL+ S  Q K++DFGL+R  + +      T            WY APE    
Sbjct: 143 HRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TS------VVVTLWYRAPEVL-L 192

Query: 96  G-RFSSASDVWSFGITLWEMYS 116
              +++  D+WS G    EM+ 
Sbjct: 193 QSSYATPVDLWSVGCIFAEMFR 214

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 56.7 bits (137), Expect = 1e-10
 Identities = 22/99 (22%), Positives = 43/99 (43%), Gaps = 16/99 (16%)

Query: 30  CRYLK-MHKSS-FHRDLAARNILL-ASRHQAKISDFGLSRAVNSERNY--YKATHGGRWP 84
            R +  +H     HRD+  +N+L+ +  +  K+ DFG ++ +        Y  +      
Sbjct: 151 FRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICS------ 204

Query: 85  IKWY-APE-SYNFGRFSSASDVWSFGITLWEMYSFGQQP 121
            ++Y APE       ++ + D+WS G    E+     +P
Sbjct: 205 -RFYRAPELMLGATEYTPSIDLWSIGCVFGEL--ILGKP 240

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 56.0 bits (136), Expect = 1e-10
 Identities = 26/82 (31%), Positives = 37/82 (45%), Gaps = 16/82 (19%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK----WY-APESYNF 95
           HRDL   NIL+ S    K++DFGL+R  + +      T            WY APE    
Sbjct: 143 HRDLKPENILVTSGGTVKLADFGLARIYSYQMAL---TP------VVVTLWYRAPEVL-L 192

Query: 96  G-RFSSASDVWSFGITLWEMYS 116
              +++  D+WS G    EM+ 
Sbjct: 193 QSTYATPVDMWSVGCIFAEMFR 214

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 56.4 bits (136), Expect = 1e-10
 Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 10/90 (11%)

Query: 31  RYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNY--YKATHGGRWPIK 86
             +K +H +   HRDL   NI++ S    KI DFGL+R   +      Y  T   R+   
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT---RY--- 228

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYS 116
           + APE      +    D+WS G  + EM  
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVR 258

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 55.9 bits (135), Expect = 2e-10
 Identities = 24/93 (25%), Positives = 37/93 (39%), Gaps = 23/93 (24%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER--------NYYKATHGGRW 83
           Y+   K+  HRD+   NIL+    + K+SDFG S  +  ++         +         
Sbjct: 166 YIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEF--------- 216

Query: 84  PIKWYAPE--SYNFGRFSSASDVWSFGITLWEM 114
                 PE  S       +  D+WS GI L+ M
Sbjct: 217 ----MPPEFFSNESSYNGAKVDIWSLGICLYVM 245

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 56.0 bits (135), Expect = 2e-10
 Identities = 28/126 (22%), Positives = 42/126 (33%), Gaps = 27/126 (21%)

Query: 29  VCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           +   +K +H +   HRDL   N L+      K+ DFGL+R V+   N             
Sbjct: 165 LLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224

Query: 87  -----------------------WY-APE-SYNFGRFSSASDVWSFGITLWEMYSFGQQP 121
                                  WY APE       ++ A DVWS G    E+ +  ++ 
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284

Query: 122 YGEMKG 127
                 
Sbjct: 285 VAYHAD 290

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 55.3 bits (134), Expect = 3e-10
 Identities = 24/88 (27%), Positives = 34/88 (38%), Gaps = 24/88 (27%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK----WY-APE--- 91
            HRD+   NIL+      K+ DFG +R +    +YY          +    WY +PE   
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DD------EVATRWYRSPELLV 175

Query: 92  ---SYNFGRFSSASDVWSFGITLWEMYS 116
               Y         DVW+ G    E+ S
Sbjct: 176 GDTQY-----GPPVDVWAIGCVFAELLS 198

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 55.5 bits (134), Expect = 3e-10
 Identities = 28/109 (25%), Positives = 43/109 (39%), Gaps = 21/109 (19%)

Query: 29  VCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           + + +K +H     HRD+   NILL +    K++DFGLSR+  + R              
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 87  -----------------WY-APES-YNFGRFSSASDVWSFGITLWEMYS 116
                            WY APE      +++   D+WS G  L E+  
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 54.9 bits (133), Expect = 3e-10
 Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 8/87 (9%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRW--PIKWYAPESYNFGRF 98
           HRD+  +NIL+ S    KI DFG+++A++        T        +++++PE       
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSET----SLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 99  SSASDVWSFGITLWEMYSFGQQPY-GE 124
              +D++S GI L+EM   G+ P+ GE
Sbjct: 190 DECTDIYSIGIVLYEMLV-GEPPFNGE 215

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 54.9 bits (133), Expect = 3e-10
 Identities = 29/83 (34%), Positives = 43/83 (51%), Gaps = 16/83 (19%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK----WY-APESYNF 95
           HRDL  +N+L+ S    K++DFGL+RA       Y  TH      +    WY AP+    
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--TH------EVVTLWYRAPDVL-M 192

Query: 96  G--RFSSASDVWSFGITLWEMYS 116
           G  ++S++ D+WS G    EM +
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMIT 215

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 54.9 bits (133), Expect = 4e-10
 Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 24/87 (27%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK----WY-APE---- 91
           HRDL  +N+L+  R Q K+ DFGL+RA     N +  +       +    WY AP+    
Sbjct: 131 HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SS------EVVTLWYRAPDVLMG 182

Query: 92  --SYNFGRFSSASDVWSFGITLWEMYS 116
             +Y     S++ D+WS G  L EM +
Sbjct: 183 SRTY-----STSIDIWSCGCILAEMIT 204

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 54.6 bits (132), Expect = 5e-10
 Identities = 26/93 (27%), Positives = 45/93 (48%), Gaps = 18/93 (19%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKAT-------HGGRWPIKWY-APES 92
           HRD+   NI++++ +  K+ DFG++RA+    N    T                Y +PE 
Sbjct: 139 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ--------YLSPEQ 190

Query: 93  YNFGRFSSASDVWSFGITLWEMYSFGQQPY-GE 124
                  + SDV+S G  L+E+ + G+ P+ G+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGD 222

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 54.6 bits (131), Expect = 5e-10
 Identities = 11/81 (13%), Positives = 27/81 (33%), Gaps = 10/81 (12%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERN-----YYKA--THGGRWPIKWYAPESY 93
           H  L   +I+L  R    ++ F       +         ++       R  I ++     
Sbjct: 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRR- 287

Query: 94  NFGRFSSASDVWSFGITLWEM 114
                + + D W+ G+ ++ +
Sbjct: 288 --TLMTFSFDAWALGLVIYWI 306

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 54.4 bits (131), Expect = 7e-10
 Identities = 25/112 (22%), Positives = 46/112 (41%), Gaps = 17/112 (15%)

Query: 29  VCRYLK-MHKSSF---HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWP 84
            CR ++ MH+      HRDL   N+LL+++   K+ DFG +  ++   +Y  +       
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204

Query: 85  IKWY---------APESYNFGR---FSSASDVWSFGITLWEMYSFGQQPYGE 124
            +            PE  +           D+W+ G  L+ +  F Q P+ +
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL-CFRQHPFED 255

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 54.1 bits (130), Expect = 9e-10
 Identities = 22/83 (26%), Positives = 35/83 (42%), Gaps = 12/83 (14%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFGRFS 99
           + DL   NI+L +  Q K+ D G    +NS    Y  T G       + APE       +
Sbjct: 205 YNDLKPENIML-TEEQLKLIDLGAVSRINSFGYLY-GTPG-------FQAPEIVR-TGPT 254

Query: 100 SASDVWSFGITLWEMYSFGQQPY 122
            A+D+++ G TL  + +      
Sbjct: 255 VATDIYTVGRTLAAL-TLDLPTR 276

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 53.8 bits (130), Expect = 9e-10
 Identities = 24/84 (28%), Positives = 42/84 (50%), Gaps = 7/84 (8%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWP--IKWYAPESYNFGRF 98
           HRD+   NIL+++   A + DFG++ A   E    K T  G     + + APE ++    
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDE----KLTQLGNTVGTLYYMAPERFSESHA 212

Query: 99  SSASDVWSFGITLWEMYSFGQQPY 122
           +  +D+++    L+E  + G  PY
Sbjct: 213 TYRADIYALTCVLYECLT-GSPPY 235

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 53.4 bits (129), Expect = 1e-09
 Identities = 27/87 (31%), Positives = 38/87 (43%), Gaps = 22/87 (25%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK---ATHGGRWPIKWY-APE---- 91
            HRD+   NIL++     K+ DFG +R + +    Y    AT       +WY APE    
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT-------RWYRAPELLVG 198

Query: 92  --SYNFGRFSSASDVWSFGITLWEMYS 116
              Y       A DVW+ G  + EM+ 
Sbjct: 199 DVKY-----GKAVDVWAIGCLVTEMFM 220

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 52.9 bits (128), Expect = 2e-09
 Identities = 29/87 (33%), Positives = 40/87 (45%), Gaps = 24/87 (27%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK----WY-APE---- 91
           HRDL  +N+L+    + KI+DFGL+RA       Y  TH      +    WY AP+    
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--TH------EIVTLWYRAPDVLMG 174

Query: 92  --SYNFGRFSSASDVWSFGITLWEMYS 116
              Y     S+  D+WS G    EM +
Sbjct: 175 SKKY-----STTIDIWSVGCIFAEMVN 196

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 53.0 bits (128), Expect = 2e-09
 Identities = 27/87 (31%), Positives = 37/87 (42%), Gaps = 24/87 (27%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK----WY-APE---- 91
           HRDL   N+LL      K++DFGL+++  S    Y  TH      +    WY APE    
Sbjct: 135 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--TH------QVVTRWYRAPELLFG 186

Query: 92  --SYNFGRFSSASDVWSFGITLWEMYS 116
              Y         D+W+ G  L E+  
Sbjct: 187 ARMY-----GVGVDMWAVGCILAELLL 208

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 53.0 bits (128), Expect = 2e-09
 Identities = 25/79 (31%), Positives = 40/79 (50%), Gaps = 8/79 (10%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFG--R 97
           HRDL  +N+L+  R + K++DFGL+RA +     Y   +       WY  P+    G   
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DN--EVVTLWYRPPDIL-LGSTD 177

Query: 98  FSSASDVWSFGITLWEMYS 116
           +S+  D+W  G   +EM +
Sbjct: 178 YSTQIDMWGVGCIFYEMAT 196

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 53.0 bits (128), Expect = 2e-09
 Identities = 19/87 (21%), Positives = 41/87 (47%), Gaps = 13/87 (14%)

Query: 40  FHRDLAARNILL-ASRHQAKISDFGLSRAVNSERNY--YKATHGGRWPIKWY-APES-YN 94
            HRD+   N+++     + ++ D+GL+   +  + Y    A+       +++  PE   +
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-------RYFKGPELLVD 204

Query: 95  FGRFSSASDVWSFGITLWEMYSFGQQP 121
           +  +  + D+WS G  L  M  F ++P
Sbjct: 205 YQMYDYSLDMWSLGCMLASMI-FRKEP 230

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 52.7 bits (127), Expect = 2e-09
 Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 16/94 (17%)

Query: 30  CRYLK-MHKSS-FHRDLAARNILL-ASRHQAKISDFGLSRAVNSERNY--YKATHGGRWP 84
            R L  +H     HRD+  +N+LL       K+ DFG ++ + +      Y  +      
Sbjct: 151 LRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICS------ 204

Query: 85  IKWY-APESYNFG--RFSSASDVWSFGITLWEMY 115
            ++Y APE   FG   +++  D+WS G  + E+ 
Sbjct: 205 -RYYRAPELI-FGATNYTTNIDIWSTGCVMAELM 236

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 52.4 bits (126), Expect = 3e-09
 Identities = 28/99 (28%), Positives = 44/99 (44%), Gaps = 16/99 (16%)

Query: 30  CRYLK-MHKSS-FHRDLAARNILL-ASRHQAKISDFGLSRAVNSERNY--YKATHGGRWP 84
            R L  +H     HRD+  +N+LL       K+ DFG ++ +        Y  +      
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS------ 219

Query: 85  IKWY-APES-YNFGRFSSASDVWSFGITLWEMYSFGQQP 121
            ++Y APE  +    ++S+ DVWS G  L E+     QP
Sbjct: 220 -RYYRAPELIFGATDYTSSIDVWSAGCVLAEL--LLGQP 255

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 52.1 bits (125), Expect = 3e-09
 Identities = 20/79 (25%), Positives = 32/79 (40%), Gaps = 5/79 (6%)

Query: 41  HRDLAARNILLASRHQA--KISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE--SYNF 95
           HRD+   N L ++      K+ DFGLS+      N        +    ++ APE  +   
Sbjct: 191 HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250

Query: 96  GRFSSASDVWSFGITLWEM 114
             +    D WS G+ L  +
Sbjct: 251 ESYGPKCDAWSAGVLLHLL 269

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 51.8 bits (125), Expect = 4e-09
 Identities = 23/88 (26%), Positives = 33/88 (37%), Gaps = 31/88 (35%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSER--------NYYKATHGGRWPIKWYAPE 91
            HRD+   N+LL S  + KI+DFG S    S R        +Y               PE
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDY-------------LPPE 177

Query: 92  -----SYNFGRFSSASDVWSFGITLWEM 114
                 ++        D+WS G+  +E 
Sbjct: 178 MIEGRMHDE-----KVDLWSLGVLCYEF 200

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 51.9 bits (125), Expect = 4e-09
 Identities = 29/98 (29%), Positives = 45/98 (45%), Gaps = 29/98 (29%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRA----VNSERNYYKATHGGRWPIK--- 86
           +H++   HRD+ A N+L+      K++DFGL+RA     NS+ N Y  T+      +   
Sbjct: 140 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY--TN------RVVT 191

Query: 87  -WY-APE------SYNFGRFSSASDVWSFGITLWEMYS 116
            WY  PE       Y         D+W  G  + EM++
Sbjct: 192 LWYRPPELLLGERDY-----GPPIDLWGAGCIMAEMWT 224

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 52.0 bits (125), Expect = 5e-09
 Identities = 30/89 (33%), Positives = 42/89 (47%), Gaps = 12/89 (13%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFG 96
           HRDL   N+LL S+ +    +I DFGLS    + +        G     +Y APE  + G
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTA---YYIAPEVLH-G 202

Query: 97  RFSSASDVWSFGITLWEMYSFGQQP-YGE 124
            +    DVWS G+ L+ + S G  P  G 
Sbjct: 203 TYDEKCDVWSTGVILYILLS-GCPPFNGA 230

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 51.8 bits (124), Expect = 5e-09
 Identities = 16/88 (18%), Positives = 32/88 (36%), Gaps = 20/88 (22%)

Query: 41  HRDLAARNILLASRHQA----KISDFGLSRAVNSERN--------YYKATHGGRWP--IK 86
           HR++   NI+           K++DFG +R +  +           Y        P   +
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH------PDMYE 188

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEM 114
                  +  ++ +  D+WS G+T +  
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHA 216

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 51.4 bits (124), Expect = 6e-09
 Identities = 24/85 (28%), Positives = 32/85 (37%), Gaps = 23/85 (27%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSER----------NYYKATHGGRWPIKWYA 89
            HRDL   N+ L    + KI DFGL+  V  +           NY              A
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY-------------IA 183

Query: 90  PESYNFGRFSSASDVWSFGITLWEM 114
           PE  +    S   DVWS G  ++ +
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTL 208

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 51.5 bits (124), Expect = 6e-09
 Identities = 27/76 (35%), Positives = 35/76 (46%), Gaps = 8/76 (10%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE--SYNFG 96
            HRD+   N+L+      KI+DFG+S            T G   P   + APE  S    
Sbjct: 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGT--PA--FMAPESLSETRK 214

Query: 97  RFS-SASDVWSFGITL 111
            FS  A DVW+ G+TL
Sbjct: 215 IFSGKALDVWAMGVTL 230

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 51.6 bits (124), Expect = 7e-09
 Identities = 30/87 (34%), Positives = 43/87 (49%), Gaps = 11/87 (12%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFG 96
           HRDL   N+LL S+ +    KI DFGLS    ++    K   G      +Y APE     
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGT----AYYIAPEVLR-K 212

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPYG 123
           ++    DVWS G+ L+ + + G  P+G
Sbjct: 213 KYDEKCDVWSIGVILFILLA-GYPPFG 238

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 51.1 bits (123), Expect = 8e-09
 Identities = 20/83 (24%), Positives = 30/83 (36%), Gaps = 21/83 (25%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSER--------NYYKATHGGRWPIKWYAPE 91
            HRD+   N+L+  + + KI+DFG S    S R        +Y               PE
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDY-------------LPPE 182

Query: 92  SYNFGRFSSASDVWSFGITLWEM 114
                      D+W  G+  +E 
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEF 205

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 50.9 bits (122), Expect = 1e-08
 Identities = 16/88 (18%), Positives = 32/88 (36%), Gaps = 20/88 (22%)

Query: 41  HRDLAARNILLASRHQA----KISDFGLSRAVNSERN--------YYKATHGGRWP--IK 86
           HR++   NI+           K++DFG +R +  +           Y        P   +
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH------PDMYE 188

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEM 114
                  +  ++ +  D+WS G+T +  
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHA 216

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 50.9 bits (122), Expect = 1e-08
 Identities = 26/86 (30%), Positives = 34/86 (39%), Gaps = 23/86 (26%)

Query: 35  MHKSS-FHRDLAARNILLASR--HQAKISDFGLSRAVNSERN--------YYKATHGGRW 83
           MH+    H DL   NIL  +R   Q KI DFGL+R                +        
Sbjct: 203 MHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEF-------- 254

Query: 84  PIKWYAPESYNFGRFSSASDVWSFGI 109
                APE  N+   S  +D+WS G+
Sbjct: 255 ----LAPEVVNYDFVSFPTDMWSVGV 276

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 50.9 bits (122), Expect = 1e-08
 Identities = 20/86 (23%), Positives = 35/86 (40%), Gaps = 23/86 (26%)

Query: 35  MHKSS-FHRDLAARNILLASRHQA--KISDFGLSRAVNSERN--------YYKATHGGRW 83
           MH+ S  H D+   NI+  ++  +  KI DFGL+  +N +           +        
Sbjct: 165 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF-------- 216

Query: 84  PIKWYAPESYNFGRFSSASDVWSFGI 109
                APE  +       +D+W+ G+
Sbjct: 217 ----AAPEIVDREPVGFYTDMWAIGV 238

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 50.6 bits (121), Expect = 1e-08
 Identities = 19/86 (22%), Positives = 39/86 (45%), Gaps = 23/86 (26%)

Query: 35  MHKSSF-HRDLAARNILLASR--HQAKISDFGLSRAVNSERN--------YYKATHGGRW 83
           MH++++ H DL   NI+  ++  ++ K+ DFGL+  ++ +++         +        
Sbjct: 271 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEF-------- 322

Query: 84  PIKWYAPESYNFGRFSSASDVWSFGI 109
                APE          +D+WS G+
Sbjct: 323 ----AAPEVAEGKPVGYYTDMWSVGV 344

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 50.7 bits (122), Expect = 1e-08
 Identities = 23/86 (26%), Positives = 36/86 (41%), Gaps = 23/86 (26%)

Query: 35  MHKSSF-HRDLAARNILLASRHQA--KISDFGLSRAVNSERN--------YYKATHGGRW 83
           +H  +  H D+   NI+  +R  +  KI +FG +R +    N         Y        
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY-------- 169

Query: 84  PIKWYAPESYNFGRFSSASDVWSFGI 109
               YAPE +     S+A+D+WS G 
Sbjct: 170 ----YAPEVHQHDVVSTATDMWSLGT 191

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 50.4 bits (121), Expect = 1e-08
 Identities = 28/86 (32%), Positives = 37/86 (43%), Gaps = 22/86 (25%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKW-----Y-APE-- 91
            HRD+   N+LL  R   KISDFGL+         ++  +  R   K      Y APE  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLA-------TVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 92  ---SYNFGRFSSASDVWSFGITLWEM 114
               ++    +   DVWS GI L  M
Sbjct: 180 KRREFH----AEPVDVWSCGIVLTAM 201

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 50.4 bits (121), Expect = 2e-08
 Identities = 24/85 (28%), Positives = 32/85 (37%), Gaps = 23/85 (27%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSER----------NYYKATHGGRWPIKWYA 89
            HRDL   N+ L    + KI DFGL+  V  +           NY              A
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY-------------IA 209

Query: 90  PESYNFGRFSSASDVWSFGITLWEM 114
           PE  +    S   DVWS G  ++ +
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTL 234

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 50.4 bits (121), Expect = 2e-08
 Identities = 23/81 (28%), Positives = 37/81 (45%), Gaps = 11/81 (13%)

Query: 35  MHKSS-FHRDLAARNILLASRHQA----KISDFGLSRAVNSERNYYKATHGGRWPIKWY- 88
           +H     H DL   NI+L  ++      K+ DFGL+  +  +   +K   G   P   + 
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGT--P--EFV 185

Query: 89  APESYNFGRFSSASDVWSFGI 109
           APE  N+      +D+WS G+
Sbjct: 186 APEIVNYEPLGLEADMWSIGV 206

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 49.9 bits (120), Expect = 2e-08
 Identities = 23/81 (28%), Positives = 37/81 (45%), Gaps = 11/81 (13%)

Query: 35  MHKSS-FHRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKATHGGRWPIKWY- 88
           +H     H DL   NI+L  ++      K+ DFGL+  +  +   +K   G   P   + 
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGT--P--EFV 185

Query: 89  APESYNFGRFSSASDVWSFGI 109
           APE  N+      +D+WS G+
Sbjct: 186 APEIVNYEPLGLEADMWSIGV 206

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 49.9 bits (120), Expect = 2e-08
 Identities = 28/86 (32%), Positives = 37/86 (43%), Gaps = 22/86 (25%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKW-----Y-APE-- 91
            HRD+   N+LL  R   KISDFGL+         ++  +  R   K      Y APE  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLA-------TVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 92  ---SYNFGRFSSASDVWSFGITLWEM 114
               ++    +   DVWS GI L  M
Sbjct: 180 KRREFH----AEPVDVWSCGIVLTAM 201

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 49.9 bits (120), Expect = 2e-08
 Identities = 28/82 (34%), Positives = 43/82 (52%), Gaps = 10/82 (12%)

Query: 35  MHKSS-FHRDLAARNILLASR---HQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-A 89
           +H+++  H DL  +NILL+S       KI DFG+SR +       +   G   P   Y A
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIMGT--P--EYLA 201

Query: 90  PESYNFGRFSSASDVWSFGITL 111
           PE  N+   ++A+D+W+ GI  
Sbjct: 202 PEILNYDPITTATDMWNIGIIA 223

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 50.1 bits (120), Expect = 2e-08
 Identities = 24/82 (29%), Positives = 35/82 (42%), Gaps = 24/82 (29%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERN--------YYKATHGGRWPIKWYA 89
           HRD+   NILL +++     KI DFGLS   + +          YY             A
Sbjct: 169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI------------A 216

Query: 90  PESYNFGRFSSASDVWSFGITL 111
           PE     +++   DVWS G+ +
Sbjct: 217 PEVLK-KKYNEKCDVWSCGVIM 237

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 49.9 bits (120), Expect = 2e-08
 Identities = 26/81 (32%), Positives = 38/81 (46%), Gaps = 11/81 (13%)

Query: 35  MHKSS-FHRDLAARNILLASRHQA----KISDFGLSRAVNSERNYYKATHGGRWPIKWY- 88
           +H     H DL   NI+L  R+      KI DFGL+  ++   N +K   G   P   + 
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGT--P--EFV 184

Query: 89  APESYNFGRFSSASDVWSFGI 109
           APE  N+      +D+WS G+
Sbjct: 185 APEIVNYEPLGLEADMWSIGV 205

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 50.0 bits (120), Expect = 2e-08
 Identities = 19/89 (21%), Positives = 32/89 (35%), Gaps = 27/89 (30%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSER------------NYYKATHGGRWPIKW 87
            H+D+   N+LL +    KIS  G++ A++                +             
Sbjct: 131 VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ------------ 178

Query: 88  YAPESYNFGRF--SSASDVWSFGITLWEM 114
             PE  N          D+WS G+TL+ +
Sbjct: 179 -PPEIANGLDTFSGFKVDIWSAGVTLYNI 206

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 49.5 bits (119), Expect = 3e-08
 Identities = 23/81 (28%), Positives = 37/81 (45%), Gaps = 11/81 (13%)

Query: 35  MHKSS-FHRDLAARNILLASRHQA----KISDFGLSRAVNSERNYYKATHGGRWPIKWY- 88
           +H     H DL   NI+L  ++      K+ DFG++  +    N +K   G   P   + 
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNIFGT--P--EFV 178

Query: 89  APESYNFGRFSSASDVWSFGI 109
           APE  N+      +D+WS G+
Sbjct: 179 APEIVNYEPLGLEADMWSIGV 199

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 49.2 bits (118), Expect = 4e-08
 Identities = 29/92 (31%), Positives = 38/92 (41%), Gaps = 26/92 (28%)

Query: 35  MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK-----ATHGGRWPIKWY 88
            H+    HRDL A N+LL +    KI+DFG S       N +          G  P   Y
Sbjct: 130 CHQKRIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDAFCGAPP---Y 179

Query: 89  -APE-----SYNFGRFSSASDVWSFGITLWEM 114
            APE      Y+        DVWS G+ L+ +
Sbjct: 180 AAPELFQGKKYD----GPEVDVWSLGVILYTL 207

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 49.1 bits (117), Expect = 4e-08
 Identities = 29/92 (31%), Positives = 45/92 (48%), Gaps = 11/92 (11%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA-THGGRWPIKWY-APESYNFG-R 97
           +RDL   NILL      +ISD GL+   + ++ +    THG       Y APE    G  
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG-------YMAPEVLQKGVA 367

Query: 98  FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           + S++D +S G  L+++   G  P+ + K  D
Sbjct: 368 YDSSADWFSLGCMLFKLLR-GHSPFRQHKTKD 398

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 48.9 bits (117), Expect = 5e-08
 Identities = 28/82 (34%), Positives = 32/82 (39%), Gaps = 24/82 (29%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERN--------YYKATHGGRWPIKWYA 89
           HRDL   NILL S+ +    KI DFGLS                YY             A
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI------------A 191

Query: 90  PESYNFGRFSSASDVWSFGITL 111
           PE    G +    DVWS G+ L
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVIL 212

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 48.8 bits (117), Expect = 5e-08
 Identities = 28/92 (30%), Positives = 38/92 (41%), Gaps = 29/92 (31%)

Query: 41  HRDLAARNILLASRHQA-----KISDFGLSRAVNSERNYYKATHGGRWPIK----WY-AP 90
           HRDL  +N+LL+    +     KI DFGL+RA       +  TH      +    WY  P
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--TH------EIITLWYRPP 206

Query: 91  E------SYNFGRFSSASDVWSFGITLWEMYS 116
           E       Y     S++ D+WS      EM  
Sbjct: 207 EILLGSRHY-----STSVDIWSIACIWAEMLM 233

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 48.3 bits (116), Expect = 7e-08
 Identities = 23/85 (27%), Positives = 30/85 (35%), Gaps = 23/85 (27%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSER----------NYYKATHGGRWPIKWYA 89
            HRDL   N+LL      KI+DFGL+  +              NY              +
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNY-------------IS 180

Query: 90  PESYNFGRFSSASDVWSFGITLWEM 114
           PE          SDVWS G   + +
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTL 205

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 48.5 bits (116), Expect = 7e-08
 Identities = 26/83 (31%), Positives = 37/83 (44%), Gaps = 19/83 (22%)

Query: 40  FHRDLAARNILL-ASRHQAKISDFGLSRAVNSERNYYKATH-----GGRWPIKWY-APES 92
            HRD+   NIL+  +R + K+ DFG            K T      G R     Y  PE 
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFGSG-------ALLKDTVYTDFDGTRV----YSPPEW 219

Query: 93  YNFGRFS-SASDVWSFGITLWEM 114
             + R+   ++ VWS GI L++M
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDM 242

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 48.4 bits (115), Expect = 8e-08
 Identities = 16/106 (15%), Positives = 29/106 (27%), Gaps = 26/106 (24%)

Query: 35  MHKSSF-HRDLAARNILLASRHQA-----------KISDFGLSRAVNSERNYYKATHGGR 82
           +H     H D+   N +L +                + D G S  +         T   +
Sbjct: 188 VHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT--AK 245

Query: 83  WPIKWY-APE-----SYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                +   E      +N+       D +    T++ M  FG    
Sbjct: 246 CETSGFQCVEMLSNKPWNY-----QIDYFGVAATVYCML-FGTYMK 285

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 48.3 bits (115), Expect = 8e-08
 Identities = 25/88 (28%), Positives = 34/88 (38%), Gaps = 19/88 (21%)

Query: 41  HRDLAARNILLASRHQA----KISDFGLSRAVNSERNYYKATHGGRWPI-KWY-APE--- 91
           HRDL   NIL+          KI+D G +R  NS              +  WY APE   
Sbjct: 151 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL--ADLDPVVVTFWYRAPELLL 208

Query: 92  ---SYNFGRFSSASDVWSFGITLWEMYS 116
               Y     + A D+W+ G    E+ +
Sbjct: 209 GARHY-----TKAIDIWAIGCIFAELLT 231

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 47.8 bits (114), Expect = 1e-07
 Identities = 22/80 (27%), Positives = 35/80 (43%), Gaps = 13/80 (16%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE-----SYN 94
            HRD+   NI++A     K+ DFG + A       +    G    I++ APE      Y 
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLFYTFCGT---IEYCAPEVLMGNPYR 207

Query: 95  FGRFSSASDVWSFGITLWEM 114
                   ++WS G+TL+ +
Sbjct: 208 ----GPELEMWSLGVTLYTL 223

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 47.9 bits (114), Expect = 1e-07
 Identities = 24/89 (26%), Positives = 40/89 (44%), Gaps = 13/89 (14%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA---THGGRWPIKWY-APESYNFG 96
           +RDL   N+LL      +ISD GL+  + + +   K    T G       + APE     
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG-------FMAPELLLGE 364

Query: 97  RFSSASDVWSFGITLWEMYSFGQQP-YGE 124
            +  + D ++ G+TL+EM +  + P    
Sbjct: 365 EYDFSVDYFALGVTLYEMIA-ARGPFRAR 392

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 47.3 bits (113), Expect = 2e-07
 Identities = 25/78 (32%), Positives = 35/78 (44%), Gaps = 9/78 (11%)

Query: 40  FHRDLAARNILL-ASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFGR 97
            HRD+   NIL+   R  AK+ DFG    +      Y    G R     Y  PE  +  +
Sbjct: 161 VHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFDGTRV----YSPPEWISRHQ 214

Query: 98  FS-SASDVWSFGITLWEM 114
           +    + VWS GI L++M
Sbjct: 215 YHALPATVWSLGILLYDM 232

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 47.4 bits (113), Expect = 2e-07
 Identities = 23/92 (25%), Positives = 39/92 (42%), Gaps = 11/92 (11%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE-------SY 93
           HRD+   NILL      +++DFG    + ++         G     + +PE         
Sbjct: 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVG--TPDYLSPEILQAVGGGP 242

Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQP-YGE 124
             G +    D W+ G+  +EM+ +GQ P Y +
Sbjct: 243 GTGSYGPECDWWALGVFAYEMF-YGQTPFYAD 273

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 47.1 bits (112), Expect = 2e-07
 Identities = 27/92 (29%), Positives = 41/92 (44%), Gaps = 7/92 (7%)

Query: 35  MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           +H+    +RDL   NILL      +ISD GL+          +   G    + + APE  
Sbjct: 302 LHRERIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKGRVGTVGYMAPEVV 357

Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQP-YGE 124
              R++ + D W+ G  L+EM + GQ P    
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIA-GQSPFQQR 388

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 46.9 bits (112), Expect = 3e-07
 Identities = 31/81 (38%), Positives = 39/81 (48%), Gaps = 15/81 (18%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE-----SY 93
            HRDL   N+LL      KI+DFGLS  + ++ N+ K + G   P   Y APE      Y
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSCGS--PN--YAAPEVINGKLY 184

Query: 94  NFGRFSSASDVWSFGITLWEM 114
                    DVWS GI L+ M
Sbjct: 185 A----GPEVDVWSCGIVLYVM 201

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 46.6 bits (111), Expect = 3e-07
 Identities = 26/75 (34%), Positives = 33/75 (44%), Gaps = 13/75 (17%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKA--THGGRWPIKWY-APESYN 94
           HRDL   N+L A+       KI+DFGLS+ V  +        T G       Y APE   
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPG-------YCAPEILR 223

Query: 95  FGRFSSASDVWSFGI 109
              +    D+WS GI
Sbjct: 224 GCAYGPEVDMWSVGI 238

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 46.3 bits (110), Expect = 4e-07
 Identities = 24/90 (26%), Positives = 40/90 (44%), Gaps = 9/90 (10%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE-----SYNF 95
           HRD+   NIL+      +++DFG    +  +     +   G     + +PE         
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG--TPDYISPEILQAMEGGK 255

Query: 96  GRFSSASDVWSFGITLWEMYSFGQQP-YGE 124
           GR+    D WS G+ ++EM  +G+ P Y E
Sbjct: 256 GRYGPECDWWSLGVCMYEML-YGETPFYAE 284

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 46.0 bits (110), Expect = 4e-07
 Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 15/81 (18%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE-----SY 93
            HRDL   N+LL +   AKI+DFGLS  + S+  + + + G   P   Y APE      Y
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSCGS--PN--YAAPEVISGRLY 187

Query: 94  NFGRFSSASDVWSFGITLWEM 114
                    D+WS G+ L+ +
Sbjct: 188 A----GPEVDIWSCGVILYAL 204

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 46.2 bits (110), Expect = 4e-07
 Identities = 13/99 (13%), Positives = 31/99 (31%), Gaps = 37/99 (37%)

Query: 41  HRDLAARNILL-------------------ASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           H D+   NI +                   +++   KI D G    ++S     +     
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS-PQVEEGD--- 193

Query: 82  RWPIKWYAPE------SYNFGRFSSASDVWSFGITLWEM 114
               ++ A E      ++        +D+++  +T+   
Sbjct: 194 --S-RFLANEVLQENYTHLP-----KADIFALALTVVCA 224

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 46.1 bits (110), Expect = 5e-07
 Identities = 19/75 (25%), Positives = 30/75 (40%), Gaps = 8/75 (10%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFG 96
           HRD+    +LLAS+  +   K+  FG++  +           G       + APE     
Sbjct: 153 HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT----PHFMAPEVVKRE 208

Query: 97  RFSSASDVWSFGITL 111
            +    DVW  G+ L
Sbjct: 209 PYGKPVDVWGCGVIL 223

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 46.2 bits (110), Expect = 5e-07
 Identities = 26/80 (32%), Positives = 36/80 (45%), Gaps = 16/80 (20%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKA--THGGRWPIKWY-APE--- 91
           HRDL   N+LL+S+ +    KI+DFG S+ +           T         Y APE   
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT-------YLAPEVLV 314

Query: 92  SYNFGRFSSASDVWSFGITL 111
           S     ++ A D WS G+ L
Sbjct: 315 SVGTAGYNRAVDCWSLGVIL 334

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 45.8 bits (109), Expect = 6e-07
 Identities = 29/96 (30%), Positives = 41/96 (42%), Gaps = 9/96 (9%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE-- 91
           +H   F HRD+   N+LL      K++DFG    +N E      T  G     + +PE  
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG--TPDYISPEVL 241

Query: 92  --SYNFGRFSSASDVWSFGITLWEMYSFGQQP-YGE 124
                 G +    D WS G+ L+EM   G  P Y +
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEML-VGDTPFYAD 276

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 45.7 bits (109), Expect = 6e-07
 Identities = 23/80 (28%), Positives = 33/80 (41%), Gaps = 16/80 (20%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA--THGGRWPIKWY-APE------ 91
           HRDL   NILL      K++DFG S  ++      +   T         Y APE      
Sbjct: 147 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPS-------YLAPEIIECSM 199

Query: 92  SYNFGRFSSASDVWSFGITL 111
           + N   +    D+WS G+ +
Sbjct: 200 NDNHPGYGKEVDMWSTGVIM 219

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 45.7 bits (109), Expect = 7e-07
 Identities = 28/77 (36%), Positives = 32/77 (41%), Gaps = 14/77 (18%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKA--THGGRWPIKWY-APESYN 94
           HRDL   NILL S+ +    KI DFGLS              T         Y APE   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY-------YIAPEVLR 196

Query: 95  FGRFSSASDVWSFGITL 111
            G +    DVWS G+ L
Sbjct: 197 -GTYDEKCDVWSAGVIL 212

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 45.3 bits (108), Expect = 9e-07
 Identities = 19/77 (24%), Positives = 28/77 (36%), Gaps = 14/77 (18%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKA--THGGRWPIKWY-APESYN 94
           HRDL   N L  +       K+ DFGL+      +       T         Y +P+   
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPY-------YVSPQVLE 181

Query: 95  FGRFSSASDVWSFGITL 111
            G +    D WS G+ +
Sbjct: 182 -GLYGPECDEWSAGVMM 197

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 45.4 bits (108), Expect = 1e-06
 Identities = 30/86 (34%), Positives = 41/86 (47%), Gaps = 10/86 (11%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE---SYNFG 96
           HRD+   NILL       I+DF ++  +  E      T  G  P   Y APE   S    
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT--TMAGTKP---YMAPEMFSSRKGA 192

Query: 97  RFSSASDVWSFGITLWEMYSFGQQPY 122
            +S A D WS G+T +E+   G++PY
Sbjct: 193 GYSFAVDWWSLGVTAYELL-RGRRPY 217

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 45.0 bits (107), Expect = 1e-06
 Identities = 24/75 (32%), Positives = 38/75 (50%), Gaps = 8/75 (10%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFG 96
           HR+L   N+LLAS+ +    K++DFGL+  V  E+  +    G   P   Y +PE     
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT--P--GYLSPEVLRKD 188

Query: 97  RFSSASDVWSFGITL 111
            +    D+W+ G+ L
Sbjct: 189 PYGKPVDLWACGVIL 203

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 44.9 bits (107), Expect = 1e-06
 Identities = 21/82 (25%), Positives = 30/82 (36%), Gaps = 24/82 (29%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERN--------YYKATHGGRWPIKWYA 89
           H+DL   NIL          KI DFGL+    S+ +         Y             A
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALY------------MA 194

Query: 90  PESYNFGRFSSASDVWSFGITL 111
           PE +     +   D+WS G+ +
Sbjct: 195 PEVFK-RDVTFKCDIWSAGVVM 215

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 44.5 bits (106), Expect = 1e-06
 Identities = 21/82 (25%), Positives = 36/82 (43%), Gaps = 17/82 (20%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKW-------Y-APES 92
           HRDL   NILL      +I+DFG ++ ++ E    +A                 Y +PE 
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA---------NSFVGTAQYVSPEL 203

Query: 93  YNFGRFSSASDVWSFGITLWEM 114
                   +SD+W+ G  ++++
Sbjct: 204 LTEKSACKSSDLWALGCIIYQL 225

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 44.6 bits (106), Expect = 1e-06
 Identities = 26/80 (32%), Positives = 36/80 (45%), Gaps = 16/80 (20%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKA--THGGRWPIKWY-APE--- 91
           HRDL   N+LL+S+ +    KI+DFG S+ +           T         Y APE   
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT-------YLAPEVLV 189

Query: 92  SYNFGRFSSASDVWSFGITL 111
           S     ++ A D WS G+ L
Sbjct: 190 SVGTAGYNRAVDCWSLGVIL 209

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 44.8 bits (106), Expect = 2e-06
 Identities = 27/86 (31%), Positives = 35/86 (40%), Gaps = 25/86 (29%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKW-----Y-APE-- 91
            HRDL   N+LL +   AKI+DFGLS       N       G +         Y APE  
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLS-------NMMS---DGEFLRTSCGSPNYAAPEVI 187

Query: 92  ---SYNFGRFSSASDVWSFGITLWEM 114
               Y         D+WS G+ L+ +
Sbjct: 188 SGRLYA----GPEVDIWSSGVILYAL 209

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 44.7 bits (106), Expect = 2e-06
 Identities = 21/75 (28%), Positives = 36/75 (48%), Gaps = 9/75 (12%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFG 96
           HRD+   N+L  S+      K++DFG ++   S  +    T     P  +Y APE     
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPCY-TP--YYVAPEVLGPE 238

Query: 97  RFSSASDVWSFGITL 111
           ++  + D+WS G+ +
Sbjct: 239 KYDKSCDMWSLGVIM 253

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 44.3 bits (105), Expect = 2e-06
 Identities = 24/80 (30%), Positives = 32/80 (40%), Gaps = 16/80 (20%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA--THGGRWPIKWY-APE------ 91
           HRDL   NILL    Q ++SDFG S  +       +   T G       Y APE      
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPG-------YLAPEILKCSM 275

Query: 92  SYNFGRFSSASDVWSFGITL 111
                 +    D+W+ G+ L
Sbjct: 276 DETHPGYGKEVDLWACGVIL 295

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 44.1 bits (105), Expect = 2e-06
 Identities = 25/77 (32%), Positives = 39/77 (50%), Gaps = 13/77 (16%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKA--THGGRWPIKWY-APESYN 94
           HR+L   N+LLAS+ +    K++DFGL+  VN    ++    T G       Y +PE   
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG-------YLSPEVLK 180

Query: 95  FGRFSSASDVWSFGITL 111
              +S   D+W+ G+ L
Sbjct: 181 KDPYSKPVDIWACGVIL 197

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 44.1 bits (105), Expect = 2e-06
 Identities = 22/81 (27%), Positives = 30/81 (37%), Gaps = 22/81 (27%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERN-------YYKATHGGRWPIKWYAP 90
           HRDL   N+L  +  +     I+DFGLS+   +           Y             AP
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGY------------VAP 176

Query: 91  ESYNFGRFSSASDVWSFGITL 111
           E      +S A D WS G+  
Sbjct: 177 EVLAQKPYSKAVDCWSIGVIT 197

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 44.2 bits (105), Expect = 2e-06
 Identities = 25/77 (32%), Positives = 39/77 (50%), Gaps = 13/77 (16%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKA--THGGRWPIKWY-APESYN 94
           HR+L   N+LLAS+ +    K++DFGL+  VN    ++    T G       Y +PE   
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG-------YLSPEVLK 203

Query: 95  FGRFSSASDVWSFGITL 111
              +S   D+W+ G+ L
Sbjct: 204 KDPYSKPVDIWACGVIL 220

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 43.8 bits (104), Expect = 3e-06
 Identities = 23/75 (30%), Positives = 31/75 (41%), Gaps = 8/75 (10%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFG 96
           HRDL   N+L    +     KI DFG +R    +    K           Y APE  N  
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT--L--HYAAPELLNQN 184

Query: 97  RFSSASDVWSFGITL 111
            +  + D+WS G+ L
Sbjct: 185 GYDESCDLWSLGVIL 199

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 43.8 bits (104), Expect = 3e-06
 Identities = 21/76 (27%), Positives = 31/76 (40%), Gaps = 9/76 (11%)

Query: 41  HRDLAARNILLASRHQA----KISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNF 95
           HRDL   NIL           +I DFG ++ + +E                + APE    
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYT--A--NFVAPEVLER 194

Query: 96  GRFSSASDVWSFGITL 111
             + +A D+WS G+ L
Sbjct: 195 QGYDAACDIWSLGVLL 210

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 43.5 bits (103), Expect = 4e-06
 Identities = 17/83 (20%), Positives = 33/83 (39%), Gaps = 14/83 (16%)

Query: 41  HRDLAARNILL------ASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESY 93
           H D+   N+L+       +  Q KI+D G +   +        T       + Y +PE  
Sbjct: 155 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT-------REYRSPEVL 207

Query: 94  NFGRFSSASDVWSFGITLWEMYS 116
               +   +D+WS    ++E+ +
Sbjct: 208 LGAPWGCGADIWSTACLIFELIT 230

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 43.1 bits (102), Expect = 6e-06
 Identities = 20/79 (25%), Positives = 33/79 (41%), Gaps = 18/79 (22%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKATHGGRWPIKWY-----APES 92
           HRD+   N+L  S+ +    K++DFG +          K T         Y     APE 
Sbjct: 151 HRDVKPENLLYTSKEKDAVLKLTDFGFA----------KETTQNALQTPCYTPYYVAPEV 200

Query: 93  YNFGRFSSASDVWSFGITL 111
               ++  + D+WS G+ +
Sbjct: 201 LGPEKYDKSCDMWSLGVIM 219

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 43.0 bits (102), Expect = 6e-06
 Identities = 23/84 (27%), Positives = 28/84 (33%), Gaps = 14/84 (16%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKATHGGRWPIK----WY-APE- 91
           HRDL   NIL    +Q    KI DF L   +                       Y APE 
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGI-KLNGDCSPISTPELLTPCGSAEYMAPEV 192

Query: 92  ----SYNFGRFSSASDVWSFGITL 111
               S     +    D+WS G+ L
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVIL 216

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 42.4 bits (100), Expect = 8e-06
 Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 11/90 (12%)

Query: 31  RYLKMHKSSF-HRDLAARNILLAS--RHQAKISDFGLSRAVNSERNYYKATHGGRWPIKW 87
            +L   + S  H DL   NILL +  R   KI DFG S  +      Y  +       ++
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS-------RF 223

Query: 88  Y-APESYNFGRFSSASDVWSFGITLWEMYS 116
           Y +PE      +  A D+WS G  L EM++
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 42.4 bits (100), Expect = 9e-06
 Identities = 30/83 (36%), Positives = 37/83 (44%), Gaps = 17/83 (20%)

Query: 40  FHRDLAARNILLASRHQA--KISDFGLSRAVNSERNYYKATHGGRWPIKWY-APE----- 91
            HRDL   N LL        KI DFG S   +   +  K+T G   P   Y APE     
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGT--PA--YIAPEVLLRQ 192

Query: 92  SYNFGRFSSASDVWSFGITLWEM 114
            Y+       +DVWS G+TL+ M
Sbjct: 193 EYD----GKIADVWSCGVTLYVM 211

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 42.0 bits (99), Expect = 1e-05
 Identities = 24/79 (30%), Positives = 36/79 (45%), Gaps = 10/79 (12%)

Query: 41  HRDLAARNILLASRHQA--KISDFGLSRAVNSERNYYKATHGGRWPIKWY-APESYNFGR 97
           H DL   NILL  + ++  K+ DFG S   +     Y  +       ++Y APE     R
Sbjct: 223 HCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS-------RFYRAPEVILGAR 275

Query: 98  FSSASDVWSFGITLWEMYS 116
           +    D+WS G  L E+ +
Sbjct: 276 YGMPIDMWSLGCILAELLT 294

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 41.3 bits (97), Expect = 3e-05
 Identities = 28/94 (29%), Positives = 43/94 (45%), Gaps = 5/94 (5%)

Query: 32  YLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE 91
           YL   K+  +RDL   N++L      KI+DFGL +    +      T  G    ++ APE
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGT--PEYLAPE 319

Query: 92  SYNFGRFSSASDVWSFGITLWEMYSFGQQP-YGE 124
                 +  A D W  G+ ++EM   G+ P Y +
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQ 352

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 40.0 bits (93), Expect = 8e-05
 Identities = 28/88 (31%), Positives = 42/88 (47%), Gaps = 11/88 (12%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH---GGRWPIKWYAPESYNFGR 97
           +RDL   N++L S    KI+DFG+ +           T    G      + APE   +  
Sbjct: 465 YRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVTTKTFCG---TPDYIAPEIIAYQP 518

Query: 98  FSSASDVWSFGITLWEMYSFGQQP-YGE 124
           +  + D W+FG+ L+EM + GQ P  GE
Sbjct: 519 YGKSVDWWAFGVLLYEMLA-GQAPFEGE 545

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 38.7 bits (91), Expect = 2e-04
 Identities = 28/88 (31%), Positives = 42/88 (47%), Gaps = 11/88 (12%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH---GGRWPIKWYAPESYNFGR 97
           +RDL   N++L S    KI+DFG+ +           T    G      + APE   +  
Sbjct: 144 YRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVTTKTFCG---TPDYIAPEIIAYQP 197

Query: 98  FSSASDVWSFGITLWEMYSFGQQP-YGE 124
           +  + D W+FG+ L+EM + GQ P  GE
Sbjct: 198 YGKSVDWWAFGVLLYEMLA-GQAPFEGE 224

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 38.8 bits (91), Expect = 2e-04
 Identities = 21/82 (25%), Positives = 39/82 (47%), Gaps = 7/82 (8%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   N+L+  +   +++DFG ++ V         T       +  APE      ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGT------PEALAPEIILSKGYNK 217

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
           A D W+ G+ ++EM + G  P+
Sbjct: 218 AVDWWALGVLIYEMAA-GYPPF 238

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 38.8 bits (91), Expect = 2e-04
 Identities = 24/95 (25%), Positives = 43/95 (45%), Gaps = 12/95 (12%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE-----SYNF 95
           +RD+   NILL S     ++DFGLS+   ++         G   I++ AP+         
Sbjct: 182 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG--TIEYMAPDIVRGGDSGH 239

Query: 96  GRFSSASDVWSFGITLWEMYSFGQQP-YGEMKGSD 129
            +   A D WS G+ ++E+ + G  P   + + + 
Sbjct: 240 DK---AVDWWSLGVLMYELLT-GASPFTVDGEKNS 270

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 38.6 bits (90), Expect = 2e-04
 Identities = 5/84 (5%), Positives = 16/84 (19%), Gaps = 31/84 (36%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
                   + ++      ++                                      + 
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPATMPDA------------------------------NP 181

Query: 101 ASDVWSFGITLWEMYSFGQQPYGE 124
             D+   G +L+ +    + P  E
Sbjct: 182 QDDIRGIGASLYALLV-NRWPLPE 204

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 38.5 bits (90), Expect = 2e-04
 Identities = 26/97 (26%), Positives = 43/97 (44%), Gaps = 20/97 (20%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH---GGRWPIKWYAPE-----S 92
           +RDL   N+LL S    K++D+G+ +           T    G      + APE      
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCKE---GLRPGDTTSTFCG---TPNYIAPEILRGED 229

Query: 93  YNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           Y F     + D W+ G+ ++EM + G+ P+  +  SD
Sbjct: 230 YGF-----SVDWWALGVLMFEMMA-GRSPFDIVGSSD 260

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 38.0 bits (89), Expect = 3e-04
 Identities = 25/88 (28%), Positives = 36/88 (40%), Gaps = 11/88 (12%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH---GGRWPIKWYAPESYNFGR 97
           +RDL   N+LL      K++DFG+ +           T    G      + APE      
Sbjct: 147 YRDLKLDNVLLDHEGHCKLADFGMCKE---GICNGVTTATFCG---TPDYIAPEILQEML 200

Query: 98  FSSASDVWSFGITLWEMYSFGQQP-YGE 124
           +  A D W+ G+ L+EM   G  P   E
Sbjct: 201 YGPAVDWWAMGVLLYEMLC-GHAPFEAE 227

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 38.0 bits (89), Expect = 3e-04
 Identities = 26/97 (26%), Positives = 43/97 (44%), Gaps = 20/97 (20%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH---GGRWPIKWYAPE-----S 92
           +RDL   N+LL S    K++D+G+ +           T    G      + APE      
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGMCKE---GLRPGDTTSTFCG---TPNYIAPEILRGED 186

Query: 93  YNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           Y F     + D W+ G+ ++EM + G+ P+  +  SD
Sbjct: 187 YGF-----SVDWWALGVLMFEMMA-GRSPFDIVGSSD 217

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 37.6 bits (88), Expect = 4e-04
 Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 11/88 (12%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH---GGRWPIKWYAPESYNFGR 97
           +RDL   NILL      KI+DFG+ +           T+   G      + APE     +
Sbjct: 141 YRDLKLDNILLDKDGHIKIADFGMCKE---NMLGDAKTNTFCG---TPDYIAPEILLGQK 194

Query: 98  FSSASDVWSFGITLWEMYSFGQQP-YGE 124
           ++ + D WSFG+ L+EM   GQ P +G+
Sbjct: 195 YNHSVDWWSFGVLLYEM-LIGQSPFHGQ 221

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 37.5 bits (88), Expect = 5e-04
 Identities = 28/85 (32%), Positives = 46/85 (54%), Gaps = 5/85 (5%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   NILL      K++DFGLS+  + +      +  G   +++ APE  N    + 
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCG--TVEYMAPEVVNRRGHTQ 205

Query: 101 ASDVWSFGITLWEMYSFGQQP-YGE 124
           ++D WSFG+ ++EM + G  P  G+
Sbjct: 206 SADWWSFGVLMFEMLT-GTLPFQGK 229

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 37.3 bits (87), Expect = 6e-04
 Identities = 16/74 (21%), Positives = 28/74 (37%), Gaps = 28/74 (37%)

Query: 41  HRDLAARNILLASRHQA---KISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR 97
           HRD+   N+L  S+      K++DFG                         A E+    +
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGF------------------------AKETTG-EK 174

Query: 98  FSSASDVWSFGITL 111
           +  + D+WS G+ +
Sbjct: 175 YDKSCDMWSLGVIM 188

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 36.8 bits (86), Expect = 7e-04
 Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 11/88 (12%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATH---GGRWPIKWYAPESYNFGR 97
           +RD+   N++L      KI+DFGL +      +         G     ++ APE      
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCG---TPEYLAPEVLEDND 181

Query: 98  FSSASDVWSFGITLWEMYSFGQQP-YGE 124
           +  A D W  G+ ++EM   G+ P Y +
Sbjct: 182 YGRAVDWWGLGVVMYEMMC-GRLPFYNQ 208

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 36.8 bits (85), Expect = 8e-04
 Identities = 13/65 (20%), Positives = 27/65 (41%), Gaps = 6/65 (9%)

Query: 52  ASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITL 111
           A + + KI+D G +  V+        T   R      + E      +++ +D+WS     
Sbjct: 230 AEKLKVKIADLGNACWVHKHFTEDIQTRQYR------SLEVLIGSGYNTPADIWSTACMA 283

Query: 112 WEMYS 116
           +E+ +
Sbjct: 284 FELAT 288

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 36.8 bits (86), Expect = 9e-04
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 5/85 (5%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   NI+L  +   K++DFGL +  +        T  G   I++ APE       + 
Sbjct: 144 YRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCG--TIEYMAPEILMRSGHNR 200

Query: 101 ASDVWSFGITLWEMYSFGQQP-YGE 124
           A D WS G  +++M + G  P  GE
Sbjct: 201 AVDWWSLGALMYDMLT-GAPPFTGE 224

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	129
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.98
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.98
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.97
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.97
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.97
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.97
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.97
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.97
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.96
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.96
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.96
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.95
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.95
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.94
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.93
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.93
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.93
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.93
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.93
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.93
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.93
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.93
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.93
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.93
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.93
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.92
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.92
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.92
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.92
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.92
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.92
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.92
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.92
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.92
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.92
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.92
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.92
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.92
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.92
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.92
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.92
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.91
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.91
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.91
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.91
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.91
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.91
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.91
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.91
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.91
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.91
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.91
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.91
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.91
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.91
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.91
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.91
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.91
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.91
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.91
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.91
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.91
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.91
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.91
3niz_A	311	Rhodanese family protein; structural genomics, str	99.9
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.9
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.9
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.9
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.9
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.9
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.9
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.9
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.9
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.9
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.9
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.9
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.9
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.9
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.9
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.9
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.9
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.9
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.9
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.9
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.9
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.9
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.9
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.9
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.9
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.9
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.9
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.9
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.9
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.9
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.89
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.89
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.89
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.89
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.89
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.89
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.89
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.89
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.89
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.89
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.89
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.89
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.89
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.89
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.89
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.89
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.89
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.89
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.89
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.89
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.89
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.89
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.89
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.89
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.89
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.89
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.89
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.89
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.89
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.89
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.89
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.89
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.89
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.89
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.89
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.88
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.88
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.88
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.88
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.88
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.88
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.88
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.88
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.88
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.88
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.88
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.88
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.88
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.88
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.88
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.88
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.88
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.88
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.88
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.88
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.88
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.88
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.88
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.88
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.88
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.88
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.88
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.88
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.88
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.88
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.88
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.88
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.88
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.88
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.88
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.88
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.88
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.88
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.88
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.88
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.88
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.88
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.88
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.88
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.88
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.88
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.88
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.88
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.88
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.88
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.88
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.88
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.88
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.87
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.87
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.87
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.87
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.87
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.87
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.87
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.87
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.87
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.87
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.87
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.87
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.87
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.87
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.87
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.87
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.87
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.87
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.87
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.87
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.87
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.87
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.87
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.87
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.87
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.87
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.87
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.87
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.87
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.86
3bhy_A	283	Death-associated protein kinase 3; death associate	99.86
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.86
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.86
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.86
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.86
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.86
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.86
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.86
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.86
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.86
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.86
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.86
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.85
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.85
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.85
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.85
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.85
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.85
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.85
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.85
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.85
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.85
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.84
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.84
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.84
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.83
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.83
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.82
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.82
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.82
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.81
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.81
3uqc_A	286	Probable conserved transmembrane protein; structur	99.78
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.65
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.49
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.12
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.99
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.88
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.36
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	97.32
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	95.4
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	94.58
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	90.49
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	90.26
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	90.11
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	88.38
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	88.13
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	87.16
3ats_A	357	Putative uncharacterized protein; hypothetical pro	86.8
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	86.59
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	83.21
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	81.28
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	80.78

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-33  Score=192.42  Aligned_cols=125  Identities=22%  Similarity=0.247  Sum_probs=99.7

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC-cEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH-QAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~-~~~l~d~~~~~~~~~~~~   73 (129)
                      ||||+|++|.+.+      .......++.|+ +.||.|+|. ++|+||||||+|||++.++ ++|++|||+++.......
T Consensus       129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi-~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQA-LEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            8999999977654      344567799999 999999998 9999999999999999887 699999999986543211


Q ss_pred             ee--eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          74 YY--KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        74 ~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                      ..  .......+|+.|+|||++.+..|+.++|+||+||++|+|++ |..||.+.+..
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt-G~~Pf~~~~~~  262 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQYFRG  262 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSTTTCCS
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CcCCCCCCCHH
Confidence            11  11112235678999999999899999999999999999999 99999876543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8e-34  Score=192.24  Aligned_cols=122  Identities=20%  Similarity=0.399  Sum_probs=102.1

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||||+||+|++.+      .+.....++.|+ +.|+.|+|. ++|+||||||+||+++.++.+|++|||+++........
T Consensus       111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi-~~al~ylH~-~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEI-VSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            8999999976644      445677899999 999999999 99999999999999999999999999999876432211


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       .......+|+.|+|||++.+..|+.++|+||+||++|+|++ |..||.+.+
T Consensus       189 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~  238 (311)
T 4aw0_A          189 -ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGN  238 (311)
T ss_dssp             -CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             -ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence             11222345678999999998899999999999999999999 999998654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.7e-33  Score=190.35  Aligned_cols=120  Identities=26%  Similarity=0.406  Sum_probs=99.8

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||||+|++|.+.+      .+.....++.|+ +.||.|+|. ++|+||||||+|||++.++.+|++|||+++........
T Consensus       105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi-~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  182 (304)
T 3ubd_A          105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL-ALALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  182 (304)
T ss_dssp             ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred             EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence            8999999986644      445577799999 999999999 99999999999999999999999999999864332211


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+|+.|+|||++.+..|+.++|+||+||++|+|++ |..||.+.+
T Consensus       183 ---~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt-G~~PF~~~~  230 (304)
T 3ubd_A          183 ---AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GTLPFQGKD  230 (304)
T ss_dssp             ---CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             ---ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHh-CCCCCCCcC
Confidence               122345678999999998899999999999999999999 999998754

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.3e-33  Score=192.38  Aligned_cols=120  Identities=25%  Similarity=0.392  Sum_probs=101.2

Q ss_pred             CCCCCCCCcccc-----CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTP-----LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      ||||+|++|...     +.+.....++.|+ +.||.|+|. ++|+||||||+|||++.++.+|++|||+++.........
T Consensus       150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi-~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  227 (346)
T 4fih_A          150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAV-LQALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  227 (346)
T ss_dssp             ECCCTTEEHHHHHHHSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred             EeCCCCCcHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence            899999997654     3344577799999 999999999 999999999999999999999999999998764432221


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ....+++.|+|||++.+..|+.++|+||+||++|+|++ |..||.+.+
T Consensus       228 ---~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~  274 (346)
T 4fih_A          228 ---KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEP  274 (346)
T ss_dssp             ---CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSC
T ss_pred             ---cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcC
Confidence               22345678999999988899999999999999999999 999998754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.98  E-value=8.1e-34  Score=194.89  Aligned_cols=120  Identities=21%  Similarity=0.363  Sum_probs=99.4

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      ||||+|++|.+.+.        +.....++.|+ +.||.|+|. ++|+||||||+|||++.++.+|++|||+++......
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi-~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI-CLALKHVHD-RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHH-HHHHHHHHH-TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            89999999876652        22356688999 999999999 999999999999999999999999999998654321


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .....   ..+++.|+|||++.+..|+.++|+||+||++|+|++ |..||.+.+
T Consensus       180 ~~~~~---~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemlt-G~~PF~~~~  229 (350)
T 4b9d_A          180 ELARA---CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT-LKHAFEAGS  229 (350)
T ss_dssp             HHHHH---HHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             ccccc---cCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcC
Confidence            11111   124567999999998899999999999999999999 999998754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.98  E-value=9e-33  Score=193.56  Aligned_cols=120  Identities=25%  Similarity=0.389  Sum_probs=100.8

Q ss_pred             CCCCCCCCccccC-----CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPL-----GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      ||||+|++|...+     .+..+..++.|+ +.||.|+|. ++|+||||||+|||++.++.+|++|||+++.........
T Consensus       227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qi-l~aL~ylH~-~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  304 (423)
T 4fie_A          227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAV-LQALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  304 (423)
T ss_dssp             EECCTTEEHHHHHHHSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred             EeCCCCCcHHHHHhccCCCHHHHHHHHHHH-HHHHHHHHH-CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence            8999999976543     344567799999 999999999 999999999999999999999999999998764432221


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ....+++.|+|||++.+..|+.++|+||+||++|+|++ |+.||.+.+
T Consensus       305 ---~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~  351 (423)
T 4fie_A          305 ---KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEP  351 (423)
T ss_dssp             ---CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSC
T ss_pred             ---cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcC
Confidence               12234567999999998899999999999999999999 999998754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.97  E-value=7.4e-33  Score=187.48  Aligned_cols=123  Identities=32%  Similarity=0.506  Sum_probs=95.7

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      ||||+|++|.+.+.       ...+..++.|+ +.|+.|+|. ++|+||||||+|||++.++.+|++|||+++.......
T Consensus       110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qi-a~gL~yLH~-~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQT-AQGMDYLHA-KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHH-HHHHHHHHH-TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            89999999876552       22355688898 999999998 8999999999999999999999999999986532211


Q ss_pred             eeeeccCCCCCceecccccccC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNF---GRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      . .......+++.|+|||.+..   ..|+.++|+||+|+++||+++ |+.||.+.++
T Consensus       188 ~-~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ellt-g~~Pf~~~~~  242 (307)
T 3omv_A          188 S-QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT-GELPYSHINN  242 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCC
T ss_pred             c-eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHH-CCCCCCCCCh
Confidence            1 11122335678999998853   358899999999999999999 9999987654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.97  E-value=1.8e-33  Score=190.11  Aligned_cols=124  Identities=35%  Similarity=0.634  Sum_probs=101.4

Q ss_pred             CCCCCCCCccccCC-------------------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEe
Q psy7529           1 MKSPNGSGVVTPLG-------------------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISD   61 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d   61 (129)
                      ||||++|+|.+.+.                   ...+..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|
T Consensus        94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi-a~gl~yLH~-~~iiHRDlKp~NILl~~~~~~Ki~D  171 (299)
T 4asz_A           94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI-AAGMVYLAS-QHFVHRDLATRNCLVGENLLVKIGD  171 (299)
T ss_dssp             EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCcccCccCHhhEEECCCCcEEECC
Confidence            79999999876542                   23456688899 999999998 9999999999999999999999999


Q ss_pred             ecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          62 FGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        62 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ||+++........ .......+++.|+|||.+.+..|+.++|+||+|+++||+++.|+.||.+.++
T Consensus       172 FGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~  236 (299)
T 4asz_A          172 FGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN  236 (299)
T ss_dssp             CSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cccceecCCCCce-eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999865432221 1111223456799999999889999999999999999999868999988764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.97  E-value=5.8e-32  Score=181.92  Aligned_cols=117  Identities=27%  Similarity=0.397  Sum_probs=95.1

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCC--CccCCCCCCCEEecC-CCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKS--SFHRDLAARNILLAS-RHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~--~ihr~lk~~nil~~~-~~~~~l~d~~~~~~~~~~   71 (129)
                      ||||+|++|...+.      ......++.|+ +.||.|+|. ++  |+||||||+|||++. ++.+|++|||+++.....
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi-~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQI-LKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            79999999776543      33456688899 999999998 66  999999999999975 789999999999754322


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .  ..   ...+|+.|+|||++.+ .|+.++|+||+|+++|++++ |..||.+.+
T Consensus       186 ~--~~---~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyellt-g~~Pf~~~~  233 (290)
T 3fpq_A          186 F--AK---AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMAT-SEYPYSECQ  233 (290)
T ss_dssp             S--BE---ESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHH-SSCTTTTCS
T ss_pred             c--cC---CcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHH-CCCCCCCCC
Confidence            1  11   1234678999998864 69999999999999999999 999998654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.97  E-value=7.5e-33  Score=187.71  Aligned_cols=124  Identities=36%  Similarity=0.636  Sum_probs=100.8

Q ss_pred             CCCCCCCCccccCC----------------------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEE
Q psy7529           1 MKSPNGSGVVTPLG----------------------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAK   58 (129)
Q Consensus         1 m~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~   58 (129)
                      ||||++|+|.+.+.                      ...+..++.|+ +.|+.|+|. +++||||||++|||++.++.+|
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi-a~gl~yLH~-~~iiHRDLK~~NILl~~~~~~K  185 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI-AAGMEYLSS-HHVVHKDLATRNVLVYDKLNVK  185 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHH-HHHHHHHHh-CCCCCCCccccceEECCCCCEE
Confidence            79999999766552                      22345688899 999999998 8999999999999999999999


Q ss_pred             EEeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          59 ISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        59 l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ++|||+++........ .......+++.|+|||.+....|+.++|+||+|+++||+++.|..||.+.+.
T Consensus       186 i~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~  253 (308)
T 4gt4_A          186 ISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN  253 (308)
T ss_dssp             ECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred             ECCcccceeccCCCce-eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999865332211 1122233567899999999889999999999999999999868899988764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.97  E-value=1e-32  Score=188.47  Aligned_cols=124  Identities=35%  Similarity=0.624  Sum_probs=94.6

Q ss_pred             CCCCCCCCccccC---------------------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEE
Q psy7529           1 MKSPNGSGVVTPL---------------------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKI   59 (129)
Q Consensus         1 m~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l   59 (129)
                      ||||++|+|...+                     ....+..++.|+ +.|+.|+|. ++|+|||||++||+++.++.+|+
T Consensus       122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi-a~gl~yLH~-~~iiHRDLKp~NILl~~~~~~Ki  199 (329)
T 4aoj_A          122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV-AAGMVYLAG-LHFVHRDLATRNCLVGQGLVVKI  199 (329)
T ss_dssp             EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEEETTTEEEE
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHH-HHHHHHHhc-CCeecccccHhhEEECCCCcEEE
Confidence            7999999986543                     223456688899 999999998 89999999999999999999999


Q ss_pred             EeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          60 SDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        60 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      +|||+++......... ......+++.|+|||.+.+..++.++|+||+|+++||+++.|+.||.+.+.
T Consensus       200 ~DFGla~~~~~~~~~~-~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~  266 (329)
T 4aoj_A          200 GDFGMSRDIYSTDYYR-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN  266 (329)
T ss_dssp             CCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred             cccccceeccCCCcce-ecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence            9999998653322111 111223467899999999989999999999999999999868999987654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.97  E-value=9.4e-33  Score=190.17  Aligned_cols=124  Identities=39%  Similarity=0.633  Sum_probs=100.9

Q ss_pred             CCCCCCCCccccCC----------------------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEE
Q psy7529           1 MKSPNGSGVVTPLG----------------------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAK   58 (129)
Q Consensus         1 m~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~   58 (129)
                      ||||++|+|.+.+.                      ...+..++.|+ +.|+.|+|. +++||||||++||+++.++.+|
T Consensus       148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi-a~gl~yLH~-~~iiHRDLK~~NILl~~~~~vK  225 (353)
T 4ase_A          148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV-AKGMEFLAS-RKCIHRDLAARNILLSEKNVVK  225 (353)
T ss_dssp             EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHH-HHHHHhHhh-CCeecCccCccceeeCCCCCEE
Confidence            79999999766553                      22345588888 999999999 9999999999999999999999


Q ss_pred             EEeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          59 ISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        59 l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ++|||+++......... ......+++.|+|||.+.+..|+.++|+||+|+++||+++.|..||.+.+.
T Consensus       226 i~DFGlar~~~~~~~~~-~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          226 ICDFGLARDIYKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             ECCCGGGSCTTTCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             ECcchhhhhcccCCCce-eeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999998654322211 122223456799999999889999999999999999999768999988764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.97  E-value=4.2e-31  Score=193.12  Aligned_cols=118  Identities=24%  Similarity=0.384  Sum_probs=100.4

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||||+||+|+..+      .+...+++++|+ +.||.|+|. ++|+||||||+|||++.++++|++|||+++......  
T Consensus       271 mEy~~GGdL~~~l~~~~~l~E~~a~~y~~qI-l~aL~yLH~-~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~--  346 (689)
T 3v5w_A          271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEI-ILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  346 (689)
T ss_dssp             ECCCCSCBHHHHHHHHCCCCHHHHHHHHHHH-HHHHHHHHT-TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC--
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCccccCCchHHeEEeCCCCEEecccceeeecCCCC--
Confidence            8999999986544      445678899999 999999999 999999999999999999999999999998654322  


Q ss_pred             eeeccCCCCCceecccccccC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNF-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ....++|+.|+|||++.. ..|+.++|+||+||++|+|++ |..||.+.+
T Consensus       347 ---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLt-G~~PF~~~~  395 (689)
T 3v5w_A          347 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHK  395 (689)
T ss_dssp             ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCGGG
T ss_pred             ---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence               123345678999999864 578999999999999999999 999997643

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.97  E-value=2.7e-31  Score=177.42  Aligned_cols=118  Identities=25%  Similarity=0.383  Sum_probs=90.4

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||| ++++.+.      +.+.....++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++....... 
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi-~~al~ylH~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~-  167 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQI-ISAVEYCHR-HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-  167 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc-
Confidence            7898 4565543      4445577799999 999999999 9999999999999999999999999999976543211 


Q ss_pred             eeeccCCCCCceecccccccCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRF-SSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+|+.|+|||++.+..+ +.++|+||+|+++|++++ |..||.+.+
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~llt-g~~PF~~~~  216 (275)
T 3hyh_A          168 ---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC-RRLPFDDES  216 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             ---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHH-CCCCCCCCC
Confidence               112234667999999988876 579999999999999999 999998643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.96  E-value=3.3e-30  Score=178.10  Aligned_cols=123  Identities=20%  Similarity=0.266  Sum_probs=96.4

Q ss_pred             CCCCCCCCccccCC---CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC-CcEEEEeecCcccccCCCce--
Q psy7529           1 MKSPNGSGVVTPLG---SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR-HQAKISDFGLSRAVNSERNY--   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~-~~~~l~d~~~~~~~~~~~~~--   74 (129)
                      |||++|+++...++   ....+.++.|+ +.|+.|+|. ++|+||||||+|||++.+ +.+|++|||+++........  
T Consensus        99 mE~~~g~~L~~~~~~l~~~~~~~~~~ql-l~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~  176 (361)
T 4f9c_A           99 MPYLEHESFLDILNSLSFQEVREYMLNL-FKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELL  176 (361)
T ss_dssp             EECCCCCCHHHHHTTCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGG
T ss_pred             EeCCCcccHHHHHcCCCHHHHHHHHHHH-HHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccc
Confidence            79999999766544   44577799999 999999999 999999999999999876 78999999999754321100  


Q ss_pred             -----------------------eeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 -----------------------YKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 -----------------------~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                                             ........+|+.|+|||++.+. .++.++|+||+||++++|++ |+.||...+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~-G~~Pf~~~~  251 (361)
T 4f9c_A          177 KFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS-GRYPFYKAS  251 (361)
T ss_dssp             GGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH-TCSSSSCCS
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH-CCCCCCCCC
Confidence                                   0001122356789999998775 48899999999999999999 999996543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.96  E-value=2.1e-30  Score=175.13  Aligned_cols=118  Identities=25%  Similarity=0.376  Sum_probs=88.5

Q ss_pred             CCCCCCCCccccCCCC------c---hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLGSY------A---LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~------~---~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~   71 (129)
                      ||||+|++|.+.+...      .   ...++.|+ +.|+.|+|. ++|+||||||+||+++.++.+|++|||+++.....
T Consensus        94 mE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi-~~al~ylH~-~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~  171 (299)
T 4g31_A           94 MQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI-AEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  171 (299)
T ss_dssp             EECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCCCC------
T ss_pred             EecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHH-HHHHHHHHH-CcCccccCcHHHeEECCCCcEEEccCccceecCCC
Confidence            8999999976654321      1   45688899 999999999 99999999999999999999999999999865432


Q ss_pred             Ccee---------eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          72 RNYY---------KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        72 ~~~~---------~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ....         ....+..+|+.|+|||++.+..|+.++|+||+||++|++++    ||.+
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~----Pf~~  229 (299)
T 4g31_A          172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY----PFST  229 (299)
T ss_dssp             --------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS----CCSS
T ss_pred             ccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc----CCCC
Confidence            1110         01112235678999999998899999999999999999984    6653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.96  E-value=1.2e-30  Score=176.66  Aligned_cols=121  Identities=21%  Similarity=0.296  Sum_probs=92.0

Q ss_pred             CCCCCCCCccccCCCC-----chhhHHhHHHHHHHHHHhcc-------CCCccCCCCCCCEEecCCCcEEEEeecCcccc
Q psy7529           1 MKSPNGSGVVTPLGSY-----ALPYIEGQIPAKVCRYLKMH-------KSSFHRDLAARNILLASRHQAKISDFGLSRAV   68 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~~h~~-------~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~   68 (129)
                      |||+++++|...+...     .+..++.|+ +.|+.|+|..       .+|+||||||+|||++.++.+|++|||+++..
T Consensus        80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~i-a~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHH-HHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecCCCCCcHHHHHHhCCCCHHHHHHHHHHH-HHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            7999999987766432     344588888 9999999972       28999999999999999999999999999865


Q ss_pred             cCCCceee-eccCCCCCceecccccccCC------CCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          69 NSERNYYK-ATHGGRWPIKWYAPESYNFG------RFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        69 ~~~~~~~~-~~~~~~~~~~~~~pe~~~~~------~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      ........ ......+++.|+|||.+.+.      .++.++|+||+|+++||+++ |..||.
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~t-g~~~~~  219 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGG  219 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH-TBCBTT
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHH-CCCCCC
Confidence            43322211 11223456789999988653      24578999999999999999 876654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.95  E-value=5.7e-29  Score=173.72  Aligned_cols=122  Identities=21%  Similarity=0.276  Sum_probs=94.3

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||||+| +++..+      .......++.|+ +.||.|+|. ++|+||||||+||+++.++.+|++|||+++........
T Consensus       138 mE~~~g-~L~~~i~~~~~l~~~~~~~~~~qi-l~al~ylH~-~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~  214 (398)
T 4b99_A          138 LDLMES-DLHQIIHSSQPLTLEHVRYFLYQL-LRGLKYMHS-AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAE  214 (398)
T ss_dssp             EECCSE-EHHHHHTSSSCCCHHHHHHHHHHH-HHHHHHHHH-TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC------
T ss_pred             EeCCCC-CHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CcCcCCCcCccccccCCCCCEEEeecceeeecccCccc
Confidence            788864 454433      334577799999 999999999 99999999999999999999999999999865322111


Q ss_pred             -eeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 -YKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 -~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       ........+|+.|+|||++.+. .++.++|+||+||++++|++ |..||.+.+
T Consensus       215 ~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~-G~~pF~g~~  267 (398)
T 4b99_A          215 HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA-RRQLFPGKN  267 (398)
T ss_dssp             -CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH-TSCSSCCSS
T ss_pred             cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHH-CCCCCCCCC
Confidence             1111223456779999998765 46899999999999999999 999998654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.95  E-value=7.4e-29  Score=179.89  Aligned_cols=119  Identities=22%  Similarity=0.351  Sum_probs=98.9

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC--CcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR--HQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~--~~~~l~d~~~~~~~~~~   71 (129)
                      ||||+|++|+..+.       ......++.|+ +.||.|||. ++|+||||||+||+++..  +.+|++|||+++.+...
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi-~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQV-CKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            89999999876553       23467789999 999999999 999999999999999754  78999999999876543


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ... ...   .+++.|+|||++.+..|+.++|+||+||++|+|++ |..||.+.+
T Consensus       311 ~~~-~~~---~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~-G~~Pf~~~~  360 (573)
T 3uto_A          311 QSV-KVT---TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGEN  360 (573)
T ss_dssp             SEE-EEE---CSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSS
T ss_pred             Cce-eee---EECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcC
Confidence            221 112   24567999999999899999999999999999999 999998754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.94  E-value=8.1e-27  Score=162.86  Aligned_cols=119  Identities=23%  Similarity=0.394  Sum_probs=98.1

Q ss_pred             CCCCCCCCccc------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVT------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|++|..      .+.......+++|+ +.||.|+|. ++++||||||+||+++.+++++++|||+++........
T Consensus       132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi-~~aL~~LH~-~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~  209 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEI-SLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  209 (396)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCc
Confidence            78999998753      34445677789999 999999999 99999999999999999999999999998753222111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                         .....+++.|+|||.+.+..++.++|+||+|++++++++ |..||...
T Consensus       210 ---~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~-G~~Pf~~~  256 (396)
T 4dc2_A          210 ---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIV  256 (396)
T ss_dssp             ---BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSTTT
T ss_pred             ---cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHh-CCCCCccc
Confidence               122234567999999998889999999999999999999 99999643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.93  E-value=5.6e-27  Score=161.53  Aligned_cols=120  Identities=24%  Similarity=0.372  Sum_probs=96.3

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|+++...      +.......+++|+ +.|+.|+|. ++++||||||+||+++.+++++++|||+++........
T Consensus       103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi-~~aL~~LH~-~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~  180 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEI-ISALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT  180 (353)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCCcccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence            789999987543      3445577789999 999999999 89999999999999999999999999998753222111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       181 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~  228 (353)
T 3txo_A          181 ---TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC-GHAPFEAEN  228 (353)
T ss_dssp             --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             ---ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHh-CCCCCCCCC
Confidence               112234567999999988788999999999999999999 999998654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.93  E-value=2.4e-26  Score=157.47  Aligned_cols=120  Identities=23%  Similarity=0.405  Sum_probs=97.8

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|+++...      +.......++.|+ +.|+.|+|. ++++||||||+||+++.+++++++|||+++........
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi-~~aL~~LH~-~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEI-VSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHH-HHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            789999987543      3344567788899 999999999 89999999999999999999999999998753222111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+++.|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       162 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~  209 (337)
T 1o6l_A          162 ---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQD  209 (337)
T ss_dssp             ---BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             ---ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhc-CCCCCCCCC
Confidence               112234567999999988889999999999999999999 999997643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.93  E-value=2.6e-26  Score=158.25  Aligned_cols=120  Identities=27%  Similarity=0.415  Sum_probs=98.3

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|++|...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.+++++++|||+++........
T Consensus       100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi-~~aL~~LH~-~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  177 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI-AIGLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  177 (353)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence            7899999876443      344567788999 999999999 89999999999999999999999999998753222111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       178 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~  225 (353)
T 2i0e_A          178 ---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGED  225 (353)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             ---cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHc-CCCCCCCCC
Confidence               122234567999999988889999999999999999999 999998654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.93  E-value=3e-26  Score=157.48  Aligned_cols=120  Identities=28%  Similarity=0.394  Sum_probs=98.4

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|++|...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.+++++++|||+++........
T Consensus        97 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi-~~aL~~LH~-~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  174 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEI-ILGLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  174 (345)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence            7899999976443      344567788999 999999999 89999999999999999999999999998754322111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+++.|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       175 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~  222 (345)
T 1xjd_A          175 ---TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPFHGQD  222 (345)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             ---ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhc-CCCCCCCCC
Confidence               122234567999999988889999999999999999999 999998654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.93  E-value=3e-26  Score=168.91  Aligned_cols=120  Identities=27%  Similarity=0.413  Sum_probs=99.2

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|++|...      +.......+++|+ +.||.|||. ++|+||||||+||+++.+++++|+|||+++........
T Consensus       421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi-~~aL~~LH~-~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~  498 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI-AIGLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  498 (674)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC
T ss_pred             EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcc
Confidence            789999997644      3444577789999 999999999 89999999999999999999999999999753322211


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+++.|+|||.+....++.++|+||+|+++|++++ |..||.+.+
T Consensus       499 ---~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~  546 (674)
T 3pfq_A          499 ---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGED  546 (674)
T ss_dssp             ---BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             ---cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHc-CCCCCCCCC
Confidence               112234567999999988889999999999999999999 999998754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.93  E-value=3.6e-26  Score=158.54  Aligned_cols=120  Identities=26%  Similarity=0.363  Sum_probs=97.8

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|+++...+      .......+++|+ +.||.|+|. ++++||||||+||+++.+++++++|||+++........
T Consensus       118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi-~~aL~~LH~-~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~  195 (373)
T 2r5t_A          118 LDYINGGELFYHLQRERCFLEPRARFYAAEI-ASALGYLHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST  195 (373)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCceecCCCHHHEEECCCCCEEEeeCccccccccCCCc
Confidence            7899999875443      344566788899 999999999 99999999999999999999999999998753322111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       196 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~  243 (373)
T 2r5t_A          196 ---TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRN  243 (373)
T ss_dssp             ---CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCSB
T ss_pred             ---cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCC
Confidence               112234567999999988889999999999999999998 999997643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.93  E-value=5.8e-26  Score=156.00  Aligned_cols=118  Identities=23%  Similarity=0.392  Sum_probs=96.9

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|++|...      +.......++.|+ +.|+.|+|. ++++||||||+||+++.+++++++|||+++........
T Consensus        89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi-~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~  166 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEI-SLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  166 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence            799999987543      3344567788999 999999999 89999999999999999999999999998753222111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                         .....+++.|+|||.+.+..++.++|+||+|++++++++ |..||..
T Consensus       167 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~  212 (345)
T 3a8x_A          167 ---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDI  212 (345)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTT
T ss_pred             ---ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHh-CCCCcCC
Confidence               112234567999999988889999999999999999999 9999975

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.93  E-value=3.8e-26  Score=157.54  Aligned_cols=120  Identities=10%  Similarity=0.021  Sum_probs=96.1

Q ss_pred             CCCCCCCCccccCC-----------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-----------CCcEE
Q psy7529           1 MKSPNGSGVVTPLG-----------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-----------RHQAK   58 (129)
Q Consensus         1 m~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-----------~~~~~   58 (129)
                      |||+++++|.+.+.           ...+..++.|+ +.|+.|+|. ++++||||||+||+++.           .+.++
T Consensus       146 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi-~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~k  223 (365)
T 3e7e_A          146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM-LYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA  223 (365)
T ss_dssp             ECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHH-HHHHHHHHT-TTEECCCCSGGGEEECGGGTCC------CTTEE
T ss_pred             EeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHH-HHHHHHHhh-CCeecCCCCHHHEEecccccCccccccccCCEE
Confidence            79999998765543           22366688899 999999999 89999999999999988           89999


Q ss_pred             EEeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          59 ISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        59 l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ++|||+++........ .......++..|+|||.+.+..++.++|+||+|++++++++ |+.||..
T Consensus       224 l~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~  287 (365)
T 3e7e_A          224 LIDLGQSIDMKLFPKG-TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF-GTYMKVK  287 (365)
T ss_dssp             ECCCTTCEEGGGSCTT-EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHH-SSCCCEE
T ss_pred             EeeCchhhhhhccCCC-ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHh-CCCcccc
Confidence            9999999754321111 11122234567999999988889999999999999999999 9999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.93  E-value=3.9e-26  Score=161.18  Aligned_cols=121  Identities=21%  Similarity=0.366  Sum_probs=97.6

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++|++|...+.       ......+++|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++.......
T Consensus       153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi-~~aL~~LH~-~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM-VIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             EecCCCCcHHHHHHHccCCCCHHHHHHHHHHH-HHHHHHHHh-CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            79999999765543       33466688899 999999999 9999999999999999999999999999976543322


Q ss_pred             eeeeccCCCCCceeccccccc-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYN-----FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..  .....+++.|+|||.+.     ...++.++|+||+|++++++++ |..||.+.+
T Consensus       231 ~~--~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~  285 (437)
T 4aw2_A          231 VQ--SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY-GETPFYAES  285 (437)
T ss_dssp             EE--CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHH-SSCTTCCSS
T ss_pred             cc--cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHh-CCCCCCCCC
Confidence            11  11223466799999886     4467899999999999999999 999998654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.93  E-value=1.4e-25  Score=161.78  Aligned_cols=120  Identities=23%  Similarity=0.333  Sum_probs=98.3

Q ss_pred             CCCCCCCCcccc----------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTP----------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||++|++|...          +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++....
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi-~~aL~~LH~-~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI-VSGLEHLHQ-RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHH-HHHHHHHHH-cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            799999997533          3333466688899 999999999 8999999999999999999999999999986543


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .....   ....+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       342 ~~~~~---~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyellt-G~~PF~~~~  393 (543)
T 3c4z_A          342 GQTKT---KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA-ARGPFRARG  393 (543)
T ss_dssp             TCCCB---CCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCTT
T ss_pred             CCccc---ccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHh-CCCCCCCCc
Confidence            32111   11234567999999988889999999999999999999 999998653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.93  E-value=4.3e-26  Score=159.83  Aligned_cols=121  Identities=21%  Similarity=0.350  Sum_probs=97.6

Q ss_pred             CCCCCCCCccccCC-----CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLG-----SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++|++|...+.     ......+++|+ +.|+.|+|. ++++||||||+||+++.+++++++|||+++........ 
T Consensus       148 ~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi-~~aL~~LH~-~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~-  224 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSNYDVPEKWARFYTAEV-VLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-  224 (410)
T ss_dssp             ECCCTTEEHHHHHHHCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE-
T ss_pred             EeCCCCCcHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc-
Confidence            79999999765443     33466688899 999999999 89999999999999999999999999999765433211 


Q ss_pred             eeccCCCCCceecccccccCCC----CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGR----FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~----~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       ......+++.|+|||.+....    ++.++|+||+|+++|++++ |..||.+.+
T Consensus       225 -~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~  277 (410)
T 3v8s_A          225 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADS  277 (410)
T ss_dssp             -ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH-SSCTTCCSS
T ss_pred             -cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh-CCCCCCCCC
Confidence             122233567899999887654    6789999999999999999 999998644

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.92  E-value=1.1e-25  Score=157.93  Aligned_cols=121  Identities=21%  Similarity=0.367  Sum_probs=97.4

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++|++|.+.+.       ......+++|+ +.|+.|+|. ++++||||||+||+++..++++++|||+++.......
T Consensus       140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi-~~aL~~LH~-~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~  217 (412)
T 2vd5_A          140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEI-VMAIDSVHR-LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT  217 (412)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence            79999999765543       33466688898 999999999 9999999999999999999999999999976543322


Q ss_pred             eeeeccCCCCCceeccccccc-------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYN-------FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..  .....+++.|+|||.+.       ...++.++|+||+|+++|++++ |..||.+.+
T Consensus       218 ~~--~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~  274 (412)
T 2vd5_A          218 VR--SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY-GQTPFYADS  274 (412)
T ss_dssp             EE--CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHH-SSCTTCCSS
T ss_pred             cc--cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHh-CCCCCCCCC
Confidence            11  11223467799999886       3457899999999999999998 999998654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.92  E-value=1e-25  Score=151.76  Aligned_cols=120  Identities=24%  Similarity=0.419  Sum_probs=98.0

Q ss_pred             CCCCCCCCccccC-----CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPL-----GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||+++++|...+     .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.........
T Consensus        96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  173 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTETCMDEGQIAAVCREC-LQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (297)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EECCCCCCHHHHHhhcCCCHHHHHHHHHHH-HHHHHHHHh-CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence            7899999876543     333456688888 999999999 899999999999999999999999999987654332211


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       174 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  220 (297)
T 3fxz_A          174 ---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNEN  220 (297)
T ss_dssp             ---CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHH-SSCTTTTSC
T ss_pred             ---CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence               12234567999999988889999999999999999999 999997654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.92  E-value=2.2e-25  Score=151.59  Aligned_cols=117  Identities=27%  Similarity=0.440  Sum_probs=97.1

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|+++...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++......  
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi-~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~--  160 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-CLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--  160 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHH-HHHHHHHHT-TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCccccCCChheEEEcCCCCEEEeecCcceecCCcc--
Confidence            79999998765443      33456688888 999999998 899999999999999999999999999987653321  


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                          ....+++.|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       161 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  207 (318)
T 1fot_A          161 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDSN  207 (318)
T ss_dssp             ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSS
T ss_pred             ----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCC
Confidence                12233567999999988889999999999999999999 999997643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.92  E-value=1.8e-25  Score=157.86  Aligned_cols=121  Identities=25%  Similarity=0.410  Sum_probs=96.8

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.||.|+|..++++||||||+||+++.++.++++|||+++........
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  305 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEI-VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT  305 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHH-HHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcc
Confidence            7999999875433      344566688898 999999996478999999999999999999999999998753322111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       306 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~  353 (446)
T 4ejn_A          306 ---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQD  353 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             ---cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhh-CCCCCCCCC
Confidence               112234567999999988889999999999999999999 999997654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.92  E-value=4.1e-25  Score=153.73  Aligned_cols=119  Identities=24%  Similarity=0.401  Sum_probs=95.8

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|++|...+      .......+++|+ +.|+.|+|. ++++||||||+||+++..+.++++|||+++....... 
T Consensus        94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi-~~aL~~LH~-~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-  170 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNVHFKEETVKLFICEL-VMALDYLQN-QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-  170 (384)
T ss_dssp             ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc-
Confidence            7899998865433      334566788899 999999999 9999999999999999999999999999976543211 


Q ss_pred             eeeccCCCCCceecccccccC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNF---GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~---~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+++.|+|||.+..   ..++.++|+||+|+++|++++ |..||...+
T Consensus       171 ---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~  221 (384)
T 4fr4_A          171 ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR-GRRPYHIRS  221 (384)
T ss_dssp             ---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHH-SSCSSCCCT
T ss_pred             ---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHh-CCCCCCCCC
Confidence               112234567999998863   357889999999999999999 999997543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.92  E-value=3.1e-25  Score=151.48  Aligned_cols=119  Identities=28%  Similarity=0.425  Sum_probs=97.0

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...      +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++....... 
T Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi-~~al~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  169 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQI-VSAVQYCHQ-KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-  169 (328)
T ss_dssp             ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred             EECCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence            789999886554      3344566788999 999999999 9999999999999999999999999999876543221 


Q ss_pred             eeeccCCCCCceecccccccCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFS-SASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~-~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+++.|+|||.+.+..+. .++|+||+|++++++++ |..||.+.+
T Consensus       170 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  218 (328)
T 3fe3_A          170 ---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGQN  218 (328)
T ss_dssp             ---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             ---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHh-CCCCCCCCC
Confidence               1222345679999999877764 78999999999999999 999998654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.92  E-value=2.3e-25  Score=161.41  Aligned_cols=119  Identities=27%  Similarity=0.416  Sum_probs=98.5

Q ss_pred             CCCCCCCCcccc--------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTP--------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++|++|...        +.......++.|+ +.|+.|+|. ++++||||||+||+++.+++++++|||+++......
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qI-l~aL~yLH~-~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEI-CCGLEDLHR-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHH-HHHHHHHHH-CCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            799999997543        3334566788899 999999999 899999999999999999999999999997654322


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..    ....+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       341 ~~----~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLlt-G~~PF~~~~  389 (576)
T 2acx_A          341 TI----KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRK  389 (576)
T ss_dssp             CE----ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHH-SSCSSSCSS
T ss_pred             cc----cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHh-CCCCCcccc
Confidence            11    12234567999999988888999999999999999999 999998754

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.92  E-value=3.8e-25  Score=154.51  Aligned_cols=119  Identities=22%  Similarity=0.432  Sum_probs=93.6

Q ss_pred             CCCCCCCCccccC--------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC---CCcEEEEeecCccccc
Q psy7529           1 MKSPNGSGVVTPL--------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS---RHQAKISDFGLSRAVN   69 (129)
Q Consensus         1 m~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~---~~~~~l~d~~~~~~~~   69 (129)
                      |||++|++|...+        .......++.|+ +.|+.|+|. ++++|||||++||+++.   ++.+|++|||+++...
T Consensus       138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi-~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~  215 (400)
T 1nxk_A          138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSI-GEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  215 (400)
T ss_dssp             EECCCSEEHHHHHHCC---CCBHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHH-HHHHHHHHH-CCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence            7899998875543        333466688899 999999999 89999999999999987   6889999999987653


Q ss_pred             CCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          70 SERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....    .....++..|+|||.+....++.++|+||+|+++|++++ |..||.+.+
T Consensus       216 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  267 (400)
T 1nxk_A          216 SHNS----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNH  267 (400)
T ss_dssp             ---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHH-SSCSCCCCT
T ss_pred             CCCc----cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCc
Confidence            3211    111223456999999988889999999999999999999 999997654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.92  E-value=3.2e-25  Score=152.56  Aligned_cols=117  Identities=23%  Similarity=0.359  Sum_probs=97.5

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|+++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++....... 
T Consensus       120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi-~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~-  196 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQI-VLTFEYLHS-LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-  196 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC-
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccccCccceEEECCCCCEEEcccccceeccCCcc-
Confidence            7899999875543      334566788999 999999998 9999999999999999999999999999976543211 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                           ...+++.|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       197 -----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~  242 (350)
T 1rdq_E          197 -----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQ  242 (350)
T ss_dssp             -----CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             -----cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhh-CCCCCCCCC
Confidence                 1223567999999988889999999999999999999 999997643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.92  E-value=1.8e-25  Score=154.72  Aligned_cols=124  Identities=37%  Similarity=0.659  Sum_probs=97.0

Q ss_pred             CCCCCCCCccccCC----------------------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEE
Q psy7529           1 MKSPNGSGVVTPLG----------------------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAK   58 (129)
Q Consensus         1 m~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~   58 (129)
                      |||+++++|...+.                      ...+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++
T Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~k  243 (370)
T 2psq_A          166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL-ARGMEYLAS-QKCIHRDLAARNVLVTENNVMK  243 (370)
T ss_dssp             EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEECTTCCEE
T ss_pred             EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHH-HHHHHHHHh-CCeeccccchhhEEECCCCCEE
Confidence            68888888654432                      12244578888 999999999 8999999999999999999999


Q ss_pred             EEeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          59 ISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        59 l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ++|||+++........ ........+..|+|||.+.+..++.++|+||+|+++|++++.|..||.+.+.
T Consensus       244 l~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          244 IADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             ECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             EccccCCcccCcccce-ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999999765432211 1112223346799999998888999999999999999999768899987653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.92  E-value=8.9e-25  Score=154.52  Aligned_cols=120  Identities=23%  Similarity=0.366  Sum_probs=96.7

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC---CCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS---RHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~---~~~~~l~d~~~~~~~~~~   71 (129)
                      |||++|+++...      +.......++.|+ +.|+.|+|. ++++||||||+||+++.   .+.++++|||+++.....
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qi-l~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQI-LEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHH-HHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            789999987543      3344566788899 999999999 89999999999999984   577999999999765433


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....   ....+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       167 ~~~~---~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~-G~~Pf~~~~  217 (444)
T 3soa_A          167 QQAW---FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV-GYPPFWDED  217 (444)
T ss_dssp             CCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             Ccee---ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHh-CCCCCCCcc
Confidence            2211   12234567999999988889999999999999999999 999997643

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.92  E-value=7e-25  Score=149.17  Aligned_cols=124  Identities=36%  Similarity=0.642  Sum_probs=97.1

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+.++++...       +.......++.|+ +.|+.|+|. ++++||||||+||+++..+.++++|||+++.......
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  170 (325)
T 3kex_A           93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI-AKGMYYLEE-HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK  170 (325)
T ss_dssp             EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHH-HHHHHHHHH-TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred             EEeCCCCCHHHHHHHccccCCHHHHHHHHHHH-HHHHHHHHh-CCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence            678888886543       3444566688898 999999999 8999999999999999999999999999986543221


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ... .....++..|++||.+....++.++|+||+|++++++++.|..||.+.+.
T Consensus       171 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  223 (325)
T 3kex_A          171 QLL-YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL  223 (325)
T ss_dssp             CCC------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred             ccc-ccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence            111 11112344699999998888999999999999999999768999987654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.92  E-value=5.1e-25  Score=150.13  Aligned_cols=120  Identities=25%  Similarity=0.383  Sum_probs=92.9

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus       100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  177 (327)
T 3a62_A          100 LEYLSGGELFMQLEREGIFMEDTACFYLAEI-SMALGHLHQ-KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV  177 (327)
T ss_dssp             EECCTTEEHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCTTTEEECTTSCEEECCCSCC---------
T ss_pred             EeCCCCCcHHHHHHhCCCCCHHHHHHHHHHH-HHHHHHHHh-CCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCcc
Confidence            6888888865443      333456688888 999999999 89999999999999999999999999998753222111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       178 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  225 (327)
T 3a62_A          178 ---THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLT-GAPPFTGEN  225 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             ---ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHH-CCCCCCCCC
Confidence               112223567999999988888999999999999999999 999998653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.92  E-value=1e-25  Score=164.62  Aligned_cols=125  Identities=50%  Similarity=0.913  Sum_probs=96.1

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+.+++|...+.       ...+..++.|+ +.|+.|+|. ++++|||||++||+++.++.+|++|||+++.......
T Consensus       414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi-~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQV-SMGMKYLEE-KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHH-HHHHHHHHH-CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            78999998765442       23455688888 999999999 8999999999999999999999999999986543222


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .........++..|+|||.+....++.++|+||+|+++|+++++|..||.+.+.
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~  545 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  545 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence            221122222345799999998888999999999999999999769999988764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.92  E-value=1.3e-25  Score=151.97  Aligned_cols=123  Identities=21%  Similarity=0.358  Sum_probs=91.7

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|++|...+      .......++.|+ +.|+.|+|. ++++|||||++||+++.++.++++|||+++........
T Consensus        95 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  172 (311)
T 3ork_A           95 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADA-CQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS  172 (311)
T ss_dssp             EECCCEEEHHHHHHHHCSCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEEETTSCEEECCCSCC---------
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccc
Confidence            6888888765433      334456688888 999999999 89999999999999999999999999998765332211


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ........++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       173 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~  223 (311)
T 3ork_A          173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDS  223 (311)
T ss_dssp             ---------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            111111223567999999988888999999999999999999 999998654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.91  E-value=5.4e-25  Score=149.93  Aligned_cols=123  Identities=15%  Similarity=0.194  Sum_probs=96.2

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc-----EEEEeecCcccc
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ-----AKISDFGLSRAV   68 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~-----~~l~d~~~~~~~   68 (129)
                      |||+ +++|...       +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.     ++++|||+++..
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi-~~~l~~LH~-~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQL-ISRMEYVHS-KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            6777 6664433       3334466688899 999999999 89999999999999998877     999999999865


Q ss_pred             cCCCcee----eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          69 NSERNYY----KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        69 ~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .......    .......++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~Pf~~~~~  222 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLR-GSLPWQGLKA  222 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCC
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhc-CCCCcccccc
Confidence            3322111    01122334567999999988889999999999999999999 9999988654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.91  E-value=1.5e-25  Score=154.54  Aligned_cols=121  Identities=19%  Similarity=0.236  Sum_probs=94.0

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEec--CCCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLA--SRHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~--~~~~~~l~d~~~~~~~~~~   71 (129)
                      |||+ |++|...       +....+..++.|+ +.||.|+|. ++++||||||+||+++  ..+.++++|||+++.....
T Consensus       131 ~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi-~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~  207 (364)
T 3op5_A          131 MDRF-GSDLQKIYEANAKRFSRKTVLQLSLRI-LDILEYIHE-HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE  207 (364)
T ss_dssp             EECE-EEEHHHHHHHTTSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGG
T ss_pred             EeCC-CCCHHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEEecCCHHHEEEecCCCCeEEEEECCcceecccC
Confidence            5666 6665433       3334566688899 999999999 8999999999999998  8899999999999765322


Q ss_pred             Cceee----eccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          72 RNYYK----ATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        72 ~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .....    ......++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.
T Consensus       208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~Pf~~~  264 (364)
T 3op5_A          208 GVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT-GHLPWEDN  264 (364)
T ss_dssp             GCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SCCTTGGG
T ss_pred             CcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHh-CCCCcccc
Confidence            11100    0111224567999999988889999999999999999999 99999863

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.91  E-value=2.6e-25  Score=151.51  Aligned_cols=124  Identities=41%  Similarity=0.689  Sum_probs=96.1

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+++++|...+       ....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi-~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  206 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV-GAGMRYLSD-LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD  206 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHH-HHHHHHHHH-CCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence            7889998865544       223455688888 999999999 9999999999999999999999999999986543322


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..........+..|++||.+.+..++.++|+||+|++++++++.|..||.+.+
T Consensus       207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  259 (325)
T 3kul_A          207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT  259 (325)
T ss_dssp             CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence            22222223334569999999877888999999999999999976899997654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.91  E-value=5.4e-25  Score=147.99  Aligned_cols=121  Identities=25%  Similarity=0.366  Sum_probs=94.6

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|++|...      +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  167 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQI-LDGIKHAHD-MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT  167 (294)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence            788999886654      3444566688888 999999999 89999999999999999999999999998765322111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .  .....++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       168 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~  216 (294)
T 4eqm_A          168 Q--TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV-GEPPFNGET  216 (294)
T ss_dssp             ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHH-SSCSSCSSC
T ss_pred             c--cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            1  111123467999999988888999999999999999999 999998654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.91  E-value=3.2e-25  Score=153.69  Aligned_cols=124  Identities=41%  Similarity=0.699  Sum_probs=87.5

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+++++|...+.       ...+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  202 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI-ASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE  202 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence            68898888665443       23355688888 999999999 8999999999999999999999999999876543221


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..........+..|+|||.+....++.++|+||+|+++++++++|..||.+.+
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~  255 (373)
T 2qol_A          203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS  255 (373)
T ss_dssp             -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred             cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence            11111222224569999999888899999999999999999976899997654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.91  E-value=5.4e-25  Score=147.74  Aligned_cols=123  Identities=24%  Similarity=0.316  Sum_probs=94.5

Q ss_pred             CCCCCCCCccccCCC-----CchhhHHhHHHHHHHHHHh--------ccCCCccCCCCCCCEEecCCCcEEEEeecCccc
Q psy7529           1 MKSPNGSGVVTPLGS-----YALPYIEGQIPAKVCRYLK--------MHKSSFHRDLAARNILLASRHQAKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~h--------~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~   67 (129)
                      |||+++++|...+..     .....++.|+ +.|+.|+|        . ++++||||||+||+++.++.++++|||+++.
T Consensus        85 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i-~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  162 (301)
T 3q4u_A           85 THYHEMGSLYDYLQLTTLDTVSCLRIVLSI-ASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKKNGQCCIADLGLAVM  162 (301)
T ss_dssp             ECCCTTCBHHHHHTTCCBCHHHHHHHHHHH-HHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             hhhccCCCHHHHHhhcccCHHHHHHHHHHH-HHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence            789999997765543     3355588888 99999999        6 8999999999999999999999999999876


Q ss_pred             ccCCCceee-eccCCCCCceecccccccCC------CCCChhhHHHHHHHHHHHHhCC----------CCCCCCCC
Q psy7529          68 VNSERNYYK-ATHGGRWPIKWYAPESYNFG------RFSSASDVWSFGITLWEMYSFG----------QQPYGEMK  126 (129)
Q Consensus        68 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~------~~~~~~di~s~g~~l~~l~~~~----------~~pf~~~~  126 (129)
                      ......... ......++..|+|||.+.+.      .++.++|+||+|++++++++ |          ..||.+..
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT-TBCBTTBCCCCCCTTTTTS
T ss_pred             cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHh-hhcCccccccccccccccC
Confidence            543322211 11122345679999988765      23368999999999999998 8          78886643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.91  E-value=1.2e-24  Score=150.36  Aligned_cols=119  Identities=24%  Similarity=0.374  Sum_probs=96.8

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC----cEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH----QAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~----~~~l~d~~~~~~~~~   70 (129)
                      |||++|++|...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++..+    .++++|||+++....
T Consensus        94 ~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi-~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~  171 (361)
T 2yab_A           94 LELVSGGELFDFLAQKESLSEEEATSFIKQI-LDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (361)
T ss_dssp             EECCCSCBHHHHHTTCSCCBHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence            78999998765543      33466688899 999999999 8999999999999998776    799999999976543


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...    .....+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       172 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~-g~~Pf~~~~  222 (361)
T 2yab_A          172 GVE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDT  222 (361)
T ss_dssp             TCC----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSS
T ss_pred             CCc----cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCC
Confidence            221    112234567999999988889999999999999999999 999997643

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.91  E-value=6.3e-25  Score=155.99  Aligned_cols=119  Identities=24%  Similarity=0.254  Sum_probs=89.9

Q ss_pred             CCCCCCCC---ccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeee
Q psy7529           1 MKSPNGSG---VVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA   77 (129)
Q Consensus         1 m~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~   77 (129)
                      |||++++.   +...+.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......    
T Consensus       146 ~E~~~~~l~~~~~~~l~~~~~~~~~~qi-l~aL~~lH~-~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~----  219 (464)
T 3ttj_A          146 MELMDANLCQVIQMELDHERMSYLLYQM-LCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----  219 (464)
T ss_dssp             EECCSEEHHHHHTSCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCC----
T ss_pred             EeCCCCCHHHHHhhcCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcc----
Confidence            45555432   12223344566788999 999999999 8999999999999999999999999999976533211    


Q ss_pred             ccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          78 THGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        78 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .....++..|+|||.+.+..++.++|+||+|++++++++ |+.||.+.+
T Consensus       220 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pF~g~~  267 (464)
T 3ttj_A          220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRD  267 (464)
T ss_dssp             C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            111223456999999988889999999999999999998 999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.91  E-value=8.2e-25  Score=148.15  Aligned_cols=120  Identities=29%  Similarity=0.439  Sum_probs=89.9

Q ss_pred             CCCCCCCCccccCCC---------CchhhHHhHHHHHHHHHHhccCC--CccCCCCCCCEEecCCCcEEEEeecCccccc
Q psy7529           1 MKSPNGSGVVTPLGS---------YALPYIEGQIPAKVCRYLKMHKS--SFHRDLAARNILLASRHQAKISDFGLSRAVN   69 (129)
Q Consensus         1 m~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~~h~~~~--~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~   69 (129)
                      |||++++++...+..         .....++.|+ +.|+.|+|. ++  ++||||||+||+++.++.++++|||+++...
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV-AKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHH-HHHHHHHHT-SSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHH-HHHHHHHHc-CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            688999887655433         2344578888 999999998 78  9999999999999999999999999987543


Q ss_pred             CCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          70 SERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .....   .....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       191 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~  243 (309)
T 3p86_A          191 STFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLN  243 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHH-CCCTTTTSC
T ss_pred             ccccc---cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            22111   111223457999999988888999999999999999999 999998754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.91  E-value=1.2e-24  Score=151.07  Aligned_cols=124  Identities=20%  Similarity=0.308  Sum_probs=95.9

Q ss_pred             CCCCCCCCcccc--------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTP--------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...        +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||.+.......
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi-~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~  182 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGV-LKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG  182 (389)
T ss_dssp             EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred             EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence            688888885543        3334466688888 999999999 899999999999999999999999999876432211


Q ss_pred             ce----eeeccCCCCCceecccccccC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          73 NY----YKATHGGRWPIKWYAPESYNF--GRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        73 ~~----~~~~~~~~~~~~~~~pe~~~~--~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ..    ........++..|+|||.+.+  ..++.++|+||+|++++++++ |..||.+.+.
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~  242 (389)
T 3gni_B          183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN-GHVPFKDMPA  242 (389)
T ss_dssp             EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHH-SSCTTTTCCS
T ss_pred             ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHH-CCCCCCCCCH
Confidence            10    001111234567999999877  468899999999999999999 9999987654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.91  E-value=2.6e-25  Score=153.73  Aligned_cols=98  Identities=17%  Similarity=0.396  Sum_probs=82.3

Q ss_pred             hHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC--CC
Q psy7529          20 YIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF--GR   97 (129)
Q Consensus        20 ~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~   97 (129)
                      .++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++......   ....   ++..|+|||.+.+  ..
T Consensus       198 ~i~~qi-~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~---~t~~y~aPE~~~~~~~~  269 (371)
T 3q60_A          198 ILTAQL-IRLAANLQS-KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASS---VPVTYAPREFLNASTAT  269 (371)
T ss_dssp             HHHHHH-HHHHHHHHH-TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGG---SCGGGCCHHHHTCSEEE
T ss_pred             HHHHHH-HHHHHHHHH-CCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc---cCcc---CCcCCcChhhccCCCCC
Confidence            555888 999999998 999999999999999999999999999987653211   1111   2357999999976  57


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|++++++++ |..||.+.+
T Consensus       270 ~~~~~DiwSlG~il~ellt-g~~Pf~~~~  297 (371)
T 3q60_A          270 FTHALNAWQLGLSIYRVWC-LFLPFGLVT  297 (371)
T ss_dssp             CCHHHHHHHHHHHHHHHHH-SSCSTTBCC
T ss_pred             cCccccHHHHHHHHHHHHh-CCCCCCCcC
Confidence            8999999999999999999 999998763

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.91  E-value=1.1e-24  Score=149.71  Aligned_cols=118  Identities=23%  Similarity=0.370  Sum_probs=94.7

Q ss_pred             CCCCCCCCcccc----------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc---EEEEeecCccc
Q psy7529           1 MKSPNGSGVVTP----------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ---AKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~---~~l~d~~~~~~   67 (129)
                      |||++|++|...          +.......++.|+ +.|+.|+|. ++++||||||+||+++..+.   ++++|||+++.
T Consensus       105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi-~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI-LEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHH-HHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            789999987532          3334456688899 999999999 89999999999999976554   99999999876


Q ss_pred             ccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          68 VNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .......   .....+++.|+|||.+.+..++.++|+||+|++++++++ |..||.+
T Consensus       183 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~  235 (351)
T 3c0i_A          183 LGESGLV---AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS-GCLPFYG  235 (351)
T ss_dssp             CCTTSCB---CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCS
T ss_pred             ecCCCee---ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHH-CCCCCCC
Confidence            5432211   112234567999999988888999999999999999999 9999975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.91  E-value=3.6e-24  Score=143.93  Aligned_cols=119  Identities=26%  Similarity=0.376  Sum_probs=94.3

Q ss_pred             CCCCCCCCccccCCC-----CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLGS-----YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++++......     .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.........
T Consensus       117 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  194 (298)
T 2zv2_A          117 FELVNQGPVMEVPTLKPLSEDQARFYFQDL-IKGIEYLHY-QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL  194 (298)
T ss_dssp             EECCTTCBSCCSSCSSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEE
T ss_pred             EecCCCCcHHHHhhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeccCCCHHHEEECCCCCEEEecCCCccccccccccc
Confidence            688888887654432     2355588888 999999999 899999999999999999999999999987654332211


Q ss_pred             eeccCCCCCceecccccccCCC---CCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGR---FSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~---~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                         ....++..|+|||.+....   ++.++|+||+|++++++++ |..||.+.
T Consensus       195 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~  243 (298)
T 2zv2_A          195 ---SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF-GQCPFMDE  243 (298)
T ss_dssp             ---CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH-SSCSSCCS
T ss_pred             ---cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH-CCCCCCCc
Confidence               1223456799999987654   3678999999999999999 99999764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.91  E-value=3.2e-24  Score=144.85  Aligned_cols=123  Identities=24%  Similarity=0.294  Sum_probs=95.2

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+.       ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi-~~al~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDI-ASGMAYLHS-MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEecCCCcHHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHh-CCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            68899988654432       23455688888 999999999 8999999999999999999999999999976532211


Q ss_pred             eee-----------eccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYK-----------ATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~-----------~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...           ......++..|+|||.+.+..++.++|+||+|++++++++ |..||.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~~~~~~~  226 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG-RVNADPDYL  226 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-TCCSSTTTS
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhc-CCCCCcchh
Confidence            100           0012234567999999988889999999999999999998 998887643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.91  E-value=2.2e-24  Score=146.69  Aligned_cols=120  Identities=24%  Similarity=0.429  Sum_probs=97.1

Q ss_pred             CCCCCCCCccccCCC-----CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLGS-----YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++++...+..     ..+..++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++.........
T Consensus       121 ~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi-~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  198 (321)
T 2c30_A          121 MEFLQGGALTDIVSQVRLNEEQIATVCEAV-LQALAYLHA-QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR  198 (321)
T ss_dssp             ECCCCSCBHHHHHTTCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred             EecCCCCCHHHHHHhcCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccc
Confidence            789999886654432     3455688888 999999999 899999999999999999999999999987654322111


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       199 ---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~pf~~~~  245 (321)
T 2c30_A          199 ---KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVD-GEPPYFSDS  245 (321)
T ss_dssp             ---CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSC
T ss_pred             ---ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence               12234567999999988888999999999999999999 999997643

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.91  E-value=1.1e-25  Score=164.89  Aligned_cols=125  Identities=49%  Similarity=0.890  Sum_probs=96.1

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+++++|...+.      ...+..++.|+ +.|+.|+|. ++++|||||++||+++.++.++++|||+++........
T Consensus       448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi-~~~L~yLH~-~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQV-SMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             EECCTTEEHHHHHHHCTTCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             EEccCCCCHHHHHhhCCCCCHHHHHHHHHHH-HHHHHHHHH-CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            78888888655432      33456688888 999999999 89999999999999999999999999998765433222


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ........++..|+|||.+....++.++|+||+|+++++++++|..||.+.+.
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~  578 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG  578 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            22222223356799999998888999999999999999999769999987653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.91  E-value=3.6e-24  Score=147.87  Aligned_cols=119  Identities=25%  Similarity=0.411  Sum_probs=95.3

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC---cEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH---QAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~---~~~l~d~~~~~~~~~~   71 (129)
                      |||++|+++...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++...   .++++|||+++.....
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi-~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAREFYSEADASHCIQQI-LESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHH-HHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            78999998755443      33456688888 999999999 8999999999999997654   5999999998765432


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..    .....+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       185 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~  234 (362)
T 2bdw_A          185 EA----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDED  234 (362)
T ss_dssp             CS----CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             cc----cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHH-CCCCCCCCC
Confidence            21    112234567999999988889999999999999999999 999997643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1.5e-24  Score=147.58  Aligned_cols=119  Identities=22%  Similarity=0.400  Sum_probs=96.0

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC--CCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS--RHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~--~~~~~l~d~~~~~~~~~~   71 (129)
                      |||++|+++...+..       .....++.|+ +.|+.|+|. ++++||||||+||+++.  ++.++++|||+++.....
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi-~~al~~lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQV-CEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            799999987654432       3355688888 999999999 89999999999999987  788999999999765433


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ... ...   .+++.|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       158 ~~~-~~~---~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  207 (321)
T 1tki_A          158 DNF-RLL---FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAET  207 (321)
T ss_dssp             CEE-EEE---ESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH-SSCTTCCSS
T ss_pred             Ccc-ccc---cCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCcCCC
Confidence            221 111   13456999999988778899999999999999999 999997654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.91  E-value=2.6e-24  Score=144.21  Aligned_cols=123  Identities=14%  Similarity=0.182  Sum_probs=95.2

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc-----EEEEeecCcccc
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ-----AKISDFGLSRAV   68 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~-----~~l~d~~~~~~~   68 (129)
                      |||+ +++|.+.       +.......++.|+ +.|+.|+|. ++++||||||+||+++..+.     ++++|||+++..
T Consensus        85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQM-LARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHH-HHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEec-CCCHHHHHHHhccCCCHHHHHHHHHHH-HHHHHHHHh-CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            5677 6665443       3334566688899 999999998 89999999999999977665     999999999865


Q ss_pred             cCCCcee----eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          69 NSERNYY----KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        69 ~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .......    .......++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~  223 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKA  223 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCS
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHc-CCCCcchhhc
Confidence            4322110    11122234567999999988888999999999999999998 9999987653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.91  E-value=1.8e-24  Score=147.30  Aligned_cols=123  Identities=26%  Similarity=0.378  Sum_probs=97.3

Q ss_pred             CCCCCCCCccccCCCC------chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGSY------ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+...      ....++.|+ +.|+.|+|. ++++||||||+||+++..+.++++|||+++........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-MAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            7899998887766532      356688888 999999998 99999999999999999999999999998754322111


Q ss_pred             eeeccCCCCCceecccccccCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRF-SSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                       .......++..|+|||.+.+..+ +.++|+||+|++++++++ |..||...+.
T Consensus       162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  213 (323)
T 3tki_A          162 -RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSD  213 (323)
T ss_dssp             -CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHH-SSCSCSSSCT
T ss_pred             -cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCch
Confidence             11112234567999999877665 678999999999999999 9999986543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.91  E-value=3.8e-24  Score=143.22  Aligned_cols=123  Identities=20%  Similarity=0.252  Sum_probs=95.7

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe---cCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL---ASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~---~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||+ ++++.+.       +.......++.|+ +.|+.|+|. ++++||||||+||++   +..+.++++|||+++....
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi-~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQM-ISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            5777 6664433       3334466688888 999999999 899999999999999   7888999999999976543


Q ss_pred             CCcee----eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          71 ERNYY----KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        71 ~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .....    .......++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~  220 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLKA  220 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCC
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhc-CCCCCcccch
Confidence            22110    11112234567999999988889999999999999999999 9999987654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.91  E-value=4.7e-25  Score=156.16  Aligned_cols=123  Identities=40%  Similarity=0.701  Sum_probs=98.2

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+++++|...+..        .....++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++......
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi-~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI-AEGMAFIEQ-RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHH-HHHHHHHHh-CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            789999987665542        2344578888 999999999 899999999999999999999999999997653211


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                        .........+..|+|||.+....++.++|+||+|++++++++.|..||.+.+.
T Consensus       339 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~  391 (454)
T 1qcf_A          339 --YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN  391 (454)
T ss_dssp             --HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             --eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence              11112223346799999998888999999999999999999768999987653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.90  E-value=2.8e-24  Score=145.55  Aligned_cols=109  Identities=24%  Similarity=0.373  Sum_probs=87.0

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++..........   ...++..|+|||.+
T Consensus       117 ~~~~~~~~~~qi-~~~l~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~t~~y~aPE~~  191 (311)
T 3niz_A          117 QDSQIKIYLYQL-LRGVAHCHQ-HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT---HEVVTLWYRAPDVL  191 (311)
T ss_dssp             CHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC------CCCCCCTTCCHHHH
T ss_pred             CHHHHHHHHHHH-HHHHHHHHH-CCcccCCCchHhEEECCCCCEEEccCcCceecCCCccccc---CCcccCCcCCHHHh
Confidence            334456688888 999999999 8999999999999999999999999999976543222111   11234569999988


Q ss_pred             cC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          94 NF-GRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        94 ~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                      .+ ..++.++|+||+|++++++++ |..||.+.+..
T Consensus       192 ~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  226 (311)
T 3niz_A          192 MGSKKYSTSVDIWSIGCIFAEMIT-GKPLFPGVTDD  226 (311)
T ss_dssp             TTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSTT
T ss_pred             cCCCCCCchHHhHHHHHHHHHHHh-CCCCCCCCChH
Confidence            76 457899999999999999999 99999876543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.90  E-value=1.6e-25  Score=155.11  Aligned_cols=99  Identities=14%  Similarity=0.181  Sum_probs=79.9

Q ss_pred             hhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC--
Q psy7529          19 PYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG--   96 (129)
Q Consensus        19 ~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--   96 (129)
                      ..++.|+ +.||.|+|. ++++||||||+||+++.++.++++|||+++.....   ....   .+ ..|+|||.+.+.  
T Consensus       209 ~~i~~qi-~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~---~g-~~y~aPE~~~~~~~  279 (377)
T 3byv_A          209 LQLTLQV-IRLLASLHH-YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSS---VS-RGFEPPELEARRAT  279 (377)
T ss_dssp             HHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCGGGCEETTCE---EECC---CC-TTCCCHHHHHHHTS
T ss_pred             HHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEechhheecCCc---ccCC---CC-cCccChhhhccccc
Confidence            3478888 999999999 89999999999999999999999999998753321   1111   12 469999998776  


Q ss_pred             ---------CCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          97 ---------RFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        97 ---------~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                               .++.++|+||+|++++++++ |..||.+.+.
T Consensus       280 ~~~~~~~~~~~~~~~DvwSlG~il~ellt-g~~Pf~~~~~  318 (377)
T 3byv_A          280 ISYHRDRRTLMTFSFDAWALGLVIYWIWC-ADLPITKDAA  318 (377)
T ss_dssp             THHHHCCEEECCHHHHHHHHHHHHHHHHH-SSCCC-----
T ss_pred             ccccccccccCChhhhHHHHHHHHHHHHH-CCCCCccccc
Confidence                     78999999999999999999 9999986543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.90  E-value=2.4e-24  Score=146.77  Aligned_cols=120  Identities=27%  Similarity=0.502  Sum_probs=80.7

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC---cEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH---QAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~---~~~l~d~~~~~~~~~~   71 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++..+   .++++|||+++.....
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi-~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           85 MELLNGGELFERIKKKKHFSETEASYIMRKL-VSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             ECCCCSCBHHHHHHHCSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             EEccCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            7899998865443      334566688898 999999998 9999999999999997665   7999999998754332


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .....   ...++..|+|||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus       163 ~~~~~---~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  213 (325)
T 3kn6_A          163 NQPLK---TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS-GQVPFQSHD  213 (325)
T ss_dssp             ------------------------CCCCHHHHHHHHHHHHHHHHH-SSCTTC---
T ss_pred             CCccc---ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCc
Confidence            21111   1123467999999988889999999999999999999 999998643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.90  E-value=3e-24  Score=147.11  Aligned_cols=118  Identities=27%  Similarity=0.375  Sum_probs=93.2

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+ ++++...      +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++....... 
T Consensus        88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi-~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~-  163 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQI-ICAIEYCHR-HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-  163 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHH-HHHHHHHHH-HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT-
T ss_pred             EECC-CCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc-
Confidence            6777 4554432      3344566788899 999999999 8999999999999999999999999999876543221 


Q ss_pred             eeeccCCCCCceecccccccCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRF-SSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+++.|+|||.+.+..+ +.++|+||+|++++++++ |..||.+..
T Consensus       164 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~  212 (336)
T 3h4j_B          164 ---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV-GRLPFDDEF  212 (336)
T ss_dssp             ---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHH-SSCSSBCSS
T ss_pred             ---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHh-CCCCCCCcc
Confidence               112234567999999987765 688999999999999999 999998654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.90  E-value=3.5e-24  Score=149.20  Aligned_cols=119  Identities=20%  Similarity=0.320  Sum_probs=95.7

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC--CCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS--RHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~--~~~~~l~d~~~~~~~~~~   71 (129)
                      |||+++++|...+..       .....++.|+ +.|+.|+|. ++++||||||+||+++.  .+.++++|||+++.....
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi-~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQA-CEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            789999997665542       2355688888 999999999 89999999999999974  467999999999865433


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .... ..   .++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       205 ~~~~-~~---~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~  254 (387)
T 1kob_A          205 EIVK-VT---TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGED  254 (387)
T ss_dssp             SCEE-EE---CSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSS
T ss_pred             ccee-ee---ccCCCccCchhccCCCCCCcccEeeHhHHHHHHHh-CCCCCCCCC
Confidence            2211 11   23467999999988888999999999999999999 999998643

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.90  E-value=9e-24  Score=143.34  Aligned_cols=122  Identities=25%  Similarity=0.327  Sum_probs=95.7

Q ss_pred             CCCCCCCCccccCCCC----------chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPLGSY----------ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||++++++...+...          ....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++....
T Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i-~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA-ARGLHYLHT-RAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHH-HHHHHHhcC-CCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            6889888877665432          244578888 999999999 9999999999999999999999999999875432


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..... ......++..|+|||.+.+..++.++|+||+|++++++++ |..||....
T Consensus       192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~p~~~~~  245 (321)
T 2qkw_B          192 LDQTH-LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC-ARSAIVQSL  245 (321)
T ss_dssp             SSCCC-CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHH-CCTTCSCSS
T ss_pred             ccccc-cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHh-CCCcccccC
Confidence            21111 0111123456999999887888999999999999999999 999987644

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.90  E-value=2.2e-24  Score=152.64  Aligned_cols=120  Identities=40%  Similarity=0.708  Sum_probs=96.2

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+++++|...+.        ......++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++......
T Consensus       266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi-~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  343 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV-CEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  343 (450)
T ss_dssp             EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence            68888888655443        22345578888 999999999 899999999999999999999999999987543221


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                      .      ....+..|+|||.+....++.++|+||+|+++|+++++|..||.+.+..
T Consensus       344 ~------~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~  393 (450)
T 1k9a_A          344 D------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK  393 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT
T ss_pred             c------CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            1      1122456999999988889999999999999999997799999887654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.90  E-value=7.6e-25  Score=150.37  Aligned_cols=107  Identities=43%  Similarity=0.759  Sum_probs=85.9

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      ...++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........ .......++..|+|||.+.+..
T Consensus       195 ~~~~~~ql-~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~  271 (359)
T 3vhe_A          195 LICYSFQV-AKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRV  271 (359)
T ss_dssp             HHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC-EEC--CEECGGGCCHHHHHHCC
T ss_pred             HHHHHHHH-HHHHHHHHH-CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc-hhccccCCCceeEChhhhcCCC
Confidence            44578888 999999999 89999999999999999999999999998765332211 1111222345699999998888


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ++.++|+||+|++++++++.|..||.+.+.
T Consensus       272 ~~~~~Di~slG~il~ellt~g~~p~~~~~~  301 (359)
T 3vhe_A          272 YTIQSDVWSFGVLLWEIFSLGASPYPGVKI  301 (359)
T ss_dssp             CCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             CCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence            899999999999999999658999987553

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.90  E-value=1.6e-24  Score=146.97  Aligned_cols=124  Identities=35%  Similarity=0.566  Sum_probs=91.1

Q ss_pred             CCCCCCCCcccc------------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccc
Q psy7529           1 MKSPNGSGVVTP------------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAV   68 (129)
Q Consensus         1 m~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~   68 (129)
                      |||++++++...            +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++..
T Consensus       110 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi-~~al~~LH~-~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~  187 (323)
T 3qup_A          110 LPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI-ACGMEYLSS-RNFIHRDLAARNCMLAEDMTVCVADFGLSRKI  187 (323)
T ss_dssp             EECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             EEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHH-HHHHHHHHc-CCcccCCCCcceEEEcCCCCEEEeeccccccc
Confidence            578888876543            3334456688899 999999999 89999999999999999999999999998765


Q ss_pred             cCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          69 NSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ...... ........+..|++||.+.+..++.++|+||+|++++++++.|..||.+.+.
T Consensus       188 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~  245 (323)
T 3qup_A          188 YSGDYY-RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN  245 (323)
T ss_dssp             --------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred             cccccc-cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh
Confidence            332211 1111222345699999998888899999999999999999757899987553

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.90  E-value=1.2e-24  Score=145.94  Aligned_cols=121  Identities=38%  Similarity=0.633  Sum_probs=91.4

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+++++|...+.       ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  169 (295)
T 3ugc_A           92 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI-CKGMEYLGT-KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE  169 (295)
T ss_dssp             EECCTTCBHHHHHHHCGGGCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCCSCC-------
T ss_pred             EEeCCCCCHHHHHHhcccccCHHHHHHHHHHH-HHHHHHHhc-CCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcc
Confidence            68888888665433       33455588888 999999998 9999999999999999999999999999976543222


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .........++..|+|||.+.+..++.++|+||+|++++++++ |..||..
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~~~~~  219 (295)
T 3ugc_A          170 FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YIEKSKS  219 (295)
T ss_dssp             ------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHH-TTCTTCS
T ss_pred             eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHh-cccccCC
Confidence            1111222223456999999988889999999999999999999 8888764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.90  E-value=3.6e-24  Score=148.63  Aligned_cols=123  Identities=39%  Similarity=0.685  Sum_probs=96.6

Q ss_pred             CCCCCCCCcccc----------------------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEE
Q psy7529           1 MKSPNGSGVVTP----------------------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAK   58 (129)
Q Consensus         1 m~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~   58 (129)
                      |||+++++|...                      +....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++
T Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi-~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~k  231 (382)
T 3tt0_A          154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV-ARGMEYLAS-KKCIHRDLAARNVLVTEDNVMK  231 (382)
T ss_dssp             EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECTTCCEE
T ss_pred             EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHH-HHHHHHHHh-CCEecCCCCcceEEEcCCCcEE
Confidence            678888875443                      3333456688898 999999999 8999999999999999999999


Q ss_pred             EEeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          59 ISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        59 l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++|||+++........ ........+..|+|||.+.+..++.++|+||+|++++++++.|..||.+.+
T Consensus       232 L~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          232 IADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             ECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EcccCccccccccccc-ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999998765432211 111222334679999999888889999999999999999975889998654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.90  E-value=8.3e-25  Score=148.71  Aligned_cols=122  Identities=25%  Similarity=0.310  Sum_probs=94.5

Q ss_pred             CCCCCCCCccccCC-----CCchhhHHhHHHHHHHHHHhccC----------CCccCCCCCCCEEecCCCcEEEEeecCc
Q psy7529           1 MKSPNGSGVVTPLG-----SYALPYIEGQIPAKVCRYLKMHK----------SSFHRDLAARNILLASRHQAKISDFGLS   65 (129)
Q Consensus         1 m~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~h~~~----------~~ihr~lk~~nil~~~~~~~~l~d~~~~   65 (129)
                      |||+++++|...+.     ......++.|+ +.|+.|+|. +          +++||||||+||+++..+.++++|||++
T Consensus       101 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi-~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a  178 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANVVSWNELCHIAETM-ARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA  178 (322)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHH-HHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EecCCCCCHHHHHHhcCCCHHHHHHHHHHH-HHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence            68899988765543     33455688888 999999998 7          9999999999999999999999999999


Q ss_pred             ccccCCCceeeeccCCCCCceecccccccCC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          66 RAVNSERNYYKATHGGRWPIKWYAPESYNFG-----RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +........ .......++..|+|||.+.+.     .++.++|+||+|+++|++++ |..||.+..
T Consensus       179 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~  242 (322)
T 3soc_A          179 LKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS-RCTAADGPV  242 (322)
T ss_dssp             EEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TBTTSSSCC
T ss_pred             cccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHh-CCCCCCCCc
Confidence            765432211 111222345679999988763     33467899999999999998 999997643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.90  E-value=4.6e-25  Score=152.95  Aligned_cols=124  Identities=43%  Similarity=0.702  Sum_probs=96.3

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+.       ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus       191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi-~~~l~~LH~-~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDA-AAGMEYLES-KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            78899888665432       33455688888 999999999 8999999999999999999999999999875432211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                       .........+..|+|||.+....++.++|+||+|+++|++++.|..||.+.+.
T Consensus       269 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~  321 (377)
T 3cbl_A          269 -AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN  321 (377)
T ss_dssp             -ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred             -eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence             11111112245699999988777889999999999999999768999987653

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.90  E-value=6.6e-24  Score=151.41  Aligned_cols=123  Identities=21%  Similarity=0.293  Sum_probs=96.1

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe---cCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL---ASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~---~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||+ +++|...       +....+..++.|+ +.||.|||. ++++|||||++||++   +..+.++++|||+++....
T Consensus        82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi-~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM-INRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            6777 6664433       3334566688899 999999999 899999999999999   5788999999999986543


Q ss_pred             CCce----eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          71 ERNY----YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        71 ~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ....    ........++..|++||.+.+..++.++|+||+|+++|++++ |..||.+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~  218 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA  218 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCC
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHh-CCCCCccccc
Confidence            2211    111112234567999999988889999999999999999999 9999988654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.90  E-value=1.5e-24  Score=147.77  Aligned_cols=124  Identities=39%  Similarity=0.660  Sum_probs=95.0

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      ||++.++++...+       .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus        95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi-~~~l~~LH~-~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  172 (327)
T 3poz_A           95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-AKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHhh-CCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence            4667777755433       223455688888 999999999 8999999999999999999999999999876543322


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .. ......++..|+|||.+.+..++.++|+||+|++++++++.|..||.+.+.
T Consensus       173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  225 (327)
T 3poz_A          173 EY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA  225 (327)
T ss_dssp             --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred             cc-cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence            11 112223345799999998888999999999999999999768899987653

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.90  E-value=5.1e-24  Score=146.47  Aligned_cols=116  Identities=26%  Similarity=0.331  Sum_probs=92.5

Q ss_pred             CCCCCCCCcccc--------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-------------------
Q psy7529           1 MKSPNGSGVVTP--------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-------------------   53 (129)
Q Consensus         1 m~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-------------------   53 (129)
                      |||+ ++++...        +....+..++.|+ +.||.|+|. ++++||||||+||+++.                   
T Consensus       115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~  191 (360)
T 3llt_A          115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEI-LKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI  191 (360)
T ss_dssp             ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred             EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence            5777 6665433        3333456688899 999999998 99999999999999975                   


Q ss_pred             ------CCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          54 ------RHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        54 ------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                            .+.++++|||+++.......      ...++..|+|||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus       192 ~~~~~~~~~~kl~DFG~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  263 (360)
T 3llt_A          192 QIYRTKSTGIKLIDFGCATFKSDYHG------SIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT-GSLLFRTHE  263 (360)
T ss_dssp             EEEEESCCCEEECCCTTCEETTSCCC------SCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             cccccCCCCEEEEeccCceecCCCCc------CccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH-CCCCCCCCc
Confidence                  77899999999875433211      1223567999999988889999999999999999999 999997644

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.90  E-value=5e-24  Score=143.79  Aligned_cols=106  Identities=24%  Similarity=0.360  Sum_probs=87.1

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      ....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........    ....++..|+|||.+
T Consensus       118 ~~~~~~~i~~qi-~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~  191 (308)
T 3g33_A          118 PAETIKDLMRQF-LRGLDFLHA-NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL----TPVVVTLWYRAPEVL  191 (308)
T ss_dssp             CHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCS----GGGGCCCSSCCHHHH
T ss_pred             CHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCccc----CCccccccccCchHH
Confidence            334466688899 999999999 89999999999999999999999999998765332211    111234569999999


Q ss_pred             cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          94 NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        94 ~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .+..++.++|+||+|++++++++ |..||.+.+
T Consensus       192 ~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~  223 (308)
T 3g33_A          192 LQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNS  223 (308)
T ss_dssp             HTSCCCSTHHHHHHHHHHHHTTT-SSCSCCCSS
T ss_pred             cCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            88889999999999999999998 999997644

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.90  E-value=2.2e-24  Score=146.25  Aligned_cols=119  Identities=18%  Similarity=0.383  Sum_probs=93.5

Q ss_pred             CCCCCCCCccccCC---------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe----cCCCcEEEEeecCccc
Q psy7529           1 MKSPNGSGVVTPLG---------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL----ASRHQAKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~----~~~~~~~l~d~~~~~~   67 (129)
                      |||++++++...+.         ......++.|+ +.|+.|+|. ++++||||||+||++    +....++++|||+++.
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi-~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV-VGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHH-HHHHHHHHH-CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            68888888655443         23455688888 999999999 899999999999998    6777799999999976


Q ss_pred             ccCCCceeeeccCCCCCceeccccccc--------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          68 VNSERNYYKATHGGRWPIKWYAPESYN--------FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .......    ....++..|+|||.+.        ...++.++|+||+|++++++++ |..||...+
T Consensus       166 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  227 (319)
T 4euu_A          166 LEDDEQF----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFE  227 (319)
T ss_dssp             CCTTCCB----CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHH-SSCSEECTT
T ss_pred             cCCCCce----eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            5433211    1222456799999875        4567889999999999999999 999997544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.90  E-value=2e-24  Score=148.16  Aligned_cols=119  Identities=24%  Similarity=0.484  Sum_probs=93.2

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC----CcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR----HQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~----~~~~l~d~~~~~~~~~   70 (129)
                      |||++|+++...+      .......++.|+ +.|+.|+|. ++++||||||+||++...    ..++++|||+++....
T Consensus        95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi-~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           95 TELMKGGELLDKILRQKFFSEREASAVLFTI-TKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            7999999865543      333466688888 999999999 899999999999998443    3499999999976543


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .....   ....++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.
T Consensus       173 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~  223 (342)
T 2qr7_A          173 ENGLL---MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT-GYTPFANG  223 (342)
T ss_dssp             TTCCB---CCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH-SSCSSCSS
T ss_pred             CCCce---eccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhc-CCCCCCCC
Confidence            22111   12223567999999877778889999999999999999 99999753

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.90  E-value=1.1e-24  Score=148.41  Aligned_cols=120  Identities=23%  Similarity=0.330  Sum_probs=90.3

Q ss_pred             CCCCCCCCccccCCC-----CchhhHHhHHHHHHHHHHhccC---------CCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529           1 MKSPNGSGVVTPLGS-----YALPYIEGQIPAKVCRYLKMHK---------SSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~h~~~---------~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      |||+++++|...+..     .....++.|+ +.||.|+|. +         +++||||||+||+++.++.++++|||+++
T Consensus        91 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi-~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~  168 (336)
T 3g2f_A           91 MEYYPNGSLXKYLSLHTSDWVSSCRLAHSV-TRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM  168 (336)
T ss_dssp             ECCCTTCBHHHHHHHCCBCHHHHHHHHHHH-HHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHhhcccchhHHHHHHHHH-HHHHHHHHh-hhccccccccceeecccccceEEEcCCCcEEEeecccee
Confidence            789999987665532     2344578888 999999998 7         99999999999999999999999999997


Q ss_pred             cccCCCce-----eeeccCCCCCceecccccccCC-------CCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          67 AVNSERNY-----YKATHGGRWPIKWYAPESYNFG-------RFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        67 ~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~-------~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      ........     ........++..|+|||.+.+.       .++.++|+||+|++++++++ |..||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~-g~~p~~  236 (336)
T 3g2f_A          169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCTDLF  236 (336)
T ss_dssp             ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT-TBGGGS
T ss_pred             ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHh-cCCcCC
Confidence            65432110     1111122346779999988762       34568999999999999998 866654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=2.8e-24  Score=149.03  Aligned_cols=125  Identities=34%  Similarity=0.582  Sum_probs=88.6

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+++++|.+.+..       .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV-AKGMKFLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHH-HHHHHHHHH-CCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            688888886655432       2345577888 999999999 8999999999999999999999999999875432211


Q ss_pred             ee-eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YY-KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .. ........+..|+|||.+....++.++|+||+|+++|++++.+..||.+.+.
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~  302 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT  302 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence            10 1111222345699999998888899999999999999999846778877654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=9.2e-24  Score=143.70  Aligned_cols=123  Identities=22%  Similarity=0.313  Sum_probs=91.7

Q ss_pred             CCCCCCCCccccCC-----CCchhhHHhHHHHHHHHHHhccC--------CCccCCCCCCCEEecCCCcEEEEeecCccc
Q psy7529           1 MKSPNGSGVVTPLG-----SYALPYIEGQIPAKVCRYLKMHK--------SSFHRDLAARNILLASRHQAKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~h~~~--------~~ihr~lk~~nil~~~~~~~~l~d~~~~~~   67 (129)
                      |||+++++|...+.     ......++.|+ +.|+.|+|. +        +++||||||+||+++.++.++++|||+++.
T Consensus       114 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i-~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~  191 (337)
T 3mdy_A          114 TDYHENGSLYDYLKSTTLDAKSMLKLAYSS-VSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK  191 (337)
T ss_dssp             ECCCTTCBHHHHHHHCCBCHHHHHHHHHHH-HHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EeccCCCcHHHHhhccCCCHHHHHHHHHHH-HHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCcee
Confidence            78999998765543     23455688888 999999998 6        899999999999999999999999999876


Q ss_pred             ccCCCceee-eccCCCCCceecccccccCCCCCCh------hhHHHHHHHHHHHHhCC----------CCCCCCCC
Q psy7529          68 VNSERNYYK-ATHGGRWPIKWYAPESYNFGRFSSA------SDVWSFGITLWEMYSFG----------QQPYGEMK  126 (129)
Q Consensus        68 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~------~di~s~g~~l~~l~~~~----------~~pf~~~~  126 (129)
                      ......... ......++..|+|||.+.+......      +|+||+|+++|++++ |          ..||.+..
T Consensus       192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~t-g~~~~~~~~~~~~p~~~~~  266 (337)
T 3mdy_A          192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLV  266 (337)
T ss_dssp             CC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHT-TBCBTTBCCCCCCTTTTTS
T ss_pred             eccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHh-ccCcccccccccccHhhhc
Confidence            533221111 1112234567999999876655443      899999999999998 8          66776543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.90  E-value=9.5e-24  Score=143.20  Aligned_cols=105  Identities=28%  Similarity=0.454  Sum_probs=85.0

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.........   ....++..|+|||.+.+
T Consensus       108 ~~~~~~~~qi-~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~t~~y~aPE~~~~  182 (317)
T 2pmi_A          108 NLVKYFQWQL-LQGLAFCHE-NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF---SSEVVTLWYRAPDVLMG  182 (317)
T ss_dssp             HHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCC---CCCCSCCTTCCHHHHTT
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccC---CCCcccccccCchHhhC
Confidence            3455677888 999999999 899999999999999999999999999987654322111   12223456999998876


Q ss_pred             C-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 G-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . .++.++|+||+|++++++++ |..||.+.+
T Consensus       183 ~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  213 (317)
T 2pmi_A          183 SRTYSTSIDIWSCGCILAEMIT-GKPLFPGTN  213 (317)
T ss_dssp             CCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             CCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            4 57899999999999999999 999997643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.90  E-value=1.6e-24  Score=144.53  Aligned_cols=123  Identities=41%  Similarity=0.692  Sum_probs=87.1

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+       .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (281)
T 1mp8_A           94 MELCTLGELRSFLQVRKYSLDLASLILYAYQL-STALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  171 (281)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence            6788888765433       233455577888 999999999 8999999999999999999999999999876533211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .  .......+..|+|||.+....++.++|+||+|++++++++.|..||.+.+.
T Consensus       172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~  223 (281)
T 1mp8_A          172 Y--KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN  223 (281)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred             c--ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH
Confidence            1  111122245699999998788899999999999999999548899987543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.90  E-value=1.4e-23  Score=140.55  Aligned_cols=123  Identities=20%  Similarity=0.252  Sum_probs=94.5

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe---cCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL---ASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~---~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||+ ++++.+.       +.......++.|+ +.|+.|+|. ++++||||||+||++   +..+.++++|||+++....
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQM-ISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEec-CCCHHHHHHhhccCCCHHHHHHHHHHH-HHHHHHHHh-CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            5777 6664433       3333456688888 999999999 899999999999999   4788899999999876543


Q ss_pred             CCcee----eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          71 ERNYY----KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        71 ~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .....    .......++..|+|||.+.+..++.++|+||+|++++++++ |+.||.+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~  220 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLKA  220 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCC
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcCc
Confidence            22110    01122234567999999988888999999999999999999 9999987543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.90  E-value=7.9e-24  Score=144.20  Aligned_cols=119  Identities=25%  Similarity=0.356  Sum_probs=95.7

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC----cEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH----QAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~----~~~l~d~~~~~~~~~   70 (129)
                      |||+++++|...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++..+    .++++|||+++....
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi-~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A           93 LELVAGGELFDFLAEKESLTEEEATEFLKQI-LNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             EECCCSCBHHHHHTTSSCCBHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             EEcCCCCCHHHHHHhcCCcCHHHHHHHHHHH-HHHHHHHHH-CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            68899988765543      23456688888 999999998 9999999999999998876    799999999876543


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...    .....++..|+|||.+....++.++|+||+|++++++++ |..||.+.+
T Consensus       171 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  221 (326)
T 2y0a_A          171 GNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDT  221 (326)
T ss_dssp             TSC----CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSS
T ss_pred             CCc----cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHH-CcCCCCCCC
Confidence            221    111223567999999988889999999999999999999 999997643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=7.3e-24  Score=145.88  Aligned_cols=120  Identities=26%  Similarity=0.388  Sum_probs=92.6

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+++++|...+      .......++.|+ +.||.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus       138 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  215 (355)
T 1vzo_A          138 LDYINGGELFTHLSQRERFTEHEVQIYVGEI-VLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE  215 (355)
T ss_dssp             ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG
T ss_pred             eecCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC
Confidence            7899998875443      334456678888 999999998 89999999999999999999999999998754322111


Q ss_pred             eeeccCCCCCceecccccccCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFG--RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~--~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .  .....++..|++||.+.+.  .++.++|+||+|++++++++ |..||...
T Consensus       216 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~  265 (355)
T 1vzo_A          216 R--AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPFTVD  265 (355)
T ss_dssp             G--GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH-SSCTTSCT
T ss_pred             c--ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH-CCCCCccC
Confidence            1  1111234679999998753  46789999999999999999 99999753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.90  E-value=5.2e-24  Score=151.71  Aligned_cols=119  Identities=25%  Similarity=0.384  Sum_probs=96.5

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+..      .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++....... 
T Consensus        95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi-~~aL~~LH~-~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~-  171 (476)
T 2y94_A           95 MEYVSGGELFDYICKNGRLDEKESRRLFQQI-LSGVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-  171 (476)
T ss_dssp             EECCSSEEHHHHTTSSSSCCHHHHHHHHHHH-HHHHHHHHT-TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC-
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCCCcccccHHHEEEecCCCeEEEeccchhhcccccc-
Confidence            789999887665543      3456688899 999999998 8999999999999999999999999999976543221 


Q ss_pred             eeeccCCCCCceecccccccCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRF-SSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+++.|+|||.+.+..+ +.++|+||+|++++++++ |..||.+.+
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~  220 (476)
T 2y94_A          172 ---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC-GTLPFDDDH  220 (476)
T ss_dssp             ---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             ---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhh-CCCCCCCCC
Confidence               112234567999999987765 678999999999999999 999998654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.90  E-value=5.6e-24  Score=145.36  Aligned_cols=105  Identities=28%  Similarity=0.440  Sum_probs=80.9

Q ss_pred             hhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC--cEEEEeecCcccccCCCc-eeeeccCCCCCceecccccccC
Q psy7529          19 PYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH--QAKISDFGLSRAVNSERN-YYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        19 ~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~--~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      ..++.|+ +.|+.|+|. ++++||||||+||+++.++  .++++|||+++....... .........++..|+|||.+..
T Consensus       171 ~~i~~qi-~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  248 (345)
T 3hko_A          171 SNIMRQI-FSALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT  248 (345)
T ss_dssp             HHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred             HHHHHHH-HHHHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence            3478888 999999999 8999999999999997665  899999999875432111 1111112234567999998865


Q ss_pred             --CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 --GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 --~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        ..++.++|+||+|++++++++ |..||.+.+
T Consensus       249 ~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  280 (345)
T 3hko_A          249 TNESYGPKCDAWSAGVLLHLLLM-GAVPFPGVN  280 (345)
T ss_dssp             SSSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCC
Confidence              567899999999999999999 999997654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.90  E-value=2.8e-24  Score=153.65  Aligned_cols=123  Identities=40%  Similarity=0.750  Sum_probs=97.9

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+++++|...+.        ...+..++.|+ +.|+.|+|. ++++|||||++||+++.++.+|++|||+++......
T Consensus       295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi-~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI-SSAMEYLEK-KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHH-HHHHHHHHh-CCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            78899888765543        22344577888 999999999 899999999999999999999999999998654321


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                        .........+..|+|||.+....++.++|+||+|+++|++++.|..||.+.+.
T Consensus       373 --~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~  425 (495)
T 1opk_A          373 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL  425 (495)
T ss_dssp             --EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             --eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence              11222333456799999998778899999999999999999768899987654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.89  E-value=1.3e-23  Score=145.90  Aligned_cols=108  Identities=29%  Similarity=0.408  Sum_probs=85.0

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce------------------eee
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY------------------YKA   77 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~------------------~~~   77 (129)
                      .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........                  ...
T Consensus       109 ~~~~~i~~qi-~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (388)
T 3oz6_A          109 VHKQYVVYQL-IKVIKYLHS-GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI  186 (388)
T ss_dssp             HHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC------------
T ss_pred             HHHHHHHHHH-HHHHHHHHh-CCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccccccccccccccc
Confidence            3456688888 999999999 89999999999999999999999999999754321000                  000


Q ss_pred             ccCCCCCceecccccccC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          78 THGGRWPIKWYAPESYNF-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        78 ~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .....++..|+|||.+.+ ..++.++|+||+|++++++++ |..||.+.+
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~  235 (388)
T 3oz6_A          187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKPIFPGSS  235 (388)
T ss_dssp             ---CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            111234567999998876 568899999999999999999 999998754

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=2.2e-24  Score=144.25  Aligned_cols=125  Identities=50%  Similarity=0.924  Sum_probs=97.9

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+.++++...+       .......++.|+ +.|+.|+|. ++++|+||+|+||+++.++.++++|||+++.......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  165 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQV-SMGMKYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  165 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHH-HHHHHHHHH-CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence            6788887765443       233455688888 999999999 8999999999999999999999999999986543332


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .........++..|++||.+....++.++|+||+|+++++++++|..||.+.+.
T Consensus       166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  219 (287)
T 1u59_A          166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  219 (287)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred             eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            222222223356799999988777889999999999999999658999987653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.89  E-value=1.3e-23  Score=144.44  Aligned_cols=119  Identities=25%  Similarity=0.375  Sum_probs=89.4

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC---CCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS---RHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~---~~~~~l~d~~~~~~~~~~   71 (129)
                      |||++++++...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++.   .+.++++|||+++.....
T Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi-~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGYYSERDAADAVKQI-LEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            78999988765443      23456688888 999999999 89999999999999975   788999999998754322


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..    .....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+..
T Consensus       205 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  254 (349)
T 2w4o_A          205 VL----MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC-GFEPFYDER  254 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCTT
T ss_pred             cc----cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHh-CCCCCCCCc
Confidence            11    111223567999999988889999999999999999999 999997654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.89  E-value=7.8e-24  Score=146.73  Aligned_cols=119  Identities=27%  Similarity=0.374  Sum_probs=94.8

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe--cCCCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL--ASRHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~--~~~~~~~l~d~~~~~~~~~~   71 (129)
                      |||+++++|...       +.......++.|+ +.|+.|+|. ++++||||||+||++  +..+.++++|||+++.....
T Consensus       165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi-~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDESYNLTELDTILFMKQI-CEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            789999886543       3334456678888 999999999 899999999999998  45678999999999865432


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...    ....+++.|+|||.+....++.++|+||+|++++++++ |..||.+.+
T Consensus       243 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  292 (373)
T 2x4f_A          243 EKL----KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS-GLSPFLGDN  292 (373)
T ss_dssp             CBC----CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHH-SSCTTCCSS
T ss_pred             ccc----ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            211    11224567999999987788899999999999999999 999997654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.89  E-value=2.7e-24  Score=152.22  Aligned_cols=122  Identities=39%  Similarity=0.643  Sum_probs=93.8

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+++++|...+..        .....++.|+ +.|+.|+|. ++++|||||++||+++.++.++++|||+++......
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi-~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI-ASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            789999987665542        2345588888 999999999 999999999999999999999999999997653221


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        .........+..|+|||.+....++.++|+||+|+++|++++.|..||.+.+
T Consensus       335 --~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~  386 (452)
T 1fmk_A          335 --YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  386 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             --eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence              1111222334679999999888899999999999999999976889998765

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.89  E-value=7.3e-24  Score=147.72  Aligned_cols=108  Identities=20%  Similarity=0.290  Sum_probs=86.8

Q ss_pred             cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEec-CCCcEEEEeecCcccccCCCceeeeccCCCCCceeccc
Q psy7529          12 PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLA-SRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP   90 (129)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~p   90 (129)
                      .+.......++.|+ +.|+.|+|. ++++||||||+||+++ ..+.++++|||+++........    ....++..|+||
T Consensus       137 ~~~~~~~~~~~~qi-~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~----~~~~~t~~y~aP  210 (394)
T 4e7w_A          137 TMPMLLIKLYMYQL-LRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN----VSYICSRYYRAP  210 (394)
T ss_dssp             CCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC----CSSCSCGGGCCH
T ss_pred             CCCHHHHHHHHHHH-HHHHHHHHH-CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCC----cccccCcCccCH
Confidence            34444566788899 999999999 8999999999999998 7889999999999765332211    112234569999


Q ss_pred             ccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          91 ESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        91 e~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      |.+.+. .++.++|+||+|++++++++ |..||.+.+
T Consensus       211 E~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~  246 (394)
T 4e7w_A          211 ELIFGATNYTTNIDIWSTGCVMAELMQ-GQPLFPGES  246 (394)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             HHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            988655 58899999999999999999 999998754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=7.6e-24  Score=144.60  Aligned_cols=124  Identities=41%  Similarity=0.706  Sum_probs=90.4

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+       ....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus       125 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  202 (333)
T 1mqb_A          125 TEYMENGALDKFLREKDGEFSVLQLVGMLRGI-AAGMKYLAN-MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  202 (333)
T ss_dssp             EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence            6788887755433       233455688888 999999999 8999999999999999999999999999876543221


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..........+..|++||.+....++.++|+||+|++++++++.|..||.+.+
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~  255 (333)
T 1mqb_A          203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS  255 (333)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence            11111222234569999999888889999999999999999966899997654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.89  E-value=7e-24  Score=143.83  Aligned_cols=119  Identities=24%  Similarity=0.356  Sum_probs=92.2

Q ss_pred             CCCCCCCCccccCCCC---------chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLGSY---------ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~   71 (129)
                      |||++++++...+...         ....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.....
T Consensus       140 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  217 (332)
T 3qd2_B          140 MQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQI-AEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  217 (332)
T ss_dssp             EECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred             EEecCCCCHHHHHhcccCccchhhHHHHHHHHHH-HHHHHHHHh-CCeeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence            6888888866554331         145588888 999999998 99999999999999999999999999998865432


Q ss_pred             Cce---------eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q psy7529          72 RNY---------YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY  122 (129)
Q Consensus        72 ~~~---------~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf  122 (129)
                      ...         ........++..|+|||.+.+..++.++|+||+|++++++++ |..|+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-~~~~~  276 (332)
T 3qd2_B          218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY-SFSTQ  276 (332)
T ss_dssp             --------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHS-CCCCH
T ss_pred             hhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHH-cCCCh
Confidence            111         011112234677999999988889999999999999999997 87664

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.89  E-value=3.8e-24  Score=144.38  Aligned_cols=108  Identities=45%  Similarity=0.716  Sum_probs=87.3

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++......... .......+..|++||.+.+.
T Consensus       151 ~~~~i~~qi-~~~l~~lH~-~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~  227 (314)
T 2ivs_A          151 DLISFAWQI-SQGMQYLAE-MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV-KRSQGRIPVKWMAIESLFDH  227 (314)
T ss_dssp             HHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE-CSSCCCSCGGGCCHHHHHHC
T ss_pred             HHHHHHHHH-HHHHHHHHH-CCCcccccchheEEEcCCCCEEEccccccccccccccce-eccCCCCcccccChhhhcCC
Confidence            355688888 999999999 899999999999999999999999999987654332221 12222334679999998877


Q ss_pred             CCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          97 RFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        97 ~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .++.++|+||+|++++++++.|..||.+.+.
T Consensus       228 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          228 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             CcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            7889999999999999999658899987653

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.89  E-value=3.1e-24  Score=147.08  Aligned_cols=120  Identities=22%  Similarity=0.302  Sum_probs=92.9

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC--cEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH--QAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~--~~~l~d~~~~~~~~~~~   72 (129)
                      |||+ +++|...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++.++  .++++|||+++......
T Consensus       131 ~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~  207 (345)
T 2v62_A          131 MERL-GIDLQKISGQNGTFKKSTVLQLGIRM-LDVLEYIHE-NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG  207 (345)
T ss_dssp             EECE-EEEHHHHCBGGGBCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGG
T ss_pred             Eecc-CCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeCCCcCHHHEEEccCCCCcEEEEeCCCceeccccc
Confidence            5677 666554443      33466688898 999999999 8999999999999998877  99999999997653221


Q ss_pred             ce----eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          73 NY----YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        73 ~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ..    ........++..|+|||.+.+..++.++|+||+|++++++++ |..||.+
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~pf~~  262 (345)
T 2v62_A          208 NHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLC-GKLPWEQ  262 (345)
T ss_dssp             CCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCTTGG
T ss_pred             ccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCccc
Confidence            10    000112234567999999988888999999999999999999 9999954

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.89  E-value=7e-24  Score=146.35  Aligned_cols=119  Identities=25%  Similarity=0.384  Sum_probs=87.4

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc--EEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ--AKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~--~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...      +.......++.|+ +.|+.|+|. ++++||||||+||+++..+.  ++++|||+++......
T Consensus        95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql-~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           95 MEYASGGELYERICNAGRFSEDEARFFFQQL-LSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            789999887544      3344567788999 999999998 99999999999999987665  9999999987432211


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCCh-hhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSA-SDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .    .....++..|+|||.+.+..+..+ +|+||+|++++++++ |..||.+.+
T Consensus       173 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~  222 (361)
T 3uc3_A          173 Q----PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV-GAYPFEDPE  222 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHH-SSCSCC---
T ss_pred             C----CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHh-CCCCCCCCc
Confidence            1    111223456999999887777655 899999999999999 999998754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.89  E-value=8.4e-24  Score=144.11  Aligned_cols=124  Identities=39%  Similarity=0.660  Sum_probs=90.8

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      ||++.++++...+       .......++.|+ +.|+.|+|. ++++||||||+||+++..+.++++|||+++.......
T Consensus        95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~  172 (327)
T 3lzb_A           95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-AKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHhh-CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence            5677777755433       233455688888 999999999 8999999999999999999999999999976533221


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .. ......++..|++||.+.+..++.++|+||+|++++++++.|..||.+.+.
T Consensus       173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~  225 (327)
T 3lzb_A          173 EY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA  225 (327)
T ss_dssp             --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred             cc-cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence            11 112223345799999998888999999999999999999658899987654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.89  E-value=6e-24  Score=145.02  Aligned_cols=107  Identities=43%  Similarity=0.781  Sum_probs=85.2

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++....... ........++..|+|||.+...
T Consensus       175 ~~~~i~~qi-~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~  251 (343)
T 1luf_A          175 EQLCIARQV-AAGMAYLSE-RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYN  251 (343)
T ss_dssp             HHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHC
T ss_pred             HHHHHHHHH-HHHHHHHHh-CCeecCCCCcceEEECCCCeEEEeecCCCcccccCcc-ccccCCCcccceecChhhhccC
Confidence            345588888 999999999 8999999999999999999999999999875432211 1111122335679999998888


Q ss_pred             CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          97 RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        97 ~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .++.++|+||+|++++++++.|..||.+.+
T Consensus       252 ~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          252 RYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             CcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            889999999999999999975888997654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.89  E-value=7.7e-24  Score=145.39  Aligned_cols=122  Identities=14%  Similarity=0.205  Sum_probs=94.7

Q ss_pred             CCCCCCCCcccc--------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC--cEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTP--------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH--QAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~--~~~l~d~~~~~~~~~   70 (129)
                      |||+ +++|.+.        +.......++.|+ +.|+.|+|. ++++||||||+||+++.++  .++++|||+++....
T Consensus       137 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi-~~~L~~LH~-~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~  213 (352)
T 2jii_A          137 LPSL-GRSLQSALDVSPKHVLSERSVLQVACRL-LDALEFLHE-NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP  213 (352)
T ss_dssp             EECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHH-HHHHHHHHH-TTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSG
T ss_pred             ecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHH-HHHHHHHHh-CCccCCCCCHHHEEEcCCCCceEEEecCcceeeccC
Confidence            5677 6665433        3344566688899 999999999 8999999999999999988  899999999976532


Q ss_pred             CCceee----eccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYK----ATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ......    ......++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~  272 (352)
T 2jii_A          214 SGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY-GFLPWTNCL  272 (352)
T ss_dssp             GGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SCCTTGGGT
T ss_pred             CCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCcccCC
Confidence            211100    0111234567999999988888999999999999999999 999998654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.89  E-value=1.2e-23  Score=145.73  Aligned_cols=106  Identities=23%  Similarity=0.311  Sum_probs=87.2

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccC-CCccCCCCCCCEEecCCC------------------------------------
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHK-SSFHRDLAARNILLASRH------------------------------------   55 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~-~~ihr~lk~~nil~~~~~------------------------------------   55 (129)
                      +.......++.|+ +.||.|+|. + +++||||||+||+++.++                                    
T Consensus       143 ~~~~~~~~i~~qi-~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (397)
T 1wak_A          143 LPLPCVKKIIQQV-LQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF  220 (397)
T ss_dssp             CCHHHHHHHHHHH-HHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTT
T ss_pred             CCHHHHHHHHHHH-HHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccc
Confidence            4444567789999 999999999 7 999999999999998664                                    


Q ss_pred             -------------cEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q psy7529          56 -------------QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY  122 (129)
Q Consensus        56 -------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf  122 (129)
                                   .++++|||+++......      ....++..|+|||.+.+..++.++|+||+|++++++++ |..||
T Consensus       221 ~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf  293 (397)
T 1wak_A          221 LVNPLEPKNAEKLKVKIADLGNACWVHKHF------TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELAT-GDYLF  293 (397)
T ss_dssp             SCCTTSGGGGGGCCEEECCGGGCEETTBCS------CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSC
T ss_pred             cccccccccccccceEeccccccccccccC------ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhh-CCCCC
Confidence                         79999999987653221      11223567999999988889999999999999999999 99999


Q ss_pred             CCCCC
Q psy7529         123 GEMKG  127 (129)
Q Consensus       123 ~~~~~  127 (129)
                      ...+.
T Consensus       294 ~~~~~  298 (397)
T 1wak_A          294 EPHSG  298 (397)
T ss_dssp             CCCCC
T ss_pred             CCCcc
Confidence            87654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.89  E-value=1.8e-23  Score=139.67  Aligned_cols=118  Identities=27%  Similarity=0.407  Sum_probs=91.6

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCC--CccCCCCCCCEEecCCCc-----EEEEeecCcc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKS--SFHRDLAARNILLASRHQ-----AKISDFGLSR   66 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~--~ihr~lk~~nil~~~~~~-----~~l~d~~~~~   66 (129)
                      |||++++++...+       .......++.|+ +.|+.|+|. ++  ++||||||+||+++..+.     ++++|||+++
T Consensus       100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l-~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~  177 (287)
T 4f0f_A          100 MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDI-ALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ  177 (287)
T ss_dssp             EECCTTCBHHHHHHCTTSCCCHHHHHHHHHHH-HHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred             EEecCCCCHHHHHhcccCCccHHHHHHHHHHH-HHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence            6889888865433       223355688888 999999998 78  999999999999987776     9999999987


Q ss_pred             cccCCCceeeeccCCCCCceeccccccc--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          67 AVNSERNYYKATHGGRWPIKWYAPESYN--FGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ......      ....++..|+|||.+.  ...++.++|+||+|++++++++ |..||.+.+.
T Consensus       178 ~~~~~~------~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~  233 (287)
T 4f0f_A          178 QSVHSV------SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT-GEGPFDEYSY  233 (287)
T ss_dssp             CCSSCE------ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH-SSCTTTTCCC
T ss_pred             cccccc------cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc-CCCCCccccc
Confidence            543221      1112345699999884  3356789999999999999999 9999987653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.89  E-value=9.1e-24  Score=146.10  Aligned_cols=107  Identities=26%  Similarity=0.304  Sum_probs=81.9

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccc
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPES   92 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~   92 (129)
                      +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......    .....++..|+|||.
T Consensus       124 ~~~~~~~~i~~qi-~~al~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~  197 (371)
T 2xrw_A          124 LDHERMSYLLYQM-LCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVVTRYYRAPEV  197 (371)
T ss_dssp             CCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCCCC--------------------CTTCCHHH
T ss_pred             cCHHHHHHHHHHH-HHHHHHHHH-CCeecccCCHHHEEEcCCCCEEEEEeecccccccccc----cCCceecCCccCHHH
Confidence            3334456688899 999999999 8999999999999999999999999999875432211    111223456999999


Q ss_pred             ccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          93 YNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        93 ~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       198 ~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  230 (371)
T 2xrw_A          198 ILGMGYKENVDIWSVGCIMGEMIK-GGVLFPGTD  230 (371)
T ss_dssp             HTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             hcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            988889999999999999999999 999998654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.89  E-value=9.4e-24  Score=139.83  Aligned_cols=122  Identities=34%  Similarity=0.634  Sum_probs=97.1

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...       +.......++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++.......
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV-CEGMAFLES-HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHH-HHHHHHHHH-TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            688888876543       3344556688888 999999999 8999999999999999999999999999876543321


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        .......++..|++||.+.+..++.++|+||+|++++++++.|..||...+
T Consensus       160 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  210 (268)
T 3sxs_A          160 --VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT  210 (268)
T ss_dssp             --EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             --hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence              122233344569999999877788999999999999999965889997654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.89  E-value=5.2e-24  Score=144.85  Aligned_cols=121  Identities=39%  Similarity=0.619  Sum_probs=96.4

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+++++|...+       ....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi-~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  182 (327)
T 3lxl_A          105 MEYLPSGCLRDFLQRHRARLDASRLLLYSSQI-CKGMEYLGS-RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD  182 (327)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS
T ss_pred             EeecCCCCHHHHHHhcccCCCHHHHHHHHHHH-HHHHHHHHh-CCccCCCCChhhEEECCCCCEEEcccccceecccCCc
Confidence            6888888865433       334456688888 999999999 9999999999999999999999999999986544333


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .........++..|++||.+.+..++.++|+||+|++++++++ |..||..
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~  232 (327)
T 3lxl_A          183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT-YCDKSCS  232 (327)
T ss_dssp             EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGGS
T ss_pred             cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHh-CCCCCcc
Confidence            2222223334566999999887778899999999999999998 9888754

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=4.4e-24  Score=145.91  Aligned_cols=107  Identities=46%  Similarity=0.796  Sum_probs=85.9

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      +..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++......... ......++..|+|||.+.+..
T Consensus       174 ~~~i~~qi-~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~  250 (344)
T 1rjb_A          174 LLCFAYQV-AKGMEFLEF-KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV-VRGNARLPVKWMAPESLFEGI  250 (344)
T ss_dssp             HHHHHHHH-HHHHHHHHH-TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE-EETTEEECGGGCCHHHHHHCC
T ss_pred             HHHHHHHH-HHHHHHHHh-CCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccce-eccCccCccCccCHHHhccCC
Confidence            44588888 999999999 999999999999999999999999999987553322111 111122245699999988888


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ++.++|+||+|++++++++.|..||.+.+.
T Consensus       251 ~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          251 YTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             CCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             CChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            899999999999999999658899987653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.89  E-value=3.9e-24  Score=143.32  Aligned_cols=124  Identities=48%  Similarity=0.879  Sum_probs=95.9

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++|+||||+||+++.++.++++|||+++........
T Consensus        96 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi-~~~l~~LH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  173 (291)
T 1xbb_A           96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQV-SMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  173 (291)
T ss_dssp             EECCTTEEHHHHHHHCTTCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             EEeCCCCCHHHHHHhCcCCCHHHHHHHHHHH-HHHHHHHHh-CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence            5778777755433      333456688888 999999999 89999999999999999999999999998765443322


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ........++..|++||.+....++.++|+||+|++++++++.|..||.+.+
T Consensus       174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  225 (291)
T 1xbb_A          174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK  225 (291)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            2222222334679999998877788899999999999999965889998754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.89  E-value=5.3e-23  Score=144.40  Aligned_cols=119  Identities=26%  Similarity=0.393  Sum_probs=90.1

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC---cEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH---QAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~---~~~l~d~~~~~~~~~~   71 (129)
                      |||++++++...+..      .....++.|+ +.|+.|+|. ++++||||||+||+++..+   .++++|||+++.....
T Consensus       218 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi-~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  295 (419)
T 3i6u_A          218 LELMEGGELFDKVVGNKRLKEATCKLYFYQM-LLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET  295 (419)
T ss_dssp             EECCTTCBGGGGTSSSCCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--
T ss_pred             EEcCCCCcHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHH-CCccccCCChHhEEEecCCCcceEEEeecccceecCCC
Confidence            789999998765543      2355588888 999999998 8999999999999997544   4999999999765432


Q ss_pred             CceeeeccCCCCCceecccccccC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNF---GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..    .....++..|+|||.+..   ..++.++|+||+|++++++++ |..||.+..
T Consensus       296 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  348 (419)
T 3i6u_A          296 SL----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPFSEHR  348 (419)
T ss_dssp             -------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH-SSCSSCCCS
T ss_pred             cc----ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH-CCCCCCCCc
Confidence            11    111223457999998753   456789999999999999999 999998654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.89  E-value=6.9e-24  Score=143.88  Aligned_cols=121  Identities=38%  Similarity=0.597  Sum_probs=96.0

Q ss_pred             CCCCCCCCccccCCC-----CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLGS-----YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||+++++|...+..     .....++.|+ +.|+.|+|. ++++|+|||++||+++.++.++++|||+++.........
T Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l-~~~l~~LH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  191 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPRHSIGLAQLLLFAQQI-CEGMAYLHA-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY  191 (318)
T ss_dssp             ECCCTTCBHHHHGGGSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEE
T ss_pred             EecccCCcHHHHHhhCCCCHHHHHHHHHHH-HHHHHHHHh-CCccCCCCchheEEEcCCCCEEECCcccccccccccccc
Confidence            789999887665543     3455578888 999999999 899999999999999999999999999998664433222


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .......++..|++||.+.+..++.++|+||+|++++++++ |..||..
T Consensus       192 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~  239 (318)
T 3lxp_A          192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQS  239 (318)
T ss_dssp             EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGGS
T ss_pred             ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHh-CCCcccc
Confidence            22222233456999999987778889999999999999998 9998864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.89  E-value=1.4e-23  Score=139.91  Aligned_cols=122  Identities=36%  Similarity=0.726  Sum_probs=96.6

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+       .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++...... 
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  174 (283)
T 3gen_A           98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDV-CEAMEYLES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-  174 (283)
T ss_dssp             ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHH-HHHHHHHHH-CCccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence            7889888865443       333456688888 999999999 899999999999999999999999999987543221 


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       ........++..|++||.+.+..++.++|+||+|++++++++.|..||...+
T Consensus       175 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~  226 (283)
T 3gen_A          175 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT  226 (283)
T ss_dssp             -HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             -cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence             1111222334569999999888889999999999999999965889998654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.89  E-value=1.9e-24  Score=149.39  Aligned_cols=123  Identities=37%  Similarity=0.672  Sum_probs=92.7

Q ss_pred             CCCCCCCCccccCC-------------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC---cEEEEeecC
Q psy7529           1 MKSPNGSGVVTPLG-------------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH---QAKISDFGL   64 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~---~~~l~d~~~   64 (129)
                      |||+++++|...+.             ...+..++.|+ +.|+.|+|. ++++||||||+||+++..+   .++++|||+
T Consensus       153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~  230 (367)
T 3l9p_A          153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI-ACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  230 (367)
T ss_dssp             EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHH-HHHHHHHHh-CCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence            68888888655432             22345588888 999999999 9999999999999998554   499999999


Q ss_pred             cccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          65 SRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++........ .......++..|+|||.+.+..++.++|+||+|++++++++.|..||.+.+
T Consensus       231 a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~  291 (367)
T 3l9p_A          231 ARDIYRAGYY-RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS  291 (367)
T ss_dssp             HHHHHHHSSC-TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cccccccccc-ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            8753211100 001111224569999999888899999999999999999965889998654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.89  E-value=1.9e-23  Score=142.23  Aligned_cols=119  Identities=25%  Similarity=0.395  Sum_probs=93.8

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC---CCcEEEEeecCccccc
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS---RHQAKISDFGLSRAVN   69 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~---~~~~~l~d~~~~~~~~   69 (129)
                      |||++++++...+..        ..+..++.|+ +.|+.|+|. ++++||||||+||+++.   .+.++++|||+++...
T Consensus       108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql-~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQI-LEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG  185 (327)
T ss_dssp             EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence            688988887665432        2355688888 999999999 89999999999999987   7889999999987653


Q ss_pred             CCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          70 SERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....    .....++..|++||.+....++.++|+||+|++++++++ |..||.+.+
T Consensus       186 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  237 (327)
T 3lm5_A          186 HACE----LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT-HTSPFVGED  237 (327)
T ss_dssp             ------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             Cccc----cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            3211    111223567999999988888999999999999999999 999997643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.89  E-value=1e-23  Score=143.22  Aligned_cols=118  Identities=28%  Similarity=0.379  Sum_probs=94.0

Q ss_pred             CCCCCCCCccccCC----------CCchhhHHhHHHHHHHHHHhccC---CCccCCCCCCCEEecCCCcEEEEeecCccc
Q psy7529           1 MKSPNGSGVVTPLG----------SYALPYIEGQIPAKVCRYLKMHK---SSFHRDLAARNILLASRHQAKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~~h~~~---~~ihr~lk~~nil~~~~~~~~l~d~~~~~~   67 (129)
                      |||++++++...+.          ......++.|+ +.|+.|+|. +   +++||||||+||+++.++.++++|||+++.
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i-~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~  183 (326)
T 3uim_A          106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGS-ARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL  183 (326)
T ss_dssp             EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHH-HHHHHHHHH-SSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHH-HHHHHHHHh-CCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence            67888888654433          22355688888 999999999 7   999999999999999999999999999976


Q ss_pred             ccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          68 VNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      .........  ....++..|+|||.+.+..++.++|+||+|++++++++ |..||.
T Consensus       184 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~  236 (326)
T 3uim_A          184 MDYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD  236 (326)
T ss_dssp             CCSSSSCEE--CCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHH-CCCSBC
T ss_pred             cCccccccc--ccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHh-CCCccc
Confidence            543222111  12224567999999887778899999999999999999 999995

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.89  E-value=2.7e-23  Score=142.50  Aligned_cols=111  Identities=20%  Similarity=0.295  Sum_probs=87.2

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce-eeeccCCCCCceecccc
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY-YKATHGGRWPIKWYAPE   91 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe   91 (129)
                      +....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........ ........++..|+|||
T Consensus       121 ~~~~~~~~i~~qi-~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  198 (351)
T 3mi9_A          121 FTLSEIKRVMQML-LNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE  198 (351)
T ss_dssp             CCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHH
T ss_pred             CCHHHHHHHHHHH-HHHHHHHHH-CCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCch
Confidence            3334566788899 999999999 89999999999999999999999999998765321111 11111223356799999


Q ss_pred             cccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          92 SYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        92 ~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .+.+. .++.++|+||+|++++++++ |..||.+.+
T Consensus       199 ~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  233 (351)
T 3mi9_A          199 LLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNT  233 (351)
T ss_dssp             HHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             hhcCCCCCCcHhHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            88754 57899999999999999999 999998643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.89  E-value=5.4e-23  Score=137.11  Aligned_cols=119  Identities=25%  Similarity=0.440  Sum_probs=94.6

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc---EEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ---AKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~---~~l~d~~~~~~~~~~   71 (129)
                      |||++++++...      +.......++.|+ +.|+.|+|. ++++|||++|+||+++.++.   ++++|||.+......
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQI-LESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            688888886433      3344566688888 999999999 89999999999999976655   999999998765432


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...    ....++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       162 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~  211 (284)
T 3kk8_A          162 EAW----HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDED  211 (284)
T ss_dssp             CBC----CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             ccc----cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHH-CCCCCCCCc
Confidence            211    12234567999999988888999999999999999999 999997643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.89  E-value=3.6e-23  Score=140.61  Aligned_cols=117  Identities=21%  Similarity=0.357  Sum_probs=92.6

Q ss_pred             CCCCCCCCcccc---CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC-cEEEEeecCcccccCCCceee
Q psy7529           1 MKSPNGSGVVTP---LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH-QAKISDFGLSRAVNSERNYYK   76 (129)
Q Consensus         1 m~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~   76 (129)
                      |||++++++...   +.......++.|+ +.|+.|+|. ++++||||||+||+++..+ .++++|||+++........  
T Consensus       112 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~--  187 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQTLTDYDIRFYMYEI-LKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--  187 (330)
T ss_dssp             EECCCCCCHHHHGGGCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC--
T ss_pred             EeccCchhHHHHHHhCCHHHHHHHHHHH-HHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc--
Confidence            678888875444   3444566788899 999999998 8999999999999999776 7999999999765432211  


Q ss_pred             eccCCCCCceecccccccC-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          77 ATHGGRWPIKWYAPESYNF-GRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        77 ~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                        ....++..|++||.+.. ..++.++|+||+|++++++++ |..||..
T Consensus       188 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~  233 (330)
T 3nsz_A          188 --NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF-RKEPFFH  233 (330)
T ss_dssp             --CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-TCSSSSC
T ss_pred             --ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHh-CCCCccc
Confidence              11223456999998876 568899999999999999998 9999854

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.89  E-value=2.9e-23  Score=139.32  Aligned_cols=125  Identities=35%  Similarity=0.624  Sum_probs=93.7

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+++++|...+..       .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql-~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV-AKGMKYLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY  183 (298)
T ss_dssp             EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred             EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHH-HHHHHHHHh-CCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence            678888886554422       2344577788 999999999 8999999999999999999999999999876533221


Q ss_pred             e-eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 Y-YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      . ........++..|++||.+.+..++.++|+||+|++++++++.+.+||.+.+.
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~  238 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT  238 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred             hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence            1 11111222345699999998888899999999999999999734567766543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.89  E-value=2e-23  Score=139.89  Aligned_cols=105  Identities=23%  Similarity=0.369  Sum_probs=84.1

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccc
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPES   92 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~   92 (129)
                      +.......++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++.........   ....++..|+|||.
T Consensus        98 l~~~~~~~~~~ql-~~~l~~lH~-~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~t~~y~aPE~  172 (292)
T 3o0g_A           98 LDPEIVKSFLFQL-LKGLGFCHS-RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY---SAEVVTLWYRPPDV  172 (292)
T ss_dssp             CCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC---CSCCSCGGGCCHHH
T ss_pred             CCHHHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc---cCCccccCCcChHH
Confidence            4444566788899 999999999 899999999999999999999999999997654322111   12223567999998


Q ss_pred             ccCCC-CCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          93 YNFGR-FSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        93 ~~~~~-~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      +.+.. ++.++|+||+|++++++++ |..||.
T Consensus       173 ~~~~~~~~~~~DiwslG~il~~l~~-~~~p~~  203 (292)
T 3o0g_A          173 LFGAKLYSTSIDMWSAGCIFAELAN-AGRPLF  203 (292)
T ss_dssp             HTTCSCCCTHHHHHHHHHHHHHHTT-TSCCSC
T ss_pred             HcCCCCcCchHHHHHHHHHHHHHHH-cCCCCc
Confidence            87665 7899999999999999997 777653

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.89  E-value=1.9e-23  Score=147.06  Aligned_cols=102  Identities=25%  Similarity=0.252  Sum_probs=85.3

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc--EEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ--AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      ..+..++.|+ +.||.|+|. ++++||||||+||+++..+.  ++++|||+++.......      ...++..|+|||.+
T Consensus       200 ~~~~~i~~qi-~~aL~~LH~-~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~~------~~~gt~~y~aPE~~  271 (429)
T 3kvw_A          200 PLVRKFAHSI-LQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY------TYIQSRFYRAPEVI  271 (429)
T ss_dssp             HHHHHHHHHH-HHHHHHHHH-HTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCCC------SSCSCGGGCCHHHH
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHeEEccCCCcceEEeecccceecCCccc------ccCCCCCccChHHH
Confidence            3456688888 999999999 89999999999999998877  99999999865432211      11234569999999


Q ss_pred             cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          94 NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        94 ~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .+..++.++|+||+|++++++++ |..||.+.+
T Consensus       272 ~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~  303 (429)
T 3kvw_A          272 LGARYGMPIDMWSLGCILAELLT-GYPLLPGED  303 (429)
T ss_dssp             HTBCCCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             hCCCCCchHHHHhHHHHHHHHHh-CCCCCCCCC
Confidence            88889999999999999999999 999998654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.89  E-value=1.3e-23  Score=141.75  Aligned_cols=109  Identities=45%  Similarity=0.747  Sum_probs=87.1

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++......... ......++..|+|||.+..
T Consensus       145 ~~~~~~~~qi-~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  221 (313)
T 1t46_A          145 EDLLSFSYQV-AKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFN  221 (313)
T ss_dssp             HHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSE-ECSSSEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCeecCCCccceEEEcCCCCEEEccccccccccccccce-eccCCCCcceeeChHHhcC
Confidence            3455688888 999999999 899999999999999999999999999987654332111 1111223456999999888


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ..++.++|+||+|++++++++.|..||.+.+.
T Consensus       222 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             CCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            88899999999999999999658899987653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.89  E-value=2.1e-23  Score=138.81  Aligned_cols=120  Identities=23%  Similarity=0.319  Sum_probs=78.1

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...       +.......++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||.+........
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQI-ITGMLYLHS-HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            678877775433       3333456688888 999999999 8999999999999999999999999999876532211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   ....++..|++||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus       168 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~  216 (278)
T 3cok_A          168 KH---YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLI-GRPPFDTDT  216 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHH-SSCSSCCCS
T ss_pred             cc---eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCChh
Confidence            11   11123456999999988788889999999999999999 999998654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.88  E-value=6.2e-23  Score=140.14  Aligned_cols=119  Identities=26%  Similarity=0.390  Sum_probs=95.7

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...      +.......++.|+ +.|+.|+|. ++++|+||+++||+++.++.++++|||+++........
T Consensus       120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi-~~aL~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  197 (335)
T 2owb_A          120 LELCRRRSLLELHKRRKALTEPEARYYLRQI-VLGCQYLHR-NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  197 (335)
T ss_dssp             ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EecCCCCCHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHH-CCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence            688888886543      3334566688888 999999999 89999999999999999999999999998765322211


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .   ....++..|++||.+.+..++.++|+||+|++++++++ |..||...
T Consensus       198 ~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~  244 (335)
T 2owb_A          198 K---KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETS  244 (335)
T ss_dssp             B---CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHH-SSCTTCCS
T ss_pred             c---cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHH-CcCCCCCC
Confidence            1   11223456999999988888899999999999999999 99999764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.88  E-value=8.1e-23  Score=145.67  Aligned_cols=118  Identities=26%  Similarity=0.383  Sum_probs=92.8

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEec---CCCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLA---SRHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~---~~~~~~l~d~~~~~~~~~~   71 (129)
                      |||++++++...      +.......++.|+ +.|+.|+|. ++++||||||+||+++   ..+.++++|||+++.....
T Consensus       100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi-~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQV-FSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            789999987543      3344566788899 999999999 8999999999999995   4457999999998765332


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..    .....+++.|+|||.+.+ .++.++|+||+|+++|++++ |..||.+.+
T Consensus       178 ~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~  226 (486)
T 3mwu_A          178 TK----MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS-GTPPFYGKN  226 (486)
T ss_dssp             --------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             Cc----cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            11    112234567999999875 58899999999999999999 999997654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.88  E-value=6.5e-23  Score=139.18  Aligned_cols=119  Identities=24%  Similarity=0.394  Sum_probs=95.6

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC----cEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH----QAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~----~~~l~d~~~~~~~~~   70 (129)
                      |||++++++...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++..+    .++++|||+++....
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi-~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~  171 (321)
T 2a2a_A           94 LELVSGGELFDFLAQKESLSEEEATSFIKQI-LDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (321)
T ss_dssp             ECCCCSCBHHHHHHTCSCEEHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence            78898888665443      23455688888 999999999 8999999999999998877    799999999876543


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....    ....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       172 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~  222 (321)
T 2a2a_A          172 GVEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDT  222 (321)
T ss_dssp             TCCC----CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSS
T ss_pred             cccc----cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHH-CCCCCCCCC
Confidence            2211    11223567999999988888999999999999999999 999997643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.88  E-value=4.7e-24  Score=153.74  Aligned_cols=122  Identities=39%  Similarity=0.643  Sum_probs=97.3

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+++++|.+.+..        ..+..++.|+ +.||.|||. ++++|||||++||+++.++.++++|||+++......
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi-~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI-ASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            789999887655542        2355688888 999999999 999999999999999999999999999987653211


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        .........+..|+|||.+....++.++|+||+|+++|++++.|..||.+.+
T Consensus       418 --~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~  469 (535)
T 2h8h_A          418 --YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  469 (535)
T ss_dssp             --HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred             --eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence              1111222334679999999888899999999999999999976889998765

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.88  E-value=3.7e-23  Score=143.53  Aligned_cols=107  Identities=18%  Similarity=0.289  Sum_probs=85.4

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEec-CCCcEEEEeecCcccccCCCceeeeccCCCCCceecccc
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLA-SRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE   91 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe   91 (129)
                      +.......++.|+ +.|+.|+|. ++++||||||+||+++ ..+.++++|||+++........    ....++..|+|||
T Consensus       138 l~~~~~~~i~~qi-~~aL~~LH~-~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE  211 (383)
T 3eb0_A          138 IPMNLISIYIYQL-FRAVGFIHS-LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS----VAYICSRFYRAPE  211 (383)
T ss_dssp             CCHHHHHHHHHHH-HHHHHHHHT-TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC----CCCCCCSSCCCHH
T ss_pred             CCHHHHHHHHHHH-HHHHHHHHH-CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC----cCcccCCCccCHH
Confidence            3334466688899 999999998 9999999999999997 5788999999999765332211    1112345699999


Q ss_pred             cccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          92 SYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        92 ~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .+.+. .++.++|+||+|++++++++ |..||.+.+
T Consensus       212 ~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  246 (383)
T 3eb0_A          212 LMLGATEYTPSIDLWSIGCVFGELIL-GKPLFSGET  246 (383)
T ss_dssp             HHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             HhcCCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCC
Confidence            88765 48899999999999999999 999998754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.88  E-value=1.8e-23  Score=141.62  Aligned_cols=123  Identities=36%  Similarity=0.662  Sum_probs=95.1

Q ss_pred             CCCCCCCCccccCC----------------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecC
Q psy7529           1 MKSPNGSGVVTPLG----------------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGL   64 (129)
Q Consensus         1 m~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~   64 (129)
                      |||+++++|...+.                ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+
T Consensus       107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~i~H~dikp~NIli~~~~~~kl~Dfg~  184 (322)
T 1p4o_A          107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI-ADGMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGM  184 (322)
T ss_dssp             EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHH-HHHHHHHHH-TTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHH-HHHHHHHHH-CCCccCCCccceEEEcCCCeEEECcCcc
Confidence            67888887655442                23445578888 999999999 8999999999999999999999999999


Q ss_pred             cccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          65 SRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++........ .......++..|+|||.+.+..++.++|+||+|++++++++.|..||.+.+
T Consensus       185 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  245 (322)
T 1p4o_A          185 TRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  245 (322)
T ss_dssp             CCGGGGGGCE-EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             cccccccccc-ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence            8754322211 111122234569999999888889999999999999999975688987654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.88  E-value=3.5e-23  Score=144.56  Aligned_cols=111  Identities=25%  Similarity=0.324  Sum_probs=82.1

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe----cCCCcEEEEeecCcccccCCCceeeeccCCCCCceec
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL----ASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY   88 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (129)
                      +....+..++.|+ +.|+.|+|. ++++||||||+||++    +..+.++++|||+++................++..|+
T Consensus       125 l~~~~~~~i~~qi-~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  202 (405)
T 3rgf_A          125 LPRGMVKSLLYQI-LDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR  202 (405)
T ss_dssp             CCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTC
T ss_pred             CCHHHHHHHHHHH-HHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCccc
Confidence            3334466788899 999999999 899999999999999    6778999999999976543211111111223356699


Q ss_pred             ccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          89 APESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        89 ~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      |||.+.+. .++.++|+||+|++++++++ |..||...+
T Consensus       203 aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~  240 (405)
T 3rgf_A          203 APELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQ  240 (405)
T ss_dssp             CHHHHTTCCSCCHHHHHHHHHHHHHHHHH-SSCTTCCCC
T ss_pred             CchhhcCCCcccchhhhHHHHHHHHHHHh-CCCCCCCcc
Confidence            99988764 48899999999999999999 999997543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.88  E-value=3.7e-23  Score=137.77  Aligned_cols=118  Identities=25%  Similarity=0.367  Sum_probs=92.7

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++|+||+|+||+++.++.++++|||++........ 
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi-~~~l~~LH~-~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~-  164 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSKFDEQRTATYITEL-ANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-  164 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHT-TTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCEecccCChHhEEEcCCCCEEEEeccccccCCcccc-
Confidence            6888888765433      333456688888 999999998 8999999999999999999999999998754322111 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                          ....++..|++||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus       165 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~  211 (279)
T 3fdn_A          165 ----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANT  211 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCTTCCSS
T ss_pred             ----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHH-CCCCCCCCc
Confidence                11123456999999988888899999999999999999 999998654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.88  E-value=2.3e-23  Score=138.87  Aligned_cols=122  Identities=43%  Similarity=0.685  Sum_probs=93.0

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+.++++...+       .......++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++.......
T Consensus        91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  168 (281)
T 3cc6_A           91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQI-CKAMAYLES-INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY  168 (281)
T ss_dssp             EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred             EecCCCCCHHHHHHhccccCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence            6788888765433       233455577888 999999999 9999999999999999999999999999876433211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .  .......+..|+|||.+....++.++|+||+|+++++++++|..||...+
T Consensus       169 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~  219 (281)
T 3cc6_A          169 Y--KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE  219 (281)
T ss_dssp             ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             c--ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC
Confidence            1  11122234569999999878889999999999999999966899997544

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.88  E-value=1.7e-23  Score=141.45  Aligned_cols=123  Identities=23%  Similarity=0.387  Sum_probs=90.1

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc---EEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ---AKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~---~~l~d~~~~~~~~~~   71 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++||||||+||+++..+.   ++++|||+++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKRRHFNELEASVVVQDV-ASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEcCCCCcHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            6888888865433      334566688888 999999999 89999999999999987765   899999998754211


Q ss_pred             Cc----eeeeccCCCCCceecccccccC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RN----YYKATHGGRWPIKWYAPESYNF-----GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~----~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..    .........++..|+|||.+..     ..++.++|+||+|++++++++ |..||.+.+
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~  230 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS-GYPPFVGRC  230 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHH-SSCSCCCCC
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHH-CCCCCcccc
Confidence            10    0001111224567999998764     346789999999999999999 999998754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.88  E-value=1.6e-23  Score=140.35  Aligned_cols=123  Identities=34%  Similarity=0.488  Sum_probs=87.4

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+..       ..+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi-~~~L~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQT-ARGMDYLHA-KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             EECCCEEEHHHHHTTC---CCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EEecCCCcHHHHHhhccCCCCHHHHHHHHHHH-HHHHHHHHh-CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            678888876554432       2345578888 999999999 8999999999999999999999999999875432111


Q ss_pred             eeeeccCCCCCceeccccccc---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYN---FGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      . .......++..|++||.+.   ...++.++|+||+|++++++++ |..||.+.+.
T Consensus       176 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~  230 (289)
T 3og7_A          176 S-HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNINN  230 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHH-SSCTTSSCCC
T ss_pred             c-ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHH-CCCCccccch
Confidence            1 0111122345699999886   4567789999999999999999 9999987543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.88  E-value=1.1e-23  Score=141.56  Aligned_cols=120  Identities=38%  Similarity=0.594  Sum_probs=94.8

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+++++|...+       .......++.|+ +.|+.|+|. ++++|+||||+||+++.++.++++|||+++.......
T Consensus       104 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  181 (302)
T 4e5w_A          104 MEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI-CKGMDYLGS-RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE  181 (302)
T ss_dssp             EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCC
T ss_pred             EEeCCCCcHHHHHHhccccCCHHHHHHHHHHH-HHHHHHhhc-CCcccCCCchheEEEcCCCCEEECcccccccccCCCc
Confidence            6788888865544       223455588888 999999999 9999999999999999999999999999986544332


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      .........++..|++||.+.+..++.++|+||+|++++++++ |..|+.
T Consensus       182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~  230 (302)
T 4e5w_A          182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-YCDSDS  230 (302)
T ss_dssp             EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGG
T ss_pred             ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHH-ccCCCc
Confidence            2222223334556999999887778889999999999999998 887753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.88  E-value=3.9e-23  Score=141.31  Aligned_cols=118  Identities=25%  Similarity=0.474  Sum_probs=91.7

Q ss_pred             CCCCCCC-Ccccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGS-GVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~-~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+.++ ++...      +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus       108 ~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi-~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  185 (335)
T 3dls_A          108 MEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL-VSAVGYLRL-KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL  185 (335)
T ss_dssp             EECCTTSCBHHHHHHTCCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCc
Confidence            5666444 54432      3334456688899 999999999 8999999999999999999999999999876543221


Q ss_pred             eeeeccCCCCCceecccccccCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRF-SSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .. .   ..++..|+|||.+.+..+ +.++|+||+|++++++++ |..||.+.
T Consensus       186 ~~-~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~  233 (335)
T 3dls_A          186 FY-T---FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF-EENPFCEL  233 (335)
T ss_dssp             BC-E---ECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH-SSCSCSSG
T ss_pred             ee-c---cCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHh-CCCchhhH
Confidence            11 1   123467999999887776 788999999999999998 99999763

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.88  E-value=1.9e-23  Score=146.40  Aligned_cols=99  Identities=15%  Similarity=0.180  Sum_probs=81.2

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc----
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY----   93 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~----   93 (129)
                      +..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++.....   .   ....+ ..|+|||.+    
T Consensus       213 ~~~i~~qi-~~aL~~LH~-~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~---~~~~g-~~y~aPE~~~~~~  283 (413)
T 3dzo_A          213 RLQLTLQV-IRLLASLHH-YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---A---VSPIG-RGFAPPETTAERM  283 (413)
T ss_dssp             HHHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---E---CCCCC-TTTCCHHHHHHHT
T ss_pred             HHHHHHHH-HHHHHHHHh-CCcccCCcccceEEEecCCeEEEEeccceeecCCc---c---ccCCC-CceeCchhhhccc
Confidence            34466888 999999998 99999999999999999999999999998754322   1   11122 469999988    


Q ss_pred             ------cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          94 ------NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        94 ------~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                            ....++.++|+||+|+++|++++ |+.||.+.+
T Consensus       284 ~~~~~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~  321 (413)
T 3dzo_A          284 LPFGQHHPTLMTFAFDTWTLGLAIYWIWC-ADLPNTDDA  321 (413)
T ss_dssp             STTGGGCCEEECHHHHHHHHHHHHHHHHH-SSCCCCTTG
T ss_pred             cccccccCcCCCchhhHHHHHHHHHHHHH-CCCCCCCcc
Confidence                  44457789999999999999999 999998754

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.88  E-value=1.8e-23  Score=139.71  Aligned_cols=124  Identities=40%  Similarity=0.653  Sum_probs=94.2

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+       .......++.|+ +.|+.|+|. ++++|+||||+||+++.++.++++|||+++.......
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  176 (291)
T 1u46_A           99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV-AEGMGYLES-KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD  176 (291)
T ss_dssp             EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred             EecccCCCHHHHHHhccCCcCHHHHHHHHHHH-HHHHHHHHh-CCcccCCCchheEEEcCCCCEEEcccccccccccccc
Confidence            5778888765433       333455688888 999999999 8999999999999999999999999999876543322


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..........+..|++||.+....++.++|+||+|++++++++.|..||.+.+
T Consensus       177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  229 (291)
T 1u46_A          177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN  229 (291)
T ss_dssp             EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence            21111222234569999998877788899999999999999965889997654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.88  E-value=2.6e-23  Score=141.78  Aligned_cols=106  Identities=42%  Similarity=0.793  Sum_probs=85.8

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      +..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........ ........+..|+|||.+.+..
T Consensus       159 ~~~i~~qi-~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~  235 (334)
T 2pvf_A          159 LVSCTYQL-ARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFDRV  235 (334)
T ss_dssp             HHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSE-ECCSCCCCCGGGCCHHHHHHCE
T ss_pred             HHHHHHHH-HHHHHHHHh-CCeeCCCCccceEEEcCCCCEEEccccccccccccccc-cccCCCCcccceeChHHhcCCC
Confidence            45578888 999999999 89999999999999999999999999998765432211 1122223346799999988777


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|++++++++.|..||.+.+
T Consensus       236 ~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             ECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            88999999999999999976889997654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.88  E-value=3.5e-23  Score=139.83  Aligned_cols=124  Identities=34%  Similarity=0.514  Sum_probs=90.5

Q ss_pred             CCCCCCCCccccC------------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccc
Q psy7529           1 MKSPNGSGVVTPL------------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAV   68 (129)
Q Consensus         1 m~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~   68 (129)
                      |||++++++...+            ....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++..
T Consensus       120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~  197 (313)
T 3brb_A          120 LPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI-ALGMEYLSN-RNFLHRDLAARNCMLRDDMTVCVADFGLSKKI  197 (313)
T ss_dssp             EECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHH-HHHHHHHHT-TTCCCCCCSGGGEEECTTSCEEECSCSCC---
T ss_pred             EecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHH-HHHHHHHHh-CCcccCCCCcceEEEcCCCcEEEeecCcceec
Confidence            5778887754433            223455688888 999999998 89999999999999999999999999998765


Q ss_pred             cCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          69 NSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ....... .......+..|++||.+.+..++.++|+||+|++++++++.|..||.+.+.
T Consensus       198 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  255 (313)
T 3brb_A          198 YSGDYYR-QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN  255 (313)
T ss_dssp             --------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             ccccccC-cccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence            3321111 111112345699999998888899999999999999999747788876543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.88  E-value=2.4e-23  Score=140.44  Aligned_cols=120  Identities=20%  Similarity=0.333  Sum_probs=90.3

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++.+...      +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l-~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQT-LQAVNFCHK-HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHH-HHHHHHHHH-CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            577777664322      3334466688888 999999999 89999999999999999999999999998765432211


Q ss_pred             eeeccCCCCCceecccccccC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNF-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   ...++..|++||.+.+ ..++.++|+||+|++++++++ |..||.+.+
T Consensus       159 ~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~  207 (311)
T 4agu_A          159 YD---DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS-GVPLWPGKS  207 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             cC---CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Confidence            11   1123456999998865 467899999999999999999 999997654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.88  E-value=7.2e-23  Score=141.43  Aligned_cols=118  Identities=22%  Similarity=0.373  Sum_probs=93.9

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|+++...      +.......++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||++........ 
T Consensus       179 ~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi-~~~L~~LH~-~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~-  255 (365)
T 2y7j_A          179 FDLMRKGELFDYLTEKVALSEKETRSIMRSL-LEAVSFLHA-NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-  255 (365)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC-
T ss_pred             EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcc-
Confidence            789999886543      3334466688888 999999999 8999999999999999999999999999876543221 


Q ss_pred             eeeccCCCCCceecccccccC------CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNF------GRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~------~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                         .....++..|+|||.+.+      ..++.++|+||+|++++++++ |..||.+.
T Consensus       256 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~-g~~pf~~~  308 (365)
T 2y7j_A          256 ---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA-GSPPFWHR  308 (365)
T ss_dssp             ---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHH-SSCSSCCS
T ss_pred             ---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHH-CCCCCCCC
Confidence               112234567999998753      246789999999999999999 99999764

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.88  E-value=5.5e-23  Score=140.53  Aligned_cols=105  Identities=22%  Similarity=0.321  Sum_probs=86.5

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe-------------------cCCCcEEEEeecCcccccCCCc
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL-------------------ASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~-------------------~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      +.......++.|+ +.|+.|+|. ++++||||||+||++                   +..+.++++|||+++.......
T Consensus       120 ~~~~~~~~i~~qi-~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~  197 (355)
T 2eu9_A          120 YPLPHVRHMAYQL-CHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT  197 (355)
T ss_dssp             CCHHHHHHHHHHH-HHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCC
T ss_pred             CCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccccc
Confidence            3344566688899 999999998 899999999999999                   5678899999999875432211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                            ...++..|+|||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus       198 ------~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~  243 (355)
T 2eu9_A          198 ------TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR-GFTLFQTHE  243 (355)
T ss_dssp             ------SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             ------CCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Confidence                  1223567999999988889999999999999999999 999998654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.88  E-value=5.9e-23  Score=139.53  Aligned_cols=102  Identities=26%  Similarity=0.338  Sum_probs=84.5

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-------------------CCcEEEEeecCcccccCCCceee
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-------------------RHQAKISDFGLSRAVNSERNYYK   76 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-------------------~~~~~l~d~~~~~~~~~~~~~~~   76 (129)
                      .....++.|+ +.|+.|+|. ++++||||||+||+++.                   .+.++++|||+++.......   
T Consensus       118 ~~~~~~~~qi-~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~---  192 (339)
T 1z57_A          118 DHIRKMAYQI-CKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHS---  192 (339)
T ss_dssp             HHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCCC---
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccccc---
Confidence            3456688898 999999999 89999999999999987                   56799999999875432211   


Q ss_pred             eccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          77 ATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        77 ~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ...++..|+|||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus       193 ---~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~  238 (339)
T 1z57_A          193 ---TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL-GFTVFPTHD  238 (339)
T ss_dssp             ---SSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH-SSCSCCCSC
T ss_pred             ---cccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Confidence               1123567999999988889999999999999999998 999998654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.88  E-value=5.3e-23  Score=142.68  Aligned_cols=117  Identities=24%  Similarity=0.255  Sum_probs=90.8

Q ss_pred             CCCCCCCCcccc--------CCCCchhhHHhHHHHHHHHHHhcc-CCCccCCCCCCCEEec--CCCcEEEEeecCccccc
Q psy7529           1 MKSPNGSGVVTP--------LGSYALPYIEGQIPAKVCRYLKMH-KSSFHRDLAARNILLA--SRHQAKISDFGLSRAVN   69 (129)
Q Consensus         1 m~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~h~~-~~~ihr~lk~~nil~~--~~~~~~l~d~~~~~~~~   69 (129)
                      |||+++ ++...        +.......++.|+ +.|+.|+|.+ .+++||||||+||++.  ..+.++++|||+++...
T Consensus       135 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi-~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~  212 (382)
T 2vx3_A          135 FEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQM-CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG  212 (382)
T ss_dssp             EECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHH-HHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred             EecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHH-HHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence            567754 53332        3333456688888 9999999952 6899999999999994  46789999999987654


Q ss_pred             CCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          70 SERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....      ...++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       213 ~~~~------~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~  262 (382)
T 2vx3_A          213 QRIY------QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT-GEPLFSGAN  262 (382)
T ss_dssp             CCCC------SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             cccc------cccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            3211      1223456999999988889999999999999999999 999998654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.88  E-value=8.9e-24  Score=142.67  Aligned_cols=106  Identities=43%  Similarity=0.783  Sum_probs=85.2

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGR   97 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   97 (129)
                      +..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++......... ......++..|+|||.+.+..
T Consensus       150 ~~~~~~qi-~~al~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~  226 (316)
T 2xir_A          150 LICYSFQV-AKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV-RKGDARLPLKWMAPETIFDRV  226 (316)
T ss_dssp             HHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSE-EETTEEECGGGCCHHHHHHCC
T ss_pred             HHHHHHHH-HHHHHHHHh-CCcccccCccceEEECCCCCEEECCCccccccccCccce-eccCCCcceeecCchhhcccc
Confidence            45578888 999999999 899999999999999999999999999987653322111 111122245699999998888


Q ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          98 FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        98 ~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++.++|+||+|++++++++.|..||.+.+
T Consensus       227 ~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          227 YTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            89999999999999999965889997754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.88  E-value=9.9e-23  Score=136.58  Aligned_cols=120  Identities=26%  Similarity=0.379  Sum_probs=95.4

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...      +.......++.|+ +.|+.|+|. ++++|+|++++||+++.++.++++|||+++........
T Consensus        94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           94 LELCRRRSLLELHKRRKALTEPEARYYLRQI-VLGCQYLHR-NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             EECCTTCBHHHHHHHHCSCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence            678888775543      3334466688888 999999999 89999999999999999999999999998765322211


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   ....++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       172 ~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~  219 (294)
T 2rku_A          172 K---KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETSC  219 (294)
T ss_dssp             B---CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHH-SSCTTCCSS
T ss_pred             c---ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            1   11223456999999988788899999999999999999 999997643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.88  E-value=1.8e-23  Score=138.60  Aligned_cols=122  Identities=35%  Similarity=0.657  Sum_probs=95.1

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+.       ......++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i-~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV-CEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHH-HHHHHHHHh-CCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            68888888654442       22345578888 999999998 9999999999999999999999999999875432211


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                        .......++..|+|||.+....++.++|+||+|++++++++.|..||.+.+
T Consensus       162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~  212 (269)
T 4hcu_A          162 --TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS  212 (269)
T ss_dssp             --HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             --ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence              111222234569999999888889999999999999999965788997654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.88  E-value=6.9e-23  Score=138.64  Aligned_cols=103  Identities=22%  Similarity=0.261  Sum_probs=81.1

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccc
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPES   92 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~   92 (129)
                      +....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......    .....++..|+|||.
T Consensus       154 l~~~~~~~i~~qi-~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~  227 (311)
T 3p1a_A          154 LPEAQVWGYLRDT-LLALAHLHS-QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA----GEVQEGDPRYMAPEL  227 (311)
T ss_dssp             CCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECGGGCEEECCCTTCEECC----------CCCCCGGGCCGGG
T ss_pred             CCHHHHHHHHHHH-HHHHHHHHH-CCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC----CcccCCCccccCHhH
Confidence            3344566688888 999999999 8999999999999999999999999999876532211    111224567999998


Q ss_pred             ccCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          93 YNFGRFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        93 ~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      +.+ .++.++|+||+|++++++++ |..||.
T Consensus       228 ~~~-~~~~~~DiwslG~il~el~~-g~~~~~  256 (311)
T 3p1a_A          228 LQG-SYGTAADVFSLGLTILEVAC-NMELPH  256 (311)
T ss_dssp             GGT-CCSTHHHHHHHHHHHHHHHH-TCCCCS
T ss_pred             hcC-CCCchhhHHHHHHHHHHHHh-CCCCCC
Confidence            875 68899999999999999998 865543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.88  E-value=3.1e-23  Score=141.05  Aligned_cols=105  Identities=24%  Similarity=0.412  Sum_probs=82.2

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.........   ....++..|+|||.+.+
T Consensus       100 ~~~~~~~~qi-~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~t~~y~aPE~~~~  174 (324)
T 3mtl_A          100 HNVKLFLFQL-LRGLAYCHR-QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY---DNEVVTLWYRPPDILLG  174 (324)
T ss_dssp             HHHHHHHHHH-HHHHHHHHH-TTEEESSCCGGGEEECTTCCEEECSSSEEECC---------------CGGGCCHHHHTT
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc---ccccCcccccChhhhcC
Confidence            3456678888 999999999 899999999999999999999999999987543222111   11123457999998876


Q ss_pred             -CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 -GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 -~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       ..++.++|+||+|++++++++ |..||.+.+
T Consensus       175 ~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~  205 (324)
T 3mtl_A          175 STDYSTQIDMWGVGCIFYEMAT-GRPLFPGST  205 (324)
T ss_dssp             CCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             CCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence             467899999999999999999 999998654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.88  E-value=1.7e-23  Score=142.33  Aligned_cols=120  Identities=40%  Similarity=0.672  Sum_probs=93.4

Q ss_pred             CCCCCCCCccccC----------------------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEE
Q psy7529           1 MKSPNGSGVVTPL----------------------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAK   58 (129)
Q Consensus         1 m~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~   58 (129)
                      |||+++++|...+                      ....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~~ivH~dlkp~NIl~~~~~~~k  182 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV-ARGMDYLSQ-KQFIHRDLAARNILVGENYVAK  182 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECGGGCEE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHH-HHHHHHHHh-CCccCCCCccceEEEcCCCeEE
Confidence            6888888865543                      333455688888 999999999 9999999999999999999999


Q ss_pred             EEeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          59 ISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        59 l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++|||+++......    .......+..|++||.+....++.++|+||+|+++++++++|..||.+.+
T Consensus       183 L~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~  246 (327)
T 1fvr_A          183 IADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  246 (327)
T ss_dssp             ECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             EcccCcCccccccc----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence            99999986432111    11111223569999998877788999999999999999965889997654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.88  E-value=1.4e-22  Score=139.11  Aligned_cols=103  Identities=21%  Similarity=0.309  Sum_probs=83.4

Q ss_pred             chhhHHhHHHHHHHHHHh--ccCCCccCCCCCCCEEecC-CCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          17 ALPYIEGQIPAKVCRYLK--MHKSSFHRDLAARNILLAS-RHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h--~~~~~ihr~lk~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      ....++.|+ +.|+.|+|  . ++++||||||+||+++. ++.++++|||+++........    ....++..|+|||.+
T Consensus       130 ~~~~~~~qi-~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~  203 (360)
T 3e3p_A          130 LIKVFLFQL-IRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN----VAYICSRYYRAPELI  203 (360)
T ss_dssp             HHHHHHHHH-HHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCC----CSTTSCGGGCCHHHH
T ss_pred             HHHHHHHHH-HHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCc----ccccCCcceeCHHHH
Confidence            345578888 99999999  6 89999999999999986 889999999999765432211    112235679999988


Q ss_pred             cCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          94 NFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        94 ~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .+. .++.++|+||+|++++++++ |..||.+.+
T Consensus       204 ~~~~~~~~~~Di~slG~il~ell~-g~~pf~~~~  236 (360)
T 3e3p_A          204 FGNQHYTTAVDIWSVGCIFAEMML-GEPIFRGDN  236 (360)
T ss_dssp             TTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHHh-CCCCcCCCC
Confidence            655 47899999999999999999 999998754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.88  E-value=1.1e-22  Score=135.77  Aligned_cols=118  Identities=20%  Similarity=0.345  Sum_probs=94.8

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++|+||+++||+++.++.++++|||++........ 
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  169 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGRFDEQRSATFMEEL-ADALHYCHE-RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR-  169 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHT-TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB-
T ss_pred             EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCceecCCCHHHEEEcCCCCEEEecccccccCccccc-
Confidence            6888887765433      333456688888 999999998 8999999999999999999999999998865432211 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                          ....++..|++||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus       170 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~  216 (284)
T 2vgo_A          170 ----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV-GMPPFDSPS  216 (284)
T ss_dssp             ----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSS
T ss_pred             ----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHH-CCCCCCCCC
Confidence                11223467999999988888899999999999999999 999997643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.88  E-value=1.6e-22  Score=134.19  Aligned_cols=123  Identities=26%  Similarity=0.377  Sum_probs=95.5

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+..      .....++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||.+.........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-MAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHH-HHHHHHHHh-CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            688888887666543      2355688888 999999999 89999999999999999999999999998754321111


Q ss_pred             eeeccCCCCCceecccccccCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRF-SSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                       .......++..|++||.+.+..+ +.++|+||+|++++++++ |..||...+.
T Consensus       162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~  213 (276)
T 2yex_A          162 -RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSD  213 (276)
T ss_dssp             -CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH-SSCCCSCSCT
T ss_pred             -hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCch
Confidence             11112234567999999877664 678999999999999999 9999986543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.88  E-value=3.6e-23  Score=152.21  Aligned_cols=122  Identities=41%  Similarity=0.693  Sum_probs=94.4

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+++++|...+.       ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......
T Consensus       469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi-~~aL~~LH~-~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          469 MELCTLGELRSFLQVRKFSLDLASLILYAYQL-STALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred             EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHh-CCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence            78999998765443       22344577888 999999999 8999999999999999999999999999876533221


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .  .......+..|+|||.+....++.++|+||+|++++++++.|..||.+.+
T Consensus       547 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  597 (656)
T 2j0j_A          547 Y--KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK  597 (656)
T ss_dssp             ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             e--eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            1  11112234579999999888889999999999999999954889998754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.88  E-value=6.7e-23  Score=139.64  Aligned_cols=120  Identities=22%  Similarity=0.307  Sum_probs=88.8

Q ss_pred             CCCCCCCCccc------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVT------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++.+..      .+.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus       103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi-~~~l~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQI-INGIGFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             EECCSEEHHHHHHHSTTCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             EecCCcchHHHHHhhccCCCHHHHHHHHHHH-HHHHHHHHH-CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            56776665322      23334466688888 999999999 89999999999999999999999999998754332211


Q ss_pred             eeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   ...++..|++||.+.+. .++.++|+||+|++++++++ |..||.+.+
T Consensus       181 ~~---~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~  229 (331)
T 4aaa_A          181 YD---DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM-GEPLFPGDS  229 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             cC---CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            11   11234569999988765 67899999999999999999 999997654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.88  E-value=5.5e-23  Score=141.30  Aligned_cols=104  Identities=29%  Similarity=0.423  Sum_probs=85.1

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccc
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPES   92 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~   92 (129)
                      +....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++......       ...++..|+|||.
T Consensus       151 l~~~~~~~i~~qi-~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~-------~~~gt~~y~aPE~  221 (348)
T 1u5q_A          151 LQEVEIAAVTHGA-LQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-------SFVGTPYWMAPEV  221 (348)
T ss_dssp             CCHHHHHHHHHHH-HHHHHHHHH-TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC-------CCCSCGGGCCHHH
T ss_pred             CCHHHHHHHHHHH-HHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC-------cccCCcceeCHhh
Confidence            3334456688888 999999999 899999999999999999999999999987653321       1123567999998


Q ss_pred             cc---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          93 YN---FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        93 ~~---~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +.   ...++.++|+||+|++++++++ |..||.+.+
T Consensus       222 ~~~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~  257 (348)
T 1u5q_A          222 ILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMN  257 (348)
T ss_dssp             HHTTSSCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSC
T ss_pred             hccccCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            74   4567889999999999999999 999997654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.88  E-value=9.1e-24  Score=143.80  Aligned_cols=107  Identities=44%  Similarity=0.785  Sum_probs=85.6

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++......... ......++..|+|||.+.+.
T Consensus       165 ~~~~~~~qi-~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~  241 (333)
T 2i1m_A          165 DLLHFSSQV-AQGMAFLAS-KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-VKGNARLPVKWMAPESIFDC  241 (333)
T ss_dssp             HHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSE-ECSSCEECGGGSCHHHHHHC
T ss_pred             HHHHHHHHH-HHHHHHHhc-CCcccCCcccceEEECCCCeEEECcccccccccccccee-ecCCCCCCccccCHHHhccC
Confidence            455578888 999999999 899999999999999999999999999987543222111 11122234569999998888


Q ss_pred             CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          97 RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        97 ~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .++.++|+||+|++++++++.|..||.+..
T Consensus       242 ~~~~~~Di~slG~il~el~t~g~~p~~~~~  271 (333)
T 2i1m_A          242 VYTVQSDVWSYGILLWEIFSLGLNPYPGIL  271 (333)
T ss_dssp             CCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             CCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence            889999999999999999975888998754

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.88  E-value=7.2e-23  Score=137.21  Aligned_cols=122  Identities=35%  Similarity=0.591  Sum_probs=92.3

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+.++++...+..       ..+..++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++.......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi-~~~l~~LH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQV-ARGMEYLAE-QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHH-HHHHHHHHh-CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            678888886554432       2345577888 999999999 8999999999999999999999999999875432211


Q ss_pred             e-eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCC-CCCC
Q psy7529          74 Y-YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQP-YGEM  125 (129)
Q Consensus        74 ~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~p-f~~~  125 (129)
                      . .........+..|++||.+.+..++.++|+||+|++++++++ |..| |...
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~~~~~~~  232 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT-RGAPPYRHI  232 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHH-TSCCTTTTS
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhh-CCCCCCccC
Confidence            1 111112233567999999988888999999999999999998 6554 5443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.88  E-value=4.9e-23  Score=137.07  Aligned_cols=122  Identities=39%  Similarity=0.672  Sum_probs=96.3

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+++++|...+..        .....++.|+ +.|+.|+|. ++++|+||+|+||+++..+.++++|||.++......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI-AEGMAFIEE-RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            688888887765543        2345578888 999999999 899999999999999999999999999987654322


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .  .......++..|++||.+....++.++|+||+|++++++++.|..||.+.+
T Consensus       164 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  215 (279)
T 1qpc_A          164 Y--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT  215 (279)
T ss_dssp             E--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             c--ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence            1  111222234569999998877788999999999999999965788997654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.88  E-value=3.4e-23  Score=140.86  Aligned_cols=120  Identities=40%  Similarity=0.656  Sum_probs=94.4

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+++++|...+       .......++.|+ +.|+.|+|. ++++|+||||+||+++.++.++++|||+++.......
T Consensus       123 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi-~~aL~~LH~-~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~  200 (326)
T 2w1i_A          123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI-CKGMEYLGT-KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE  200 (326)
T ss_dssp             ECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCS
T ss_pred             EECCCCCCHHHHHHhcccCCCHHHHHHHHHHH-HHHHHHHHh-CCEeccCCCcceEEEcCCCcEEEecCcchhhcccccc
Confidence            6888888865433       233455578888 999999999 9999999999999999999999999999986544332


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      ..........+..|+|||.+.+..++.++|+||+|++++++++ |..||.
T Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~~~~  249 (326)
T 2w1i_A          201 YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YIEKSK  249 (326)
T ss_dssp             EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHH-TTCGGG
T ss_pred             ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHh-cCCCCC
Confidence            2222222233456999999887778899999999999999999 888875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.88  E-value=8e-23  Score=145.98  Aligned_cols=118  Identities=28%  Similarity=0.492  Sum_probs=93.4

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC---CcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~---~~~~l~d~~~~~~~~~~   71 (129)
                      ||||+++++...      +.......++.|+ +.|+.|+|. ++++||||||+||+++..   ..++++|||+++.....
T Consensus       115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQV-LSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            789999987543      3344566688898 999999999 899999999999999764   44999999998765432


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..    .....+++.|+|||.+. ..++.++|+||+|+++|++++ |..||.+.+
T Consensus       193 ~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  241 (494)
T 3lij_A          193 KK----MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA-GYPPFGGQT  241 (494)
T ss_dssp             BC----BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             cc----ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            21    11223456799999876 468899999999999999999 999998654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.88  E-value=4e-23  Score=145.51  Aligned_cols=106  Identities=25%  Similarity=0.313  Sum_probs=79.5

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee-------------------
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY-------------------   75 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-------------------   75 (129)
                      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.........                   
T Consensus       128 ~~~~~~i~~qi-l~aL~~LH~-~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (432)
T 3n9x_A          128 EEHIKTILYNL-LLGENFIHE-SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK  205 (432)
T ss_dssp             HHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEEC--------------------------
T ss_pred             HHHHHHHHHHH-HHHHHHHHH-CCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchh
Confidence            34566789999 999999999 899999999999999999999999999998653221100                   


Q ss_pred             eeccCCCCCceecccccc-cCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESY-NFGRFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~-~~~~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      .......++..|+|||.+ ....++.++|+||+||+++++++ |..||.
T Consensus       206 ~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~-g~~p~~  253 (432)
T 3n9x_A          206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN-MLQSHI  253 (432)
T ss_dssp             -----CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHT-TCTTTC
T ss_pred             ccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHh-cccccc
Confidence            001122335669999986 45568999999999999999996 554443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.88  E-value=1.3e-22  Score=134.90  Aligned_cols=118  Identities=19%  Similarity=0.326  Sum_probs=93.1

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe---cCCCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL---ASRHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~---~~~~~~~l~d~~~~~~~~~~   71 (129)
                      |||++++++...      +.......++.|+ +.|+.|+|. ++++|+|+||+||++   +..+.++++|||++......
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i-~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRVFRESDAARIMKDV-LSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            688888886443      3334466688888 999999999 899999999999999   77889999999998765432


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...    ....++..|+|||.+.+ .++.++|+||+|++++++++ |..||...+
T Consensus       163 ~~~----~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~p~~~~~  211 (277)
T 3f3z_A          163 KMM----RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLC-GYPPFSAPT  211 (277)
T ss_dssp             SCB----CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             cch----hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHH-CCCCCCCCC
Confidence            211    11223456999998765 47889999999999999999 999998654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.88  E-value=1.4e-22  Score=142.32  Aligned_cols=104  Identities=24%  Similarity=0.292  Sum_probs=83.4

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC-CcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR-HQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      .....++.|+ +.||.|+|. ++++||||||+||+++.+ ..+|++|||+++........    ....++..|+|||.+.
T Consensus       156 ~~~~~~~~qi-~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~----~~~~~t~~y~aPE~~~  229 (420)
T 1j1b_A          156 IYVKLYMYQL-FRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN----VSYICSRYYRAPELIF  229 (420)
T ss_dssp             HHHHHHHHHH-HHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC----CSCCSCTTSCCHHHHT
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCc----eeeeeCCCcCCHHHHc
Confidence            3456688888 999999998 999999999999999965 56799999999865332111    1122345699999886


Q ss_pred             CC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 FG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 ~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +. .++.++|+||+|++++++++ |+.||.+.+
T Consensus       230 ~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~  261 (420)
T 1j1b_A          230 GATDYTSSIDVWSAGCVLAELLL-GQPIFPGDS  261 (420)
T ss_dssp             TCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             CCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCC
Confidence            64 68899999999999999999 999998754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.88  E-value=9.6e-23  Score=140.55  Aligned_cols=108  Identities=27%  Similarity=0.374  Sum_probs=85.7

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++................++..|+|||.+..
T Consensus       128 ~~~~~i~~qi-~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  205 (364)
T 3qyz_A          128 DHICYFLYQI-LRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN  205 (364)
T ss_dssp             HHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHT
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcC
Confidence            3455688888 999999999 89999999999999999999999999999765432211111112234567999998654


Q ss_pred             C-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 G-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      . .++.++|+||+|++++++++ |..||.+.+
T Consensus       206 ~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  236 (364)
T 3qyz_A          206 SKGYTKSIDIWSVGCILAEMLS-NRPIFPGKH  236 (364)
T ss_dssp             BCSCSTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             CCCCCcchhHHHHHHHHHHHHH-CCCCCCCCC
Confidence            4 57899999999999999999 999998754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.88  E-value=8.1e-23  Score=137.50  Aligned_cols=120  Identities=28%  Similarity=0.461  Sum_probs=95.6

Q ss_pred             CCCCCCCCccccCC-----CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPLG-----SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |||++++++...+.     ......++.|+ +.|+.|+|. ++++|+||+|+||+++.++.++++|||.+..........
T Consensus        99 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A           99 MEYLGGGSALDLLEPGPLDETQIATILREI-LKGLDYLHS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             EECCTTEEHHHHHTTSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred             EEeCCCCcHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence            67888877655443     23455688888 999999999 899999999999999999999999999987654322111


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ....++..|++||.+....++.++|+||+|++++++++ |..||.+.+
T Consensus       177 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~  223 (303)
T 3a7i_A          177 ---NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR-GEPPHSELH  223 (303)
T ss_dssp             ---CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSC
T ss_pred             ---CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHcc-CCCCCCCcC
Confidence               12223467999999988888899999999999999999 999997653

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.88  E-value=1.1e-22  Score=137.36  Aligned_cols=118  Identities=29%  Similarity=0.491  Sum_probs=88.3

Q ss_pred             CCCCCCCCccccCCC---------CchhhHHhHHHHHHHHHHhcc--CCCccCCCCCCCEEecCCCc-EEEEeecCcccc
Q psy7529           1 MKSPNGSGVVTPLGS---------YALPYIEGQIPAKVCRYLKMH--KSSFHRDLAARNILLASRHQ-AKISDFGLSRAV   68 (129)
Q Consensus         1 m~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~~h~~--~~~ihr~lk~~nil~~~~~~-~~l~d~~~~~~~   68 (129)
                      |||+++++|...+..         .....++.|+ ++|+.|+|..  ++++||||||+||+++.++. ++++|||++...
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi-~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC-SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHH-HHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHH-HHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            688999887655432         1234466788 9999999974  57999999999999988876 799999998654


Q ss_pred             cCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          69 NSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .....      ...++..|+|||.+.+..++.++|+||+|++++++++ |..||.+..
T Consensus       157 ~~~~~------~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~  207 (307)
T 2eva_A          157 QTHMT------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT-RRKPFDEIG  207 (307)
T ss_dssp             --------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHH-TCCTTTTTC
T ss_pred             ccccc------cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHH-CCCCchhhC
Confidence            32211      1123456999999988888999999999999999999 999998653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.88  E-value=5.2e-23  Score=146.48  Aligned_cols=118  Identities=25%  Similarity=0.417  Sum_probs=93.2

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe---cCCCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL---ASRHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~---~~~~~~~l~d~~~~~~~~~~   71 (129)
                      |||+.++++...+      .......++.|+ +.|+.|+|. ++++||||||+||++   +..+.++++|||+++.....
T Consensus       105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKRFSEVDAARIIRQV-LSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            6899999875433      333456688898 999999999 899999999999999   45678999999998765432


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ... .   ...+++.|+|||.+.+ .++.++|+||+|+++|++++ |..||.+.+
T Consensus       183 ~~~-~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~  231 (484)
T 3nyv_A          183 KKM-K---DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLS-GCPPFNGAN  231 (484)
T ss_dssp             CSH-H---HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             ccc-c---cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHH-CCCCCCCCC
Confidence            211 1   1123467999998865 68899999999999999999 999998654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.88  E-value=6.8e-24  Score=147.88  Aligned_cols=119  Identities=18%  Similarity=0.361  Sum_probs=92.9

Q ss_pred             CCCCCCCCccccCCC---------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe----cCCCcEEEEeecCccc
Q psy7529           1 MKSPNGSGVVTPLGS---------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL----ASRHQAKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~----~~~~~~~l~d~~~~~~   67 (129)
                      |||++++++...+..         ..+..++.|+ +.|+.|+|. ++++||||||+||++    +....++++|||+++.
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi-~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV-VGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHH-HHHHHHHHH-CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            789999887666554         2345588888 999999999 899999999999998    6677799999999976


Q ss_pred             ccCCCceeeeccCCCCCceecccccccC--------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          68 VNSERNYYKATHGGRWPIKWYAPESYNF--------GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ......    .....++..|+|||.+..        ..++.++|+||+|+++|++++ |..||...+
T Consensus       166 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~t-g~~Pf~~~~  227 (396)
T 4eut_A          166 LEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFE  227 (396)
T ss_dssp             CCCGGG----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHH-SSCSEECTT
T ss_pred             ccCCCc----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHH-CCCCCCCCC
Confidence            543221    112223567999998754        345678999999999999999 999997544

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.88  E-value=1.2e-22  Score=135.84  Aligned_cols=118  Identities=22%  Similarity=0.443  Sum_probs=90.0

Q ss_pred             CCCCCCCCccccC----------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe---cCCCcEEEEeecCccc
Q psy7529           1 MKSPNGSGVVTPL----------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL---ASRHQAKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~---~~~~~~~l~d~~~~~~   67 (129)
                      |||++++++...+          .......++.|+ +.|+.|+|. ++++||||||+||++   +..+.++++|||+++.
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi-~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQM-MNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHH-HHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            7899998865433          333456688888 999999999 899999999999999   4457899999999875


Q ss_pred             ccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          68 VNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ......    .....++..|++||.+. ..++.++|+||+|++++++++ |..||.+.+
T Consensus       177 ~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~-g~~pf~~~~  229 (285)
T 3is5_A          177 FKSDEH----STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLT-GCLPFTGTS  229 (285)
T ss_dssp             --------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             cCCccc----CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHh-CCCCCCCCC
Confidence            433211    11122346799999875 467889999999999999999 999998654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.88  E-value=9.7e-23  Score=136.43  Aligned_cols=107  Identities=26%  Similarity=0.394  Sum_probs=83.9

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++..........   ...++..|+|||.+
T Consensus        98 ~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~t~~y~aPE~~  172 (288)
T 1ob3_A           98 ESVTAKSFLLQL-LNGIAYCHD-RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT---HEIVTLWYRAPDVL  172 (288)
T ss_dssp             CHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------------CCCTTCCHHHH
T ss_pred             CHHHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc---cccccccccCchhe
Confidence            334456688899 999999999 8999999999999999999999999999876432211111   11234569999988


Q ss_pred             cCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          94 NFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        94 ~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .+. .++.++|+||+|++++++++ |..||.+.+
T Consensus       173 ~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~  205 (288)
T 1ob3_A          173 MGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVS  205 (288)
T ss_dssp             TTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             eCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            654 57899999999999999999 999997643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.88  E-value=5.1e-23  Score=136.39  Aligned_cols=118  Identities=34%  Similarity=0.576  Sum_probs=88.3

Q ss_pred             CCCCCCCCccccCC-----CCchhhHHhHHHHHHHHHHhccCC---CccCCCCCCCEEecC--------CCcEEEEeecC
Q psy7529           1 MKSPNGSGVVTPLG-----SYALPYIEGQIPAKVCRYLKMHKS---SFHRDLAARNILLAS--------RHQAKISDFGL   64 (129)
Q Consensus         1 m~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~h~~~~---~ihr~lk~~nil~~~--------~~~~~l~d~~~   64 (129)
                      |||++++++...+.     ......++.|+ +.|+.|+|. ++   ++|||+||+||+++.        .+.++++|||+
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l-~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGKRIPPDILVNWAVQI-ARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             EECCTTEEHHHHHTSSCCCHHHHHHHHHHH-HHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EEcCCCCCHHHHhhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            67888887654432     23355688888 999999999 77   889999999999986        67799999999


Q ss_pred             cccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          65 SRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++........     ...++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       163 ~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~  218 (271)
T 3dtc_A          163 AREWHRTTKM-----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT-GEVPFRGID  218 (271)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHH-CCCTTTTSC
T ss_pred             cccccccccc-----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            8754332111     1123467999999988888999999999999999999 999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.88  E-value=3.9e-23  Score=142.12  Aligned_cols=119  Identities=28%  Similarity=0.405  Sum_probs=94.2

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+++++|...+.      ......++.|+ +.|+.|+|..++++||||||+||+++.++.++++|||+++....... 
T Consensus       110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i-~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  187 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAV-IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-  187 (360)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred             EECCCCCCHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccc-
Confidence            78999988665432      33455688888 99999999834899999999999999999999999999865422110 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                          ....++..|+|||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus       188 ----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~  234 (360)
T 3eqc_A          188 ----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPD  234 (360)
T ss_dssp             -------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHH-TSCCSSCCC
T ss_pred             ----cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence                11123456999999988889999999999999999999 999997643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.88  E-value=7.9e-23  Score=138.73  Aligned_cols=120  Identities=28%  Similarity=0.404  Sum_probs=87.8

Q ss_pred             CCCCCCCCccccC--------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPL--------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+++++|...+        .......++.|+ +.|+.|+|. ++++|+||+|+||+++.++.++++|||++.......
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  183 (326)
T 2x7f_A          106 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI-LRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  183 (326)
T ss_dssp             EECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCSGGGEEECTTCCEEECCCTTTC------
T ss_pred             EEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHH-HHHHHHHHH-CCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc
Confidence            6788887754433        223355578888 999999999 899999999999999999999999999987543221


Q ss_pred             ceeeeccCCCCCceeccccccc-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYN-----FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...   ....++..|+|||.+.     ...++.++|+||+|++++++++ |..||.+.+
T Consensus       184 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~  238 (326)
T 2x7f_A          184 GRR---NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPPLCDMH  238 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHH-SSCTTTTSC
T ss_pred             ccc---ccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHh-CCCCCCCCc
Confidence            111   1112345799999886     4467889999999999999999 999997654

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.88  E-value=1.8e-22  Score=142.28  Aligned_cols=108  Identities=27%  Similarity=0.379  Sum_probs=78.3

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-----CCcEEEEeecCcccccCCCceeeeccCCCCCceeccc
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-----RHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAP   90 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-----~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~p   90 (129)
                      .....++.|+ +.|+.|+|. ++++||||||+||+++.     ...++++|||+++................++..|+||
T Consensus       118 ~~~~~i~~qi-~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~AP  195 (432)
T 3p23_A          118 LEPITLLQQT-TSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP  195 (432)
T ss_dssp             SCHHHHHHHH-HHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCG
T ss_pred             hhHHHHHHHH-HHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccCh
Confidence            3456788898 999999999 89999999999999943     3457899999987654322111112223345679999


Q ss_pred             ccccC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          91 ESYNF---GRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        91 e~~~~---~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      |.+..   ..++.++|+||+|++++++++.|..||.+.
T Consensus       196 E~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~  233 (432)
T 3p23_A          196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS  233 (432)
T ss_dssp             GGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred             hhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence            99873   456779999999999999997577888653

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.87  E-value=2.8e-22  Score=134.13  Aligned_cols=117  Identities=27%  Similarity=0.411  Sum_probs=91.4

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCC--CccCCCCCCCEEec-CCCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKS--SFHRDLAARNILLA-SRHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~--~ihr~lk~~nil~~-~~~~~~l~d~~~~~~~~~~   71 (129)
                      |||+++++|...+      .......++.|+ +.|+.|+|. ++  ++|+||||+||+++ ..+.++++|||++......
T Consensus       108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~  185 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQI-LKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EEecCCCCHHHHHHHccCCCHHHHHHHHHHH-HHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence            6788888865443      233455578888 999999998 77  99999999999997 7889999999998654332


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...  ..   .++..|++||.+. ..++.++|+||+|++++++++ |..||.+..
T Consensus       186 ~~~--~~---~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~  233 (290)
T 1t4h_A          186 FAK--AV---IGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMAT-SEYPYSECQ  233 (290)
T ss_dssp             SBE--ES---CSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHH-SSCTTTTCS
T ss_pred             ccc--cc---cCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHh-CCCCCCCcC
Confidence            111  11   2345699999876 458899999999999999999 999998744

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.87  E-value=5.7e-23  Score=140.71  Aligned_cols=107  Identities=21%  Similarity=0.401  Sum_probs=80.2

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      ....+..++.|+ +.|+.|+|. ++++||||||+||+++ ++.++++|||+++......... ......++..|+|||.+
T Consensus       106 ~~~~~~~i~~qi-~~al~~lH~-~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~  181 (343)
T 3dbq_A          106 DPWERKSYWKNM-LEAVHTIHQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV-VKDSQVGTVNYMPPEAI  181 (343)
T ss_dssp             CHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------------CCCCSSCCHHHH
T ss_pred             CHHHHHHHHHHH-HHHHHHHHh-CCeecCCCCcceEEEE-CCcEEEeecccccccCcccccc-cCCCCcCCcCcCCHHHH
Confidence            334566788888 999999999 8999999999999997 5779999999997653321111 11122345679999987


Q ss_pred             cC-----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          94 NF-----------GRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        94 ~~-----------~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ..           ..++.++|+||+|++++++++ |..||.+.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~  223 (343)
T 3dbq_A          182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQI  223 (343)
T ss_dssp             HHCC-----------CCHHHHHHHHHHHHHHHHH-SSCTTTTC
T ss_pred             hhccccccccccccCCCchhhHHHHHHHHHHHHh-CCCcchhh
Confidence            54           567889999999999999999 99999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.87  E-value=1.3e-22  Score=136.99  Aligned_cols=120  Identities=29%  Similarity=0.440  Sum_probs=95.2

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...       +.......++.|+ +.|+.|+|. ++++|+||+|+||+++.++.++++|||.+........
T Consensus       103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i-~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQST-LKGLEYLHF-MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHh-CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            678888775443       3333456688888 999999999 8999999999999999999999999999876543221


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..   ....++..|++||.+....++.++|+||+|++++++++ |..||.+.+
T Consensus       181 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~  229 (314)
T 3com_A          181 KR---NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE-GKPPYADIH  229 (314)
T ss_dssp             CB---CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHH-SSCTTTTSC
T ss_pred             cc---CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCC
Confidence            11   11223467999999988888899999999999999999 999998653

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.87  E-value=2.2e-23  Score=142.57  Aligned_cols=118  Identities=20%  Similarity=0.425  Sum_probs=78.4

Q ss_pred             CCCCCCCCccccC--------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC---CcEEEEeecCccccc
Q psy7529           1 MKSPNGSGVVTPL--------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVN   69 (129)
Q Consensus         1 m~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~---~~~~l~d~~~~~~~~   69 (129)
                      |||+++++|...+        ....+..++.|+ +.|+.|+|. ++++||||||+||+++..   +.++++|||+++...
T Consensus       105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql-~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~  182 (336)
T 3fhr_A          105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDI-GTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT  182 (336)
T ss_dssp             EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence            6889888865443        333456688888 999999999 899999999999999764   459999999987543


Q ss_pred             CCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          70 SERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....     ....++..|++||.+....++.++|+||+|++++++++ |..||.+.+
T Consensus       183 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~  233 (336)
T 3fhr_A          183 QNAL-----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GFPPFYSNT  233 (336)
T ss_dssp             --------------------------CHHHHHHHHHHHHHHHHHHHH-SSCCC----
T ss_pred             cccc-----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHH-CCCCCCCcc
Confidence            2211     11123456999999877778889999999999999999 999997544

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.87  E-value=8.6e-23  Score=139.24  Aligned_cols=123  Identities=21%  Similarity=0.288  Sum_probs=93.3

Q ss_pred             CCCCCCCCccccCCC-----CchhhHHhHHHHHHHHHHh--------ccCCCccCCCCCCCEEecCCCcEEEEeecCccc
Q psy7529           1 MKSPNGSGVVTPLGS-----YALPYIEGQIPAKVCRYLK--------MHKSSFHRDLAARNILLASRHQAKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~h--------~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~   67 (129)
                      |||+++++|...+..     .....++.|+ +.|+.|+|        . ++++||||||+||+++.++.++++|||+++.
T Consensus       119 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i-~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~  196 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKKNGTCCIADLGLAVR  196 (342)
T ss_dssp             ECCCTTCBHHHHHHHCCBCHHHHHHHHHHH-HHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EeecCCCcHHHHHhccCccHHHHHHHHHHH-HHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECCCCCEEEEECCCcee
Confidence            688888887665432     3355588888 99999999        5 8999999999999999999999999999876


Q ss_pred             ccCCCceee-eccCCCCCceecccccccCCCC------CChhhHHHHHHHHHHHHhCC----------CCCCCCCC
Q psy7529          68 VNSERNYYK-ATHGGRWPIKWYAPESYNFGRF------SSASDVWSFGITLWEMYSFG----------QQPYGEMK  126 (129)
Q Consensus        68 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~------~~~~di~s~g~~l~~l~~~~----------~~pf~~~~  126 (129)
                      ......... ......++..|+|||.+.....      +.++|+||+|++++++++ |          ..||.+..
T Consensus       197 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t-g~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             EETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT-TBCBTTBCCCCCCTTTTTS
T ss_pred             ccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh-ccCcCCcccccccCccccC
Confidence            543322111 1122234567999998876522      257999999999999998 8          77887653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.87  E-value=4.6e-23  Score=140.06  Aligned_cols=110  Identities=20%  Similarity=0.333  Sum_probs=72.9

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccCC--CccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee---------eeccCCC
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHKS--SFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY---------KATHGGR   82 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~~--~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~---------~~~~~~~   82 (129)
                      .......++.|+ +.|+.|+|. ++  ++||||||+||+++.++.++++|||+++.........         .......
T Consensus       134 ~~~~~~~i~~qi-~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (337)
T 3ll6_A          134 SCDTVLKIFYQT-CRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN  211 (337)
T ss_dssp             CHHHHHHHHHHH-HHHHHHHHT-SSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------
T ss_pred             CHHHHHHHHHHH-HHHHHHHHh-CCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhcccc
Confidence            334456688888 999999998 77  9999999999999999999999999987654321110         0001122


Q ss_pred             CCceecccccc---cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          83 WPIKWYAPESY---NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        83 ~~~~~~~pe~~---~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++..|++||.+   ....++.++|+||+|++++++++ |..||.+.+
T Consensus       212 ~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~  257 (337)
T 3ll6_A          212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF-RQHPFEDGA  257 (337)
T ss_dssp             ------------CCTTSCSSHHHHHHHHHHHHHHHHH-SSCCC----
T ss_pred             CCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHh-CCCCCcchh
Confidence            35679999988   45567889999999999999999 999997643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.87  E-value=2.4e-22  Score=135.35  Aligned_cols=122  Identities=28%  Similarity=0.338  Sum_probs=93.5

Q ss_pred             CCCCCCCCccccCC---------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLG---------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~   71 (129)
                      |||++++++...+.         ......++.|+ +.|+.|+|. ++++|+||+|+||+++.++.++++|||+++.....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i-~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA-ANGINFLHE-NHHIHRDIKSANILLDEAFTAKISDFGLARASEKF  186 (307)
T ss_dssp             EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHH-HHHHHHHhc-CCeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence            67888887654332         22344577888 999999999 89999999999999999999999999998765432


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .... ......++..|++||.+.+ .++.++|+||+|++++++++ |..||.+.+.
T Consensus       187 ~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~  239 (307)
T 2nru_A          187 AQTV-MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIIT-GLPAVDEHRE  239 (307)
T ss_dssp             SSCE-ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHH-CCCSBCTTBS
T ss_pred             cccc-cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHH-CCCCcccCcc
Confidence            2111 1112234567999998764 46789999999999999999 9999987543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.87  E-value=1.9e-22  Score=135.88  Aligned_cols=118  Identities=25%  Similarity=0.397  Sum_probs=93.6

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe---cCCCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL---ASRHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~---~~~~~~~l~d~~~~~~~~~~   71 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++|+||+|+||++   +..+.++++|||+++.....
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           85 MQLVSGGELFDRILERGVYTEKDASLVIQQV-LSAVKYLHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             EEcCCCccHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            6888888865433      334456688888 999999999 899999999999999   67788999999998654321


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..  .   ...++..|+|||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       163 ~~--~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~  211 (304)
T 2jam_A          163 IM--S---TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC-GYPPFYEET  211 (304)
T ss_dssp             TT--H---HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHH-SSCTTTTSC
T ss_pred             cc--c---cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHH-CCCCCCCCC
Confidence            11  0   0112456999999988888999999999999999999 999997643

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.87  E-value=5.4e-23  Score=136.90  Aligned_cols=118  Identities=41%  Similarity=0.733  Sum_probs=89.4

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...+.        ......++.|+ +.|+.|+|. ++++|+|+||+||+++.++.++++|||+++......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  171 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV-CEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  171 (278)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EecCCCCCHHHHHHhcccccCCHHHHHHHHHHH-HHHHHHHHh-CCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence            67888877655443        22345578888 999999999 899999999999999999999999999987543221


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .      ....+..|++||.+....++.++|+||+|+++++++++|..||...+
T Consensus       172 ~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  219 (278)
T 1byg_A          172 D------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  219 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred             c------CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence            1      11223469999999888889999999999999999966889998654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.87  E-value=2e-22  Score=139.36  Aligned_cols=103  Identities=29%  Similarity=0.440  Sum_probs=85.5

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......      ...++..|+|||.+.
T Consensus       127 ~~~~~~~~~qi-~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~------~~~~t~~y~aPE~~~  198 (367)
T 1cm8_A          127 EDRIQFLVYQM-LKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT------GYVVTRWYRAPEVIL  198 (367)
T ss_dssp             HHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCC------SSCSCGGGCCTHHHH
T ss_pred             HHHHHHHHHHH-HHHHHHHHH-CCccccCcCHHHEEEcCCCCEEEEeeecccccccccC------cCcCCCCcCCHHHHh
Confidence            33466688899 999999999 8999999999999999999999999999976433211      112345699999887


Q ss_pred             C-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 F-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 ~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      + ..++.++|+||+|++++++++ |..||.+.+
T Consensus       199 ~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  230 (367)
T 1cm8_A          199 NWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSD  230 (367)
T ss_dssp             TTTCCCTTHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             CCCCCChhhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            6 568899999999999999999 999998654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.87  E-value=5.4e-23  Score=140.13  Aligned_cols=119  Identities=20%  Similarity=0.289  Sum_probs=85.9

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEec-----CCCcEEEEeecCccccc
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLA-----SRHQAKISDFGLSRAVN   69 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~-----~~~~~~l~d~~~~~~~~   69 (129)
                      |||+++ ++...      +....+..++.|+ +.|+.|+|. ++++||||||+||+++     ....++++|||+++...
T Consensus       112 ~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql-~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL-INGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             EECCSE-EHHHHHHHCTTCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             EecCCC-CHHHHHhhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            566664 43322      3333456688898 999999999 8999999999999994     44459999999987653


Q ss_pred             CCCceeeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          70 SERNYYKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .......   ...++..|+|||.+.+. .++.++|+||+|++++++++ |..||.+.+
T Consensus       189 ~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  242 (329)
T 3gbz_A          189 IPIRQFT---HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPLFPGDS  242 (329)
T ss_dssp             --------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             CcccccC---CCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHH-CCCCcCCCC
Confidence            2211111   11224569999998764 47899999999999999999 999997643

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.87  E-value=1.4e-22  Score=136.94  Aligned_cols=120  Identities=23%  Similarity=0.334  Sum_probs=86.2

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+++++|...      +.......++.|+ +.|+.|+|. ++++|+||+|+||+++.++.++++|||++.........
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQI-GSALDAAHA-AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             EECCCCEEHHHHHHHHCSCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence            577888775543      3334456688888 999999999 89999999999999999999999999998754332111


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .  .....++..|++||.+.+..++.++|+||+|++++++++ |..||.+.
T Consensus       191 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~  238 (309)
T 2h34_A          191 Q--LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLT-GSPPYQGD  238 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHH-SSCSSCSC
T ss_pred             c--ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHH-CCCCCCCc
Confidence            1  111223467999999988888899999999999999999 99999754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.87  E-value=2.2e-22  Score=144.01  Aligned_cols=118  Identities=26%  Similarity=0.453  Sum_probs=94.3

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC---cEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH---QAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~---~~~l~d~~~~~~~~~~   71 (129)
                      ||||+|+++...      +.......++.|+ +.|+.|+|. ++++||||||+||+++..+   .++++|||+++.....
T Consensus       125 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  202 (504)
T 3q5i_A          125 TEFYEGGELFEQIINRHKFDECDAANIMKQI-LSGICYLHK-HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD  202 (504)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC
Confidence            789999987543      3344566788899 999999999 8999999999999998765   6899999999765432


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..    .....+++.|+|||.+. ..++.++|+||+|+++|++++ |..||.+.+
T Consensus       203 ~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  251 (504)
T 3q5i_A          203 YK----LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLC-GYPPFGGQN  251 (504)
T ss_dssp             SC----BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             Cc----cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence            21    11222456799999876 468899999999999999999 999998754

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.87  E-value=2e-22  Score=136.66  Aligned_cols=104  Identities=25%  Similarity=0.376  Sum_probs=85.9

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      ..+..++.|+ +.|+.|+|. ++++|+||||+||+++.++.++++|||+++.......    .....++..|++||.+.+
T Consensus       120 ~~~~~~~~qi-~~~l~~lH~-~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~  193 (326)
T 1blx_A          120 ETIKDMMFQL-LRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----LTSVVVTLWYRAPEVLLQ  193 (326)
T ss_dssp             HHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGG----GCCCCCCCTTCCHHHHTT
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCceeccCCHHHeEEcCCCCEEEecCcccccccCCCC----ccccccccceeCHHHHhc
Confidence            3455688888 999999999 8999999999999999999999999999875432211    112223456999999988


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..++.++|+||+|++++++++ |..||.+.+
T Consensus       194 ~~~~~~~Di~slG~il~~l~~-g~~pf~~~~  223 (326)
T 1blx_A          194 SSYATPVDLWSVGCIFAEMFR-RKPLFRGSS  223 (326)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             CCCCcchhHHHHHHHHHHHHc-CCCCCCCCC
Confidence            888999999999999999998 999997643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.87  E-value=2.1e-22  Score=139.27  Aligned_cols=101  Identities=26%  Similarity=0.410  Sum_probs=76.7

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC-
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF-   95 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-   95 (129)
                      ....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......      ...++..|+|||.+.+ 
T Consensus       133 ~~~~i~~qi-~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~------~~~~t~~y~aPE~~~~~  204 (367)
T 2fst_X          133 HVQFLIYQI-LRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT------GYVATRWYRAPEIMLNW  204 (367)
T ss_dssp             HHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECC---------------------CCCTTCCHHHHTTC
T ss_pred             HHHHHHHHH-HHHHHHHHH-CCeeeCCCCHhhEEECCCCCEEEeeccccccccccCC------CcCcCcCccChHHHcCC
Confidence            456688888 999999998 9999999999999999999999999999876432211      1123456999998876 


Q ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 ~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..++.++|+||+|++++++++ |..||.+.+
T Consensus       205 ~~~~~~~DiwslG~il~ell~-g~~pf~~~~  234 (367)
T 2fst_X          205 MHYNQTVDIWSVGCIMAELLT-GRTLFPGTD  234 (367)
T ss_dssp             CSCCTTHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             cCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            568899999999999999999 999998754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.87  E-value=5e-23  Score=137.49  Aligned_cols=122  Identities=40%  Similarity=0.745  Sum_probs=94.7

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...+.        ...+..++.|+ +.|+.|+|. ++++|+||||+||+++.++.++++|||.++......
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i-~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI-SSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHH-HHHHHHHHH-HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHH-HHHHHHHHH-CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            67888877554332        23345577888 999999999 899999999999999999999999999987654322


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..  ......++..|++||.+.+..++.++|+||+|++++++++.|..||.+.+
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~  217 (288)
T 3kfa_A          166 YT--AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  217 (288)
T ss_dssp             SE--EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cc--cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            11  11122234569999999888889999999999999999965788988654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.87  E-value=3.3e-22  Score=136.69  Aligned_cols=120  Identities=23%  Similarity=0.440  Sum_probs=94.7

Q ss_pred             CCCCCCCCcccc------CCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529           1 MKSPNGSGVVTP------LGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      |||+++++|...      +..        ..+..++.|+ +.|+.|+|..++++|+|++|+||+++.++.++++|||.++
T Consensus       122 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi-~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  200 (348)
T 2pml_X          122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV-LNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE  200 (348)
T ss_dssp             EECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHH-HHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHH-HHHHHHHhccCCEeecCCChHhEEEcCCCcEEEecccccc
Confidence            688888887665      332        2345588888 9999999975789999999999999999999999999987


Q ss_pred             cccCCCceeeeccCCCCCceecccccccCC-CCCC-hhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          67 AVNSERNYYKATHGGRWPIKWYAPESYNFG-RFSS-ASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~-~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ......     .....++..|++||.+.+. .++. ++|+||+|++++++++ |..||...+.
T Consensus       201 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~  257 (348)
T 2pml_X          201 YMVDKK-----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY-NVVPFSLKIS  257 (348)
T ss_dssp             ECBTTE-----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH-SSCSSCCSSC
T ss_pred             cccccc-----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCCCc
Confidence            653321     1122335679999998876 5555 8999999999999999 9999986543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.87  E-value=1.5e-22  Score=140.07  Aligned_cols=104  Identities=27%  Similarity=0.420  Sum_probs=82.7

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      ....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.......      ...++..|+|||.+
T Consensus       142 ~~~~~~~i~~qi-~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~------~~~~t~~y~aPE~~  213 (371)
T 4exu_A          142 SEEKIQYLVYQM-LKGLKYIHS-AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT------GYVVTRWYRAPEVI  213 (371)
T ss_dssp             CHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECSTTCC--------------CTTCCCTTSCHHHH
T ss_pred             CHHHHHHHHHHH-HHHHHHHHH-CCCcCCCcCHHHeEECCCCCEEEEecCcccccccCcC------CcccCccccCHHHh
Confidence            334466688888 999999999 8999999999999999999999999999875432211      11234569999988


Q ss_pred             cC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          94 NF-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        94 ~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .+ ..++.++|+||+|++++++++ |..||.+.+
T Consensus       214 ~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  246 (371)
T 4exu_A          214 LSWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKD  246 (371)
T ss_dssp             SCCSCCCTTHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             cCCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            76 578899999999999999999 999998654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.87  E-value=7.3e-23  Score=144.25  Aligned_cols=106  Identities=28%  Similarity=0.466  Sum_probs=79.1

Q ss_pred             hhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC-------------CcEEEEeecCcccccCCCceee-eccCCCC
Q psy7529          18 LPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR-------------HQAKISDFGLSRAVNSERNYYK-ATHGGRW   83 (129)
Q Consensus        18 ~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~-------------~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~   83 (129)
                      ...++.|+ +.|+.|+|. ++++||||||+||+++..             ..++++|||+++.......... ......+
T Consensus       117 ~~~i~~qi-~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~g  194 (434)
T 2rio_A          117 PISLLRQI-ASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG  194 (434)
T ss_dssp             HHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------
T ss_pred             HHHHHHHH-HHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCC
Confidence            34588899 999999998 899999999999999754             4789999999986543221111 1111234


Q ss_pred             CceecccccccC-------CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          84 PIKWYAPESYNF-------GRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        84 ~~~~~~pe~~~~-------~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      +..|+|||.+.+       ..++.++|+||+|++++++++.|..||.+.
T Consensus       195 t~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             CCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence            567999998865       457899999999999999996578899764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.87  E-value=1.9e-22  Score=134.28  Aligned_cols=116  Identities=22%  Similarity=0.317  Sum_probs=92.6

Q ss_pred             CCCCCCCCccccC--------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPL--------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+++++|...+        .......++.|+ +.|+.|+|. ++++|+||+|+||+++.++.++++|||+++......
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  176 (284)
T 2a19_B           99 MEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI-TKGVDYIHS-KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG  176 (284)
T ss_dssp             ECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS
T ss_pred             EeccCCCCHHHHHhhccCCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeeccCCHHHEEEcCCCCEEECcchhheeccccc
Confidence            6889988865543        223355588888 999999999 899999999999999999999999999987654322


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      ..    ....++..|++||.+.+..++.++|+||+|++++++++ +..||.
T Consensus       177 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-~~~~~~  222 (284)
T 2a19_B          177 KR----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH-VCDTAF  222 (284)
T ss_dssp             CC----CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHS-CCSSHH
T ss_pred             cc----cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHh-cCCcch
Confidence            11    11223457999999988888999999999999999998 877763

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.87  E-value=4.8e-23  Score=138.25  Aligned_cols=123  Identities=29%  Similarity=0.466  Sum_probs=91.4

Q ss_pred             CCCCCCCCccccC--------------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529           1 MKSPNGSGVVTPL--------------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus         1 m~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      |||++++++...+              .......++.|+ +.|+.|+|. ++++|+||+|+||+++.++.++++|||++.
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV-LEGLEYLHK-NGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHH-HHHHHHHHh-CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            6788888754433              333455688888 999999999 899999999999999999999999999886


Q ss_pred             cccCCCce--eeeccCCCCCceecccccccC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          67 AVNSERNY--YKATHGGRWPIKWYAPESYNF-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        67 ~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ........  ........++..|++||.+.. ..++.++|+||+|++++++++ |..||.+.+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~  231 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT-GAAPYHKYP  231 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHH-SSCTTTTSC
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHh-CCCCCccCc
Confidence            54321110  000111123456999998865 467899999999999999999 999998654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.87  E-value=1.5e-22  Score=133.81  Aligned_cols=122  Identities=36%  Similarity=0.681  Sum_probs=94.4

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+       .......++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||+++...... 
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-  158 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV-CEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-  158 (267)
T ss_dssp             ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred             EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHH-HHHHHHHHh-CCcccCCCchheEEECCCCCEEEccccccccccccc-
Confidence            6888888865433       223355577888 999999999 899999999999999999999999999987543211 


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       ........++..|++||.+....++.++|+||+|++++++++.|..||.+.+
T Consensus       159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  210 (267)
T 3t9t_A          159 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS  210 (267)
T ss_dssp             -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             -ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence             1111122234569999999877888999999999999999964788987653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.87  E-value=3.9e-22  Score=141.16  Aligned_cols=100  Identities=26%  Similarity=0.381  Sum_probs=77.3

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee-------------------
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY-------------------   75 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-------------------   75 (129)
                      ......++.|+ +.||.|+|. ++++||||||+||+++.++.+|++|||+++.........                   
T Consensus       155 ~~~~~~~~~qi-~~aL~~LH~-~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (458)
T 3rp9_A          155 ELHIKTLLYNL-LVGVKYVHS-AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH  232 (458)
T ss_dssp             HHHHHHHHHHH-HHHHHHHHH-TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------
T ss_pred             HHHHHHHHHHH-HHHHHHHHh-CCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccc
Confidence            34466788999 999999999 899999999999999999999999999998653211100                   


Q ss_pred             -----eeccCCCCCceecccccc-cCCCCCChhhHHHHHHHHHHHHh
Q psy7529          76 -----KATHGGRWPIKWYAPESY-NFGRFSSASDVWSFGITLWEMYS  116 (129)
Q Consensus        76 -----~~~~~~~~~~~~~~pe~~-~~~~~~~~~di~s~g~~l~~l~~  116 (129)
                           .......++..|+|||++ ....++.++|+||+||+++++++
T Consensus       233 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             ------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence                 011112235669999976 45568999999999999999996

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.87  E-value=1.1e-22  Score=137.27  Aligned_cols=107  Identities=21%  Similarity=0.356  Sum_probs=80.8

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEec-CCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLA-SRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      ....++.|+ +.|+.|+|. ++++||||||+||+++ ....++++|||+++.................+..|++||.+..
T Consensus       121 ~~~~~~~qi-~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  198 (320)
T 2i6l_A          121 HARLFMYQL-LRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS  198 (320)
T ss_dssp             HHHHHHHHH-HHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC
T ss_pred             HHHHHHHHH-HHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcC
Confidence            355578888 999999999 8999999999999997 4568999999998765322111111111122456999998765


Q ss_pred             -CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 -GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 -~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       ..++.++|+||+|++++++++ |..||.+.+
T Consensus       199 ~~~~~~~~Di~slG~il~el~~-g~~pf~~~~  229 (320)
T 2i6l_A          199 PNNYTKAIDMWAAGCIFAEMLT-GKTLFAGAH  229 (320)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             cccCCchhhhHhHHHHHHHHHh-CCCCCCCCC
Confidence             567899999999999999999 999998654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.87  E-value=5.9e-23  Score=137.19  Aligned_cols=114  Identities=30%  Similarity=0.433  Sum_probs=88.3

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc--------EEEEeecCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ--------AKISDFGLS   65 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~--------~~l~d~~~~   65 (129)
                      |||+++++|...+.       ......++.|+ +.|+.|+|. ++++||||||+||+++.++.        ++++|||++
T Consensus        91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi-~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~  168 (289)
T 4fvq_A           91 QEFVKFGSLDTYLKKNKNCINILWKLEVAKQL-AAAMHFLEE-NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS  168 (289)
T ss_dssp             EECCTTCBHHHHHHHTGGGCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSC
T ss_pred             EECCCCCCHHHHHHhCCCCCCHHHHHHHHHHH-HHHHHHHhh-CCeECCCcCcceEEEecCCcccccccceeeeccCccc
Confidence            68888888665443       22345578888 999999999 89999999999999988876        999999998


Q ss_pred             ccccCCCceeeeccCCCCCceecccccccC-CCCCChhhHHHHHHHHHHHHhCCC-CCCCC
Q psy7529          66 RAVNSERNYYKATHGGRWPIKWYAPESYNF-GRFSSASDVWSFGITLWEMYSFGQ-QPYGE  124 (129)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~g~~l~~l~~~~~-~pf~~  124 (129)
                      ........    .   .++..|+|||.+.+ ..++.++|+||+|++++++++ |. .||..
T Consensus       169 ~~~~~~~~----~---~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~~~~~~  221 (289)
T 4fvq_A          169 ITVLPKDI----L---QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS-GGDKPLSA  221 (289)
T ss_dssp             TTTSCHHH----H---HHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHT-TTCCTTTT
T ss_pred             ccccCccc----c---CCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHc-CCCCCccc
Confidence            65432211    1   11345999998876 568899999999999999998 55 45544

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.87  E-value=8.6e-22  Score=134.99  Aligned_cols=108  Identities=23%  Similarity=0.262  Sum_probs=86.7

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccc
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPES   92 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~   92 (129)
                      +....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++.........   ....++..|+|||.
T Consensus       109 ~~~~~~~~~~~qi-~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~t~~y~aPE~  183 (346)
T 1ua2_A          109 LTPSHIKAYMLMT-LQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY---THQVVTRWYRAPEL  183 (346)
T ss_dssp             CCSSHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC---CCSCCCCTTCCHHH
T ss_pred             CCHHHHHHHHHHH-HHHHHHHHH-CCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccC---CcccccccccCchH
Confidence            4445567788898 999999999 899999999999999999999999999987654322111   11223456999998


Q ss_pred             ccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          93 YNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        93 ~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +.+. .++.++|+||+|++++++++ |..||.+.+
T Consensus       184 ~~~~~~~~~~~DiwslG~il~ell~-g~~~~~~~~  217 (346)
T 1ua2_A          184 LFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDS  217 (346)
T ss_dssp             HTTCSCCCHHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             hhCCCCCCchhhhHhHHHHHHHHHH-CCCCCCCCC
Confidence            8654 47889999999999999999 999987643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.87  E-value=2.7e-23  Score=138.22  Aligned_cols=120  Identities=24%  Similarity=0.442  Sum_probs=91.2

Q ss_pred             CCCCCCCCccccC----------CCCchhhHHhHHHHHHHHHHhccCC-----CccCCCCCCCEEecCCCcEEEEeecCc
Q psy7529           1 MKSPNGSGVVTPL----------GSYALPYIEGQIPAKVCRYLKMHKS-----SFHRDLAARNILLASRHQAKISDFGLS   65 (129)
Q Consensus         1 m~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~h~~~~-----~ihr~lk~~nil~~~~~~~~l~d~~~~   65 (129)
                      |||+++++|...+          .......++.|+ +.|+.|+|. ++     ++|+||+|+||+++.++.++++|||.+
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i-~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL-TLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHH-HHHHHHHHH-HC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHH-HHHHHHHhc-ccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            6788887754443          333456688888 999999998 67     999999999999999999999999998


Q ss_pred             ccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          66 RAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +............   .++..|++||.+.+..++.++|+||+|++++++++ |..||.+.+
T Consensus       164 ~~~~~~~~~~~~~---~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~  220 (279)
T 2w5a_A          164 RILNHDTSFAKTF---VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA-LMPPFTAFS  220 (279)
T ss_dssp             HHC---CHHHHHH---HSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             eeecccccccccc---CCCccccChHHhccCCCCchhhHHHHHHHHHHHHH-CCCCCcccC
Confidence            7543321111111   12346999999988888899999999999999999 999998754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.87  E-value=3.9e-22  Score=138.90  Aligned_cols=106  Identities=21%  Similarity=0.397  Sum_probs=80.7

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      ..+..++.|+ +.|+.|+|. ++++||||||+||+++ ++.++++|||+++......... ......+++.|+|||.+..
T Consensus       155 ~~~~~i~~qi-~~aL~~lH~-~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~  230 (390)
T 2zmd_A          155 WERKSYWKNM-LEAVHTIHQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV-VKDSQVGAVNYMPPEAIKD  230 (390)
T ss_dssp             HHHHHHHHHH-HHHHHHHHT-TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----------CCSCCCGGGCCHHHHHC
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc-cCCCCCcCCCccChHHhhh
Confidence            3466688888 999999999 8999999999999995 5789999999997653321111 1112234567999998754


Q ss_pred             -----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 -----------GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 -----------~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                                 ..++.++|+||+|++++++++ |..||.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~  271 (390)
T 2zmd_A          231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQII  271 (390)
T ss_dssp             C------------CCHHHHHHHHHHHHHHHHH-SSCTTTTCC
T ss_pred             ccccccccccccCCCChhhHHHHHHHHHHHHH-CCCcchhhh
Confidence                       357889999999999999999 999998653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.87  E-value=3.3e-22  Score=134.90  Aligned_cols=119  Identities=20%  Similarity=0.311  Sum_probs=85.8

Q ss_pred             CCCCCCCCccccC----------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPL----------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||++++++...+          .......++.|+ +.|+.|+|. ++++|+||+++||+++.++.++++|||+++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi-~~~l~~LH~-~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL-CSALEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHH-HHHHHHHhh-CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            6788888765433          233455688888 999999999 8999999999999999999999999999875433


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .....   ....++..|++||.+....++.++|+||+|++++++++ |..||.+.
T Consensus       189 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~  239 (310)
T 2wqm_A          189 KTTAA---HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGD  239 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTC--
T ss_pred             CCccc---cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHh-CCCCCccc
Confidence            21111   11123456999999988888999999999999999999 99998653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.86  E-value=1e-22  Score=140.32  Aligned_cols=102  Identities=19%  Similarity=0.294  Sum_probs=80.9

Q ss_pred             CchhhHHhHHHHHHHHHHhccC-CCccCCCCCCCEEecC------CCcEEEEeecCcccccCCCceeeeccCCCCCceec
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHK-SSFHRDLAARNILLAS------RHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY   88 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~-~~ihr~lk~~nil~~~------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (129)
                      .....++.|+ +.|+.|+|. + +++||||||+||+++.      ...++++|||+++.......      ...++..|+
T Consensus       131 ~~~~~i~~qi-~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~~t~~y~  202 (373)
T 1q8y_A          131 IYVKQISKQL-LLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT------NSIQTREYR  202 (373)
T ss_dssp             HHHHHHHHHH-HHHHHHHHH-TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCC------SCCSCGGGC
T ss_pred             HHHHHHHHHH-HHHHHHHHh-cCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCCC------CCCCCcccc
Confidence            3455688888 999999999 7 9999999999999943      34789999999876533211      112356799


Q ss_pred             ccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          89 APESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        89 ~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      |||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus       203 aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~  239 (373)
T 1q8y_A          203 SPEVLLGAPWGCGADIWSTACLIFELIT-GDFLFEPDE  239 (373)
T ss_dssp             CHHHHHTCCCCTHHHHHHHHHHHHHHHH-SSCCC----
T ss_pred             CcHHHhCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCc
Confidence            9999988889999999999999999999 999998644

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.86  E-value=3.8e-22  Score=132.92  Aligned_cols=119  Identities=24%  Similarity=0.395  Sum_probs=92.8

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC----cEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH----QAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~----~~~l~d~~~~~~~~~   70 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++|+||+|+||+++..+    .++++|||.++....
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           87 LELVSGGELFDFLAEKESLTEDEATQFLKQI-LDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EeecCCCcHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            6788888865433      334466688888 999999999 8999999999999998776    799999999876533


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....    ....++..|++||.+....++.++|+||+|++++++++ |..||.+.+
T Consensus       165 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~  215 (283)
T 3bhy_A          165 GNEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGET  215 (283)
T ss_dssp             -----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCSS
T ss_pred             CCcc----cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHH-CCCCCCCcc
Confidence            2111    11123457999999988888999999999999999999 999997643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.86  E-value=2.1e-22  Score=136.62  Aligned_cols=120  Identities=26%  Similarity=0.417  Sum_probs=91.4

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc---EEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ---AKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~---~~l~d~~~~~~~~~~   71 (129)
                      |||++++++...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++..+.   ++++|||+++.....
T Consensus        93 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  170 (322)
T 2ycf_A           93 LELMEGGELFDKVVGNKRLKEATCKLYFYQM-LLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET  170 (322)
T ss_dssp             EECCTTEETHHHHSTTCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC
T ss_pred             EecCCCCcHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEEEccCccceecccc
Confidence            68888887655332      23455678888 999999999 89999999999999987654   999999998765332


Q ss_pred             CceeeeccCCCCCceeccccccc---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYN---FGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ... ...   .++..|++||.+.   ...++.++|+||+|++++++++ |..||.+...
T Consensus       171 ~~~-~~~---~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~  224 (322)
T 2ycf_A          171 SLM-RTL---CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPFSEHRT  224 (322)
T ss_dssp             HHH-HHH---HSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHH-SSCSSCSTTC
T ss_pred             ccc-ccc---cCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCcccch
Confidence            110 011   1235699999863   4567889999999999999999 9999986543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.86  E-value=3.7e-22  Score=137.02  Aligned_cols=102  Identities=27%  Similarity=0.424  Sum_probs=82.5

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      ..+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++......      ....++..|+|||.+.+
T Consensus       126 ~~~~~i~~qi-~~al~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~------~~~~~t~~y~aPE~~~~  197 (353)
T 3coi_A          126 EKIQYLVYQM-LKGLKYIHS-AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM------TGYVVTRWYRAPEVILS  197 (353)
T ss_dssp             HHHHHHHHHH-HHHHHHHHH-TTCCCSSCCGGGEEECTTCCEEECSTTCTTC--------------CCSBCCSCHHHHSC
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCcccCCCCHHHEeECCCCcEEEeecccccCCCCCc------cccccCcCcCCHHHHhC
Confidence            3456688888 999999999 899999999999999999999999999987543221      11123456999998876


Q ss_pred             -CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 -GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 -~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       ..++.++|+||+|++++++++ |..||.+.+
T Consensus       198 ~~~~~~~~Di~slG~il~el~~-g~~pf~~~~  228 (353)
T 3coi_A          198 WMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKD  228 (353)
T ss_dssp             CSCCCTTHHHHHHHHHHHHHHH-SSCSSBSSC
T ss_pred             cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence             567899999999999999999 999998654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.86  E-value=6.8e-22  Score=133.67  Aligned_cols=122  Identities=22%  Similarity=0.265  Sum_probs=88.4

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...+..       .....++.|+ +.|+.|+|. ++++|+||||+||+++ ++.++++|||+++.......
T Consensus       108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi-~~al~~lH~-~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEI-VKGMGYLHA-KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             eecccCCcHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHh-CCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            788888886655443       3455688888 999999999 8999999999999998 67899999998764321110


Q ss_pred             e--eeeccCCCCCceecccccccC---------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 Y--YKATHGGRWPIKWYAPESYNF---------GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~--~~~~~~~~~~~~~~~pe~~~~---------~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .  ........++..|++||.+..         ..++.++|+||+|++++++++ |..||.+.+
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~  247 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA-REWPFKTQP  247 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHH-SSCSSSSCC
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            0  011111223467999998764         346789999999999999999 999998654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.86  E-value=4.7e-22  Score=131.45  Aligned_cols=115  Identities=19%  Similarity=0.342  Sum_probs=90.0

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCC--CccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKS--SFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~--~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||+++++|.+.+.        ......++.|+ +.|+.|+|. ++  ++|||+||+||+++.++.+++.|+++......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM-ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHH-HHHHHHHTT-SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHH-HHHHHHHhc-CCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            68888888655443        23455688888 999999998 78  99999999999999999999998887643221


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCC---hhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSS---ASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~---~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .        ...++..|+|||.+.+..++.   ++|+||+|++++++++ |..||.+.+
T Consensus       166 ~--------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~  215 (271)
T 3kmu_A          166 P--------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT-REVPFADLS  215 (271)
T ss_dssp             T--------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHH-CSCTTTTSC
T ss_pred             c--------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHh-CCCCccccC
Confidence            1        112345799999987654443   7999999999999999 999998654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.86  E-value=2.6e-22  Score=134.02  Aligned_cols=106  Identities=31%  Similarity=0.403  Sum_probs=76.9

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccC-CCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccc
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHK-SSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE   91 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~-~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe   91 (129)
                      +.......++.|+ +.|+.|+|. + +++||||||+||+++..+.++++|||+++........    ....++..|+|||
T Consensus       106 ~~~~~~~~i~~qi-~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~t~~y~aPE  179 (290)
T 3fme_A          106 IPEDILGKIAVSI-VKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK----DIDAGCKPYMAPE  179 (290)
T ss_dssp             CCHHHHHHHHHHH-HHHHHHHHH-HSCCCCCCCSGGGCEECTTCCEEBCCC-------------------CCCCCCSCHH
T ss_pred             CCHHHHHHHHHHH-HHHHHHHhh-cCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccc----cccCCCccccChh
Confidence            3334456688898 999999998 6 9999999999999999999999999998754332111    1112345699999


Q ss_pred             cc----cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          92 SY----NFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        92 ~~----~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .+    ....++.++|+||+|++++++++ |..||.+.
T Consensus       180 ~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~  216 (290)
T 3fme_A          180 RINPELNQKGYSVKSDIWSLGITMIELAI-LRFPYDSW  216 (290)
T ss_dssp             HHSCCTTC--CCHHHHHHHHHHHHHHHHH-TSCSSCCC
T ss_pred             hcChhhcCcCCCcHHHHHHHHHHHHHHHH-CCCCcccc
Confidence            86    44467889999999999999999 99999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.86  E-value=4e-22  Score=132.71  Aligned_cols=113  Identities=18%  Similarity=0.221  Sum_probs=88.3

Q ss_pred             CCCCCCCCccccC----------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-----------------
Q psy7529           1 MKSPNGSGVVTPL----------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-----------------   53 (129)
Q Consensus         1 m~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-----------------   53 (129)
                      |||+++++|.+.+          .......++.|+ +.|+.|+|. ++++||||||+||+++.                 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi-~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV-GRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEEC------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHH-HHHHHHHHh-CCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            6888888866443          334566688899 999999999 89999999999999984                 


Q ss_pred             --CCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          54 --RHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        54 --~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                        ...++++|||.+........       ..++..|+|||.+.+. .++.++|+||+|++++++++ +..|+.
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~-------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-~~~~~~  232 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQV-------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG-AEPLPR  232 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSCC-------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT-CCCCCS
T ss_pred             CCceEEEEcccccccccCCccc-------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc-CCCCCc
Confidence              44789999999876543221       1234579999988765 45579999999999999997 876654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.86  E-value=4.1e-22  Score=137.07  Aligned_cols=104  Identities=27%  Similarity=0.325  Sum_probs=79.6

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccC
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNF   95 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~   95 (129)
                      .....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........    ....++..|+|||.+.+
T Consensus       134 ~~~~~~~~qi-~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~t~~y~aPE~~~~  207 (362)
T 3pg1_A          134 QHIQYFMYHI-LLGLHVLHE-AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK----THYVTHRWYRAPELVMQ  207 (362)
T ss_dssp             HHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCTTC-------------------CGGGCCHHHHTT
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CcCEecCCChHHEEEcCCCCEEEEecCccccccccccc----ceecccceecCcHHhcC
Confidence            3456688888 999999999 89999999999999999999999999998753322111    11123456999998876


Q ss_pred             -CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          96 -GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        96 -~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       ..++.++|+||+|++++++++ |..||.+.+
T Consensus       208 ~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~  238 (362)
T 3pg1_A          208 FKGFTKLVDMWSAGCVMAEMFN-RKALFRGST  238 (362)
T ss_dssp             CTTCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             CCCCCcHhHHHhHHHHHHHHHh-CCCCCCCCC
Confidence             568899999999999999999 999998643

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.86  E-value=7.6e-22  Score=131.04  Aligned_cols=118  Identities=25%  Similarity=0.415  Sum_probs=88.8

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++|+|++|+||+++.++.++++|||++........ 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  166 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHGRVEEMEARRLFQQI-LSAVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-  166 (276)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHH-HHHHHHHHH-HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred             EeccCCCcHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHH-CCCccCCCChhhEEECCCCCEEEeecccccccCCCcc-
Confidence            6788888765433      334456688888 999999999 8999999999999999999999999999876533211 


Q ss_pred             eeeccCCCCCceecccccccCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRF-SSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                         .....++..|++||.+.+..+ +.++|+||+|++++++++ |..||.+.
T Consensus       167 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~  214 (276)
T 2h6d_A          167 ---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC-GTLPFDDE  214 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHH-SSCSSCCS
T ss_pred             ---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Confidence               111123456999999887665 578999999999999999 99999764

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.85  E-value=1.7e-22  Score=135.72  Aligned_cols=120  Identities=27%  Similarity=0.373  Sum_probs=90.7

Q ss_pred             CCCCCCCCccc-------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVT-------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++..       .+.......++.|+ +.|+.|+|. ++++|+||+|+||+++.++.++++|||++........
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQM-LEALNFLHS-KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHH-HHHHHHHhc-CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence            57787777542       23344566688888 999999999 8999999999999999999999999998653211100


Q ss_pred             eeeeccCCCCCceecccccc-----cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESY-----NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~-----~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   .....++..|++||.+     ....++.++|+||+|++++++++ |..||...+
T Consensus       173 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~  226 (302)
T 2j7t_A          173 K---RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ-IEPPHHELN  226 (302)
T ss_dssp             C--------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHH-SSCTTTTSC
T ss_pred             c---cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhc-CCCCCccCC
Confidence            0   0111234569999987     35567889999999999999999 999998654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.85  E-value=3.7e-21  Score=141.27  Aligned_cols=117  Identities=26%  Similarity=0.413  Sum_probs=94.2

Q ss_pred             CCCCCCCCcccc---------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc---EEEEeecCcccc
Q psy7529           1 MKSPNGSGVVTP---------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ---AKISDFGLSRAV   68 (129)
Q Consensus         1 m~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~---~~l~d~~~~~~~   68 (129)
                      |||++|++|...         +....+..++.|+ +.|+.|+|. ++++||||+|+||+++..+.   ++++|||.++..
T Consensus        97 mEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QL-l~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~  174 (676)
T 3qa8_A           97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI-SSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL  174 (676)
T ss_dssp             EECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHH-HHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred             EEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHH-HHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence            688888886443         4455567788999 999999999 99999999999999986654   899999998765


Q ss_pred             cCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          69 NSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ......    ....++..|+|||.+.+..++.++|+||+|++++++++ |..||..
T Consensus       175 ~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLlt-G~~Pf~~  225 (676)
T 3qa8_A          175 DQGELC----TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT-GFRPFLP  225 (676)
T ss_dssp             TSCCCC----CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHS-SCSSCCS
T ss_pred             cccccc----ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHH-CCCCCCc
Confidence            432211    11223467999999988889999999999999999998 9999964

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.85  E-value=1.4e-22  Score=137.74  Aligned_cols=123  Identities=37%  Similarity=0.671  Sum_probs=90.7

Q ss_pred             CCCCCCCCccccCC-------------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC---CCcEEEEeecC
Q psy7529           1 MKSPNGSGVVTPLG-------------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS---RHQAKISDFGL   64 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~---~~~~~l~d~~~   64 (129)
                      |||+++++|...+.             ...+..++.|+ +.|+.|+|. ++++||||||+||+++.   ...++++|||+
T Consensus       112 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi-~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~  189 (327)
T 2yfx_A          112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI-ACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  189 (327)
T ss_dssp             EECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHH-HHHHHHHhh-CCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence            67787777554332             22345578888 999999999 89999999999999984   44699999998


Q ss_pred             cccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          65 SRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++......... ......++..|+|||.+....++.++|+||+|++++++++.|..||.+.+
T Consensus       190 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  250 (327)
T 2yfx_A          190 ARDIYRASYYR-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS  250 (327)
T ss_dssp             HHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccccccccccc-cCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence            87542211110 01111224569999998888889999999999999999975889997654

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.85  E-value=8.9e-22  Score=133.74  Aligned_cols=106  Identities=31%  Similarity=0.425  Sum_probs=71.0

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccC-CCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccc
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHK-SSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPES   92 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~-~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~   92 (129)
                      .......++.|+ +.|+.|+|. + +++|||||++||+++.++.++++|||+++........    ....++..|+|||.
T Consensus       123 ~~~~~~~i~~~i-~~~l~~lH~-~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~----~~~~gt~~y~aPE~  196 (327)
T 3aln_A          123 PEEILGKITLAT-VKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMAPER  196 (327)
T ss_dssp             CHHHHHHHHHHH-HHHHHHHHH-HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------------------------
T ss_pred             cHHHHHHHHHHH-HHHHHHHhc-cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccccc----ccCCCCccccCcee
Confidence            334455688888 999999998 7 9999999999999999999999999998765322111    11123456999998


Q ss_pred             c----cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          93 Y----NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        93 ~----~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +    ....++.++|+||+|++++++++ |..||.+.+
T Consensus       197 ~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~  233 (327)
T 3aln_A          197 IDPSASRQGYDVRSDVWSLGITLYELAT-GRFPYPKWN  233 (327)
T ss_dssp             ---------CCSHHHHHHHHHHHHHHHH-SCCCSSCC-
T ss_pred             eccccCcCCCCchhhHHHHHHHHHHHHH-CCCCCCCcc
Confidence            8    44567899999999999999999 999998643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.85  E-value=2.4e-22  Score=134.48  Aligned_cols=119  Identities=29%  Similarity=0.498  Sum_probs=89.2

Q ss_pred             CCCCCCCCccccCC---------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-CCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPLG---------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-RHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-~~~~~l~d~~~~~~~~~   70 (129)
                      |||++++++...+.         ...+..++.|+ +.|+.|+|. ++++|+||+|+||+++. .+.++++|||+++....
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI-LEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHH-HHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            56777776544332         12244467788 999999999 89999999999999987 88999999999876533


Q ss_pred             CCceeeeccCCCCCceecccccccCCC--CCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGR--FSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ....   .....++..|++||.+....  ++.++|+||+|++++++++ |..||.+.
T Consensus       176 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~  228 (295)
T 2clq_A          176 INPC---TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT-GKPPFYEL  228 (295)
T ss_dssp             --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHH-TSCTTGGG
T ss_pred             CCCc---ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHH-CCCCccCC
Confidence            2111   11222356799999886543  7889999999999999999 99999754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.85  E-value=1.4e-21  Score=130.97  Aligned_cols=119  Identities=23%  Similarity=0.349  Sum_probs=93.2

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++++++...+      .......++.|+ +.|+.|+|. ++++|+||+|+||+++.++.++++|||.+........ 
T Consensus       103 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  179 (298)
T 1phk_A          103 FDLMKKGELFDYLTEKVTLSEKETRKIMRAL-LEVICALHK-LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-  179 (298)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC-
T ss_pred             EeccCCCcHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHH-CCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcc-
Confidence            6788888765433      334456688888 999999999 8999999999999999999999999999876533211 


Q ss_pred             eeeccCCCCCceeccccccc------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYN------FGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~------~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....++..|++||.+.      ...++.++|+||+|++++++++ |..||.+.+
T Consensus       180 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~  233 (298)
T 1phk_A          180 ---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRK  233 (298)
T ss_dssp             ---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             ---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHH-CCCCCcCcc
Confidence               11122345799999874      3457789999999999999999 999997643

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.85  E-value=1.1e-22  Score=138.87  Aligned_cols=112  Identities=17%  Similarity=0.115  Sum_probs=87.3

Q ss_pred             CCCCCCCCccccC-----CCCchhhHHhHHHHHHHHHHh-ccCCCccCCCCCCCEEecCCC-------------------
Q psy7529           1 MKSPNGSGVVTPL-----GSYALPYIEGQIPAKVCRYLK-MHKSSFHRDLAARNILLASRH-------------------   55 (129)
Q Consensus         1 m~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~h-~~~~~ihr~lk~~nil~~~~~-------------------   55 (129)
                      |||++++++...+     .......++.|+ +.|+.|+| . ++++||||||+||+++..+                   
T Consensus       141 ~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi-~~aL~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  218 (336)
T 2vuw_A          141 LEFEFGGIDLEQMRTKLSSLATAKSILHQL-TASLAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCG  218 (336)
T ss_dssp             EEEECCCEETGGGTTTCCCHHHHHHHHHHH-HHHHHHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTT
T ss_pred             EEecCCCccHHHHHhcCCCHHHHHHHHHHH-HHHHHHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCC
Confidence            7888888755544     233466689999 99999999 7 8999999999999999876                   


Q ss_pred             -cEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHH-HHHHHhCCCCCCCC
Q psy7529          56 -QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGIT-LWEMYSFGQQPYGE  124 (129)
Q Consensus        56 -~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~-l~~l~~~~~~pf~~  124 (129)
                       .+|++|||+++......     .   .++..|+|||.+.+.. +.++|+||++.+ .+++++ |..||.+
T Consensus       219 ~~vkL~DFG~a~~~~~~~-----~---~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~-g~~p~~~  279 (336)
T 2vuw_A          219 LQVSIIDYTLSRLERDGI-----V---VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWG-EYHPYSN  279 (336)
T ss_dssp             EEEEECCCTTCBEEETTE-----E---ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTT-SCCTHHH
T ss_pred             ceEEEeeccccEecCCCc-----E---EEeecccChhhhcCCC-ccceehhhhhCCCCccccc-ccCCCcc
Confidence             89999999998654321     1   2345699999998666 889999998766 666776 7788753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.85  E-value=2.3e-21  Score=132.74  Aligned_cols=109  Identities=26%  Similarity=0.354  Sum_probs=84.2

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceee-------eccCCCCCcee
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK-------ATHGGRWPIKW   87 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-------~~~~~~~~~~~   87 (129)
                      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++..........       ......++..|
T Consensus       111 ~~~~~~~~~qi-~~~L~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  188 (353)
T 2b9h_A          111 DDHIQYFIYQT-LRAVKVLHG-SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY  188 (353)
T ss_dssp             HHHHHHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGG
T ss_pred             HHHHHHHHHHH-HHHHHHHHH-CCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccc
Confidence            33456688888 999999999 8999999999999999999999999999876532211100       01112335679


Q ss_pred             cccccccC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          88 YAPESYNF-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        88 ~~pe~~~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +|||.+.. ..++.++|+||+|++++++++ |..||.+.+
T Consensus       189 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~  227 (353)
T 2b9h_A          189 RAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRD  227 (353)
T ss_dssp             CCHHHHHSCCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             cCCeeeccCCCccchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence            99998754 567899999999999999998 999998654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.85  E-value=5.2e-22  Score=134.23  Aligned_cols=121  Identities=24%  Similarity=0.335  Sum_probs=90.3

Q ss_pred             CCCCCCCCcccc----------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTP----------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~   70 (129)
                      |||+.+++|...          +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi-~~~L~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI-CRGLEAIHA-KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHh-CCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            678888886432          3334456688888 999999999 8999999999999999999999999998765321


Q ss_pred             CCcee------eeccCCCCCceecccccccCCC---CCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          71 ERNYY------KATHGGRWPIKWYAPESYNFGR---FSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        71 ~~~~~------~~~~~~~~~~~~~~pe~~~~~~---~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .....      .......++..|+|||.+....   ++.++|+||+|++++++++ |..||..
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~  248 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF-GEGPYDM  248 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHH-SSCTTHH
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHh-CCCChhh
Confidence            10000      0000011245699999886543   5789999999999999998 9999853

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.85  E-value=1.3e-21  Score=131.60  Aligned_cols=106  Identities=23%  Similarity=0.292  Sum_probs=83.5

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||.+.......... ......++..|++||.+.+.
T Consensus       110 ~~~~~~~qi-~~al~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~  186 (305)
T 2wtk_C          110 QAHGYFCQL-IDGLEYLHS-QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD-TCRTSQGSPAFQPPEIANGL  186 (305)
T ss_dssp             HHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSC-EECCCCSCGGGCCHHHHTCC
T ss_pred             HHHHHHHHH-HHHHHHHHH-CCeeecCCCcccEEEcCCCcEEeeccccccccCcccccc-ccccCCCCCCCcChhhccCc
Confidence            455588888 999999999 899999999999999999999999999987653221111 11122345679999988754


Q ss_pred             C--CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          97 R--FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        97 ~--~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .  ++.++|+||+|++++++++ |..||.+.+
T Consensus       187 ~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~  217 (305)
T 2wtk_C          187 DTFSGFKVDIWSAGVTLYNITT-GLYPFEGDN  217 (305)
T ss_dssp             SCEESHHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             ccCCcchhhHHHHHHHHHHHHh-CCCCCCCch
Confidence            3  3678999999999999999 999998643

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.84  E-value=2.3e-23  Score=151.12  Aligned_cols=108  Identities=16%  Similarity=0.165  Sum_probs=71.0

Q ss_pred             CCCCCCCCccccCC---CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeee
Q psy7529           1 MKSPNGSGVVTPLG---SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA   77 (129)
Q Consensus         1 m~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~   77 (129)
                      |||++|++|.+.+.   ......|+.|+ +.||.|+|. ++||||||||+|||++.++.+|++|||+++.......... 
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~~I~~QI-l~AL~ylH~-~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~-  397 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDREKILGSL-LRSLAALEK-QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT-  397 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHHHHHHHH-HHHHHHHHH-TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH-
T ss_pred             EecCCCCcHHHHHHhCCCCCHHHHHHHH-HHHHHHHHH-CCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc-
Confidence            89999999776554   34566799999 999999999 9999999999999999999999999999986543221111 


Q ss_pred             ccCCCCCceecccccccCCCCCChhhHHHHHHHHHHH
Q psy7529          78 THGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEM  114 (129)
Q Consensus        78 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l  114 (129)
                        ...+++.|++||++.+. +...+|+|+.|+..+.+
T Consensus       398 --t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l  431 (569)
T 4azs_A          398 --NLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNL  431 (569)
T ss_dssp             --HHHHHHHHHHHHHC------------------CCC
T ss_pred             --CceechhhccHHHhCCC-CCCcccccccccchhhh
Confidence              11245679999998754 45678999999875543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.84  E-value=1.9e-21  Score=143.50  Aligned_cols=112  Identities=23%  Similarity=0.205  Sum_probs=87.6

Q ss_pred             CCCCCCCCccccCC----CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceee
Q psy7529           1 MKSPNGSGVVTPLG----SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK   76 (129)
Q Consensus         1 m~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~   76 (129)
                      |||++|+++...+.    ......++.|+ +.||.|+|. ++++||||||+||+++.+ .++++|||+++......    
T Consensus       163 ~E~~~g~~L~~~~~~~l~~~~~~~~~~qi-~~aL~~lH~-~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~~----  235 (681)
T 2pzi_A          163 MEYVGGQSLKRSKGQKLPVAEAIAYLLEI-LPALSYLHS-IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG----  235 (681)
T ss_dssp             EECCCCEECC----CCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECSS-CEEECCCTTCEETTCCS----
T ss_pred             EEeCCCCcHHHHHhCCCCHHHHHHHHHHH-HHHHHHHHH-CCCeecccChHHeEEeCC-cEEEEecccchhcccCC----
Confidence            78888888765443    23455688888 999999999 899999999999999875 89999999987654321    


Q ss_pred             eccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          77 ATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        77 ~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                         ...+++.|++||.+.... +.++|+||+|++++++++ |..||.+
T Consensus       236 ---~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~-g~~~~~~  278 (681)
T 2pzi_A          236 ---YLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTL-DLPTRNG  278 (681)
T ss_dssp             ---CCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHS-CCCEETT
T ss_pred             ---ccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHh-CCCCCcc
Confidence               112345799999886543 789999999999999997 8888764

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.83  E-value=5.5e-21  Score=127.76  Aligned_cols=118  Identities=27%  Similarity=0.399  Sum_probs=90.4

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC---CcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR---HQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~---~~~~l~d~~~~~~~~~~   71 (129)
                      |||++++++...      +.......++.|+ +.|+.|+|. ++++|+||+|+||+++..   ..++++|||+++.....
T Consensus       100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi-~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQV-FSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            678888876433      3344566688888 999999999 899999999999999654   46999999998754322


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...    ....++..|++||.+.+ .++.++|+||+|++++++++ |..||.+.+
T Consensus       178 ~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~p~~~~~  226 (287)
T 2wei_A          178 TKM----KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS-GTPPFYGKN  226 (287)
T ss_dssp             SSC----SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             Ccc----ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHh-CCCCCCCCC
Confidence            111    11112456999998865 47899999999999999999 999997643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.83  E-value=5.2e-21  Score=129.86  Aligned_cols=101  Identities=25%  Similarity=0.396  Sum_probs=82.0

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEec-CCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLA-SRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      .....++.|+ +.|+.|+|. ++++||||||+||+++ ..+.++++|||+++.......     ....++..|+|||.+.
T Consensus       149 ~~~~~i~~qi-~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~-----~~~~gt~~y~aPE~~~  221 (320)
T 3a99_A          149 ELARSFFWQV-LEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-----TDFDGTRVYSPPEWIR  221 (320)
T ss_dssp             HHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCB-----CCCCSCGGGSCHHHHH
T ss_pred             HHHHHHHHHH-HHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccccc-----cCCCCCccCCChHHhc
Confidence            3455688888 999999999 9999999999999998 678999999999876543211     1122356799999887


Q ss_pred             CCCC-CChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          95 FGRF-SSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        95 ~~~~-~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ...+ +.++|+||+|++++++++ |..||..
T Consensus       222 ~~~~~~~~~Di~slG~il~el~~-g~~pf~~  251 (320)
T 3a99_A          222 YHRYHGRSAAVWSLGILLYDMVC-GDIPFEH  251 (320)
T ss_dssp             HSCBCHHHHHHHHHHHHHHHHHH-SSCSCCS
T ss_pred             cCCCCCccchHHhHHHHHHHHHH-CCCCCCC
Confidence            6665 578899999999999999 9999964

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.82  E-value=1.9e-20  Score=126.54  Aligned_cols=107  Identities=21%  Similarity=0.396  Sum_probs=79.5

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ......++.|+ +.|+.|+|. ++++||||||+||+++. +.++++|||+++......... ......++..|+|||.+.
T Consensus       126 ~~~~~~i~~qi-~~aL~~LH~-~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~  201 (313)
T 3cek_A          126 PWERKSYWKNM-LEAVHTIHQ-HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV-VKDSQVGTVNYMPPEAIK  201 (313)
T ss_dssp             HHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEEET-TEEEECCCSSSCC---------------CCGGGCCHHHHT
T ss_pred             HHHHHHHHHHH-HHHHHHHHH-CCceecCCCcccEEEEC-CeEEEeeccccccccCccccc-cccCCCCCCCcCCHHHHh
Confidence            34556688888 999999999 89999999999999964 789999999987653221111 111122356799999876


Q ss_pred             C-----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          95 F-----------GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        95 ~-----------~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .           ..++.++|+||+|++++++++ |..||.+..
T Consensus       202 ~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~  243 (313)
T 3cek_A          202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQII  243 (313)
T ss_dssp             TCC----------CCCHHHHHHHHHHHHHHHHH-SSCTTTTCC
T ss_pred             hcccccccccccccCCchHHHHHHHHHHHHHHh-CCCchhhHH
Confidence            4           357789999999999999998 999997653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.82  E-value=9.5e-21  Score=126.86  Aligned_cols=114  Identities=23%  Similarity=0.321  Sum_probs=83.5

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+++++|...+..       .....++.|+ +.|+.|+|. ++++|+||+|+||+++.++.++++|||+++.......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi-~~~l~~LH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  171 (303)
T 1zy4_A           94 MEYCENGTLYDLIHSENLNQQRDEYWRLFRQI-LEALSYIHS-QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD  171 (303)
T ss_dssp             EECCCSCBHHHHHHHSCGGGCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC---
T ss_pred             EecCCCCCHHHhhhccccccchHHHHHHHHHH-HHHHHHHHh-CCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccc
Confidence            678888886655432       2234578888 999999999 8999999999999999999999999999875432110


Q ss_pred             e-----------eeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHh
Q psy7529          74 Y-----------YKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYS  116 (129)
Q Consensus        74 ~-----------~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~  116 (129)
                      .           ........++..|+|||.+.+. .++.++|+||+|++++++++
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             ----------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             hhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            0           0001111234569999988754 67899999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.82  E-value=5.7e-21  Score=128.95  Aligned_cols=102  Identities=25%  Similarity=0.395  Sum_probs=82.0

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEec-CCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLA-SRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      ......++.|+ +.|+.|+|. ++++||||+++||+++ .++.++++|||+++.......     ....++..|++||.+
T Consensus       138 ~~~~~~~~~qi-~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~  210 (312)
T 2iwi_A          138 EGPSRCFFGQV-VAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-----TDFDGTRVYSPPEWI  210 (312)
T ss_dssp             HHHHHHHHHHH-HHHHHHHHH-HTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSCB-----CCCCSCTTTSCHHHH
T ss_pred             HHHHHHHHHHH-HHHHHHHHH-CCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCcc-----cccCCcccccCceee
Confidence            33456688888 999999999 8999999999999998 788899999999876543211     112234569999988


Q ss_pred             cCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          94 NFGRFS-SASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        94 ~~~~~~-~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ....+. .++|+||+|++++++++ |..||..
T Consensus       211 ~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~  241 (312)
T 2iwi_A          211 SRHQYHALPATVWSLGILLYDMVC-GDIPFER  241 (312)
T ss_dssp             HHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCS
T ss_pred             ecCCCCCccchHHHHHHHHHHHHH-CCCCCCC
Confidence            766554 58999999999999999 9999964

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.81  E-value=2.9e-20  Score=125.06  Aligned_cols=98  Identities=22%  Similarity=0.476  Sum_probs=79.1

Q ss_pred             CCCCCCCCccccC--------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC---CCcEEEEeecCccccc
Q psy7529           1 MKSPNGSGVVTPL--------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS---RHQAKISDFGLSRAVN   69 (129)
Q Consensus         1 m~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~---~~~~~l~d~~~~~~~~   69 (129)
                      |||++++++...+        .......++.|+ +.|+.|+|. ++++||||||+||+++.   .+.++++|||+++...
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi-~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A           94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSI-GEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  171 (299)
T ss_dssp             ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHH-HHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence            7899998865433        334466688898 999999999 99999999999999988   7889999999875321


Q ss_pred             CCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          70 SERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                                               ...++.++|+||+|++++++++ |..||.+.+
T Consensus       172 -------------------------~~~~~~~~DiwslG~il~el~t-g~~pf~~~~  202 (299)
T 3m2w_A          172 -------------------------GEKYDKSCDMWSLGVIMYILLC-GYPPFYSNH  202 (299)
T ss_dssp             -------------------------TCGGGGHHHHHHHHHHHHHHHH-SSCSCCC--
T ss_pred             -------------------------cccCCchhhHHHHHHHHHHHHH-CCCCCCCCc
Confidence                                     1234678999999999999999 999997643

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.81  E-value=3.9e-20  Score=124.90  Aligned_cols=106  Identities=33%  Similarity=0.498  Sum_probs=77.8

Q ss_pred             CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccc
Q psy7529          14 GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        14 ~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   93 (129)
                      .......++.|+ +.|+.|+|...+++|+||+|+||+++.++.++++|||+++........    ....++..|++||.+
T Consensus       122 ~~~~~~~~~~~i-~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~  196 (318)
T 2dyl_A          122 PERILGKMTVAI-VKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK----DRSAGCAAYMAPERI  196 (318)
T ss_dssp             CHHHHHHHHHHH-HHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------------------CCTTCCHHHH
T ss_pred             CHHHHHHHHHHH-HHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc----cccCCCccccChhhc
Confidence            334455688888 999999998238999999999999999999999999998654322111    111234569999988


Q ss_pred             c-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          94 N-----FGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        94 ~-----~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .     ...++.++|+||+|++++++++ |..||.+.
T Consensus       197 ~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~  232 (318)
T 2dyl_A          197 DPPDPTKPDYDIRADVWSLGISLVELAT-GQFPYKNC  232 (318)
T ss_dssp             C--------CCTHHHHHHHHHHHHHHHH-SSCTTTTC
T ss_pred             ccccccccCCccccchhhHHHHHHHHHh-CCCCCCCC
Confidence            4     3457889999999999999999 99999864

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.78  E-value=1.7e-19  Score=120.90  Aligned_cols=94  Identities=7%  Similarity=0.002  Sum_probs=76.6

Q ss_pred             CCCCCCCCccccCCC----CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceee
Q psy7529           1 MKSPNGSGVVTPLGS----YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK   76 (129)
Q Consensus         1 m~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~   76 (129)
                      |||++|++|.+.+..    .....++.|+ +.|+.|+|. ++++||||||+||+++.++.+++.+.+             
T Consensus       110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql-~~aL~~lH~-~givH~Dikp~NIll~~~g~~kl~~~~-------------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTSPSPVGAIRAMQSL-AAAADAAHR-AGVALSIDHPSRVRVSIDGDVVLAYPA-------------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred             EEecCCCCHHHHHhcCCChHHHHHHHHHH-HHHHHHHHH-CCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence            788988887665543    2345588888 999999999 999999999999999999999887432             


Q ss_pred             eccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          77 ATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        77 ~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                                |++       .++.++|+||+|+++|++++ |+.||.+.+.
T Consensus       175 ----------~~~-------~~~~~~Di~slG~il~ellt-g~~Pf~~~~~  207 (286)
T 3uqc_A          175 ----------TMP-------DANPQDDIRGIGASLYALLV-NRWPLPEAGV  207 (286)
T ss_dssp             ----------CCT-------TCCHHHHHHHHHHHHHHHHH-SEECSCCCSB
T ss_pred             ----------ccC-------CCCchhHHHHHHHHHHHHHH-CCCCCCcCCc
Confidence                      222       35788999999999999999 9999987554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.65  E-value=5.8e-18  Score=122.28  Aligned_cols=116  Identities=19%  Similarity=0.190  Sum_probs=88.2

Q ss_pred             CCCCCCCCccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceee----
Q psy7529           1 MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYK----   76 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~----   76 (129)
                      |||++|++|.+.+..  ...++.|+ +.|+.|+|. ++++||||||+||+++.  .++++|||+++..........    
T Consensus       418 mE~~~ggsL~~~l~~--~~~i~~qi-~~aL~~LH~-~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~  491 (540)
T 3en9_A          418 MSYINGKLAKDVIED--NLDIAYKI-GEIVGKLHK-NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIV  491 (540)
T ss_dssp             EECCCSEEHHHHSTT--CTHHHHHH-HHHHHHHHH-TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHH
T ss_pred             EECCCCCCHHHHHHH--HHHHHHHH-HHHHHHHHH-CcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhh
Confidence            799999998888877  66788899 999999998 99999999999999998  999999999987643211000    


Q ss_pred             eccCCCCCceecccccccC--CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          77 ATHGGRWPIKWYAPESYNF--GRFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        77 ~~~~~~~~~~~~~pe~~~~--~~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      ......++..|++||.+..  ..|+...|+|+...-..+-.. .+.+|.
T Consensus       492 ~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~-~r~rY~  539 (540)
T 3en9_A          492 FKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVE-RRARYV  539 (540)
T ss_dssp             HHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHH-TCSCCC
T ss_pred             hhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHH-hccccC
Confidence            0011123456999998865  456667789998887777666 666654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.49  E-value=3.4e-14  Score=95.14  Aligned_cols=63  Identities=17%  Similarity=0.141  Sum_probs=57.4

Q ss_pred             CCCCCCCCccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCccc
Q psy7529           1 MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRA   67 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~   67 (129)
                      |||++|++|.+ +.......++.|+ +.|+.|+|. ++++|||+||+||+++ ++.++++|||+++.
T Consensus       179 mE~~~g~~L~~-l~~~~~~~i~~qi-~~~l~~lH~-~giiHrDlkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          179 MELIDAKELYR-VRVENPDEVLDMI-LEEVAKFYH-RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             EECCCCEEGGG-CCCSCHHHHHHHH-HHHHHHHHH-TTEECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             EEecCCCcHHH-cchhhHHHHHHHH-HHHHHHHHH-CCCEeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence            79999999998 7666677789999 999999998 9999999999999999 99999999999864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.12  E-value=3.1e-11  Score=79.69  Aligned_cols=48  Identities=19%  Similarity=0.241  Sum_probs=42.9

Q ss_pred             chhhHHhHHHHHHHHHHh-ccCCCccCCCCCCCEEecCCCcEEEEeecCcccc
Q psy7529          17 ALPYIEGQIPAKVCRYLK-MHKSSFHRDLAARNILLASRHQAKISDFGLSRAV   68 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h-~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~   68 (129)
                      ....++.|+ +.++.|+| . .+++|||+||.||+++.  .++++|||++...
T Consensus       171 ~~~~i~~qi-~~~l~~lH~~-~givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          171 DVEGIFNDV-VENVKRLYQE-AELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CHHHHHHHH-HHHHHHHHHT-SCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHHHHHHH-HHHHHHHHHH-CCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            556688888 99999999 6 99999999999999988  8999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.99  E-value=2.7e-10  Score=79.32  Aligned_cols=63  Identities=14%  Similarity=0.086  Sum_probs=53.3

Q ss_pred             CCCCCCCCccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC----------cEEEEeecCc
Q psy7529           1 MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH----------QAKISDFGLS   65 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~----------~~~l~d~~~~   65 (129)
                      |||+.|..+...........++.|+ +.++.++|. ++++||||||.|||++.++          .+.++||+=+
T Consensus       190 ME~i~G~~L~~l~~~~~~~~l~~ql-l~~l~~lH~-~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~  262 (397)
T 4gyi_A          190 MSLVDALPMRQVSSVPDPASLYADL-IALILRLAK-HGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQM  262 (397)
T ss_dssp             EECCSCEEGGGCCCCSCHHHHHHHH-HHHHHHHHH-TTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTC
T ss_pred             EEecCCccHhhhcccHHHHHHHHHH-HHHHHHHHH-CCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCc
Confidence            8999998887776666677788888 999999998 8999999999999998765          3678998744

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.88  E-value=9.5e-06  Score=52.72  Aligned_cols=28  Identities=21%  Similarity=0.221  Sum_probs=23.8

Q ss_pred             CccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          39 SFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        39 ~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      ++|+|+++.||+++....+.++||+.+.
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhcc
Confidence            7899999999999876556799998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.36  E-value=0.00013  Score=49.90  Aligned_cols=30  Identities=23%  Similarity=0.358  Sum_probs=24.9

Q ss_pred             CCCccCCCCCCCEEecCCCc--EEEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLASRHQ--AKISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~~~~--~~l~d~~~~~   66 (129)
                      ..++|+|+++.||+++..+.  +.++||+.+.
T Consensus       216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~  247 (359)
T 3dxp_A          216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELST  247 (359)
T ss_dssp             CEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred             ceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence            35789999999999987653  5899999875

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=97.32  E-value=0.00011  Score=47.91  Aligned_cols=28  Identities=29%  Similarity=0.351  Sum_probs=23.1

Q ss_pred             CccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          39 SFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        39 ~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      ++|+|+++.||+++....+.++||+.+.
T Consensus       185 l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EECCCCCcCcEEEECCcEEEEEEchhcc
Confidence            6899999999999765555799998763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=94.58  E-value=0.053  Score=36.30  Aligned_cols=30  Identities=23%  Similarity=0.294  Sum_probs=26.5

Q ss_pred             CCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      ..++|+|+.+.|++++....+.++||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            678999999999999877789999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=90.49  E-value=0.093  Score=34.84  Aligned_cols=30  Identities=27%  Similarity=0.445  Sum_probs=24.7

Q ss_pred             CCccCCCCCCCEEecC--CCcEEEEeecCccc
Q psy7529          38 SSFHRDLAARNILLAS--RHQAKISDFGLSRA   67 (129)
Q Consensus        38 ~~ihr~lk~~nil~~~--~~~~~l~d~~~~~~   67 (129)
                      .++|+|+.+.|++++.  ...+.++||+.+..
T Consensus       192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             EEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             eeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence            3689999999999988  45568999988753

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=90.26  E-value=0.12  Score=36.11  Aligned_cols=29  Identities=17%  Similarity=0.316  Sum_probs=25.4

Q ss_pred             CCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      ..++|+|+.+.||+++... +.++||+.+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~  260 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSF  260 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence            6789999999999998766 9999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=90.11  E-value=0.16  Score=32.95  Aligned_cols=28  Identities=18%  Similarity=0.238  Sum_probs=23.7

Q ss_pred             CccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          39 SFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        39 ~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      ++|+|+.+.|++++....+.++||+.+.
T Consensus       195 l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          195 VTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEcCCCCCCeEEEECCeEEEEEECcccc
Confidence            6899999999999876666799998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=88.38  E-value=0.16  Score=33.78  Aligned_cols=29  Identities=21%  Similarity=0.345  Sum_probs=24.1

Q ss_pred             CCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          38 SSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        38 ~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .++|+|+.+.|++++....+.++||+.+.
T Consensus       188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            57899999999999876555799998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=87.16  E-value=0.23  Score=33.38  Aligned_cols=30  Identities=27%  Similarity=0.406  Sum_probs=25.3

Q ss_pred             CCCccCCCCCCCEEecCC----CcEEEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLASR----HQAKISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~~----~~~~l~d~~~~~   66 (129)
                      ..++|+|+.+.|++++..    ..+.++||+.+.
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~  216 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK  216 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence            457899999999999764    578999998775

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=86.80  E-value=0.21  Score=33.84  Aligned_cols=30  Identities=13%  Similarity=0.185  Sum_probs=24.2

Q ss_pred             CCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      ..++|+|+.+.||+++....+.++||..+.
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence            457899999999999853346899998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=86.59  E-value=0.31  Score=32.49  Aligned_cols=30  Identities=27%  Similarity=0.347  Sum_probs=24.2

Q ss_pred             CCCccCCCCCCCEEecC---CCcE-EEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLAS---RHQA-KISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~---~~~~-~l~d~~~~~   66 (129)
                      ..++|+|+.+.|++++.   .+.+ .++||+.+.
T Consensus       190 ~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          190 PRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             CEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             CeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence            35689999999999987   3554 799998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=83.21  E-value=0.53  Score=31.38  Aligned_cols=28  Identities=29%  Similarity=0.281  Sum_probs=23.5

Q ss_pred             CCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      ..++|+|+.+.||+++ + .+.++||..+.
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            3478999999999998 4 78999997664

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=81.28  E-value=0.71  Score=31.45  Aligned_cols=28  Identities=29%  Similarity=0.425  Sum_probs=22.7

Q ss_pred             CCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          38 SSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        38 ~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .++|.|+.+.|++++... +.++||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            478999999999987544 8899998664

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=80.78  E-value=0.74  Score=30.40  Aligned_cols=28  Identities=25%  Similarity=0.308  Sum_probs=23.3

Q ss_pred             CCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          38 SSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        38 ~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .++|+|+.+.|++ ...+.+.++||..+.
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence            3689999999999 556678999998764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	129
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-26
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-25
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-24
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-24
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-24
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-24
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-24
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-23
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-23
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-23
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-23
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-22
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-22
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-22
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-22
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-22
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-21
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-21
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-21
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-21
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-20
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-20
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-20
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-19
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-18
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-17
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-17
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-17
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-17
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-17
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-16
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-16
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-16
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-16
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-15
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-15
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-15
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-15
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-15
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-15
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-14
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-14
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-14
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-14
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-14
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-14
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-13
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-13
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-13
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-13
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-13
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-12
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-12
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-12
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-10
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-10
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-10
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-09
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-09
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-08
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-08
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-07
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-04

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.1 bits (241), Expect = 3e-26
 Identities = 59/103 (57%), Positives = 79/103 (76%), Gaps = 1/103 (0%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           +   +YL+      HRDLAARN+LL ++H AKISDFGLS+A+ ++ NYYKA   G+WP+K
Sbjct: 117 SMGMKYLEESNF-VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           WYAPE  N+ +FSS SDVWSFG+ +WE +S+GQ+PY  MKGS+
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.1 bits (233), Expect = 5e-25
 Identities = 45/95 (47%), Positives = 66/95 (69%)

Query: 35  MHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN 94
            + +  HRDLAARNIL+ S    K+SDFGLSR +  +      T GG+ PI+W APE+ +
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186

Query: 95  FGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           + +F+SASDVWSFGI +WE+ ++G++PY E+   +
Sbjct: 187 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.9 bits (230), Expect = 1e-24
 Identities = 59/108 (54%), Positives = 83/108 (76%), Gaps = 2/108 (1%)

Query: 24  QIPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++  +V   +K + + +F HRDLAARN+LL +RH AKISDFGLS+A+ ++ +YY A   G
Sbjct: 113 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           +WP+KWYAPE  NF +FSS SDVWS+G+T+WE  S+GQ+PY +MKG +
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 220

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.0 bits (228), Expect = 2e-24
 Identities = 35/106 (33%), Positives = 49/106 (46%), Gaps = 6/106 (5%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A+   YL       HRDL + NI L      KI DFGL+   +     ++        I 
Sbjct: 114 AQGMDYLHAKSI-IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-LSGSIL 171

Query: 87  WYAPESY---NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W APE     +   +S  SDV++FGI L+E+ + GQ PY  +   D
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRD 216

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.9 bits (230), Expect = 2e-24
 Identities = 40/108 (37%), Positives = 64/108 (59%), Gaps = 3/108 (2%)

Query: 24  QIPAKVCRYLK--MHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
               ++ + +     +   HRDLAARN+L+ +    KI+DFGL++ + +E   Y    GG
Sbjct: 115 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGG 173

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           + PIKW A ES     ++  SDVWS+G+T+WE+ +FG +PY  +  S+
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.9 bits (225), Expect = 7e-24
 Identities = 44/103 (42%), Positives = 60/103 (58%), Gaps = 3/103 (2%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           A    Y++      HRDL A NIL+      K++DFGL+R +    N Y A  G ++PIK
Sbjct: 123 ASGMAYVERMNY-VHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIK 179

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           W APE+  +GRF+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 91.0 bits (225), Expect = 9e-24
 Identities = 47/110 (42%), Positives = 70/110 (63%), Gaps = 4/110 (3%)

Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN--YYKATH 79
            +   +   +K     +  HRDLAARNIL+ S    K+SDFGLSR +  + +   Y +  
Sbjct: 132 GMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191

Query: 80  GGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           GG+ PI+W APE+  + +F+SASDVWS+GI +WE+ S+G++PY +M   D
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.4 bits (221), Expect = 2e-23
 Identities = 43/108 (39%), Positives = 68/108 (62%), Gaps = 4/108 (3%)

Query: 24  QIPAKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
            +   VC  +   + +   HRDLAARN L+      K+SDFG++R V  ++  Y ++ G 
Sbjct: 105 GMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGT 162

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ++P+KW +PE ++F R+SS SDVWSFG+ +WE++S G+ PY     S+
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.8 bits (222), Expect = 2e-23
 Identities = 38/91 (41%), Positives = 56/91 (61%), Gaps = 1/91 (1%)

Query: 40  FHRDLAARNILLASRHQAKISDFGLSRAV-NSERNYYKATHGGRWPIKWYAPESYNFGRF 98
            HRDLAARN +L  +   K++DFGL+R + + E +      G + P+KW A ES    +F
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 211

Query: 99  SSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ++ SDVWSFG+ LWE+ + G  PY ++   D
Sbjct: 212 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.9 bits (220), Expect = 3e-23
 Identities = 44/108 (40%), Positives = 66/108 (61%), Gaps = 4/108 (3%)

Query: 24  QIPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
            + A++   +  + + ++ HRDL A NIL++     KI+DFGL+R +    N Y A  G 
Sbjct: 113 DMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGA 170

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ++PIKW APE+ N+G F+  SDVWSFGI L E+ + G+ PY  M   +
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.7 bits (217), Expect = 7e-23
 Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 4/85 (4%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           HRDL   N+ L  +   K+ DFGL+R +N + ++ KA         + +PE  N   ++ 
Sbjct: 137 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV---GTPYYMSPEQMNRMSYNE 193

Query: 101 ASDVWSFGITLWEMYSFGQQPYGEM 125
            SD+WS G  L+E+ +    P+   
Sbjct: 194 KSDIWSLGCLLYELCA-LMPPFTAF 217

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.2 bits (218), Expect = 1e-22
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 6/96 (6%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
            K   YL+      HRD+   NIL+ SR + K+ DFG+S  +         +  G     
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRS-- 168

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           + +PE      +S  SD+WS G++L EM   G+ P 
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPI 203

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.7 bits (214), Expect = 2e-22
 Identities = 43/108 (39%), Positives = 66/108 (61%), Gaps = 4/108 (3%)

Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++   VC  ++    K   HRDLAARN L+  +   K+SDFGLSR V  +   Y ++ G 
Sbjct: 104 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGS 161

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           ++P++W  PE   + +FSS SD+W+FG+ +WE+YS G+ PY     S+
Sbjct: 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.2 bits (215), Expect = 3e-22
 Identities = 45/108 (41%), Positives = 61/108 (56%), Gaps = 6/108 (5%)

Query: 24  QIPAKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
              A V R +         HRDLAARNIL+   + AKI+DFGLSR     +  Y     G
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVKKTMG 186

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           R P++W A ES N+  +++ SDVWS+G+ LWE+ S G  PY  M  ++
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 87.2 bits (215), Expect = 3e-22
 Identities = 45/108 (41%), Positives = 65/108 (60%), Gaps = 3/108 (2%)

Query: 24  QIPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
            I  +V   +  + +  F HRDLA RN L+      KI+DFGLSR + S  +YYKA    
Sbjct: 144 CIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA-DYYKADGND 202

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
             PI+W  PES  + R+++ SDVW++G+ LWE++S+G QPY  M   +
Sbjct: 203 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.6 bits (211), Expect = 5e-22
 Identities = 46/96 (47%), Positives = 60/96 (62%), Gaps = 1/96 (1%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           +    F HRDLAARN+LLA+R   KI DFGL RA+    ++Y      + P  W APES 
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
               FS ASD W FG+TLWEM+++GQ+P+  + GS 
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 222

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.8 bits (209), Expect = 2e-21
 Identities = 47/100 (47%), Positives = 61/100 (61%), Gaps = 2/100 (2%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   +L+  KS  HRDLAARN+L+      KI DFGL+R + S+ NY       R P+K
Sbjct: 174 AKGMEFLE-FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG-NARLPVK 231

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
           W APES   G ++  SDVWS+GI LWE++S G  PY  + 
Sbjct: 232 WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.5 bits (206), Expect = 3e-21
 Identities = 46/108 (42%), Positives = 68/108 (62%), Gaps = 8/108 (7%)

Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           +    VC  ++     +  HRDLAARN+L++  + AK+SDFGL++  +S ++       G
Sbjct: 107 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT------G 160

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
           + P+KW APE+    +FS+ SDVWSFGI LWE+YSFG+ PY  +   D
Sbjct: 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 84.0 bits (207), Expect = 3e-21
 Identities = 43/92 (46%), Positives = 60/92 (65%), Gaps = 3/92 (3%)

Query: 35  MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           + K +  HRDLAARN L+   H  K++DFGLSR +  +   Y A  G ++PIKW APES 
Sbjct: 131 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 188

Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            + +FS  SDVW+FG+ LWE+ ++G  PY  +
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.1 bits (205), Expect = 7e-21
 Identities = 32/109 (29%), Positives = 47/109 (43%), Gaps = 11/109 (10%)

Query: 24  QIPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
            +  +    L  +H +   HRDL A NIL       K++DFG+S           +  G 
Sbjct: 114 VVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT 173

Query: 82  RWPIKWYAPE-----SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
            +   W APE     +     +   +DVWS GITL EM    + P+ E+
Sbjct: 174 PY---WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE-IEPPHHEL 218

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.6 bits (198), Expect = 4e-20
 Identities = 46/107 (42%), Positives = 64/107 (59%), Gaps = 4/107 (3%)

Query: 25  IPAKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
              ++   L   +S    HRD+AARN+L++S    K+ DFGLSR +      Y     G+
Sbjct: 113 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGK 170

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
            PIKW APES NF RF+SASDVW FG+ +WE+   G +P+  +K +D
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.4 bits (198), Expect = 6e-20
 Identities = 29/101 (28%), Positives = 45/101 (44%), Gaps = 9/101 (8%)

Query: 27  AKVCRYLKMHKSSF-HRDLAARNILLASRH-QAKISDFGLSRAVNSERNYYKATHGGRWP 84
            K  ++L        HRDL   NI +       KI D GL+    +   + KA  G    
Sbjct: 122 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPE- 178

Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
             + APE Y   ++  + DV++FG+ + EM +  + PY E 
Sbjct: 179 --FMAPEMYE-EKYDESVDVYAFGMCMLEMAT-SEYPYSEC 215

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.4 bits (198), Expect = 7e-20
 Identities = 28/92 (30%), Positives = 41/92 (44%), Gaps = 5/92 (5%)

Query: 35  MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESY 93
           +H +   HRD+ + NILL      K++DFG    +  E++      G  +   W APE  
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY---WMAPEVV 188

Query: 94  NFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
               +    D+WS GI   EM   G+ PY   
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNE 219

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.3 bits (190), Expect = 7e-19
 Identities = 26/101 (25%), Positives = 39/101 (38%), Gaps = 8/101 (7%)

Query: 24  QIPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
               ++   L   H     HRD+   N+LL S  + KI+DFG S    S R         
Sbjct: 110 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG--- 166

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
              + +  PE           D+WS G+  +E    G+ P+
Sbjct: 167 --TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPF 204

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.1 bits (186), Expect = 3e-18
 Identities = 44/104 (42%), Positives = 64/104 (61%), Gaps = 3/104 (2%)

Query: 24  QIPAKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
               +V R ++   S    HRDLAARN+L+   +  KI+DFGL+R ++   +YYK T  G
Sbjct: 139 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-DYYKKTTNG 197

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
           R P+KW APE+     ++  SDVWSFG+ LWE+++ G  PY  +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.1 bits (181), Expect = 2e-17
 Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 8/104 (7%)

Query: 30  CRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWY- 88
               +   +  HRDL ++NIL+       I+D GL+   +S  +        R   K Y 
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 89  APE------SYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
           APE      +         +D+++ G+  WE+        G  +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHE 222

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 73.6 bits (180), Expect = 2e-17
 Identities = 26/110 (23%), Positives = 44/110 (40%), Gaps = 5/110 (4%)

Query: 24  QIPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNY--YKATH 79
           +I   +   +  +HK +  HRDL   NILL      K++DFG S  ++          T 
Sbjct: 114 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 173

Query: 80  GGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
               P       + N   +    D+WS G+ ++ + + G  P+   K   
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQML 222

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.4 bits (179), Expect = 3e-17
 Identities = 40/104 (38%), Positives = 63/104 (60%), Gaps = 3/104 (2%)

Query: 24  QIPAKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           Q+  ++   +    ++   HRDLAARN ++A     KI DFG++R +  E +YY+    G
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYYRKGGKG 195

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
             P++W +PES   G F++ SDVWSFG+ LWE+ +  +QPY  +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 72.7 bits (178), Expect = 5e-17
 Identities = 30/108 (27%), Positives = 47/108 (43%), Gaps = 13/108 (12%)

Query: 24  QIPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
            +     + L  +H  +  HRD+ A NILL+     K+ DFG +  +    ++     G 
Sbjct: 119 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF----VGT 174

Query: 82  RWPIKWYAPESY---NFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            +   W APE     + G++    DVWS GIT  E+    + P   M 
Sbjct: 175 PY---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMN 218

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.4 bits (177), Expect = 6e-17
 Identities = 24/100 (24%), Positives = 45/100 (45%), Gaps = 4/100 (4%)

Query: 25  IPAKVCRYLKMHKSSF--HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
             A++   L+        HRDL   NILL      +I+DFG ++ ++ E    +A     
Sbjct: 113 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               + +PE         +SD+W+ G  ++++ + G  P+
Sbjct: 173 TAQ-YVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 210

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.7 bits (172), Expect = 3e-16
 Identities = 42/104 (40%), Positives = 63/104 (60%), Gaps = 3/104 (2%)

Query: 25  IPAKVCRYLK-MHKSS-FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
              +V + ++ +      HRDLAARNILL+ ++  KI DFGL+R +  + +Y +     R
Sbjct: 139 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDAR 197

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
            P+KW APE+     ++  SDVWSFG+ LWE++S G  PY  +K
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.7 bits (172), Expect = 3e-16
 Identities = 25/103 (24%), Positives = 43/103 (41%), Gaps = 5/103 (4%)

Query: 24  QIPAKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++   +   L     +   HRD+ A N+L+      K++DFGL+RA +  +N     +  
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 82  RWPIKWYAPESYNFGR--FSSASDVWSFGITLWEMYSFGQQPY 122
           R    WY P     G   +    D+W  G  + EM++      
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIM 222

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.3 bits (169), Expect = 8e-16
 Identities = 28/95 (29%), Positives = 41/95 (43%), Gaps = 4/95 (4%)

Query: 25  IPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
              ++   +  +H     HRD+   N+LL  R   KISDFGL+       N  +  +   
Sbjct: 108 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMC 166

Query: 83  WPIKWYAPESYNFGRFSS-ASDVWSFGITLWEMYS 116
             + + APE      F +   DVWS GI L  M +
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 201

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.5 bits (169), Expect = 9e-16
 Identities = 47/100 (47%), Positives = 60/100 (60%), Gaps = 2/100 (2%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIK 86
           AK   +L   K+  HRDLAARNILL      KI DFGL+R + ++ NY    +  R P+K
Sbjct: 155 AKGMAFLA-SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA-RLPVK 212

Query: 87  WYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
           W APES     ++  SDVWS+GI LWE++S G  PY  M 
Sbjct: 213 WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 69.7 bits (170), Expect = 1e-15
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 9/106 (8%)

Query: 24  QIPAKVCRYLK-MHKSSF-HRDLAARNILLASRH--QAKISDFGLSRAVNSERNYYKATH 79
           +   +VC+ L  MH++++ H DL   NI+  ++   + K+ DFGL+  ++ +++      
Sbjct: 128 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----VK 183

Query: 80  GGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
                 ++ APE          +D+WS G+  + + S G  P+G  
Sbjct: 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGE 228

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.5 bits (169), Expect = 1e-15
 Identities = 28/102 (27%), Positives = 47/102 (46%), Gaps = 4/102 (3%)

Query: 24  QIPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
               ++ R LK +H ++  HRDL   N+LL +    KI DFGL+R  + + ++       
Sbjct: 113 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172

Query: 82  RWPIKWYAPESYNFGRFSS-ASDVWSFGITLWEMYSFGQQPY 122
                + APE     +  + + D+WS G  L EM    +  +
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIF 213

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.3 bits (169), Expect = 1e-15
 Identities = 28/110 (25%), Positives = 49/110 (44%), Gaps = 9/110 (8%)

Query: 24  QIPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQA--KISDFGLSRAVNSERNYYKATH 79
               +VC  L+ +H  +  H D+   NI+  +R  +  KI +FG +R +    N+     
Sbjct: 106 SYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LF 164

Query: 80  GGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                  +YAPE +     S+A+D+WS G  ++ + S G  P+       
Sbjct: 165 TAPE---YYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQ 210

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.2 bits (166), Expect = 2e-15
 Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 6/101 (5%)

Query: 24  QIPAKVCRYLK--MHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
              A++   L+    K   +RDL   NILL      KI+DFG+ +             G 
Sbjct: 107 FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCG- 165

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                + APE     +++ + D WSFG+ L+EM   GQ P+
Sbjct: 166 --TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPF 203

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 67.4 bits (164), Expect = 5e-15
 Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 9/103 (8%)

Query: 25  IPAKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
             A+VC  L+   S    +RDL   NILL      KI+DFG ++ V              
Sbjct: 109 YAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC------ 162

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
               + APE  +   ++ + D WSFGI ++EM + G  P+ + 
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDS 204

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 67.1 bits (163), Expect = 9e-15
 Identities = 30/109 (27%), Positives = 49/109 (44%), Gaps = 9/109 (8%)

Query: 24  QIPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
              A++   L+ MH     +RDL   NILL      +ISD GL+   + ++      H  
Sbjct: 111 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHAS 165

Query: 82  RWPIKWYAPESYNFGR-FSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
                + APE    G  + S++D +S G  L+++   G  P+ + K  D
Sbjct: 166 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKD 213

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 66.6 bits (162), Expect = 1e-14
 Identities = 26/98 (26%), Positives = 44/98 (44%), Gaps = 9/98 (9%)

Query: 29  VCRYLK-MHKSSF-HRDLAARNILLASRH--QAKISDFGLSRAVNSERNYYKATHGGRWP 84
            C  LK MH+ S  H D+   NI+  ++     KI DFGL+  +N +             
Sbjct: 136 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI----VKVTTAT 191

Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
            ++ APE  +       +D+W+ G+  + + S G  P+
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPF 228

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.1 bits (160), Expect = 1e-14
 Identities = 21/101 (20%), Positives = 44/101 (43%), Gaps = 4/101 (3%)

Query: 24  QIPAKVCRYLK--MHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
               ++ + L     ++  HRDL  +N+L+    + K+++FGL+RA       Y  +   
Sbjct: 105 SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEV 162

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                      +    +S++ D+WS G    E+ + G+  +
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.3 bits (158), Expect = 3e-14
 Identities = 28/102 (27%), Positives = 45/102 (44%), Gaps = 7/102 (6%)

Query: 24  QIPAKVCRYLKMHKSSF--HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
               ++ + L    S    HRDL  +N+L+ +    K++DFGL+RA       Y      
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 165

Query: 82  RWPIKWYAPESY-NFGRFSSASDVWSFGITLWEMYSFGQQPY 122
            W   + APE       +S+A D+WS G    EM +  +  +
Sbjct: 166 LW---YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALF 203

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 64.4 bits (156), Expect = 4e-14
 Identities = 27/104 (25%), Positives = 51/104 (49%), Gaps = 3/104 (2%)

Query: 24  QIPAKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++ A  C+ L     +   HRD+   NI++++ +  K+ DFG++RA+    N    T   
Sbjct: 115 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM 125
               ++ +PE        + SDV+S G  L+E+ + G+ P+   
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGD 217

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.5 bits (156), Expect = 5e-14
 Identities = 26/101 (25%), Positives = 40/101 (39%), Gaps = 7/101 (6%)

Query: 25  IPAKVCRYLKMHKSSF--HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
                 + L+     +  HRDL   N+LL      K++DFGL+++  S    Y      R
Sbjct: 105 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR 164

Query: 83  WPIKWYAPESYNFGR-FSSASDVWSFGITLWEMYSFGQQPY 122
           W   + APE     R +    D+W+ G  L E+        
Sbjct: 165 W---YRAPELLFGARMYGVGVDMWAVGCILAELL-LRVPFL 201

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.6 bits (154), Expect = 9e-14
 Identities = 25/105 (23%), Positives = 45/105 (42%), Gaps = 11/105 (10%)

Query: 24  QIPAKVCRYLKMHKSSF--HRDLAARNILLASRH----QAKISDFGLSRAVNSERNYYKA 77
           +   ++   +    S    H DL   NI+L  R+    + KI DFGL+  ++    +   
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176

Query: 78  THGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                   ++ APE  N+      +D+WS G+  + + S G  P+
Sbjct: 177 F----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPF 216

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.6 bits (154), Expect = 1e-13
 Identities = 26/101 (25%), Positives = 45/101 (44%), Gaps = 6/101 (5%)

Query: 24  QIPAKVCRYLKMH--KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
              A++   L+    +   +RD+   N++L      KI+DFGL +   S+    K   G 
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG- 167

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
               ++ APE      +  A D W  G+ ++EM   G+ P+
Sbjct: 168 --TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF 205

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 63.3 bits (153), Expect = 1e-13
 Identities = 14/112 (12%), Positives = 35/112 (31%), Gaps = 11/112 (9%)

Query: 24  QIPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQ-----AKISDFGLSRAVNSERN--- 73
               ++   ++ +H+ S  +RD+   N L+   +        + DFG+ +          
Sbjct: 105 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164

Query: 74  -YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE 124
             Y+         ++ +  ++     S   D+ + G              G 
Sbjct: 165 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.2 bits (153), Expect = 2e-13
 Identities = 23/111 (20%), Positives = 48/111 (43%), Gaps = 10/111 (9%)

Query: 24  QIPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQ---AKISDFGLSRAVNSERNYYKAT 78
           +I   +   ++ +H  +  HRD+   N+L  S+      K++DFG ++   S  +     
Sbjct: 115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---- 170

Query: 79  HGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGSD 129
               +   + APE     ++  + D+WS G+ ++ +   G  P+    G  
Sbjct: 171 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL-CGYPPFYSNHGLA 220

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.9 bits (152), Expect = 2e-13
 Identities = 22/98 (22%), Positives = 37/98 (37%), Gaps = 3/98 (3%)

Query: 27  AKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWP 84
            ++   L+        +RD+   NILL S     ++DFGLS+   ++         G   
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                           A D WS G+ ++E+   G  P+
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELL-TGASPF 232

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.0 bits (147), Expect = 9e-13
 Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 7/100 (7%)

Query: 25  IPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           +  ++ R L  +H     HRDL  +NIL+ S  Q K++DFGL+R  +  +    +     
Sbjct: 121 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS-FQMALTSVVVTL 179

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
           W   + APE      +++  D+WS G    EM+   +  +
Sbjct: 180 W---YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLF 215

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 59.9 bits (144), Expect = 2e-12
 Identities = 19/99 (19%), Positives = 38/99 (38%), Gaps = 9/99 (9%)

Query: 27  AKVCRYLK-MHKSSF-HRDLAARNILLASR---HQAKISDFGLSRAVNSERNY----YKA 77
            ++   ++ +H  +F HRD+   N L+      +   I DFGL++     R +    Y+ 
Sbjct: 110 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169

Query: 78  THGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYS 116
                   ++ +  ++     S   D+ S G  L     
Sbjct: 170 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 208

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 59.5 bits (143), Expect = 3e-12
 Identities = 24/98 (24%), Positives = 39/98 (39%), Gaps = 5/98 (5%)

Query: 27  AKVCRYLKMHKSS--FHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWP 84
            ++   +         HRDL  +N+L+    + KI+DFGL+RA       Y   H     
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT--HEIVTL 164

Query: 85  IKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                       ++S+  D+WS G    EM + G   +
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLF 201

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.6 bits (141), Expect = 7e-12
 Identities = 24/106 (22%), Positives = 41/106 (38%), Gaps = 8/106 (7%)

Query: 24  QIPAKVCRYLK--MHKSSFHRDLAARNILL-ASRHQAKISDFGLSRAVNSERNYYKATHG 80
               +V   ++   +    HRD+   NIL+  +R + K+ DFG    +            
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 173

Query: 81  GRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK 126
              P +W     Y       ++ VWS GI L++M   G  P+   +
Sbjct: 174 VYSPPEWIRYHRY----HGRSAAVWSLGILLYDMVC-GDIPFEHDE 214

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 54.7 bits (131), Expect = 2e-10
 Identities = 28/99 (28%), Positives = 40/99 (40%), Gaps = 9/99 (9%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASRH---QAKISDFGLSRAVNSERNYYKATHGGRW 83
               +YL       HRDL   N+L  S     +  ISDFGLS+ +    +      G   
Sbjct: 117 LDAVKYLHDLGI-VHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPG 174

Query: 84  PIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
              + APE      +S A D WS G+  + +   G  P+
Sbjct: 175 ---YVAPEVLAQKPYSKAVDCWSIGVIAYILL-CGYPPF 209

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.6 bits (128), Expect = 4e-10
 Identities = 21/97 (21%), Positives = 37/97 (38%), Gaps = 6/97 (6%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASR-HQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
            +   Y+       HRD+  +N+LL       K+ DFG ++ +              +  
Sbjct: 132 FRSLAYIHSFGI-CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY-- 188

Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                  +    ++S+ DVWS G  L E+   GQ  +
Sbjct: 189 -RAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIF 223

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 52.9 bits (126), Expect = 7e-10
 Identities = 20/82 (24%), Positives = 37/82 (45%), Gaps = 7/82 (8%)

Query: 41  HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSS 100
           +RDL   N+L+  +   +++DFG ++ V                 +  APE      ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL------CGTPEALAPEIILSKGYNK 217

Query: 101 ASDVWSFGITLWEMYSFGQQPY 122
           A D W+ G+ ++EM   G  P+
Sbjct: 218 AVDWWALGVLIYEMA-AGYPPF 238

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.5 bits (125), Expect = 1e-09
 Identities = 26/100 (26%), Positives = 44/100 (44%), Gaps = 8/100 (8%)

Query: 25  IPAKVCRYLK-MH-KSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           +  ++ + L+ +H     HRDL   N+ +    + KI DFGL+R  +SE      T    
Sbjct: 126 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVV 180

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                      N+ R++   D+WS G  + EM   G+  +
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTLF 219

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 52.3 bits (124), Expect = 1e-09
 Identities = 14/97 (14%), Positives = 34/97 (35%), Gaps = 3/97 (3%)

Query: 27  AKVCRYLKMHKSSFHRDLAARNILLASR-HQAKISDFGLSRAVNSERNYYKATHGGRWPI 85
                Y+       H D+   N+L+        +    ++   N+       T+  +   
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 86  KWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
            + +PE      +   +D+WS    ++E+ + G   +
Sbjct: 195 -YRSPEVLLGAPWGCGADIWSTACLIFELIT-GDFLF 229

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 49.5 bits (117), Expect = 1e-08
 Identities = 24/113 (21%), Positives = 48/113 (42%), Gaps = 9/113 (7%)

Query: 12  PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR-HQAKISDFGLSRAVNS 70
            L  Y + +   +I  K   Y        HRD+   N+++     + ++ D+GL+   + 
Sbjct: 125 TLTDYDIRFYMYEI-LKALDYCHSMGI-MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182

Query: 71  ERNYYKATHGGRWPIKWYAPESY-NFGRFSSASDVWSFGITLWEMYSFGQQPY 122
            + Y       R+   +  PE   ++  +  + D+WS G  L  M  F ++P+
Sbjct: 183 GQEYNV-RVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMI-FRKEPF 230

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.5 bits (117), Expect = 1e-08
 Identities = 26/100 (26%), Positives = 42/100 (42%), Gaps = 8/100 (8%)

Query: 25  IPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGR 82
           +  ++ R LK        HRDL   N+ +    + KI DFGL+R  + E   Y AT    
Sbjct: 126 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT---- 181

Query: 83  WPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                      N+  ++   D+WS G  + E+   G+  +
Sbjct: 182 -RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLF 219

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (107), Expect = 2e-07
 Identities = 24/101 (23%), Positives = 38/101 (37%), Gaps = 7/101 (6%)

Query: 24  QIPAKVCRYLKM--HKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
            +  ++   +K        HRDL   NI++ S    KI DFGL+R   +           
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP----Y 178

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPY 122
                + APE      +    D+WS G  + EM    +  +
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILF 218

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 35.5 bits (81), Expect = 6e-04
 Identities = 16/92 (17%), Positives = 32/92 (34%), Gaps = 9/92 (9%)

Query: 24  QIPAKVCRYLK-MHKSSF-HRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGG 81
           ++   +   +   +     H DL+  N+L+ S     I DF  S  V  E          
Sbjct: 107 EVLDMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERDV 165

Query: 82  RWPIKWYAPESYNFGRFSSASDVWSFGITLWE 113
           R  I +++        + +  D+ S    + +
Sbjct: 166 RNIITYFS------RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	129
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.97
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.97
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.97
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.97
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.96
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.96
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.96
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.96
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.96
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.96
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.96
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.96
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.96
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.96
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.96
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.96
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.96
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.96
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.96
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.95
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.95
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.95
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.95
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.95
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.95
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.95
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.95
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.95
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.95
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.95
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.95
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.95
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.95
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.94
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.94
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.94
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.94
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.94
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.94
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.93
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.93
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.93
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.93
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.93
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.93
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.93
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.93
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.93
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.92
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.92
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.92
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.92
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.92
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.92
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.92
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.92
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.9
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.89
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.89
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.89
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.84
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.36
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	92.38
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	89.12
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	87.45

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-31  Score=176.15  Aligned_cols=118  Identities=24%  Similarity=0.358  Sum_probs=99.0

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||||+++++...      +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++....... 
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi-~~al~~lH~-~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~-  161 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITEL-ANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-  161 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC-
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeeeeeccccceecCCCCEeecccceeeecCCCcc-
Confidence            899999997543      3344566789999 999999998 9999999999999999999999999999976543221 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                          ....+++.|+|||++.+..++.++|+||+|+++|++++ |+.||.+.+
T Consensus       162 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~  208 (263)
T d2j4za1         162 ----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANT  208 (263)
T ss_dssp             ----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCTTCCSS
T ss_pred             ----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhc-CCCCCCCCC
Confidence                11234567999999998889999999999999999999 999998754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.4e-31  Score=175.98  Aligned_cols=123  Identities=26%  Similarity=0.377  Sum_probs=99.5

Q ss_pred             CCCCCCCCccccCCC------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLGS------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||||+|++|...+..      .....++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++........
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi-~~al~ylH~-~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-MAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            899999998877654      2355689999 999999998 99999999999999999999999999999865322211


Q ss_pred             eeeccCCCCCceecccccccCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRF-SSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                       .......+++.|+|||++.+..+ +.++|+||+|+++|++++ |+.||...+.
T Consensus       160 -~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~-G~~pf~~~~~  211 (271)
T d1nvra_         160 -RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSD  211 (271)
T ss_dssp             -CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHH-SSCSCSSSST
T ss_pred             -ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHh-CCCCCCCCCh
Confidence             11122345678999999987776 467999999999999999 9999976543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4e-31  Score=176.62  Aligned_cols=120  Identities=24%  Similarity=0.422  Sum_probs=100.1

Q ss_pred             CCCCCCCCcccc-----CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTP-----LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      ||||+|++|...     +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++.........
T Consensus        96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi-~~aL~yLH~-~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  173 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTETCMDEGQIAAVCREC-LQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (293)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EEecCCCcHHHHhhccCCCHHHHHHHHHHH-HHHHHHHHH-CCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence            899999996644     3334567799999 999999998 999999999999999999999999999998754332211


Q ss_pred             eeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ....+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       174 ---~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~  220 (293)
T d1yhwa1         174 ---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNEN  220 (293)
T ss_dssp             ---CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHH-SSCTTTTSC
T ss_pred             ---cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhh-CCCCCCCCC
Confidence               22234567999999998889999999999999999999 999998654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.2e-32  Score=179.97  Aligned_cols=125  Identities=50%  Similarity=0.924  Sum_probs=102.7

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+++++|...+..       ..+..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++.......
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi-~~gL~ylH~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQV-SMGMKYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHH-HHHHHHHHh-CCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            899999997654322       2355688899 999999999 9999999999999999999999999999987654433


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .........+++.|+|||.+....++.++|+||+|+++||+++.|..||.+.+.
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~  218 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  218 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred             ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH
Confidence            333333334567899999998888999999999999999999768999998764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.5e-31  Score=178.20  Aligned_cols=120  Identities=23%  Similarity=0.405  Sum_probs=100.2

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|++|...      +.+...+.+++|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++........
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qi-l~al~ylH~-~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEI-VSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHH-HHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHH-hhhhhhhhh-cCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            799999997543      3344577899999 999999999 99999999999999999999999999999865332221


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         .....+++.|+|||.+.+..|+.++|+||+||++|+|++ |..||.+.+
T Consensus       162 ---~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~-G~~pf~~~~  209 (337)
T d1o6la_         162 ---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQD  209 (337)
T ss_dssp             ---BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             ---cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHH-CCCCCCCcC
Confidence               112234567999999999999999999999999999999 999998765

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.9e-31  Score=175.99  Aligned_cols=123  Identities=34%  Similarity=0.484  Sum_probs=94.6

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      ||||++++|...+..       ..+..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++.......
T Consensus        82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi-~~gl~yLH~-~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQT-AQGMDYLHA-KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHH-HHHHHHHhc-CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            799999997665422       2355588898 999999998 8999999999999999999999999999976532211


Q ss_pred             eeeeccCCCCCceecccccccC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNF---GRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      . .......+++.|+|||.+..   ..++.++|+||+|+++||+++ |+.||.+.++
T Consensus       160 ~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~t-g~~Pf~~~~~  214 (276)
T d1uwha_         160 S-HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINN  214 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCC
T ss_pred             c-ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHH-CCCCCCCCCh
Confidence            1 11122234678999998854   357889999999999999999 9999988664

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2e-31  Score=180.33  Aligned_cols=124  Identities=41%  Similarity=0.671  Sum_probs=100.0

Q ss_pred             CCCCCCCCccccCCC-----------------------------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEe
Q psy7529           1 MKSPNGSGVVTPLGS-----------------------------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILL   51 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~   51 (129)
                      ||||++++|.+.+..                             ..+..++.|+ +.|+.|||. ++|+||||||+||++
T Consensus       120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi-~~gl~yLH~-~~IiHRDlKp~Nill  197 (325)
T d1rjba_         120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV-AKGMEFLEF-KSCVHRDLAARNVLV  197 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH-HHHHHHHHH-TTEEETTCSGGGEEE
T ss_pred             EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeeccCchhcccc
Confidence            799999997665432                             2355588899 999999999 899999999999999


Q ss_pred             cCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          52 ASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        52 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      +.++.+|++|||+++.......... .....+++.|+|||.+....++.++|+||+|+++||+++.|..||.+.+.
T Consensus       198 ~~~~~~Kl~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         198 THGKVVKICDFGLARDIMSDSNYVV-RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             ETTTEEEECCCGGGSCGGGCTTSEE-ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             ccCCeEEEeeccccccccCCCceee-eccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999986543322111 11223456799999998889999999999999999999758999987654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2e-31  Score=176.92  Aligned_cols=125  Identities=49%  Similarity=0.890  Sum_probs=100.9

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+++++|...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        86 mE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi-~~gl~ylH~-~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQV-SMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             EECCTTEEHHHHHHHCTTCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             EEcCCCCcHHHHHhhccCCCHHHHHHHHHHH-HHHHhhHHh-CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            79999999765443      23455688899 999999998 89999999999999999999999999999876544333


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ........+++.|+|||.+....++.++|+||+|+++||+++.|+.||.+.+.
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~  216 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG  216 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH
Confidence            33333334567899999998888899999999999999999768999988653

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-30  Score=174.05  Aligned_cols=122  Identities=20%  Similarity=0.397  Sum_probs=98.0

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||||+|++|...      +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi-~~al~ylH~-~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEI-VSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHH-HHHHHhhcc-ccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            899999986543      3344567788999 999999999 99999999999999999999999999999865432211


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       .......+++.|+|||++.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       165 -~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~  214 (288)
T d1uu3a_         165 -ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGN  214 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             -cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhh-CCCCCCCcC
Confidence             11112234678999999998899999999999999999999 999998654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.8e-31  Score=175.53  Aligned_cols=121  Identities=24%  Similarity=0.426  Sum_probs=90.5

Q ss_pred             CCCCCCCCcccc----------CCCCchhhHHhHHHHHHHHHHhccC----CCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529           1 MKSPNGSGVVTP----------LGSYALPYIEGQIPAKVCRYLKMHK----SSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus         1 m~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~h~~~----~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      ||||++++|.+.          +.......++.|+ +.|+.|+|...    +++||||||+||+++.++.+|++|||+++
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi-~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL-TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHH-HHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHH-HHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            899999997654          3344566789999 99999999722    49999999999999999999999999998


Q ss_pred             cccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          67 AVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..........   ...+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       163 ~~~~~~~~~~---~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~t-g~~Pf~~~~  218 (269)
T d2java1         163 ILNHDTSFAK---AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA-LMPPFTAFS  218 (269)
T ss_dssp             HC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             ecccCCCccc---cCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhh-CCCCCCCCC
Confidence            7543222111   2233567999999988889999999999999999999 999998754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.4e-31  Score=179.00  Aligned_cols=120  Identities=28%  Similarity=0.402  Sum_probs=98.0

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|++|...+      .......++.|+ +.|+.|+|..++|+||||||+||+++.++.+|++|||+++....... 
T Consensus        83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi-l~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~-  160 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAV-IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-  160 (322)
T ss_dssp             EECCTTEEHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC-
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHH-HHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc-
Confidence            7999999976543      334466788999 99999999635899999999999999999999999999986532211 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                          ....+++.|+|||++.+..|+.++|+||+||+++++++ |+.||.+.+.
T Consensus       161 ----~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~-G~~Pf~~~~~  208 (322)
T d1s9ja_         161 ----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDA  208 (322)
T ss_dssp             -------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHH-SSCCSSCCCT
T ss_pred             ----ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCH
Confidence                11234567999999999899999999999999999999 9999976543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=4.6e-31  Score=176.77  Aligned_cols=125  Identities=41%  Similarity=0.709  Sum_probs=90.8

Q ss_pred             CCCCCCCCccccC-------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPL-------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      ||||++++|...+       ....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++.......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qi-a~gl~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI-AAGMKYLAD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHH-HHHHHHHhh-CCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence            7999999965432       233455688899 999999999 9999999999999999999999999999986543221


Q ss_pred             e--eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 Y--YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .  .....+..+++.|+|||.+....++.++|+||+|+++||+++.|+.||.+.+.
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~  239 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN  239 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence            1  11112223456799999998888999999999999999999768999987653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.2e-30  Score=168.51  Aligned_cols=118  Identities=27%  Similarity=0.401  Sum_probs=94.4

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCC--CccCCCCCCCEEec-CCCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKS--SFHRDLAARNILLA-SRHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~--~ihr~lk~~nil~~-~~~~~~l~d~~~~~~~~~~   71 (129)
                      ||||++++|.+.+.      ......++.|+ +.|+.|+|. ++  ++||||||+||+++ .++.+|++|||+++.....
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi-~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQI-LKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHH-HHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            79999999765443      23456688899 999999998 66  99999999999996 4789999999999754332


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ..  .   ...+++.|+|||.+.+ .++.++|+||+|+++|++++ |+.||.+.++
T Consensus       169 ~~--~---~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~-g~~Pf~~~~~  217 (270)
T d1t4ha_         169 FA--K---AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMAT-SEYPYSECQN  217 (270)
T ss_dssp             SB--E---ESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHH-SSCTTTTCSS
T ss_pred             cc--C---CcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHH-CCCCCCCccc
Confidence            11  1   1224567999998865 68999999999999999999 9999986543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-30  Score=174.04  Aligned_cols=124  Identities=39%  Similarity=0.633  Sum_probs=93.0

Q ss_pred             CCCCCCCCccccCC----------------------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEE
Q psy7529           1 MKSPNGSGVVTPLG----------------------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAK   58 (129)
Q Consensus         1 m~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~   58 (129)
                      ||||+++++.+.+.                      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.+|
T Consensus        97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi-~~gl~ylH~-~~ivHrDlKp~NILl~~~~~~K  174 (299)
T d1ywna1          97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV-AKGMEFLAS-RKCIHRDLAARNILLSEKNVVK  174 (299)
T ss_dssp             EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECGGGCEE
T ss_pred             EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHH-HHHHHHHHh-CCCcCCcCCccceeECCCCcEE
Confidence            78999999765542                      22355688899 999999998 9999999999999999999999


Q ss_pred             EEeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          59 ISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        59 l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ++|||+++......... ......+++.|+|||.+.+..++.++|+||+|+++|++++.+..||.+.+.
T Consensus       175 l~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         175 ICDFGLARDIYKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             ECC------CCSCTTSC-CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             EccCcchhhcccccccc-ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999998654322111 112223467799999998888999999999999999999844678877653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9e-31  Score=174.53  Aligned_cols=121  Identities=29%  Similarity=0.362  Sum_probs=96.9

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      ||||+++++...       +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++.......
T Consensus        88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi-~~gL~ylH~-~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQT-LDALNYLHD-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence            899999985443       3344567799999 999999998 9999999999999999999999999999875432111


Q ss_pred             eeeeccCCCCCceeccccccc-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYN-----FGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                         ......+++.|+|||.+.     ...|+.++|+||+|+++|++++ |..||.+.+.
T Consensus       166 ---~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemlt-g~~Pf~~~~~  220 (288)
T d2jfla1         166 ---RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE-IEPPHHELNP  220 (288)
T ss_dssp             ---HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHH-SSCTTTTSCG
T ss_pred             ---cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhh-CCCCCCCCCH
Confidence               111223456799999873     3457899999999999999999 9999987654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=7.6e-30  Score=174.81  Aligned_cols=119  Identities=24%  Similarity=0.378  Sum_probs=98.7

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|++|...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++..+.+|++|||+++......  
T Consensus        86 mE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi-~~aL~ylH~-~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~--  161 (364)
T d1omwa3          86 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEI-ILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  161 (364)
T ss_dssp             ECCCCSCBHHHHHHHHCSCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC--
T ss_pred             EEecCCCcHHHHHHhcccccHHHHHHHHHHH-HHHHHHHHH-CCccceeeccceeEEcCCCcEEEeeeceeeecCCCc--
Confidence            89999999776543      23466688898 999999999 999999999999999999999999999998654322  


Q ss_pred             eeeccCCCCCceecccccccC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNF-GRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                         .....+++.|+|||.+.. ..++.++|+||+||++|+|++ |..||.+.+.
T Consensus       162 ---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~  211 (364)
T d1omwa3         162 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKT  211 (364)
T ss_dssp             ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCSSCS
T ss_pred             ---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHh-CCCCCCCCCH
Confidence               122235678999999864 468999999999999999999 9999987654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=7.8e-30  Score=171.89  Aligned_cols=117  Identities=27%  Similarity=0.442  Sum_probs=97.4

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||||+|+++...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++....... 
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi-~~al~~lH~-~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~-  159 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-CLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-  159 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHH-HHHHHHHHT-TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC-
T ss_pred             eeecCCccccccccccccccccHHHHHHHHH-HHhhhhhcc-CcEEccccCchheeEcCCCCEEEecCccceEeccccc-
Confidence            89999998544332      23355688898 999999998 9999999999999999999999999999987543321 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                           ...+++.|+|||++.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       160 -----~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemlt-G~~Pf~~~~  205 (316)
T d1fota_         160 -----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDSN  205 (316)
T ss_dssp             -----CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSS
T ss_pred             -----cccCcccccCHHHHcCCCCCchhhccccchhHHHHHh-CCCCCCCcC
Confidence                 2234567999999988889999999999999999999 999998754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=7e-30  Score=171.52  Aligned_cols=119  Identities=24%  Similarity=0.366  Sum_probs=89.4

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEec---CCCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLA---SRHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~---~~~~~~l~d~~~~~~~~~~   71 (129)
                      ||||+|++|.+.+      .......++.|+ +.|+.|+|. ++++||||||+||++.   .++.+|++|||+++.....
T Consensus        86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi-~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKGFYTERDASRLIFQV-LDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             EeccCCCcHHHhhhcccCCCHHHHHHHHHHH-HHHHHhhhh-ceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            8999999976544      334566799999 999999998 9999999999999995   4678999999999765322


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ..    .....+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       164 ~~----~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~  213 (307)
T d1a06a_         164 SV----LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC-GYPPFYDEN  213 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             Ce----eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHh-CCCCCCCCC
Confidence            11    112234567999999998889999999999999999999 999998654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.96  E-value=9.3e-30  Score=173.70  Aligned_cols=119  Identities=20%  Similarity=0.314  Sum_probs=98.0

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEec--CCCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLA--SRHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~--~~~~~~l~d~~~~~~~~~~   71 (129)
                      ||||+|++|+..+.       +.....++.|+ +.||.|+|. ++++||||||+||+++  ..+.+|++|||+++.....
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi-~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQA-CEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            89999999765433       33456689999 999999998 9999999999999997  5678999999999876543


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .... ..   .+++.|+|||.+.+..++.++|+||+||++|+|++ |..||.+.+
T Consensus       183 ~~~~-~~---~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~  232 (352)
T d1koba_         183 EIVK-VT---TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGED  232 (352)
T ss_dssp             SCEE-EE---CSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSS
T ss_pred             Ccee-ec---cCcccccCHHHHcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Confidence            2221 11   23457999999998889999999999999999999 999998754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=2.5e-29  Score=171.41  Aligned_cols=117  Identities=22%  Similarity=0.353  Sum_probs=98.3

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+.|+++...      +.......++.|+ +.||.|+|. ++++||||||+||+++.++.+|++|||+++....... 
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi-~~aL~yLH~-~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~-  196 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQI-VLTFEYLHS-LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-  196 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC-
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHH-HHHHHHHHh-CCEecCcCCHHHcccCCCCCEEeeeceeeeecccccc-
Confidence            688888885444      3344577799999 999999998 9999999999999999999999999999987643321 


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                           ...+++.|+|||++.+..++.++|+||+||++|++++ |..||.+.+
T Consensus       197 -----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~  242 (350)
T d1rdqe_         197 -----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQ  242 (350)
T ss_dssp             -----CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             -----cccCccccCCHHHHcCCCCCccccccchhHHHHHHHh-CCCCCCCcC
Confidence                 1234567999999998889999999999999999999 999998654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=9.2e-30  Score=172.73  Aligned_cols=119  Identities=22%  Similarity=0.432  Sum_probs=97.5

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC---CCcEEEEeecCccccc
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS---RHQAKISDFGLSRAVN   69 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~---~~~~~l~d~~~~~~~~   69 (129)
                      ||||+|++|++.+.        +.....++.|+ +.|+.|+|. ++++||||||+||+++.   .+.+|++|||+++...
T Consensus        88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi-~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~  165 (335)
T d2ozaa1          88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSI-GEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  165 (335)
T ss_dssp             EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred             EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHH-HHHHHHHHH-cCCccccccccccccccccccccccccccceeeecc
Confidence            89999999766543        33466799999 999999998 99999999999999975   4569999999998654


Q ss_pred             CCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          70 SERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....    .....+++.|+|||.+.+..|+.++|+||+|+++|++++ |..||.+.+
T Consensus       166 ~~~~----~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~llt-g~~Pf~~~~  217 (335)
T d2ozaa1         166 SHNS----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNH  217 (335)
T ss_dssp             CCCC----CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTT-SSCSCEETT
T ss_pred             CCCc----cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhh-CCCCCCCCC
Confidence            3221    112234567999999988889999999999999999998 999997654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.3e-29  Score=168.07  Aligned_cols=120  Identities=27%  Similarity=0.379  Sum_probs=99.8

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+++++|...+.      +.....++.|+ +.|+.|+|. ++++|||+||+||+++..++++++|||+++........
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi-~~al~ylH~-~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEI-ILGLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHH-HHHHHHHHh-CCeeeccCcccceeecCCCceeccccchhhhccccccc
Confidence            79999999765443      33467788999 999999999 89999999999999999999999999999865432221


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   ....+++.|+|||.+.+..++.++|+||+||++|++++ |+.||.+.+
T Consensus       160 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemlt-G~~PF~~~~  207 (320)
T d1xjda_         160 T---NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPFHGQD  207 (320)
T ss_dssp             B---CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             c---cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCC
Confidence            1   12234567999999999899999999999999999999 999998754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.6e-29  Score=166.19  Aligned_cols=121  Identities=39%  Similarity=0.677  Sum_probs=96.0

Q ss_pred             CCCCCCCCccccCCC--------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLGS--------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...+..        ..+..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++......
T Consensus        86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi-~~gl~~lH~-~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI-AEGMAFIEE-RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHH-HHHHHHHHh-CCcccCccchhheeeecccceeeccccceEEccCCc
Confidence            799999997664432        3355688898 999999999 999999999999999999999999999998764322


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .  .......+++.|+|||.+....++.++|+||+|+++||+++.+.+||...
T Consensus       164 ~--~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~  214 (272)
T d1qpca_         164 Y--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM  214 (272)
T ss_dssp             E--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             c--ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence            1  12223334567999999988888999999999999999998344555543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.9e-29  Score=166.20  Aligned_cols=123  Identities=41%  Similarity=0.715  Sum_probs=87.4

Q ss_pred             CCCCCCCCccc-------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVT-------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++.+..       .+....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++.......
T Consensus        88 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i-~~gl~~lH~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          88 TEYMENGALDKFLREKDGEFSVLQLVGMLRGI-AAGMKYLAN-MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             EEecccCcchhhhhcccccccHHHHHHHHHHH-HHhhhhccc-cccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence            67787776433       22333455688888 999999999 9999999999999999999999999999986543222


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .........++..|+|||.+....++.++|+||+|+++||+++.+.+||.+.
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~  217 (283)
T d1mqba_         166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL  217 (283)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC
Confidence            1112223334567999999988899999999999999999998334445443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.95  E-value=2.9e-29  Score=171.14  Aligned_cols=119  Identities=21%  Similarity=0.328  Sum_probs=97.2

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC--CCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS--RHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~--~~~~~l~d~~~~~~~~~~   71 (129)
                      |||++|++|...+.       ......++.|+ +.||.|+|. ++++||||||+||+++.  ++.+|++|||+++.....
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi-~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQV-CKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHH-HHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            89999999765542       23466689999 999999999 99999999999999954  578999999999876543


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .... ..   .+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+
T Consensus       180 ~~~~-~~---~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~  229 (350)
T d1koaa2         180 QSVK-VT---TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGEN  229 (350)
T ss_dssp             SCEE-EE---CSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             cccc-ee---cCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHh-CCCCCCCCC
Confidence            2221 11   23457999999988889999999999999999999 999998654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2e-29  Score=166.00  Aligned_cols=122  Identities=35%  Similarity=0.656  Sum_probs=88.5

Q ss_pred             CCCCCCCCccccCCCC-------chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGSY-------ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+++++|...+...       .+..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++.......
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi-a~gl~~lH~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV-CEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHH-HHHHHhhhc-cceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            7999999866544321       244588888 999999999 9999999999999999999999999999986543221


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .  ......++..|+|||.+....++.++|+||+|+++||+++.|.+||...+
T Consensus       157 ~--~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~  207 (263)
T d1sm2a_         157 T--SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS  207 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC
T ss_pred             e--eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC
Confidence            1  11222345679999999988999999999999999999984566666543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=4.4e-29  Score=167.73  Aligned_cols=116  Identities=29%  Similarity=0.415  Sum_probs=95.2

Q ss_pred             CCCCCCCCcc------ccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVV------TPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      ||||+++.+.      .++....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++......  
T Consensus        94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi-~~aL~yLH~-~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~--  169 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGA-LQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN--  169 (309)
T ss_dssp             EECCSEEHHHHHHHHTSCCCHHHHHHHHHHH-HHHHHHHHH-TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC--
T ss_pred             EEecCCCchHHHHHhCCCCCHHHHHHHHHHH-HHHHHHHHh-CCEeccCCCcceEEECCCCCEEEeecccccccCCCC--
Confidence            7899888743      234445577799999 999999999 999999999999999999999999999997643321  


Q ss_pred             eeeccCCCCCceecccccccC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNF---GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~---~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                           ...+++.|+|||.+.+   ..|+.++|+||+|+++|++++ |..||.+.+
T Consensus       170 -----~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~-g~~Pf~~~~  218 (309)
T d1u5ra_         170 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMN  218 (309)
T ss_dssp             -----CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSC
T ss_pred             -----ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHH-CCCCCCCCC
Confidence                 2234567999998853   357889999999999999999 999998654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.95  E-value=2.9e-29  Score=166.28  Aligned_cols=123  Identities=21%  Similarity=0.361  Sum_probs=93.9

Q ss_pred             CCCCCCCCcccc------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTP------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||++|+++...      +.......++.|+ +.|+.|+|. ++++||||||+||+++.++..+++|||..+........
T Consensus        90 mE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi-~~al~~lH~-~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~  167 (277)
T d1o6ya_          90 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADA-CQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS  167 (277)
T ss_dssp             EECCCEEEHHHHHHHHCSCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEEETTSCEEECCCTTCEECC-----
T ss_pred             EECCCCCEehhhhcccCCCCHHHHHHHHHHH-HHHHHHHHh-CCccCccccCcccccCccccceeehhhhhhhhcccccc
Confidence            789999885533      3334466789999 999999998 99999999999999999999999999988754322221


Q ss_pred             eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ........+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       168 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~  218 (277)
T d1o6ya_         168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDS  218 (277)
T ss_dssp             -----------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHh-CCCCCCCcC
Confidence            112222234567999999988889999999999999999999 999998654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.95  E-value=6.3e-29  Score=165.49  Aligned_cols=118  Identities=39%  Similarity=0.658  Sum_probs=94.1

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      ||||+++++...+.        ...+..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++......
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi-~~gL~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI-SSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHH-HHHHHHHHH-CCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            79999998655432        22355688899 999999999 899999999999999999999999999998654332


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYG  123 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~  123 (129)
                      ..  ......++..|+|||.+....++.++|+||+|+++|++++ +..||.
T Consensus       170 ~~--~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~-~~~p~~  217 (287)
T d1opja_         170 YT--AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPY  217 (287)
T ss_dssp             SE--EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT-TSCCSS
T ss_pred             ce--eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHh-CCCCCC
Confidence            21  1222234567999999988899999999999999999998 655543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.7e-29  Score=165.56  Aligned_cols=124  Identities=40%  Similarity=0.647  Sum_probs=98.6

Q ss_pred             CCCCCCCCccc-------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVT-------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++..       .+....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++.......
T Consensus        89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi-~~gl~ylH~-~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~  166 (273)
T d1u46a_          89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV-AEGMGYLES-KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD  166 (273)
T ss_dssp             EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred             eeeecCcchhhhhhcccCCCCHHHHHHHHHHH-HHHHHHhhh-CCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence            68888888553       34555677789999 999999999 9999999999999999999999999999987644332


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .........++..|+|||.+.+..++.++|+||+|+++||++++|..||.+.+
T Consensus       167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~  219 (273)
T d1u46a_         167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN  219 (273)
T ss_dssp             EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence            22222222335679999999888889999999999999999976899998765

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.6e-28  Score=161.95  Aligned_cols=119  Identities=22%  Similarity=0.213  Sum_probs=95.5

Q ss_pred             CCCCCCCCcc------ccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVV------TPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+.++.+.      ..+....+..++.|+ +.|+.|+|. ++++||||||+||+++..+.+|++|||+++........
T Consensus        79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qi-l~aL~~lH~-~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMT-LQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             EECCSEEHHHHHTTCCSSCCSSHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             hhhhcchHHhhhhhcccCCCHHHHHHHHHHH-HHHHHHhhc-cceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            6788776633      235556678899999 999999999 99999999999999999999999999999765433222


Q ss_pred             eeeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      .   ....+++.|+|||.+... .++.++|+||+||+++++++ |..||.+.
T Consensus       157 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~-g~~pf~~~  204 (299)
T d1ua2a_         157 Y---THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGD  204 (299)
T ss_dssp             C---CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH-SSCSSCCS
T ss_pred             c---cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHh-CcCCCCCC
Confidence            1   122335669999988654 57899999999999999999 99999754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.8e-28  Score=162.03  Aligned_cols=119  Identities=25%  Similarity=0.351  Sum_probs=97.3

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC----cEEEEeecCcccccC
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH----QAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~----~~~l~d~~~~~~~~~   70 (129)
                      ||||+|++|...+      .......++.|+ +.|+.|+|. ++++||||||+||+++..+    .+|++|||+++....
T Consensus        92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi-~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          92 LELVAGGELFDFLAEKESLTEEEATEFLKQI-LNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEcCCCccccchhccccccchhHHHHHHHHH-HHHHHhhhh-cceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            7999999976543      334567789999 999999998 9999999999999998765    589999999876543


Q ss_pred             CCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ...    .....+++.|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       170 ~~~----~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~  220 (293)
T d1jksa_         170 GNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDT  220 (293)
T ss_dssp             SCB----CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             Ccc----ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHc-CCCCCCCCC
Confidence            221    112234567999999988889999999999999999999 999998754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5e-28  Score=162.01  Aligned_cols=119  Identities=23%  Similarity=0.331  Sum_probs=95.0

Q ss_pred             CCCCCCCCcc-------ccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVV-------TPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++.+.       ..+.......++.|+ +.|+.|+|. ++++||||||+||+++..+.++++|||+++...... 
T Consensus        94 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi-~~aL~yLH~-~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~-  170 (305)
T d1blxa_          94 FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL-LRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-  170 (305)
T ss_dssp             EECCSCBHHHHHHHSCTTCSCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG-
T ss_pred             EEeccCCchhhhhhccCCCCCHHHHHHHHHHH-HHHHHHHHh-CCEEecCCCccEEEEcCCCCeeecchhhhhhhcccc-
Confidence            5777776532       122333466789999 999999999 999999999999999999999999999987543221 


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ......+++.|+|||.+.+..++.++|+||+||+++++++ |..||.+.+
T Consensus       171 ---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~-g~~pf~~~~  219 (305)
T d1blxa_         171 ---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSS  219 (305)
T ss_dssp             ---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             ---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHH-CCCCCCCCC
Confidence               1122334567999999998899999999999999999999 999998654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.2e-28  Score=163.01  Aligned_cols=124  Identities=40%  Similarity=0.689  Sum_probs=90.1

Q ss_pred             CCCCCCCCcccc-------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTP-------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++++...       +.......++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++.......
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi-~~gl~ylH~-~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQL-STALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHH-HHHhhhhcc-cCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence            789999886542       2233466688888 999999999 9999999999999999999999999999976543221


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKGS  128 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~~  128 (129)
                      .  ......+++.|+|||.+....++.++|+||+|+++||+++.|..||.+.+..
T Consensus       164 ~--~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~  216 (273)
T d1mp8a_         164 Y--KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN  216 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             e--eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH
Confidence            1  1112234567999999988889999999999999999997688999877643

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.5e-28  Score=165.62  Aligned_cols=124  Identities=38%  Similarity=0.642  Sum_probs=95.1

Q ss_pred             CCCCCCCCccc-------cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVT-------PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      ||++.++++..       .+....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++.......
T Consensus        89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi-~~gl~yLH~-~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-AKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred             EEeccCCcccccccccccCCCHHHHHHHHHHH-HHHHHHHHH-cCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence            46666776433       22233456688899 999999999 8999999999999999999999999999986543222


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      . .......++..|+|||.+.+..++.++|+||+|+++||+++.|..||.+.+.
T Consensus       167 ~-~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~  219 (317)
T d1xkka_         167 E-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA  219 (317)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG
T ss_pred             c-ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH
Confidence            1 1112223456799999998888999999999999999999867899987654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.7e-28  Score=159.58  Aligned_cols=123  Identities=35%  Similarity=0.691  Sum_probs=98.0

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||++++.+...+.       ...+..++.|+ ++|+.|+|. ++++|||||++||+++.++.+|++|||+++.......
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi-~~gl~~LH~-~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDV-CEAMEYLES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHH-HHHHHHHHH-TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHH-HHHHHHHhh-cCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            78888887544322       23455678888 999999999 8999999999999999999999999999976543221


Q ss_pred             eeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .  ......++..|+|||.+....++.++|+||+|+++||+++.|+.||.+.+.
T Consensus       156 ~--~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~  207 (258)
T d1k2pa_         156 T--SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN  207 (258)
T ss_dssp             C--CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred             e--eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH
Confidence            1  122233456799999998888999999999999999999767999987654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.5e-27  Score=160.97  Aligned_cols=119  Identities=23%  Similarity=0.410  Sum_probs=96.1

Q ss_pred             CCCCCCCCccccCC-------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC--CcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSGVVTPLG-------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR--HQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~--~~~~l~d~~~~~~~~~~   71 (129)
                      ||||+|++|...+.       +.....++.|+ +.|+.|+|. ++++||||||+||+++.+  ..++++|||+++.....
T Consensus        80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi-~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          80 FEFISGLDIFERINTSAFELNEREIVSYVHQV-CEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHH-HHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            89999999766543       23456688999 999999998 899999999999999754  47899999998765432


Q ss_pred             CceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          72 RNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ... ...   .+++.|++||...+..++.++|+||+|+++|++++ |..||.+.+
T Consensus       158 ~~~-~~~---~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~-G~~Pf~~~~  207 (321)
T d1tkia_         158 DNF-RLL---FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAET  207 (321)
T ss_dssp             CEE-EEE---ESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH-SSCTTCCSS
T ss_pred             Ccc-ccc---ccccccccchhccCCCCCchhhcccHHHHHHHHHh-CCCCCCCCC
Confidence            211 111   23456999999988889999999999999999998 999998754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.2e-27  Score=160.00  Aligned_cols=123  Identities=38%  Similarity=0.670  Sum_probs=98.7

Q ss_pred             CCCCCCCCccccC----------------------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEE
Q psy7529           1 MKSPNGSGVVTPL----------------------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAK   58 (129)
Q Consensus         1 m~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~   58 (129)
                      |||++++++...+                      ....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|
T Consensus        98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi-~~al~ylH~-~~ivHrDiKp~NiLl~~~~~~k  175 (299)
T d1fgka_          98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV-ARGMEYLAS-KKCIHRDLAARNVLVTEDNVMK  175 (299)
T ss_dssp             ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECTTCCEE
T ss_pred             EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHH-HHHHHHhhh-CCEEeeeecccceeecCCCCeE
Confidence            7999999865544                      223356688888 999999999 9999999999999999999999


Q ss_pred             EEeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          59 ISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        59 l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++|||+++......... ......+++.|+|||.+....++.++|+||+|+++|++++.|..||.+.+
T Consensus       176 l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         176 IADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             ECSTTCCCCGGGCCTTC-CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eccchhhcccccccccc-ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence            99999998654332211 11222345679999999888999999999999999999975688887654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.94  E-value=4.3e-27  Score=155.89  Aligned_cols=119  Identities=23%  Similarity=0.351  Sum_probs=96.5

Q ss_pred             CCCCCCCCccccC------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPL------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+++++|...+      .......++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++........
T Consensus        89 mE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi-~~al~~lH~-~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~  166 (277)
T d1phka_          89 FDLMKKGELFDYLTEKVTLSEKETRKIMRAL-LEVICALHK-LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL  166 (277)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCB
T ss_pred             EEcCCCchHHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHH-cCCcccccccceEEEcCCCCeEEccchheeEccCCCce
Confidence            8999999975444      345577799999 999999998 99999999999999999999999999999865432211


Q ss_pred             eeeccCCCCCceecccccccC------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNF------GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~------~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                          ....++..|++||.+..      ..++.++|+||+|++++++++ |..||.+.+
T Consensus       167 ----~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~-g~~Pf~~~~  219 (277)
T d1phka_         167 ----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRK  219 (277)
T ss_dssp             ----CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             ----eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhcc-CCCCCCCCC
Confidence                12234567999997642      346789999999999999999 999998754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.94  E-value=5.5e-28  Score=161.80  Aligned_cols=107  Identities=41%  Similarity=0.712  Sum_probs=85.4

Q ss_pred             chhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccccccCC
Q psy7529          17 ALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFG   96 (129)
Q Consensus        17 ~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   96 (129)
                      ....++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++...+..... ......+++.|+|||.+...
T Consensus       141 ~~~~i~~qi-~~gl~ylH~-~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~  217 (301)
T d1lufa_         141 EQLCIARQV-AAGMAYLSE-RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK-ADGNDAIPIRWMPPESIFYN  217 (301)
T ss_dssp             HHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC-----CCBCGGGCCHHHHHHC
T ss_pred             HHHHHHHHH-HHHhhhccc-CCeEeeEEcccceEECCCCcEEEccchhheeccCCcccc-ccCCCCcCcCcCCHHHHccC
Confidence            355578888 999999998 999999999999999999999999999997653322111 11122335679999999988


Q ss_pred             CCCChhhHHHHHHHHHHHHhCC-CCCCCCCCC
Q psy7529          97 RFSSASDVWSFGITLWEMYSFG-QQPYGEMKG  127 (129)
Q Consensus        97 ~~~~~~di~s~g~~l~~l~~~~-~~pf~~~~~  127 (129)
                      .++.++|+||+|+++||+++ + ..||.+.+.
T Consensus       218 ~~t~ksDVwS~Gvvl~ell~-~~~~p~~~~~~  248 (301)
T d1lufa_         218 RYTTESDVWAYGVVLWEIFS-YGLQPYYGMAH  248 (301)
T ss_dssp             CCCHHHHHHHHHHHHHHHHT-TTCCTTTTSCH
T ss_pred             CCChhhhhccchhhHHHHHc-cCCCCCCCCCH
Confidence            99999999999999999998 6 568877653

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=6.6e-27  Score=159.09  Aligned_cols=123  Identities=25%  Similarity=0.352  Sum_probs=94.9

Q ss_pred             CCCCCCCCccccC-----CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPL-----GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |+++.+++|++.+     ....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++.........
T Consensus        89 ~~~~~~g~L~~~l~~~~l~~~~i~~i~~qi-l~al~yLH~-~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~  166 (345)
T d1pmea_          89 VTHLMGADLYKLLKTQHLSNDHICYFLYQI-LRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT  166 (345)
T ss_dssp             EEECCCEEHHHHHHHCCCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred             EEeecCCchhhhhhcCCCCHHHHHHHHHHH-HHHHHHHHH-CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence            3556676655433     334566799999 999999998 999999999999999999999999999997653322221


Q ss_pred             eeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .......+++.|+|||.+... .++.++|+||+|++++++++ |..||.+.+
T Consensus       167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~-g~~pf~~~~  217 (345)
T d1pmea_         167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFPGKH  217 (345)
T ss_dssp             CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhh-CCCCCCCCC
Confidence            122223345679999987544 57889999999999999998 999997654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.93  E-value=6e-27  Score=156.46  Aligned_cols=124  Identities=20%  Similarity=0.244  Sum_probs=93.9

Q ss_pred             CCCCCCCC------ccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC---CCcEEEEeecCcccccCC
Q psy7529           1 MKSPNGSG------VVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS---RHQAKISDFGLSRAVNSE   71 (129)
Q Consensus         1 m~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~---~~~~~l~d~~~~~~~~~~   71 (129)
                      |||+.++.      ....+....+..++.|+ +.|+.|+|. ++++||||||+||++..   ...++++|||+++.....
T Consensus        82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi-~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQM-ISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             EECCCCBHHHHHHHTTTCCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             EEEcCCchhhhhhhccCCCcHHHHHHHHHHH-HHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            56665443      12234445567788899 999999999 99999999999998753   456999999999875432


Q ss_pred             Cce----eeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          72 RNY----YKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        72 ~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ...    ........+++.|+|||.+.+..++.++|+||+|++++++++ |+.||...+.
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~t-g~~P~~~~~~  218 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLKA  218 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHH-SSCTTCCCC-
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHh-CCCcccccch
Confidence            211    111122235678999999998889999999999999999999 9999987654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.93  E-value=2.3e-26  Score=153.35  Aligned_cols=110  Identities=15%  Similarity=0.182  Sum_probs=87.9

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecC-----CCcEEEEeecCcccccCCCcee----eeccCCCCCc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLAS-----RHQAKISDFGLSRAVNSERNYY----KATHGGRWPI   85 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~-----~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~~   85 (129)
                      ......++.|+ +.|+.|+|. ++++||||||+||+++.     .+.++++|||+++.........    .......+|+
T Consensus       100 ~~~~~~i~~q~-~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~  177 (293)
T d1csna_         100 VKTVAMAAKQM-LARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA  177 (293)
T ss_dssp             HHHHHHHHHHH-HHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred             hHHHHHHHHHH-HHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEch
Confidence            34456688888 999999999 99999999999999964     5679999999998754322111    1111223567


Q ss_pred             eecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          86 KWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        86 ~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .|+|||.+.+..++.++|+||+|++++++++ |..||...+.
T Consensus       178 ~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~Pf~~~~~  218 (293)
T d1csna_         178 RYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKA  218 (293)
T ss_dssp             TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCS
T ss_pred             hhcCHHHhcCCCCChHHHHHHhhHHHHHHHh-CCCcCCCccc
Confidence            8999999998889999999999999999999 9999986554

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=7.2e-27  Score=156.12  Aligned_cols=120  Identities=22%  Similarity=0.266  Sum_probs=93.8

Q ss_pred             CCCCCCCCc-------cccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGV-------VTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      |||+.++.+       ...+....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||.++.......
T Consensus        80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qi-l~~L~yLH~-~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQL-LQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             EeecCCchhhhhhhhcccCCCHHHHHHHHHHH-HHHHHHhhc-CCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            567766531       2234455677799999 999999998 9999999999999999999999999999976543322


Q ss_pred             eeeeccCCCCCceecccccccCCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          74 YYKATHGGRWPIKWYAPESYNFGR-FSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        74 ~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .   .....+++.|++||.+.... ++.++|+||+|+++|++++ |+.||.+.+
T Consensus       158 ~---~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~-G~~Pf~~~~  207 (298)
T d1gz8a_         158 T---YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDS  207 (298)
T ss_dssp             C---TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             c---ceeecccceeeehhhhccccCCCccccccccchhhhHHhh-CCCCCCCCC
Confidence            1   11223456799999876665 4789999999999999999 999997643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=9.4e-27  Score=154.77  Aligned_cols=120  Identities=38%  Similarity=0.609  Sum_probs=90.0

Q ss_pred             CCCCCCCCcccc--------CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTP--------LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++...        +....+..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|++|||+++......
T Consensus        90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i-~~gl~~LH~-~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI-ASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEecCCCchhhhhhhcccccchHHHHHHHHHHH-HHHHHHHhh-hheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            799999884433        3334566688888 999999999 899999999999999999999999999997653222


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ..  ......++..|+|||.+....++.++|+||+|+++|++++.+.+||..
T Consensus       168 ~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~  217 (285)
T d1fmka3         168 YT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  217 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             ce--eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence            11  112223456799999998888999999999999999999833444444

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.6e-27  Score=155.00  Aligned_cols=116  Identities=22%  Similarity=0.364  Sum_probs=90.1

Q ss_pred             CCCCCCC-Ccc------ccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCC-CcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGS-GVV------TPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASR-HQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~-~~~------~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~-~~~~l~d~~~~~~~~~~~   72 (129)
                      |||+.++ .+.      ..+.......++.|+ +.|+.|+|. ++++||||||+||+++.+ +.++++|||+++......
T Consensus        88 ~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi-~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~  165 (273)
T d1xwsa_          88 LERPEPVQDLFDFITERGALQEELARSFFWQV-LEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV  165 (273)
T ss_dssp             EECCSSEEEHHHHHHHHCSCCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC
T ss_pred             EEeccCcchHHHHHhccCCCCHHHHHHHHHHH-HHHHHHHHH-CCCccccCcccceEEecCCCeEEECccccceeccccc
Confidence            5677653 322      234445567789999 999999999 999999999999999854 689999999997643321


Q ss_pred             ceeeeccCCCCCceecccccccCCCC-CChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRF-SSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      .     ....+++.|+|||.+.+..+ +.++|+||+|+++|++++ |..||.+
T Consensus       166 ~-----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~  212 (273)
T d1xwsa_         166 Y-----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC-GDIPFEH  212 (273)
T ss_dssp             B-----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCS
T ss_pred             c-----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhh-CCCCCCC
Confidence            1     12234567999999877665 567899999999999999 9999975

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=6.4e-27  Score=157.23  Aligned_cols=124  Identities=40%  Similarity=0.635  Sum_probs=97.3

Q ss_pred             CCCCCCCCccccC------------------------CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCc
Q psy7529           1 MKSPNGSGVVTPL------------------------GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQ   56 (129)
Q Consensus         1 m~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~   56 (129)
                      ||||+++++...+                        .......++.|+ +.|+.|+|. ++++||||||+||+++..+.
T Consensus       106 mE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi-~~gl~~LH~-~~ivHrDLKp~NIl~~~~~~  183 (311)
T d1t46a_         106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQV-AKGMAFLAS-KNCIHRDLAARNILLTHGRI  183 (311)
T ss_dssp             EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEEETTTE
T ss_pred             EEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHH-HHHHHHHHh-CCeeecccccccccccccCc
Confidence            7888888754443                        233456688898 999999999 99999999999999999999


Q ss_pred             EEEEeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          57 AKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        57 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ++++|||.++........ .......+++.|+|||.+....++.++|+||+|+++|++++.|.+||...+.
T Consensus       184 ~ki~DfG~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         184 TKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             EEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccchheeccCCCcc-eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            999999999865433221 1122233467899999998888999999999999999999845666666543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.4e-27  Score=157.13  Aligned_cols=122  Identities=21%  Similarity=0.279  Sum_probs=92.4

Q ss_pred             CCCCCCCCccccCCCC-----chhhHHhHHHHHHHHHHhc-------cCCCccCCCCCCCEEecCCCcEEEEeecCcccc
Q psy7529           1 MKSPNGSGVVTPLGSY-----ALPYIEGQIPAKVCRYLKM-------HKSSFHRDLAARNILLASRHQAKISDFGLSRAV   68 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~~h~-------~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~   68 (129)
                      |||+++++|...+...     .+..++.|+ +.|+.|+|.       .++++||||||+||+++.++.+|++|||+++..
T Consensus        80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~i-a~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHH-HHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             EecccCCCHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            7999999976665532     234578888 999999996       268999999999999999999999999999875


Q ss_pred             cCCCceee-eccCCCCCceecccccccCCC------CCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          69 NSERNYYK-ATHGGRWPIKWYAPESYNFGR------FSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        69 ~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~------~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ........ ......+++.|+|||.+....      ++.++|+||+|+++||+++ |..||..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~t-g~~~~~~  220 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGI  220 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH-TBCBTTB
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhh-CCCCCCc
Confidence            43322211 112233567899999876532      4568999999999999999 8877754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=7.5e-27  Score=153.61  Aligned_cols=119  Identities=40%  Similarity=0.712  Sum_probs=92.4

Q ss_pred             CCCCCCCCccccCC--------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCC
Q psy7529           1 MKSPNGSGVVTPLG--------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSER   72 (129)
Q Consensus         1 m~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~   72 (129)
                      |||++++++.+.+.        ...+..++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++......
T Consensus        80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i-~~al~ylH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~  157 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV-CEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  157 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHH-Hhhcccccc-CceeccccchHhheecCCCCEeecccccceecCCCC
Confidence            78999999765543        23355688888 999999999 999999999999999999999999999987643322


Q ss_pred             ceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          73 NYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        73 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ..      ...+..|+|||.+.+..++.++|+||+|+++||+++.|..||...+.
T Consensus       158 ~~------~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~  206 (262)
T d1byga_         158 DT------GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL  206 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred             cc------ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH
Confidence            11      12235699999998888999999999999999999757888887654

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.92  E-value=7e-26  Score=152.93  Aligned_cols=119  Identities=18%  Similarity=0.297  Sum_probs=95.4

Q ss_pred             CCCCCCCCccccCC---CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC-cEEEEeecCcccccCCCceee
Q psy7529           1 MKSPNGSGVVTPLG---SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH-QAKISDFGLSRAVNSERNYYK   76 (129)
Q Consensus         1 m~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~   76 (129)
                      |||++++++....+   ...++.++.|+ +.||.|||. ++|+||||||+||+++..+ .++++|||+++.......   
T Consensus       111 ~e~~~~~~L~~~~~~l~e~~i~~i~~qi-l~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---  185 (328)
T d3bqca1         111 FEHVNNTDFKQLYQTLTDYDIRFYMYEI-LKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---  185 (328)
T ss_dssp             EECCCSCBGGGTTTSCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---
T ss_pred             EeecCCCcHHHHhcCCCHHHHHHHHHHH-HHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccCCCc---
Confidence            78999998766444   44577799999 999999998 9999999999999998765 589999999976543221   


Q ss_pred             eccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          77 ATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        77 ~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       .....++..|+|||.+.+. .++.++|+||+|++++++++ |..||....
T Consensus       186 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~-g~~pf~~~~  234 (328)
T d3bqca1         186 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF-RKEPFFHGH  234 (328)
T ss_dssp             -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-TCSSSSCCS
T ss_pred             -ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhcc-CCCCCCCCc
Confidence             1122235679999987765 47899999999999999998 999987643

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=9.3e-27  Score=156.25  Aligned_cols=124  Identities=35%  Similarity=0.657  Sum_probs=97.5

Q ss_pred             CCCCCCCCccccCC----------------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecC
Q psy7529           1 MKSPNGSGVVTPLG----------------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGL   64 (129)
Q Consensus         1 m~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~   64 (129)
                      |||++++++...+.                ...+..++.|+ ++|+.|+|. ++++|||||++||+++.+..+|++|||+
T Consensus       102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i-a~gl~~LH~-~~ivHrDlk~~NiLld~~~~~Kl~DFGl  179 (308)
T d1p4oa_         102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI-ADGMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGM  179 (308)
T ss_dssp             EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHH-HHHHHHHHH-TTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHH-HHHHHHHhh-CCeeeceEcCCceeecCCceEEEeeccc
Confidence            68888888655432                22345578888 999999999 8999999999999999999999999999


Q ss_pred             cccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          65 SRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      ++........ .......+++.|++||.+.+..++.++|+||+|+++||+++.+.+||.+.+.
T Consensus       180 a~~~~~~~~~-~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~  241 (308)
T d1p4oa_         180 TRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN  241 (308)
T ss_dssp             CCGGGGGGCE-EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred             ceeccCCcce-eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH
Confidence            9865433221 1122223457799999998888999999999999999999933688887653

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=4.1e-26  Score=153.31  Aligned_cols=121  Identities=33%  Similarity=0.531  Sum_probs=94.1

Q ss_pred             CCCCCCCCccccCCC-------CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCc
Q psy7529           1 MKSPNGSGVVTPLGS-------YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERN   73 (129)
Q Consensus         1 m~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~   73 (129)
                      ||||+++++...+..       ..+..++.|+ +.|+.|+|. ++++|||||++||+++.+..+|++|||+++.......
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qi-a~gL~~lH~-~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV-AKGMKFLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHH-HHhhhhhcc-cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            789999986543321       2345688888 999999998 9999999999999999999999999999986543322


Q ss_pred             eee-eccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q psy7529          74 YYK-ATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGE  124 (129)
Q Consensus        74 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~  124 (129)
                      ... ......++..|++||.+....++.++|+||+|+++||+++ +..||..
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t-~~~p~~~  236 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYP  236 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT-TSCCSCC
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHH-CCCCCCC
Confidence            111 1112234567999999888889999999999999999998 6666543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=4.9e-26  Score=155.02  Aligned_cols=119  Identities=22%  Similarity=0.241  Sum_probs=91.9

Q ss_pred             CCCCCCCC---c------cccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC-cEEEEeecCcccccC
Q psy7529           1 MKSPNGSG---V------VTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH-QAKISDFGLSRAVNS   70 (129)
Q Consensus         1 m~~~~~~~---~------~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~-~~~l~d~~~~~~~~~   70 (129)
                      |||+.++.   +      ...+....+..++.|+ +.||.|+|. ++|+||||||+||+++.++ .+|++|||+++....
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi-l~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-FRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHH-HHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHH-HHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            67777653   1      1124445577799999 999999998 9999999999999998775 789999999876543


Q ss_pred             CCceeeeccCCCCCceecccccccC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          71 ERNYYKATHGGRWPIKWYAPESYNF-GRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ....    ....++..|++||.+.+ ..++.++|+||+||+++++++ |..||...+
T Consensus       176 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~-g~~pf~~~~  227 (350)
T d1q5ka_         176 GEPN----VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDS  227 (350)
T ss_dssp             TSCC----CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-TSCSSCCSS
T ss_pred             Cccc----ccccccccccChHHhhcccCCCcceeecccceEEEehhh-CCCCCCCCC
Confidence            2211    11233456999998765 468999999999999999998 999997643

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=5.6e-26  Score=153.27  Aligned_cols=122  Identities=25%  Similarity=0.381  Sum_probs=94.5

Q ss_pred             CCCCCCCCccccCC------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce
Q psy7529           1 MKSPNGSGVVTPLG------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY   74 (129)
Q Consensus         1 m~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~   74 (129)
                      |||+.+++|...+.      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........
T Consensus       108 ~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi-~~al~~lH~-~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~  185 (322)
T d1vzoa_         108 LDYINGGELFTHLSQRERFTEHEVQIYVGEI-VLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE  185 (322)
T ss_dssp             ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG
T ss_pred             eecccccHHHHHHHhcccccHHHHHHHHHHH-HHHHHHhhc-CCEEeccCCccceeecCCCCEEEeeccchhhhcccccc
Confidence            78999998654433      23455688888 999999999 99999999999999999999999999998765432221


Q ss_pred             eeeccCCCCCceecccccccCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q psy7529          75 YKATHGGRWPIKWYAPESYNFG--RFSSASDVWSFGITLWEMYSFGQQPYGEMKG  127 (129)
Q Consensus        75 ~~~~~~~~~~~~~~~pe~~~~~--~~~~~~di~s~g~~l~~l~~~~~~pf~~~~~  127 (129)
                      .  .....+++.|++||.+...  .++.++|+||+||++|++++ |..||.+.+.
T Consensus       186 ~--~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt-G~~PF~~~~~  237 (322)
T d1vzoa_         186 R--AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPFTVDGE  237 (322)
T ss_dssp             G--GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH-SSCTTSCTTS
T ss_pred             c--ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh-CCCCCCCCCH
Confidence            1  1112234569999988654  35789999999999999999 9999987654

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=7e-26  Score=152.31  Aligned_cols=109  Identities=20%  Similarity=0.298  Sum_probs=86.5

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCce-eeeccCCCCCceecccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNY-YKATHGGRWPIKWYAPESY   93 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~   93 (129)
                      ......++.|+ +.|+.|+|. ++++||||||+||+++.++.++++|||+++........ ........+++.|+|||.+
T Consensus       116 ~~~~~~i~~qi-l~~l~~lH~-~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~  193 (318)
T d3blha1         116 LSEIKRVMQML-LNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL  193 (318)
T ss_dssp             HHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHH
T ss_pred             cHHHHHHHHHH-HHHHHHhcc-CCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHH
Confidence            34466788899 999999998 99999999999999999999999999999765432211 1111222346779999988


Q ss_pred             cCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          94 NFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        94 ~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .+. .++.++|+||+|++++++++ |..||.+.+
T Consensus       194 ~~~~~~~~k~DiwSlGvil~el~~-g~~pf~~~~  226 (318)
T d3blha1         194 LGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNT  226 (318)
T ss_dssp             TTCSSCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             cCCCCCCcHHHcccCCceeeeHhh-CCCCCCCCC
Confidence            655 68899999999999999999 999997643

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.9e-26  Score=154.78  Aligned_cols=120  Identities=40%  Similarity=0.672  Sum_probs=94.7

Q ss_pred             CCCCCCCCccccCC----------------------CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEE
Q psy7529           1 MKSPNGSGVVTPLG----------------------SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAK   58 (129)
Q Consensus         1 m~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~   58 (129)
                      |||++++++...+.                      ...+..++.|+ +.|+.|+|. ++++||||||+||+++.++.+|
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi-a~gl~~lH~-~~iiHrDlkp~NIL~~~~~~~k  167 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV-ARGMDYLSQ-KQFIHRDLAARNILVGENYVAK  167 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHH-HHHHHHHHH-TTEECSCCSGGGEEECGGGCEE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHH-HHHHHhhhc-CCccccccccceEEEcCCCceE
Confidence            79999999766542                      23456688999 999999999 9999999999999999999999


Q ss_pred             EEeecCcccccCCCceeeeccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          59 ISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        59 l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      ++|||+++.......    .....++..|++||.+....++.++|+||+|+++|++++.+.+||.+.+
T Consensus       168 l~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~  231 (309)
T d1fvra_         168 IADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  231 (309)
T ss_dssp             ECCTTCEESSCEECC----C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             Ecccccccccccccc----ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence            999999875432211    1122345679999999888899999999999999999983346787654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.92  E-value=7.1e-26  Score=150.35  Aligned_cols=108  Identities=27%  Similarity=0.403  Sum_probs=85.5

Q ss_pred             CCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccc
Q psy7529          13 LGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPES   92 (129)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~   92 (129)
                      +....+..++.|+ +.||.|+|. ++|+||||||+||+++.++.+|++|||.+...........   ...+++.|++||.
T Consensus        97 l~~~~~~~i~~qi-~~~L~~LH~-~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~---~~~~~~~y~~pE~  171 (286)
T d1ob3a_          97 LESVTAKSFLLQL-LNGIAYCHD-RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT---HEIVTLWYRAPDV  171 (286)
T ss_dssp             CCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------------CCCTTCCHHH
T ss_pred             cchhhhHHHHHHH-HHHHHHhcc-CcEEecCCCCceeeEcCCCCEEecccccceecccCccccc---eecccchhhhHHH
Confidence            4445677799999 999999998 8999999999999999999999999999876543322111   1123456999998


Q ss_pred             ccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          93 YNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        93 ~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      +... .++.++|+||+|++++++++ |..||.+.+
T Consensus       172 ~~~~~~~~~~~DiwslGv~l~el~~-G~~pf~~~~  205 (286)
T d1ob3a_         172 LMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVS  205 (286)
T ss_dssp             HTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             HhCCCCCCcceeehhcCcHHHHHHH-CCCCCCCCC
Confidence            8654 46899999999999999998 999997653

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=8.4e-25  Score=149.11  Aligned_cols=119  Identities=24%  Similarity=0.255  Sum_probs=90.3

Q ss_pred             CCCCCCCC---ccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeee
Q psy7529           1 MKSPNGSG---VVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKA   77 (129)
Q Consensus         1 m~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~   77 (129)
                      |||+.++.   +...+.....+.++.|+ +.|+.|+|. ++++|||+||+||+++.++.++++|||+++........   
T Consensus       101 ~Ey~~~~l~~~~~~~~~~~~i~~~~~qi-l~gl~~LH~-~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~---  175 (355)
T d2b1pa1         101 MELMDANLCQVIQMELDHERMSYLLYQM-LCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---  175 (355)
T ss_dssp             EECCSEEHHHHHTSCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC-------------
T ss_pred             EeccchHHHHhhhcCCCHHHHHHHHHHH-HHHHHHhhh-cccccccCCccccccccccceeeechhhhhcccccccc---
Confidence            57776654   33444455677899999 999999999 99999999999999999999999999988754332111   


Q ss_pred             ccCCCCCceecccccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          78 THGGRWPIKWYAPESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        78 ~~~~~~~~~~~~pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                       ....+++.|+|||.+.+..++.++|+||+||+++++++ |..||.+.+
T Consensus       176 -~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~-g~~pF~~~~  222 (355)
T d2b1pa1         176 -TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRD  222 (355)
T ss_dssp             ------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             -ccccccccccChhhhcCCCCCCCcccccccchHHHHhh-CCCCCCCCC
Confidence             11223457999999988889999999999999999998 999997543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=6e-24  Score=144.31  Aligned_cols=106  Identities=30%  Similarity=0.457  Sum_probs=88.0

Q ss_pred             cCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceecccc
Q psy7529          12 PLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPE   91 (129)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe   91 (129)
                      .+.......++.|+ +.||.|+|. ++++||||||+||+++.++.++++|||+++.......      ...+++.|+|||
T Consensus       117 ~l~~~~~~~~~~qi-~~aL~~LH~-~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~~------~~~~t~~y~aPE  188 (346)
T d1cm8a_         117 KLGEDRIQFLVYQM-LKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT------GYVVTRWYRAPE  188 (346)
T ss_dssp             CCCHHHHHHHHHHH-HHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCC------SSCSCGGGCCTH
T ss_pred             cccHHHHHHHHHHH-HHHHHHHHh-CCCcccccCcchhhcccccccccccccceeccCCccc------cccccccccCHH
Confidence            34455677799999 999999998 9999999999999999999999999999986543321      222356799999


Q ss_pred             cccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          92 SYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        92 ~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                      .+.+. .++.++|+||+|++++++++ |..||.+.+
T Consensus       189 ~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~  223 (346)
T d1cm8a_         189 VILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSD  223 (346)
T ss_dssp             HHHTTTCCCTTHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred             HHcCCCCCCccchhhcchHHHHHHHH-CcCCCCCCC
Confidence            88654 46889999999999999998 999997653

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=3.8e-24  Score=142.04  Aligned_cols=105  Identities=22%  Similarity=0.344  Sum_probs=83.8

Q ss_pred             CCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCceeeeccCCCCCceeccccccc
Q psy7529          15 SYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYYKATHGGRWPIKWYAPESYN   94 (129)
Q Consensus        15 ~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   94 (129)
                      ...+..++.|+ +.|+.|+|. ++++||||||+||+++..+.++++|||.++..........   ....+..|.+||.+.
T Consensus       100 ~~~~~~~~~q~-~~aL~~lH~-~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~---~~~~~~~~~~pe~~~  174 (292)
T d1unla_         100 PEIVKSFLFQL-LKGLGFCHS-RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS---AEVVTLWYRPPDVLF  174 (292)
T ss_dssp             HHHHHHHHHHH-HHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC---SCCSCGGGCCHHHHT
T ss_pred             hhHHHHHHHHH-HHHHHHhhc-CCEeeecccCcccccccCCceeeeecchhhcccCCCccce---eeccccchhhhhHhc
Confidence            34567789999 999999998 9999999999999999999999999999986543322111   112234588999876


Q ss_pred             CCC-CCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          95 FGR-FSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        95 ~~~-~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ... ++.++|+||+|++++++++ |..||.+.
T Consensus       175 ~~~~~~~~~DiwSlG~il~ell~-g~~p~~~~  205 (292)
T d1unla_         175 GAKLYSTSIDMWSAGCIFAELAN-AGRPLFPG  205 (292)
T ss_dssp             TCSCCCTHHHHHHHHHHHHHHTT-TSCCSCCC
T ss_pred             cCCCCCchhhccccchHHHHHhh-CCCCCCCC
Confidence            654 6889999999999999998 99887543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=1.5e-24  Score=147.29  Aligned_cols=117  Identities=23%  Similarity=0.360  Sum_probs=89.4

Q ss_pred             CCCCCCCCccccC-----CCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCcccccCCCcee
Q psy7529           1 MKSPNGSGVVTPL-----GSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVNSERNYY   75 (129)
Q Consensus         1 m~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~~~~~~~   75 (129)
                      |+++.+++|...+     ....+..++.|+ +.||.|+|. ++++||||||+||+++.++.++++|||++.......   
T Consensus       101 ~~~~~gg~L~~~~~~~~l~e~~~~~i~~qi-l~aL~~LH~-~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~---  175 (348)
T d2gfsa1         101 VTHLMGADLNNIVKCQKLTDDHVQFLIYQI-LRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---  175 (348)
T ss_dssp             EEECCSEEHHHHHTTCCCCHHHHHHHHHHH-HHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCC----CCTGGG---
T ss_pred             EEeecCCchhhhcccccccHHHHHHHHHHH-HHHHHHHHh-CCCcccccCCccccccccccccccccchhcccCccc---
Confidence            4566777765443     344567789999 999999998 999999999999999999999999999986543221   


Q ss_pred             eeccCCCCCceecccccccCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7529          76 KATHGGRWPIKWYAPESYNFG-RFSSASDVWSFGITLWEMYSFGQQPYGEMK  126 (129)
Q Consensus        76 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~di~s~g~~l~~l~~~~~~pf~~~~  126 (129)
                         ....++..|++||...+. .++.++|+||+|++++++++ |..||.+.+
T Consensus       176 ---~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~-g~~pF~~~~  223 (348)
T d2gfsa1         176 ---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD  223 (348)
T ss_dssp             ---SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHH-SSCSCCCSS
T ss_pred             ---ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHh-CCCCCCCCC
Confidence               122334669999987665 45789999999999999999 999997643

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.84  E-value=8.6e-22  Score=134.01  Aligned_cols=102  Identities=19%  Similarity=0.281  Sum_probs=81.7

Q ss_pred             CchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCC------cEEEEeecCcccccCCCceeeeccCCCCCceecc
Q psy7529          16 YALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRH------QAKISDFGLSRAVNSERNYYKATHGGRWPIKWYA   89 (129)
Q Consensus        16 ~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (129)
                      ..+..++.|+ +.|+.|+|...+|+||||||+||+++..+      .++++|||.+.......      ....+++.|+|
T Consensus       125 ~~i~~i~~qi-l~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~------~~~~gt~~y~a  197 (362)
T d1q8ya_         125 IYVKQISKQL-LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY------TNSIQTREYRS  197 (362)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC------CSCCSCGGGCC
T ss_pred             HHHHHHHHHH-HHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccccc------ccccccccccC
Confidence            3456688899 99999999767899999999999997654      38999999987543321      12223567999


Q ss_pred             cccccCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q psy7529          90 PESYNFGRFSSASDVWSFGITLWEMYSFGQQPYGEM  125 (129)
Q Consensus        90 pe~~~~~~~~~~~di~s~g~~l~~l~~~~~~pf~~~  125 (129)
                      ||.+....++.++|+||+|++++++++ |+.||...
T Consensus       198 PE~~~~~~~~~~~DiwSlG~il~el~~-g~~pF~~~  232 (362)
T d1q8ya_         198 PEVLLGAPWGCGADIWSTACLIFELIT-GDFLFEPD  232 (362)
T ss_dssp             HHHHHTCCCCTHHHHHHHHHHHHHHHH-SSCCC---
T ss_pred             hhhccccCCCccccccchHHHHHHHHH-CCCCCCCC
Confidence            999988889999999999999999999 99999754

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.36  E-value=3.7e-13  Score=83.74  Aligned_cols=65  Identities=18%  Similarity=0.151  Sum_probs=52.2

Q ss_pred             CCCCCCCCccccCCCCchhhHHhHHHHHHHHHHhccCCCccCCCCCCCEEecCCCcEEEEeecCccccc
Q psy7529           1 MKSPNGSGVVTPLGSYALPYIEGQIPAKVCRYLKMHKSSFHRDLAARNILLASRHQAKISDFGLSRAVN   69 (129)
Q Consensus         1 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~h~~~~~ihr~lk~~nil~~~~~~~~l~d~~~~~~~~   69 (129)
                      ||++++..+. .+.......++.|+ +.++.|+|. ++++|||+||+||+++.. .++++|||.++...
T Consensus        89 me~~~~~~~~-~l~~~~~~~i~~ql-~~~l~~lH~-~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~  153 (191)
T d1zara2          89 MELIDAKELY-RVRVENPDEVLDMI-LEEVAKFYH-RGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG  153 (191)
T ss_dssp             EECCCCEEGG-GCCCSCHHHHHHHH-HHHHHHHHH-TTEECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred             EEeecccccc-chhhHHHHHHHHHH-HHHHHHHhh-CCEEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence            6777765543 34555667788898 999999999 899999999999999864 58899999886543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=92.38  E-value=0.018  Score=36.93  Aligned_cols=30  Identities=20%  Similarity=0.329  Sum_probs=25.9

Q ss_pred             CCCccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          37 KSSFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        37 ~~~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      .++||.|+.++|++++.+....+.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            457999999999999987777899999764

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=89.12  E-value=0.097  Score=32.18  Aligned_cols=28  Identities=29%  Similarity=0.351  Sum_probs=23.6

Q ss_pred             CccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          39 SFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        39 ~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      ++|+|+.+.|++++......++||..+.
T Consensus       185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEeeccCcceeecCCceEEEeechhcc
Confidence            6899999999999876656799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=87.45  E-value=0.095  Score=32.07  Aligned_cols=28  Identities=21%  Similarity=0.221  Sum_probs=23.7

Q ss_pred             CccCCCCCCCEEecCCCcEEEEeecCcc
Q psy7529          39 SFHRDLAARNILLASRHQAKISDFGLSR   66 (129)
Q Consensus        39 ~ihr~lk~~nil~~~~~~~~l~d~~~~~   66 (129)
                      ++|+|+.+.|+++.....+.++||..+.
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            6899999999999876666799998764